Citrus Sinensis ID: 008201
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 574 | 2.2.26 [Sep-21-2011] | |||||||
| P0DH62 | 567 | Inactive protein kinase S | N/A | no | 0.639 | 0.647 | 0.411 | 7e-84 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.322 | 0.242 | 0.516 | 3e-52 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.341 | 0.300 | 0.497 | 2e-51 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.358 | 0.290 | 0.5 | 2e-51 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.344 | 0.312 | 0.478 | 5e-51 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.385 | 0.329 | 0.469 | 6e-51 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.324 | 0.258 | 0.513 | 5e-50 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.311 | 0.262 | 0.516 | 6e-50 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.310 | 0.248 | 0.530 | 1e-49 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.324 | 0.261 | 0.513 | 4e-49 |
| >sp|P0DH62|Y4407_SELML Inactive protein kinase SELMODRAFT_444075 OS=Selaginella moellendorffii GN=SELMODRAFT_444075 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 311 bits (798), Expect = 7e-84, Method: Compositional matrix adjust.
Identities = 194/471 (41%), Positives = 254/471 (53%), Gaps = 104/471 (22%)
Query: 106 QLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIV 165
+L ++D K++ ++I+ + G + +EAK+ +A WVVLD+ LK E K C++EL NIV
Sbjct: 5 KLRKIHDLKKVHTTLEILQFARRGVIPSEAKRFRATWVVLDRNLKSEGKLCLQELNSNIV 64
Query: 166 VMKRSQAKVLRLNLVGASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPV--VTPI 223
V+ RS K+LRLNL +++ LP D +ES DSSS + G V P
Sbjct: 65 VVHRSNPKILRLNL---KRRD------LPYDEEESI-------DSSSVLLNGLSLSVMPK 108
Query: 224 SSPELGTPFTATEAGTSSVSSSDPGTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDS 283
+L + + + SS S F +S + LK E+ S ++
Sbjct: 109 GFDQLYWESSTSSSEASSPDSRLVTAPKFELSVLEELLKNETR--------RKGPSPSEV 160
Query: 284 ENLSVSSASMRFQPWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRD 343
N + SS + + +FLR + E + R + +DR
Sbjct: 161 LNSTTSSPASHKPQVLNDFLRMKESREYTEETDTQRNVSRP---------------VDR- 204
Query: 344 AGVGMSSYRTDLEFSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELEL 403
+VR+ I L + + P PPPLCSICQHK PVFGKPPR F++AEL+L
Sbjct: 205 --------------VSSVRKQIHLRKQSSPQPPPLCSICQHKTPVFGKPPRKFTFAELQL 250
Query: 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN 463
ATGGFS NFLAEGG+GSV+RG LPDGQAVAVKQHKLAS+QGD EFC+EVEVLSCAQ RN
Sbjct: 251 ATGGFSDVNFLAEGGYGSVYRGRLPDGQAVAVKQHKLASTQGDKEFCAEVEVLSCAQQRN 310
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+VMLIG+C ED++RLLVYE++CNGSLDSHLYG R K
Sbjct: 311 LVMLIGYCAEDKKRLLVYEFVCNGSLDSHLYG---------RRSKT-------------- 347
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
VGDFGLARWQP+G++GVETRVIG FG
Sbjct: 348 -------------------------VGDFGLARWQPNGELGVETRVIGAFG 373
|
Selaginella moellendorffii (taxid: 88036) |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (525), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 96/186 (51%), Positives = 129/186 (69%), Gaps = 1/186 (0%)
Query: 389 FGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE 448
FG+ FSY EL +AT GFS N L EGGFG V++GVLPD + VAVKQ K+ QGD E
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
F +EV+ +S HRN++ ++G+CI + RRLL+Y+Y+ N +L HL+ L+W+ R K
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVK 530
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
IA GAARGL YLHE+C I+HRD++ +NILL ++F LV DFGLA+ D + + TR
Sbjct: 531 IAAGAARGLAYLHEDCH-PRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHITTR 589
Query: 569 VIGTFG 574
V+GTFG
Sbjct: 590 VMGTFG 595
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (518), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 101/203 (49%), Positives = 136/203 (66%), Gaps = 7/203 (3%)
Query: 372 PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQ 431
P PPP + V G F+Y EL AT GFS+AN L +GGFG VH+G+LP G+
Sbjct: 250 PVLPPPSPGL------VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGK 303
Query: 432 AVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491
VAVKQ K S QG+ EF +EVE++S HR++V LIG+C+ +RLLVYE++ N +L+
Sbjct: 304 EVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEF 363
Query: 492 HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551
HL+G + +EWS R KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V D
Sbjct: 364 HLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKVAD 422
Query: 552 FGLARWQPDGDMGVETRVIGTFG 574
FGLA+ D + V TRV+GTFG
Sbjct: 423 FGLAKIASDTNTHVSTRVMGTFG 445
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (517), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 104/208 (50%), Positives = 134/208 (64%), Gaps = 2/208 (0%)
Query: 367 LSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 426
+ +AP G Q ++ G FSY EL AT GFSQ N L EGGFG V++G+
Sbjct: 336 MQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGI 395
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
LPDG+ VAVKQ K+ QGD EF +EVE LS HR++V ++G CI RRLL+Y+Y+ N
Sbjct: 396 LPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSN 455
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
L HL+G + L+W+ R KIA GAARGL YLHE+C I+HRD++ +NILL +F+
Sbjct: 456 NDLYFHLHG-EKSVLDWATRVKIAAGAARGLAYLHEDCHP-RIIHRDIKSSNILLEDNFD 513
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFG 574
V DFGLAR D + + TRVIGTFG
Sbjct: 514 ARVSDFGLARLALDCNTHITTRVIGTFG 541
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (515), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 99/207 (47%), Positives = 139/207 (67%), Gaps = 9/207 (4%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
SR P P P ++ +K+ F+Y EL ATGGF+ AN L +GGFG VH+GVL
Sbjct: 252 SRPVLPPPSPALALGFNKS--------TFTYQELAAATGGFTDANLLGQGGFGYVHKGVL 303
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
P G+ VAVK K S QG+ EF +EV+++S HR +V L+G+CI D +R+LVYE++ N
Sbjct: 304 PSGKEVAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNK 363
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
+L+ HL+G + +E+S R +IA+GAA+GL YLHE+C I+HRD++ NILL +F+
Sbjct: 364 TLEYHLHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHP-RIIHRDIKSANILLDFNFDA 422
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFG 574
+V DFGLA+ D + V TRV+GTFG
Sbjct: 423 MVADFGLAKLTSDNNTHVSTRVMGTFG 449
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (514), Expect = 6e-51, Method: Compositional matrix adjust.
Identities = 109/232 (46%), Positives = 146/232 (62%), Gaps = 11/232 (4%)
Query: 344 AGVGMSSYRTDLEFSGNVREAISLS-RNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELE 402
AG G ++ SG +A +L+ R A P P +A G F+Y EL
Sbjct: 256 AGQGGGNWGPQQPVSGPHSDASNLTGRTAIPSP---------QAATLGHNQSTFTYDELS 306
Query: 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR 462
+AT GF+Q+N L +GGFG VH+GVLP G+ VAVK KL S QG+ EF +EV+++S HR
Sbjct: 307 IATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHR 366
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
++V L+G+CI +RLLVYE+I N +L+ HL+G + L+W R KIA+G+ARGL YLHE
Sbjct: 367 HLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHE 426
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+C I+HRD++ NILL FE V DFGLA+ D V TRV+GTFG
Sbjct: 427 DCHP-RIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTFG 477
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 199 bits (506), Expect = 5e-50, Method: Compositional matrix adjust.
Identities = 96/187 (51%), Positives = 126/187 (67%), Gaps = 1/187 (0%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
+ G FSY EL T GF++ N L EGGFG V++G L DG+ VAVKQ K S QGD
Sbjct: 351 ILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDR 410
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V L+G+CI D+ RLL+YEY+ N +L+ HL+G LEWS R
Sbjct: 411 EFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRV 470
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
+IA+G+A+GL YLHE+C I+HRD++ NILL ++E V DFGLAR V T
Sbjct: 471 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVST 529
Query: 568 RVIGTFG 574
RV+GTFG
Sbjct: 530 RVMGTFG 536
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 6e-50, Method: Compositional matrix adjust.
Identities = 94/182 (51%), Positives = 128/182 (70%), Gaps = 3/182 (1%)
Query: 395 WFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVE 454
WFSY EL T GFS+ N L EGGFG V++GVL DG+ VAVKQ K+ SQG+ EF +EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
++S HR++V L+G+CI ++ RLLVY+Y+ N +L HL+ + + W R ++A GAA
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAA 445
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGT 572
RG+ YLHE+C I+HRD++ +NILL + FE LV DFGLA+ + D+ V TRV+GT
Sbjct: 446 RGIAYLHEDCHP-RIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGT 504
Query: 573 FG 574
FG
Sbjct: 505 FG 506
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 95/179 (53%), Positives = 129/179 (72%), Gaps = 1/179 (0%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
F+Y EL AT GFS+AN L +GGFG V +G+L +G+ VAVKQ K SSQG+ EF +EV +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
+S HR++V L+G+CI D +RLLVYE++ N +L+ HL+G + +EWS+R KIAVG+A+
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
GL YLHE C I+HRD++ +NIL+ FE V DFGLA+ D + V TRV+GTFG
Sbjct: 462 GLSYLHENCNP-KIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 519
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 4e-49, Method: Compositional matrix adjust.
Identities = 96/187 (51%), Positives = 127/187 (67%), Gaps = 1/187 (0%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
V G F+Y EL T GFS+ N L EGGFG V++G L DG+ VAVKQ K+ S QGD
Sbjct: 333 VMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDR 392
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V L+G+CI D RLL+YEY+ N +L+ HL+G + LEW+ R
Sbjct: 393 EFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRV 452
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
+IA+G+A+GL YLHE+C I+HRD++ NILL +FE V DFGLA+ V T
Sbjct: 453 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVST 511
Query: 568 RVIGTFG 574
RV+GTFG
Sbjct: 512 RVMGTFG 518
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 574 | ||||||
| 255572979 | 754 | ATP binding protein, putative [Ricinus c | 0.991 | 0.754 | 0.846 | 0.0 | |
| 224128638 | 694 | predicted protein [Populus trichocarpa] | 0.980 | 0.811 | 0.843 | 0.0 | |
| 225442323 | 737 | PREDICTED: inactive protein kinase SELMO | 0.973 | 0.758 | 0.811 | 0.0 | |
| 449458185 | 751 | PREDICTED: tyrosine-protein kinase Lck-l | 0.993 | 0.758 | 0.808 | 0.0 | |
| 449531434 | 751 | PREDICTED: LOW QUALITY PROTEIN: tyrosine | 0.993 | 0.758 | 0.804 | 0.0 | |
| 356550454 | 698 | PREDICTED: LOW QUALITY PROTEIN: inactive | 0.980 | 0.806 | 0.802 | 0.0 | |
| 356556706 | 699 | PREDICTED: uncharacterized protein LOC10 | 0.980 | 0.805 | 0.792 | 0.0 | |
| 356526029 | 750 | PREDICTED: tyrosine-protein kinase Lck-l | 0.980 | 0.750 | 0.807 | 0.0 | |
| 356522578 | 750 | PREDICTED: inactive protein kinase SELMO | 0.980 | 0.750 | 0.798 | 0.0 | |
| 15231330 | 753 | protein kinase protein with adenine nucl | 0.994 | 0.758 | 0.764 | 0.0 |
| >gi|255572979|ref|XP_002527420.1| ATP binding protein, putative [Ricinus communis] gi|223533230|gb|EEF34986.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 956 bits (2472), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/574 (84%), Positives = 515/574 (89%), Gaps = 5/574 (0%)
Query: 3 MSGEVKKG-KQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSH 61
MS E K+G KQEKG SDVA KVVVAVKASKEIP+TALVWALTHVVQ GDCITLLVVVPSH
Sbjct: 1 MSREQKRGGKQEKGGSDVAVKVVVAVKASKEIPKTALVWALTHVVQAGDCITLLVVVPSH 60
Query: 62 SSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIK 121
S GR+ W FPRFAGDCASGHRKS SG SEQR DITDSCSQMILQLHDVYDPNKIN KIK
Sbjct: 61 SPGRKLWGFPRFAGDCASGHRKSHSGATSEQRCDITDSCSQMILQLHDVYDPNKINVKIK 120
Query: 122 IVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVG 181
IVSGSPCG+VAAEAK+A A WVVLDKQLKHEEK CMEELQCNIVVMKR+Q KVLRLNLVG
Sbjct: 121 IVSGSPCGSVAAEAKRALANWVVLDKQLKHEEKRCMEELQCNIVVMKRTQPKVLRLNLVG 180
Query: 182 ASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSS 241
SK EA A PLPS+ DE+ +K KNK+ SS SIRGPVVTP SSPELGTPFTATE GTSS
Sbjct: 181 TSK-EAESAIPLPSELDEAPDKQTKNKNDSSDSIRGPVVTPTSSPELGTPFTATEVGTSS 239
Query: 242 VSSSDPGTSPFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQPWMT 300
VSS DPGTSPFFIS N DLKKE S VI+E ++++SSSDTDSE+LS +SAS+RF+PW+
Sbjct: 240 VSS-DPGTSPFFISDTNADLKKEESLVIKEHGDVDESSSDTDSEHLSTASASLRFEPWIG 298
Query: 301 EFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGN 360
E L SH QSS MEE RRT+ QASTTKALLEKFS+LDR G+GMS+YRTD + SGN
Sbjct: 299 EILSSHIQSSRHMEEGPQRRTS-MAQASTTKALLEKFSKLDRQTGIGMSNYRTDSDLSGN 357
Query: 361 VREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFG 420
VREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFG
Sbjct: 358 VREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFG 417
Query: 421 SVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480
SVHRGVLPDGQAVAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLV
Sbjct: 418 SVHRGVLPDGQAVAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLV 477
Query: 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 540
YEYICNGSLDSHLYG H+EPLEWSARQ+IAVGAARGLRYLHEECRVGCIVHRDMRPNNIL
Sbjct: 478 YEYICNGSLDSHLYGRHREPLEWSARQRIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 537
Query: 541 LTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+THDFEPLVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 538 ITHDFEPLVGDFGLARWQPDGDTGVETRVIGTFG 571
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128638|ref|XP_002329053.1| predicted protein [Populus trichocarpa] gi|222839724|gb|EEE78047.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 948 bits (2451), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/568 (84%), Positives = 513/568 (90%), Gaps = 5/568 (0%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
KKGKQEKG SDVA KVVVAVKASKEIP+TALVWALTHVVQPGDCITLLVVVPSH+ GRR
Sbjct: 2 KKGKQEKGGSDVAVKVVVAVKASKEIPKTALVWALTHVVQPGDCITLLVVVPSHAPGRRL 61
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W FPRFA DCA+GHRKS SG S+QR DITDSCSQMILQLHDVYDPNKIN KIKIVSGSP
Sbjct: 62 WGFPRFAADCANGHRKSHSGATSDQRCDITDSCSQMILQLHDVYDPNKINVKIKIVSGSP 121
Query: 128 CGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
CGAV+AEAKKAQA WVVLDKQLKHEEK CMEELQCNIVVMKRSQAKVLRLNLVG SK E
Sbjct: 122 CGAVSAEAKKAQANWVVLDKQLKHEEKRCMEELQCNIVVMKRSQAKVLRLNLVGTSK-EP 180
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSDP 247
V P PS +E+ E+ KNK++SSGSIRGPVVTP SSPELGTPFT TEAGTSSVSS DP
Sbjct: 181 EVVGPSPSKLNEASEQHSKNKNNSSGSIRGPVVTPTSSPELGTPFTVTEAGTSSVSS-DP 239
Query: 248 GTSPFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSH 306
G SPFFIS NG+LKKE VI+E+R+L++SSSDTD+E+LS++S S+RF+PW+ E L SH
Sbjct: 240 GASPFFISETNGELKKEEPLVIKENRDLDESSSDTDTEHLSLAS-SLRFEPWVGELLGSH 298
Query: 307 HQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAIS 366
+SS +EE S+R+N Q STT+ALLEKFS+LDR G+GMS+YRTDL+ S NVREAIS
Sbjct: 299 IKSSRHVEES-SQRSNCMAQTSTTEALLEKFSKLDRQTGIGMSNYRTDLDLSVNVREAIS 357
Query: 367 LSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 426
LSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV
Sbjct: 358 LSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 417
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
LPDGQAVAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN
Sbjct: 418 LPDGQAVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 477
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
GSLDSHLYG H+EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+THDFE
Sbjct: 478 GSLDSHLYGHHREPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDFE 537
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFG 574
PLVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 538 PLVGDFGLARWQPDGDTGVETRVIGTFG 565
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442323|ref|XP_002280107.1| PREDICTED: inactive protein kinase SELMODRAFT_444075 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 945 bits (2443), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/573 (81%), Positives = 508/573 (88%), Gaps = 14/573 (2%)
Query: 3 MSGEVKKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHS 62
MS + K+GKQEK SS+ AEKVVVAVKAS+EIP+TALVWALTHVVQPGDCITLLVVVP+ S
Sbjct: 1 MSKDQKRGKQEK-SSEAAEKVVVAVKASREIPKTALVWALTHVVQPGDCITLLVVVPAQS 59
Query: 63 SGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKI 122
GR+ W FPRFAGDCASGHRKS SG SEQ+ +ITDSCSQMILQLHDVYDPNKIN KIKI
Sbjct: 60 PGRKLWGFPRFAGDCASGHRKSHSGASSEQKCEITDSCSQMILQLHDVYDPNKINVKIKI 119
Query: 123 VSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGA 182
VSGSPCGAV+ EAK+ +A WVVLDKQLKHEEKCCMEELQCNIVVMKRSQ KVLRLNLVG+
Sbjct: 120 VSGSPCGAVSGEAKRTEANWVVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGS 179
Query: 183 SKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSV 242
K E+ A EK K K+ S SIRGPVVTP SSPELGTPFTATE GTSSV
Sbjct: 180 PKMESETAS----------EKHSKTKNDSMKSIRGPVVTPSSSPELGTPFTATEVGTSSV 229
Query: 243 SSSDPGTSPFFISGINGDLKKE-SSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTE 301
SSSDPGTSPFF S +NGDLKKE SS +E+ +L++SSSDTD+ENLS SS S+ FQPWM
Sbjct: 230 SSSDPGTSPFFNSEVNGDLKKEESSHTKENLDLDESSSDTDNENLSPSS-SVGFQPWMAG 288
Query: 302 FLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNV 361
L SHHQSS +E+ S+++ +KTQ T+KALL+KFS++DRDA +GM +YR++L+FSGNV
Sbjct: 289 VLTSHHQSSQHIEQS-SKKSRDKTQPPTSKALLDKFSKIDRDARIGMMNYRSELDFSGNV 347
Query: 362 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 421
REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS
Sbjct: 348 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 407
Query: 422 VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481
VHRGVLPDGQAVAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIG+CIEDRRRLLVY
Sbjct: 408 VHRGVLPDGQAVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGYCIEDRRRLLVY 467
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
EYICNGSLDSHLYG H++PLEWSARQK+AVGAARGLRYLHEECRVGCIVHRDMRPNNIL+
Sbjct: 468 EYICNGSLDSHLYGRHRDPLEWSARQKVAVGAARGLRYLHEECRVGCIVHRDMRPNNILI 527
Query: 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
THDFEPLVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 528 THDFEPLVGDFGLARWQPDGDTGVETRVIGTFG 560
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458185|ref|XP_004146828.1| PREDICTED: tyrosine-protein kinase Lck-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2433), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/573 (80%), Positives = 505/573 (88%), Gaps = 3/573 (0%)
Query: 3 MSGEVKKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHS 62
MS ++K+GKQ+KGS DV +KV+VAVKASKEIP+TALVWALTHVVQ GDCITLLVVVPS S
Sbjct: 1 MSRDLKRGKQDKGSDDV-QKVIVAVKASKEIPKTALVWALTHVVQIGDCITLLVVVPSQS 59
Query: 63 SGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKI 122
SGR+FW FPRFAGDCASGH+K+ SGT SE + DITDSCSQMILQLHDVYDPNKIN KIKI
Sbjct: 60 SGRKFWGFPRFAGDCASGHKKAHSGTSSELKCDITDSCSQMILQLHDVYDPNKINVKIKI 119
Query: 123 VSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGA 182
VSGSP GAVAAEAK+AQA WVVLDKQLKHEEKCCMEELQCNIVVMKRSQ KVLRLNLVG+
Sbjct: 120 VSGSPSGAVAAEAKRAQASWVVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGS 179
Query: 183 SKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSV 242
KKE V P PSD E E K + IRGPVVTP SSPELGTPFTATEAGTSSV
Sbjct: 180 PKKEPEVPSPSPSDIYEGSESHQKENNDPLDFIRGPVVTPSSSPELGTPFTATEAGTSSV 239
Query: 243 SSSDPGTSPFFISGINGDLKKES-SVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTE 301
SSSDPGTSPFF S +NGD KKE VI+E++ L+ +SSD+D ENLSVSSAS+RFQPWMTE
Sbjct: 240 SSSDPGTSPFFNSEMNGDTKKEELFVIKENKELDAASSDSDIENLSVSSASLRFQPWMTE 299
Query: 302 FLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNV 361
FL SH QSS + S+R +++ QAST + L K S+LDR++ +GMSS+R+D +F G+V
Sbjct: 300 FLSSHLQSSQHISGR-SQRCDDRNQASTRNSFLLKSSKLDRESSIGMSSHRSDNDFHGDV 358
Query: 362 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 421
R+A+SLSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGG+GS
Sbjct: 359 RDAVSLSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGYGS 418
Query: 422 VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481
VHRGVLPDGQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIE++RRLLVY
Sbjct: 419 VHRGVLPDGQVVAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEEKRRLLVY 478
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
EYICNGSLDSHLYG QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+
Sbjct: 479 EYICNGSLDSHLYGRQQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILI 538
Query: 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
THDFEPLVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 539 THDFEPLVGDFGLARWQPDGDTGVETRVIGTFG 571
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531434|ref|XP_004172691.1| PREDICTED: LOW QUALITY PROTEIN: tyrosine-protein kinase Lck-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2421), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/573 (80%), Positives = 503/573 (87%), Gaps = 3/573 (0%)
Query: 3 MSGEVKKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHS 62
MS ++K+GKQ+KGS DV +KV+VAVKASKEIP+TALVWALTHVVQ GDCITLLVVVPS S
Sbjct: 1 MSRDLKRGKQDKGSDDV-QKVIVAVKASKEIPKTALVWALTHVVQIGDCITLLVVVPSQS 59
Query: 63 SGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKI 122
S R+FW FPRFAGDCASGH+K+ SGT SE + DITDSCSQMILQLHDVYDPNKIN KIKI
Sbjct: 60 SDRKFWGFPRFAGDCASGHKKAHSGTSSELKCDITDSCSQMILQLHDVYDPNKINVKIKI 119
Query: 123 VSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGA 182
VSGSP GAVAAEAK+AQA WVVLDKQLKHEEKCCMEELQCNIVVMKRSQ KVLRLNLVG+
Sbjct: 120 VSGSPSGAVAAEAKRAQASWVVLDKQLKHEEKCCMEELQCNIVVMKRSQPKVLRLNLVGS 179
Query: 183 SKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSV 242
KKE V P PSD E K K + IRGPVVTP SSPELGTPFTATEAGTSSV
Sbjct: 180 PKKEPEVPSPSPSDIYEGSXKHQKENNDPLDFIRGPVVTPSSSPELGTPFTATEAGTSSV 239
Query: 243 SSSDPGTSPFFISGINGDLKKES-SVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTE 301
SSSDPGTSPFF S +NGD KKE VI+E++ L+ +SSD+D ENLS SSAS+RFQPWMTE
Sbjct: 240 SSSDPGTSPFFNSEMNGDTKKEELFVIKENKELDAASSDSDIENLSASSASLRFQPWMTE 299
Query: 302 FLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNV 361
FL SH QSS + S+R +++ QAST + L K S+LDR++ +GMSS+R+D +F G+V
Sbjct: 300 FLSSHLQSSQHISGR-SQRCDDRNQASTRNSFLLKSSKLDRESSIGMSSHRSDNDFHGDV 358
Query: 362 REAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGS 421
R+A+SLSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGG+GS
Sbjct: 359 RDAVSLSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGYGS 418
Query: 422 VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481
VHRGVLPDGQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIE++RRLLVY
Sbjct: 419 VHRGVLPDGQVVAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEEKRRLLVY 478
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
EYICNGSLDSHLYG QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL+
Sbjct: 479 EYICNGSLDSHLYGRQQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILI 538
Query: 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
THDFEPLVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 539 THDFEPLVGDFGLARWQPDGDTGVETRVIGTFG 571
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550454|ref|XP_003543602.1| PREDICTED: LOW QUALITY PROTEIN: inactive protein kinase SELMODRAFT_444075-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2420), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/568 (80%), Positives = 501/568 (88%), Gaps = 5/568 (0%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D AEKV+VAVKASKEIP+TALVW+LTHVVQPGDCITLLVVVPS S+GRR
Sbjct: 8 KRGKQEKGS-DGAEKVIVAVKASKEIPKTALVWSLTHVVQPGDCITLLVVVPSQSAGRRL 66
Query: 68 WVFPRFAGDCASGHRK-SFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGS 126
W FPRFAGDCA+G +K + + SE + DITDSCSQMILQLHDVYDPNKIN KIKIVSGS
Sbjct: 67 WGFPRFAGDCANGQKKSTSGSSSSEHKSDITDSCSQMILQLHDVYDPNKINVKIKIVSGS 126
Query: 127 PCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKE 186
PCGAVAAEAKK+QA WVVLDKQLKHEEK CMEELQCNIVVMKRSQ KVLRLNLVG KK+
Sbjct: 127 PCGAVAAEAKKSQANWVVLDKQLKHEEKQCMEELQCNIVVMKRSQPKVLRLNLVGTQKKD 186
Query: 187 AGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSD 246
CPLPS+ +E K K K+ S SI+GPVVTP SSPELGTPFT TEAGTSSVSSSD
Sbjct: 187 FEELCPLPSEQNEMPGKQIKKKNDSLNSIKGPVVTPTSSPELGTPFTTTEAGTSSVSSSD 246
Query: 247 PGTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSH 306
GTSPFFIS +NG+ KKE + I+E+ L+DS SDTDSENLS SS S+RFQPW+T+ L
Sbjct: 247 QGTSPFFISEMNGESKKEET-IKENPELDDSISDTDSENLSTSSTSLRFQPWITDLLL-- 303
Query: 307 HQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAIS 366
HQ S Q +EE + R+ N+ Q+STT+ALLEKFSRLDR+A + +S+Y+TD +FSGNVREA++
Sbjct: 304 HQQSSQPKEERTERSYNRLQSSTTRALLEKFSRLDREAEIEISTYKTDYDFSGNVREAVA 363
Query: 367 LSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 426
LSRN PPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGF +ANFLAEGGFGSVHRG+
Sbjct: 364 LSRNTPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFXKANFLAEGGFGSVHRGL 423
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
LPDGQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYICN
Sbjct: 424 LPDGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYICN 483
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
GSLDSHLYG EPLEWSARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THDFE
Sbjct: 484 GSLDSHLYGRQPEPLEWSARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHDFE 543
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFG 574
PLVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 544 PLVGDFGLARWQPDGDTGVETRVIGTFG 571
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556706|ref|XP_003546664.1| PREDICTED: uncharacterized protein LOC100804766 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2369), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/570 (79%), Positives = 496/570 (87%), Gaps = 7/570 (1%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D AEKV+VAVKASKEIP+TALVW+LTHVVQPGDCITLLVVVPS S+GRR
Sbjct: 7 KRGKQEKGS-DGAEKVIVAVKASKEIPKTALVWSLTHVVQPGDCITLLVVVPSQSTGRRL 65
Query: 68 WVFPRFAGDCASGHRK-SFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGS 126
W FPRFAGDCA+G +K + + SE + DITDSCSQMILQLHDVYDPNKIN KIKIVSGS
Sbjct: 66 WGFPRFAGDCANGQKKSTSGSSSSEHKSDITDSCSQMILQLHDVYDPNKINVKIKIVSGS 125
Query: 127 PCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKE 186
PCGAVAAEAKK+QA WVVLDKQLKHEEK CMEELQCNIVVMK SQ KVLRLNLVG KK+
Sbjct: 126 PCGAVAAEAKKSQANWVVLDKQLKHEEKQCMEELQCNIVVMKHSQPKVLRLNLVGTQKKD 185
Query: 187 AGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSD 246
CPL S+ E K K K S SI+GPVVTP SSPELGTPFT EAGTSSVSSSD
Sbjct: 186 FEELCPLLSEQIEMPGKQTKKKHDSLNSIKGPVVTPTSSPELGTPFTTIEAGTSSVSSSD 245
Query: 247 PGTSPFFISGIN--GDLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLR 304
GTSPFFIS +N G+ KKE ++I E+ L+DS SDTDSENLS SSAS+RFQPW+T+ L
Sbjct: 246 QGTSPFFISEMNGGGESKKEETII-ENPELDDSISDTDSENLSTSSASLRFQPWITDLLL 304
Query: 305 SHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREA 364
HQ S Q +EE + R+ NK Q+ST +ALLEKFSRLDR+A + +S+Y+TD FSGNVREA
Sbjct: 305 --HQRSSQPKEERTERSYNKLQSSTARALLEKFSRLDREAEIELSTYKTDFNFSGNVREA 362
Query: 365 ISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHR 424
++LSRN PPGPPPLCSICQHKAPVFGKPP+WFSYAELELATGGFS+ANFLAEGGFGSVHR
Sbjct: 363 VALSRNTPPGPPPLCSICQHKAPVFGKPPKWFSYAELELATGGFSKANFLAEGGFGSVHR 422
Query: 425 GVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484
G+LPDGQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYI
Sbjct: 423 GLLPDGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYI 482
Query: 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544
CN SLDSHLYG +EPLEW+ARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THD
Sbjct: 483 CNRSLDSHLYGRQREPLEWTARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHD 542
Query: 545 FEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
FEPLVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 543 FEPLVGDFGLARWQPDGDTGVETRVIGTFG 572
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526029|ref|XP_003531622.1| PREDICTED: tyrosine-protein kinase Lck-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2365), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/567 (80%), Positives = 499/567 (88%), Gaps = 4/567 (0%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D EKV+VAVKASKEIP+TALVW+L+HVVQPGDCITLLVVVPS SSGRR
Sbjct: 7 KRGKQEKGS-DGVEKVIVAVKASKEIPKTALVWSLSHVVQPGDCITLLVVVPSQSSGRRL 65
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W FPRFAGDCASG +K GTISEQ+ DITDSCSQMILQLH+VYDPNKIN +IKIVSGSP
Sbjct: 66 WGFPRFAGDCASGIKKYPPGTISEQKSDITDSCSQMILQLHNVYDPNKINVRIKIVSGSP 125
Query: 128 CGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
CGAVAAEAKKAQA WVVLDKQLKHEEK CMEELQCNIVVMKRSQ KVLRLNL+G KKE
Sbjct: 126 CGAVAAEAKKAQANWVVLDKQLKHEEKRCMEELQCNIVVMKRSQPKVLRLNLIGPQKKEV 185
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSDP 247
A P PS+ D+ E K K S SI+GP VTP SSPELGTPFTATEAGTSSVSSSDP
Sbjct: 186 EEAGPSPSEQDDMPENRTKIKLDSLNSIKGPAVTPTSSPELGTPFTATEAGTSSVSSSDP 245
Query: 248 GTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSHH 307
GTSPFFIS +NG+ KKE + I+E + L D++SDT+SE+LS SSASMR+QPW+TE L H
Sbjct: 246 GTSPFFISEMNGEFKKEET-IKESQELVDTNSDTESESLSTSSASMRYQPWITELLL--H 302
Query: 308 QSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAISL 367
Q S Q EE S ++ QASTT+A LEK+SRLDR AG +S+YR D++FSGN+REAI+L
Sbjct: 303 QPSTQCNEERSEMSHGMPQASTTRAFLEKYSRLDRGAGFEISTYRNDMDFSGNLREAIAL 362
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S NAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL
Sbjct: 363 SGNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 422
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
P+GQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYICNG
Sbjct: 423 PEGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYICNG 482
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SLDSHLYG ++PLEWSARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THDFEP
Sbjct: 483 SLDSHLYGRQRDPLEWSARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHDFEP 542
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFG 574
LVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 543 LVGDFGLARWQPDGDTGVETRVIGTFG 569
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522578|ref|XP_003529923.1| PREDICTED: inactive protein kinase SELMODRAFT_444075-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/567 (79%), Positives = 498/567 (87%), Gaps = 4/567 (0%)
Query: 8 KKGKQEKGSSDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
K+GKQEKGS D AEKV+VAVKASKEIP+TALVW+L+HVVQPGDCITLLVVVPS SSGRR
Sbjct: 7 KRGKQEKGS-DGAEKVIVAVKASKEIPKTALVWSLSHVVQPGDCITLLVVVPSQSSGRRL 65
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W FPRFAGDCASG +K GTISEQ+ D+TDSCSQMILQLH+VYDPNKIN +IKIVSGSP
Sbjct: 66 WGFPRFAGDCASGIKKYPPGTISEQKSDLTDSCSQMILQLHNVYDPNKINVRIKIVSGSP 125
Query: 128 CGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
CGAVAAEAKK QA WVVLDKQLKHEEK CMEELQCNIVVMKRSQ KVLRLNL+G KK+
Sbjct: 126 CGAVAAEAKKTQANWVVLDKQLKHEEKRCMEELQCNIVVMKRSQPKVLRLNLIGPQKKDV 185
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAGTSSVSSSDP 247
A P PS+ D+ E K K S SI+GP VTP SSPELGTPFTATEAGTSSVSSSDP
Sbjct: 186 EEAGPSPSEQDDMPENRTKIKLDSLNSIKGPTVTPTSSPELGTPFTATEAGTSSVSSSDP 245
Query: 248 GTSPFFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSSASMRFQPWMTEFLRSHH 307
GTSPFFIS +NG+ KKE + I+E + L D++SDT+SE+LS SSASMR+QPW+TE L H
Sbjct: 246 GTSPFFISEMNGEFKKEET-IKESQELVDTNSDTESESLSTSSASMRYQPWITELLL--H 302
Query: 308 QSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAISL 367
Q S Q EE S ++ QASTT+A LEK+SRLDR AG +S+YR D++FSGN+REAI+L
Sbjct: 303 QQSSQRNEERSDISHGIPQASTTRAFLEKYSRLDRGAGFEISTYRNDMDFSGNLREAIAL 362
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S NAPPGPPPLCSICQHKAPVFGKPPRWF+Y+ELELATGGFSQANFLAEGGFGSVHRGVL
Sbjct: 363 SGNAPPGPPPLCSICQHKAPVFGKPPRWFTYSELELATGGFSQANFLAEGGFGSVHRGVL 422
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
P+GQ +AVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED+RRLLVYEYICNG
Sbjct: 423 PEGQVIAVKQHKLASSQGDLEFCSEVEVLSCAQHRNVVMLIGFCIEDKRRLLVYEYICNG 482
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SLDSHLYG ++ LEWSARQKIAVGAARGLRYLHEECRVGCI+HRDMRPNNIL+THDFEP
Sbjct: 483 SLDSHLYGRQRDTLEWSARQKIAVGAARGLRYLHEECRVGCIIHRDMRPNNILITHDFEP 542
Query: 548 LVGDFGLARWQPDGDMGVETRVIGTFG 574
LVGDFGLARWQPDGD GVETRVIGTFG
Sbjct: 543 LVGDFGLARWQPDGDTGVETRVIGTFG 569
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231330|ref|NP_187982.1| protein kinase protein with adenine nucleotide alpha hydrolases-like domain-containing protein [Arabidopsis thaliana] gi|9294015|dbj|BAB01918.1| unnamed protein product [Arabidopsis thaliana] gi|332641878|gb|AEE75399.1| protein kinase protein with adenine nucleotide alpha hydrolases-like domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2322), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/578 (76%), Positives = 497/578 (85%), Gaps = 7/578 (1%)
Query: 3 MSGEVKKGKQEKGS-SDVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSH 61
MS K+GKQEK SD A+KV+VAVKAS+EIP+TAL+WALTHVVQPGDCITL+VVVPSH
Sbjct: 1 MSRLQKRGKQEKPVVSDGAQKVIVAVKASREIPKTALIWALTHVVQPGDCITLIVVVPSH 60
Query: 62 SSGRRFW----VFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKIN 117
+SGR+ W FP FAGDCASGHRKS S + E + D+TD+CSQMILQLHDVYDPNKIN
Sbjct: 61 NSGRKLWGFTKSFPMFAGDCASGHRKSHSEALPEIKSDLTDTCSQMILQLHDVYDPNKIN 120
Query: 118 FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRL 177
KIKIVSGSPCGAVAAE+KKAQA WVV+DK LK EEK CM+ELQCNIVVMKRSQAKVLRL
Sbjct: 121 VKIKIVSGSPCGAVAAESKKAQANWVVMDKHLKQEEKRCMDELQCNIVVMKRSQAKVLRL 180
Query: 178 NLVGASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEA 237
NLVG+ KK+AG CPLPS P+ + EK KN + RG VTP SSPELGTPFT+TEA
Sbjct: 181 NLVGSPKKDAGKECPLPSGPEAASEKHSKNTKGLLDADRGLPVTPTSSPELGTPFTSTEA 240
Query: 238 GTSSVSSSDPGTSPFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQ 296
GTSSVSSSD GTSPFF G+NG +KK+ + VI+E+ L+DS S+T+SEN S++S SMRFQ
Sbjct: 241 GTSSVSSSDLGTSPFFTLGMNGYMKKDGALVIKENDGLDDSGSETESENQSLASTSMRFQ 300
Query: 297 PWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLE 356
PW++E++ +H SS + EE + +++ Q STTKALLEKFS+LD + G+ SS R DLE
Sbjct: 301 PWISEYIGTHRHSSQEAEESLLWKNDDRAQISTTKALLEKFSKLDVEVGLS-SSRRMDLE 359
Query: 357 FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAE 416
FSGNVR+AISLSR+APPGPPPLCSICQHKAPVFGKPPR F+YAELELATGGFSQANFLAE
Sbjct: 360 FSGNVRDAISLSRSAPPGPPPLCSICQHKAPVFGKPPRLFTYAELELATGGFSQANFLAE 419
Query: 417 GGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476
GG+GSVHRGVLP+GQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED R
Sbjct: 420 GGYGSVHRGVLPEGQVVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSR 479
Query: 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536
RLLVYEYICNGSLDSHLYG +E LEW ARQKIAVGAARGLRYLHEECRVGCIVHRDMRP
Sbjct: 480 RLLVYEYICNGSLDSHLYGRQKETLEWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 539
Query: 537 NNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
NNIL+THD EPLVGDFGLARWQPDG+MGV+TRVIGTFG
Sbjct: 540 NNILITHDNEPLVGDFGLARWQPDGEMGVDTRVIGTFG 577
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 574 | ||||||
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.994 | 0.758 | 0.704 | 2.2e-217 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.961 | 0.825 | 0.541 | 1.2e-152 | |
| TAIR|locus:2035686 | 676 | AT1G55200 [Arabidopsis thalian | 0.672 | 0.571 | 0.637 | 2e-127 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.365 | 0.3 | 0.452 | 8.9e-52 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.358 | 0.290 | 0.5 | 8.7e-51 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.351 | 0.312 | 0.486 | 1.4e-50 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.322 | 0.242 | 0.516 | 5e-50 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.324 | 0.285 | 0.518 | 7.7e-50 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.311 | 0.262 | 0.516 | 1.3e-49 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.404 | 0.322 | 0.445 | 6e-49 |
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2100 (744.3 bits), Expect = 2.2e-217, P = 2.2e-217
Identities = 407/578 (70%), Positives = 458/578 (79%)
Query: 3 MSGEVKKGKQEKGXXXXXXXXXXXXXXXXX-IPRTALVWALTHVVQPGDCITLLVVVPSH 61
MS K+GKQEK IP+TAL+WALTHVVQPGDCITL+VVVPSH
Sbjct: 1 MSRLQKRGKQEKPVVSDGAQKVIVAVKASREIPKTALIWALTHVVQPGDCITLIVVVPSH 60
Query: 62 SSGRRFW----VFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKIN 117
+SGR+ W FP FAGDCASGHRKS S + E + D+TD+CSQMILQLHDVYDPNKIN
Sbjct: 61 NSGRKLWGFTKSFPMFAGDCASGHRKSHSEALPEIKSDLTDTCSQMILQLHDVYDPNKIN 120
Query: 118 FKIKIVSGSPCGXXXXXXXXXXXGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRL 177
KIKIVSGSPCG WVV+DK LK EEK CM+ELQCNIVVMKRSQAKVLRL
Sbjct: 121 VKIKIVSGSPCGAVAAESKKAQANWVVMDKHLKQEEKRCMDELQCNIVVMKRSQAKVLRL 180
Query: 178 NLVGASKKEAGVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEA 237
NLVG+ KK+AG CPLPS P+ + EK KN + RG VTP SSPELGTPFT+TEA
Sbjct: 181 NLVGSPKKDAGKECPLPSGPEAASEKHSKNTKGLLDADRGLPVTPTSSPELGTPFTSTEA 240
Query: 238 XXXXXXXXXXXXXXFFISGINGDLKKESS-VIREDRNLEDSSSDTDSENLSVSSASMRFQ 296
FF G+NG +KK+ + VI+E+ L+DS S+T+SEN S++S SMRFQ
Sbjct: 241 GTSSVSSSDLGTSPFFTLGMNGYMKKDGALVIKENDGLDDSGSETESENQSLASTSMRFQ 300
Query: 297 PWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLE 356
PW++E++ +H SS + EE + +++ Q STTKALLEKFS+LD + G+ SS R DLE
Sbjct: 301 PWISEYIGTHRHSSQEAEESLLWKNDDRAQISTTKALLEKFSKLDVEVGLS-SSRRMDLE 359
Query: 357 FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAE 416
FSGNVR+AISLSR+APPGPPPLCSICQHKAPVFGKPPR F+YAELELATGGFSQANFLAE
Sbjct: 360 FSGNVRDAISLSRSAPPGPPPLCSICQHKAPVFGKPPRLFTYAELELATGGFSQANFLAE 419
Query: 417 GGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476
GG+GSVHRGVLP+GQ VAVKQHKLASSQGD EFCSEVEVLSCAQHRNVVMLIGFCIED R
Sbjct: 420 GGYGSVHRGVLPEGQVVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSR 479
Query: 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536
RLLVYEYICNGSLDSHLYG +E LEW ARQKIAVGAARGLRYLHEECRVGCIVHRDMRP
Sbjct: 480 RLLVYEYICNGSLDSHLYGRQKETLEWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 539
Query: 537 NNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
NNIL+THD EPLVGDFGLARWQPDG+MGV+TRVIGTFG
Sbjct: 540 NNILITHDNEPLVGDFGLARWQPDGEMGVDTRVIGTFG 577
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 1.2e-152, P = 1.2e-152
Identities = 308/569 (54%), Positives = 378/569 (66%)
Query: 8 KKGKQEKGXXXXXXXXXXXXXXXXXIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRF 67
+KG +E+G IP+ AL+W LTHVVQPGD I LLVVVPS+ + ++
Sbjct: 3 QKGFKERGVVVGKKVMVAVRASKE-IPKAALLWTLTHVVQPGDRIRLLVVVPSNYTSKKI 61
Query: 68 WVFPRFAGDCASGHRKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSP 127
W F RF DCASG+ + +GT S+++ DI +SCSQM+ QLH+VYD KIN +IKIV S
Sbjct: 62 WGFSRFTSDCASGYGRFLAGTNSDRKDDIHESCSQMMFQLHNVYDAEKINVRIKIVFASL 121
Query: 128 CGXXXXXXXXXXXGWVVLDKQLKHEEKCCMEELQCNIVVMKRSQAKVLRLNLVGASKKEA 187
G WV+LD+ LK+E+KCC+E+L+CN+VV+K+SQ KVLRLNLV K A
Sbjct: 122 DGVIAAEAKKSNSNWVILDRGLKYEKKCCIEQLECNLVVIKKSQPKVLRLNLV----KNA 177
Query: 188 GVACPLPSDPDESFEKDPKNKDSSSGSIRGPVVTPISSPELGTPFTATEAXXXXXXXXXX 247
P S + + + +R P VTP SSP+ + T+
Sbjct: 178 DTEHPEAISRLASKSVESRRSSRTGKKLREPFVTPASSPDQEVS-SHTDIGTSSISSSDA 236
Query: 248 XXXXFFISGINGDLKKESSVIRE-DRNLEDSSSDTDSENLS-VSSASMRFQPWMTEFLRS 305
F S + LKKE+ + + ++ +S SD+D E S +S AS P T L S
Sbjct: 237 GASPFLASRVFEGLKKENLWVNDGSKSFFESDSDSDGEKWSPLSMASSSSHPVTTADLLS 296
Query: 306 HHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAI 365
+ E R K++ + + L SR + +AG + + D + +VRE +
Sbjct: 297 PSGDLSKAHTETPR----KSRFAVLRLAL---SRKEPEAGKEIR--KPDSCLNKSVREVV 347
Query: 366 SLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRG 425
SLSR PGPPPLC+ICQHKAP FG PPRWF+Y+ELE AT GFS+ +FLAEGGFGSVH G
Sbjct: 348 SLSRKPAPGPPPLCTICQHKAPKFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLG 407
Query: 426 VLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485
LPDGQ +AVKQ+K+AS+QGD EFCSEVEVLSCAQHRNVVMLIG C+ED +RLLVYEYIC
Sbjct: 408 TLPDGQIIAVKQYKIASTQGDREFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYIC 467
Query: 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
NGSL SHLYG +EPL WSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF
Sbjct: 468 NGSLHSHLYGMGREPLGWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 527
Query: 546 EPLVGDFGLARWQPDGDMGVETRVIGTFG 574
EPLVGDFGLARWQP+GD GVETRVIGTFG
Sbjct: 528 EPLVGDFGLARWQPEGDKGVETRVIGTFG 556
|
|
| TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 258/405 (63%), Positives = 300/405 (74%)
Query: 175 LRLNLVGASKKEAGVACP--LPSDPDESFEKDPKNKDSSSGSIRGPVVT-PISSPELGTP 231
L+ N+V + EA V + S E KNK+ S++ V T P+SSPE+ T
Sbjct: 155 LQCNIVAMKRSEAKVLRLNLVGSSTKEPELASEKNKNRLLDSVKAVVTTTPMSSPEVETS 214
Query: 232 FTATEAXXXXXXXXXXXXXX-FFISGINGDLKKESSVIREDRNLEDSSSDTDSENLSVSS 290
FT TEA F + + D E+ V++E+ +S SD++SENLS+ S
Sbjct: 215 FTGTEAWTSSVSSSDLGTSSPVFTAEVRKD---ETLVVKEN----ESDSDSESENLSLPS 267
Query: 291 ASMRFQPWMTEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSS 350
S RFQPW++E+L +H S +E +R + Q ST KALLEK S+LD MSS
Sbjct: 268 LSKRFQPWISEYLSTHCVSM----QESTRGDDKAVQVSTKKALLEKISKLDEGEEAAMSS 323
Query: 351 YRTDLE-FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFS 409
R DLE +SG +R +LSRNAPP PPLCSICQHKAPVFGKPPR+FSY ELELAT GFS
Sbjct: 324 KRKDLEEYSGTLR---ALSRNAPPVSPPLCSICQHKAPVFGKPPRFFSYKELELATNGFS 380
Query: 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ANFLAEGGFGSVHRGVLP+GQ VAVKQHK+AS+QGD EFCSEVEVLSCAQHRNVVMLIG
Sbjct: 381 RANFLAEGGFGSVHRGVLPEGQIVAVKQHKVASTQGDVEFCSEVEVLSCAQHRNVVMLIG 440
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
FCIED RRLLVYEYICNGSLDSHLYG H++ L W ARQKIAVGAARGLRYLHEECRVGCI
Sbjct: 441 FCIEDTRRLLVYEYICNGSLDSHLYGRHKDTLGWPARQKIAVGAARGLRYLHEECRVGCI 500
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
VHRDMRPNNIL+THD+EPLVGDFGLARWQPDG++GV+TRVIGTFG
Sbjct: 501 VHRDMRPNNILITHDYEPLVGDFGLARWQPDGELGVDTRVIGTFG 545
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 8.9e-52, Sum P(3) = 8.9e-52
Identities = 99/219 (45%), Positives = 140/219 (63%)
Query: 358 SGNVREAISLSRNAPPGP--PPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLA 415
+GN + S + + P GP PP H + G F+Y EL AT GFSQ+ L
Sbjct: 291 NGNSSD-FSSNYSGPHGPSVPP-----PHPSVALGFNKSTFTYDELAAATQGFSQSRLLG 344
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475
+GGFG VH+G+LP+G+ +AVK K S QG+ EF +EV+++S HR +V L+G+CI
Sbjct: 345 QGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGG 404
Query: 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR 535
+R+LVYE++ N +L+ HL+G + L+W R KIA+G+A+GL YLHE+C I+HRD++
Sbjct: 405 QRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALGSAKGLAYLHEDCHPR-IIHRDIK 463
Query: 536 PNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+NILL FE V DFGLA+ D V TR++GTFG
Sbjct: 464 ASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGTFG 502
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 8.7e-51, Sum P(2) = 8.7e-51
Identities = 104/208 (50%), Positives = 134/208 (64%)
Query: 367 LSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV 426
+ +AP G Q ++ G FSY EL AT GFSQ N L EGGFG V++G+
Sbjct: 336 MQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGI 395
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
LPDG+ VAVKQ K+ QGD EF +EVE LS HR++V ++G CI RRLL+Y+Y+ N
Sbjct: 396 LPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSN 455
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
L HL+G + L+W+ R KIA GAARGL YLHE+C I+HRD++ +NILL +F+
Sbjct: 456 NDLYFHLHG-EKSVLDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLEDNFD 513
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFG 574
V DFGLAR D + + TRVIGTFG
Sbjct: 514 ARVSDFGLARLALDCNTHITTRVIGTFG 541
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 1.4e-50, Sum P(2) = 1.4e-50
Identities = 105/216 (48%), Positives = 141/216 (65%)
Query: 372 PPGPPPLCS-----------ICQHKAP--VFGKPPRWFSYAELELATGGFSQANFLAEGG 418
PP PPP S + +P V G F+Y EL AT GFS+AN L +GG
Sbjct: 226 PPPPPPFMSSSGGSDYSDRPVLPPPSPGLVLGFSKSTFTYEELARATNGFSEANLLGQGG 285
Query: 419 FGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478
FG VH+GVLP G+ VAVKQ K+ S QG+ EF +EVE++S HR++V L+G+CI +RL
Sbjct: 286 FGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRL 345
Query: 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538
LVYE++ N +L+ HL+G + +EWS R KIA+G+A+GL YLHE+C I+HRD++ +N
Sbjct: 346 LVYEFVPNNNLELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPK-IIHRDIKASN 404
Query: 539 ILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
IL+ FE V DFGLA+ D + V TRV+GTFG
Sbjct: 405 ILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 440
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 5.0e-50, Sum P(2) = 5.0e-50
Identities = 96/186 (51%), Positives = 129/186 (69%)
Query: 389 FGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE 448
FG+ FSY EL +AT GFS N L EGGFG V++GVLPD + VAVKQ K+ QGD E
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
F +EV+ +S HRN++ ++G+CI + RRLL+Y+Y+ N +L HL+ L+W+ R K
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVK 530
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
IA GAARGL YLHE+C I+HRD++ +NILL ++F LV DFGLA+ D + + TR
Sbjct: 531 IAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHITTR 589
Query: 569 VIGTFG 574
V+GTFG
Sbjct: 590 VMGTFG 595
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 7.7e-50, Sum P(2) = 7.7e-50
Identities = 97/187 (51%), Positives = 131/187 (70%)
Query: 388 VFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH 447
V G F+Y EL AT GFS+AN L +GGFG VH+G+LP G+ VAVKQ K S QG+
Sbjct: 260 VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGER 319
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
EF +EVE++S HR++V LIG+C+ +RLLVYE++ N +L+ HL+G + +EWS R
Sbjct: 320 EFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRL 379
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE V DFGLA+ D + V T
Sbjct: 380 KIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVST 438
Query: 568 RVIGTFG 574
RV+GTFG
Sbjct: 439 RVMGTFG 445
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 1.3e-49, Sum P(2) = 1.3e-49
Identities = 94/182 (51%), Positives = 128/182 (70%)
Query: 395 WFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVE 454
WFSY EL T GFS+ N L EGGFG V++GVL DG+ VAVKQ K+ SQG+ EF +EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
++S HR++V L+G+CI ++ RLLVY+Y+ N +L HL+ + + W R ++A GAA
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAA 445
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETRVIGT 572
RG+ YLHE+C I+HRD++ +NILL + FE LV DFGLA+ + D+ V TRV+GT
Sbjct: 446 RGIAYLHEDCHPR-IIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGT 504
Query: 573 FG 574
FG
Sbjct: 505 FG 506
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 6.0e-49, Sum P(2) = 6.0e-49
Identities = 106/238 (44%), Positives = 146/238 (61%)
Query: 342 RDAGVGMSSYRTDLEFSGNVREAISLSRN---APPGPP--PLCSICQHKAPVFGKPPRWF 396
+D G G SS ++ + ++ S+ + A G P + S + + G F
Sbjct: 300 QDPGKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHF 359
Query: 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVL 456
SY EL T GF++ N L EGGFG V++G L DG+ VAVKQ K S QGD EF +EVE++
Sbjct: 360 SYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEII 419
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG 516
S HR++V L+G+CI D+ RLL+YEY+ N +L+ HL+G LEWS R +IA+G+A+G
Sbjct: 420 SRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKG 479
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
L YLHE+C I+HRD++ NILL ++E V DFGLAR V TRV+GTFG
Sbjct: 480 LAYLHEDCHPK-IIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFG 536
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.97.79.1 | hypothetical protein (694 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 574 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-29 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-29 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-26 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 0.001 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.003 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-32
Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVML 467
L EG FG V++G L VAVK K +S+ EF E ++ H NVV L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C E+ +V EY+ G L S+L ++ L S A+ ARG+ YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK---- 121
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
+HRD+ N L+ + + DFGL+R D D
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 157
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 52/156 (33%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V++G L VAVK K AS Q EF E ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C E+ ++V EY+ G L +L + L S A+ ARG+ YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---- 122
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
+HRD+ N L+ + + DFGL+R D D
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 52/167 (31%), Positives = 73/167 (43%), Gaps = 16/167 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQ----AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLI 468
L EG FG V++G L VAVK K +S+ + +F E V+ H NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSAR------QKIAVGAARGLRYLH 521
G C E+ LV EY+ G L +L P + A+ A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
+ VHRD+ N L+ D + DFGL+R D D +
Sbjct: 123 SK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 49/149 (32%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V++G L VAVK K AS + EF E ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C + +V EY+ G L L H E L ++A+ A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES---KN 122
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ HRD+ N L+T + + DFGL+R
Sbjct: 123 FV-HRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 55/164 (33%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L EGGFG+V+ G+ VA+K K SS E E+E+L H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
++ LV EY GSL L ++ L +I + GL YLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN----GIIH 115
Query: 532 RDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
RD++P NILL D + + DFGL++ D + ++GT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSK-LLTSDKSLLKTIVGTPA 158
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 47/147 (31%), Positives = 67/147 (45%), Gaps = 8/147 (5%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIG 469
L EG FG V+ G+ VA+K K + D E E+++L +H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
++ + LV EY G L L + + + + L YLH + I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA--RFYLRQILSALEYLHSKG----I 118
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD++P NILL D + DFGLAR
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR 145
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 53/148 (35%), Positives = 72/148 (48%), Gaps = 13/148 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
L G FG+V++ G+ VAVK + S+ D E+ +L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 471 CIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ LV EY G L +L G PL +KIA+ RGL YLH G
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G- 118
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P NILL + + DFGLA+
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAK 146
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 58/170 (34%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 412 NFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLI 468
L G FGSV+ + D G+ +AVK +L+ + E+ +LS QH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 469 GFCI-EDRRRLLVY-EYICNGSLDSHL--YGCHQEPLEWS-ARQKIAVGAARGLRYLHEE 523
G E++ L ++ EY+ GSL S L +G EP+ RQ + GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EGLAYLHSN 120
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR-VIGT 572
IVHRD++ NIL+ D + DFG A+ D + G T V GT
Sbjct: 121 G----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 408 FSQANFLAEGGFGSVHRG-VLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
F + +GGFG V++ G+ VA+K KL S + + +E+++L +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G ++ +V E+ GSL L +Q L S + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLKGLEYLHSNG-- 118
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I+HRD++ NILLT D E + DFGL+
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 22/165 (13%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVMLIGFCIE 473
G FG V++G+ L G VA+KQ L + + E+++L +H N+V IG IE
Sbjct: 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS-IE 69
Query: 474 DRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAA---RGLRYLHEECRVG 527
L ++ EY NGSL + +G E L +AV +GL YLHE+
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAYLHEQG--- 119
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
++HRD++ NIL T D + DFG+A + + + V+GT
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 414 LAEGGFGSV---HRGVLPDGQA--VAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVM 466
L EG FG V L D VAVK S + H +F E+E+L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 467 LIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G C + R L+ EY+ +GSL +L H++ + + +G+ YL +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ- 128
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
I HRD+ NIL+ + + DFGLA+ P+
Sbjct: 129 --RYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 54/162 (33%), Positives = 77/162 (47%), Gaps = 23/162 (14%)
Query: 414 LAEGGFGSVHRG----VLPDGQA--VAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVM 466
L EG FG V G + P+ VAVK K +S + F E E+L+ QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSLD----SH------LYGCHQEPLEWSARQ--KIAVGAA 514
G C E ++V+EY+ +G L+ SH L E + Q +IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G+ YL + VHRD+ N L+ +D +GDFG++R
Sbjct: 133 SGMVYLASQ----HFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 82.1 bits (201), Expect = 9e-17
Identities = 55/162 (33%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 413 FLAEGGFGSVHRGVLPDGQAVAVKQ--HKLASSQGDHE-FCSEVEVL-SCAQHRNVVMLI 468
L EG FG V+ D + VA+K KL S + E F E+++L S N+V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRVG 527
F ++ LV EY+ GSL+ L ++ PL S I L YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 528 CIVHRDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETR 568
I+HRD++P NILL D + DFGLA+ PD
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLA-SSQGDHEFC-SEVEVLSCAQHRNVVMLIGF 470
+ +G FG V+ DG+ +K+ L+ S+ + E +EV++L H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
E + +V EY G L + +P V L+YLH +
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-K--- 123
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
I+HRD++P NI LT + +GDFG+++ + + V+GT
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 46/141 (32%), Positives = 71/141 (50%), Gaps = 6/141 (4%)
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475
+G FG V G GQ VAVK K S+ F +E V++ +H N+V L+G ++
Sbjct: 16 KGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQGN 73
Query: 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR 535
+V EY+ GSL +L + + + + A+ G+ YL E+ VHRD+
Sbjct: 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLA 129
Query: 536 PNNILLTHDFEPLVGDFGLAR 556
N+L++ D V DFGLA+
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G FG V++GVL VAVK + F E E+L H N+V LIG C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ + +V E + GSL + L L ++++ AA G+ YL + CI HR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CI-HR 117
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDG 561
D+ N L+ + + DFG++R + G
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGG 146
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 414 LAEGGFGSVHRGVL--PDGQ--AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLI 468
+ G FG V RG L P + VA+K K SS +F +E ++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + R +++ EY+ NGSLD L + + G A G++YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN---- 126
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
VHRD+ NIL+ + V DFGL+R D + T+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 49/157 (31%), Positives = 84/157 (53%), Gaps = 16/157 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQ------HKLASSQGDHEFCSEVEVLSCAQH 461
+++ L +G +G+V+ G+ GQ +AVKQ + LA+ + + EV++L +H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRY 519
N+V +G C++D + E++ GS+ S L +G EP+ ++I G A Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----Y 117
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
LH C+VHRD++ NN++L + + DFG AR
Sbjct: 118 LHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 9/149 (6%)
Query: 410 QANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRNVVM 466
+ N + G FG V+ V L G+ +AVK+ ++ + E E++VL +H N+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G + + + EY G+L+ L + + GL YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH--VIRVYTLQLLEGLAYLHSHG-- 119
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
IVHRD++P NI L H+ +GDFG A
Sbjct: 120 --IVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 4/149 (2%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
F+ L G FG V G+ + VA+K K +F EV+ L +H++++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
C ++ E + GSL + L + L ++ +A A G+ YL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---- 123
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+HRD+ NIL+ D V DFGLAR
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 49/152 (32%), Positives = 69/152 (45%), Gaps = 20/152 (13%)
Query: 414 LAEGGFGSVHRGV--LPDGQ--AVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G FGSV +GV + G+ VAVK + + G EF E V++ H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEP----LEWSARQKIAVGAARGLRYLHEEC 524
G C + +LV E G L +L + P E A A G+ YL E
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYL-ESK 114
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD+ N+LL + + + DFG++R
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 413 FLAEGGFGSVHRGVL-PDGQAVAVK-QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
L +G G V++ P G+ A+K H + + E++ L + VV G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHLY--GCHQEP-LEWSARQKIAVGAARGLRYLHEECRVG 527
++ +V EY+ GSL L G EP L + ARQ +GL YLH +
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQ-----ILKGLDYLHTKRH-- 120
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P+N+L+ E + DFG+++
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 51/153 (33%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS-----EVEVLSCAQHRNVVM 466
L G FGSV+ G+ L DG AVK+ LA + E+ +LS QH N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPL-EWSARQKIAVGAARGLRYLHEE 523
+G E+ + E + GSL L YG EP+ RQ + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD++ NIL+ + + DFG+A+
Sbjct: 122 N----TVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHR 462
+ + L EG +G V++ G+ VA+K+ +L + E+ +L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHP 58
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYL 520
N+V L+ +R+ LV+EY C+ L +L + P S I RGL Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEY-CDMDLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H I+HRD++P NIL+ D + DFGLAR
Sbjct: 115 HS----HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 49/158 (31%), Positives = 66/158 (41%), Gaps = 19/158 (12%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L G FG V+ G+ VAVK + S Q + +F E ++S H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGC-----HQEPLEWSARQKIAVGAARGLRYLH 521
LIG E R ++ E + G L S L L A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL- 132
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV---GDFGLAR 556
EE +HRD+ N LLT V DFG+AR
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 29/165 (17%)
Query: 414 LAEGGFGSVH----RGVLPDGQA--VAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V +LP+ VAVK K AS +F E E+L+ QH+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 468 IGFCIEDRRRLLVYEYICNGSL---------DSHLYGCHQE----PLEWSARQKIAVGAA 514
G C E R L+V+EY+ +G L D+ + ++ L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 515 RGLRY---LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G+ Y LH VHRD+ N L+ +GDFG++R
Sbjct: 133 SGMVYLASLH-------FVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 12/149 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+V++GV +P+G+ VA+K + +S + + E E V++ H +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ + L+ + + G L ++ H++ + V A+G+ YL EE R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYL-EEKR-- 129
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+VHRD+ N+L+ + DFGLA+
Sbjct: 130 -LVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 58/155 (37%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 414 LAEGGFGSVHR---GVLPD--GQAVAVK--QHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FGSV L D G+ VAVK QH A D E E+E+L QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILKSLQHDNIVK 69
Query: 467 LIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G C RR LV EY+ GSL +L H+E L+ A +G+ YL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559
R VHRD+ NIL+ + +GDFGL + P
Sbjct: 128 RY---VHRDLATRNILVESENRVKIGDFGLTKVLP 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 51/150 (34%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G FG V +G L D VAVK K Q +F SE +L H N+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ + +V E + G S L ++ L+ K A+ AA G+ YL + CI H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESK---NCI-H 116
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
RD+ N L+ + + DFG++R + DG
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDG 146
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 27/178 (15%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRG--VLPDG----QAVAVKQHK-LASSQGDHEFCSE 452
E+ L+ F + L EG FG V++G P+ +VA+K K A + EF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 453 VEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--------YGCH------Q 498
E++S QH N+V L+G C +++ +++EY+ +G L L G +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 499 EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
L+ S IA+ A G+ YL VHRD+ N L+ + DFGL+R
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 45/147 (30%), Positives = 64/147 (43%), Gaps = 6/147 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG VH G VA+K + + D +F E +V+ H N+V L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
R +V EY+ NG L ++L + L + + YL +HRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESN----GFIHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPD 560
+ N L+ D V DFGLAR+ D
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLD 152
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 17/150 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLAS------SQGDHEFCSEVEVLSCAQHRNVVM 466
+ EG +G+V + + VA+K+ +L S E C +L +H+N+V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELKHKNIVR 63
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L D++ LV+EY C+ L + C+ + + + +GL + H
Sbjct: 64 LYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAFCHSHN-- 119
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
++HRD++P N+L+ + E + DFGLAR
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 6/143 (4%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G +G V++ + G+ VA+K KL E+ +L +H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ +V EY GSL +Y + PL + +GL YLHE ++ HR
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKI----HR 125
Query: 533 DMRPNNILLTHDFEPLVGDFGLA 555
D++ NILLT D + + DFG++
Sbjct: 126 DIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 14/173 (8%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQGD-HEFCSEVEVL 456
E+ ++ + G FG V RG+L AVA+K K ++ +F SE ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAA 514
H N++ L G + + +++ EY+ NG+LD +L E+S+ Q + + G A
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIA 117
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
G++YL + VHRD+ NIL+ + E V DFGL+R D G T
Sbjct: 118 AGMKYLSDMN----YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 38/174 (21%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHRNVVMLIGF 470
EG +G V++ G+ VA+K K+ F E+++L +H N+V L
Sbjct: 9 EGTYGQVYKARNKKTGELVALK--KIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 471 CIEDRRR--LLVYEYI---CNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GL 517
+ +V+EY+ G LDS K + GL
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEV-------------KFTESQIKCYMKQLLEGL 113
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVI 570
+YLH I+HRD++ +NIL+ +D + DFGLAR + RVI
Sbjct: 114 QYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 30/167 (17%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHE---FCSEVEVL-SCAQHRN 463
L EG FG V + + VAVK L + + SE+E++ +H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG--------------CHQEPLEWSARQKI 509
++ L+G C ++ +V EY +G+L L +E L
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A ARG+ +L + CI HRD+ N+L+T D + DFGLAR
Sbjct: 138 AYQVARGMEFLASK---KCI-HRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 56/172 (32%), Positives = 73/172 (42%), Gaps = 20/172 (11%)
Query: 414 LAEGGFGSVHRGVL--PDG--QAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FGSV G L DG VAVK KL + EF SE + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 468 IGFCIEDRRR------LLVYEYICNGSLDSHLY----GCHQEPLEWSARQKIAVGAARGL 517
IG C E +++ ++ +G L S L G E L K V A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
YL +HRD+ N +L D V DFGL++ GD + R+
Sbjct: 127 EYLSNRN----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 13/163 (7%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNV 464
F + N + EG +G V+R G+ VA+K+ ++ + + S E+ +L +H N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 465 VMLIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
V L + LV EY C L S L P S + + + RGL+YLHE
Sbjct: 69 VELKEVVVGKHLDSIFLVMEY-CEQDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHE 126
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW--QPDGDM 563
I+HRD++ +N+LLT + DFGLAR P M
Sbjct: 127 NF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 28/167 (16%)
Query: 414 LAEGGFGSVHR----GVLPDGQ----AVAVKQHKLASSQGD-HEFCSEVEVLSC-AQHRN 463
L EG FG V R G+ VAVK K ++ D + SE+E++ +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG--------------CHQEPLEWSARQKI 509
++ L+G C ++ ++ EY G+L L +E L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A ARG+ YL CI HRD+ N+L+T D + DFGLAR
Sbjct: 140 AYQVARGMEYLESR---RCI-HRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 39/152 (25%), Positives = 66/152 (43%), Gaps = 7/152 (4%)
Query: 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNV 464
F N + +G FG V + V D + A+KQ L+ ++ + E E VL+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
+ ++ + +V EY NG L L PL + + GL +LH +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++ N+ L +GD G+A+
Sbjct: 122 ----ILHRDIKSLNLFLDAYDNVKIGDLGVAK 149
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 6/156 (3%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ 460
E+ + + L G +G V+ GV VAVK K + EF E V+ +
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 60
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
H N+V L+G C + ++ E++ G+L +L C+++ + +A + + YL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
++ +HRD+ N L+ + V DFGL+R
Sbjct: 121 EKK----NFIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 13/164 (7%)
Query: 414 LAEGGFGSVHR-GVLPDGQAVAVKQHKLASSQGD----HEFCSEVEVLSCAQHRNVVMLI 468
+ EG G V + G+ VA+K K+A + + ++ E++ L QH VV L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALK--KVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+LV EY L L + PL + + +G+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEY-MPSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANG---- 119
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
I+HRD++P N+L++ D + DFGLAR + + + + + T
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT 163
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 14/152 (9%)
Query: 417 GGFGSVHRGVL-PDGQA---VAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
G FG V RG L G+ VA+K K + + +F SE ++ H N++ L G
Sbjct: 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLHEECRVGCI 529
+ R +++ E++ NG+LDS L Q +++ Q + + G A G++YL E
Sbjct: 75 TKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEM----NY 127
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
VHRD+ NIL+ + V DFGL+R+ D
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 52/160 (32%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 414 LAEGGFGSVHRG----VLP--DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + P D VAVK K AS +F E E+L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 468 IGFCIEDRRRLLVYEYICNGSL---------DSHLYGCHQEPLEWSARQ--KIAVGAARG 516
G C+E ++V+EY+ +G L D+ L P E + Q IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ YL + VHRD+ N L+ + +GDFG++R
Sbjct: 133 MVYLASQ----HFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 412 NFLAEGGFGSVHRG-VLPDG--QAVAVKQHKLASSQGDH-EFCSEVEVL-SCAQHRNVVM 466
+ + EG FG V + + DG A+K+ K +S+ DH +F E+EVL H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSL------------DSHLYGCHQEPLEWSARQKIAVGA- 513
L+G C L EY +G+L D + S++Q + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 514 -ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
ARG+ YL ++ +HRD+ NIL+ ++ + DFGL+R Q
Sbjct: 133 VARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQ 174
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 11/145 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG G V++ G+ VA+K+ +L Q +E+ ++ +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA--RGLRYLHEECRVGCIV 530
+V EY+ GSL + + + Q V +GL YLH I
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLH---SQNVI- 138
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLA 555
HRD++ +NILL+ D + DFG A
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 47/151 (31%), Positives = 66/151 (43%), Gaps = 18/151 (11%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ-HK---LASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G FG V G+ A+K K + Q +H +E +L +H +V L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIRHPFLVNLY 67
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWS---ARQKIAVGAARGLRYLHEECR 525
G +D LV EY+ G L SHL + P + A Q + L YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL-----ALEYLHSL-- 120
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
IV+RD++P N+LL D + DFG A+
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 48/144 (33%), Positives = 69/144 (47%), Gaps = 12/144 (8%)
Query: 417 GGFGSVH--RGVLPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIGFC 471
G FG+V+ R V + VA+K+ + Q + + EV L +H N + G
Sbjct: 26 GSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ + LV EY C GS S + H++PL+ I GA +GL YLH R+ H
Sbjct: 85 LREHTAWLVMEY-CLGSA-SDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI----H 138
Query: 532 RDMRPNNILLTHDFEPLVGDFGLA 555
RD++ NILLT + DFG A
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRN 463
+ + L EG GSV + L + + + D + E+E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 464 VVMLIGFCIEDRRRLL--VYEYICNGSLDSHLYGCHQEPLEWSARQ------KIAVGAAR 515
+V G +++ + EY GSLDS +Y + + R KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYK---KVKKRGGRIGEKVLGKIAESVLK 116
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553
GL YLH I+HRD++P+NILLT + + DFG
Sbjct: 117 GLSYLHSRK----IIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G G V HR P G+ +AVK +L + E+++L +V
Sbjct: 9 LGAGNSGVVSKVLHR---PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + + EY+ GSLD + Q + KIAV +GL YLHE+ +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--- 121
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P+NIL+ + + DFG++
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVVMLIG 469
+ EG +G V++ G+ VA+K+ KL + E+++L H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ L LV+E+ +D+ LY Q L S + +GL + H
Sbjct: 66 -VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G + HRD++P N+L+ + + DFGLAR
Sbjct: 117 HGIL-HRDLKPENLLINTEGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 412 NFLAEGGFGSVHRGVLP-DG--QAVAVKQHKLASSQGDH-EFCSEVEVL-SCAQHRNVVM 466
+ + EG FG V R ++ DG A+K K +S+ DH +F E+EVL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 467 LIGFCIEDRRRLLV-YEYICNGSL------------DSHLYGCHQEPLEWSARQ--KIAV 511
L+G C E+R L + EY G+L D H +++Q + A
Sbjct: 68 LLGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A G++YL E+ +HRD+ N+L+ + + DFGL+R
Sbjct: 127 DVATGMQYLSEKQ----FIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 407 GFSQANFLAEGGFGSVHR-GVLPDGQAVAVKQHKLAS-SQGD-HEFCSEVEVLSCAQHRN 463
F L +G +GSV++ L D Q A+K+ L S SQ + + +E+ +L+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE--PLEWSARQKIAVGAARGLRYLH 521
++ ++ + +V EY G L + ++ + +I + RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
E+ I+HRD++ NILL + +GD G+++
Sbjct: 121 EQK----ILHRDLKSANILLVANDLVKIGDLGISK 151
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 19/158 (12%)
Query: 414 LAEGGFGSVHRGV---LPDGQA---VAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L +G FG V+ G+ + G+ VA+K +S + EF +E V+ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWS-----ARQKI---AVGAARGLR 518
L+G + L+V E + G L S+L E QK A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
YL + VHRD+ N ++ D +GDFG+ R
Sbjct: 134 YLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 46/170 (27%), Positives = 69/170 (40%), Gaps = 31/170 (18%)
Query: 414 LAEGGFGSVHR----GVLPDGQ--AVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ +G FG V + G+LP VAVK K AS+ +F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK------------------ 508
L+G C + L++EY+ G L+ L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 509 --IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
IA A G+ YL E VHRD+ N L+ + + DFGL+R
Sbjct: 133 LCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 414 LAEGGFGSVHRGVLPDGQAVA---VKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG V G G + A VK+ + +++ F EV+ H NV+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAVGAARGLRYLHEECR 525
CIE LLV E+ G L ++L + + A+ Q++A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSN-RGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+H D+ N LT D +GD+GLA
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 5e-11
Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 20/149 (13%)
Query: 417 GGFGSV----HRGVLPDGQAVAVKQ-HK---LASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G FG V + G+ A+K K + + +H +E +LS H +V L
Sbjct: 4 GSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ + +L LV EY G L SHL + E + A L YLH +G
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLH---SLG 113
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I++RD++P NILL D + DFGLA+
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAK 141
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 10/146 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG+V+ + VAVK+ + Q + + EV+ L +H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+++ LV EY C GS S L H++PL+ I GA +GL YLH +
Sbjct: 89 CYLKEHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN----M 142
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLA 555
+HRD++ NILLT + + DFG A
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 7e-11
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 412 NFLAEGGFGSVHRGVLP-DG--QAVAVKQHKLASSQGDH-EFCSEVEVL-SCAQHRNVVM 466
+ + EG FG V + + DG A+K+ K +S+ DH +F E+EVL H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 467 LIGFCIEDRRRLLV-YEYICNGSL------------DSHLYGCHQEPLEWSARQ--KIAV 511
L+G C E R L + EY +G+L D + S++Q A
Sbjct: 61 LLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
ARG+ YL ++ +HRD+ NIL+ ++ + DFGL+R
Sbjct: 120 DVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 49/151 (32%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 414 LAEGGFGSVHRGV---LPDGQA---VAVKQHKLASSQGDHE-FCSEVEVLS-CAQHRNVV 465
L G FG V L A VAVK K + + E SE++++S H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L+G C L++ EY C G L + L + L + A+G+ +L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-- 160
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
CI HRD+ N+LLTH + DFGLAR
Sbjct: 161 -NCI-HRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRN 463
FS + G FG+V+ + + + VA+K+ + Q + + EV L +H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ G + + LV EY C GS S L H++PL+ + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
++HRD++ NILL+ +GDFG A
Sbjct: 135 N----MIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 34/162 (20%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS--EVEVLSCAQHRNVV 465
L EG + V++ G+ VA+K+ KL + + F + E+++L +H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA----------- 514
L+ LV+E+ +++ L E + K V
Sbjct: 66 GLLDVFGHKSNINLVFEF-----METDL--------EKVIKDKSIVLTPADIKSYMLMTL 112
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RGL YLH I+HRD++PNN+L+ D + DFGLAR
Sbjct: 113 RGLEYLHSNW----ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 54/163 (33%), Positives = 78/163 (47%), Gaps = 22/163 (13%)
Query: 412 NFLAEGGFGSVHRG----VLPDG---QAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRN 463
NFL G FG V+ G +L G VAVK K A+ Q EF E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEP-----LEWSARQKIAVGAARGLR 518
+V L+G C+ + + ++ E + G L S+L E L I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 519 YLHEECRVGCIVHRDMRPNNILLT---HDFEPLV--GDFGLAR 556
YL E+ +HRD+ N L++ +D + +V GDFGLAR
Sbjct: 121 YL-EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 414 LAEGGFGSVHRGVLPDGQA--VAVKQ---HKLASSQGDHE-------FCSEVEVLSCA-Q 460
L G FG V++ + +A+K+ H A + E SEV ++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLR 518
H N+V +E+ R +V + I L H ++ ++ + I V LR
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGT 572
YLH+E R IVHRD+ PNNI+L D + + DFGLA+ QP+ + T V+GT
Sbjct: 128 YLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 18/169 (10%)
Query: 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVL 456
+ E+ L Q + VAVK + AS +F EV++L
Sbjct: 18 FGEVHLCEADGLQDFSEKAFAENDNADAPV----LVAVKVLRPDASDNAREDFLKEVKIL 73
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK-------- 508
S N+ L+G C D ++ EY+ NG L+ L E + K
Sbjct: 74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133
Query: 509 -IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+A A G+RYL VHRD+ N L+ ++ + DFG++R
Sbjct: 134 YMATQIASGMRYLESL----NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQA----VAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+VH+G+ +P+G + VA+K + Q E + + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C +L V + GSL H+ H++ L+ V A+G+ YL E
Sbjct: 75 LGICPGASLQL-VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+VHR++ NILL D + DFG+A D
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 9/144 (6%)
Query: 416 EGGFGSVHRG-VLPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVVMLIGFCI 472
EG +G V + G+ VA+K+ K + D + + EV+VL +H N+V L
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR 70
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
R LV+EY+ L+ L L A + + + Y H I+HR
Sbjct: 71 RKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN----IIHR 124
Query: 533 DMRPNNILLTHDFEPLVGDFGLAR 556
D++P NIL++ + DFG AR
Sbjct: 125 DIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFC 471
L EG + +V++G +G+ VA+K +L +G E +L +H N+V+L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 472 IEDRRRLLVYEYI----CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
LV+EY+ C +D H G H E ++ Q + RGL Y+H+
Sbjct: 73 HTKETLTLVFEYVHTDLCQ-YMDKHPGGLHPENVKLFLFQLL-----RGLSYIHQRY--- 123
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P N+L++ E + DFGLAR
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 40/191 (20%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDG-----------QAVAVKQHKLA 441
PRW E+ L EG FG V V+ + VAVK K
Sbjct: 11 PRW------EVPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSD 61
Query: 442 SSQGD-HEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL------ 493
+++ D + SE+E++ +H+N++ L+G C +D ++ EY G+L +L
Sbjct: 62 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121
Query: 494 -----YGCHQEPLEWSARQKI---AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
Y Q P E + + + A ARG+ YL + CI HRD+ N+L+T D
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCI-HRDLAARNVLVTEDN 177
Query: 546 EPLVGDFGLAR 556
+ DFGLAR
Sbjct: 178 VMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L EG +GSV++ + GQ VA+K + + E E+ +L +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGCI 529
++ +V EY GS+ + ++ E ++IA +GL YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTE----EEIAAILYQTLKGLEYLHSNK----K 120
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+HRD++ NILL + + + DFG++ Q M VIGT
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 46/165 (27%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSC-AQHRNVVMLI 468
+ EG F +V + A+K +L + E EVL+ H ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIA--VGAARGLRYLHEE 523
+ +D L V EY NG L ++ YG E R A + A L YLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTRFYAAEILLA---LEYLH-- 119
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
G I+HRD++P NILL D + DFG A+ +
Sbjct: 120 -SKG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 21/159 (13%)
Query: 414 LAEGGFGSV--------HRGVLPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNV 464
L EG FG V + G G+ VAVK K Q + + E+ +L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 465 VMLIGFCIE--DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
V G C E + L+ EY+ GSL +L + L + A G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
+ +HRD+ N+LL +D +GDFGLA+ P+G
Sbjct: 126 QH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 5/143 (3%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G+ + VAVK K + +F +E +++ +H ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V E + GSL +L G L+ +A A G+ YL + +HRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRD 128
Query: 534 MRPNNILLTHDFEPLVGDFGLAR 556
+ N+L+ + V DFGLAR
Sbjct: 129 LAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 49/172 (28%), Positives = 69/172 (40%), Gaps = 33/172 (19%)
Query: 414 LAEGGFGSVHRGV------LPDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L EG FG V + VAVK K +S + + SE +L H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL-----YGC-----------------HQEPLEWS 504
L G C +D LL+ EY GSL S L G + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 505 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A +RG++YL E +VHRD+ N+L+ + + DFGL+R
Sbjct: 128 DLISFAWQISRGMQYLAEM----KLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRN 463
F+ + G FG+V+ + + VA+K+ + Q + + EV+ L +H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ G + + LV EY C GS S L H++PL+ I GA +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
++HRD++ NILLT + + DFG A
Sbjct: 145 N----MIHRDIKAGNILLTEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 45/144 (31%), Positives = 62/144 (43%), Gaps = 7/144 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG V G VAVK K + S F E +++ +H +V L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
E+ +V EY+ GSL L + L +A A G+ YL E +HR
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRNY---IHR 127
Query: 533 DMRPNNILLTHDFEPLVGDFGLAR 556
D+ NIL+ + + DFGLAR
Sbjct: 128 DLAARNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 10/145 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G FG V G G VAVK K A++Q F +E V++ +H N+V L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 473 EDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
E++ L +V EY+ GSL +L + L K ++ + YL VH
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----FVH 125
Query: 532 RDMRPNNILLTHDFEPLVGDFGLAR 556
RD+ N+L++ D V DFGL +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 42/181 (23%), Positives = 67/181 (37%), Gaps = 52/181 (28%)
Query: 407 GFSQANFLAEGGFGSVHRGVL---PDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQ 460
+ + G +G V++ DG+ A+K+ K Q C E+ +L +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 461 HRNVVMLIGFCIEDRRRL--LVYEY-------ICNGSLDSHLYGCHQEPLEWSARQKIAV 511
H NVV L+ +E + L+++Y I H RQ V
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK----FH-------------RQAKRV 103
Query: 512 GAAR------------GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLA 555
G+ YLH ++HRD++P NIL+ + +GD GLA
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
Query: 556 R 556
R
Sbjct: 160 R 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 46/147 (31%), Positives = 66/147 (44%), Gaps = 6/147 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VA+K K S D EF E +V+ H +V L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
R +V EY+ NG L ++L H + + S ++ G+ YL + +HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESK----QFIHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPD 560
+ N L+ V DFGL+R+ D
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD 152
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 50/156 (32%), Positives = 67/156 (42%), Gaps = 14/156 (8%)
Query: 414 LAEGGFGSVHRG--VLPDGQ--AVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V RG G+ VAVK KL+ D F E ++ H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENLIR 60
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L G + ++V E GSL L S AV A G+RYL +
Sbjct: 61 LYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR-- 117
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+HRD+ NILL D + +GDFGL R P +
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLI 468
+ EG FG V++GV + AVAVK K +S E F E ++ H ++V LI
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + +V E G L S+L ++ L+ ++ + + L YL +
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKR---- 127
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560
VHRD+ N+L++ +GDFGL+R+ D
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
SE+ + QH N+V LIG C ++ L++EYI +L L L W R+KIA
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
+G A+ LR+LH C +V ++ P I++ EP
Sbjct: 787 IGIAKALRFLHCRCSPAVVVG-NLSPEKIIIDGKDEP 822
|
Length = 968 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 410 QANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGD-----HEFCSEVEVLSCAQHRN 463
+ L +G FG V+ D G+ +AVKQ + + E+++L QH
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 464 VVMLIGFCIEDRRRLLVY-EYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYL 520
+V G C+ D L ++ EY+ GS+ L YG E + ++I G+ YL
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYL 120
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H IVHRD++ NIL +GDFG ++
Sbjct: 121 HSNM----IVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 30/175 (17%)
Query: 414 LAEGGFGSVH----RGVLP---------DGQA--VAVKQHKL-ASSQGDHEFCSEVEVLS 457
L EG FG VH G+ DGQ VAVK + + ++F E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 458 CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG-------CHQEPLEWSARQKI- 509
++ N++ L+G C+ D ++ EY+ NG L+ L H + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 510 --AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
AV A G++YL VHRD+ N L+ + + + DFG++R GD
Sbjct: 133 YMAVQIASGMKYLASL----NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 21/156 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKL-ASSQGDHE---------FCSEVEVLSCAQHR 462
+ +G +G V+ + + G+ +AVKQ +L A+ G H+ SE+E L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYL 520
N+V +GF + + EY+ GS+ S L YG +E L +++ GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAYL 124
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H + I+HRD++ +N+L+ D + DFG+++
Sbjct: 125 HSKG----ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 6/147 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG V G + + VA+K + + + +F E +V+ H +V L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
LV+E++ +G L +L + + + G+ YL ++HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLES----SNVIHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPD 560
+ N L+ + V DFG+ R+ D
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLD 152
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG FG+V +G GQ VAVK K ++Q F E V++ H+N+V L+G +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ + V E + G+L + L + + + ++ A G+ YL + +VHR
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK----LVHR 124
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDG 561
D+ NIL++ D V DFGLAR G
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMG 153
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 16/157 (10%)
Query: 414 LAEGGFGSVHRGVLPDGQAVA---VKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG V + VA VK+ K ASS+ +EF + + QH N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAVGAARGLRYLHEECR 525
C+E LLV+EY G L S+L ++ +++ Q++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYL--SQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-- 118
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGL--ARWQPD 560
+H D+ N LT D VGD+G+ +R++ D
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 414 LAEGGFGSVHRGVLPDG---QAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG V G + G V VK+ ++ AS Q +F E + QH N++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL---EWSARQKIAVGAARGLRYLHEECRV 526
C E LLV E+ G L +L C + L + + Q++A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+H D+ N LLT D +GD+GL+
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 56/183 (30%), Positives = 76/183 (41%), Gaps = 24/183 (13%)
Query: 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVL-SCA 459
TG F + EG +G V++ GQ VA+K + D E E +L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYS 60
Query: 460 QHRNVVMLIGFCIEDRRRL------LVYEYICNGS---LDSHLYGCHQE-PLEWSARQKI 509
H N+ G I+ LV E GS L L + EW A I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--I 118
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
RGL YLHE ++HRD++ NILLT + E + DFG++ Q D +G
Sbjct: 119 LRETLRGLAYLHENK----VIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTF 173
Query: 570 IGT 572
IGT
Sbjct: 174 IGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFC-SEVEVLSCAQHRNVV 465
F Q L EG + +V++G G+ VA+K+ L + +G E+ ++ +H N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
L + + +LV+EY + L ++ +G + L+ + + +G+ + HE
Sbjct: 62 RLHDVIHTENKLMLVFEY-MDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
++HRD++P N+L+ E + DFGLAR
Sbjct: 120 R----VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 36/189 (19%)
Query: 393 PRW-FSYAELELATGGFSQANFLAEGGFGSV--------HRGVLPDGQAVAVKQHKLASS 443
PRW FS +L L L EG FG V + + VAVK K ++
Sbjct: 8 PRWEFSRDKLTLGKP-------LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 444 QGD-HEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG------ 495
+ D + SE+E++ +H+N++ L+G C +D ++ EY G+L +L
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 496 --------CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
E + + ARG+ YL + CI HRD+ N+L+T +
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCI-HRDLAARNVLVTENNVM 176
Query: 548 LVGDFGLAR 556
+ DFGLAR
Sbjct: 177 KIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 46/152 (30%), Positives = 67/152 (44%), Gaps = 11/152 (7%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
+ G FG V G L D VAVK + +F E +L H N+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 472 IEDRRRLLVYEYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ + +V E + G + L G L+ ++ AA G+ YL + CI
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
HRD+ N L+T + DFG++R + DG
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSREEEDG 147
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 22/160 (13%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQH 461
F + L G FG+V++G+ +P+G+ VA+K+ + A+S + + E E V++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG-----CHQEPLEWSARQKIAVGAARG 516
+V L+G C+ +L + + + G L ++ Q L W V A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ YL E +VHRD+ N+L+ + DFGLA+
Sbjct: 122 MNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ + G A K ++ S + +F E+++LS +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ + ++ E+ G+LDS + + L + + L +LH ++HR
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSHK----VIHR 127
Query: 533 DMRPNNILLTHDFEPLVGDFGLA 555
D++ NILLT D + + DFG++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQ---HRNVVML 467
L +G FGSV+ G+ VA+K+ K S E + EV S + H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVKL 63
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRV 526
E+ V+EY G+L L + P S + I +GL ++H +
Sbjct: 64 KEVFRENDELYFVFEY-MEGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G HRD++P N+L++ + DFGLAR
Sbjct: 119 G-FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 416 EGGFGSV----HRGVLPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHRNVVML 467
EG +G V H+ GQ VA+K K S+ D E+ +L +H N+V L
Sbjct: 11 EGSYGMVMKCKHK---ETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
I +R LV+E++ + LD + L+ S +K RG+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---- 119
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P NIL++ + DFG AR
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQA---VAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L EG FGSV G L + VAVK K+A + +F SE + H NV+ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 469 GFCIEDRRR------LLVYEYICNGSLDSHLY----GCHQEPLEWSARQKIAVGAARGLR 518
G C++ +++ ++ +G L S L G + L K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
YL + +HRD+ N +L + V DFGL++ +GD + R+
Sbjct: 127 YLSSKS----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 24/163 (14%)
Query: 414 LAEGGFGSV------HRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + D VAVK K + +F E E+L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYG--------CHQEPLE------WSARQKIAVGA 513
G C + ++V+EY+ +G L+ L +P + S IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A G+ YL + VHRD+ N L+ + +GDFG++R
Sbjct: 133 ASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 17/145 (11%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIED 474
G FG V++ + Q VA+K L ++ + E E++ LS + + G ++
Sbjct: 12 GSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71
Query: 475 RRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGCIV 530
+ ++ EY GS LD G E IA GL YLHEE ++
Sbjct: 72 SKLWIIMEYCGGGSCLDLLKPGKLDE-------TYIAFILREVLLGLEYLHEEGKI---- 120
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLA 555
HRD++ NILL+ + + + DFG++
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 6/143 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VA+K K S + F +E ++ QH +V L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
++ EY+ NGSL L L + +A A G+ ++ + +HRD
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN----YIHRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLAR 556
+R NIL++ + DFGLAR
Sbjct: 128 LRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 412 NFLAEGGFGSVHRGVL--PDGQAV--AVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ +G FG V+ G L DGQ + AVK +++ + +F E ++ H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 467 LIGFCIEDR-RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG--AARGLRYLHEE 523
L+G C+ L+V Y+ +G L + + P + + I G A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGMEYLASK 117
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD+ N +L F V DFGLAR
Sbjct: 118 K----FVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 27/155 (17%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCAQHRNVV 465
+ EG +G V +R GQ VA+K K S+ D E+ +L +H N+V
Sbjct: 9 IGEGSYGVVFKCRNR---ETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 466 MLIGFCIEDRRRLLVYEYICNGS----LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
LI R+ LV+EY C+ + L+ + G + + +KI + + + H
Sbjct: 64 NLIEVFRRKRKLHLVFEY-CDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNFCH 117
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ CI HRD++P NIL+T + + DFG AR
Sbjct: 118 KH---NCI-HRDVKPENILITKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 16/160 (10%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL-ASSQGDHEFC-SEVEVL---SCAQH 461
+ + + EG +G+V++ L G+ VA+K+ ++ S +G E+ +L +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 462 RNVVMLIGFC--IEDRRRL---LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG 516
N+V L+ C R L LV+E+ + L ++L C + L + + RG
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ +LH IVHRD++P NIL+T D + + DFGLAR
Sbjct: 120 VDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 20/155 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---------FCSEVEVLSCAQHRN 463
+ G FGSV+ G+ G+ +AVKQ +L S + E+ +L QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLH 521
+V +G ++ + EY+ GS+ + L YG +E L + ++I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYLH 123
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++ NIL+ + + DFG+++
Sbjct: 124 NRG----IIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 23/157 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVVMLIGF 470
L EG FG V++ + G+ VA+K+ + + + + E+++L +H NVV LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 471 CIE-----DRRRLLVY---EYICNGSLDSHLYGCHQEP---LEWSARQKIAVGAARGLRY 519
+E R+R VY Y +D L G + P L S + + G+ Y
Sbjct: 76 AVERPDKSKRKRGSVYMVTPY-----MDHDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
LHE I+HRD++ NIL+ + + DFGLAR
Sbjct: 131 LHENH----ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 417 GGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEV-----LSCAQHRNVVMLIGF 470
G +G+V++ P G VA+K ++ +++ + EV L H N+V L+
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 471 CIEDR-----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
C R + LV+E++ + L ++L L + + RGL +LH
Sbjct: 71 CATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---- 125
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
CIVHRD++P NIL+T + + DFGLAR
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLIG 469
L EG + +V +G VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKNLKHANIVTLHD 70
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV-GAARGLRYLHEECRVGC 528
+R LV+EY+ + L +L C L KI + RGL Y H+
Sbjct: 71 IIHTERCLTLVFEYL-DSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---- 123
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P N+L+ E + DFGLAR
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 14/147 (9%)
Query: 417 GGFGSVHRGVL--PDGQ--AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIGFC 471
G FG V G L P + VA+K K ++ +F SE ++ H N++ L G
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLHEECRVGCI 529
+ + ++V EY+ NGSLD+ L + +++ Q + + G A G++YL +
Sbjct: 75 TKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM----GY 127
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD+ NIL+ + V DFGL+R
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 56/188 (29%), Positives = 84/188 (44%), Gaps = 34/188 (18%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSV----HRGVLPDGQA----VAVKQHKLASSQ 444
P+W EL+ + L EG FG V G+ D VAVK K ++
Sbjct: 5 PKW------ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 445 GD-HEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG------- 495
D + SE+E++ +H+N++ L+G C +D ++ EY G+L +L
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMD 118
Query: 496 -----CH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548
C +E L + A ARG+ YL + CI HRD+ N+L+T D
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI-HRDLAARNVLVTEDNVMK 174
Query: 549 VGDFGLAR 556
+ DFGLAR
Sbjct: 175 IADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 10/163 (6%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIE 473
G V+ + LP+ + VA+K+ L Q + EV+ +S H NVV +
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70
Query: 474 DRRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
LV Y+ GS LD + L+ + + +GL YLH ++ HR
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI----HR 126
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPD-GDMGVETR--VIGT 572
D++ NILL D + DFG++ D GD + R +GT
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVML 467
L +G FG L D V K+ L S + + +E+ +LS QH N++
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAV--GAARGLRYLHEE 523
++D L+ EY NG LY Q+ + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEY-ANGG---TLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
I+HRD++ NI LT +GDFG+++ ET V+GT
Sbjct: 121 G----ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 44/149 (29%), Positives = 80/149 (53%), Gaps = 12/149 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAV----AVK-QHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ +P+G+ V A+K ++ + + EF E +++ H ++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ +L V + + +G L +++ H++ + V A+G+ YL EE R
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYL-EERR-- 129
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+VHRD+ N+L+ + DFGLAR
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 20/163 (12%)
Query: 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL--ASSQGDHEFC-SEVEVLSCAQ 460
G F + +G F V++ + L DG+ VA+K+ ++ + C E+++L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQ-------EPLEWSARQKIAVGA 513
H NV+ + IE+ +V E G L S + + E W K V
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIW----KYFVQL 115
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
L ++H + R I+HRD++P N+ +T +GD GL R
Sbjct: 116 CSALEHMHSK-R---IMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 414 LAEGGFGSVHRGVLPD---GQA---VAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V+ G D G+A VAVK ++ AS + EF +E V+ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------KIAVGAARGLR 518
L+G + + L+V E + +G L S+L E R ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
YL+ + VHRD+ N ++ HDF +GDFG+ R
Sbjct: 134 YLNAKK----FVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 42/162 (25%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLIG 469
L EG + +V++G GQ VA+K+ +L +G + E +L +H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP--FTAIREASLLKDLKHANIVTLHD 70
Query: 470 FCIEDRRRLLVYEYI----------CNGSLDSH-----LYGCHQEPLEWSARQKIAVGAA 514
+ LV+EY+ C G L H L+ Q +
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF------------QLL----- 113
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RGL Y H+ ++HRD++P N+L++ E + DFGLAR
Sbjct: 114 RGLAYCHQRR----VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 46/149 (30%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L +G FG V G VA+K K + F E +V+ +H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V EY+ GSL L G + L +A A G+ Y+ R+ VHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN-YVHRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+R NIL+ + V DFGLAR D +
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 16/149 (10%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFC 471
L EG + +V++G+ +GQ VA+K + + +G E +L +H N+V+L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI- 71
Query: 472 IEDRRRL-LVYEYICNG---SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
I + L V+EY+ + H G H + Q + RGL Y+H +
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-----RGLAYIHGQH--- 123
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P N+L+++ E + DFGLAR
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 23/156 (14%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQHRNVV--- 465
N + EG +G V+R G+ VA+K+ K+ + S E+ +L QH N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 466 -MLIGFCIEDRRRLLVYEYICNGSLDSH----LYGCHQEPLEWSARQKIAVGAARGLRYL 520
+++G ++ +V EY+ H L ++P S + + + G+ +L
Sbjct: 71 EVVVGSNLDKI--YMVMEYV------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H+ I+HRD++ +N+LL + + DFGLAR
Sbjct: 123 HDNW----ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 29/160 (18%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ G +G V V G+ VA+K K+++ D E+++L +H N++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 467 LIG-FCIEDRRRL----LVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARG 516
L+ +V E +++ L H+ +PL Q RG
Sbjct: 64 LLDILRPPSPEDFNDVYIVTEL-----METDL---HKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
L+YLH ++HRD++P+NIL+ + + + DFGLAR
Sbjct: 116 LKYLHS----ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 27/178 (15%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRG--VLP---DGQAVAVKQHK-LASSQGDHEFCSEV 453
EL L+ F + L E FG +++G LP Q VA+K K + + Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 454 EVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--------YGCHQE------ 499
+++ H N+V L+G +++ +++EY+ G L L GC +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 500 -PLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
L+ IA+ A G+ YL VH+D+ NIL+ + D GL+R
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 20/171 (11%)
Query: 408 FSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHK--LASSQGDHEFCSEVEVLSCAQH 461
F+ L +G FGSV L Q VAVK K + SS EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 462 RNVVMLIGFCIEDRRR------LLVYEYICNGSLDSHLYGCH--QEPLEWSARQ--KIAV 511
NV+ LIG + R + +++ ++ +G L + L +EP + + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
A G+ YL + +HRD+ N +L + V DFGL++ GD
Sbjct: 121 DIASGMEYLSSKN----FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 19/170 (11%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVL-------PDGQAVAVKQHKLASSQGDHEFCSEVE 454
E+A + + L +G FG V+ G+ P+ + ++ AS + EF +E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSAR 506
V+ +VV L+G + + L++ E + G L S+L Q P
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 507 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
++A A G+ YL+ VHRD+ N ++ DF +GDFG+ R
Sbjct: 122 IQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 49/153 (32%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 414 LAEGGFGSVH------RGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVV 465
L EG FG V G G+ VAVK K S G+H + E+E+L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIV 69
Query: 466 MLIGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
G C ED L+ E++ +GSL +L ++ + + K AV +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD+ N+L+ + + +GDFGL +
Sbjct: 129 Q----YVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 50/150 (33%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 417 GGFGSVH---RGVLPDGQAVAV--KQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
G +G V + D A+ V K + +Q D +E ++LS AQ VV L +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY-YS 61
Query: 472 IEDRRRL-LVYEYICNGSLDS--HLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECRV 526
+ ++ L LV EY+ G L S G E AR IA V A L YLH
Sbjct: 62 FQGKKNLYLVMEYLPGGDLASLLENVGSLDED---VARIYIAEIVLA---LEYLH---SN 112
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G I+HRD++P+NIL+ + + DFGL++
Sbjct: 113 G-IIHRDLKPDNILIDSNGHLKLTDFGLSK 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 12/172 (6%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRN 463
F Q L +GGFG V V G+ A K + ++ +G+ +E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
VV L + E + L LV + G L H+Y E A GL LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
E V+RD++P NILL + D GLA P+G+ + RV GT G
Sbjct: 121 EN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 22/152 (14%)
Query: 414 LAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLI 468
L EG + +V++G L D VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLH 70
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEEC 524
++ LV+EY+ + L +L C + ++ Q + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL-----RGLNYCHRRK 124
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
++HRD++P N+L+ E + DFGLAR
Sbjct: 125 ----VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 8e-08
Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRN 463
G F + G +G V++G + GQ A+K + + + E E+ +L + HRN
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRN 64
Query: 464 VVMLIGFCIE------DRRRLLVYEYICNGSLDSHLYGCHQEPL--EWSARQKIAVGAAR 515
+ G I+ D + LV E+ GS+ + L EW A I R
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
GL +LH+ ++HRD++ N+LLT + E + DFG++ Q D +G IGT
Sbjct: 123 GLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 28/166 (16%)
Query: 408 FSQANFLAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA 459
F L G FG V H+G G+ A+K + L Q H E +L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQH-VAQEKSILMEL 75
Query: 460 QHRNVV-MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLE----WSARQKIAVGAA 514
H +V M+ F ++ R + E++ G L +HL + P + + A +A
Sbjct: 76 SHPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA---- 130
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560
YLH + I++RD++P N+LL + V DFG A+ PD
Sbjct: 131 --FEYLHSKD----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
|
Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 414 LAEGGFGSVHR------GVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L +G FG V++ GVL + + K S + ++ E+++L+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKL 67
Query: 468 I-GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ F E+ +L+ E+ G++D+ + + PL + + L YLHE
Sbjct: 68 LDAFYYENNLWILI-EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK-- 123
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I+HRD++ NIL T D + + DFG++
Sbjct: 124 --IIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQ-AVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F++ + +G FG V +G+ Q VA+K L ++ + E E+ VLS V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G ++D + ++ EY+ GS L PL+ + I +GL YLH E +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+ HRD++ N+LL+ E + DFG+A
Sbjct: 123 I----HRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 414 LAEGGFGSVH--RGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV-----LSCAQHRNVVM 466
+ EG +G V R + G+ VA+K+ ++ + + + EV L +H NVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 467 LIGFCIEDR-----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
L C R + LV+E++ + L ++L + + + + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RV VHRD++P NIL+T + + DFGLAR
Sbjct: 128 SH-RV---VHRDLKPQNILVTSSGQIKLADFGLAR 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 35/178 (19%)
Query: 414 LAEGGFGSVH----RGVLP-------------DGQAVAVKQHKL-ASSQGDHEFCSEVEV 455
L EG FG VH G+ VAVK + A+ ++F E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK------- 508
+S + N++ L+ CI ++ EY+ NG L+ L EP E + +
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL--SRHEPQEAAEKADVVTISYS 130
Query: 509 ----IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+A A G++YL VHRD+ N L+ ++ + DFG++R GD
Sbjct: 131 TLIFMATQIASGMKYLSSL----NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 35/194 (18%)
Query: 373 PGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSV----HRGVLP 428
P P S + P S +ELE + N + G G+V HR P
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELE-------RVNRIGSGAGGTVYKVIHR---P 97
Query: 429 DGQAVAVKQHKLASSQGDHE------FCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482
G+ A+K G+HE C E+E+L H NVV + ++ E
Sbjct: 98 TGRLYALK-----VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542
++ GSL+ ++ L ARQ ++ G+ YLH IVHRD++P+N+L+
Sbjct: 153 FMDGGSLEGTHIA-DEQFLADVARQILS-----GIAYLHRRH----IVHRDIKPSNLLIN 202
Query: 543 HDFEPLVGDFGLAR 556
+ DFG++R
Sbjct: 203 SAKNVKIADFGVSR 216
|
Length = 353 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 14/145 (9%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-HEFCSEVEVLS---CAQHRNVVMLIGFC 471
G +G+V+RG +P G+ VA+K L + D + EV +LS +Q N+ G
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY 71
Query: 472 IEDRRRLLVYEYICNGSLDSHLY-GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
++ R ++ EY GS+ + + G E +++ V L+Y+H +VG ++
Sbjct: 72 LKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA----LKYIH---KVG-VI 123
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLA 555
HRD++ NIL+T+ + DFG+A
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 19/42 (45%), Positives = 30/42 (71%), Gaps = 4/42 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RGL+Y+H ++HRD++P+N+L+ D E +GDFG+AR
Sbjct: 118 RGLKYIHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 10/145 (6%)
Query: 417 GGFGSVH--RGVLPDGQAVAVKQHKLASSQGDHEFC--SEVEVLSCAQHRNVVMLIGFCI 472
G FG VH R D + V +KQ + D +E +VL H N++ +
Sbjct: 11 GAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL 69
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
ED+ ++V EY G+L ++ L+ V L ++H + I+HR
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----LILHR 125
Query: 533 DMRPNNILLT-HDFEPLVGDFGLAR 556
D++ NILL H +GDFG+++
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISK 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 39/184 (21%)
Query: 414 LAEGGFGSVHRGVLPDGQA-----------------VAVKQHKL-ASSQGDHEFCSEVEV 455
L EG FG VH + + Q VAVK + A+ ++F EV++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE---------------- 499
LS + N++ L+G C+++ ++ EY+ NG L+ L H +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 500 -PLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
+ +S+ +A+ A G++YL VHRD+ N L+ + + DFG++R
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL----NFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 559 PDGD 562
GD
Sbjct: 189 YAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 5/143 (3%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G + VAVK K + F E ++ QH +V L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ ++ EY+ GSL L + + A G+ Y+ + +HRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 534 MRPNNILLTHDFEPLVGDFGLAR 556
+R N+L++ + DFGLAR
Sbjct: 129 LRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 38/146 (26%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
EG +G V++ G+ VA+K+ +L D S E+ +L H N+V L+
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRL--ETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ + LV+E++ + L ++ L+ + +G+ Y H R ++
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-R---VL 121
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLAR 556
HRD++P N+L+ + + DFGLAR
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 54/172 (31%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRN 463
F Q L +GGFG V V G+ A K+ ++ +G+ +E ++L R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
VV L + E + L LV + G L H+Y + E A GL LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
E IV+RD++P NILL + D GLA P+G ++ RV GT G
Sbjct: 121 ER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 20/143 (13%)
Query: 414 LAEGGFGSVHRGVL---PD------GQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRN 463
L +G F ++++GVL D GQ V+V L S D F ++S H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLH 521
+V L G C+ D ++V EY+ G LD L H+E S K+ V A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFL---HREKNNVSLHWKLDVAKQLASALHYLE 118
Query: 522 EECRVGCIVHRDMRPNNILLTHD 544
++ +VH ++ NIL+
Sbjct: 119 DK----KLVHGNVCGKNILVARY 137
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 29/117 (24%), Positives = 46/117 (39%), Gaps = 8/117 (6%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
E +L H +V L + +D + LV + + G L HL + +
Sbjct: 50 ERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLS--QKVKFSEEQVKFWI 106
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
L YLH + I+HRD++P+NILL + DF +A + T
Sbjct: 107 CEIVLALEYLHSKG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 414 LAEGGFGSVHRGVLPDGQA-VAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G +G V+ Q +A+K+ S+ E+ + S +HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 473 EDRRRLLVYEYICNGSLDSHL------YGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
E+ + E + GSL + L +++ + + +Q + GL+YLH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDN--- 127
Query: 527 GCIVHRDMRPNNILL-THDFEPLVGDFG----LARWQP 559
IVHRD++ +N+L+ T+ + DFG LA P
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 39/147 (26%), Positives = 73/147 (49%), Gaps = 14/147 (9%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ + G A K + S + ++ E+E+L+ H +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 473 EDRRRLLVYEYICNGSLDSHLY----GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
D + ++ E+ G++D+ + G + ++ RQ + L+YLH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSMK---- 130
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLA 555
I+HRD++ N+LLT D + + DFG++
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 24/171 (14%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
+++ + EG +G V++G GQ VA+K+ +L S + S E+ +L QH
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHP 59
Query: 463 NVVMLIGFCIEDRRRLLVYEYIC---NGSLDSHLYGCHQEP-LEWSARQKIAVGAARGLR 518
N+V L +++ R L++E++ LDS G + + L S +I +G+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI----LQGIL 115
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
+ H RV +HRD++P N+L+ + + DFGLAR G+ RV
Sbjct: 116 FCHSR-RV---LHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRV 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 412 NFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ + G +G V G+ VA+K KL+ E+ +L H NV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78
Query: 467 LIG-FCIEDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEEC 524
L+ F Y+ + + L + L Q + RGL+Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS-- 136
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETR 568
G I+HRD++P+NI + D E + DFGLAR D +M V TR
Sbjct: 137 -AG-IIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 44/149 (29%), Positives = 63/149 (42%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K + F E +++ +H +V L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V EY+ GSL L L+ +A A G+ Y+ R+ I HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI-HRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+R NIL+ + DFGLAR D +
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 414 LAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRNVVMLI 468
L EG + +V +G L + VA+K+ +L +G C+ EV +L +H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLH 70
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
D+ LV+EY+ + L ++ C + + RGL Y H
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---- 124
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR 556
++HRD++P N+L+ E + DFGLAR
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL-ASSQG-DHEFCSEVEVLSCAQHRNV 464
F + + EG +G V++ G+ VA+K+ +L ++G E+ +L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
V L+ + + LV+E++ + L + + + +GL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH- 119
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RV +HRD++P N+L+ + + DFGLAR
Sbjct: 120 RV---LHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQ----AVAVK-QHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ +PDG+ VA+K + S + + E E V++ V L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHE 522
+G C+ +L V + + G L ++ Q+ L W V A+G+ YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL-E 126
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
E R +VHRD+ N+L+ + DFGLAR
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F++ + +G FG V++G+ + VA+K L ++ + E E+ VLS +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G ++ + ++ EY+ GS LD G PLE + I +GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER 121
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
++ HRD++ N+LL+ + + DFG+A
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 14/182 (7%)
Query: 399 AELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS 457
+ L G F + G +G V++G + GQ A+K + + + E E+ +L
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLK 67
Query: 458 -CAQHRNVVMLIGFCIE------DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
+ HRN+ G I+ D + LV E+ GS+ + L+ I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
RGL +LH ++HRD++ N+LLT + E + DFG++ Q D +G I
Sbjct: 128 REILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFI 182
Query: 571 GT 572
GT
Sbjct: 183 GT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 47/167 (28%), Positives = 70/167 (41%), Gaps = 15/167 (8%)
Query: 417 GGFGSVHRGV--LPDGQAVAVKQHKLASSQGDHE---FCSEVEVLSCAQHRNVVMLIGFC 471
G FG+V + V DG+ + K+ + + E SEV +L +H N+V
Sbjct: 11 GSFGTVRK-VRRKSDGKILVWKEIDY-GNMTEKEKQQLVSEVNILRELKHPNIVRYYDR- 67
Query: 472 IEDRRRLLVY---EYICNGSLDSHLYGCHQE--PLEWSARQKIAVGAARGLRYLH-EECR 525
I DR +Y EY G L + C +E +E +I L H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
++HRD++P NI L + +GDFGLA+ +T V GT
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 10/145 (6%)
Query: 414 LAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGDHE---FCSEVEVLSCAQHRNVVMLI 468
L G FG + RG L P + + V H L + D + F +E L H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G ++V EY+ NG+LDS L H+ L + G A G++YL E +G
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSE---MG- 127
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFG 553
VH+ + + +L+ D + F
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 36/185 (19%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHE-------FCSEVEVLSCA 459
F + EG +G V++ D G+ VA+K+ +L D+E E+++L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIREIKILRQL 63
Query: 460 QHRNVVMLIGFCIEDRRRL----------LVYEYICN---GSLDSHLYGCHQEPLEWSAR 506
HRN+V L + + L LV+EY+ + G L+S L ++ ++ +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 507 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGV 565
Q + GL Y H++ +HRD++ +NILL + + + DFGLAR + +
Sbjct: 124 QLL-----EGLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 566 ETRVI 570
+VI
Sbjct: 175 TNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 14/144 (9%)
Query: 430 GQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICN 486
GQ VA+K+ ++ E+++L +H N++ L I + V E +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-- 92
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
D H PLE Q RGL+Y+H +VHRD++P+NIL+ + +
Sbjct: 93 -GTDLHRL-LTSRPLEKQFIQYFLYQILRGLKYVHS----AGVVHRDLKPSNILINENCD 146
Query: 547 PLVGDFGLARWQPDGDMG--VETR 568
+ DFGLAR Q D M V TR
Sbjct: 147 LKICDFGLARIQ-DPQMTGYVSTR 169
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKL--ASSQGDHEFCS---EVEVLSCAQH 461
+ + L +G FG V+ D G+ +A KQ + S + E + E+++L QH
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 462 RNVVMLIGFCIEDR--RRLLVY-EYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARG 516
+V G C+ DR + L ++ EY+ GS+ L YG E S +K G
Sbjct: 64 ERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE----SVTRKYTRQILEG 118
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ YLH IVHRD++ NIL +GDFG ++
Sbjct: 119 MSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 18/151 (11%)
Query: 414 LAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIG- 469
L +G +GSV++ VL P G +A+K+ +L + ++ E+++L A +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 470 FCIEDRRRLLVY---EYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
F IE VY EY+ GSLD LY G E + ++I +GL++L EE
Sbjct: 68 FFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I+HRD++P N+L+ + + + DFG++
Sbjct: 123 N---IIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 44/151 (29%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ EG +G V++ D + +A+K+ +L Q D S E+ +L QH N+V
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRL--EQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L ++R LV+EY+ + L H+ + RG+ Y H RV
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-RV 123
Query: 527 GCIVHRDMRPNNILLTHDFEPL-VGDFGLAR 556
+HRD++P N+L+ L + DFGLAR
Sbjct: 124 ---LHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 12/172 (6%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRN 463
F L +GGFG V V G+ A K + ++ +G+ +E ++L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
VV L + E + L LV + G L H+Y + A GL LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
E IV+RD++P NILL + D GLA P+G+ + RV GT G
Sbjct: 121 ER----IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 24/153 (15%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHK----LASSQGDHEFCSEVEVLSCAQHRNVV 465
+ G FG V + GQ A+K + + +Q H +E ++L+ A +V
Sbjct: 9 IGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIV 64
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHE 522
L + +D L LV EY+ G L + L P E AR IA V A L +H
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA---LDSVH- 118
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
++G I HRD++P+NIL+ D + DFGL
Sbjct: 119 --KLGFI-HRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 30/80 (37%), Positives = 48/80 (60%), Gaps = 10/80 (12%)
Query: 479 LVYEYICNGSLDS--HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536
LV EY+ G + S H+YG E + A + I+ A L YLH R G I+HRD++P
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLH---RHG-IIHRDLKP 132
Query: 537 NNILLTHDFEPLVGDFGLAR 556
+N+L++++ + DFGL++
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 39/157 (24%), Positives = 55/157 (35%), Gaps = 18/157 (11%)
Query: 414 LAEGGFGSVHRGVLP------DGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L G FG V V VK K EF E+++ H+NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL-------YGCHQEPLEWSARQKIAVGAARGLRY 519
L+G C E ++ EY G L L PL + + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
L VHRD+ N L++ E V L++
Sbjct: 133 LSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 17/158 (10%)
Query: 412 NFLAEGGFGSVHRGVLPDG-----QAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVV 465
+ L EG FG + G+L D + V VK K +S+ E +L H+N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 466 MLIGFCIEDRRR-LLVYEYICNGSLDSHLYGCH----QEPLEWSARQ--KIAVGAARGLR 518
++ CIED ++Y Y+ G+L L C P S +Q +A+ A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
YLH + G ++H+D+ N ++ + + + D L+R
Sbjct: 132 YLH---KRG-VIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGF 470
L G FG VH G VA+K A ++G + +F E +V+ H +V L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIK----AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
C + + +V E++ NG L ++L G + + S Q + G+ YL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDV----CEGMEYLERN---- 119
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560
+HRD+ N L++ V DFG+ R+ D
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 414 LAEGGFGSVHRGV--LPDGQA-VAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIG 469
L G FG V +GV + Q VA+K K + + E E E++ + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C E +LV E G L+ L G ++ + S ++ + G++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKN----F 116
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD+ N+LL + + DFGL++
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAV-AVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F++ + +G FG V +G+ Q V A+K L ++ + E E+ VLS V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 466 MLIGFCIEDRRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
G ++ + ++ EY+ GS LD G E + ++I +GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL----KGLDYLHSEK 121
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
++ HRD++ N+LL+ + + DFG+A D + T V
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 24/160 (15%)
Query: 410 QANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCA-------QH 461
L G FG V+ D G+ +AVKQ + E EV L C +H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQ--VPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 462 RNVVMLIGFCIED--RRRLLVY-EYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARG 516
+V G C+ D ++L ++ EY+ GS+ L YG E + ++I +G
Sbjct: 64 DRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QG 118
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ YLH IVHRD++ NIL +GDFG ++
Sbjct: 119 VSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 14/146 (9%)
Query: 414 LAEGGFGSVHRG-VLPDGQAVAVKQHKL-ASSQGDHEFCSEVEVL-SCAQHRNVVMLIGF 470
L G G+V++ L + +AVK L + + + SE+E+L C + F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+E+R + E++ GSLD +Y E + +IAV +GL YL I+
Sbjct: 69 FVENRISICT-EFMDGGSLD--VYRKIPEHV----LGRIAVAVVKGLTYLWSLK----IL 117
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLAR 556
HRD++P+N+L+ + + DFG++
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 4/42 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ L+Y+H G ++HRD++P+NILL D + DFGLAR
Sbjct: 118 KALKYIHS----GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 25/161 (15%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FC----SEVEVLSCAQH 461
+ +++ EG +G V P G VA+K K+ S +H+ FC E+++L +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KI--SPFEHQTFCQRTLREIKILRRFKH 62
Query: 462 RNVVMLIGFCIEDRRRLLVYE-----YICNGSLDSHLYGC-HQEPLEWSARQKIAVGAAR 515
N++ I D R +E YI +++ LY + L Q R
Sbjct: 63 ENII-----GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR 117
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
GL+Y+H ++HRD++P+N+LL + + + DFGLAR
Sbjct: 118 GLKYIHS----ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 4/42 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RGL+Y+H ++HRD++P+N+LL + + + DFGLAR
Sbjct: 119 RGLKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 45/153 (29%), Positives = 65/153 (42%), Gaps = 10/153 (6%)
Query: 414 LAEGGFGSV-HRGVLPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +GGFG V V G+ A K+ +L G+ E E+L +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ E + L LV + G L H+Y + LE + G+ +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD- 115
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
IV+RDM+P N+LL + D GLA DG
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 5/47 (10%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPD 560
RGL+YLH I+HRD++P N+L+ + + DFGLAR +PD
Sbjct: 114 RGLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G +G V++ + G+ A+K KL + E+ ++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 473 EDRRRLLVYEYICNGSLDS--HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ + E+ GSL H+ G PL S ++ +GL YLH + ++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKGKM---- 128
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLA 555
HRD++ NILLT + + DFG++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G +G V++ L G+ AVK KL E+ ++ +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 473 EDRRRLLVYEYICNGSLDS--HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ + EY GSL H+ G PL + +GL YLH + ++
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSKGKM---- 128
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLA 555
HRD++ NILLT + + + DFG+A
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 21/49 (42%), Positives = 31/49 (63%), Gaps = 5/49 (10%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
+GL+Y+H I+HRD++P N+ + D E + DFGLAR Q D +M
Sbjct: 129 KGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEM 172
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 18/48 (37%), Positives = 31/48 (64%), Gaps = 3/48 (6%)
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
KIAV + L YLH + V +HRD++P+N+L+ + + + DFG++
Sbjct: 107 KIAVSIVKALEYLHSKLSV---IHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L +G FG V G VA+K K + F E +++ +H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V E++ GSL L + L+ +A A G+ Y+ R+ I HRD
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI-HRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+R NIL+ + + DFGLAR D +
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 9/125 (7%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK+ L Q +EV ++ QH N+V + + +V E++ G+L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 490 -DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548
D + E + + + L +LH + ++HRD++ ++ILLT D
Sbjct: 104 TDIVTHTRMNEE----QIATVCLAVLKALSFLHAQG----VIHRDIKSDSILLTSDGRVK 155
Query: 549 VGDFG 553
+ DFG
Sbjct: 156 LSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 7/125 (5%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK+ L Q +EV ++ QH NVV + + +V E++ G+L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549
+ + +A + + + L LH + ++HRD++ ++ILLTHD +
Sbjct: 105 TDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQG----VIHRDIKSDSILLTHDGRVKL 157
Query: 550 GDFGL 554
DFG
Sbjct: 158 SDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 25/56 (44%), Positives = 35/56 (62%), Gaps = 7/56 (12%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETR 568
RGL+Y+H I+HRD++P+N+ + D E + DFGLAR Q D +M V TR
Sbjct: 129 RGLKYIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 15/156 (9%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEF-CSEVE--VLSCA-QHRNVVMLI 468
L +G FG V L Q A+K K D + C+ VE VLS A +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 469 GFCIEDRRRLL--VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+C + L V EY+ G L H+ CH+ L + A GL++LH +
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKG-- 116
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
IV+RD++ +NILL D + DFG+ + GD
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD 150
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 17/135 (12%)
Query: 430 GQAVAVKQHKL----ASSQGD--HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483
G +AVKQ +S Q + E+ +++ H +++ ++G ED L E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 484 ICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
+ GS+ L YG +E + + +++ RGL YLHE I+HRD++ N+L+
Sbjct: 85 MAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHENQ----IIHRDVKGANLLI 136
Query: 542 THDFEPL-VGDFGLA 555
+ L + DFG A
Sbjct: 137 DSTGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 54/175 (30%), Positives = 75/175 (42%), Gaps = 18/175 (10%)
Query: 408 FSQANFLAEGGFGSVHR-GVLPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRN 463
F L +GGFG V V G+ A K+ ++ +G+ +E +L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR---GLRY 519
VV L + E + L LV + G L H+Y + Q+ AA GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIFYAAELCCGLED 117
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
L E IV+RD++P NILL + D GLA P+G+ V RV GT G
Sbjct: 118 LQRER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVG 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 10/153 (6%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +GGFG V + G+ A K + +L +G+ +E ++L R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ E + L LV + G L H+Y + + A GL +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---- 115
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
IV+RD++P N+LL + D GLA G
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 11/146 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L G GSV + +P G +A K H A S + E++++ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 472 IEDRRRLLVYEYICNGSLD--SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ + + E++ GSLD G P+ KIAV GL YL+ R I
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR---I 125
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLA 555
+HRD++P+NIL+ + + DFG++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVML 467
+ EG FG + +L DG+ +K+ ++ S + E EV VLS +H N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECR 525
E+ +V +Y G L + Q + + Q + V L+++H+
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK- 121
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++ NI LT D +GDFG+AR
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 52/153 (33%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIG-F 470
+ +G +G V++ DG AVK S D E +E +L S H NVV G F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 471 CIEDR----RRLLVYEYICNG----SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
D+ + LV E +CNG L L C Q L+ + I GA GL++LH
Sbjct: 89 YKADKLVGGQLWLVLE-LCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I+HRD++ NNILLT + + DFG++
Sbjct: 147 NR----IIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 38/116 (32%), Positives = 54/116 (46%), Gaps = 20/116 (17%)
Query: 452 EVEVLSCAQHRNVVMLIGFC-----IEDRRR---LLVYEYICNGSLDSHLYGCHQEP--- 500
E+++L +H NVV LI C +R + LV+E+ C + L G
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-C----EHDLAGLLSNKNVK 115
Query: 501 LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
S +K+ GL Y+H I+HRDM+ NIL+T D + DFGLAR
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNK----ILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 8/142 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA+KQ L +E+ V+ +H N+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+V EY+ GSL + + + +A + + A L +LH ++HR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA---LEFLHSNQ----VIHR 139
Query: 533 DMRPNNILLTHDFEPLVGDFGL 554
D++ +NILL D + DFG
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 24/55 (43%), Positives = 33/55 (60%), Gaps = 5/55 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-VETR 568
RGL+Y+H I+HRD++P+N+ + D E + DFGLAR D G V TR
Sbjct: 131 RGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 411 ANFLAE-----GGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQH 461
ANF E G F V+R L D + VA+K+ ++ ++ + E+++L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRY 519
NV+ + IED +V E G L + ++ R K V + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557
+H ++HRD++P N+ +T +GD GL R+
Sbjct: 122 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRF 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 22/159 (13%)
Query: 408 FSQANFLAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA 459
F ++ G +G+V H+ Q A+K Q+ + +Q F E ++L+ A
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVF-VERDILTFA 58
Query: 460 QHRNVVMLIGFC-IEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGL 517
++ VV + FC E +R L +V EY+ G + L P++ AR A L
Sbjct: 59 ENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFA-ETVLAL 114
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
YLH IVHRD++P+N+L+T + DFGL++
Sbjct: 115 EYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 7/156 (4%)
Query: 402 ELATGGFSQANFLAEGGFGSVHR-GVLPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCA 459
EL F + + L G G V + P G +A K H ++ E++VL
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
+V G D + E++ GSLD L + P E + IAV RGL Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAY 118
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
L E+ + I+HRD++P+NIL+ E + DFG++
Sbjct: 119 LREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQ-HKLASSQGDHEFCSEVE--VLSCAQHRNVVMLIG 469
L +G FG V L G+ AVK K Q D C+ E +LS A++ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 470 FCIEDRRRLL-VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
C + RL V E++ G L H+ + + + + A L +LH++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKG---- 116
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I++RD++ +N+LL H+ + DFG+ +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 17/167 (10%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQHRNVVML 467
+ +G +G V HR DG+ +K+ L AS + E ++LS +H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 468 I-GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ ED +V + G L L + L + + V A L+YLHE+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGT 572
I+HRD++ N+ LT VGD G+AR + DM + +IGT
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 31/140 (22%), Positives = 62/140 (44%), Gaps = 15/140 (10%)
Query: 414 LAEGGFGSVHRGV---LPDGQAVAVKQHKLASSQGDHEFCSE-----VEVLSCAQHRNVV 465
L +G F + +G+ + D + + L H SE ++S H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEEC 524
+ G C+ ++V EY+ GSLD++L + W + ++A A L +L ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 525 RVGCIVHRDMRPNNILLTHD 544
+ H ++ N+LL +
Sbjct: 120 ---GLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 5/43 (11%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILL-THDFEPLVGDFGLAR 556
RGL+Y+H ++HRD++P N+ + T D +GDFGLAR
Sbjct: 125 RGLKYIHS----ANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE--YICNGSLDSHLYGCHQEPLEWSARQKI 509
E+ ++ C H+N++ L+ ++ L ++ YI +D++L Q L+ +
Sbjct: 73 ELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G+++LH I+HRD++P+NI++ D + DFGLAR
Sbjct: 132 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
E++ GSLD L + P + IAV RGL YL E+ + I+HRD++P+NIL+
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGLTYLREKHK---IMHRDVKPSNILV 133
Query: 542 THDFEPLVGDFGLA 555
E + DFG++
Sbjct: 134 NSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE--YICNGSLDSHLYGCHQEPLEWSARQKI 509
E+ ++ C H+N++ L+ ++ L ++ Y+ +D++L Q L+ +
Sbjct: 66 ELVLMKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G+++LH I+HRD++P+NI++ D + DFGLAR
Sbjct: 125 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 413 FLAEGGFGSVHRGVLPD-GQAVAVKQHKL-----ASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V+ D G+ +AVKQ + +S+ + E+++L H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 467 LIGFCIEDRRRLL--VYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHE 522
G + R L E++ GS+ L YG E + ++I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
IVHRD++ NIL +GDFG ++
Sbjct: 125 NM----IVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 31/110 (28%), Positives = 46/110 (41%), Gaps = 31/110 (28%)
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA------ 514
H+N+ L I V+ N LY ++E +E Q I G
Sbjct: 61 HKNITCLYDMDI-------VFPGNFNE-----LY-LYEELMEADLHQIIRSGQPLTDAHF 107
Query: 515 --------RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
GL+Y+H ++HRD++P N+L+ D E + DFGLAR
Sbjct: 108 QSFIYQILCGLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 44/153 (28%), Positives = 66/153 (43%), Gaps = 13/153 (8%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIG-F 470
G +GSV + G+ VA+K KL+ F E+ +L QH NV+ L+ F
Sbjct: 26 GAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVF 83
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
Y+ + + L PL Q + GL+Y+H I+
Sbjct: 84 TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS----AGII 139
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
HRD++P N+ + D E + DFGLAR D +M
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR-HADAEM 171
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 35/121 (28%), Positives = 51/121 (42%), Gaps = 14/121 (11%)
Query: 454 EVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG 512
E + +H +V L C + + V EY G L H+ H + A
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAAC 109
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
GL+YLHE IV+RD++ +N+LL + + DFGL + MG R T
Sbjct: 110 VVLGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRT-ST 160
Query: 573 F 573
F
Sbjct: 161 F 161
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 7/107 (6%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE--YICNGSLDSHLYGCHQEPLEWSARQKI 509
E+ +L C H+N++ L+ ++ L ++ Y+ +D++L L+ +
Sbjct: 70 ELVLLKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G+++LH I+HRD++P+NI++ D + DFGLAR
Sbjct: 129 LYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 16/158 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLP-----DGQAVAVKQHK----LASSQGDHEFCSEVEVLSC 458
+ NF+ G GS R +L D VA+K+ + + Q DH F SE ++L+
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNY 87
Query: 459 AQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLR 518
H V L G ++ LV E++ G + L + P + A +
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP------NDVGCFYAAQIV 141
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ E + IV+RD++P N+LL D + DFG A+
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 26/162 (16%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS--------------EVEVL 456
L EG +G V + G+ VA+K+ K+ D E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 457 SCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK--IAVGAA 514
+ +H N++ L+ +E LV + + S L + + Q I +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
GL LH+ +HRD+ P NI + + DFGLAR
Sbjct: 130 NGLNVLHKWY----FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 471 CIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKI-AVGAARGLRYLHEECRVGC 528
C + + RL V EY+ G L H+ + R + A GL++LHE
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP---RARFYAAEIVLGLQFLHERG---- 116
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I++RD++ +N+LL + + DFG+ +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 26/116 (22%)
Query: 451 SEVEVLSCAQHRNVVMLIGFCIE-DRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
+E VL H ++ L F E D+R L ++ EY+ G L S+L +
Sbjct: 50 NEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL----------RNSGR 97
Query: 509 IAVGAAR--------GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ L YLH + IV+RD++P NILL + + DFG A+
Sbjct: 98 FSNSTGLFYASEIVCALEYLHSKE----IVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 414 LAEGGFGSVHRG-VLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA--QHRNVVMLIGF 470
+ EG FG ++ D + +K+ L + S+ EV+ A +H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECRVGC 528
E+ R +V EY G L + Q + +S Q ++ V + GL+++H+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRIN--RQRGVLFSEDQILSWFVQISLGLKHIHDR----K 121
Query: 529 IVHRDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETRVIGT 572
I+HRD++ NI L+ + +GDFG+AR Q + M + +GT
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 33/125 (26%), Positives = 57/125 (45%), Gaps = 7/125 (5%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK+ L Q +EV ++ H NVV + + +V E++ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549
+ + + + + R L YLH + ++HRD++ ++ILLT D +
Sbjct: 107 TDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG----VIHRDIKSDSILLTSDGRIKL 159
Query: 550 GDFGL 554
DFG
Sbjct: 160 SDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 15/158 (9%)
Query: 411 ANFLAE-----GGFGSVHRGV-LPDGQAVAVKQHK---LASSQGDHEFCSEVEVLSCAQH 461
ANF E G F V+R L DG VA+K+ + L ++ + E+++L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRY 519
NV+ IED +V E G L + + + + K V L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557
+H ++HRD++P N+ +T +GD GL R+
Sbjct: 122 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRF 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 47/180 (26%), Positives = 74/180 (41%), Gaps = 31/180 (17%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHK-LASSQGDHEFCSE 452
E+ L+T F + L E FG V++G L QAVA+K K A EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 453 VEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEP------------ 500
+ S QH N+V L+G +++ +++ Y + L H + + P
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL--HEFLVMRSPHSDVGSTDDDKT 116
Query: 501 ----LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
LE + I A G+ +L +VH+D+ N+L+ + D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538
LV EY+ G S + P +W A+Q IA G+ LH+ I+HRD++P N
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQRG----IIHRDIKPEN 127
Query: 539 ILLTHDFEPLVGDFGLARWQPDGDMGVET-RVIGT 572
+L+ + DFGL+R G+E + +GT
Sbjct: 128 LLIDQTGHLKLTDFGLSR------NGLENKKFVGT 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 8/143 (5%)
Query: 430 GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489
G+ VAVK L Q +EV ++ QH+NVV + + ++ E++ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549
+ Q L + + L YLH + ++HRD++ ++ILLT D +
Sbjct: 106 TDIV---SQTRLNEEQIATVCESVLQALCYLHSQG----VIHRDIKSDSILLTLDGRVKL 158
Query: 550 GDFGLARWQPDGDMGVETRVIGT 572
DFG Q D+ ++GT
Sbjct: 159 SDFGFCA-QISKDVPKRKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 10/143 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA+KQ L +E+ V+ ++ N+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 473 EDRRRLLVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+V EY+ GSL D C E + + L +LH ++H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALDFLHSNQ----VIH 138
Query: 532 RDMRPNNILLTHDFEPLVGDFGL 554
RD++ +NILL D + DFG
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 36/165 (21%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-----FCSEVEVL-SCAQHRNVVM 466
+ EG +G V++ G+ VA+K+ +L D E E+ +L ++ +V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEM---DEEGIPPTALREISLLQMLSESIYIVR 65
Query: 467 LIGFCIEDRRR-------LLVYEYICNGSLDSHL-------YGCHQEPLEWSARQKIAVG 512
L+ +E LV+EY LDS L PL +
Sbjct: 66 LL--DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLAR 556
+G+ + H+ ++HRD++P N+L+ L + D GL R
Sbjct: 119 LLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 34/146 (23%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQH-RNVVMLIG- 469
+ G FG+V++ + G +AVK+ + + + +++V+ + +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 470 --------FCIE------DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
C+E D+ VYE + + + G KIAV +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILG------------KIAVATVK 118
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILL 541
L YL EE + I+HRD++P+NILL
Sbjct: 119 ALNYLKEELK---IIHRDVKPSNILL 141
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 17/41 (41%), Positives = 27/41 (65%), Gaps = 4/41 (9%)
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G+++LH I+HRD++P+NI++ D + DFGLAR
Sbjct: 130 GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 14/134 (10%)
Query: 430 GQAVAVKQ-HKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
G+ VA+K+ + + D E+++L +H ++V + + RR Y+
Sbjct: 25 GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84
Query: 488 SLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542
++S L HQ + L Q R L+Y+H + HRD++P NIL
Sbjct: 85 LMESDL---HQVIKANDDLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILAN 137
Query: 543 HDFEPLVGDFGLAR 556
D + + DFGLAR
Sbjct: 138 ADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 10/143 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA++Q L +E+ V+ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 473 EDRRRLLVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+V EY+ GSL D C E + + L +LH ++H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSNQ----VIH 139
Query: 532 RDMRPNNILLTHDFEPLVGDFGL 554
RD++ +NILL D + DFG
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH-----EFCSEVEVLSCAQHRNVVMLI 468
L G FG+V +G+ ++ K+ + + E E V+ + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV--GAARGLRYLHEECRV 526
G C E +LV E G L+ L Q+ + + + + G++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
VHRD+ N+LL + DFGL++
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV 511
E++VL +V G D + E++ GSLD L + P + + IAV
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+GL YL E+ + I+HRD++P+NIL+ E + DFG++
Sbjct: 113 --IKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 23/124 (18%), Positives = 44/124 (35%), Gaps = 25/124 (20%)
Query: 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGH 81
+++VAV S+E AL WA + G + LL VV S
Sbjct: 1 RILVAVDGSEE-SERALRWAARLARRLGAELVLLHVVDPPPSS----------------- 42
Query: 82 RKSFSGTISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAG 141
+E + + ++ L + + + ++ G P A+ A++ A
Sbjct: 43 -------AAELAELLEEEARALLEALREALAEAGVKVETVVLEGDPAEAILEAAEELGAD 95
Query: 142 WVVL 145
+V+
Sbjct: 96 LIVM 99
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQ------AVAV-KQHKLASSQGDHEFC-SEVEVLSCAQHRNVV 465
L +GG+G V + G A+ V K+ + +Q D +E +L +H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAARGLRYLHEE 523
LI + L+ EY+ G L HL G E +I++ L +LH++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLHQQ 119
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I++RD++P NILL + DFGL +
Sbjct: 120 G----IIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 12/155 (7%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +GGFG V + G+ A K+ +L +G E +L+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA--RGLRYLHEECRV 526
+ + + L LV + G L H+Y +E + + A GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
I++RD++P N+LL +D + D GLA DG
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 39/149 (26%), Positives = 58/149 (38%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V VAVK K S F +E V+ QH +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
++ E++ GSL L + A G+ ++ + +HRD
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+R NIL++ + DFGLAR D +
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 20/60 (33%), Positives = 32/60 (53%), Gaps = 12/60 (20%)
Query: 504 SARQKIAV--------GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+A++ IA+ R ++YLHE I+HRD++ NI + H + +GDFG A
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.002
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 414 LAEGGFGSVHR-GVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L GGFG V V + A+K +H + + Q +H F E E+L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 469 -GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL--EWSARQKIAVGAARGLRYLHEEC 524
F +D++ + ++ EY G L + L L E++AR IA YLH
Sbjct: 60 RTF--KDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIA-CVVLAFEYLHNRG 113
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I++RD++P N+LL + + DFG A+
Sbjct: 114 ----IIYRDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 33/180 (18%)
Query: 408 FSQANFLAEGGFGSV----HRGVLPDGQAVAVKQHKLASSQGDHEF----CSEVEVLSCA 459
F + EG +G V H+ + VA+K+ K S+ + E E+++L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKET---KEIVAIKKFK--DSEENEEVKETTLRELKMLRTL 57
Query: 460 QHRNVVMLI-GFCIEDRRR---LLVYEYICNGSLD---SHLYGCHQEPLEWSARQKIAVG 512
+ N+V L F RRR LV+EY+ L+ G E + Q I
Sbjct: 58 KQENIVELKEAF----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI--- 110
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+ + + H+ IVHRD++P N+L++H+ + DFG AR +G T + T
Sbjct: 111 --KAIHWCHKND----IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 27/80 (33%), Positives = 37/80 (46%), Gaps = 12/80 (15%)
Query: 480 VYEYICNGSLDSHLY--GCHQEPLEWSARQKI-AVGAARGLRYLHEECRVGCIVHRDMRP 536
V +Y+ G L HL EP R + A A L YLH I++RD++P
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN----IIYRDLKP 124
Query: 537 NNILLTHDFEPLVGDFGLAR 556
NILL ++ DFGL +
Sbjct: 125 ENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 18/155 (11%)
Query: 412 NFLAEGGFGSVHRGVLPD----GQAVAVK-QHKLASSQGDHEFCSEVE--VLSCAQHRNV 464
NFL G GS + +L + + A+K K Q D C+ VE VL+
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLH 521
+ + C + RL V EY+ G L H+ G +EP +I+VG L +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLH 118
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I++RD++ +N++L + + DFG+ +
Sbjct: 119 RRG----IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 37.2 bits (87), Expect = 0.003
Identities = 18/54 (33%), Positives = 23/54 (42%), Gaps = 16/54 (29%)
Query: 389 FGKPPRWFSYAELE---LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVK-QH 438
G P +AE + +A +Q VHR VL DG+ VAVK Q
Sbjct: 3 LGAPVE-EVFAEFDEEPIAAASIAQ-----------VHRAVLKDGEEVAVKVQR 44
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 34/148 (22%), Positives = 67/148 (45%), Gaps = 8/148 (5%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
+++ + +G G+V + + GQ VA+KQ L +E+ V+ ++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ + +V EY+ GSL + + + +A + + L +LH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA---VCRECLQALEFLH----A 133
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGL 554
++HRD++ +N+LL D + DFG
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 574 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.95 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.95 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.93 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.93 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.92 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.92 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.92 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.92 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.92 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.92 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.92 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.92 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.92 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.92 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.92 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.92 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.92 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.91 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.91 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.91 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.91 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.91 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.91 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.91 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.91 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.91 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.9 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.9 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.9 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.9 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.9 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.9 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.9 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.9 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.9 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.9 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.9 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.9 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.9 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.9 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.9 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.9 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.89 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.89 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.89 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.89 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.89 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.89 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.89 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.89 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.89 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.89 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.89 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.89 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.89 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.89 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.89 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.89 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.89 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.89 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.88 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.88 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.88 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.88 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.88 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.88 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.88 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.88 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.88 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.88 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.88 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.88 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.88 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.88 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.88 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.88 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.88 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.88 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.88 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.88 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.88 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.88 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.88 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.88 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.87 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.87 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.87 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.87 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.87 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.87 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.87 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.87 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.87 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.87 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.87 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.87 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.87 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.87 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.87 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.87 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.87 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.87 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.87 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.87 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.87 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.86 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.86 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.86 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.86 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.86 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.86 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.86 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.86 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.86 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.86 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.86 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.86 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.86 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.86 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.86 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.86 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.86 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.86 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.85 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.85 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.85 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.85 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.85 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.85 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.85 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.85 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.85 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.85 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.85 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.85 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.84 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.84 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.84 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.84 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.84 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.84 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.84 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.84 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.83 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.83 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.83 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.83 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.83 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.83 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.83 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.83 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.83 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.83 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.83 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.83 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.83 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.82 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.82 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.82 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.82 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.82 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.81 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.81 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.81 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.81 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.81 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.8 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.79 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.79 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.79 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.78 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.78 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.78 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.78 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.77 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.75 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.75 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.74 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.71 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.68 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.64 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.68 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.48 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.21 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.02 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.01 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.0 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.74 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 97.58 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.52 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 97.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.46 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.32 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.24 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.0 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.86 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.66 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 96.64 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 96.63 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 96.44 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.44 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.3 | |
| PLN02236 | 344 | choline kinase | 96.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.2 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.17 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.13 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 95.81 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.68 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.65 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.55 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 95.37 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.26 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 95.17 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 94.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.89 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.67 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=302.91 Aligned_cols=182 Identities=56% Similarity=0.960 Sum_probs=158.8
Q ss_pred CCCccchhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEE
Q 008201 392 PPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471 (574)
Q Consensus 392 ~~~~fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 471 (574)
+.+.|++.++..+|++|...+.||+|+||.||+|.+.+|..||||.+.....+...+|..|+.+|.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56889999999999999999999999999999999999999999987765443145699999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 472 IEDR-RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 472 ~~~~-~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
.+.+ ..+|||||+++|+|.++|+.....+++|..+++|+.++|+||+|||+.|.+ .|||||||++|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCEEcc
Confidence 9988 599999999999999999863332899999999999999999999999865 59999999999999999999999
Q ss_pred eecceeecCCCCCCccceeeccCC
Q 008201 551 DFGLARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 551 DFGLAr~~~~~~~~~~t~v~GT~G 574 (574)
|||||+..+.......+...||+|
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~g 243 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFG 243 (361)
T ss_pred CccCcccCCccccceeeecCCCCc
Confidence 999998765412222222278876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=277.23 Aligned_cols=161 Identities=29% Similarity=0.438 Sum_probs=142.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.++|...+.||.|+||+||+|++ .++..||||.+.... ....+.+..|+.+|+.++|||||.|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788888999999999999994 468999999987663 333456889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC------CcEEEeeecce
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD------FEPLVGDFGLA 555 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~------~~vKLsDFGLA 555 (574)
|||.||+|..+|. ..+.+++..++.++.||+.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999997 456899999999999999999999999 99999999999999864 46899999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
|.+.++.+ ..++||+|
T Consensus 163 R~L~~~~~--a~tlcGSp 178 (429)
T KOG0595|consen 163 RFLQPGSM--AETLCGSP 178 (429)
T ss_pred hhCCchhH--HHHhhCCc
Confidence 99986654 34688886
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.38 Aligned_cols=163 Identities=28% Similarity=0.413 Sum_probs=142.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc-------hhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG-------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~-------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
..+.|.+.+.||+|+||.|-+|. ..+|+.||||+++...... ...+.+|+++|++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45568899999999999999998 6689999999987643221 124579999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC---CcEEEeee
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDF 552 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~---~~vKLsDF 552 (574)
..||||||+.||+|.+++- .++.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999997 567788888899999999999999999 99999999999999766 78999999
Q ss_pred cceeecCCCCCCccceeeccCC
Q 008201 553 GLARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 553 GLAr~~~~~~~~~~t~v~GT~G 574 (574)
|||++...+ ....++||||+
T Consensus 324 GlAK~~g~~--sfm~TlCGTps 343 (475)
T KOG0615|consen 324 GLAKVSGEG--SFMKTLCGTPS 343 (475)
T ss_pred chhhccccc--eehhhhcCCcc
Confidence 999988643 34567999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=270.40 Aligned_cols=161 Identities=27% Similarity=0.412 Sum_probs=146.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
..|...++||+|||+.||.++. .+|+.||+|++... .....+.+.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999995 78999999998753 3344567999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|+|..++|..++. ..+++++.++++++.||+.||.|||++ +|||||||..||+|+++.++||+|||||..+...
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999987 678899999999999999999999999 9999999999999999999999999999988754
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
+. ...++||||
T Consensus 172 ~E-rk~TlCGTP 182 (592)
T KOG0575|consen 172 GE-RKKTLCGTP 182 (592)
T ss_pred cc-ccceecCCC
Confidence 43 335799998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=257.94 Aligned_cols=162 Identities=25% Similarity=0.312 Sum_probs=144.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
..+|+++++||+|+||.||.++. .+++.+|+|+++.... ...+....|..||..++||+||.++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 34799999999999999999994 5699999999886533 2334678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+||+.||.|..+|. +.+.+++..+..++.+|+.||.|||+. |||||||||+|||||.+|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999997 578899999999999999999999999 999999999999999999999999999996544
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
.+. .+.++|||+
T Consensus 178 ~~~-~t~tfcGT~ 189 (357)
T KOG0598|consen 178 DGD-ATRTFCGTP 189 (357)
T ss_pred CCC-ccccccCCc
Confidence 333 445699997
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=253.97 Aligned_cols=158 Identities=28% Similarity=0.406 Sum_probs=138.8
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-RRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LVmEy 483 (574)
+++.++.||+|..|+||++.+ .+++.+|+|.+..... ...+++.+|+++|+.++|||||.+||.|..++ .++|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 345567899999999999995 5799999999965533 33468999999999999999999999999998 49999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|.+|+|+.++. ..+++++.....|+.+|++||.|||+ + +||||||||+|||++..|++||||||.++.+.+.
T Consensus 160 MDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999997 34789999999999999999999997 5 8999999999999999999999999999988654
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
...+++||.
T Consensus 233 --~a~tfvGT~ 241 (364)
T KOG0581|consen 233 --IANTFVGTS 241 (364)
T ss_pred --hcccccccc
Confidence 335678874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=258.60 Aligned_cols=161 Identities=33% Similarity=0.471 Sum_probs=137.6
Q ss_pred eEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEEEEecC
Q 008201 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-RRLLVYEYIC 485 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~LVmEy~~ 485 (574)
...+.||.|+||.||+|.+.....||||++....... .+.|.+|+.+|.+++|||||+++|+|..+. ..+|||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445599999999999998554459999988644322 458999999999999999999999999887 7999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC-eEeeCCCCCCeEEcCCC-cEEEeeecceeecCCCCC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC-IVHRDMRPNNILLTHDF-EPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g-IIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~~~~~ 563 (574)
+|+|..+++......+++..++.|+.+|++||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999864578899999999999999999999999 7 99999999999999997 99999999999876432
Q ss_pred CccceeeccCC
Q 008201 564 GVETRVIGTFG 574 (574)
Q Consensus 564 ~~~t~v~GT~G 574 (574)
...+...||++
T Consensus 199 ~~~~~~~GT~~ 209 (362)
T KOG0192|consen 199 TSMTSVAGTYR 209 (362)
T ss_pred ccccCCCCCcc
Confidence 12233677763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=256.83 Aligned_cols=152 Identities=24% Similarity=0.387 Sum_probs=134.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 479 (574)
...|..++.||+|+||.||+|+ ..+|+.||+|++..... .......+||.||++|+||||++|.+..... ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457778899999999999999 67899999999887653 3345678999999999999999999998876 68999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+||| ..+|.-++.. ..-.|++.++..|+.||+.||.|||.+ ||+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 99999 6788887753 455799999999999999999999999 99999999999999999999999999999886
Q ss_pred CCC
Q 008201 560 DGD 562 (574)
Q Consensus 560 ~~~ 562 (574)
...
T Consensus 270 ~~~ 272 (560)
T KOG0600|consen 270 PSG 272 (560)
T ss_pred CCC
Confidence 544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=238.97 Aligned_cols=157 Identities=27% Similarity=0.321 Sum_probs=141.5
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+|...+.||.|+||.|.+++ ..+|..+|+|++.....- ..+-..+|..+|+.+.||+++++++.|.+.+++|||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 57888999999999999999 446899999998765332 23457889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|++||.|..+++ ..+++++..++.++.||+.||+|||.. +|++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 125 yv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred ccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999997 567899999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
+-++||||
T Consensus 198 ---T~TlCGTP 205 (355)
T KOG0616|consen 198 ---TWTLCGTP 205 (355)
T ss_pred ---EEEecCCc
Confidence 45799998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=248.61 Aligned_cols=165 Identities=27% Similarity=0.410 Sum_probs=143.9
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC----CC-cchhHHHHHHHHHHhcC-CCCeeEEEEEEEeC
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA----SS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIED 474 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~----~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~ 474 (574)
....++|.+.+.||+|+||.|+.|. ..+|..||+|++... .. ...+.+.+|+.+++.++ ||||++++.++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3456789999999999999999998 557899999977653 12 23346778999999999 99999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeec
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFG 553 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFG 553 (574)
..+|+||||+.||+|.+++.. .+++.+..+..+++|++.|++|||++ ||+||||||+|||++.+ +++||+|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999999974 67899999999999999999999999 99999999999999999 999999999
Q ss_pred ceeecCCCCCCccceeeccC
Q 008201 554 LARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~ 573 (574)
++.... .......+.|||+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp 185 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSP 185 (370)
T ss_pred cccccC-CCCCcccCCCCCc
Confidence 999874 2222345688886
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=235.85 Aligned_cols=152 Identities=27% Similarity=0.455 Sum_probs=137.1
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.+|...+.||+|.||.||+|+ ..+|+.||||+++.....+ .....+||..|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 367888999999999999999 6789999999998764432 2468899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|+ ..+|+..+.+ ....++...+..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||||+.+...+
T Consensus 82 fm-~tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 6799998875 567899999999999999999999999 89999999999999999999999999999887554
Q ss_pred C
Q 008201 563 M 563 (574)
Q Consensus 563 ~ 563 (574)
.
T Consensus 156 ~ 156 (318)
T KOG0659|consen 156 R 156 (318)
T ss_pred c
Confidence 3
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=251.79 Aligned_cols=151 Identities=26% Similarity=0.342 Sum_probs=136.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC---CCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 479 (574)
..+|..++.||+|+|++|++|+ ..+++.||||++... .....+.+.+|-++|..| .||.|++||..|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3468888999999999999999 667999999988643 223345678899999999 79999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+||+++|+|.++|. ..+.|++..++.++.+|+.||+|||++ |||||||||+|||||.++++||+|||.|+.+.
T Consensus 152 vLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999997 568899999999999999999999999 99999999999999999999999999999886
Q ss_pred CC
Q 008201 560 DG 561 (574)
Q Consensus 560 ~~ 561 (574)
+.
T Consensus 226 ~~ 227 (604)
T KOG0592|consen 226 PS 227 (604)
T ss_pred hh
Confidence 53
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=253.27 Aligned_cols=159 Identities=30% Similarity=0.423 Sum_probs=141.6
Q ss_pred hHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 399 AELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 399 ~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..+++....+..++.||+|.||.||.|.+.....||+|.++... ...+.|.+|+++|++|+|+|||+|+++|..++.+|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 34455555566778899999999999999777799999998653 44567999999999999999999999999988999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
||||||+.|+|.++|.......+.....+.++.|||+|++||.++ ++|||||.++||||+++..+||+||||||..
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999876678899999999999999999999999 8999999999999999999999999999965
Q ss_pred CCCC
Q 008201 559 PDGD 562 (574)
Q Consensus 559 ~~~~ 562 (574)
.++.
T Consensus 354 ~d~~ 357 (468)
T KOG0197|consen 354 GDDE 357 (468)
T ss_pred CCCc
Confidence 5443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=247.89 Aligned_cols=161 Identities=21% Similarity=0.369 Sum_probs=144.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcch---hHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~---~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
..+|.+.+.||+|.||.|-+++ ...|+.||||.++...-.+. -.+.+||+||+.|+||||+.+|.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4468888999999999999998 56799999998886654433 3578999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||..+|.|++++. ..+.|++.++..+++||..|+.|+|.+ +++|||||.+|||||.++++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998 567899999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
+.. .+++||+|
T Consensus 206 ~kf--LqTFCGSP 216 (668)
T KOG0611|consen 206 KKF--LQTFCGSP 216 (668)
T ss_pred ccH--HHHhcCCc
Confidence 553 45688876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-28 Score=246.06 Aligned_cols=166 Identities=27% Similarity=0.384 Sum_probs=142.8
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEE-EEEeCCe-EEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIG-FCIEDRR-RLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g-~~~~~~~-~~LVm 481 (574)
+|.+++.||.|.||.||++. +.+|..+|.|.++.... ...+.+..|+.+|+.|+|||||++++ .|..++. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 57788899999999999998 77999999998875433 33457899999999999999999999 5666666 89999
Q ss_pred EecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|||.+|+|.+++... ..+.+++..+++++.|++.||..+|...+.+-|+||||||.||+|+..|.+||+||||+|.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999998532 467899999999999999999999995443459999999999999999999999999999886
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
... .....++|||
T Consensus 180 s~~-tfA~S~VGTP 192 (375)
T KOG0591|consen 180 SKT-TFAHSLVGTP 192 (375)
T ss_pred chh-HHHHhhcCCC
Confidence 544 3556789997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=238.59 Aligned_cols=147 Identities=25% Similarity=0.350 Sum_probs=128.0
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-c-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-G-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.|+.+..+|+|+||.||+|+. .+|+.||||++...... . .+-..+||.+|+.++|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 577788999999999999995 46999999998744321 1 23478999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+.. +.+.|.. ....++...+..|+.|++.|+.|+|.+ ++|||||||+||||+.+|.+||||||+||.+.
T Consensus 83 ~dhT-vL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 83 CDHT-VLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred cchH-HHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9554 4444443 456789999999999999999999999 89999999999999999999999999999887
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=245.37 Aligned_cols=150 Identities=21% Similarity=0.279 Sum_probs=136.3
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|.++.+||+|+||.||+|+ ..+|..+|+|+++...... .+-++.|-.+|...++|+||+||..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45679999999999999999999 4569999999998654433 3457889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||++||++..+|. ..+.|++..+++++.+++.|++-||.. |+|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999997 578899999999999999999999999 99999999999999999999999999997543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=235.43 Aligned_cols=163 Identities=30% Similarity=0.398 Sum_probs=137.3
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--RRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LVmE 482 (574)
.+|...+.||+|+||.||++... +|...|||..........+.+.+|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35677889999999999999954 49999999887664333567899999999999999999999855444 6899999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeecCC-
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPD- 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~~~- 560 (574)
|+++|+|.+++.+... .|++..++.+.+||++||.|||++ |||||||||+||||+. ++.+||+|||+|+....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999986433 799999999999999999999998 9999999999999999 79999999999997753
Q ss_pred -CCCCccceeeccC
Q 008201 561 -GDMGVETRVIGTF 573 (574)
Q Consensus 561 -~~~~~~t~v~GT~ 573 (574)
........+.||+
T Consensus 172 ~~~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 172 GTKSDSELSVQGTP 185 (313)
T ss_pred cccccccccccCCc
Confidence 1112233466664
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=246.27 Aligned_cols=165 Identities=25% Similarity=0.344 Sum_probs=143.0
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCC
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDR 475 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~ 475 (574)
..+...+|..+++||+|.||+|+++.. .+++.+|||.++...- .+.+....|..|+..+. ||.+++|+.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 345567899999999999999999995 4689999999987643 34456788988888775 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
++|+||||+.||++..+. ..+.+++..+..|+..|+.||+|||++ ||||||||.+|||||.+|++||+||||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecccccc
Confidence 999999999999954444 467899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
|.....+ ..++++||||
T Consensus 516 Ke~m~~g-~~TsTfCGTp 532 (694)
T KOG0694|consen 516 KEGMGQG-DRTSTFCGTP 532 (694)
T ss_pred cccCCCC-CccccccCCh
Confidence 9654222 2567899997
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=237.85 Aligned_cols=166 Identities=20% Similarity=0.267 Sum_probs=141.0
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
+....++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 445567899999999999999999995 468899999986422 1223457889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+||||+++|+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999985 34688999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCCCccceeeccC
Q 008201 557 WQPDGDMGVETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~ 573 (574)
.+...........+||+
T Consensus 191 ~~~~~~~~~~~~~~gt~ 207 (370)
T cd05621 191 KMDETGMVRCDTAVGTP 207 (370)
T ss_pred ecccCCceecccCCCCc
Confidence 77543332223456665
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=232.80 Aligned_cols=150 Identities=28% Similarity=0.409 Sum_probs=131.3
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVm 481 (574)
.|+.++.|++|+||.||+|+ ..+++.||+|+++...... .-.-.+||.+|.+++|||||.+..+... -+.+||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 47778899999999999999 5679999999988654322 1246899999999999999999988764 45799999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||| ..+|..+|.. ..+++...++..++.|+++||+|||.+ .|+|||||++|+|+++.|.+||+||||||.+.+.
T Consensus 157 e~~-EhDLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYV-EHDLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHH-HhhHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999 6789998875 457899999999999999999999999 9999999999999999999999999999988765
Q ss_pred C
Q 008201 562 D 562 (574)
Q Consensus 562 ~ 562 (574)
.
T Consensus 231 ~ 231 (419)
T KOG0663|consen 231 L 231 (419)
T ss_pred c
Confidence 3
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.01 Aligned_cols=148 Identities=21% Similarity=0.306 Sum_probs=133.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.+|..++||||++++++|...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999995 468999999987532 223345788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999986 345799999999999999999999999 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=235.03 Aligned_cols=148 Identities=22% Similarity=0.298 Sum_probs=132.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.++..++|+||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3689999999999999999984 468999999987532 122346788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++|+|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999986 356799999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-26 Score=239.22 Aligned_cols=164 Identities=27% Similarity=0.382 Sum_probs=136.2
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--------------cchhHHHHHHHHHHhcCCCCeeEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--------------QGDHEFCSEVEVLSCAQHRNVVML 467 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--------------~~~~~f~~Ei~iL~~L~HpNIV~L 467 (574)
...+.|.+...||+|.||.|-+|+ ..+++.||||++..... ...+.+.+||.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 445789999999999999999999 55799999998764321 012478999999999999999999
Q ss_pred EEEEEeC--CeEEEEEEecCCCChHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 468 IGFCIED--RRRLLVYEYICNGSLDSHLYGCHQEP-LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 468 ~g~~~~~--~~~~LVmEy~~ggsL~~~L~~~~~~~-Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+.+..+. +.+|||+|||..|.+...- ...+ |++.++++|++++..||+|||.+ |||||||||+|+||+.+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCC
Confidence 9998764 5799999999988876533 3445 99999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecceeecCCCCC----CccceeeccC
Q 008201 545 FEPLVGDFGLARWQPDGDM----GVETRVIGTF 573 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~~~~~----~~~t~v~GT~ 573 (574)
|++||+|||.+-.++.+.. ....+.+|||
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTP 279 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTP 279 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCc
Confidence 9999999999997744321 1223467776
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-27 Score=247.59 Aligned_cols=150 Identities=26% Similarity=0.336 Sum_probs=134.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhH--HHHHHHHHHhcC-CCCeeEEEEEEEeCC-eEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE--FCSEVEVLSCAQ-HRNVVMLIGFCIEDR-RRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~--f~~Ei~iL~~L~-HpNIV~L~g~~~~~~-~~~L 479 (574)
.++|...+.||.|+||.||+|+ ..+|..||||.++..-.. .++ =.||+..|++|+ |||||+|.+++.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4578899999999999999999 667999999998754322 333 368999999999 999999999999888 8999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||| ..+|.+++.++ +..|++..++.|+.||++||+|+|.+ |+.||||||+|||+.....+||+||||||...
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccccc
Confidence 99999 78999999875 88999999999999999999999999 99999999999999999999999999999775
Q ss_pred CC
Q 008201 560 DG 561 (574)
Q Consensus 560 ~~ 561 (574)
..
T Consensus 162 Sk 163 (538)
T KOG0661|consen 162 SK 163 (538)
T ss_pred cC
Confidence 43
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=222.63 Aligned_cols=150 Identities=28% Similarity=0.335 Sum_probs=132.9
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|+..+.||+|+||.||+|. ..+|+.||+|.+..... .....+.+|+.+|+.++|+||+.+++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47889999999999999998 45799999998865322 223457889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|..++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999888654455789999999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=231.91 Aligned_cols=167 Identities=24% Similarity=0.324 Sum_probs=147.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcch-hHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
...+.|++...||.|..+.||+|+ .+.++.||||++.+...... ..+.+|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 445689999999999999999999 67789999999998765554 7899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|.||.+|++.+++...-...+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+.+
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999766666799999999999999999999999 999999999999999999999999999887755
Q ss_pred CCCCcc---ceeeccC
Q 008201 561 GDMGVE---TRVIGTF 573 (574)
Q Consensus 561 ~~~~~~---t~v~GT~ 573 (574)
.+.... .+++|||
T Consensus 179 ~G~R~~~rf~tfvgtp 194 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTP 194 (516)
T ss_pred cCceeeEeeccccCcc
Confidence 443333 3356664
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=229.52 Aligned_cols=149 Identities=25% Similarity=0.368 Sum_probs=133.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5799999999999999999995 468999999987532 223356889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+.+++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999986 356789999999999999999999998 999999999999999999999999999997654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-25 Score=228.49 Aligned_cols=163 Identities=20% Similarity=0.227 Sum_probs=138.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+++. .+++.||+|.+.... ......+..|+.++..++|+||+.+++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 468899999886422 122345788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++|+|..++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999964 245789999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
........+||+
T Consensus 156 ~~~~~~~~~gt~ 167 (331)
T cd05624 156 GTVQSSVAVGTP 167 (331)
T ss_pred CceeeccccCCc
Confidence 332333455665
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-25 Score=228.62 Aligned_cols=163 Identities=22% Similarity=0.254 Sum_probs=138.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.++..++|+||+.++++|..++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4689999999999999999994 468999999986421 222345888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999864 345789999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
........+||+
T Consensus 156 ~~~~~~~~~gt~ 167 (331)
T cd05597 156 GTVQSNVAVGTP 167 (331)
T ss_pred CCccccceeccc
Confidence 332233345664
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=234.03 Aligned_cols=169 Identities=21% Similarity=0.253 Sum_probs=143.1
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 473 (574)
+..+.+..++|.+.+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344566678999999999999999999995 468899999986422 1223457889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
++..|+||||+++++|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999985 34588889999999999999999999 99999999999999999999999999
Q ss_pred ceeecCCCCCCccceeeccC
Q 008201 554 LARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~ 573 (574)
+|+.+...........+||+
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~ 207 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTP 207 (371)
T ss_pred ceeEcCcCCcccccCcccCc
Confidence 99977543332334556765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=229.34 Aligned_cols=149 Identities=23% Similarity=0.306 Sum_probs=133.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+..|+.+|..++||||+++++++...+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46999999999999999999954 589999999875421 23356889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999996 345789999999999999999999998 999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=226.22 Aligned_cols=161 Identities=27% Similarity=0.386 Sum_probs=143.5
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+++.||+|.||.||+|+ .+++-.||+|++.... .+..+++.+|++|-+.|+||||.++|++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 468889999999999999999 4568899999876532 234467999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||..+|+|...|.......+++.....++.|++.||.|+|.. +||||||||+|+|++..+.+||+|||-+..-+.+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 999999999999876677899999999999999999999998 8999999999999999999999999999876533
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
...++|||+
T Consensus 178 ---kR~tlcgt~ 186 (281)
T KOG0580|consen 178 ---KRKTLCGTL 186 (281)
T ss_pred ---Cceeeeccc
Confidence 346789985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=234.39 Aligned_cols=165 Identities=21% Similarity=0.248 Sum_probs=139.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.+..++|.+.+.||+|+||.||+++. .+++.||+|.+.... ......+..|+.+|+.++||||+++++++..++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34556899999999999999999985 468999999986432 22334578899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+++|+|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~---~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999885 34688889999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
............+||+
T Consensus 192 ~~~~~~~~~~~~~gt~ 207 (370)
T cd05596 192 MDANGMVRCDTAVGTP 207 (370)
T ss_pred ccCCCcccCCCCCCCc
Confidence 6543322223345664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=232.34 Aligned_cols=146 Identities=23% Similarity=0.267 Sum_probs=130.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+|+.++|+||+++++.|...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4699999999999999999994 568999999986432 123356889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|..
T Consensus 81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 99999999999863 45788999999999999999999998 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=244.90 Aligned_cols=160 Identities=30% Similarity=0.368 Sum_probs=143.3
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|-+.+.||+|.||.||+|+ ..+.+.||+|.+...... ..+.+.+|++|++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467778899999999999999 456899999988765433 34568999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|+.| +|..+|. ..+.++++.++.|+.++..||.|||++ +|+|||+||.|||++..+.+|++|||+||.... +
T Consensus 82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9965 9999997 578899999999999999999999999 999999999999999999999999999997765 4
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
....+++.|||
T Consensus 154 t~vltsikGtP 164 (808)
T KOG0597|consen 154 TSVLTSIKGTP 164 (808)
T ss_pred ceeeeeccCcc
Confidence 45778899997
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=227.31 Aligned_cols=163 Identities=23% Similarity=0.244 Sum_probs=139.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||++.. .+|+.||+|.++.... .....+..|+.+++.++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999984 4699999999875422 23346888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999964 335799999999999999999999998 9999999999999999999999999999877544
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
.........||+
T Consensus 156 ~~~~~~~~~gt~ 167 (330)
T cd05601 156 KMVNSKLPVGTP 167 (330)
T ss_pred CceeeecccCCc
Confidence 332223334554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=226.41 Aligned_cols=161 Identities=23% Similarity=0.283 Sum_probs=136.6
Q ss_pred CeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCC----CcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~ 477 (574)
+|.+.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+.+|..++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999984 358899999986432 122345788999999994 89999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++||||+.+++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999986 345789999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
+..........++||+
T Consensus 155 ~~~~~~~~~~~~~gt~ 170 (332)
T cd05614 155 FLSEEKERTYSFCGTI 170 (332)
T ss_pred ccccCCCccccccCCc
Confidence 6444333333456665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=227.51 Aligned_cols=148 Identities=26% Similarity=0.401 Sum_probs=130.8
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCC-eeEEEEEEEeCC------e
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDR------R 476 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~------~ 476 (574)
.|..++.||+|+||.||+|+ ..+|+.||+|++...... ......+|+.+|+.++|+| |+.|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 46666779999999999999 667999999999876542 3346789999999999999 999999999877 7
Q ss_pred EEEEEEecCCCChHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQ--EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~--~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
++||+||+ ..+|..++..... ..++...++.++.||+.||+|||++ +|+||||||.||||+..|.+||+|||+
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccch
Confidence 89999998 7899999976432 4677789999999999999999999 999999999999999999999999999
Q ss_pred eeecC
Q 008201 555 ARWQP 559 (574)
Q Consensus 555 Ar~~~ 559 (574)
|+.+.
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99664
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=232.31 Aligned_cols=146 Identities=21% Similarity=0.286 Sum_probs=131.1
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||++. ..+|+.||||++.... ......+.+|+++|+.++||||++++++|.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368999999999999999998 4579999999886432 122346788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||+++++|.+++. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999986 356789999999999999999999998 999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=226.92 Aligned_cols=155 Identities=25% Similarity=0.247 Sum_probs=131.6
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+.+|+.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999984 579999999987532 122346788999999999999999999999999999999999999
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCccc
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~t 567 (574)
+|..++. ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 9999886 356789999999999999999999998 999999999999999999999999999986432221 223
Q ss_pred eeeccC
Q 008201 568 RVIGTF 573 (574)
Q Consensus 568 ~v~GT~ 573 (574)
..+||+
T Consensus 154 ~~~gt~ 159 (323)
T cd05571 154 TFCGTP 159 (323)
T ss_pred ceecCc
Confidence 456665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=225.45 Aligned_cols=149 Identities=26% Similarity=0.314 Sum_probs=133.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36899999999999999999954 689999999875322 23346889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+++++|.+++. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999986 345789999999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=227.91 Aligned_cols=154 Identities=29% Similarity=0.421 Sum_probs=130.5
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 473 (574)
.+..++|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.+|..+ +||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 45567899999999999999999973 2356899999874332 2235688999999999 89999999999876
Q ss_pred CC-eEEEEEEecCCCChHHHHhccC-------------------------------------------------------
Q 008201 474 DR-RRLLVYEYICNGSLDSHLYGCH------------------------------------------------------- 497 (574)
Q Consensus 474 ~~-~~~LVmEy~~ggsL~~~L~~~~------------------------------------------------------- 497 (574)
.+ ..+++|||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 44 5899999999999999886421
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 498 -----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 498 -----~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
..++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~ 225 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIY 225 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccc
Confidence 13578888999999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=230.95 Aligned_cols=146 Identities=23% Similarity=0.265 Sum_probs=131.1
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|..++.||+|+||.||+|+ ..+++.||+|++..... .....+.+|+.+|+.++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68899999999999999998 45689999999875422 223468899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|+++|+|.+++. ....+++..+..++.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999986 345789999999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=227.64 Aligned_cols=160 Identities=24% Similarity=0.286 Sum_probs=137.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-C-CCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-D-GQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~-g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..++|.+.+.||+|+||.||+|... + +..||+|.+.... ......+.+|+.+|+.++||||+++++++...+..|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3457999999999999999999843 3 4689999886432 223456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999997 355789999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
.... ...+||+
T Consensus 182 ~~~~----~~~~gt~ 192 (340)
T PTZ00426 182 DTRT----YTLCGTP 192 (340)
T ss_pred CCCc----ceecCCh
Confidence 4322 2455664
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.89 Aligned_cols=150 Identities=23% Similarity=0.300 Sum_probs=134.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+..|+.+|..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999954 69999999987532 233456889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999974 36799999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=227.33 Aligned_cols=148 Identities=23% Similarity=0.319 Sum_probs=132.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|...+.||+|+||.||++.. .+++.||+|++.... ......+..|+.++..++|+||+++++++...+..||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3689999999999999999985 468999999987432 223356788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999986 356789999999999999999999998 99999999999999999999999999998553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=224.11 Aligned_cols=163 Identities=21% Similarity=0.240 Sum_probs=137.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.... ......+..|+.++..++|+||+.+++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36899999999999999999954 58889999886421 122345788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ey~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999964 345789999999999999999999998 9999999999999999999999999999866443
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
........+||+
T Consensus 156 ~~~~~~~~~gt~ 167 (332)
T cd05623 156 GTVQSSVAVGTP 167 (332)
T ss_pred CcceecccccCc
Confidence 332333456665
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=230.34 Aligned_cols=145 Identities=23% Similarity=0.250 Sum_probs=130.2
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|..++.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.+|+.++|+||++++++|...+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999984 5689999999875321 223468899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999999863 45788999999999999999999998 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=239.39 Aligned_cols=157 Identities=34% Similarity=0.466 Sum_probs=136.6
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEeCC--C--CE-EEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEE
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPD--G--QA-VAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLI 468 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~--g--~~-VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~ 468 (574)
.-..|++..++..+.+.||+|+||.||+|.+.. + .. ||||..+... .....+|++|+++|+.++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344566777777778999999999999999532 2 23 8999887522 34456899999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEE
Q 008201 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (574)
Q Consensus 469 g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vK 548 (574)
|++.....++||||+|.||+|.++|.. ....++..+...++.+.+.||+|||.. ++|||||-.+|+|++.++.+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k-~~~~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKK-NKKSLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEE
Confidence 999999999999999999999999975 333699999999999999999999999 899999999999999999999
Q ss_pred Eeeecceeec
Q 008201 549 VGDFGLARWQ 558 (574)
Q Consensus 549 LsDFGLAr~~ 558 (574)
|+||||++.-
T Consensus 303 ISDFGLs~~~ 312 (474)
T KOG0194|consen 303 ISDFGLSRAG 312 (474)
T ss_pred eCccccccCC
Confidence 9999999854
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=225.02 Aligned_cols=155 Identities=25% Similarity=0.263 Sum_probs=131.3
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+|+.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999984 569999999987532 223356788999999999999999999999999999999999999
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCccc
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~t 567 (574)
+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 9998886 356789999999999999999999998 999999999999999999999999999986432211 123
Q ss_pred eeeccC
Q 008201 568 RVIGTF 573 (574)
Q Consensus 568 ~v~GT~ 573 (574)
.++||+
T Consensus 154 ~~~gt~ 159 (328)
T cd05593 154 TFCGTP 159 (328)
T ss_pred cccCCc
Confidence 355664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=223.05 Aligned_cols=153 Identities=24% Similarity=0.266 Sum_probs=130.6
Q ss_pred eeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.+|..++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999995 468899999987432 22335678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcccee
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~t~v 569 (574)
.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 99986 356789999999999999999999998 99999999999999999999999999998643322 123345
Q ss_pred eccC
Q 008201 570 IGTF 573 (574)
Q Consensus 570 ~GT~ 573 (574)
+||+
T Consensus 154 ~gt~ 157 (312)
T cd05585 154 CGTP 157 (312)
T ss_pred cCCc
Confidence 6665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=217.70 Aligned_cols=162 Identities=23% Similarity=0.318 Sum_probs=135.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|.+.+.||+|+||.||+|+.. +++.+|+|++..... ...+.+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46999999999999999999954 688999999875432 233568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|++++.+..+.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 998877765543 345789999999999999999999998 99999999999999999999999999999765433
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
........||+
T Consensus 155 ~~~~~~~~~~~ 165 (287)
T cd07848 155 NANYTEYVATR 165 (287)
T ss_pred ccccccccccc
Confidence 32223345554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=234.89 Aligned_cols=154 Identities=31% Similarity=0.522 Sum_probs=138.7
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 474 (574)
+..+|++..+.+.+...||+|.||+||+|++.. .||||.++..... ..+.|.+|+.+|++-+|.||+-++|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 447788888899999999999999999999743 5999999876544 346799999999999999999999999988
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
.. .||..+|+|.+|+.+|+. ....|.....+.|++||++|+.|||.+ +|||||||..||+|.+++.|||+||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccc
Confidence 76 899999999999999976 446789999999999999999999999 999999999999999999999999999
Q ss_pred eeec
Q 008201 555 ARWQ 558 (574)
Q Consensus 555 Ar~~ 558 (574)
+...
T Consensus 535 atvk 538 (678)
T KOG0193|consen 535 ATVK 538 (678)
T ss_pred eeee
Confidence 9743
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=234.84 Aligned_cols=164 Identities=20% Similarity=0.228 Sum_probs=139.4
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CC-CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.|.+.+.||+|+||.||+|.. .+ ++.||+|.+..........+.+|+.+|+.++||||++++++|...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 499999999999999999984 34 6788999776554444456788999999999999999999999999999999999
Q ss_pred CCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 485 CNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 485 ~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
++|+|.+++... ...++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999888532 345789999999999999999999998 99999999999999999999999999999775432
Q ss_pred C-CccceeeccCC
Q 008201 563 M-GVETRVIGTFG 574 (574)
Q Consensus 563 ~-~~~t~v~GT~G 574 (574)
. .....++||++
T Consensus 224 ~~~~~~~~~gt~~ 236 (478)
T PTZ00267 224 SLDVASSFCGTPY 236 (478)
T ss_pred ccccccccCCCcc
Confidence 2 23445677764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=224.48 Aligned_cols=141 Identities=25% Similarity=0.285 Sum_probs=125.7
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.+|+.++||||++++++|...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999984 569999999987532 122345778999999999999999999999999999999999999
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9998886 345789999999999999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=219.93 Aligned_cols=153 Identities=29% Similarity=0.492 Sum_probs=131.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCC-----------------CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCee
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPD-----------------GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVV 465 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----------------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV 465 (574)
..++|.+.+.||+|+||.||+|...+ +..||+|.+...... ....|.+|+.+|..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 34679999999999999999997432 346999988754322 235689999999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCChHHHHhccC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC
Q 008201 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH-----------------QEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (574)
Q Consensus 466 ~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~-----------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g 528 (574)
++++++...+..++||||+.+++|.+++.... ...+++..+..++.||+.||.|||+. +
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ 158 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----N 158 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----C
Confidence 99999999999999999999999999885321 12467888999999999999999998 9
Q ss_pred eEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 529 IIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+||||||+|||++.++.+||+|||+++.+..
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceeccc
Confidence 99999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=221.79 Aligned_cols=142 Identities=25% Similarity=0.278 Sum_probs=125.6
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|+.++..++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999984 579999999987532 122346778999999999999999999999999999999999999
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|..++. ....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9998886 35578999999999999999999997 5 89999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=230.32 Aligned_cols=158 Identities=23% Similarity=0.327 Sum_probs=134.1
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
+..++|.+.+.||+|+||.||+|. ..+++.||+|... ...+.+|+++|+.++||||++++++|......++||
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 345689999999999999999999 4578999999643 234678999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+ +++|..++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 163 e~~-~~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRY-KTDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecC-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 998 578888886 345789999999999999999999998 9999999999999999999999999999864332
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
........+||+
T Consensus 236 ~~~~~~~~~gt~ 247 (391)
T PHA03212 236 NANKYYGWAGTI 247 (391)
T ss_pred cccccccccCcc
Confidence 222223456665
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=237.59 Aligned_cols=160 Identities=24% Similarity=0.373 Sum_probs=145.8
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
..|.....||+|+-|.||.+. ..+++.||||++.+......+-+.+|+.+|+..+|+|||++++.|...+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 357777889999999999998 6679999999999887777778999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
+||+|.+.+. ...+++.++..|++++++||.|||.+ ||+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999884 45699999999999999999999999 999999999999999999999999999998765443
Q ss_pred ccceeeccC
Q 008201 565 VETRVIGTF 573 (574)
Q Consensus 565 ~~t~v~GT~ 573 (574)
..++.+|||
T Consensus 425 KR~TmVGTP 433 (550)
T KOG0578|consen 425 KRSTMVGTP 433 (550)
T ss_pred ccccccCCC
Confidence 567789997
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=216.99 Aligned_cols=148 Identities=28% Similarity=0.421 Sum_probs=130.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|...+.||.|+||.||+|.. .+++.||+|.++.... .....+.+|+.+|+.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5699999999999999999984 4689999999875432 2334678999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LD-SDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CC-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 96 589888864 344678999999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=228.78 Aligned_cols=162 Identities=26% Similarity=0.312 Sum_probs=142.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~ 478 (574)
....|.+.+.||.|.||.||+|.. .+|+.+|+|.+....... ...+.+|+.+|+.+. |||||.+++.|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 455799999999999999999994 459999999987654433 357999999999998 999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC----CcEEEeeecc
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD----FEPLVGDFGL 554 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~----~~vKLsDFGL 554 (574)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+. ||+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999753 399999999999999999999998 99999999999999643 4799999999
Q ss_pred eeecCCCCCCccceeeccCC
Q 008201 555 ARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 555 Ar~~~~~~~~~~t~v~GT~G 574 (574)
|.....+ .....++|||+
T Consensus 186 a~~~~~~--~~~~~~~Gtp~ 203 (382)
T KOG0032|consen 186 AKFIKPG--ERLHTIVGTPE 203 (382)
T ss_pred ceEccCC--ceEeeecCCcc
Confidence 9988762 24467899985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=217.13 Aligned_cols=149 Identities=28% Similarity=0.459 Sum_probs=131.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.++|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.+|+.++||||+++++++......|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357999999999999999999954 6899999998754322 23457889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+ .++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CC-CcCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 99 5788887754 345688999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=219.29 Aligned_cols=160 Identities=23% Similarity=0.254 Sum_probs=133.3
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVm 481 (574)
+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++..+.| ++|+.+++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4889999999999999999854 58899999987532 2234567889999999976 56889999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886 345789999999999999999999998 9999999999999999999999999999854322
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
.. .....+||+
T Consensus 155 ~~-~~~~~~gt~ 165 (324)
T cd05587 155 GK-TTRTFCGTP 165 (324)
T ss_pred CC-ceeeecCCc
Confidence 21 123355664
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-24 Score=214.50 Aligned_cols=150 Identities=29% Similarity=0.352 Sum_probs=132.7
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+|+..+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++|+||+.+++++..++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999994 4689999999875322 222457789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|..++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888654455799999999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=220.38 Aligned_cols=151 Identities=27% Similarity=0.341 Sum_probs=134.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
..++|++.+.||+|+||.||++.. .+|..+|+|.+..... .....+.+|+++|+.++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 457899999999999999999995 4688999998875432 22356899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.++|+|||+++.+.
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999963 456899999999999999999999852 69999999999999999999999999998664
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=220.59 Aligned_cols=155 Identities=26% Similarity=0.336 Sum_probs=130.1
Q ss_pred eeeeccCcEEEEEEEe----CCCCEEEEEEeecCC----CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 412 NFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+.||+|+||.||+++. .+++.||+|.++... ......+..|+.+|+.++||||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 358899999987532 12234577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~ 563 (574)
+.+++|.+++. ....+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986 356788889999999999999999998 999999999999999999999999999986433222
Q ss_pred CccceeeccC
Q 008201 564 GVETRVIGTF 573 (574)
Q Consensus 564 ~~~t~v~GT~ 573 (574)
.....+||+
T Consensus 156 -~~~~~~gt~ 164 (323)
T cd05584 156 -VTHTFCGTI 164 (323)
T ss_pred -cccccCCCc
Confidence 223345654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=211.20 Aligned_cols=153 Identities=25% Similarity=0.401 Sum_probs=137.4
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 3456799999999999999999998788899999876433 234678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999754556789999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=236.33 Aligned_cols=160 Identities=26% Similarity=0.351 Sum_probs=141.6
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
+-|++++.||.|+-|.|-+|+ ..+|+.+|||++..... .....+.+||.||+.+.||||++||+++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 358889999999999999999 56899999999876522 22346889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||++||.|.++|. ..++|++.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|....++
T Consensus 92 Eyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999997 578899999999999999999999999 9999999999999999999999999999977665
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
... .+-||.|
T Consensus 166 klL--eTSCGSP 175 (786)
T KOG0588|consen 166 KLL--ETSCGSP 175 (786)
T ss_pred ccc--cccCCCc
Confidence 542 2357765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=227.58 Aligned_cols=151 Identities=28% Similarity=0.238 Sum_probs=136.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
....|++++.||.|.-|+||+++..+ +..+|+|++...... ...+...|-+||+.++||.++.||..|..+.+.||
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 33457778899999999999999654 789999999865433 23467789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+||+|..++++...+.+++..++.++.+++.||+|||.. |||+|||||+||||.++|++.|+||.|+...
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999887889999999999999999999999999 9999999999999999999999999998754
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=220.12 Aligned_cols=144 Identities=26% Similarity=0.359 Sum_probs=125.8
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHH---HhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVL---SCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL---~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
|.+.+.||+|+||.||+|.. .+|+.||||.++... ....+.+.+|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999984 468999999987532 22234566776665 466799999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|||+++++|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999998874 45799999999999999999999998 9999999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=209.47 Aligned_cols=153 Identities=27% Similarity=0.409 Sum_probs=137.7
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++..++|.+.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++++++|+||+++++++...+..|++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34566799999999999999999997778889999987543 33567899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 999999999999754445789999999999999999999998 99999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=212.88 Aligned_cols=150 Identities=27% Similarity=0.403 Sum_probs=132.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..++|++.+.||+|+||.||+|.+. .+..||+|.++..... ....+.+|+.+|..++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3457999999999999999999742 3678999988754322 2346889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+|||++.++.++++|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999864 345789999999999999999999998 9999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=218.78 Aligned_cols=155 Identities=25% Similarity=0.350 Sum_probs=128.7
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSC-AQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.. .+++.||+|.++... ....+.+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 458899999987532 2223445667777765 4799999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999998863 45789999999999999999999998 99999999999999999999999999998654333 223
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (316)
T cd05592 154 STFCGTP 160 (316)
T ss_pred ccccCCc
Confidence 3456664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=218.85 Aligned_cols=155 Identities=25% Similarity=0.279 Sum_probs=131.1
Q ss_pred eeeeccCcEEEEEEEe----CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 412 NFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
+.||+|+||.||+++. .+|+.+|+|++..... .....+..|+++|+.++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999873 3589999999875432 223457789999999999999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCc
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~ 565 (574)
+++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 999999986 355789999999999999999999998 999999999999999999999999999986543321 2
Q ss_pred cceeeccC
Q 008201 566 ETRVIGTF 573 (574)
Q Consensus 566 ~t~v~GT~ 573 (574)
...++||+
T Consensus 155 ~~~~~g~~ 162 (318)
T cd05582 155 AYSFCGTV 162 (318)
T ss_pred eecccCCh
Confidence 23345554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=217.49 Aligned_cols=146 Identities=23% Similarity=0.391 Sum_probs=126.9
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRL 478 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 478 (574)
+|.+.+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|+.+|+.++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 488999999999999999994 568999999887432 223346889999999999999999999986432 479
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+ +++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 578998886 345799999999999999999999999 9999999999999999999999999999865
Q ss_pred C
Q 008201 559 P 559 (574)
Q Consensus 559 ~ 559 (574)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=217.50 Aligned_cols=160 Identities=22% Similarity=0.238 Sum_probs=133.2
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVm 481 (574)
+|...+.||+|+||.||+|+.. +++.||+|.+..... .....+..|..++..+ +|++|+.+++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4888999999999999999854 588999999875422 2223567788888777 4899999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886 345789999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
.. .....+||+
T Consensus 155 ~~-~~~~~~gt~ 165 (323)
T cd05616 155 GV-TTKTFCGTP 165 (323)
T ss_pred CC-ccccCCCCh
Confidence 21 223455664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=218.64 Aligned_cols=155 Identities=23% Similarity=0.294 Sum_probs=129.5
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|+. .+++.||+|++.... ......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999995 458899999987532 22334577889998866 799999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 99998886 345789999999999999999999999 999999999999999999999999999986533222 22
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (321)
T cd05591 154 TTFCGTP 160 (321)
T ss_pred cccccCc
Confidence 3445654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=219.23 Aligned_cols=143 Identities=26% Similarity=0.407 Sum_probs=125.1
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+|...+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+++|+.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 466678899999999999984 46899999998654322 2356889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
.+++|.... .+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999986532 346677889999999999999998 99999999999999999999999999998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=232.36 Aligned_cols=163 Identities=27% Similarity=0.328 Sum_probs=145.2
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcch--hHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-EEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRNVVMLIGFCIEDRR-RLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~--~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-~~LVm 481 (574)
++|..++++|+|+||.+++++ ..++..+++|.+........ +...+|+.++++++|||||.+++.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578889999999999999998 44688999999987654333 467899999999999999999999999887 99999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+||+||+|.+.+...+...++++.++.|+.|++.|+.|||+. .|+|||||+.||+++.++.++|+|||+|+.+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999876667899999999999999999999988 8999999999999999999999999999988765
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
. ....+++|||
T Consensus 160 ~-~~a~tvvGTp 170 (426)
T KOG0589|consen 160 D-SLASTVVGTP 170 (426)
T ss_pred h-hhhheecCCC
Confidence 4 2445789987
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=219.25 Aligned_cols=155 Identities=22% Similarity=0.264 Sum_probs=130.4
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+++. .+++.||+|+++.... .....+..|..++..+ +||||++++++|...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999985 4689999999875422 2234578899999888 699999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99998886 346799999999999999999999998 99999999999999999999999999998532211 122
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
..++||+
T Consensus 154 ~~~~gt~ 160 (329)
T cd05588 154 STFCGTP 160 (329)
T ss_pred ccccCCc
Confidence 3456664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=220.04 Aligned_cols=152 Identities=26% Similarity=0.323 Sum_probs=133.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+..++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+++|+.++|+||++++++|...+..|+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34578999999999999999999954 688999998875432 2235688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999863 456889999999999999999999752 69999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=218.87 Aligned_cols=155 Identities=23% Similarity=0.266 Sum_probs=129.5
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+++. .+++.+|+|+++... ......+..|+.++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999994 468899999987542 22234577899888776 799999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99998886 346799999999999999999999998 999999999999999999999999999985432221 12
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
..++||+
T Consensus 154 ~~~~gt~ 160 (329)
T cd05618 154 STFCGTP 160 (329)
T ss_pred ccccCCc
Confidence 3455664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=208.70 Aligned_cols=148 Identities=26% Similarity=0.419 Sum_probs=132.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
++|...+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.+|+.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4588899999999999999998788889999876432 334578899999999999999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 9999999864 234689999999999999999999998 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=218.28 Aligned_cols=155 Identities=26% Similarity=0.327 Sum_probs=127.7
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.. .+|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999984 579999999987532 122234555655 56789999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 99998886 456789999999999999999999998 99999999999999999999999999998543221 122
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (325)
T cd05604 154 TTFCGTP 160 (325)
T ss_pred ccccCCh
Confidence 3455664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=217.19 Aligned_cols=155 Identities=25% Similarity=0.325 Sum_probs=127.1
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|+. .+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 4689999999874321 22234555554 67889999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99998886 356788999999999999999999998 99999999999999999999999999998542222 122
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (321)
T cd05603 154 STFCGTP 160 (321)
T ss_pred ccccCCc
Confidence 3455664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=217.31 Aligned_cols=155 Identities=25% Similarity=0.327 Sum_probs=129.7
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|+. .+++.||+|++.... ......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 468999999987432 22334677888888876 699999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++....... ..
T Consensus 81 g~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 99999886 345789999999999999999999998 999999999999999999999999999986432221 22
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
....||+
T Consensus 154 ~~~~gt~ 160 (320)
T cd05590 154 STFCGTP 160 (320)
T ss_pred cccccCc
Confidence 3455664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=217.22 Aligned_cols=155 Identities=26% Similarity=0.334 Sum_probs=127.6
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.. .+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999995 4699999999875321 22234555554 56789999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999886 356789999999999999999999998 99999999999999999999999999998543222 122
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (323)
T cd05575 154 STFCGTP 160 (323)
T ss_pred ccccCCh
Confidence 3455664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=221.48 Aligned_cols=148 Identities=26% Similarity=0.366 Sum_probs=125.3
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRLLV 480 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~LV 480 (574)
.|...+++|.|+||.||+|.. .+++.||||+...+.. .-.+|+++|+.++|||||+|..+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 478889999999999999994 4589999998764432 2347999999999999999998886432 34589
Q ss_pred EEecCCCChHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~--~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFGLAr~ 557 (574)
|||| ..+|.+.+.. ..+..++...++-+..||++||.|||+. ||+||||||.|||+|.+ |.+||||||.|+.
T Consensus 101 leym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999 5688888853 2467788889999999999999999998 99999999999999977 9999999999998
Q ss_pred cCCCCC
Q 008201 558 QPDGDM 563 (574)
Q Consensus 558 ~~~~~~ 563 (574)
+..+..
T Consensus 176 L~~~ep 181 (364)
T KOG0658|consen 176 LVKGEP 181 (364)
T ss_pred eccCCC
Confidence 876554
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=216.73 Aligned_cols=147 Identities=22% Similarity=0.264 Sum_probs=128.3
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm 481 (574)
+|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 377889999999999999984 468999999987532 223345778999998886 577888999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++...
T Consensus 81 Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999886 346799999999999999999999998 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=209.62 Aligned_cols=149 Identities=29% Similarity=0.426 Sum_probs=126.1
Q ss_pred CeeEEeeeeccCcEEEEEEEe-C-CCCEEEEEEeecCCCc--chhHHHHHHHHHHhc---CCCCeeEEEEEEEe-----C
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-P-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA---QHRNVVMLIGFCIE-----D 474 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~-----~ 474 (574)
+|.+.+.||+|+||.||+|+. . +|+.||+|.++..... ....+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 688999999999999999984 3 4788999988754322 234567788887766 69999999999853 4
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
...++||||+. ++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 46899999994 6899988754556789999999999999999999998 999999999999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
++....
T Consensus 157 ~~~~~~ 162 (290)
T cd07862 157 ARIYSF 162 (290)
T ss_pred eEeccC
Confidence 987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=223.68 Aligned_cols=156 Identities=31% Similarity=0.444 Sum_probs=133.0
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 472 (574)
+.+..++|.+.+.||+|+||.||+|.. .++..||||+++.... ...+.+.+|+.+|..+ +||||++++++|.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344456789999999999999999962 2366899999874432 2335688999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC-------------------------------------------------------
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCH------------------------------------------------------- 497 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~------------------------------------------------------- 497 (574)
..+..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999885321
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 498 ------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 498 ------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 12578889999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 266 ~ 266 (375)
T cd05104 266 N 266 (375)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=210.46 Aligned_cols=154 Identities=29% Similarity=0.417 Sum_probs=139.3
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
....+|...+.||.|+||.||+|...++..+++|.+..........+..|+.+|+.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34456888999999999999999987799999999886655456678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|.+++.......+++..+..++.||+.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999765566789999999999999999999998 999999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=210.90 Aligned_cols=144 Identities=27% Similarity=0.359 Sum_probs=125.9
Q ss_pred eeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||+|+||.||++.. .+|+.+|+|.+...... ..+.+..|+.+|+.++|+||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999984 47899999988643221 224577899999999999999999999999999999999999999
Q ss_pred HHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 490 DSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 490 ~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
..++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++.+..+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 9887532 345789999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=208.77 Aligned_cols=150 Identities=33% Similarity=0.503 Sum_probs=131.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRL 478 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~ 478 (574)
.+|++.+.||+|+||.||++.. .++..||+|.+........+.+.+|+++|+.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 2578999999876554445678999999999999999999998754 34689
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999864 234689999999999999999999998 9999999999999999999999999999976
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=209.18 Aligned_cols=149 Identities=29% Similarity=0.333 Sum_probs=131.8
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|+..+.||+|+||.||++.. .+++.+|+|.+...... ....+.+|+++|+.++|+||+.+++++..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999984 56899999988754322 22357789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+++++|..++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999999888654455799999999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=216.34 Aligned_cols=155 Identities=26% Similarity=0.313 Sum_probs=126.6
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|+. .+++.||+|++.... ......+..|.. +++.++|+||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999995 468899999987432 122234444444 56789999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+.+..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 99999886 345688889999999999999999998 999999999999999999999999999986432221 23
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
..++||+
T Consensus 154 ~~~~gt~ 160 (325)
T cd05602 154 STFCGTP 160 (325)
T ss_pred ccccCCc
Confidence 3456665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=207.64 Aligned_cols=153 Identities=26% Similarity=0.423 Sum_probs=135.8
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
+...+|...+.||+|+||.||+|.. .+++.+|+|.+... ......+.+|+++|+.++|+||+++++++...+..+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 3445688999999999999999995 45889999988643 233457899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999755556789999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-24 Score=238.67 Aligned_cols=154 Identities=26% Similarity=0.333 Sum_probs=135.7
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCC-CEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEE-EEEe---C
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDG-QAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIG-FCIE---D 474 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g-~~~~---~ 474 (574)
+++...++++.+.|.+|||+.||++....+ ..||+|++-.......+.+.+||++|+.|. |+|||.|++ .... .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 445566789999999999999999996554 999999988777777788999999999997 999999999 3322 1
Q ss_pred ---CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEee
Q 008201 475 ---RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (574)
Q Consensus 475 ---~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsD 551 (574)
-.++|+||||.||.|-++|..+....|++.++++|+.++++|+.+||...+ .|||||||-+||||+.++..||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p--PiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP--PIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC--ccchhhhhhhheEEcCCCCEEeCc
Confidence 256899999999999999987777779999999999999999999999854 599999999999999999999999
Q ss_pred eccee
Q 008201 552 FGLAR 556 (574)
Q Consensus 552 FGLAr 556 (574)
||.|.
T Consensus 190 FGSat 194 (738)
T KOG1989|consen 190 FGSAT 194 (738)
T ss_pred ccccc
Confidence 99886
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=235.27 Aligned_cols=160 Identities=34% Similarity=0.432 Sum_probs=136.0
Q ss_pred eeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEEE
Q 008201 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------RRLL 479 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------~~~L 479 (574)
|...+.||+|+||.||+|+ ..+|+.||||.++.... ...+...+|+++|++++|+|||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556789999999999999 66799999999886543 33457899999999999999999998865543 4579
Q ss_pred EEEecCCCChHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC--CC--cEEEeeecc
Q 008201 480 VYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--DF--EPLVGDFGL 554 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~-~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~--~~--~vKLsDFGL 554 (574)
|||||.||+|+..|... +...|++.+.+.++..+..||.|||++ ||+||||||.||++-. +| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999765 346799999999999999999999998 9999999999999943 33 478999999
Q ss_pred eeecCCCCCCccceeeccC
Q 008201 555 ARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 555 Ar~~~~~~~~~~t~v~GT~ 573 (574)
||-+.++. .-+.++||.
T Consensus 171 Arel~d~s--~~~S~vGT~ 187 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTE 187 (732)
T ss_pred cccCCCCC--eeeeecCch
Confidence 99987766 346788885
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=215.34 Aligned_cols=155 Identities=25% Similarity=0.329 Sum_probs=128.7
Q ss_pred eeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|+.. +|+.||+|.++... ......+..|..++..+ +||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999954 68999999987532 12334567788888754 899999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||+++....... ..
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence 999998863 45789999999999999999999998 999999999999999999999999999985432221 22
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
+.++||+
T Consensus 154 ~~~~gt~ 160 (316)
T cd05620 154 STFCGTP 160 (316)
T ss_pred eccCCCc
Confidence 3455664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=215.37 Aligned_cols=155 Identities=25% Similarity=0.259 Sum_probs=130.0
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|+.++..+ +||||+.+++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 4688999999875422 2234578899999888 599999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 99998886 345799999999999999999999998 999999999999999999999999999985422111 22
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (327)
T cd05617 154 STFCGTP 160 (327)
T ss_pred ecccCCc
Confidence 3456664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=205.87 Aligned_cols=149 Identities=26% Similarity=0.349 Sum_probs=134.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
..+|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34689999999999999999994 57899999998765444445688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999886 345789999999999999999999998 99999999999999999999999999998664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=219.47 Aligned_cols=150 Identities=25% Similarity=0.416 Sum_probs=132.4
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEee--cCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe-----CC
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHK--LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-----DR 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-----~~ 475 (574)
....|...+.||.|+||.|+.+. ..+|+.||||++. .......++..+|+.+|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44567778999999999999998 5679999999887 3344455788999999999999999999999876 34
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
.+|+|+|+| +.+|.+.+. .+..|+...++.++.||++||.|+|+. +|+||||||.|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccce
Confidence 689999999 889999996 455599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
|....
T Consensus 173 R~~~~ 177 (359)
T KOG0660|consen 173 RYLDK 177 (359)
T ss_pred eeccc
Confidence 98853
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=210.63 Aligned_cols=148 Identities=27% Similarity=0.409 Sum_probs=130.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||+|+. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5699999999999999999984 46889999998754332 234678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|..++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LD-KDLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 95 588888754 344688999999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=205.86 Aligned_cols=149 Identities=30% Similarity=0.428 Sum_probs=133.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.+|...+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999997777779999887433 334678999999999999999999999998889999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++|.+++... ...+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 99999998642 34789999999999999999999998 999999999999999999999999999986644
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=205.13 Aligned_cols=152 Identities=28% Similarity=0.391 Sum_probs=135.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++..++|.+.+.||+|+||.||+|...+++.+|+|.+.... .....+.+|+.+++.++|+||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 34566899999999999999999998889999999887443 33457899999999999999999999874 45789999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+.+++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999999998754556789999999999999999999998 99999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=215.59 Aligned_cols=161 Identities=26% Similarity=0.385 Sum_probs=141.3
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc----ch----hHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ----GD----HEFCSEVEVLSCA-QHRNVVMLIGFCIEDR 475 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~----~~----~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~ 475 (574)
..|...+.||.|..+.|-+|. ..+|+.+|+|++...... .. +...+|+.||+++ .||+|+.+.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 356777889999999999887 567999999988754321 11 3467899999987 5999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
.+++|+|.|+.|.|.++|. ..-.+++.....|++|+++|+.|||.. +|+||||||+|||++++.+++|+|||+|
T Consensus 97 F~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999997 566799999999999999999999999 8999999999999999999999999999
Q ss_pred eecCCCCCCccceeeccCC
Q 008201 556 RWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~G 574 (574)
..+..+.. ...+|||||
T Consensus 171 ~~l~~Gek--LrelCGTPg 187 (411)
T KOG0599|consen 171 CQLEPGEK--LRELCGTPG 187 (411)
T ss_pred eccCCchh--HHHhcCCCc
Confidence 99988774 346899998
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-23 Score=207.21 Aligned_cols=143 Identities=28% Similarity=0.329 Sum_probs=125.5
Q ss_pred eeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||+|+||.||++.. .+|+.+|+|.+..... .....+..|+++|+.++||||+++++++......|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999984 4699999998864321 1233466799999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
..++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9888654555689999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=213.40 Aligned_cols=155 Identities=28% Similarity=0.327 Sum_probs=128.5
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSC-AQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|+. .+++.||+|.++... ......+..|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999995 458899999987542 1233456778888876 4899999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999863 45789999999999999999999998 999999999999999999999999999986432221 22
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (316)
T cd05619 154 CTFCGTP 160 (316)
T ss_pred eeecCCc
Confidence 3445554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=219.75 Aligned_cols=147 Identities=26% Similarity=0.368 Sum_probs=128.3
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRL 478 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 478 (574)
+|+..+.||+|+||.||++.. .+|+.||+|.+.... ....+.+.+|+.+|+.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999994 579999999876432 123356889999999999999999999998776 789
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+. ++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999985 67888775 456799999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=207.21 Aligned_cols=150 Identities=30% Similarity=0.377 Sum_probs=131.8
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|+..+.||+|+||.||++.. .+++.+|+|.+...... ....+..|+.+|+.++|+||+.+++.+...+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999984 56899999988654322 22357789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999988654455789999999999999999999998 999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=206.21 Aligned_cols=152 Identities=30% Similarity=0.414 Sum_probs=132.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+..++|.+.+.||+|+||.||+|...+...||+|.+.... .....+.+|+++++.++|+||+++++++. .+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 3456799999999999999999997666779999887433 23457899999999999999999999874 456899999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 99999999999754445689999999999999999999998 999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=234.38 Aligned_cols=149 Identities=27% Similarity=0.334 Sum_probs=133.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|... +++.||||+++..... ....+..|+.++..++|+||+++++++...+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999954 6899999998754322 2256889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+.+++|..++.. ...+++..++.|+.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999999863 45688999999999999999999998 999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=203.38 Aligned_cols=153 Identities=29% Similarity=0.442 Sum_probs=138.1
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++..++|.+.+.||+|+||.||++...+++.+|+|.+.... ....++.+|+.+++.++|+||+++++++......+++|
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45667899999999999999999998778889999887543 34567999999999999999999999999888999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++.+.
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999999764446789999999999999999999998 89999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=205.30 Aligned_cols=152 Identities=28% Similarity=0.418 Sum_probs=134.0
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+..++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 34457888999999999999999987888899998875433 3457899999999999999999999885 456899999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999999754455689999999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=239.79 Aligned_cols=159 Identities=34% Similarity=0.476 Sum_probs=138.7
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 472 (574)
-.++...+....+.||+|+||.||+|+. .+.+.||||.++..... ...+|.+|+++|..++|||||+|+|+|.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 3456667778888999999999999983 23567999999876554 6678999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhcc--------C----CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeE
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGC--------H----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 540 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~--------~----~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NIL 540 (574)
.++.+|||+|||..|||.+||..+ . ..+|+..+.+.|+.|||.|+.||-++ .+|||||..+|+|
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCL 635 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCL 635 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhce
Confidence 999999999999999999999632 1 22388899999999999999999999 8999999999999
Q ss_pred EcCCCcEEEeeecceeecCCCC
Q 008201 541 LTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 541 Ld~~~~vKLsDFGLAr~~~~~~ 562 (574)
|.++..+||+||||+|-.-..+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssD 657 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSD 657 (774)
T ss_pred eccceEEEecccccchhhhhhh
Confidence 9999999999999999654443
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=203.50 Aligned_cols=151 Identities=26% Similarity=0.378 Sum_probs=132.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
..++|.+...||+|+||.||++....+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 345799999999999999999997777789999876433 23457889999999999999999999875 4568999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 9999999999754455689999999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=212.56 Aligned_cols=150 Identities=28% Similarity=0.497 Sum_probs=129.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCC----EEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..+|++.+.||+|+||.||+|.+ .+|+ .||+|.++.... ...+++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 35699999999999999999984 3444 489998875432 3345788999999999999999999999765 578
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999864 345688999999999999999999998 9999999999999999999999999999976
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 160 ~~ 161 (316)
T cd05108 160 GA 161 (316)
T ss_pred cC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=220.73 Aligned_cols=155 Identities=30% Similarity=0.454 Sum_probs=132.0
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 473 (574)
....++|.+.+.||+|+||.||+|.. .++..||+|.++..... ....+.+|+.+|+.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34455799999999999999999873 12457999998754322 234688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccC--------------------------------------------------------
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCH-------------------------------------------------------- 497 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~-------------------------------------------------------- 497 (574)
.+..|+||||+++|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999885311
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 498 ------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 498 ------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
..++++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 13578888999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-23 Score=207.50 Aligned_cols=150 Identities=29% Similarity=0.336 Sum_probs=133.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+++|+.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999995 468999999886432 223356889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999863 46789999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-24 Score=227.86 Aligned_cols=158 Identities=30% Similarity=0.484 Sum_probs=139.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcch-hHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+.......+.+.||+|.||.|.+|....+..||||.++....... .+|..|+++|.+|+||||++|+|+|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 455666778899999999999999988889999999997655444 7899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+||+++|+|.+|+.......+.-.....|+.||+.||+||.+. ++|||||.++|+|++.++++||+|||++|-+-.
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999754323345555668999999999999998 899999999999999999999999999997766
Q ss_pred CCC
Q 008201 561 GDM 563 (574)
Q Consensus 561 ~~~ 563 (574)
++.
T Consensus 690 g~y 692 (807)
T KOG1094|consen 690 GDY 692 (807)
T ss_pred CCc
Confidence 654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=209.74 Aligned_cols=149 Identities=28% Similarity=0.349 Sum_probs=131.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||++.. .++..+|+|.+...... ....+.+|+++++.++||||++++++|..++..|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999984 46888999988754222 234688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.++|+|||+++...
T Consensus 81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999963 467899999999999999999999842 79999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=200.48 Aligned_cols=151 Identities=26% Similarity=0.357 Sum_probs=134.8
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|...+.||+|+||.||++.. .+++.|++|.+.... ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478889999999999999995 468999999887543 23345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999764456789999999999999999999998 9999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=212.01 Aligned_cols=141 Identities=27% Similarity=0.361 Sum_probs=124.6
Q ss_pred eeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+++.. +++.||+|++.... ......+..|+.++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999854 58899999987532 22334577899999887 699999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++..
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 99998886 345799999999999999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=213.55 Aligned_cols=153 Identities=24% Similarity=0.227 Sum_probs=125.6
Q ss_pred eeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhc---CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCA---QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
||+|+||.||+|+. .+|+.||+|++..... .....+..|..++..+ +||||+.+++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999994 4689999999864321 1223455677777655 699999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++....... ..
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99998886 456789999999999999999999998 999999999999999999999999999986433221 12
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 154 ~~~~gt~ 160 (330)
T cd05586 154 NTFCGTT 160 (330)
T ss_pred cCccCCc
Confidence 3345654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=201.29 Aligned_cols=148 Identities=27% Similarity=0.411 Sum_probs=131.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-----chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-----GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
++|.+.+.||+|+||.||+|.. .+++.+|+|.+...... ....+.+|+++++.++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4789999999999999999984 56899999987654221 22468889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999863 45688999999999999999999998 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=203.95 Aligned_cols=148 Identities=30% Similarity=0.448 Sum_probs=131.9
Q ss_pred CeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+|.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++|+||+++++++...+..|+||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477888999999999999997777789999876432 2345688999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...+
T Consensus 84 ~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999864 234789999999999999999999998 999999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=220.47 Aligned_cols=157 Identities=27% Similarity=0.373 Sum_probs=135.2
Q ss_pred EeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 411 ANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
.++||.|.||+||-|. .++|+.||||++....- .....++.|++||+.+.||.||.|.-.|+..+.+|+|||.+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 4789999999999998 56799999999875432 33457999999999999999999999999999999999999 56
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecceeecCCCCCC
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGLAr~~~~~~~~ 564 (574)
+..+++-....++|++...++++.||+.||+|||.. +|+|+||||+|||+.. .-.+||||||+||++++..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 666666555778999999999999999999999999 9999999999999964 3579999999999987544
Q ss_pred ccceeeccCC
Q 008201 565 VETRVIGTFG 574 (574)
Q Consensus 565 ~~t~v~GT~G 574 (574)
....++|||.
T Consensus 722 FRrsVVGTPA 731 (888)
T KOG4236|consen 722 FRRSVVGTPA 731 (888)
T ss_pred hhhhhcCCcc
Confidence 3456899973
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-23 Score=225.60 Aligned_cols=169 Identities=20% Similarity=0.237 Sum_probs=138.9
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC--
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-- 475 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-- 475 (574)
.....++|.+.+.||+|+||.||+|+ ..+|+.||||.+..... .....+.+|+.+|..++|+||++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34455789999999999999999998 55799999999876432 23346888999999999999999988775432
Q ss_pred ------eEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcE
Q 008201 476 ------RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (574)
Q Consensus 476 ------~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~v 547 (574)
.+++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCE
Confidence 368999999999999988642 345789999999999999999999998 99999999999999999999
Q ss_pred EEeeecceeecCCCCC-CccceeeccC
Q 008201 548 LVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 548 KLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
||+|||+++.+..... ......+||+
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~ 209 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTP 209 (496)
T ss_pred EEEecccCeeccccccccccccccCCc
Confidence 9999999987653221 1233456665
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=205.13 Aligned_cols=148 Identities=25% Similarity=0.364 Sum_probs=133.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
++|...+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..|++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677888999999999999984 568999999987665444456888999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++++|.+++. ..+.+++..++.++.|++.||.|||+. ||+|+||||+||+++.++.++|+|||++....
T Consensus 89 ~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 9999999886 355789999999999999999999998 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=202.67 Aligned_cols=150 Identities=31% Similarity=0.488 Sum_probs=135.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
..++|...+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3457888999999999999999864 78899999876543 456789999999999999999999999988999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999999754445799999999999999999999998 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-24 Score=231.61 Aligned_cols=156 Identities=30% Similarity=0.440 Sum_probs=138.4
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcch---hHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~---~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|..++.||.|+||.||.++ ..+.+.||||++.....+.. .++..|+..|..++|||+|.|.|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 37777889999999999999 56789999999887655443 578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|| -|+..+++.- ..+++.+..+..|..+.+.||.|||++ +.||||||..||||++.|.+||+|||.|.+..+.+
T Consensus 107 YC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 107 YC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred HH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 98 6777777754 567899999999999999999999999 89999999999999999999999999999876554
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
.|+|||
T Consensus 181 -----sFvGTP 186 (948)
T KOG0577|consen 181 -----SFVGTP 186 (948)
T ss_pred -----cccCCc
Confidence 478886
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=202.61 Aligned_cols=145 Identities=34% Similarity=0.474 Sum_probs=130.1
Q ss_pred eeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchh--HHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~--~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
|++.+.||+|+||.||++... +++.+|+|.+......... ...+|+.+++.++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999954 5779999999866443332 3456999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
.+++|.+++. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc--ccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccc
Confidence 9889999996 356789999999999999999999999 9999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=202.01 Aligned_cols=153 Identities=26% Similarity=0.379 Sum_probs=135.4
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++..++|.+.+.||+|+||.||++....+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 45667899999999999999999997777889999876432 234578899999999999999999999887 7789999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+++++|.+++.......+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++..+..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999754456688999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=199.38 Aligned_cols=150 Identities=23% Similarity=0.340 Sum_probs=134.2
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|+..+.||.|+||.||.++ ..+++.+++|.+.... ......+.+|+++|+.++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999998 4568999999877543 23345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 9999999999754456789999999999999999999998 899999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=204.24 Aligned_cols=151 Identities=30% Similarity=0.475 Sum_probs=131.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-C---CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-D---GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~---g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..+|.+.+.||+|+||.||+|... + +..+|+|.++.... .....+..|+.+|+.++||||+++++++...+..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357899999999999999999843 2 33789998865332 223578999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999964 345689999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 158 ~ 158 (267)
T cd05066 158 D 158 (267)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=220.32 Aligned_cols=157 Identities=29% Similarity=0.391 Sum_probs=133.7
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcC-CCCeeEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQ-HRNVVMLIGFC 471 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~L~g~~ 471 (574)
.+....++|.+.+.||+|+||.||+|... .+..||||.+...... ..+.+.+|+++|+.+. ||||++++++|
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 45556778999999999999999999842 2347999998754322 2356899999999996 99999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC------------------------------------------------------
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH------------------------------------------------------ 497 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~------------------------------------------------------ 497 (574)
...+..||||||+++|+|.++|....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999999885321
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 498 ----------------------------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 498 ----------------------------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
...+++..+..++.|++.||.|||+. +|+||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~ 266 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChH
Confidence 12478888899999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecCC
Q 008201 538 NILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||++.++.+||+|||+++.+..
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMH 289 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccc
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=203.85 Aligned_cols=151 Identities=27% Similarity=0.419 Sum_probs=132.3
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeC------C
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED------R 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~------~ 475 (574)
+.+.|...+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++..+ +|+||++++++|... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 456788889999999999999985 468899999987543 3445788999999998 699999999999753 4
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|++|||+.+++|.+++.......+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 689999999999999998754456789999999999999999999998 9999999999999999999999999999
Q ss_pred eecC
Q 008201 556 RWQP 559 (574)
Q Consensus 556 r~~~ 559 (574)
+...
T Consensus 159 ~~~~ 162 (272)
T cd06637 159 AQLD 162 (272)
T ss_pred eecc
Confidence 8654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=205.33 Aligned_cols=150 Identities=28% Similarity=0.436 Sum_probs=130.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.+|++.+.||+|+||.||+|.. ..+..+++|.+..... .....+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999983 2467899998874332 223568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 480 VYEYICNGSLDSHLYGCH---------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~---------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~ 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCC
Confidence 999999999999985321 23478888999999999999999998 99999999999999999
Q ss_pred CcEEEeeecceeecC
Q 008201 545 FEPLVGDFGLARWQP 559 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~ 559 (574)
+.+||+|||+++...
T Consensus 161 ~~~kl~dfg~~~~~~ 175 (283)
T cd05090 161 LHVKISDLGLSREIY 175 (283)
T ss_pred CcEEecccccccccc
Confidence 999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-23 Score=205.28 Aligned_cols=154 Identities=30% Similarity=0.443 Sum_probs=131.7
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 474 (574)
.+.+++|++.+.||+|+||.||+|... .+..||+|.+..... ....++.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456778999999999999999998742 356799998764322 2334688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~--------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCC
Confidence 99999999999999999986421 12467888899999999999999998 9999999999999999999
Q ss_pred EEEeeecceeecC
Q 008201 547 PLVGDFGLARWQP 559 (574)
Q Consensus 547 vKLsDFGLAr~~~ 559 (574)
++|+|||+++...
T Consensus 158 ~~l~dfg~~~~~~ 170 (277)
T cd05062 158 VKIGDFGMTRDIY 170 (277)
T ss_pred EEECCCCCccccC
Confidence 9999999998553
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=202.47 Aligned_cols=150 Identities=31% Similarity=0.475 Sum_probs=132.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.++|+..+.||+|+||.||+|.+. +...||+|.+...... ....|..|+.+++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357899999999999999999853 2457999988754322 23568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999864 345789999999999999999999998 99999999999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=197.98 Aligned_cols=150 Identities=25% Similarity=0.316 Sum_probs=133.6
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+|.+.+.||+|+||.||++.. .+++.+|+|.++... ....+.+..|+.+++.++|+||+++++++...+..|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478899999999999999984 468999999886543 233456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++++|.+++.......+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999988654556789999999999999999999998 999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=221.75 Aligned_cols=158 Identities=25% Similarity=0.300 Sum_probs=133.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
...+|.+.+.||+|+||.||+|... +++.||||... ...+.+|+++|++++|+||+++++++...+..+||||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3457999999999999999999954 58899999533 2246789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|+ .++|..++.. ....+++..++.|+.||+.||.|||+. ||+||||||+||||+.++.++|+|||+++.+....
T Consensus 241 ~~-~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KY-RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 98 5788888754 345799999999999999999999998 99999999999999999999999999998764332
Q ss_pred C-CccceeeccC
Q 008201 563 M-GVETRVIGTF 573 (574)
Q Consensus 563 ~-~~~t~v~GT~ 573 (574)
. .....++||+
T Consensus 315 ~~~~~~~~~GT~ 326 (461)
T PHA03211 315 STPFHYGIAGTV 326 (461)
T ss_pred ccccccccCCCc
Confidence 1 1223456665
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=200.09 Aligned_cols=147 Identities=25% Similarity=0.419 Sum_probs=131.1
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.|...+.||+|.||+||+|+ ..+++.||+|..+.+.... .....+||.+|+.++|.|||+++++...++.+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667789999999999999 5569999999988764432 24688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
| ..+|..+... .++.++...+..++.|+++||.|+|++ +++||||||.|+||+.+|++|++||||||-+.
T Consensus 83 c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 83 C-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred h-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 8 7788888765 567899999999999999999999999 89999999999999999999999999999664
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=222.32 Aligned_cols=163 Identities=23% Similarity=0.351 Sum_probs=143.3
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
...+.|.+...||+|.|+.|.+++ ..+|..||||.+....... ...+.+|+++|..++|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 456789999999999999999999 4569999999988654322 2458899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+.+|.+.+++. ..+.+.+..+..++.|+..|++|||++ +|+|||||++||||+.+.++||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999997 456677788999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
.+.. ..+.||++
T Consensus 207 ~~~~--lqt~cgsp 218 (596)
T KOG0586|consen 207 YGLM--LQTFCGSP 218 (596)
T ss_pred cccc--ccccCCCC
Confidence 5543 34577775
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=206.17 Aligned_cols=148 Identities=23% Similarity=0.365 Sum_probs=134.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||++++++|...+..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5799999999999999999994 579999999987665555567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 99 ~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 99 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999985 35688999999999999999999998 999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=205.83 Aligned_cols=150 Identities=25% Similarity=0.379 Sum_probs=134.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||.|+||.||++.. .++..+|+|.+..........+..|+++++.++|+||+++++++..++..|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 34688889999999999999995 46899999998766544556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++++|..++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999998864 345799999999999999999999998 99999999999999999999999999987553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=203.09 Aligned_cols=146 Identities=40% Similarity=0.599 Sum_probs=127.6
Q ss_pred eEEeeeeccCcEEEEEEEeC-----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 409 SQANFLAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.+.+.||.|.||.||+|.+. .+..|+||.++..... ..+.|.+|+++|++++||||++++|++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46788999999999999965 2678999999654332 35689999999999999999999999998888999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|+++|+|.++|.......+++..+..|+.||+.||.|||+. +|+|+||+++|||++.++.+||+|||+++..
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccc
Confidence 99999999999875467899999999999999999999998 8999999999999999999999999999877
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=200.97 Aligned_cols=154 Identities=25% Similarity=0.310 Sum_probs=133.4
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
++..+.++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 445566666677899999999999994 4688899998876555555679999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeeccee
Q 008201 480 VYEYICNGSLDSHLYGCHQEPL--EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLAR 556 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~L--s~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr 556 (574)
++||+++++|..++.. ....+ ++..+..++.||+.||.|||+. +|+||||||+||+++. ++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHH-hcccCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999864 22345 7888889999999999999998 9999999999999976 6799999999998
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
...
T Consensus 158 ~~~ 160 (268)
T cd06624 158 RLA 160 (268)
T ss_pred ecc
Confidence 654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=200.62 Aligned_cols=142 Identities=29% Similarity=0.452 Sum_probs=126.0
Q ss_pred eeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChH
Q 008201 413 FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLD 490 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~ 490 (574)
.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|+++|+.++||||++++++|...+..|+||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 589999999999985 4789999998764322 22356899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 491 SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 491 ~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCcccc
Confidence 99864 345689999999999999999999998 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=202.79 Aligned_cols=143 Identities=26% Similarity=0.361 Sum_probs=127.1
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+|+..+.||+|+||.||+|. ..+++.||+|.+..... .....+.+|+.+|+.++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 57788999999999999998 45789999998865422 23356889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence 999997543 467888899999999999999998 99999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=198.54 Aligned_cols=142 Identities=33% Similarity=0.510 Sum_probs=126.9
Q ss_pred eeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChHH
Q 008201 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~ 491 (574)
.||+|+||.||+|...++..+|+|.+....... ...+.+|+++++.++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 689999999999998788999999887543322 2468899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 492 HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 492 ~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 82 FLRK-KKDELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceecc
Confidence 8864 345688999999999999999999998 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-22 Score=197.08 Aligned_cols=151 Identities=25% Similarity=0.395 Sum_probs=134.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|... +|+.+|+|.++.... .....+.+|+++++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999965 799999998864322 22457889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|..++... ....+++..+..++.+++.||.|||+. ||+||||+|+||+++.++.++|+|||+++.+.
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999988542 345689999999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 158 ~ 158 (267)
T cd08224 158 S 158 (267)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=218.25 Aligned_cols=158 Identities=29% Similarity=0.472 Sum_probs=142.2
Q ss_pred eeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
|.++..||+|+||.||++. ...|+.+|||.+... .+.+++..|+.+|+.++.+++|++||.|.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 6677889999999999998 456999999987654 3567899999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
|++.+.+.. ++++|.+.++..+++..++||+|||.. .-||||||..||||+.+|.+||+|||.|..+.+ .+...
T Consensus 113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR 186 (502)
T KOG0574|consen 113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR 186 (502)
T ss_pred CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence 999999865 678999999999999999999999998 689999999999999999999999999997754 45556
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
.+++|||
T Consensus 187 NTVIGTP 193 (502)
T KOG0574|consen 187 NTVIGTP 193 (502)
T ss_pred CccccCc
Confidence 7799997
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=213.74 Aligned_cols=143 Identities=24% Similarity=0.350 Sum_probs=126.3
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
...+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.+|+.++|+||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999954 5788999974322 24569999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|+ .++|..++.. ....+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 138 ~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 138 HY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred cc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 98 5788888854 456799999999999999999999998 9999999999999999999999999999854
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=198.99 Aligned_cols=151 Identities=23% Similarity=0.358 Sum_probs=132.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|+. .+++.||||.+..... .....+.+|+.+|+.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999994 5789999998764322 22346889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|..++... ....+++..+..++.|++.||.|||++ +|+|+||+|+|||++.++.++|+|||++..+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999888532 234578899999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 158 ~ 158 (267)
T cd08228 158 S 158 (267)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=215.72 Aligned_cols=157 Identities=23% Similarity=0.230 Sum_probs=132.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC---CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
..+|.+.+.||+|+||.||+|... .+..||+|.+... ..+.+|+.+|+.++||||+++++++...+..|++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999743 3678999987532 24568999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+ +++|..++. ....+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++.+...
T Consensus 166 e~~-~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKY-KCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhc-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 998 578888884 456799999999999999999999998 9999999999999999999999999999866543
Q ss_pred CCC-ccceeeccC
Q 008201 562 DMG-VETRVIGTF 573 (574)
Q Consensus 562 ~~~-~~t~v~GT~ 573 (574)
... ......||+
T Consensus 239 ~~~~~~~~~~gt~ 251 (392)
T PHA03207 239 PDTPQCYGWSGTL 251 (392)
T ss_pred ccccccccccccc
Confidence 221 122345654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=205.47 Aligned_cols=154 Identities=30% Similarity=0.442 Sum_probs=130.7
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 474 (574)
++..++|.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456678999999999999999999742 245799998764332 2234578899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~--------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
+..|+||||+++++|.+++.... ...+.+..+..++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCc
Confidence 99999999999999999996421 13456778889999999999999998 9999999999999999999
Q ss_pred EEEeeecceeecC
Q 008201 547 PLVGDFGLARWQP 559 (574)
Q Consensus 547 vKLsDFGLAr~~~ 559 (574)
++|+|||+++...
T Consensus 158 ~~L~Dfg~~~~~~ 170 (288)
T cd05061 158 VKIGDFGMTRDIY 170 (288)
T ss_pred EEECcCCcccccc
Confidence 9999999998543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=201.53 Aligned_cols=160 Identities=26% Similarity=0.338 Sum_probs=136.0
Q ss_pred cchhHHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEE-
Q 008201 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCI- 472 (574)
Q Consensus 396 fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~- 472 (574)
+.+..+....++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.+++.+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44556667788999999999999999999984 468899999876432 2235688899999999 6999999999884
Q ss_pred ----eCCeEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 473 ----EDRRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 473 ----~~~~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
.++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCC
Confidence 345789999999999999887532 345688999999999999999999998 9999999999999999999
Q ss_pred EEEeeecceeecCC
Q 008201 547 PLVGDFGLARWQPD 560 (574)
Q Consensus 547 vKLsDFGLAr~~~~ 560 (574)
++|+|||+++....
T Consensus 163 ~kl~dfg~~~~~~~ 176 (286)
T cd06638 163 VKLVDFGVSAQLTS 176 (286)
T ss_pred EEEccCCceeeccc
Confidence 99999999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=204.63 Aligned_cols=147 Identities=22% Similarity=0.366 Sum_probs=133.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.+|...+.||+|+||.||+|.. .+++.+++|.+..........+.+|+.+++.+.|+||++++++|......|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4799999999999999999984 568999999988665555667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++++|.+++. ...+++..+..++.|++.||.|||.. +|+||||||+|||++.++.++|+|||+++...
T Consensus 100 ~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 100 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred CCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 9999999985 34688999999999999999999998 99999999999999999999999999988653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=203.70 Aligned_cols=149 Identities=26% Similarity=0.385 Sum_probs=133.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.+.|++.+.||.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++++..++..|+||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 45688999999999999999995 45899999998765555556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+++++|..++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 91 ~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 91 CPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 999999887753 345689999999999999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=202.50 Aligned_cols=147 Identities=25% Similarity=0.427 Sum_probs=131.0
Q ss_pred eeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||++++++|...+..|+||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999954 5788899988755544456788999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++|..++.. ...++++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999988754 346799999999999999999999998 99999999999999999999999999997553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=202.07 Aligned_cols=154 Identities=29% Similarity=0.406 Sum_probs=132.6
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 474 (574)
++..++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+|+.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 345668999999999999999999853 246899999764432 2234688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~--------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCC
Confidence 99999999999999999986421 23478889999999999999999998 9999999999999999999
Q ss_pred EEEeeecceeecC
Q 008201 547 PLVGDFGLARWQP 559 (574)
Q Consensus 547 vKLsDFGLAr~~~ 559 (574)
+||+|||+++...
T Consensus 158 ~kl~dfg~~~~~~ 170 (277)
T cd05032 158 VKIGDFGMTRDIY 170 (277)
T ss_pred EEECCcccchhhc
Confidence 9999999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=201.89 Aligned_cols=149 Identities=26% Similarity=0.376 Sum_probs=130.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
.+|.+...||.|+||.||+|+.. +.+.+++|.+...... ....+.+|+++|++++|+||+++++++...+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57899999999999999999843 3467899987654433 3457899999999999999999999999988999
Q ss_pred EEEEecCCCChHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEee
Q 008201 479 LVYEYICNGSLDSHLYGCHQ-------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~-------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsD 551 (574)
+||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999964321 2689999999999999999999998 999999999999999999999999
Q ss_pred ecceeec
Q 008201 552 FGLARWQ 558 (574)
Q Consensus 552 FGLAr~~ 558 (574)
||+++..
T Consensus 161 ~~~~~~~ 167 (275)
T cd05046 161 LSLSKDV 167 (275)
T ss_pred ccccccc
Confidence 9998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=231.29 Aligned_cols=149 Identities=23% Similarity=0.314 Sum_probs=130.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999995 46899999998753222 2346899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcc---------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 482 EYICNGSLDSHLYGC---------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~---------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
||++|++|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEec
Confidence 999999999988531 123456777889999999999999998 9999999999999999999999999
Q ss_pred cceeec
Q 008201 553 GLARWQ 558 (574)
Q Consensus 553 GLAr~~ 558 (574)
|+|+..
T Consensus 158 GLAk~i 163 (932)
T PRK13184 158 GAAIFK 163 (932)
T ss_pred Ccceec
Confidence 999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=205.40 Aligned_cols=142 Identities=19% Similarity=0.294 Sum_probs=124.9
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEEEEEec
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRLLVYEYI 484 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LVmEy~ 484 (574)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5699999999999998 78899999987553333 3567899999999999999999999977 34789999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
.+|+|.+++.. ...+++.....++.+++.||.|||... +++||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 99999999973 457899999999999999999999842 78899999999999999999999999998654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=218.03 Aligned_cols=148 Identities=22% Similarity=0.346 Sum_probs=123.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--------C
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--------R 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--------~ 475 (574)
..+|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+|+.+|+.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999995 468999999875332 2356799999999999999999887532 2
Q ss_pred eEEEEEEecCCCChHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeee
Q 008201 476 RRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDF 552 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~--~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDF 552 (574)
.+++||||++ ++|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeecc
Confidence 4679999995 577776642 2456799999999999999999999998 999999999999998664 7999999
Q ss_pred cceeecCCC
Q 008201 553 GLARWQPDG 561 (574)
Q Consensus 553 GLAr~~~~~ 561 (574)
|+|+.+..+
T Consensus 216 Gla~~~~~~ 224 (440)
T PTZ00036 216 GSAKNLLAG 224 (440)
T ss_pred ccchhccCC
Confidence 999976543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=204.02 Aligned_cols=156 Identities=30% Similarity=0.473 Sum_probs=134.6
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 472 (574)
+++..++|+..+.||+|+||.||++... ....+|+|.+..... .....+.+|+.++..+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4556678999999999999999999853 236799998875322 2234688999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCC
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGC--------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~--------------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~N 538 (574)
..+..+++|||+++++|..++... ....+++..++.++.|++.||.|||+. +|+||||||+|
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~N 162 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARN 162 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----Cccccccceee
Confidence 999999999999999999998531 245689999999999999999999998 99999999999
Q ss_pred eEEcCCCcEEEeeecceeecCC
Q 008201 539 ILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 539 ILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||++.++.+||+|||+++.+..
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred EEEcCCCeEEeCcccccccccc
Confidence 9999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=200.16 Aligned_cols=152 Identities=32% Similarity=0.521 Sum_probs=132.8
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CC---CEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..++|...+.||+|+||.||+|... ++ ..+++|.+..... .....+..|+++++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 3457889999999999999999854 33 3789998865432 23456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++..
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999864 346789999999999999999999998 9999999999999999999999999999866
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 158 ~~ 159 (268)
T cd05063 158 ED 159 (268)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-22 Score=200.94 Aligned_cols=148 Identities=29% Similarity=0.456 Sum_probs=125.2
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhc---CCCCeeEEEEEEEe-----CC
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA---QHRNVVMLIGFCIE-----DR 475 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~-----~~ 475 (574)
+|.+.+.||+|+||.||+|.. .+|+.||+|.++..... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999984 46899999988754322 223566788877765 69999999999864 24
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..+++|||+. ++|..++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5799999996 5898888654455689999999999999999999999 9999999999999999999999999999
Q ss_pred eecC
Q 008201 556 RWQP 559 (574)
Q Consensus 556 r~~~ 559 (574)
+...
T Consensus 156 ~~~~ 159 (288)
T cd07863 156 RIYS 159 (288)
T ss_pred cccc
Confidence 8764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=210.88 Aligned_cols=147 Identities=25% Similarity=0.346 Sum_probs=125.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----- 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----- 475 (574)
..++|.+.+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 346899999999999999999984 568999999986432 223456889999999999999999999986543
Q ss_pred -eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 476 -~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
..|+||||+. ++|...+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 4799999995 56766663 2478889999999999999999999 999999999999999999999999999
Q ss_pred eeecC
Q 008201 555 ARWQP 559 (574)
Q Consensus 555 Ar~~~ 559 (574)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-22 Score=196.98 Aligned_cols=150 Identities=27% Similarity=0.400 Sum_probs=135.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|...+.||.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35799999999999999999985 46889999998866555567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++++|..++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhh
Confidence 999999998864 336789999999999999999999998 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=203.55 Aligned_cols=150 Identities=31% Similarity=0.459 Sum_probs=130.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRR 477 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 477 (574)
..|++.+.||+|+||.||++.+ .++..||+|.++.... .....+.+|+.+|+.++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999973 3578899999875432 2335789999999999999999999999875 568
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999999864 234689999999999999999999998 999999999999999999999999999987
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=200.86 Aligned_cols=150 Identities=31% Similarity=0.494 Sum_probs=131.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CC---CEEEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DG---QAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+.|.+.+.||+|+||.||+|... ++ ..||+|.+.... ......|..|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46889999999999999999853 33 369999887542 22345799999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. |++||||||+|||++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999864 345689999999999999999999998 999999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=202.19 Aligned_cols=149 Identities=27% Similarity=0.300 Sum_probs=130.9
Q ss_pred CeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCCC----cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASS----QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 477 (574)
+|++.+.||+|+||.||+++. .+|+.||+|.+..... ...+.+.+|+.+|..+ +|+||+.+++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999984 3689999999875322 2235678899999999 589999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999863 45688999999999999999999998 999999999999999999999999999987
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
....
T Consensus 155 ~~~~ 158 (290)
T cd05613 155 FHED 158 (290)
T ss_pred cccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=201.42 Aligned_cols=146 Identities=33% Similarity=0.498 Sum_probs=127.3
Q ss_pred eeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLL 479 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 479 (574)
|...+.||+|+||.||++.+ .++..||+|.+..... .....+.+|+++|+.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988652 3578899999875432 2345688999999999999999999998753 46899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999853 4699999999999999999999998 99999999999999999999999999998765
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=199.07 Aligned_cols=150 Identities=25% Similarity=0.344 Sum_probs=132.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|+....||+|+||.||+|... +|+.||+|.+..... ...+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46899999999999999999954 689999998764432 223467899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|++++.|..++. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887765 345689999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=199.88 Aligned_cols=149 Identities=28% Similarity=0.409 Sum_probs=133.2
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|.+.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 488999999999999999995 4689999999876542 2235789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+ +++|.+++.. ....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 9999999864 346799999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=202.62 Aligned_cols=149 Identities=30% Similarity=0.468 Sum_probs=126.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCC----EEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.+|.+.+.||+|+||.||+|.+ .+++ .+++|.+...... ...++..|+.+++.++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4688889999999999999985 3454 4777776533222 2346778888999999999999999885 456789
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999964 345789999999999999999999998 89999999999999999999999999999764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 161 ~ 161 (279)
T cd05111 161 P 161 (279)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=206.35 Aligned_cols=152 Identities=27% Similarity=0.435 Sum_probs=129.9
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCC---------------CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPD---------------GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVML 467 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~---------------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L 467 (574)
..++|.+.+.||+|+||.||+|+... ...||+|.+..... .....|.+|+++|+.++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34579999999999999999987432 23589998875432 223468999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCH----------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 468 ~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~----------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
++++...+..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~ 158 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATR 158 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChh
Confidence 999999999999999999999999985321 12468889999999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecC
Q 008201 538 NILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|||++.++.+||+|||+++...
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred hEEEcCCCcEEecccccccccc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=196.96 Aligned_cols=148 Identities=30% Similarity=0.418 Sum_probs=131.5
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-----cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+|+..+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999965 789999998865432 1335688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999863 45688999999999999999999998 999999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=206.02 Aligned_cols=154 Identities=31% Similarity=0.442 Sum_probs=132.0
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC--------CCCEEEEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
++..++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+..|+.++..+ +|+||++++++|
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344567999999999999999999742 23579999887542 22335688899999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
...+..|+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~ 169 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAAR 169 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHH
Confidence 99999999999999999999996432 13588999999999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecC
Q 008201 538 NILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|||++.++.++|+|||+++...
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIH 191 (307)
T ss_pred heEEcCCCcEEECCCccccccc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=199.39 Aligned_cols=148 Identities=26% Similarity=0.406 Sum_probs=130.1
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|.+.+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 488899999999999999995 4689999998875432 2235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~-~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|.+++.... ...+++..+..++.||+.||.|||+. +|+||||+|+|||++.++.++|+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 96 68888885432 36789999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=221.27 Aligned_cols=153 Identities=25% Similarity=0.332 Sum_probs=134.6
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-C-----CCeeEEEEEEEeC
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-H-----RNVVMLIGFCIED 474 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-H-----pNIV~L~g~~~~~ 474 (574)
+....+|.+.++||+|.||.|.+|+ ..+++.||||+++... ....+...|+.+|..|+ | -|+|+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3444479999999999999999999 6679999999998653 23345677999999997 4 3899999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC--CcEEEeee
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD--FEPLVGDF 552 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~--~~vKLsDF 552 (574)
++.|||+|.+ ..+|.++|..+...+|+...++.|+.||+.||.+||+. +|||+||||+||||.+- ..+||+||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEec
Confidence 9999999998 88999999987788899999999999999999999999 99999999999999754 47999999
Q ss_pred cceeecCC
Q 008201 553 GLARWQPD 560 (574)
Q Consensus 553 GLAr~~~~ 560 (574)
|.|.....
T Consensus 336 GSSc~~~q 343 (586)
T KOG0667|consen 336 GSSCFESQ 343 (586)
T ss_pred ccccccCC
Confidence 99986643
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=203.38 Aligned_cols=151 Identities=32% Similarity=0.475 Sum_probs=132.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..+|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+++|++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45789999999999999999973 234568999887554444567899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcE
Q 008201 479 LVYEYICNGSLDSHLYGC-----------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~-----------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~v 547 (574)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcE
Confidence 999999999999998632 123589999999999999999999998 99999999999999999999
Q ss_pred EEeeecceeecC
Q 008201 548 LVGDFGLARWQP 559 (574)
Q Consensus 548 KLsDFGLAr~~~ 559 (574)
+|+|||+++...
T Consensus 160 kl~dfg~~~~~~ 171 (288)
T cd05093 160 KIGDFGMSRDVY 171 (288)
T ss_pred EeccCCcccccc
Confidence 999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=200.69 Aligned_cols=142 Identities=31% Similarity=0.408 Sum_probs=120.9
Q ss_pred eeeccCcEEEEEEEeCC---CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 008201 413 FLAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~---g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggs 488 (574)
.||+|+||.||+|...+ ...+++|.+...... ....+.+|+.+++.++|+||+++++++...+..|+||||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 456888876543322 23468899999999999999999999999999999999999999
Q ss_pred hHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 489 LDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 489 L~~~L~~~~---~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEecccccccc
Confidence 999996532 23356778889999999999999998 9999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=227.44 Aligned_cols=167 Identities=28% Similarity=0.419 Sum_probs=145.4
Q ss_pred CCCCccchhHHHhhcCCeeEEeeeeccCcEEEEEEEeCC----CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCee
Q 008201 391 KPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVV 465 (574)
Q Consensus 391 ~~~~~fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV 465 (574)
.|.++...-.-++..+...+.++||.|.||.||+|+++- ...||||.++.... ....+|+.|+.||..++||||+
T Consensus 614 DPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNII 693 (996)
T KOG0196|consen 614 DPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 693 (996)
T ss_pred CccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEE
Confidence 344443333346777788999999999999999999542 35799999987644 3446899999999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC
Q 008201 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (574)
Q Consensus 466 ~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~ 545 (574)
+|.|+........||.|||++|+|+.||.. +.+.|.+.+...++++|+.|++||-+. ++|||||.++|||++.+.
T Consensus 694 rLEGVVTks~PvMIiTEyMENGsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnL 768 (996)
T KOG0196|consen 694 RLEGVVTKSKPVMIITEYMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNL 768 (996)
T ss_pred EEEEEEecCceeEEEhhhhhCCcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhc----Cchhhhhhhhheeeccce
Confidence 999999999999999999999999999987 456699999999999999999999999 999999999999999999
Q ss_pred cEEEeeecceeecCCCC
Q 008201 546 EPLVGDFGLARWQPDGD 562 (574)
Q Consensus 546 ~vKLsDFGLAr~~~~~~ 562 (574)
.+||+||||+|++.++.
T Consensus 769 vCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 769 VCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEeccccceeecccCC
Confidence 99999999999887655
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-22 Score=199.63 Aligned_cols=148 Identities=28% Similarity=0.453 Sum_probs=129.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+.+|.+.+.||+|+||.||+|.. .+|+.||+|.+....... ...+.+|+.+|+.++|+||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46899999999999999999984 468999999987543322 3467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|+ +++|..++.. ....+.+..+..++.|++.||.|||.. +|+||||||+|||++.++.++|+|||+++..
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 84 YM-HTDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred cc-cCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99 4778777653 335678888999999999999999998 9999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.5e-22 Score=194.74 Aligned_cols=149 Identities=26% Similarity=0.340 Sum_probs=130.9
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LVmE 482 (574)
+|.+.+.||.|+||.||++.. .+++.+|+|.+..... ...+.+.+|+++++.++|+|++++++.+.. .+..|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 588999999999999999994 4588999999875432 233468899999999999999999998864 446899999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+++++|.+++.......+++..+..++.+++.||.|||+. +|+||||||+||+++.++.++|+|||+++...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 99999999999754456789999999999999999999998 99999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=195.63 Aligned_cols=148 Identities=24% Similarity=0.441 Sum_probs=132.3
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.+|+..+.||+|+||.||++...++..+|+|.+.... .....+.+|+++++.++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688899999999999999997678899999876432 234578999999999999999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 83 HGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecc
Confidence 9999999864 345688999999999999999999998 89999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=199.84 Aligned_cols=148 Identities=30% Similarity=0.474 Sum_probs=123.8
Q ss_pred eEEeeeeccCcEEEEEEEeCC-CC--EEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeE
Q 008201 409 SQANFLAEGGFGSVHRGVLPD-GQ--AVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------RRR 477 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~-g~--~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~ 477 (574)
.+.+.||+|+||.||+|.... +. .+|+|.++... ....+.+..|+++|+.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999644 33 58999877542 22345688999999999999999999987532 246
Q ss_pred EEEEEecCCCChHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 478 LLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~----~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
+++|||+.+++|..++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCC
Confidence 8999999999999887421 234588999999999999999999998 99999999999999999999999999
Q ss_pred ceeecCC
Q 008201 554 LARWQPD 560 (574)
Q Consensus 554 LAr~~~~ 560 (574)
+++....
T Consensus 158 ~~~~~~~ 164 (272)
T cd05075 158 LSKKIYN 164 (272)
T ss_pred cccccCc
Confidence 9997644
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=201.82 Aligned_cols=148 Identities=27% Similarity=0.411 Sum_probs=130.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|...+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4699999999999999999985 4688999999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|..++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++...
T Consensus 86 ~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 95 689888864 345688999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=212.28 Aligned_cols=155 Identities=29% Similarity=0.418 Sum_probs=130.0
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 473 (574)
++..++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+..|+.++..+ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 34456799999999999999999963 23578999988743322 234678899999999 79999999998865
Q ss_pred -CCeEEEEEEecCCCChHHHHhccC-------------------------------------------------------
Q 008201 474 -DRRRLLVYEYICNGSLDSHLYGCH------------------------------------------------------- 497 (574)
Q Consensus 474 -~~~~~LVmEy~~ggsL~~~L~~~~------------------------------------------------------- 497 (574)
+...+++|||+++++|.+++....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 456889999999999999885321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 498 ----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 498 ----~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
..++++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++.+..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 13688999999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=202.14 Aligned_cols=151 Identities=34% Similarity=0.495 Sum_probs=131.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
..+|.+.+.||+|+||.||+|... ++..||+|.++..... ....+.+|+++|+.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346888899999999999999853 3578999998755443 345799999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC
Q 008201 478 LLVYEYICNGSLDSHLYGCH------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~ 545 (574)
+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCC
Confidence 99999999999999986421 24578889999999999999999998 999999999999999999
Q ss_pred cEEEeeecceeecC
Q 008201 546 EPLVGDFGLARWQP 559 (574)
Q Consensus 546 ~vKLsDFGLAr~~~ 559 (574)
.++|+|||+++...
T Consensus 160 ~~kl~d~g~~~~~~ 173 (280)
T cd05049 160 VVKIGDFGMSRDVY 173 (280)
T ss_pred eEEECCcccceecc
Confidence 99999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=200.30 Aligned_cols=147 Identities=28% Similarity=0.435 Sum_probs=130.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57999999999999999999954 6899999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++..
T Consensus 85 ~~-~~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LD-TDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CC-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECcccccccc
Confidence 96 589998864 334789999999999999999999998 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-22 Score=202.34 Aligned_cols=148 Identities=22% Similarity=0.390 Sum_probs=134.5
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.+|+..+.||.|+||.||+|. ..+|+.|++|.+........+.+.+|+.+++.++|+||+++++++...+..|+|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 469999999999999999998 4579999999987665555667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
.+++|..++. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++....
T Consensus 99 ~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999885 34689999999999999999999999 999999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=201.49 Aligned_cols=148 Identities=28% Similarity=0.412 Sum_probs=131.3
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-----chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-----GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+|...+.||+|+||.||+|.. .+|+.||+|.+...... ....+..|+++++.++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999995 46899999998765432 234577899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+ +++|..++... ...+++..+..++.||+.||.|||+. +|+|+||+|+|||++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 99999999642 23799999999999999999999999 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=204.40 Aligned_cols=155 Identities=28% Similarity=0.455 Sum_probs=132.4
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe--------CCCCEEEEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
.+...+|.+.+.||+|+||.||+|+. .++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 34456789999999999999999973 124579999876432 23345788999999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
...+..|++|||+++++|.+++.... ...+++..+..++.||+.||.|||++ ||+||||||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~ 166 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAAR 166 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeecccccc
Confidence 99999999999999999999986431 23578888999999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecCC
Q 008201 538 NILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||++.++.+||+|||+++....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNN 189 (304)
T ss_pred eEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=199.65 Aligned_cols=150 Identities=28% Similarity=0.457 Sum_probs=129.4
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCC----EEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
...+|...+.||+|+||.||+|.+ .+|. .||+|.++..... ....+.+|+.+++.++|+||+.+++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 345789999999999999999984 4554 4899988754332 345688999999999999999999999754 57
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++++||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceee
Confidence 899999999999999864 345789999999999999999999998 999999999999999999999999999987
Q ss_pred cC
Q 008201 558 QP 559 (574)
Q Consensus 558 ~~ 559 (574)
..
T Consensus 159 ~~ 160 (279)
T cd05109 159 LD 160 (279)
T ss_pred cc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=196.83 Aligned_cols=148 Identities=29% Similarity=0.427 Sum_probs=129.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEE-eCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI-EDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~~~LVmEy 483 (574)
..+|.+.+.||+|+||.||++.. .|..+|+|.++.. ...+.+.+|+.+++.++|+||+++++++. ..+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 45789999999999999999986 4778999987643 23457899999999999999999999765 45678999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++++|.+++.......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceecc
Confidence 9999999999754445689999999999999999999998 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=210.42 Aligned_cols=149 Identities=27% Similarity=0.374 Sum_probs=128.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------ 474 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 474 (574)
..++|.+.+.||.|+||.||+|. ..+++.||||.+..... .....+.+|+.+|+.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34679999999999999999998 45688999998864322 2234577899999999999999999988643
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
...|+++|++ +++|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999987 889988874 45799999999999999999999998 999999999999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=202.59 Aligned_cols=150 Identities=25% Similarity=0.272 Sum_probs=134.3
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.+|...+.||+|+||.||+|... +++.+|+|.+...... ..+.+..|+++|+.++|+||+++++++...+..|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36899999999999999999954 5899999998765332 3346889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+.+++|.+++.......+++..+..++.|++.||.|||.. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998754456799999999999999999999998 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=215.58 Aligned_cols=155 Identities=26% Similarity=0.368 Sum_probs=132.3
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcC-CCCeeEEEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQ-HRNVVMLIGFCI 472 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~ 472 (574)
+++..++|.+.+.||+|+||.||+|++. .++.||+|+++..... ..+.+.+|+.+|..+. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4555667888999999999999999843 3468999999754322 2346889999999997 999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC-------------------------------------------------------
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCH------------------------------------------------------- 497 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~------------------------------------------------------- 497 (574)
..+..++||||+.+|+|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986421
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCC
Q 008201 498 -----------------------------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (574)
Q Consensus 498 -----------------------------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP 536 (574)
...+++..++.++.||+.||.|||+. +|+||||||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp 267 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAA 267 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCc
Confidence 12467778889999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeecceeecC
Q 008201 537 NNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 537 ~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|||++.++.++|+|||+++.+.
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIM 290 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecc
Confidence 99999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=210.82 Aligned_cols=154 Identities=27% Similarity=0.380 Sum_probs=129.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 473 (574)
....++|++.+.||+|+||.||+|.. .+++.||||.++..... ....+.+|+.+|..+ +|+||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 34556899999999999999999972 34788999998754322 234688999999999 68999999998865
Q ss_pred C-CeEEEEEEecCCCChHHHHhccC-------------------------------------------------------
Q 008201 474 D-RRRLLVYEYICNGSLDSHLYGCH------------------------------------------------------- 497 (574)
Q Consensus 474 ~-~~~~LVmEy~~ggsL~~~L~~~~------------------------------------------------------- 497 (574)
. ...+++|||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 46789999999999999885321
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 498 ----------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 498 ----------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 12467888899999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=197.75 Aligned_cols=146 Identities=32% Similarity=0.532 Sum_probs=130.6
Q ss_pred CeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+|...+.||+|+||.||+|...+|+.+|+|.+...... ....+.+|+++|+.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47778899999999999999878999999988754321 123588899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999996 345788999999999999999999998 8999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=199.02 Aligned_cols=151 Identities=26% Similarity=0.335 Sum_probs=132.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|++.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+++|+.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46999999999999999999954 688999998865322 234578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|++++.+..++. ....+++..+..++.||+.||.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998877766554 345689999999999999999999998 99999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=220.77 Aligned_cols=160 Identities=25% Similarity=0.363 Sum_probs=142.8
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.|...+.||+|.||.||+|. ..+++.||+|++.+..... .+++.+|+.+|..++++||.++|+.|..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 47778899999999999999 5679999999999865443 467999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
.||++.+.|. ....+.+..+..++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||++..+......
T Consensus 94 ~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999996 344558888889999999999999999 8999999999999999999999999999988765543
Q ss_pred ccceeeccC
Q 008201 565 VETRVIGTF 573 (574)
Q Consensus 565 ~~t~v~GT~ 573 (574)
. .+++|||
T Consensus 168 r-~tfvGTP 175 (467)
T KOG0201|consen 168 R-KTFVGTP 175 (467)
T ss_pred c-ccccccc
Confidence 3 6789997
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=198.76 Aligned_cols=148 Identities=24% Similarity=0.363 Sum_probs=130.5
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
+|+..+.||+|+||.||++. ..+++.+|+|.+...... ..+.+.+|+.+|+.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999998 467899999988754321 23568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeec
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQ 558 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~ 558 (574)
||||+++++|.+++.. ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999863 45789999999999999999999998 999999999999998775 5999999999866
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=202.91 Aligned_cols=152 Identities=26% Similarity=0.428 Sum_probs=130.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-----------------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCee
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-----------------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVV 465 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----------------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV 465 (574)
..++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+.+|+.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3457999999999999999998532 244689998875432 2345789999999999999999
Q ss_pred EEEEEEEeCCeEEEEEEecCCCChHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCC
Q 008201 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH---------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (574)
Q Consensus 466 ~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~---------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP 536 (574)
++++++...+..+++|||+++++|..++.... ...+++..+..++.|++.||.|||+. +|+||||||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp 158 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLAT 158 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCh
Confidence 99999999999999999999999999986421 12477888999999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeecceeecC
Q 008201 537 NNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 537 ~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|||++.++.++|+|||+++.+.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred heEEEcCCCCEEeccCccccccc
Confidence 99999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=199.44 Aligned_cols=151 Identities=29% Similarity=0.392 Sum_probs=129.8
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCC----CCEEEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
...+|.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.. +..|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34568899999999999999998533 3468999876544 2334578999999999999999999999875 5678
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999964 234689999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 158 ~~ 159 (270)
T cd05056 158 ED 159 (270)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=200.76 Aligned_cols=150 Identities=32% Similarity=0.515 Sum_probs=130.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCC------CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
++|++.+.||+|+||.||+|.... ...||+|.+...... ....+.+|+.+|..++||||+++++++...+..|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998432 257999988744322 2346899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 479 LVYEYICNGSLDSHLYGCHQ--------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~--------------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCC
Confidence 99999999999999864311 5688899999999999999999998 99999999999999999
Q ss_pred CcEEEeeecceeecC
Q 008201 545 FEPLVGDFGLARWQP 559 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~ 559 (574)
+.++|+|||+++...
T Consensus 161 ~~~~L~dfg~~~~~~ 175 (283)
T cd05048 161 LTVKISDFGLSRDIY 175 (283)
T ss_pred CcEEECCCcceeecc
Confidence 999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=202.46 Aligned_cols=146 Identities=25% Similarity=0.334 Sum_probs=130.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|...+.||+|+||.||++.. .+++.|++|.+..... .....+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4689999999999999999995 4588999998875432 22346789999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++.
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999963 45789999999999999999999998 999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=209.16 Aligned_cols=148 Identities=22% Similarity=0.328 Sum_probs=126.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------ 474 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 474 (574)
..++|...+.||+|+||.||++.. ..++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456899999999999999999984 4688999998875322 2235678899999999999999999998653
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
...|+||||+. ++|...+. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 35799999995 56776664 2488899999999999999999998 999999999999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=197.49 Aligned_cols=147 Identities=27% Similarity=0.420 Sum_probs=129.6
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc----------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ----------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~----------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
+|...+.||+|+||.||+|.. .+|+.+|+|.++..... ..+.+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999984 46899999987642111 1135788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+. +++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999864 36789999999999999999999998 9999999999999999999999999999
Q ss_pred eecC
Q 008201 556 RWQP 559 (574)
Q Consensus 556 r~~~ 559 (574)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=197.17 Aligned_cols=147 Identities=28% Similarity=0.457 Sum_probs=130.1
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---------hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
+|.+...||+|+||.||+|.. .+++.+|+|.+....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999984 468899999886543321 1457889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.+++|||+++++|..++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999963 46788999999999999999999998 99999999999999999999999999998
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
.+.
T Consensus 155 ~~~ 157 (267)
T cd06628 155 KLE 157 (267)
T ss_pred ccc
Confidence 765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=198.83 Aligned_cols=151 Identities=25% Similarity=0.376 Sum_probs=132.6
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||.|+||.||++. ..++..++||.+..... ....++.+|+.+++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468888999999999999999 45799999998764322 22346889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|.+++... ....+++..+..++.||+.||.|||+. +|+|+||+|+||+++.++.++|+|||++..+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999988532 245689999999999999999999998 99999999999999999999999999998764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 158 ~ 158 (267)
T cd08229 158 S 158 (267)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=204.30 Aligned_cols=149 Identities=30% Similarity=0.498 Sum_probs=127.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCE--EEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQA--VAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~--VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 479 (574)
.++|++.+.||+|+||.||+|... ++.. +++|.+..... .....+.+|+++|.++ +|+||+++++++...+..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457899999999999999999953 4544 57776653322 2335688999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC
Q 008201 480 VYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~ 545 (574)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCC
Confidence 999999999999986421 23578999999999999999999998 999999999999999999
Q ss_pred cEEEeeecceee
Q 008201 546 EPLVGDFGLARW 557 (574)
Q Consensus 546 ~vKLsDFGLAr~ 557 (574)
.+||+|||+++.
T Consensus 162 ~~kl~dfg~~~~ 173 (303)
T cd05088 162 VAKIADFGLSRG 173 (303)
T ss_pred cEEeCccccCcc
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=213.52 Aligned_cols=163 Identities=18% Similarity=0.266 Sum_probs=129.3
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC------CCeeEEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH------RNVVMLIGFCI 472 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H------pNIV~L~g~~~ 472 (574)
++....++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+..|+.++..++| .+|+.++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 4455678999999999999999999984 468899999986432 223456678888877755 45889999887
Q ss_pred eC-CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC------
Q 008201 473 ED-RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF------ 545 (574)
Q Consensus 473 ~~-~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~------ 545 (574)
.. +..|+|||++ +++|.+++.. ...+++..+..|+.||+.||.|||..+ |||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 64 4789999987 8889888863 467999999999999999999999732 899999999999998765
Q ss_pred ----------cEEEeeecceeecCCCCCCccceeeccC
Q 008201 546 ----------EPLVGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 546 ----------~vKLsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
.+||+|||++..... ..+.++||+
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~ 309 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTR 309 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCc
Confidence 499999999864322 223456665
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=200.95 Aligned_cols=149 Identities=28% Similarity=0.406 Sum_probs=131.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|+..+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|+++|+.++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46899999999999999999964 5899999987643322 23568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+.++.|..+.. ....+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999998888765 344589999999999999999999998 899999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=201.61 Aligned_cols=151 Identities=30% Similarity=0.441 Sum_probs=131.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..+|.+.+.||+|+||.||+|.. .++..+++|.+........+.+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 34688999999999999999973 235568899887555444567899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 479 LVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccC
Confidence 9999999999999986421 23488999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecceeecC
Q 008201 545 FEPLVGDFGLARWQP 559 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~ 559 (574)
+.++|+|||+++...
T Consensus 160 ~~~~l~dfg~a~~~~ 174 (291)
T cd05094 160 LLVKIGDFGMSRDVY 174 (291)
T ss_pred CcEEECCCCcccccC
Confidence 999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=202.46 Aligned_cols=141 Identities=21% Similarity=0.285 Sum_probs=120.2
Q ss_pred eeeccCcEEEEEEEeCC-------------------------CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEE
Q 008201 413 FLAEGGFGSVHRGVLPD-------------------------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L 467 (574)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13588888865443344578889999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC--
Q 008201 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-- 545 (574)
Q Consensus 468 ~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-- 545 (574)
+++|...+..++||||+++++|..++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998864 345789999999999999999999998 999999999999997643
Q ss_pred -----cEEEeeecceeec
Q 008201 546 -----EPLVGDFGLARWQ 558 (574)
Q Consensus 546 -----~vKLsDFGLAr~~ 558 (574)
.++++|||++...
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 4899999998644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=196.91 Aligned_cols=149 Identities=34% Similarity=0.504 Sum_probs=126.9
Q ss_pred eeEEeeeeccCcEEEEEEEeC-C---CCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-----
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-D---GQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR----- 476 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~---g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~----- 476 (574)
|.+.+.||+|+||.||+|... + +..||+|.++..... ....+.+|+.+|+.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999853 2 478999998754322 23568999999999999999999999876554
Q ss_pred -EEEEEEecCCCChHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEee
Q 008201 477 -RLLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (574)
Q Consensus 477 -~~LVmEy~~ggsL~~~L~~~----~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsD 551 (574)
.+++|||+++++|..++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECC
Confidence 79999999999999888432 234689999999999999999999998 999999999999999999999999
Q ss_pred ecceeecCC
Q 008201 552 FGLARWQPD 560 (574)
Q Consensus 552 FGLAr~~~~ 560 (574)
||+++....
T Consensus 157 fg~~~~~~~ 165 (273)
T cd05035 157 FGLSKKIYS 165 (273)
T ss_pred ccceeeccc
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=202.95 Aligned_cols=143 Identities=24% Similarity=0.378 Sum_probs=119.2
Q ss_pred EeeeeccCcEEEEEEEeC---CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEEecC
Q 008201 411 ANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVYEYIC 485 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVmEy~~ 485 (574)
...||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.+|+.++||||+++++++.. ....|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 357999999999999853 46789999886432 23467899999999999999999999864 45689999998
Q ss_pred CCChHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE----cCCCcEEEeeecc
Q 008201 486 NGSLDSHLYGC-------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGL 554 (574)
Q Consensus 486 ggsL~~~L~~~-------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL----d~~~~vKLsDFGL 554 (574)
+++|..++... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +..+.+||+|||+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 56888776421 123588999999999999999999998 99999999999999 4567899999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
|+.+..
T Consensus 159 a~~~~~ 164 (317)
T cd07868 159 ARLFNS 164 (317)
T ss_pred eeccCC
Confidence 987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=202.73 Aligned_cols=150 Identities=25% Similarity=0.390 Sum_probs=131.1
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+|++.+.||+|+||.||++... +|..+|+|.+..... .....+.+|+.+|+.++|+||+++++++...+..|+||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999954 689999998875422 22356889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~-~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++++|..++... ....+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||++..+.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999988642 1347899999999999999999999742 89999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-22 Score=196.87 Aligned_cols=141 Identities=28% Similarity=0.480 Sum_probs=122.5
Q ss_pred eeccCcEEEEEEEeC---CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.+|+.++|+||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999743 3567999988755332 2356889999999999999999999885 4578999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
.+++.. ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 82 NKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred HHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 999864 345789999999999999999999998 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=204.41 Aligned_cols=154 Identities=29% Similarity=0.417 Sum_probs=132.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED 474 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 474 (574)
...++|...+.||+|+||.||++.. ..+..+|+|.++.... ...+.+.+|+.+++++ +|+||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3445799999999999999999973 1355799998775432 2235688999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
+..|++|||+++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999999754444589999999999999999999998 999999999999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
++.+..
T Consensus 188 ~~~~~~ 193 (302)
T cd05055 188 ARDIMN 193 (302)
T ss_pred cccccC
Confidence 986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=196.88 Aligned_cols=148 Identities=26% Similarity=0.370 Sum_probs=128.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-----cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRR 477 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 477 (574)
.+|.+.+.||+|+||.||++.. .+|..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999985 4689999998764321 1224688899999999999999999998763 468
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+|+||+|+|||++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999863 35688899999999999999999998 999999999999999999999999999986
Q ss_pred cC
Q 008201 558 QP 559 (574)
Q Consensus 558 ~~ 559 (574)
..
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-22 Score=195.03 Aligned_cols=148 Identities=30% Similarity=0.458 Sum_probs=133.3
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|...+.||+|+||.||+|.. .+++.+++|.+...... ....+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999985 46899999998765443 446789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.. ...+++..+..++.+++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999999863 45688999999999999999999998 999999999999999999999999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=194.39 Aligned_cols=149 Identities=32% Similarity=0.494 Sum_probs=131.0
Q ss_pred eEEeeeeccCcEEEEEEEeCC-----CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 409 SQANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++.+.||.|+||.||++.... +..||+|.+...... ....+..|+.+|..++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999543 388999998765433 45678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|+++++|.+++.......+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999643333389999999999999999999999 9999999999999999999999999999876543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-24 Score=211.68 Aligned_cols=162 Identities=27% Similarity=0.358 Sum_probs=138.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC--CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.+.|++-+.||+|.|+.||++. .++|+.+|+|+++.. ...+.+++.+|+.|.+.|+||||++|.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4568888899999999999998 567999999987754 2335578999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC---CcEEEeeecceeec
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDFGLARWQ 558 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~---~~vKLsDFGLAr~~ 558 (574)
|+|.|++|..-+-. ...+++..+-.+++||+++|.|+|.+ +|||||+||+|+|+... -.+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999866642 24567778889999999999999999 99999999999999643 46999999999998
Q ss_pred CCCCCCccceeeccCC
Q 008201 559 PDGDMGVETRVIGTFG 574 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~G 574 (574)
.++. ...-++||||
T Consensus 164 ~~g~--~~~G~~GtP~ 177 (355)
T KOG0033|consen 164 NDGE--AWHGFAGTPG 177 (355)
T ss_pred CCcc--ccccccCCCc
Confidence 8443 3345788886
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=197.00 Aligned_cols=141 Identities=24% Similarity=0.355 Sum_probs=121.8
Q ss_pred eeeeccCcEEEEEEEeCC-C----------CEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 412 NFLAEGGFGSVHRGVLPD-G----------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~-g----------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+.||+|+||.||+|.... + ..+++|.+...... ...+.+|+.+|+.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999999643 3 25778876644333 5678999999999999999999999988 778999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-------cEEEeeec
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-------EPLVGDFG 553 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-------~vKLsDFG 553 (574)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999874 233789999999999999999999998 999999999999999887 79999999
Q ss_pred ceeecC
Q 008201 554 LARWQP 559 (574)
Q Consensus 554 LAr~~~ 559 (574)
+++...
T Consensus 154 ~a~~~~ 159 (259)
T cd05037 154 IPITVL 159 (259)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=193.68 Aligned_cols=152 Identities=26% Similarity=0.388 Sum_probs=134.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|++.+.||.|+||.||+|.. .++..+++|++..... .....+.+|+++|+.++|+||+++++.+...+..+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4689999999999999999994 4688999998875432 2446789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~-~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999964332 5689999999999999999999998 9999999999999999999999999999866543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=212.05 Aligned_cols=162 Identities=25% Similarity=0.263 Sum_probs=140.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchh---HHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH---EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~---~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|..+++||+|.||.|.+|+ ..+|+.+|+|+++..---... --..|-.+|+..+||.+..|...|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3467778899999999999998 667999999998865333332 245688999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||..||.|.-+|. +...+++.....+...|..||.|||++ +||+||||.+|+|+|.+|++||+||||++.-..
T Consensus 247 MeyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999887 567899999999999999999999998 999999999999999999999999999995443
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
.. ....++||||
T Consensus 321 ~g-~t~kTFCGTP 332 (516)
T KOG0690|consen 321 YG-DTTKTFCGTP 332 (516)
T ss_pred cc-ceeccccCCh
Confidence 22 2456799997
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=200.31 Aligned_cols=149 Identities=32% Similarity=0.427 Sum_probs=128.0
Q ss_pred CeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
+|.+.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+|+.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999842 235788888764432 223568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 480 VYEYICNGSLDSHLYGCH----------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~----------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
+|||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----Ceehhhhhhh
Confidence 999999999999885321 23578999999999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecC
Q 008201 538 NILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|||+++++.++|+|||+++...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred eEEEcCCCcEEecccccccccc
Confidence 9999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.4e-22 Score=198.32 Aligned_cols=150 Identities=28% Similarity=0.471 Sum_probs=130.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCC----EEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQ----AVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..+|.+.+.||+|+||.||+|... +|. .+|+|.+...... ....+.+|+.+|+.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356889999999999999999843 343 5899987655432 33578899999999999999999999987 7899
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999864 344689999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 160 ~~ 161 (279)
T cd05057 160 DV 161 (279)
T ss_pred cC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-22 Score=200.23 Aligned_cols=151 Identities=30% Similarity=0.450 Sum_probs=131.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCC-----------------CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPD-----------------GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVM 466 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~ 466 (574)
..+|.+.+.||+|+||.||++.... +..||+|.+..... .....+.+|+++|+.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999988432 24589998875433 23457889999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCH---------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 467 L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~---------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
+++++..++..+++|||+++++|..++.... ...+++..++.++.|++.||.|||+. +|+||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchh
Confidence 9999999999999999999999999986432 12689999999999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecC
Q 008201 538 NILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++.++.++|+|||+++...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred ceeecCCCceEEccccceeecc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=197.93 Aligned_cols=143 Identities=30% Similarity=0.431 Sum_probs=122.7
Q ss_pred eeeccCcEEEEEEEeC---CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 008201 413 FLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggs 488 (574)
.||+|+||.||+|... ++..+|+|.++..... ....+.+|+.+++.++||||+++++++......++||||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999853 3467899987754432 23468889999999999999999999999889999999999999
Q ss_pred hHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 489 LDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 489 L~~~L~~~~---~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 999986422 23567778889999999999999998 99999999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=196.29 Aligned_cols=146 Identities=31% Similarity=0.479 Sum_probs=129.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.+|.+.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.+++.++||||+++++++... ..+++|||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999875 67889999886432 345788999999999999999999998764 5799999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++|.+++.......+++..+..++.|++.||.|||+. |++||||||+|||++.++.++|+|||+++...
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999999754455689999999999999999999998 99999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=200.08 Aligned_cols=151 Identities=33% Similarity=0.463 Sum_probs=131.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..+|...+.||+|+||.||++.. .++..+|+|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35688889999999999999963 235678999877655455567999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC
Q 008201 479 LVYEYICNGSLDSHLYGCHQ-------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~-------------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~ 545 (574)
++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCC
Confidence 99999999999999864211 3588999999999999999999998 999999999999999999
Q ss_pred cEEEeeecceeecC
Q 008201 546 EPLVGDFGLARWQP 559 (574)
Q Consensus 546 ~vKLsDFGLAr~~~ 559 (574)
.++|+|||+++...
T Consensus 160 ~~kL~dfg~~~~~~ 173 (280)
T cd05092 160 VVKIGDFGMSRDIY 173 (280)
T ss_pred CEEECCCCceeEcC
Confidence 99999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9e-22 Score=207.37 Aligned_cols=147 Identities=22% Similarity=0.319 Sum_probs=125.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------C
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------R 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~ 475 (574)
.++|.+.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999984 468899999887532 22335688999999999999999999988643 3
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+. ++|..++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCC-CCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 5799999995 57777764 2478889999999999999999998 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 174 ~~~~~ 178 (364)
T cd07875 174 RTAGT 178 (364)
T ss_pred cccCC
Confidence 86543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=192.75 Aligned_cols=150 Identities=26% Similarity=0.345 Sum_probs=133.2
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|++.+.||+|+||.||++. ..+|+.+|+|.+.... .....++.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 48899999999999999998 4568999999887542 22335789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+.+++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988654445688999999999999999999998 999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=202.78 Aligned_cols=154 Identities=31% Similarity=0.469 Sum_probs=131.1
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC--------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
.+...+|.+.+.||+|+||.||++... ....+|+|.++.... .....+..|+.+++.+ +||||++++++|
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567899999999999999999731 245789998774322 2234688999999999 599999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
...+..|++|||+++++|.+++.... ...+++..+..++.|++.||.|||++ ||+||||||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~ 163 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAAR 163 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----Ceeeccccce
Confidence 99899999999999999999986421 24588999999999999999999998 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecC
Q 008201 538 NILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|||++.++.+||+|||+++...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVH 185 (314)
T ss_pred eEEEcCCCcEEEcccccccccc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=198.93 Aligned_cols=141 Identities=29% Similarity=0.414 Sum_probs=119.8
Q ss_pred eeeccCcEEEEEEEeCCC---CEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 008201 413 FLAEGGFGSVHRGVLPDG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggs 488 (574)
.||+|+||.||++...++ ..+++|.+..... ...+.+.+|+.+++.++||||++++++|......|+||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999984433 3456676654332 234579999999999999999999999999999999999999999
Q ss_pred hHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 489 LDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 489 L~~~L~~~~--~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|.+++.... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccc
Confidence 999996431 23466777889999999999999998 899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=196.73 Aligned_cols=149 Identities=30% Similarity=0.470 Sum_probs=131.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRR 477 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~ 477 (574)
..|...+.||+|+||.||++.+. ++..+|+|.+...... ....+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777899999999999999843 3788999998755433 35679999999999999999999999877 5578
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
+++|||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999964 233689999999999999999999998 999999999999999999999999999987
Q ss_pred cC
Q 008201 558 QP 559 (574)
Q Consensus 558 ~~ 559 (574)
..
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=197.25 Aligned_cols=142 Identities=23% Similarity=0.330 Sum_probs=122.0
Q ss_pred eeeccCcEEEEEEEeCC-------------CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 413 FLAEGGFGSVHRGVLPD-------------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~-------------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.||+|+||.||+|.+.+ ...+++|.+..........+..|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998432 23588888765544444578889999999999999999999999889999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc-------EEEeee
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-------PLVGDF 552 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~-------vKLsDF 552 (574)
+|||+++++|..++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999988864 345689999999999999999999998 9999999999999987654 899999
Q ss_pred cceeecC
Q 008201 553 GLARWQP 559 (574)
Q Consensus 553 GLAr~~~ 559 (574)
|++....
T Consensus 157 g~~~~~~ 163 (262)
T cd05077 157 GIPITVL 163 (262)
T ss_pred CCCcccc
Confidence 9987553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=200.40 Aligned_cols=149 Identities=25% Similarity=0.359 Sum_probs=131.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.++|++.+.||+|+||.||++.. .+|+.+|+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35688889999999999999994 4689999998765432 234578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|+++++|..++.. .+.+++..+..++.+++.||.|||+.. +|+||||+|+||+++.++.++|+|||++...
T Consensus 84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999999998863 457899999999999999999999742 7999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-23 Score=236.90 Aligned_cols=171 Identities=22% Similarity=0.233 Sum_probs=149.6
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEE
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 472 (574)
...++.+...+|.++++||+|+||.|.+++ ..+++.||+|+++... .....-|..|-.+|...+.+=|+.|+..|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 345667778899999999999999999999 4579999999987632 223346889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
+++++||||||++||+|-.+|.. ..++++..+.+|+..|..||.-||+. |+|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999974 33899999999999999999999999 9999999999999999999999999
Q ss_pred cceeecCCCCCCccceeeccC
Q 008201 553 GLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 553 GLAr~~~~~~~~~~t~v~GT~ 573 (574)
|.+--+..++.-....-+|||
T Consensus 220 GsClkm~~dG~V~s~~aVGTP 240 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTP 240 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCC
Confidence 998777655555556678987
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=204.02 Aligned_cols=144 Identities=20% Similarity=0.254 Sum_probs=125.9
Q ss_pred EEeeeecc--CcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 410 QANFLAEG--GFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 410 ~~~~LG~G--~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
++++||+| +|+.||++. ..+|+.||+|.+..... .....+.+|+.+++.++||||++++++|..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 788999998 45799999999875432 22345778999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++++|||.+..
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 999999998654455689999999999999999999998 999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=196.41 Aligned_cols=148 Identities=26% Similarity=0.359 Sum_probs=132.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|...+.||.|+||.||+|.. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++..+...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3678889999999999999995 468999999987553 22335688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.. .++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 81 CGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 999999999863 3889999999999999999999998 899999999999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=231.21 Aligned_cols=154 Identities=34% Similarity=0.497 Sum_probs=134.3
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCC--CC----EEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPD--GQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~--g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
+...+..+.+.||+|.||.||.|.+.+ |. .||||.++.... +...+|.+|..+|++++|||||+++|+|....
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345567788999999999999999543 43 489998876543 44568999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 476 RRLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~-----~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
..+|++|||++|+|..||...+ ...+.....+.++.+||+|+.||+++ ++|||||..+|+||+....+||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEc
Confidence 9999999999999999997641 45688899999999999999999999 89999999999999999999999
Q ss_pred eecceeecCC
Q 008201 551 DFGLARWQPD 560 (574)
Q Consensus 551 DFGLAr~~~~ 560 (574)
||||||.+.+
T Consensus 845 DFGlArDiy~ 854 (1025)
T KOG1095|consen 845 DFGLARDIYD 854 (1025)
T ss_pred ccchhHhhhh
Confidence 9999994433
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=197.31 Aligned_cols=153 Identities=25% Similarity=0.427 Sum_probs=131.8
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCC-----CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEe-CC
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DR 475 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~ 475 (574)
+..++|.+.+.||+|+||.||+|.... +..|++|.+..... .....+.+|+.+|+.++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345689999999999999999999654 68899998764322 223568899999999999999999998876 46
Q ss_pred eEEEEEEecCCCChHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQ------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
..++++||+++++|..++..... ..+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEE
Confidence 78999999999999999864322 4689999999999999999999998 9999999999999999999999
Q ss_pred eeecceeecC
Q 008201 550 GDFGLARWQP 559 (574)
Q Consensus 550 sDFGLAr~~~ 559 (574)
+|||+++.+.
T Consensus 159 ~d~g~~~~~~ 168 (280)
T cd05043 159 TDNALSRDLF 168 (280)
T ss_pred CCCCCccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=192.66 Aligned_cols=148 Identities=27% Similarity=0.411 Sum_probs=134.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
++|...+.||+|+||.||+|.... ++.+++|.+..... ...+.+|+.+++.++|+||+++++++......|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999654 88999998875432 567999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 81 GAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999864 346789999999999999999999998 899999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=217.32 Aligned_cols=165 Identities=21% Similarity=0.280 Sum_probs=126.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCC--CCEEEEEEee--------------c---CCCcchhHHHHHHHHHHhcCCCCe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPD--GQAVAVKQHK--------------L---ASSQGDHEFCSEVEVLSCAQHRNV 464 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~--g~~VAVK~l~--------------~---~~~~~~~~f~~Ei~iL~~L~HpNI 464 (574)
..++|.+.+.||+|+||.||+|.... +...++|.+. . ........+.+|+.+|+.++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999987432 2222222110 0 111123457899999999999999
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCChHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE
Q 008201 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (574)
Q Consensus 465 V~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~---~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL 541 (574)
+++++++...+..|+++|++ +++|..++.... ........+..|+.||+.||.|||+. +|+||||||+|||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEE
Confidence 99999999999999999998 567877775321 12234566778999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecceeecCCCCCCccceeeccC
Q 008201 542 THDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 542 d~~~~vKLsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
+.++.+||+|||+++.+...........+||+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~ 332 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCc
Confidence 99999999999999987654433333456664
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=191.16 Aligned_cols=150 Identities=25% Similarity=0.370 Sum_probs=132.1
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|...+.||+|+||.||++.. .+++.+|+|.+..... .....+.+|+.+|+.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999984 4688999998875432 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.......+++..+..++.+++.||.|||++ +|+|+||+|+||+++.+ +.++|+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999754455689999999999999999999998 99999999999999855 4689999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=200.46 Aligned_cols=148 Identities=29% Similarity=0.491 Sum_probs=127.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCC--EEEEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQ--AVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
++|++.+.||+|+||.||+|... ++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..|++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57899999999999999999854 343 46888776422 22345688999999999 799999999999999999999
Q ss_pred EEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 481 YEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCe
Confidence 99999999999986421 13588899999999999999999998 9999999999999999999
Q ss_pred EEEeeecceee
Q 008201 547 PLVGDFGLARW 557 (574)
Q Consensus 547 vKLsDFGLAr~ 557 (574)
+||+|||++..
T Consensus 158 ~kl~dfg~~~~ 168 (297)
T cd05089 158 SKIADFGLSRG 168 (297)
T ss_pred EEECCcCCCcc
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=192.06 Aligned_cols=145 Identities=35% Similarity=0.513 Sum_probs=129.6
Q ss_pred eeeeccCcEEEEEEEeCC----CCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.... +..+++|.+....... ...+.+|+.++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999543 7889999987654433 56789999999999999999999999999999999999999
Q ss_pred CChHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 487 GSLDSHLYGCH-------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 487 gsL~~~L~~~~-------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999997531 36799999999999999999999998 99999999999999999999999999998775
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 157 ~ 157 (262)
T cd00192 157 D 157 (262)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-23 Score=226.83 Aligned_cols=160 Identities=24% Similarity=0.353 Sum_probs=138.8
Q ss_pred eeEEeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
|.++..||.|+||.||++..++ +-..|.|.+........+++.-||+||..++||+||+|++.|..++.+||+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 5566779999999999999554 556678888877777778999999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
|-++..+-. ...+|.+..++.++.|++.||.|||++ +|||||||..|||++-+|.++|+|||.+.-... ..-..
T Consensus 114 GAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred chHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 999887754 577899999999999999999999999 899999999999999999999999998763322 12234
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
..++|||
T Consensus 188 DsFIGTP 194 (1187)
T KOG0579|consen 188 DSFIGTP 194 (1187)
T ss_pred ccccCCc
Confidence 5688886
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=203.73 Aligned_cols=156 Identities=31% Similarity=0.452 Sum_probs=132.6
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeC--------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGF 470 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~ 470 (574)
+++...+|.+.+.||+|+||.||+++.. .+..||+|.++.... .....+.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4555567999999999999999999732 123689998774322 2345788999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCC
Q 008201 471 CIEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (574)
Q Consensus 471 ~~~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP 536 (574)
|...+..+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp 162 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAA 162 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----Ceecccccc
Confidence 999999999999999999999986421 23578889999999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeecceeecCC
Q 008201 537 NNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 537 ~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+|||++.++.+||+|||+++....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHN 186 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccc
Confidence 999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=192.38 Aligned_cols=143 Identities=30% Similarity=0.493 Sum_probs=127.9
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChH
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLD 490 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~ 490 (574)
+.||+|+||.||++...+++.|++|.+...... ....+..|+.+++.++|+||+++++++...+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999766999999988765433 3457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 491 SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 491 ~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++.. ....+++..+..++.+++.||.|||++ +++||||+|+|||++.++.++|+|||+++...
T Consensus 81 ~~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 99864 244688999999999999999999998 89999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=195.57 Aligned_cols=148 Identities=26% Similarity=0.422 Sum_probs=131.5
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LVm 481 (574)
.|+..+.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|+.+++.++ |||++++++++......|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999994 5789999998875432 33456889999999997 999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998853 4789999999999999999999998 9999999999999999999999999999877543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=197.29 Aligned_cols=151 Identities=30% Similarity=0.425 Sum_probs=130.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
.+++|.+.+.||+|+||.||+|... .+..|++|.+...... ....+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567999999999999999999854 3567899987644322 23468999999999999999999999999889
Q ss_pred EEEEEEecCCCChHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC---cEE
Q 008201 477 RLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPL 548 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~-----~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~---~vK 548 (574)
.++||||+++++|.+++.... ...+++..++.++.||+.||.|||+. +++||||||+|||++.++ .+|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceE
Confidence 999999999999999986432 13589999999999999999999998 899999999999998654 599
Q ss_pred Eeeecceeec
Q 008201 549 VGDFGLARWQ 558 (574)
Q Consensus 549 LsDFGLAr~~ 558 (574)
|+|||+++..
T Consensus 160 l~dfg~~~~~ 169 (277)
T cd05036 160 IADFGMARDI 169 (277)
T ss_pred eccCcccccc
Confidence 9999999865
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=194.76 Aligned_cols=150 Identities=22% Similarity=0.381 Sum_probs=126.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEV-LSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~i-L~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|++.+.||+|+||.||++.. .+|+.||+|.++.... .....+..|+.+ ++.++||||+++++++...+..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4689999999999999999995 4699999998875432 223456667665 566789999999999999999999999
Q ss_pred ecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|++ ++|.+++... ....+++..+..++.|++.||.|||+++ +++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 995 7888777532 3457899999999999999999999863 79999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=200.88 Aligned_cols=149 Identities=28% Similarity=0.366 Sum_probs=128.4
Q ss_pred CeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
+|.+.+.||+|+||.||+|... +++.||+|.+....... ...+..|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667788999999999999842 25789999987543322 3468899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC
Q 008201 480 VYEYICNGSLDSHLYGC--------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~--------------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~ 545 (574)
++||+.+++|..++... ....+++..++.++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCC
Confidence 99999999999998521 124588889999999999999999998 999999999999999999
Q ss_pred cEEEeeecceeecC
Q 008201 546 EPLVGDFGLARWQP 559 (574)
Q Consensus 546 ~vKLsDFGLAr~~~ 559 (574)
.+||+|||+++...
T Consensus 162 ~~kl~Dfg~~~~~~ 175 (283)
T cd05091 162 NVKISDLGLFREVY 175 (283)
T ss_pred ceEecccccccccc
Confidence 99999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=198.15 Aligned_cols=147 Identities=24% Similarity=0.398 Sum_probs=129.2
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|...+.||+|+||.||+|.. .+|+.+|+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999995 46999999988754322 234678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|..++.. ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 95 688887754 345789999999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=195.87 Aligned_cols=148 Identities=23% Similarity=0.281 Sum_probs=133.1
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+|.+.+.||.|+||.||+|... +++.+|+|.+..... ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999954 689999999875432 234578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+.+++|..++.. ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999964 35789999999999999999999998 999999999999999999999999999986644
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=195.18 Aligned_cols=146 Identities=29% Similarity=0.452 Sum_probs=129.9
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
|+..+.||.|+||.||+|.. .++..+|+|.+..... .....+.+|+.+++.++|+||+++++++..++..|+||||+.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 67788899999999999984 4688999998764432 223468899999999999999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++|..++. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 86 ~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 86 GGSALDLLE---PGPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999885 45689999999999999999999998 999999999999999999999999999986643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=193.03 Aligned_cols=147 Identities=26% Similarity=0.401 Sum_probs=128.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC-----CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRR 477 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~ 477 (574)
.+|.+.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+++++.++|+||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999984 569999999875421 12234688999999999999999999998764 468
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998863 45688999999999999999999998 999999999999999999999999999986
Q ss_pred c
Q 008201 558 Q 558 (574)
Q Consensus 558 ~ 558 (574)
.
T Consensus 156 ~ 156 (264)
T cd06653 156 I 156 (264)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=198.69 Aligned_cols=148 Identities=24% Similarity=0.377 Sum_probs=133.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
++|...+.||+|+||.||++.. .++..|++|.+........+.+.+|+.+++.++||||++++++|...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788999999999999999984 468899999987554444567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++++|.+++. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++..+..
T Consensus 99 ~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 99 AGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999985 34688999999999999999999999 999999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=198.65 Aligned_cols=152 Identities=30% Similarity=0.447 Sum_probs=131.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
..++|...+.||+|+||.||++... ++..+|+|.+..... .....+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4567999999999999999999843 467899998875432 223568899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCC
Q 008201 477 RLLVYEYICNGSLDSHLYGCH--------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~--------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP 536 (574)
.+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p 158 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLAT 158 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccH
Confidence 999999999999999986321 13478888999999999999999998 999999999
Q ss_pred CCeEEcCCCcEEEeeecceeecC
Q 008201 537 NNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 537 ~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|||++.++.++|+|||+++...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred hheEecCCCceEECccccceecc
Confidence 99999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=194.19 Aligned_cols=144 Identities=33% Similarity=0.451 Sum_probs=126.7
Q ss_pred eeeeccCcEEEEEEEeCC--C--CEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLPD--G--QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~--g--~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|...+ + ..||+|.+..... ...+.+.+|+.++++++|+||+++++++.. +..+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998532 3 3689999876655 445679999999999999999999999988 889999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++|.+++.......+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEeccccccccccc
Confidence 9999999753335789999999999999999999998 999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=196.54 Aligned_cols=156 Identities=28% Similarity=0.404 Sum_probs=133.7
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEe--
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE-- 473 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~-- 473 (574)
+.++....+.|+..+.||.|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 344444567899999999999999999995 568999999886543 2335688899999988 69999999999863
Q ss_pred ----CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 474 ----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 474 ----~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
.+..|++|||+++++|.+++.......+++..++.++.||+.||.|||+. +|+||||+|+||+++.++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999998754556788989999999999999999998 9999999999999999999999
Q ss_pred eeecceeec
Q 008201 550 GDFGLARWQ 558 (574)
Q Consensus 550 sDFGLAr~~ 558 (574)
+|||+++..
T Consensus 163 ~dfg~~~~~ 171 (282)
T cd06636 163 VDFGVSAQL 171 (282)
T ss_pred eeCcchhhh
Confidence 999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=211.83 Aligned_cols=167 Identities=27% Similarity=0.364 Sum_probs=146.6
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.+..+.|+.-++||+|+||.||-|+ ..+|+-+|.|.+.... .+...-..+|-.||.+++.+.||.+-..|.+.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 3456678999999999999999998 4579999999776432 23334578899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||..|.||+|.-+|+...+..+++..++.++.+|+.||++||.. +||+|||||+|||||+.|+++|+|+|||..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999999999876677899999999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
++.+.. ...+ +||.|
T Consensus 337 i~~g~~-~~~r-vGT~G 351 (591)
T KOG0986|consen 337 IPEGKP-IRGR-VGTVG 351 (591)
T ss_pred cCCCCc-cccc-cCccc
Confidence 887664 3333 88887
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-21 Score=195.21 Aligned_cols=158 Identities=30% Similarity=0.365 Sum_probs=135.0
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED 474 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~ 474 (574)
.+..+....++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3445556678999999999999999999995 568999999886432 2245678899999998 799999999998754
Q ss_pred -----CeEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcE
Q 008201 475 -----RRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (574)
Q Consensus 475 -----~~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~v 547 (574)
+..|+||||+++++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCE
Confidence 3589999999999999988532 345789999999999999999999998 99999999999999999999
Q ss_pred EEeeecceeecC
Q 008201 548 LVGDFGLARWQP 559 (574)
Q Consensus 548 KLsDFGLAr~~~ 559 (574)
+|+|||+++...
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999988654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-21 Score=196.91 Aligned_cols=143 Identities=25% Similarity=0.373 Sum_probs=118.6
Q ss_pred EeeeeccCcEEEEEEEeC---CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEEecC
Q 008201 411 ANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVYEYIC 485 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVmEy~~ 485 (574)
...||+|+||.||+|+.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.. ....|+||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999854 45789999876432 23467899999999999999999999854 457899999984
Q ss_pred CCChHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE----cCCCcEEEeeecc
Q 008201 486 NGSLDSHLYGC-------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGL 554 (574)
Q Consensus 486 ggsL~~~L~~~-------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL----d~~~~vKLsDFGL 554 (574)
++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 5777776421 123588899999999999999999998 99999999999999 4567999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
++....
T Consensus 159 a~~~~~ 164 (317)
T cd07867 159 ARLFNS 164 (317)
T ss_pred eeccCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=196.34 Aligned_cols=148 Identities=24% Similarity=0.400 Sum_probs=131.1
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|+..+.||.|+||.||+|.. .+|+.||||.+..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 588999999999999999985 4689999998875432 2234688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|..++.......+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 95 6899888655566789999999999999999999998 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=193.61 Aligned_cols=148 Identities=26% Similarity=0.405 Sum_probs=128.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-----cchhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRR 477 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~ 477 (574)
.+|...+.||+|+||.||++.. .++..|++|.+..... .....+.+|+.+++.++|+||+++++++.. .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999985 4689999998764322 122458889999999999999999999875 3578
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
+++|||+++++|.+++.. ...+++...+.++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999863 45689999999999999999999998 899999999999999999999999999985
Q ss_pred cC
Q 008201 558 QP 559 (574)
Q Consensus 558 ~~ 559 (574)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=196.75 Aligned_cols=148 Identities=26% Similarity=0.409 Sum_probs=127.2
Q ss_pred CeeEEeeeeccCcEEEEEEEeC---CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRL 478 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~ 478 (574)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++... +..|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999953 58899999988643 23345678899999999999999999999988 7899
Q ss_pred EEEEecCCCChHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC----CCcEEEee
Q 008201 479 LVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH----DFEPLVGD 551 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~---~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~----~~~vKLsD 551 (574)
+||||++ ++|..++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 9999985 5676666422 123789999999999999999999998 8999999999999999 89999999
Q ss_pred ecceeecC
Q 008201 552 FGLARWQP 559 (574)
Q Consensus 552 FGLAr~~~ 559 (574)
||+++...
T Consensus 156 fg~~~~~~ 163 (316)
T cd07842 156 LGLARLFN 163 (316)
T ss_pred CccccccC
Confidence 99998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=193.36 Aligned_cols=141 Identities=28% Similarity=0.436 Sum_probs=122.9
Q ss_pred eeeccCcEEEEEEEe---CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 413 FLAEGGFGSVHRGVL---PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~---~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
.||+|+||.||+|.+ .++..+|+|+++.... ...+.+..|+.+|+.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3578899998865432 22357899999999999999999999885 45678999999999
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||.|||++.++.++|+|||+++....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 9999986 345789999999999999999999998 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-22 Score=220.12 Aligned_cols=156 Identities=26% Similarity=0.363 Sum_probs=131.6
Q ss_pred EeeeeccCcEEEEEEEe-CCCCEEEEEEeecC----CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe--EEEEEEe
Q 008201 411 ANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA----SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR--RLLVYEY 483 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~--~~LVmEy 483 (574)
...||+|+|-+||+|.. .+|..||--.++.. .....+.|..|+++|+.|+|+||+++|.++.+... +.+|.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 35699999999999994 45888876544432 23334689999999999999999999999988765 7789999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeecCCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~~~~~ 562 (574)
+..|+|..++. +.+.+....+..|++||++||.|||++.| .|||||||.+||+|+. -|.+||+|+|||.......
T Consensus 125 ~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999997 45678888999999999999999999866 6999999999999975 5899999999999875433
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
. ..++|||
T Consensus 201 a---ksvIGTP 208 (632)
T KOG0584|consen 201 A---KSVIGTP 208 (632)
T ss_pred c---ceeccCc
Confidence 3 4599998
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=192.88 Aligned_cols=151 Identities=30% Similarity=0.429 Sum_probs=132.4
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCC------
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~------ 475 (574)
.+++|.+.+.||+|+||.||+|.. .+++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 457899999999999999999995 4688999998875433 345789999999999 6999999999997644
Q ss_pred eEEEEEEecCCCChHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 476 RRLLVYEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~--~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
..|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886433 56789999999999999999999998 99999999999999999999999999
Q ss_pred ceeecC
Q 008201 554 LARWQP 559 (574)
Q Consensus 554 LAr~~~ 559 (574)
++....
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 998654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-21 Score=190.35 Aligned_cols=149 Identities=25% Similarity=0.380 Sum_probs=134.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||++... +++.|++|++..... .....+..|+.++..++|+||+++++++...+..+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999955 599999999876543 3346799999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999963 3678999999999999999999999 8 999999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=201.52 Aligned_cols=142 Identities=27% Similarity=0.352 Sum_probs=127.8
Q ss_pred EeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 411 ANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
...||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++++++..++..|++|||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34699999999999984 46899999998765555556788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
..++. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++.+.
T Consensus 106 ~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 106 TDIVS---QTRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred HHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 98874 35689999999999999999999998 99999999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-21 Score=187.95 Aligned_cols=149 Identities=30% Similarity=0.442 Sum_probs=133.8
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|.+.+.||+|+||.||++... +++.+++|.+..... .....+.+|+++++.++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999854 688999999876543 2345789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+.+++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999863 36799999999999999999999998 9999999999999999999999999999976543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=225.96 Aligned_cols=161 Identities=22% Similarity=0.308 Sum_probs=132.3
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe--C
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--D 474 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~ 474 (574)
..+...++|.+.+.||+|+||.||+|.. .++..+|+|.+..... .....|..|+.+|+.|+||||++++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3445567899999999999999999994 4588899998875432 223568899999999999999999999865 3
Q ss_pred CeEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCc---CCCeEeeCCCCCCeEEcCC-----
Q 008201 475 RRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECR---VGCIVHRDMRPNNILLTHD----- 544 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~---~~gIIHRDLKP~NILLd~~----- 544 (574)
..+||||||+++++|..+|... ....+++..++.|+.||+.||.|||.... ..+||||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999998642 23579999999999999999999998521 0159999999999999642
Q ss_pred ------------CcEEEeeecceeecCC
Q 008201 545 ------------FEPLVGDFGLARWQPD 560 (574)
Q Consensus 545 ------------~~vKLsDFGLAr~~~~ 560 (574)
+.+||+|||+++.+..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc
Confidence 3589999999987643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-22 Score=211.72 Aligned_cols=162 Identities=24% Similarity=0.298 Sum_probs=142.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcch--hHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~--~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.+-|.+.+.||+|.|+.|-+++ .-+|..||||++........ ..+.+|+..|+.++|||||+||.+...+..+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3458888999999999999998 45899999999986654433 35889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~~~ 560 (574)
|+=.+|+|.+||.+ +...+.+..+++|+.||+.|+.|+|.. .+|||||||+|+++-+ -|-+||.|||++.-+.+
T Consensus 97 ELGD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999976 667899999999999999999999999 8999999999998865 58899999999988877
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
+.. .++.||+.
T Consensus 172 G~k--L~TsCGSL 182 (864)
T KOG4717|consen 172 GKK--LTTSCGSL 182 (864)
T ss_pred cch--hhcccchh
Confidence 664 35677763
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-21 Score=185.59 Aligned_cols=150 Identities=32% Similarity=0.474 Sum_probs=135.1
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.|...+.||+|+||.||++... +++.+++|.+..........+.+|+++++.++|+||+++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999964 689999999876554455679999999999999999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+++|.+++.. ....+++..+..++.|++.||.|||.. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 9999999864 225789999999999999999999998 9999999999999999999999999999876543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=207.33 Aligned_cols=140 Identities=27% Similarity=0.298 Sum_probs=113.3
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC--CCCEEEEEEeecCC-----CcchhHHHHHHHHHHhcCCCCeeE-EEEEEEeCC
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP--DGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVM-LIGFCIEDR 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~-L~g~~~~~~ 475 (574)
..++|.+.+.||+|+||.||+|+.. +++.+|||++.... ......|.+|+++|+.++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4467999999999999999999853 57888999865321 112346899999999999999985 4432 4
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCC-CCCCeEEcCCCcEEEeeecc
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM-RPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDL-KP~NILLd~~~~vKLsDFGL 554 (574)
..||||||++|++|.. +. .. . ...++.+++++|.|||+. ||+|||| ||+|||++.++.++|+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~-~~--~~---~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR--PH---G---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHH-hC--cc---c---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 6899999999999963 21 11 1 146788999999999998 9999999 99999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
|+.+..
T Consensus 159 A~~~~~ 164 (365)
T PRK09188 159 ASVFRR 164 (365)
T ss_pred ceeccc
Confidence 997754
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=191.46 Aligned_cols=143 Identities=34% Similarity=0.484 Sum_probs=123.8
Q ss_pred eeeeccCcEEEEEEEeC--C--CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLP--D--GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~--~--g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.+. + +..+|+|.+...... ..+.+.+|+.+|+.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36899999999999742 2 368999988755432 3457899999999999999999999876 4568999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
++|.+++.. ...+++..+..++.|++.||.|||.. +++||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 999999974 34789999999999999999999998 8999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=218.34 Aligned_cols=159 Identities=26% Similarity=0.437 Sum_probs=144.9
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
+..|++...+....+.||-|.||.||.|.|+. ...||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 36778888888899999999999999999764 6789999988554 456789999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
+|||.|||+.|+|.++|..+....++.-..++++.||..|+.||... ++|||||..+|+|+.++..+||+||||+|
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999988888888888889999999999999998 89999999999999999999999999999
Q ss_pred ecCCC
Q 008201 557 WQPDG 561 (574)
Q Consensus 557 ~~~~~ 561 (574)
+...+
T Consensus 414 lMtgD 418 (1157)
T KOG4278|consen 414 LMTGD 418 (1157)
T ss_pred hhcCC
Confidence 87543
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=187.38 Aligned_cols=151 Identities=25% Similarity=0.377 Sum_probs=135.0
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|.+.+.||.|+||.||++... ++..+++|.+..... .....+..|+++++.++|+|++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999954 689999999876543 3445788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~--~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999986532 47799999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=215.04 Aligned_cols=172 Identities=26% Similarity=0.348 Sum_probs=149.2
Q ss_pred cchhHHHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 008201 396 FSYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE 473 (574)
Q Consensus 396 fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~ 473 (574)
..+..+...++-|.+...||.|.+|.||+++ ..+|+..|+|++.... ...+++..|.++|+.. .|||++.+||+|..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555667789999999999999999999 6679999999988654 4456788899999877 59999999999964
Q ss_pred -----CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEE
Q 008201 474 -----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (574)
Q Consensus 474 -----~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vK 548 (574)
++.+|||||||.+|+.-+++.......+.|..+..|++.++.||.+||.+ .+||||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEE
Confidence 56899999999999999999887788999999999999999999999999 899999999999999999999
Q ss_pred EeeecceeecCCCCCCccceeeccC
Q 008201 549 VGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 549 LsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
|.|||++..+.... +...+++|||
T Consensus 164 LvDFGvSaQldsT~-grRnT~iGtP 187 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV-GRRNTFIGTP 187 (953)
T ss_pred Eeeeeeeeeeeccc-ccccCcCCCc
Confidence 99999999885533 3455688886
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=192.55 Aligned_cols=148 Identities=26% Similarity=0.432 Sum_probs=130.1
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+|+..+.||.|+||.||+|+.. +|+.||+|.+...... ....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999954 6899999998765432 2356778999999999999999999999999999999999
Q ss_pred CCCChHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~-~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+ ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 6 5888887542 235689999999999999999999998 99999999999999999999999999998553
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=195.56 Aligned_cols=152 Identities=26% Similarity=0.360 Sum_probs=130.4
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC----
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR---- 475 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~---- 475 (574)
...++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45568999999999999999999954 589999999875432 22346788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 476 ------RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 476 ------~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
..++|+||+++ +|..++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEe
Confidence 78999999965 77777753 245789999999999999999999998 9999999999999999999999
Q ss_pred eeecceeecCC
Q 008201 550 GDFGLARWQPD 560 (574)
Q Consensus 550 sDFGLAr~~~~ 560 (574)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-22 Score=201.39 Aligned_cols=144 Identities=26% Similarity=0.372 Sum_probs=128.3
Q ss_pred eEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 409 SQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..|+||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3345699999999999985 468899999987655455567889999999999999999999999999999999999999
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 105 ~L~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 105 ALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred cHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999884 34689999999999999999999998 99999999999999999999999999997553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=195.39 Aligned_cols=149 Identities=26% Similarity=0.309 Sum_probs=129.7
Q ss_pred CeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCCC----cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASS----QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 477 (574)
+|.+.+.||+|+||.||+++. .+++.+|||.++.... .....+..|+.++..+ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999973 3578899998874321 2234678999999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998863 45689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
+...
T Consensus 155 ~~~~ 158 (288)
T cd05583 155 FLAE 158 (288)
T ss_pred cccc
Confidence 6443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=194.07 Aligned_cols=147 Identities=27% Similarity=0.416 Sum_probs=131.1
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.|+..+.||.|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 477788899999999999985 4688999998875432 33456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++++|.+++. ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999885 35688999999999999999999998 999999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=195.34 Aligned_cols=149 Identities=27% Similarity=0.376 Sum_probs=129.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LV 480 (574)
++|...+.||.|+||.||+|... +++.+++|.++..... ....+.+|+.+++.++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 36888899999999999999954 5889999998754322 223567899999999999999999999877 889999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+. ++|.+++.. ....+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.++|+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99995 589888864 234689999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=198.07 Aligned_cols=149 Identities=28% Similarity=0.499 Sum_probs=127.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCC----EEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..+|+..+.||+|+||.||+|.. .+|. .+|+|.+...... ....+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 45688899999999999999984 3454 4788887644322 223688999999999999999999998754 577
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+++||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999864 344688999999999999999999998 9999999999999999999999999999876
Q ss_pred C
Q 008201 559 P 559 (574)
Q Consensus 559 ~ 559 (574)
.
T Consensus 160 ~ 160 (303)
T cd05110 160 E 160 (303)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=194.38 Aligned_cols=142 Identities=27% Similarity=0.340 Sum_probs=125.4
Q ss_pred eeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||+|+||.||+|.. .+|+.+|+|.+.... ......+..|+++|+.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468999999886432 12234567899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
.+++.......+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 9999754445789999999999999999999998 99999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=197.77 Aligned_cols=147 Identities=28% Similarity=0.423 Sum_probs=129.9
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.|+..+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 366677899999999999984 4688999998874432 23356889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999884 45789999999999999999999998 999999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=193.14 Aligned_cols=149 Identities=21% Similarity=0.345 Sum_probs=127.3
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCe-----
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRR----- 476 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~----- 476 (574)
++|++.+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999995 46899999987654322 2356888999999995 6999999999987665
Q ss_pred EEEEEEecCCCChHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeee
Q 008201 477 RLLVYEYICNGSLDSHLYGCH---QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDF 552 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~---~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDF 552 (574)
.|++|||+++ +|.+++.... ...+++..++.++.||+.||.|||+. +|+||||+|+||+++. ++.++|+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999965 8888875422 34689999999999999999999998 9999999999999998 899999999
Q ss_pred cceeecC
Q 008201 553 GLARWQP 559 (574)
Q Consensus 553 GLAr~~~ 559 (574)
|+++.+.
T Consensus 156 g~~~~~~ 162 (295)
T cd07837 156 GLGRAFS 162 (295)
T ss_pred ccceecC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=216.35 Aligned_cols=157 Identities=27% Similarity=0.431 Sum_probs=134.3
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
|++.......++.||.|+.|.||+|++ .++.||||+++... ..+|.-|++|+|+||+.|.|+|....-+|||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 333334445567899999999999998 46789999765322 3478899999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||||..|-|...|. ....+.......|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++.+.+
T Consensus 191 MEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999997 567788888899999999999999999 899999999999999999999999999997754
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
. .....|+||.
T Consensus 265 ~--STkMSFaGTV 275 (904)
T KOG4721|consen 265 K--STKMSFAGTV 275 (904)
T ss_pred h--hhhhhhhhhH
Confidence 3 4455688884
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.4e-21 Score=190.78 Aligned_cols=148 Identities=26% Similarity=0.368 Sum_probs=129.8
Q ss_pred eeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLVYE 482 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LVmE 482 (574)
|.+.+.||.|+||.||+|... +|+.+|+|.+.... ......+.+|+.+++.++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999954 58999999988653 22335688999999999999999999999988 89999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|++ ++|..++.. ....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 996 588888864 235789999999999999999999998 9999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=191.23 Aligned_cols=143 Identities=28% Similarity=0.436 Sum_probs=120.6
Q ss_pred eeeeccCcEEEEEEEeC----CCCEEEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEEecC
Q 008201 412 NFLAEGGFGSVHRGVLP----DGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLLVYEYIC 485 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LVmEy~~ 485 (574)
+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999843 24579999875432 2334578899999999999999999998764 556899999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999964 234567788889999999999999998 99999999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-20 Score=192.17 Aligned_cols=149 Identities=25% Similarity=0.379 Sum_probs=127.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|...+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+++++.++|+||+++++++...+..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4799999999999999999995 4689999998865432 223568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~~ 559 (574)
|++ ++|..++.......+++..+..++.||+.||.|||+. +|+||||+|+||+++. ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 994 6888887643444568888889999999999999998 9999999999999985 5679999999998653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=189.56 Aligned_cols=150 Identities=25% Similarity=0.368 Sum_probs=131.8
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|...+.||+|+||.||++... +|..+|+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5888999999999999999954 588999998875422 2335688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++ .++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999754445689999999999999999999998 999999999999999875 569999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=192.41 Aligned_cols=141 Identities=31% Similarity=0.542 Sum_probs=121.1
Q ss_pred eeeeccCcEEEEEEEeC-CCC--EEEEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLP-DGQ--AVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|... ++. .+++|.++... ......+.+|++++.++ +||||+++++++...+..|++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999954 444 46888776432 22335688999999999 799999999999999999999999999
Q ss_pred CChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 487 GSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 487 gsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 99999986421 13578999999999999999999998 9999999999999999999999999
Q ss_pred ccee
Q 008201 553 GLAR 556 (574)
Q Consensus 553 GLAr 556 (574)
|+++
T Consensus 157 gl~~ 160 (270)
T cd05047 157 GLSR 160 (270)
T ss_pred CCcc
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=190.13 Aligned_cols=142 Identities=25% Similarity=0.329 Sum_probs=126.5
Q ss_pred eeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||.|+||.||++... +++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++..++..|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999954 589999999875432 2335689999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||+++.....
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999963 45689999999999999999999998 9999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-21 Score=193.48 Aligned_cols=141 Identities=23% Similarity=0.278 Sum_probs=119.1
Q ss_pred eeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHh---cCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 413 FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSC---AQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~---L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.||+|+||.||++.. .+++.+|+|.+...... ....+.+|..+++. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 46899999988654321 12234455544443 479999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++|..++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999886 345799999999999999999999998 99999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=188.48 Aligned_cols=151 Identities=25% Similarity=0.412 Sum_probs=130.3
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LVm 481 (574)
+|.+.+.||.|+||.||++. ..+|+.+|+|.+..... ...+.+..|+.+++.++|+||+++++++.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48889999999999999998 45688999998875432 223468889999999999999999998864 45689999
Q ss_pred EecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLH-----EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLH-----s~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
||+++++|.+++... ....+++..++.++.||+.||.||| +. +|+|+||+|+||+++.++.++|+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999998642 2467899999999999999999999 66 899999999999999999999999999
Q ss_pred eeecCCC
Q 008201 555 ARWQPDG 561 (574)
Q Consensus 555 Ar~~~~~ 561 (574)
+......
T Consensus 157 ~~~~~~~ 163 (265)
T cd08217 157 AKILGHD 163 (265)
T ss_pred cccccCC
Confidence 9977543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=199.31 Aligned_cols=147 Identities=24% Similarity=0.400 Sum_probs=127.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~ 477 (574)
.++|.+.+.||+|+||.||+|. ..+|+.||+|.+..... .....+.+|+.+|+.++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999998 45799999998864322 23346788999999999999999999876543 57
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+++||+. ++|..++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999985 58887774 45799999999999999999999998 999999999999999999999999999987
Q ss_pred cC
Q 008201 558 QP 559 (574)
Q Consensus 558 ~~ 559 (574)
..
T Consensus 156 ~~ 157 (336)
T cd07849 156 AD 157 (336)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=193.48 Aligned_cols=149 Identities=26% Similarity=0.342 Sum_probs=133.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LV 480 (574)
++|.+.+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+++++.++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999995 479999999886532 222356889999999999 99999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999963 45799999999999999999999998 999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-20 Score=192.51 Aligned_cols=149 Identities=30% Similarity=0.406 Sum_probs=127.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
-++|.+.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 34799999999999999999995 46999999988654322 2235678999999999999999999987654
Q ss_pred --eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 476 --RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 476 --~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
..++||||+. ++|..++.. ....+++..+..++.||+.||.|||++ +|+|+||||+|||++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999984 688887754 334689999999999999999999998 99999999999999999999999999
Q ss_pred ceeecC
Q 008201 554 LARWQP 559 (574)
Q Consensus 554 LAr~~~ 559 (574)
++..+.
T Consensus 165 ~~~~~~ 170 (310)
T cd07865 165 LARAFS 170 (310)
T ss_pred Cccccc
Confidence 998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=191.60 Aligned_cols=150 Identities=28% Similarity=0.357 Sum_probs=129.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LVm 481 (574)
++|...+.||.|+||.||++.. .+++.+|+|.+..... .....+.+|+++++.++||||++++++|... +..|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688999999999999999995 4688999998875433 2345689999999999999999999998653 4689999
Q ss_pred EecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|.+++... ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887532 345688999999999999999999998 99999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=192.60 Aligned_cols=145 Identities=24% Similarity=0.363 Sum_probs=130.0
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
|...+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++++...+..++++||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 45567899999999999984 56899999988765544456688999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||+|+||+++.++.++|+|||++....
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999863 5689999999999999999999998 99999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-21 Score=193.11 Aligned_cols=147 Identities=29% Similarity=0.392 Sum_probs=131.2
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+|+..+.||.|+||.||++... +++.+++|.+..... .....+.+|+++++.++||||+++++++...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777888999999999999954 689999998876533 33456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
.+++|.+++... ...+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 82 DGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred CCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 999999998642 2678999999999999999999999 7 9999999999999999999999999998755
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=190.27 Aligned_cols=140 Identities=29% Similarity=0.384 Sum_probs=125.3
Q ss_pred eeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||.|+||.||+++.. +|+.+++|.+..... .....+.+|+++++.++|+||+++++.+...+..|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 499999998875433 2345688999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
..++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 999874 34789999999999999999999998 99999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.79 Aligned_cols=150 Identities=31% Similarity=0.421 Sum_probs=129.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 479 (574)
..+|...+.||+|+||.||+|.. .+|+.||+|.+....... ...+.+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45799999999999999999995 469999999987543222 23467899999999999999999998765 46899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 86 v~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999985 588888764 246789999999999999999999999 99999999999999999999999999998765
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=212.24 Aligned_cols=150 Identities=23% Similarity=0.273 Sum_probs=132.8
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcch---hHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~---~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
-.....-|..++.||-|+||.|.+++ ..+...+|+|.++....... .-+..|-.||...+++-||+||..|.+.+.
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 34556679999999999999999998 44577899998876543222 246779999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
+|+||||++||++..+|. +-+-|++..+++++.++..|+++.|.. |+|||||||+|||||.+|++||.||||+.
T Consensus 704 LYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred eEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999887 457799999999999999999999999 99999999999999999999999999984
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=194.81 Aligned_cols=142 Identities=22% Similarity=0.364 Sum_probs=121.4
Q ss_pred eeeccCcEEEEEEEeCC--------CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 413 FLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.||.|+||.||+|.... ...+++|.+........+.+..|+.+|+.++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999998432 2347888776544444457889999999999999999999999989999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc--------EEEeeeccee
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--------PLVGDFGLAR 556 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~--------vKLsDFGLAr 556 (574)
.+++|..++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999964 234689999999999999999999998 9999999999999987765 6899999987
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
...
T Consensus 157 ~~~ 159 (258)
T cd05078 157 TVL 159 (258)
T ss_pred ccC
Confidence 554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=183.34 Aligned_cols=149 Identities=32% Similarity=0.421 Sum_probs=133.7
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~LVm 481 (574)
+|...+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+.++++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999965 689999999876543 3346789999999999999999999999988 8899999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999874 33899999999999999999999998 9999999999999999999999999999877544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=198.38 Aligned_cols=148 Identities=23% Similarity=0.326 Sum_probs=127.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------ 474 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 474 (574)
..++|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++|+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999994 579999999876432 22334678899999999999999999998644
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
...|+||||+ .++|.+.+.. .++...+..++.|++.||.|||.. ||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 3579999999 5688887752 288899999999999999999998 999999999999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=193.45 Aligned_cols=148 Identities=30% Similarity=0.410 Sum_probs=128.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
..|...+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+|+.+++.++||||++++++|...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999985 46899999988644322 2246889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 95 e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9985 677776643 345789999999999999999999998 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=189.39 Aligned_cols=152 Identities=28% Similarity=0.418 Sum_probs=127.9
Q ss_pred CeeEEeeeeccCcEEEEEEEeCC--CCEEEEEEeecCCC----------cchhHHHHHHHHHHh-cCCCCeeEEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPD--GQAVAVKQHKLASS----------QGDHEFCSEVEVLSC-AQHRNVVMLIGFCIE 473 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~VAVK~l~~~~~----------~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~ 473 (574)
+|++.+.||+|+||.||++.... ++.+|+|.+..... ....++..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999644 78899998764321 112356778888865 789999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEee
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsD 551 (574)
.+..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+.. +|+|+||+|+|||++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887432 3457899999999999999999999631 799999999999999999999999
Q ss_pred ecceeecCCC
Q 008201 552 FGLARWQPDG 561 (574)
Q Consensus 552 FGLAr~~~~~ 561 (574)
||++......
T Consensus 158 fg~~~~~~~~ 167 (269)
T cd08528 158 FGLAKQKQPE 167 (269)
T ss_pred ccceeecccc
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=198.03 Aligned_cols=148 Identities=26% Similarity=0.398 Sum_probs=128.7
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----- 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----- 475 (574)
..++|...+.||+|+||.||++. ..+|..||||.+..... .....+.+|+.+|+.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46789999999999999999998 45799999998864322 12346789999999999999999999987654
Q ss_pred -eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 476 -~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
..++||||+ +++|..++. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999998 789988874 45789999999999999999999998 999999999999999999999999999
Q ss_pred eeecC
Q 008201 555 ARWQP 559 (574)
Q Consensus 555 Ar~~~ 559 (574)
++...
T Consensus 165 ~~~~~ 169 (343)
T cd07880 165 ARQTD 169 (343)
T ss_pred ccccc
Confidence 98654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=190.67 Aligned_cols=141 Identities=23% Similarity=0.274 Sum_probs=119.0
Q ss_pred eeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHH---HHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 413 FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVE---VLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~---iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.||+|+||.||++.. .+++.||+|.+...... ....+..|.. +++...||||+.+++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 46899999988754322 1122344443 3445579999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|++|..++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.+.
T Consensus 81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999886 356799999999999999999999998 89999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=187.05 Aligned_cols=139 Identities=17% Similarity=0.190 Sum_probs=109.2
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--c-------hhH-----------------HHHHHHHHHhcCCCCee
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--G-------DHE-----------------FCSEVEVLSCAQHRNVV 465 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~-------~~~-----------------f~~Ei~iL~~L~HpNIV 465 (574)
..||+|+||.||+|...+|+.||||+++..... . ... ...|+.+|..+.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999778999999998754221 1 011 23499999999887764
Q ss_pred EEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL-HEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 466 ~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yL-Hs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
....+... ..+|||||++++++...+. ...++++..+..++.|++.+|.|| |.. ||+||||||+|||++ +
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEE-C
Confidence 43333222 3489999998877765432 345789999999999999999999 677 899999999999998 4
Q ss_pred CcEEEeeecceeecC
Q 008201 545 FEPLVGDFGLARWQP 559 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~ 559 (574)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=198.38 Aligned_cols=148 Identities=24% Similarity=0.427 Sum_probs=128.6
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRL 478 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~ 478 (574)
.+|.+.+.||+|+||.||+|. ..+|+.||+|.+..... .....+.+|+.+|+.++||||+++++++.. ....|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 679999999999999999999 45699999998875422 234567889999999999999999998763 34689
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+ +++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 lv~e~~-~~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLM-ESDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehh-hhhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 999999 568998886 345699999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=189.93 Aligned_cols=147 Identities=24% Similarity=0.393 Sum_probs=129.3
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
|+..+.||.|++|.||+|.. .+|..||+|++..... .....+.+|+++++.++|+||+++++++...+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999985 4799999998875432 22346888999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++|..++.......+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.+.
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 57899988654435789999999999999999999998 89999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=189.43 Aligned_cols=148 Identities=28% Similarity=0.442 Sum_probs=124.1
Q ss_pred eeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 408 FSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
|.+.+.||+|+||.||+|... +++.+|||.+..... ...+++.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999842 368899998875432 23456889999999999999999999986542
Q ss_pred eEEEEEEecCCCChHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEee
Q 008201 476 RRLLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~----~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsD 551 (574)
..++++||+.+++|..++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECc
Confidence 247889999999999887422 123578889999999999999999998 999999999999999999999999
Q ss_pred ecceeecC
Q 008201 552 FGLARWQP 559 (574)
Q Consensus 552 FGLAr~~~ 559 (574)
||+++...
T Consensus 157 fg~~~~~~ 164 (273)
T cd05074 157 FGLSKKIY 164 (273)
T ss_pred cccccccc
Confidence 99998664
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.5e-21 Score=194.66 Aligned_cols=142 Identities=26% Similarity=0.389 Sum_probs=127.4
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChH
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLD 490 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~ 490 (574)
..||+|+||.||++.. .+|+.||+|.+..........+.+|+.+++.++|+||+++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999985 578999999886554444567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 491 SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 491 ~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9874 34689999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=224.58 Aligned_cols=148 Identities=29% Similarity=0.399 Sum_probs=123.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC-------
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------- 474 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------- 474 (574)
...+|+.+.+||+||||.||+++ .-||+.||||++..... .....+.+|+.+|++|+|||||+||..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 34567888899999999999999 44899999999887642 2234688999999999999999998665421
Q ss_pred --------------------------------------------------------------------------------
Q 008201 475 -------------------------------------------------------------------------------- 474 (574)
Q Consensus 475 -------------------------------------------------------------------------------- 474 (574)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEEecCCCChHHHHhccCCCCC-CHHHHHHHHHHHHHHHHHHH
Q 008201 475 --------------------------------RRRLLVYEYICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLRYLH 521 (574)
Q Consensus 475 --------------------------------~~~~LVmEy~~ggsL~~~L~~~~~~~L-s~~~~~~Ia~qIa~gL~yLH 521 (574)
-.+||-||||+...|.+++... ... .....++++++|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHHHHHHH
Confidence 0247889999888888887632 222 46677899999999999999
Q ss_pred hhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 522 s~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
+. |||||||||.||+|+.+..+||+|||+|..
T Consensus 715 ~~----giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 715 DQ----GIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred hC----ceeeccCCcceeEEcCCCCeeecccccchh
Confidence 99 999999999999999999999999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-22 Score=207.50 Aligned_cols=165 Identities=28% Similarity=0.419 Sum_probs=137.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcch-------hHHHHHHHHHHhcCCCCeeEEEEEEE-eCC
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-------HEFCSEVEVLSCAQHRNVVMLIGFCI-EDR 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~-------~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~ 475 (574)
..+|-++++||+|||+.||++. +...+.||||+...+..-.. +-.++|..|-+.|+||.||++|+||. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3467788999999999999999 55688899998776533211 24689999999999999999999996 455
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeee
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDF 552 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDF 552 (574)
.+|-|+|||+|.+|+.+|. ....+++.++..|+.||+.||.||.+..+ .|||-||||.||||-. .|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikp--PIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKP--PIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCC--CeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999997 46678999999999999999999999866 6999999999999954 589999999
Q ss_pred cceeecCCCC------CCccceeeccC
Q 008201 553 GLARWQPDGD------MGVETRVIGTF 573 (574)
Q Consensus 553 GLAr~~~~~~------~~~~t~v~GT~ 573 (574)
||+++..+.. +..+....||+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTY 644 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTY 644 (775)
T ss_pred chhhhccCCccCcccceeeecccCcee
Confidence 9999886533 23455677775
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-21 Score=211.57 Aligned_cols=155 Identities=27% Similarity=0.371 Sum_probs=136.7
Q ss_pred eeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChHH
Q 008201 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~ 491 (574)
+||+|.||+||-|+ ..+...+|||.+........+.+..||.+-+.|+|.|||+++|.|..++++-++||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999 44567899999887777777789999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc-CCCcEEEeeecceeecCCCCCCccce
Q 008201 492 HLYGCHQEPL--EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLARWQPDGDMGVETR 568 (574)
Q Consensus 492 ~L~~~~~~~L--s~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd-~~~~vKLsDFGLAr~~~~~~~~~~t~ 568 (574)
+|.. ..+++ .+...-++..||++||.|||++ .|||||||-+|+||+ ..|.+||+|||.++.+. +-...+.+
T Consensus 662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TET 735 (1226)
T KOG4279|consen 662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTET 735 (1226)
T ss_pred HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhc-cCCccccc
Confidence 9965 67788 7888889999999999999999 899999999999996 56999999999999774 33345556
Q ss_pred eeccC
Q 008201 569 VIGTF 573 (574)
Q Consensus 569 v~GT~ 573 (574)
+-||.
T Consensus 736 FTGTL 740 (1226)
T KOG4279|consen 736 FTGTL 740 (1226)
T ss_pred cccch
Confidence 77773
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=189.61 Aligned_cols=150 Identities=24% Similarity=0.367 Sum_probs=134.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
..++|...+.||+|+||.||++... ++..+++|.+..... ....+..|+++++.++|+||+++++++...+..|+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4556888889999999999999965 688999999876544 45678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+++++|.+++... ...+++..+..++.|++.||.|||.. ||+|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~~~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 96 YMDGGSLTDIITQN-FVRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred ccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999742 24799999999999999999999998 99999999999999999999999999887553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=211.13 Aligned_cols=158 Identities=30% Similarity=0.463 Sum_probs=135.5
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCC---CC--EEEEEEeecC-CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPD---GQ--AVAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~---g~--~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
++......+.+.||+|.||.||.|.+.+ |+ .||||..+.+ .....+.|..|.-+|++++|||||+|+|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3444445566789999999999998532 33 5889988864 445567899999999999999999999999764
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|||||+++-|.|..+|.. +...|+......++.||+.||.|||+. .+|||||..+|||+...--+||+||||+
T Consensus 464 P~WivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceeeecccchh
Confidence 69999999999999999976 566789999999999999999999999 8999999999999999999999999999
Q ss_pred eecCCCCCCc
Q 008201 556 RWQPDGDMGV 565 (574)
Q Consensus 556 r~~~~~~~~~ 565 (574)
|++.+.....
T Consensus 539 R~~ed~~yYk 548 (974)
T KOG4257|consen 539 RYLEDDAYYK 548 (974)
T ss_pred hhccccchhh
Confidence 9987765543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.4e-21 Score=197.54 Aligned_cols=148 Identities=27% Similarity=0.427 Sum_probs=127.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecC--CCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeC--CeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED--RRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~--~~~~ 478 (574)
.++|.+.+.||+|+||.||+|... +|+.+|+|.+... .......+.+|+.+++.+ +|+||++++++|... ...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457888899999999999999954 6889999987542 222334677899999999 999999999998654 3689
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+. ++|..++.. ..+++..+..++.||+.||.|||+. ||+||||||+||+++.++.++|+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999995 699888853 3788999999999999999999998 9999999999999999999999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 158 ~~ 159 (337)
T cd07852 158 SE 159 (337)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=196.44 Aligned_cols=149 Identities=24% Similarity=0.392 Sum_probs=128.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC-----Ce
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 476 (574)
.++|.+.+.||+|+||.||++. ..+++.||||.+.... ......+.+|+.+|+.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4579999999999999999998 4569999999876432 22334678899999999999999999988654 34
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|++|||+ +++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELM-DTDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCC-CCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 79999999 578988886 346799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCC
Q 008201 557 WQPD 560 (574)
Q Consensus 557 ~~~~ 560 (574)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=195.64 Aligned_cols=155 Identities=25% Similarity=0.350 Sum_probs=132.0
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 473 (574)
....+....++|.+.+.||+|+||.||++. ..+|+.||+|++..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 344566678899999999999999999998 45799999998875322 223567889999999999999999998864
Q ss_pred C------CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcE
Q 008201 474 D------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (574)
Q Consensus 474 ~------~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~v 547 (574)
. +..|++++++ +++|..++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCE
Confidence 3 3468888886 889988874 34689999999999999999999998 99999999999999999999
Q ss_pred EEeeecceeecC
Q 008201 548 LVGDFGLARWQP 559 (574)
Q Consensus 548 KLsDFGLAr~~~ 559 (574)
+|+|||+++...
T Consensus 160 kl~dfg~~~~~~ 171 (345)
T cd07877 160 KILDFGLARHTD 171 (345)
T ss_pred EEeccccccccc
Confidence 999999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-21 Score=205.92 Aligned_cols=148 Identities=33% Similarity=0.486 Sum_probs=127.8
Q ss_pred eeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHH--hcCCCCeeEEEEEEEeCC----eEEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLS--CAQHRNVVMLIGFCIEDR----RRLLVY 481 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~--~L~HpNIV~L~g~~~~~~----~~~LVm 481 (574)
..+.++||+|.||.||+|.+ +++.||||++.. +..+.|..|-+|.+ .++|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 44557799999999999998 458999999874 34557888888877 457999999999876554 789999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcC-----CCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV-----GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~-----~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
||.+.|+|.++|. ...++|....+|+.-+++||+|||+..+. ++|+|||||..||||..|++..|+|||||.
T Consensus 288 ~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999995 56799999999999999999999987543 369999999999999999999999999999
Q ss_pred ecCCCC
Q 008201 557 WQPDGD 562 (574)
Q Consensus 557 ~~~~~~ 562 (574)
.+..+.
T Consensus 365 ~~~p~~ 370 (534)
T KOG3653|consen 365 RLEPGK 370 (534)
T ss_pred EecCCC
Confidence 887543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=186.94 Aligned_cols=145 Identities=25% Similarity=0.315 Sum_probs=124.2
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcC-CCCeeEEEEEEEeC--CeEEEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIED--RRRLLVYE 482 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LVmE 482 (574)
|.+.+.||+|+||.||+|.. .+++.+|+|.++.... .......+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 66788999999999999984 5689999998875422 22234557899998885 99999999999987 88999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++. +.+||+|||+++...
T Consensus 81 ~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 81 LMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cCC-ccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 995 688887754 235789999999999999999999998 9999999999999999 999999999998664
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=185.84 Aligned_cols=142 Identities=24% Similarity=0.277 Sum_probs=120.3
Q ss_pred eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHH-HhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVL-SCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL-~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.. .+|+.||+|.+...... ....+..|..++ ...+|+||+++++++...+..|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 46899999988643221 122344555544 455899999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++|..++. ....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999986 345789999999999999999999998 99999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=185.41 Aligned_cols=150 Identities=27% Similarity=0.406 Sum_probs=132.4
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|++.+.||+|+||.||++. ..+++.+++|.+..... .....+.+|+.+++.++|+||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58889999999999999998 45788999998875432 2334678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|..++... ....+++..+..++.|++.||.|||+. |++|+||+|.||+++.++.++|+|||+++....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999999988642 235789999999999999999999998 999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=189.39 Aligned_cols=143 Identities=32% Similarity=0.485 Sum_probs=123.0
Q ss_pred eeeccCcEEEEEEEeCC-------CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 413 FLAEGGFGSVHRGVLPD-------GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~-------g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.||+|+||.||+|...+ ++.+|+|.+..... .....+.+|+.+|+.++||||+++++++...+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998532 35789998764332 23457889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-----cEEEeeecc
Q 008201 485 CNGSLDSHLYGC-----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-----EPLVGDFGL 554 (574)
Q Consensus 485 ~ggsL~~~L~~~-----~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-----~vKLsDFGL 554 (574)
++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+|||++.++ .++|+|||+
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999998642 223478899999999999999999998 899999999999999877 899999999
Q ss_pred eeecC
Q 008201 555 ARWQP 559 (574)
Q Consensus 555 Ar~~~ 559 (574)
++...
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=191.51 Aligned_cols=148 Identities=30% Similarity=0.431 Sum_probs=128.0
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|...+.||+|+||.||++.. .++..+|+|.+...... ....+..|+++++.++|+|++++++++...+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 367788899999999999994 46899999988644322 22468889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+. |+|.+++.. ...++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 995 577777653 356789999999999999999999998 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=180.34 Aligned_cols=142 Identities=21% Similarity=0.181 Sum_probs=112.8
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc--------------------------hhHHHHHHHHHHhcCCCCe
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------------------------DHEFCSEVEVLSCAQHRNV 464 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ei~iL~~L~HpNI 464 (574)
...||+|+||.||+|...+|+.||||+++...... ...+..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999997689999999988642210 1123578999999999987
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEcC
Q 008201 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTH 543 (574)
Q Consensus 465 V~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd~ 543 (574)
.....+... ..||||||++|+++..... ....++......++.|++.+|.|||. . ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEEEE-
Confidence 554444333 2489999998876544321 23567888899999999999999999 7 999999999999999
Q ss_pred CCcEEEeeecceeecCCC
Q 008201 544 DFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 544 ~~~vKLsDFGLAr~~~~~ 561 (574)
++.++|+|||+|+.....
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 889999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=199.29 Aligned_cols=151 Identities=26% Similarity=0.400 Sum_probs=127.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC---C--CCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP---D--GQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRR 477 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~---~--g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~ 477 (574)
..|+....||+|.||.||+|... + .+.+|+|.++..... -....++|+.+++.++|+||+.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35888999999999999999632 2 236899988754322 23568999999999999999999999987 7789
Q ss_pred EEEEEecCCCChHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC----CcEEEe
Q 008201 478 LLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD----FEPLVG 550 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~---~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~----~~vKLs 550 (574)
+|++||. ..+|...++-. ....++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+
T Consensus 104 ~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 104 WLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEee
Confidence 9999998 56888877532 335788889999999999999999999 89999999999999877 899999
Q ss_pred eecceeecCCC
Q 008201 551 DFGLARWQPDG 561 (574)
Q Consensus 551 DFGLAr~~~~~ 561 (574)
||||||.+.+.
T Consensus 179 DlGlaR~~~~p 189 (438)
T KOG0666|consen 179 DLGLARLFNNP 189 (438)
T ss_pred cccHHHHhhcc
Confidence 99999988654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=198.97 Aligned_cols=141 Identities=30% Similarity=0.462 Sum_probs=128.4
Q ss_pred eeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
+.||+|+|+.|-.|. +.+|..+|||++.........++.+|++++..++ |+||++|+++|.++...|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999998 7789999999998876667778999999998886 99999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC---cEEEeeecceeec
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPLVGDFGLARWQ 558 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~---~vKLsDFGLAr~~ 558 (574)
..+|. ....+++.++.++..+|+.||.|||.. ||.||||||+|||-..-. -+||+||.|+.-.
T Consensus 164 LshI~--~~~~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQ--KRKHFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99997 456799999999999999999999999 999999999999996543 5899999998644
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=193.52 Aligned_cols=151 Identities=29% Similarity=0.393 Sum_probs=130.4
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEe-CCe
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRR 476 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~ 476 (574)
+...+++|...+.||.|+||.||++. ..+++.||+|.+.... ....+.+..|+++++.++||||++++++|.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34567889999999999999999998 4579999999875432 2234568899999999999999999999876 557
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+++||+ +++|..++. ..++++..+..++.|++.||.|||+. +|+||||+|+|||++.++.++|+|||+++
T Consensus 85 ~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999998 678988874 45688888999999999999999998 99999999999999999999999999998
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
...
T Consensus 157 ~~~ 159 (328)
T cd07856 157 IQD 159 (328)
T ss_pred ccC
Confidence 553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-21 Score=191.09 Aligned_cols=156 Identities=26% Similarity=0.321 Sum_probs=138.4
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC----
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR---- 475 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~---- 475 (574)
+.+..++|.+.+.||+|||+-||+++ ..++..+|+|++.....++.+..++|++..++++||||++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 44567789999999999999999999 7789999999998877677788999999999999999999998876543
Q ss_pred -eEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 476 -RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 476 -~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
..||++.|...|+|.+.+... .+..+++..++.|+.+|++||++||+.-+ .+.||||||.|||+.+.+.++|.||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEec
Confidence 489999999999999998654 34478999999999999999999999843 4999999999999999999999999
Q ss_pred cceeec
Q 008201 553 GLARWQ 558 (574)
Q Consensus 553 GLAr~~ 558 (574)
|.+...
T Consensus 174 GS~~~a 179 (302)
T KOG2345|consen 174 GSATQA 179 (302)
T ss_pred cCcccc
Confidence 998743
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=193.29 Aligned_cols=147 Identities=25% Similarity=0.365 Sum_probs=127.2
Q ss_pred CCee-EEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc--------------hhHHHHHHHHHHhcCCCCeeEEEE
Q 008201 406 GGFS-QANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG--------------DHEFCSEVEVLSCAQHRNVVMLIG 469 (574)
Q Consensus 406 ~~y~-~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~iL~~L~HpNIV~L~g 469 (574)
++|. +.+.||.|+||.||+|.. .+++.||+|.+....... ...+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 457799999999999994 469999999886543221 124778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 470 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
++...+..+++|||+. ++|.+++. ....+++.....++.|++.||.|||+. +|+||||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEE
Confidence 9999999999999995 68998886 345689999999999999999999998 9999999999999999999999
Q ss_pred eeecceeecC
Q 008201 550 GDFGLARWQP 559 (574)
Q Consensus 550 sDFGLAr~~~ 559 (574)
+|||+++...
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-20 Score=191.50 Aligned_cols=147 Identities=26% Similarity=0.356 Sum_probs=124.5
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-C--CCEEEEEEeecCCC--cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeC----Ce
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-D--GQAVAVKQHKLASS--QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIED----RR 476 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~--g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~----~~ 476 (574)
+|.+.+.||+|+||.||++... . +..||+|.+..... ...+.+.+|+.+++.+ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999943 4 78999998764322 2235678899999999 599999999876432 45
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+++||+ +++|..++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~~~e~~-~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELM-EADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEecc-cCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78999998 578998886 456789999999999999999999998 99999999999999999999999999998
Q ss_pred ecCC
Q 008201 557 WQPD 560 (574)
Q Consensus 557 ~~~~ 560 (574)
.+..
T Consensus 154 ~~~~ 157 (332)
T cd07857 154 GFSE 157 (332)
T ss_pred eccc
Confidence 7643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=188.89 Aligned_cols=149 Identities=29% Similarity=0.374 Sum_probs=127.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
.++|.+.+.||+|+||.||+|.. .+++.+|+|.+...... ....+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999994 46899999988654322 2345788999999999999999999875433
Q ss_pred --eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 476 --RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 476 --~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
.+++||||+. ++|...+.. ....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCc
Confidence 4699999985 567776653 345799999999999999999999998 99999999999999999999999999
Q ss_pred ceeecC
Q 008201 554 LARWQP 559 (574)
Q Consensus 554 LAr~~~ 559 (574)
+++...
T Consensus 161 ~~~~~~ 166 (311)
T cd07866 161 LARPYD 166 (311)
T ss_pred cchhcc
Confidence 998654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=192.98 Aligned_cols=148 Identities=26% Similarity=0.394 Sum_probs=130.3
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRL 478 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~ 478 (574)
+|.+.+.||.|+||.||+|... +|+.+|+|.+.... ....+.+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999954 58999999887543 233457899999999999999999999998775 789
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
++|||+. ++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999996 58888886 344899999999999999999999998 9999999999999999999999999999977
Q ss_pred CCC
Q 008201 559 PDG 561 (574)
Q Consensus 559 ~~~ 561 (574)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=189.25 Aligned_cols=149 Identities=26% Similarity=0.399 Sum_probs=124.4
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|...+.||+|+||.||++.. .+++.+|+|.+...... ....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999984 46899999988754322 3346889999999996 99999999999999999999999
Q ss_pred cCCCChHHHH---hccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L---~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|..+. .......+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.++|+|||+++.+.
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 84 5655433 2223467999999999999999999999742 79999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.2e-21 Score=204.50 Aligned_cols=160 Identities=22% Similarity=0.311 Sum_probs=137.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc--------chhHHHHHHHHHHhcC---CCCeeEEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--------GDHEFCSEVEVLSCAQ---HRNVVMLIGFCIE 473 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~ 473 (574)
..|...+.||+|+||.|++|.++ +...|+||.+....-. ....+-.||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35889999999999999999954 5678999987643211 1124567999999998 9999999999999
Q ss_pred CCeEEEEEEec-CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 474 DRRRLLVYEYI-CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 474 ~~~~~LVmEy~-~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
+++.||+||-. ++.+|.+++. ....+++.++..|+.|++.|+++||+. ||||||||-+|++++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeec
Confidence 99999999976 4668888886 567799999999999999999999999 9999999999999999999999999
Q ss_pred cceeecCCCCCCccceeeccCC
Q 008201 553 GLARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 553 GLAr~~~~~~~~~~t~v~GT~G 574 (574)
|.|.+..++.. ..++||.|
T Consensus 715 gsaa~~ksgpf---d~f~gtv~ 733 (772)
T KOG1152|consen 715 GSAAYTKSGPF---DVFVGTVD 733 (772)
T ss_pred cchhhhcCCCc---ceeeeecc
Confidence 99998877765 46888864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=190.96 Aligned_cols=144 Identities=20% Similarity=0.188 Sum_probs=122.7
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecC--CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggs 488 (574)
.+.+|.|+++.||++.. +++.||+|++... .......+..|+.+|+.++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 7999999998764 22334578999999999999999999999999999999999999999
Q ss_pred hHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 489 LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 489 L~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|.+++.......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++..+.
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeec
Confidence 99999754456789999999999999999999999 99999999999999999999999999987553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=182.89 Aligned_cols=148 Identities=30% Similarity=0.454 Sum_probs=126.3
Q ss_pred eeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc--chhHHHHHHHHHHhc---CCCCeeEEEEEEEeCCe-----
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA---QHRNVVMLIGFCIEDRR----- 476 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~----- 476 (574)
|++.+.||+|+||.||+|... +++.+|+|.+...... ....+.+|+.++..+ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999965 4899999998754322 123566788877666 59999999999988776
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.+++|||+. ++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999995 5898888654445689999999999999999999998 89999999999999999999999999998
Q ss_pred ecCC
Q 008201 557 WQPD 560 (574)
Q Consensus 557 ~~~~ 560 (574)
.+..
T Consensus 156 ~~~~ 159 (287)
T cd07838 156 IYSF 159 (287)
T ss_pred eccC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-20 Score=187.21 Aligned_cols=150 Identities=17% Similarity=0.224 Sum_probs=113.6
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCC----CCEEEEEEeecCCCcchh-----------HHHHHHHHHHhcCCCCeeEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGDH-----------EFCSEVEVLSCAQHRNVVML 467 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~~~~~-----------~f~~Ei~iL~~L~HpNIV~L 467 (574)
+..++|.+.+.||+|+||.||+|...+ +..+|+|........... ....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345689999999999999999999543 456677754433221111 11223344556789999999
Q ss_pred EEEEEeCC----eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC
Q 008201 468 IGFCIEDR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (574)
Q Consensus 468 ~g~~~~~~----~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~ 543 (574)
++++.... ..++++|++ ..++.+.+.. ....++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcC
Confidence 99876543 457888886 4566666642 33467888899999999999999998 9999999999999999
Q ss_pred CCcEEEeeecceeecC
Q 008201 544 DFEPLVGDFGLARWQP 559 (574)
Q Consensus 544 ~~~vKLsDFGLAr~~~ 559 (574)
++.++|+|||+|+.+.
T Consensus 162 ~~~~~l~DFGla~~~~ 177 (294)
T PHA02882 162 NNRGYIIDYGIASHFI 177 (294)
T ss_pred CCcEEEEEcCCceeec
Confidence 9999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=203.71 Aligned_cols=153 Identities=23% Similarity=0.329 Sum_probs=121.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-----------------CCCCEEEEEEeecCCCcchh--------------HHHHH
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-----------------PDGQAVAVKQHKLASSQGDH--------------EFCSE 452 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-----------------~~g~~VAVK~l~~~~~~~~~--------------~f~~E 452 (574)
..++|.+.+.||+|+||.||+|.. ..++.||||.+........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999963 23567999998754332222 23457
Q ss_pred HHHHHhcCCCCe-----eEEEEEEEe--------CCeEEEEEEecCCCChHHHHhccC----------------------
Q 008201 453 VEVLSCAQHRNV-----VMLIGFCIE--------DRRRLLVYEYICNGSLDSHLYGCH---------------------- 497 (574)
Q Consensus 453 i~iL~~L~HpNI-----V~L~g~~~~--------~~~~~LVmEy~~ggsL~~~L~~~~---------------------- 497 (574)
+.++.+++|.++ ++++++|.. .+..||||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677777753 356899999999999999886321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 498 QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 498 ~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
...+++..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 361 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence 12346778889999999999999998 899999999999999999999999999976543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=185.13 Aligned_cols=148 Identities=26% Similarity=0.361 Sum_probs=129.4
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
|...+.||.|++|.||+|.. .+|+.+++|.+...... ....+.+|+.+|+.++|+||+++++++..++..+++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678899999999999985 46899999988754332 3456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+ ++|..++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~-~~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 D-TDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred C-CCHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 6 588888764 336789999999999999999999998 9999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=186.51 Aligned_cols=148 Identities=28% Similarity=0.386 Sum_probs=128.8
Q ss_pred eeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEec
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
|.+.+.||+|+||.||+|... +++.|++|.+...... ......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999965 5889999987654322 2234567999999999 999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+++|.+++.......+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 88999988754445789999999999999999999998 999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=193.20 Aligned_cols=147 Identities=28% Similarity=0.397 Sum_probs=127.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC---------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--------- 474 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--------- 474 (574)
.++|...+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999994 56899999998776655566788999999999999999999776543
Q ss_pred -----CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEE
Q 008201 475 -----RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPL 548 (574)
Q Consensus 475 -----~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vK 548 (574)
...|+||||+. ++|..++. ...+++..+..++.||+.||.|||+. ||+||||||+||+++. ++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEE
Confidence 35789999995 68988874 34689999999999999999999998 9999999999999974 56789
Q ss_pred EeeecceeecC
Q 008201 549 VGDFGLARWQP 559 (574)
Q Consensus 549 LsDFGLAr~~~ 559 (574)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=191.67 Aligned_cols=140 Identities=22% Similarity=0.290 Sum_probs=122.6
Q ss_pred eeecc--CcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 413 FLAEG--GFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 413 ~LG~G--~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
.||.| +||.||+++. .+|+.||+|++...... ..+.+.+|+.+++.++||||++++++|..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45666 9999999995 57999999998754322 2356889999999999999999999999999999999999999
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++++|||.+.
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 999998754455689999999999999999999998 99999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=182.20 Aligned_cols=145 Identities=22% Similarity=0.239 Sum_probs=120.5
Q ss_pred cCCeeEEeee--eccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFL--AEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~L--G~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +|+||++++++|...+..|+|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3556666655 9999999999994 5688999998865322111 22222222 699999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeecC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQP 559 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~ 559 (574)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .++|+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999963 34899999999999999999999998 999999999999999988 99999999998764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 162 ~ 162 (267)
T PHA03390 162 T 162 (267)
T ss_pred C
Confidence 3
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-20 Score=180.22 Aligned_cols=141 Identities=30% Similarity=0.323 Sum_probs=125.8
Q ss_pred eeccCcEEEEEEEeC-CCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 414 LAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
||+|+||.||++... +++.+++|.+...... ....+..|+.+++.++|+||+++++.+..++..|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999954 5899999988754322 234788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999963 44689999999999999999999998 999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=185.39 Aligned_cols=145 Identities=32% Similarity=0.449 Sum_probs=126.0
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
|...+.||+|+||.||+|.. .+|+.|++|.+...... ....+..|+++++.++|+|++++++++...+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999985 46889999988754322 224678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+. ++|.+++.. ...++++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++...
T Consensus 103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 95 677777753 345789999999999999999999998 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=183.49 Aligned_cols=147 Identities=31% Similarity=0.421 Sum_probs=129.4
Q ss_pred eeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
|+..+.||+|+||.||+|... +++.+|+|.+.... ......+..|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999954 59999999987653 223356888999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+ ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++....
T Consensus 81 ~-~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 6 6899999642 25799999999999999999999998 999999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.9e-20 Score=185.64 Aligned_cols=152 Identities=24% Similarity=0.376 Sum_probs=127.7
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCC-cchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~L 479 (574)
+..++|.+.+.||+|+||.||+|...+ ++.||||.++.... .....+..|+.++..+. |+||++++++|......|+
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 344678999999999999999999654 89999999875432 22345677887776665 9999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|||+ +++|..++.. ....+++..+..++.|++.||.|||+.+ +|+||||+|+||+++.++.++|+|||++..+.
T Consensus 92 v~e~~-~~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELM-STCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred Eeecc-CcCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99998 5577776653 3457899999999999999999999742 89999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-21 Score=221.25 Aligned_cols=152 Identities=34% Similarity=0.440 Sum_probs=133.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.+-+|....+||.|.||.||.|. ..+|...|+|.++..... ....+.+|..+|..++|||+|++||+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34467778899999999999999 667999999987754332 335688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||||.+|+|.+.+. +.+..++.....+..|++.|+.|||++ |||||||||+||+|+.+|.+|++|||.|+.+.+
T Consensus 1313 MEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999996 455667777778899999999999999 999999999999999999999999999987754
Q ss_pred C
Q 008201 561 G 561 (574)
Q Consensus 561 ~ 561 (574)
.
T Consensus 1387 ~ 1387 (1509)
T KOG4645|consen 1387 N 1387 (1509)
T ss_pred c
Confidence 3
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-20 Score=188.62 Aligned_cols=147 Identities=26% Similarity=0.313 Sum_probs=123.9
Q ss_pred hcCCeeEE-eeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHh-cCCCCeeEEEEEEEe----CCe
Q 008201 404 ATGGFSQA-NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC-AQHRNVVMLIGFCIE----DRR 476 (574)
Q Consensus 404 ~~~~y~~~-~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~----~~~ 476 (574)
.+.+|++. ++||-|-.|.|..|. ..+|+.+|+|++.- ....++|+++--. -.|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45567664 579999999999998 55799999998752 2345678876543 469999999999864 235
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeec
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFG 553 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFG 553 (574)
+.+|||.|+||.|...+..+....+.+.++-.|+.||+.|+.|||+. +|.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEecccc
Confidence 67899999999999999887788899999999999999999999999 8999999999999964 4579999999
Q ss_pred ceeecC
Q 008201 554 LARWQP 559 (574)
Q Consensus 554 LAr~~~ 559 (574)
+|+...
T Consensus 210 FAK~t~ 215 (400)
T KOG0604|consen 210 FAKETQ 215 (400)
T ss_pred cccccC
Confidence 999654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=185.93 Aligned_cols=147 Identities=30% Similarity=0.434 Sum_probs=126.8
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|...+.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366778899999999999994 4688999998864322 223467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+. ++|.+++.. ...++++..+..++.|++.||.|||+. +++||||+|+|||++.++.++|+|||++....
T Consensus 96 ~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 96 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred ccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 995 678777643 345689999999999999999999998 99999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=206.17 Aligned_cols=151 Identities=29% Similarity=0.405 Sum_probs=133.0
Q ss_pred CeeEEeeeeccCcEEEEEEEeC--CCC--EEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP--DGQ--AVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~--~g~--~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
...+.+.||+|.||.|++|.|. .|+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|||+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3455678999999999999864 355 5799999876554 45689999999999999999999999987 5788999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|+++.|+|.+.|.+.....|-......|+.||+.||.||..+ ++|||||..+||||.....+||+||||.|-+..+
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999876667788888899999999999999999 8999999999999999999999999999988654
Q ss_pred C
Q 008201 562 D 562 (574)
Q Consensus 562 ~ 562 (574)
+
T Consensus 266 e 266 (1039)
T KOG0199|consen 266 E 266 (1039)
T ss_pred C
Confidence 4
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=181.12 Aligned_cols=149 Identities=23% Similarity=0.278 Sum_probs=124.3
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC-----CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+|.+.+.||+|+||.||++... .+..+++|.++... ......+..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4888899999999999999843 34555566554321 12233577899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 481 YEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|||+++++|..++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999888532 345789999999999999999999998 9999999999999975 56999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 156 ~~ 157 (260)
T cd08222 156 MG 157 (260)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-20 Score=195.67 Aligned_cols=165 Identities=22% Similarity=0.240 Sum_probs=137.7
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc---chhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRR 476 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~ 476 (574)
.+...+|..+.+||+|+||.|.++..+ +.+.+|||+++.+-.- +.+--..|-.+|.... -|.+++++.+|+..++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345567888999999999999999844 5788999998865322 2223456777777654 6899999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
+|+||||+.||+|.-++. .-+.+.+..+..++..|+-||-|||+. |||+||||.+||||+.+|++||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999998886 467788899999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCCccceeeccC
Q 008201 557 WQPDGDMGVETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~ 573 (574)
.-.-++. .+.++||||
T Consensus 499 Eni~~~~-TTkTFCGTP 514 (683)
T KOG0696|consen 499 ENIFDGV-TTKTFCGTP 514 (683)
T ss_pred ccccCCc-ceeeecCCC
Confidence 5433332 345699997
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.9e-20 Score=190.55 Aligned_cols=148 Identities=26% Similarity=0.393 Sum_probs=128.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe----
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR---- 476 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~---- 476 (574)
..++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3568999999999999999999954 68899999876432 2223567889999999999999999988876554
Q ss_pred --EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 477 --RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 477 --~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 779999885 35799999999999999999999998 999999999999999999999999999
Q ss_pred eeecC
Q 008201 555 ARWQP 559 (574)
Q Consensus 555 Ar~~~ 559 (574)
+....
T Consensus 165 ~~~~~ 169 (343)
T cd07851 165 ARHTD 169 (343)
T ss_pred ccccc
Confidence 98654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.4e-19 Score=186.49 Aligned_cols=146 Identities=27% Similarity=0.414 Sum_probs=124.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
..+|...+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999994 569999999886432 122346889999999999999999999987543
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+|+||+. .+|..++ ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4689999984 5776655 23688999999999999999999998 8999999999999999999999999999
Q ss_pred eecC
Q 008201 556 RWQP 559 (574)
Q Consensus 556 r~~~ 559 (574)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=190.74 Aligned_cols=150 Identities=29% Similarity=0.404 Sum_probs=128.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHH--hcCCCCeeEEEEEEEeCC----eEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLS--CAQHRNVVMLIGFCIEDR----RRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~--~L~HpNIV~L~g~~~~~~----~~~ 478 (574)
.....+.+.||+|.||.||+|.+ .|+.||||++... +...+.+|.+|++ .|+|+||..+++.-..++ ++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 44678899999999999999998 5789999998743 3456888999887 469999999988765443 689
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC----cCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~----~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
||.+|.+.|+|.+||. ...++....++++.-++.||.+||... ..+.|.|||||..|||+..++...|+|+||
T Consensus 286 LvTdYHe~GSL~DyL~---r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN---RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHh---hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 9999999999999995 478999999999999999999999753 223799999999999999999999999999
Q ss_pred eeecCCC
Q 008201 555 ARWQPDG 561 (574)
Q Consensus 555 Ar~~~~~ 561 (574)
|-.....
T Consensus 363 Av~h~~~ 369 (513)
T KOG2052|consen 363 AVRHDSD 369 (513)
T ss_pred eEEeccc
Confidence 9876543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=195.96 Aligned_cols=165 Identities=21% Similarity=0.286 Sum_probs=137.0
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecC--CCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~ 478 (574)
.+....|++++.||.||.+.||++...+.+.+|+|.+... ..+....|+.|+.+|.+|+ |.+||+||+|-..++++|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 3445569999999999999999999888888999876543 3344567999999999996 899999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
||||| ...+|..+|.........| .++.|..|++.++.++|++ ||||.||||.|+|+- .|.+||+|||+|..+
T Consensus 437 mvmE~-Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMEC-GDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeec-ccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99998 5789999997543333334 7789999999999999999 999999999999994 578999999999988
Q ss_pred CCCCCC-ccceeeccC
Q 008201 559 PDGDMG-VETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~-~~t~v~GT~ 573 (574)
..+... ....-+||+
T Consensus 510 ~~DTTsI~kdsQvGT~ 525 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTV 525 (677)
T ss_pred CccccceeeccccCcc
Confidence 655432 244567886
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-20 Score=187.59 Aligned_cols=163 Identities=21% Similarity=0.232 Sum_probs=139.4
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC---cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~ 478 (574)
...+|.++++||+|+|+.|.+++ .++.+.+|+|+++..-. .+..-...|-.+.... +||.+|-|..+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34579999999999999999999 55789999998875432 2333466777777655 6999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+|.||++||+|.-++. ....|+++.+..+...|+.||.|||++ |||+||||..|+|||..|++||.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999988886 567899999999999999999999999 9999999999999999999999999999853
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
.. ....+.++||||
T Consensus 402 l~-~gd~tstfcgtp 415 (593)
T KOG0695|consen 402 LG-PGDTTSTFCGTP 415 (593)
T ss_pred CC-CCcccccccCCC
Confidence 22 223467899998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-18 Score=167.00 Aligned_cols=148 Identities=34% Similarity=0.415 Sum_probs=132.3
Q ss_pred eeEEeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
|...+.||.|+||.||++...+ ++.+++|.+...... ..+.+.+|++.+..++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999654 899999998865544 56688999999999999999999999999899999999999
Q ss_pred CCChHHHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 486 NGSLDSHLYGCHQEP-LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 486 ggsL~~~L~~~~~~~-Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+++|.+++... .. +++..+..++.+++.+|.|||.. +++|+||+|.||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 99999998642 23 88999999999999999999998 9999999999999999999999999999977543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=174.34 Aligned_cols=138 Identities=20% Similarity=0.225 Sum_probs=108.1
Q ss_pred eEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-----CCCCeeEEEEEEEeCC---eEE-E
Q 008201 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-----QHRNVVMLIGFCIEDR---RRL-L 479 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-----~HpNIV~L~g~~~~~~---~~~-L 479 (574)
.....||+|+||.||. ...++.. +||++........+.+.+|+.+|+.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999996 3334444 69988765555566799999999999 5799999999998863 434 7
Q ss_pred EEEe--cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhhCcCCCeEeeCCCCCCeEEcC----CCcEEEee-
Q 008201 480 VYEY--ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGL-RYLHEECRVGCIVHRDMRPNNILLTH----DFEPLVGD- 551 (574)
Q Consensus 480 VmEy--~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL-~yLHs~~~~~gIIHRDLKP~NILLd~----~~~vKLsD- 551 (574)
|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 557999999953 346555 35677888777 999999 9999999999999974 34799999
Q ss_pred ecceee
Q 008201 552 FGLARW 557 (574)
Q Consensus 552 FGLAr~ 557 (574)
||.+.+
T Consensus 154 ~G~~~~ 159 (210)
T PRK10345 154 IGESTF 159 (210)
T ss_pred CCCcce
Confidence 555444
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=175.60 Aligned_cols=132 Identities=24% Similarity=0.198 Sum_probs=115.0
Q ss_pred cCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChHHHHhc
Q 008201 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG 495 (574)
Q Consensus 417 G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~ 495 (574)
|.||.||+++ ..+++.+|+|.+.... .+.+|...+....||||+++++++...+..|++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999 4578999999987542 234455555666799999999999999999999999999999998863
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 496 CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 496 ~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||++....
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 34689999999999999999999998 99999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-19 Score=198.65 Aligned_cols=162 Identities=20% Similarity=0.168 Sum_probs=112.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CC----CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEE------EE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PD----GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF------CI 472 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~------~~ 472 (574)
..++|.+.+.||+|+||.||+|.. .+ +..||+|.+..... .+.+..| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 467899999999999999999995 34 78999998753221 1111111 1122222222222211 23
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCC------------------CCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCC
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCHQE------------------PLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM 534 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~~~------------------~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDL 534 (574)
.....+|||||+.+++|.+++...... ......+..++.||+.||.|||+. +|+||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcC
Confidence 456789999999999999988642110 011234557899999999999998 9999999
Q ss_pred CCCCeEEcC-CCcEEEeeecceeecCCCCCCccceeeccC
Q 008201 535 RPNNILLTH-DFEPLVGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 535 KP~NILLd~-~~~vKLsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
||+|||++. ++.+||+|||+|+.+..+.......++||+
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~ 321 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDP 321 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCC
Confidence 999999986 589999999999876544333334455554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-21 Score=202.11 Aligned_cols=161 Identities=21% Similarity=0.246 Sum_probs=139.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCC-CEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDG-QAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g-~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
..++..+..||-|+||.|=++..... ..+|+|+++...- ...+-+..|-.||..++.|.||++|-.|.+..++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34566777899999999999886443 3488888775432 2234578899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||-|-||.|...|. ..+.++...+++++..+++|++|||.+ |||+|||||+|+||+.+|-+||.|||+|+.+..
T Consensus 499 mEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999997 567899999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
+.. +-++||||
T Consensus 573 g~K--TwTFcGTp 583 (732)
T KOG0614|consen 573 GRK--TWTFCGTP 583 (732)
T ss_pred CCc--eeeecCCc
Confidence 664 45799998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-19 Score=174.71 Aligned_cols=158 Identities=22% Similarity=0.390 Sum_probs=131.3
Q ss_pred hHHHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHH-hcCCCCeeEEEEEEEeCC
Q 008201 399 AELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLS-CAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 399 ~~le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~-~L~HpNIV~L~g~~~~~~ 475 (574)
..+++..+....+..||+|+||.|-+-+ ..+|+..|+|.+...-. +..+++.+|+.+.. ....|++|.+||.+....
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3355566666667889999999987777 45799999998875432 33456788888665 456999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 476 RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
..|+.||.| ..+|+.|.... .++.+++..+-+|+..+..||.|||++- .|||||+||+||||+.+|++|+||||
T Consensus 119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEcccc
Confidence 999999998 78888775432 5677888888899999999999999984 79999999999999999999999999
Q ss_pred ceeecCC
Q 008201 554 LARWQPD 560 (574)
Q Consensus 554 LAr~~~~ 560 (574)
++.++.+
T Consensus 195 IsG~L~d 201 (282)
T KOG0984|consen 195 ISGYLVD 201 (282)
T ss_pred cceeehh
Confidence 9987754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-21 Score=190.47 Aligned_cols=149 Identities=29% Similarity=0.443 Sum_probs=125.3
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC--CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--------
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-------- 474 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-------- 474 (574)
+.|.....||+|.||.||+|+ ..+|+.||+|+.-.. .........+|+.+|..+.|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456677889999999999999 456888999865432 222334678999999999999999998887532
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
..+||||++| ..+|.-+|.. ....++..++.+++.+++.||.|+|.. .|+|||+||+|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~c-ehDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFC-EHDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHh-hhhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeecccc
Confidence 2479999998 6788888864 456899999999999999999999999 899999999999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
||.+..
T Consensus 171 ar~fs~ 176 (376)
T KOG0669|consen 171 ARAFST 176 (376)
T ss_pred ccceec
Confidence 987753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-20 Score=204.11 Aligned_cols=162 Identities=25% Similarity=0.376 Sum_probs=144.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
..+|.++..+|.|.||.||+++ ...++..|+|++++.......-+..|+-+++..+|||||.|+|.|...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4578999999999999999999 567999999999988777777788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~ 563 (574)
|.+|+|.+..+ -.+++++.++.++.+..++||.|||+. |-+|||||-.|||+++.|.+|++|||.+..+.. ..
T Consensus 94 cgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti 166 (829)
T KOG0576|consen 94 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TI 166 (829)
T ss_pred cCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhh-hh
Confidence 99999998765 568899999999999999999999999 899999999999999999999999999886643 22
Q ss_pred CccceeeccC
Q 008201 564 GVETRVIGTF 573 (574)
Q Consensus 564 ~~~t~v~GT~ 573 (574)
.....++|||
T Consensus 167 ~KrksfiGtp 176 (829)
T KOG0576|consen 167 AKRKSFIGTP 176 (829)
T ss_pred hhhhcccCCc
Confidence 3344578876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=173.81 Aligned_cols=157 Identities=24% Similarity=0.372 Sum_probs=126.9
Q ss_pred eEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 409 SQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
..+..||.|..|.|++++ ..+|...|||.+..... ...++++..+.++...+ .|+||+.+|||..+...++.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 345669999999999999 45699999999876543 33456777777766554 899999999999999999999998
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCc
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~ 565 (574)
+..++.++.. ..+++++.-+-++...+..||.||.+.. +|||||+||+|||+|+.|++||||||++..+.+...
T Consensus 174 s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH---~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 174 STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc---ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 5556666653 5677888877899999999999999874 899999999999999999999999999987755432
Q ss_pred cceeecc
Q 008201 566 ETRVIGT 572 (574)
Q Consensus 566 ~t~v~GT 572 (574)
.++-.|.
T Consensus 248 htrsAGC 254 (391)
T KOG0983|consen 248 HTRSAGC 254 (391)
T ss_pred cccccCC
Confidence 3444444
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-19 Score=200.44 Aligned_cols=149 Identities=27% Similarity=0.474 Sum_probs=130.7
Q ss_pred eeEEeeeeccCcEEEEEEE-eCCCC----EEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGV-LPDGQ----AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~-~~~g~----~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
....++||.|+||+||+|. .+.|+ +||+|++..... +...++..|+-+|..++||||++|+++|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3456789999999999998 44444 689998775433 44578999999999999999999999998765 88999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+|++.|.|.++++. +..++.....+.|..||++||.|||++ .++||||-.+|+|+..-..+||.|||+|+.+...
T Consensus 777 q~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999976 667888899999999999999999998 8999999999999999999999999999988654
Q ss_pred C
Q 008201 562 D 562 (574)
Q Consensus 562 ~ 562 (574)
.
T Consensus 852 ~ 852 (1177)
T KOG1025|consen 852 E 852 (1177)
T ss_pred c
Confidence 3
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.8e-18 Score=157.39 Aligned_cols=142 Identities=35% Similarity=0.500 Sum_probs=126.3
Q ss_pred eeccCcEEEEEEEeCC-CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChHH
Q 008201 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDS 491 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~ 491 (574)
||+|.+|.||++.... ++.+++|.+...... ....+.+|+..++.++|++|+++++++......++++||+.+++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999654 899999998765432 24578999999999999999999999999899999999999899999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeecCC
Q 008201 492 HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPD 560 (574)
Q Consensus 492 ~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~~~ 560 (574)
++... ...+++..+..++.+++.+|.|||+. +++|+||+|.||+++. ++.++|+|||.+.....
T Consensus 81 ~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 81 LLKEN-EGKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred HHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccC
Confidence 98642 14689999999999999999999999 9999999999999999 89999999999987654
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=202.99 Aligned_cols=141 Identities=30% Similarity=0.524 Sum_probs=120.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
..|...+.||+|+||.||+|.. .+|..||||.+..... ....|+++|++++|||||+++++|...+..|+||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999995 5799999998864322 1235688999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++|+|.+++. .++|..+..|+.|++.||+|||..+.. +|+||||||+||+++.++..++. ||++..
T Consensus 766 ~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 766 EGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999995 389999999999999999999965432 79999999999999999888875 666553
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-19 Score=175.20 Aligned_cols=160 Identities=20% Similarity=0.408 Sum_probs=133.0
Q ss_pred CCCccchhHHHhh---cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeE
Q 008201 392 PPRWFSYAELELA---TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVM 466 (574)
Q Consensus 392 ~~~~fs~~~le~~---~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~ 466 (574)
|..++++....+. .++|++.+.+|+|.|+.||.|. ..+.+.++||++++- ..+.+.+|+.||..|. ||||++
T Consensus 21 p~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 21 PREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred chhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeee
Confidence 3444555443332 3568899999999999999998 567889999998853 3457899999999997 999999
Q ss_pred EEEEEEeCC--eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 467 LIGFCIEDR--RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 467 L~g~~~~~~--~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
|+++..++. ...||+||+.+.+...+. ..|+...+..++.+++.||.|+|+. ||+|||+||.|++||..
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~ 168 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHE 168 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechh
Confidence 999987654 567999999888877654 3577788999999999999999999 99999999999999975
Q ss_pred -CcEEEeeecceeecCCCCC
Q 008201 545 -FEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 545 -~~vKLsDFGLAr~~~~~~~ 563 (574)
..++|+|+|||.++-++..
T Consensus 169 ~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 169 LRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hceeeeeecchHhhcCCCce
Confidence 5799999999998866543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.7e-18 Score=169.11 Aligned_cols=143 Identities=20% Similarity=0.143 Sum_probs=113.0
Q ss_pred CeeEEeeeeccCcEEEEEEE--eCCCCEEEEEEeecCCCc------------------------chhHHHHHHHHHHhcC
Q 008201 407 GFSQANFLAEGGFGSVHRGV--LPDGQAVAVKQHKLASSQ------------------------GDHEFCSEVEVLSCAQ 460 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~--~~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~iL~~L~ 460 (574)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38889999999999999998 568999999998754211 0023568999999997
Q ss_pred CC--CeeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC-eEeeCCCCC
Q 008201 461 HR--NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC-IVHRDMRPN 537 (574)
Q Consensus 461 Hp--NIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g-IIHRDLKP~ 537 (574)
+. .+.+++++ ...+|||||+.+.+|..++. ....+.......++.|++.+|.|||.. | |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCChh
Confidence 53 34445543 23589999999888876542 233456666779999999999999999 8 999999999
Q ss_pred CeEEcCCCcEEEeeecceeecCC
Q 008201 538 NILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+++ ++.++|+|||+|.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999996644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=161.65 Aligned_cols=137 Identities=31% Similarity=0.401 Sum_probs=123.2
Q ss_pred CcEEEEEEEeC-CCCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChHHHHhc
Q 008201 418 GFGSVHRGVLP-DGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG 495 (574)
Q Consensus 418 ~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~ 495 (574)
+||.||+|... +|+.+++|++....... .+.+.+|++.++.++|+||+++++++......++++||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999987655444 57899999999999999999999999999999999999999999999864
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 496 CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 496 ~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
...+++..+..++.+++.+|.|||.. +|+|+||+|.||+++.++.++|+|||++.....
T Consensus 81 --~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 81 --RGRLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 23388999999999999999999998 999999999999999999999999999987754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.6e-18 Score=163.15 Aligned_cols=136 Identities=19% Similarity=0.271 Sum_probs=114.2
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc--------hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+.||+|++|.||+|.. +|..+++|......... ...+.+|+.++..+.|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 67789999765432211 13577899999999999998877777777888999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++|++|.+++... .. ....++.+++.+|.+||.. +++|||++|.|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988531 12 7788999999999999998 999999999999999 7899999999998643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.7e-20 Score=184.56 Aligned_cols=147 Identities=26% Similarity=0.378 Sum_probs=123.6
Q ss_pred eEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC--CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEEE
Q 008201 409 SQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-----RRLLV 480 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-----~~~LV 480 (574)
+-.+.||-|+||.||... -++|+.||+|++..- +....+.+.+|+.+|..++|.|+...++.....+ .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 334679999999999988 457999999976532 1223467899999999999999999998876543 45788
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
.|+| ..+|.+.+- ..+.++.+.+.-++.||++||.|||+. +|+||||||.|+|++.+..+||+||||||....
T Consensus 136 TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence 8888 567887775 577899999999999999999999999 999999999999999999999999999997654
Q ss_pred CC
Q 008201 561 GD 562 (574)
Q Consensus 561 ~~ 562 (574)
++
T Consensus 209 d~ 210 (449)
T KOG0664|consen 209 RD 210 (449)
T ss_pred hh
Confidence 44
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-18 Score=191.73 Aligned_cols=160 Identities=31% Similarity=0.436 Sum_probs=135.3
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeC----C----CCEEEEEEeecCCC-cchhHHHHHHHHHHhcC-CCCeeEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLP----D----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNVVMLIG 469 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~----~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNIV~L~g 469 (574)
.+++...+..+.+.||+|.||.|++|... . ...||||.++.... .+.+.+..|+++|+.+. |+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 35566666677779999999999999832 1 45799998875543 34467999999999985 999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccC------------C--CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCC
Q 008201 470 FCIEDRRRLLVYEYICNGSLDSHLYGCH------------Q--EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR 535 (574)
Q Consensus 470 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~------------~--~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLK 535 (574)
+|...+..++|+||+..|+|..+|...+ . ..+.....+.++.||+.|++||++. .+|||||-
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLA 445 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----Cccchhhh
Confidence 9999899999999999999999997543 0 1388889999999999999999999 89999999
Q ss_pred CCCeEEcCCCcEEEeeecceeecCCCCC
Q 008201 536 PNNILLTHDFEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 536 P~NILLd~~~~vKLsDFGLAr~~~~~~~ 563 (574)
.+|||+..+..+||+||||||.......
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~ 473 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDY 473 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCc
Confidence 9999999999999999999996554443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-19 Score=180.66 Aligned_cols=149 Identities=25% Similarity=0.401 Sum_probs=123.6
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+.+.+..||.|+||+|++-. .+.|+..|||+++.... ...++++.|.+...+- +.||||++||.+..++..|+.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 44556779999999999987 55699999999987654 3345788888865544 689999999999999999999999
Q ss_pred cCCCChHHHH---hccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L---~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
| ..+|+.+. +......+++.-.-.|...+..||.||-+.. .|||||+||+||||+..|.+||||||++..+.
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9 67776654 2334567888877788888999999999874 79999999999999999999999999987653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=165.83 Aligned_cols=142 Identities=11% Similarity=0.081 Sum_probs=117.4
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhH---------HHHHHHHHHhcCCCCeeEEEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE---------FCSEVEVLSCAQHRNVVMLIGFCI 472 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~iL~~L~HpNIV~L~g~~~ 472 (574)
.+..++|...++||.|+||.||+... ++..+|+|.+.......... +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45688999999999999999999765 57789999987543332222 678999999999999999998876
Q ss_pred eC--------CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 473 ED--------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 473 ~~--------~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
.. +..+|+|||++|.+|.++.. ++. ....+++.+|..||.. |++|||++|+||+++.+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCC
Confidence 43 35789999999999988742 222 3456899999999999 99999999999999998
Q ss_pred CcEEEeeecceeecC
Q 008201 545 FEPLVGDFGLARWQP 559 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~ 559 (574)
+ ++|+|||..+...
T Consensus 172 g-i~liDfg~~~~~~ 185 (232)
T PRK10359 172 G-LRIIDLSGKRCTA 185 (232)
T ss_pred C-EEEEECCCccccc
Confidence 8 9999999988663
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=164.84 Aligned_cols=150 Identities=22% Similarity=0.370 Sum_probs=128.6
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LV 480 (574)
+..+.|.+++.||.|+||.+|.|. ...|+.||||.-..... .-.+..|..+...|++ ..|..+..|+.+..+-.||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 456789999999999999999999 66799999997553321 2257789999999985 7888999999899999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGLAr~ 557 (574)
|+++ |.+|++++.-+ ...++..+++.++-|++.-++|+|.+ ++|||||||+|+|..- ...+.|+|||||+.
T Consensus 90 MdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhh
Confidence 9998 99999988653 45789999999999999999999999 8999999999999963 46789999999986
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
+-+
T Consensus 164 y~d 166 (341)
T KOG1163|consen 164 YRD 166 (341)
T ss_pred hcc
Confidence 643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=171.54 Aligned_cols=145 Identities=22% Similarity=0.293 Sum_probs=124.2
Q ss_pred CeeEEeeeeccCcEEEEEEEeCC--CCEEEEEEeecCCCcchhHHHHHHHHHHhcCC----CCeeEEEEEE-EeCCeEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPD--GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH----RNVVMLIGFC-IEDRRRLL 479 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H----pNIV~L~g~~-~~~~~~~L 479 (574)
+|.+.+.||+|+||.||.+.... ...+|+|............+..|+.+|..+.. +++..+++.+ ....+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999544 35788887765433333368889999998873 6899999999 47778999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-----CcEEEeeecc
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-----FEPLVGDFGL 554 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-----~~vKLsDFGL 554 (574)
||+.+ |.+|.++......+.++..++..|+.|++.+|++||+. |++||||||.|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99997 99999988654568899999999999999999999999 99999999999999865 4689999999
Q ss_pred ee
Q 008201 555 AR 556 (574)
Q Consensus 555 Ar 556 (574)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 98
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=176.07 Aligned_cols=135 Identities=26% Similarity=0.371 Sum_probs=117.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-----C---CCeeEEEEEEEe--
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----H---RNVVMLIGFCIE-- 473 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----H---pNIV~L~g~~~~-- 473 (574)
.++|-+.+.||.|.|++||+|+ ..+.+.||+|+.+... .-.+....||.+|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3789999999999999999999 5568899999987442 33456788999999884 3 369999999975
Q ss_pred --CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 474 --DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 474 --~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+.++|||+|++ |.+|..+|.....+.++...+..|++||+.||.|||..| ||||-||||+|||+...
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeeecc
Confidence 44899999998 899999998878889999999999999999999999998 89999999999999543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=157.99 Aligned_cols=132 Identities=23% Similarity=0.314 Sum_probs=107.8
Q ss_pred eeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc--------hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.||+|+||.||+|.+ +|..+++|......... ...+.+|++++..+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67789999865432111 145778999999999887666655666677789999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+|++|.+++.. ... .++.+++.+|.+||.. +++|+|++|.|||++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~--~~~-------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEE--GND-------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhh--cHH-------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999988753 111 7889999999999998 999999999999999 8899999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=157.68 Aligned_cols=138 Identities=22% Similarity=0.182 Sum_probs=110.2
Q ss_pred CeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc----------------------chhHHHHHHHHHHhcCCCC-
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ----------------------GDHEFCSEVEVLSCAQHRN- 463 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ei~iL~~L~HpN- 463 (574)
.|.+.+.||+|+||.||++...+|+.||||++...... ....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 37888999999999999999878999999987653210 0113567899999988774
Q ss_pred -eeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc
Q 008201 464 -VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (574)
Q Consensus 464 -IV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd 542 (574)
++..++. ...+++|||++|++|..+... .....++.+++.++.++|.. ||+||||+|+||+++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nill~ 159 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNILVD 159 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEEEc
Confidence 4444442 456899999999998765420 23457889999999999998 999999999999999
Q ss_pred CCCcEEEeeecceeecCC
Q 008201 543 HDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 543 ~~~~vKLsDFGLAr~~~~ 560 (574)
.++.++|+|||++..+..
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999976644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=180.55 Aligned_cols=139 Identities=19% Similarity=0.283 Sum_probs=112.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecC--CC------cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA--SS------QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~--~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
...|...+.||+|+||.||+|.+.... +++|..... .. .....+.+|++++..++|++++..+.++...+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 334566789999999999999875443 444432211 11 112458899999999999999988888887778
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.++||||+++++|.+++. ....++.+++.+|.|||+. +|+||||||+|||+ .++.++|+|||+|+
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999884 3467899999999999998 99999999999999 67899999999998
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
...
T Consensus 476 ~~~ 478 (535)
T PRK09605 476 YSD 478 (535)
T ss_pred cCC
Confidence 653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-17 Score=172.76 Aligned_cols=159 Identities=22% Similarity=0.271 Sum_probs=132.6
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC--C----CeeEEEEE
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--R----NVVMLIGF 470 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--p----NIV~L~g~ 470 (574)
|......+++|.+...+|+|.||.|..|. ...+..||||+++.-. .-.+...-|+++|.++.+ | -+|.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 33345558899999999999999999998 4458899999987432 223456779999999942 2 37888899
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-------
Q 008201 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH------- 543 (574)
Q Consensus 471 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~------- 543 (574)
|...++.|||+|.+ |.++.++|..+...+++...++.|+.|+++++.|||+. +++|-||||+|||+..
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEe
Confidence 99999999999998 88999999877778999999999999999999999999 8999999999999932
Q ss_pred -------------CCcEEEeeecceeecCCCC
Q 008201 544 -------------DFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 544 -------------~~~vKLsDFGLAr~~~~~~ 562 (574)
...++|+|||-|+......
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc
Confidence 2358999999999765444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-17 Score=185.66 Aligned_cols=158 Identities=29% Similarity=0.343 Sum_probs=123.9
Q ss_pred eeEEeeeeccCcEE-EEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 408 FSQANFLAEGGFGS-VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 408 y~~~~~LG~G~fG~-Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
|...+++|.|.-|+ ||+|.+ +|+.||||.+-.. ......+||..|+.-+ |||||++|+.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 45557799999985 799998 6789999976532 2234678999998875 999999999999999999999998
Q ss_pred CCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---C--CcEEEeeecceeec
Q 008201 486 NGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---D--FEPLVGDFGLARWQ 558 (574)
Q Consensus 486 ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~--~~vKLsDFGLAr~~ 558 (574)
..+|.+++... ......-.....++.|++.||++||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 78999999752 111111134567889999999999997 9999999999999976 3 47899999999988
Q ss_pred CCCCCCc--cceeeccCC
Q 008201 559 PDGDMGV--ETRVIGTFG 574 (574)
Q Consensus 559 ~~~~~~~--~t~v~GT~G 574 (574)
..+.... .....||.|
T Consensus 662 ~~~~sS~~r~s~~sGt~G 679 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSG 679 (903)
T ss_pred CCCcchhhcccCCCCccc
Confidence 7665533 334566654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-16 Score=156.43 Aligned_cols=133 Identities=20% Similarity=0.107 Sum_probs=105.8
Q ss_pred EEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc----hhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEec
Q 008201 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG----DHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~----~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
....|+.|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|+.|. |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 67777777665433211 124789999999996 5889999886 4579999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCC-CCCCeEEcCCCcEEEeeecceeecCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM-RPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDL-KP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
.|.+|...+. .. ...++.|++.+|.|+|.. ||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 81 ~G~~L~~~~~---~~------~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP---RG------DLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh---hh------hHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999876442 11 135778999999999999 9999999 79999999999999999999996543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=162.85 Aligned_cols=149 Identities=21% Similarity=0.290 Sum_probs=127.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.-+|.+.+.||+|+||.++.|. +-+++.||||.-...+ ..-++..|...++.|. .++|...|-+...+.+..||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3469999999999999999999 6689999999644322 2235777888888775 6999999999888889999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-----CcEEEeeecceee
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-----FEPLVGDFGLARW 557 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-----~~vKLsDFGLAr~ 557 (574)
++ |.+|++++.- -...|+..++..++.|++.-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 98 9999998865 356799999999999999999999999 89999999999999753 4588999999998
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
+.+.
T Consensus 179 YrDp 182 (449)
T KOG1165|consen 179 YRDP 182 (449)
T ss_pred hcCc
Confidence 7654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-17 Score=165.32 Aligned_cols=145 Identities=19% Similarity=0.308 Sum_probs=120.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEE-EEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGF-CIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~-~~~~~~~~LVmE 482 (574)
+.|.+.+.||+|.||.+.+++.+ ..+.+++|.+.. ......+|.+|...--.|. |.||+.-|++ |+..+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45888999999999999999954 577899997653 2344568999987655554 8999987754 667778889999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc--CCCcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT--HDFEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd--~~~~vKLsDFGLAr~~ 558 (574)
|++.|+|..-+. ...+.+....+++.|++.|+.|+|+. ++||||||.+||||- +..++||||||+.+-.
T Consensus 103 ~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999998773 46688888899999999999999999 899999999999994 3458999999998744
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-15 Score=147.64 Aligned_cols=149 Identities=34% Similarity=0.455 Sum_probs=127.9
Q ss_pred eeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCC-CeeEEEEEEEeCCeEEEEEEe
Q 008201 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHR-NVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~Hp-NIV~L~g~~~~~~~~~LVmEy 483 (574)
|.....||.|+||.||++... ..+++|.+....... ...+.+|+.+++.+.|+ +|+.+++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999965 788999887654432 56799999999999988 799999999777778999999
Q ss_pred cCCCChHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~-~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~~~ 561 (574)
+.++++.+++..... ..+.......++.|++.++.|+|.. +++|||+||+|||++..+ .++++|||+++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999977653211 2688999999999999999999999 899999999999999988 7999999999966544
Q ss_pred C
Q 008201 562 D 562 (574)
Q Consensus 562 ~ 562 (574)
.
T Consensus 156 ~ 156 (384)
T COG0515 156 G 156 (384)
T ss_pred C
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=174.23 Aligned_cols=146 Identities=26% Similarity=0.310 Sum_probs=121.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+..|.....+|.|+|+.|..|. ..+++..++|++..... +..+|+.++... +|+||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4567777889999999999998 56789999999875522 234577665544 69999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE-cCCCcEEEeeecceeecCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL-THDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL-d~~~~vKLsDFGLAr~~~~~ 561 (574)
++.|+-|.+.+. ..+.....+..|+.+|+.|+.|||++ |||||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~---~~~~~~~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKPEFCSEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcchhHHHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999888877664 22333367778999999999999998 99999999999999 68899999999999977554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-16 Score=170.79 Aligned_cols=164 Identities=21% Similarity=0.262 Sum_probs=139.5
Q ss_pred CCccchhHHHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC------CCCee
Q 008201 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ------HRNVV 465 (574)
Q Consensus 393 ~~~fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~------HpNIV 465 (574)
..++.+...++..++|.+....|+|-|++|.+|. ...|+.||||++..+. ...+.=+.|++||++|+ --+++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4567777788999999999999999999999998 4458899999998653 23345568999999996 24789
Q ss_pred EEEEEEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 466 ~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~-~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+|+-.|...+++|||+|-+ ..+|.+.|... .+-.|....+..|+.|+..||..|-.. ||+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccC
Confidence 9999999999999999987 78999998653 456788899999999999999999987 99999999999999875
Q ss_pred -CcEEEeeecceeecCCCC
Q 008201 545 -FEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 545 -~~vKLsDFGLAr~~~~~~ 562 (574)
..+||||||.|.......
T Consensus 573 k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE 591 (752)
T ss_pred cceeeeccCcccccccccc
Confidence 568999999998776544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=135.96 Aligned_cols=137 Identities=22% Similarity=0.181 Sum_probs=113.9
Q ss_pred EEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++.++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999744 7899998765432 4578899999999986 58999999988888899999999887
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
.+..+ +......++.+++.+|.+||.... .+++|+||+|+|||++..+.++++|||+++...
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~-~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPL-LVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCc-eEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 77543 455667788999999999998532 169999999999999998999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=145.85 Aligned_cols=137 Identities=22% Similarity=0.179 Sum_probs=99.6
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc--hhH----------------------HHHHHHHHHhcCCCC--e
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--DHE----------------------FCSEVEVLSCAQHRN--V 464 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~--~~~----------------------f~~Ei~iL~~L~HpN--I 464 (574)
.+.||+|+||.||+|...+|+.||||++....... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999997789999999887532211 111 135666666665443 4
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCChHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEc
Q 008201 465 VMLIGFCIEDRRRLLVYEYICNGSLDS-HLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLT 542 (574)
Q Consensus 465 V~L~g~~~~~~~~~LVmEy~~ggsL~~-~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd 542 (574)
.+++++ ...++||||++++.+.. .+... ... ..+..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEEEE
Confidence 455543 24689999998854322 12110 011 5677899999999999999 7 899999999999999
Q ss_pred CCCcEEEeeecceeecCC
Q 008201 543 HDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 543 ~~~~vKLsDFGLAr~~~~ 560 (574)
++.++|+|||+|.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.6e-16 Score=165.66 Aligned_cols=146 Identities=25% Similarity=0.334 Sum_probs=126.7
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-C---CCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-P---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRR 476 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~ 476 (574)
....+.|..++.||+|.|++||++.. . ..+.||+|.+...+. ...+..|+++|..+. +.||+.+.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34456789999999999999999983 2 467899998876543 346889999999986 8999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeecce
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLA 555 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFGLA 555 (574)
..+|+||++.....+++. .++...+..+++.++.||.++|.+ |||||||||.|+|.+.. +.-.|.|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhH
Confidence 999999999999888875 367888999999999999999999 99999999999999864 67789999999
Q ss_pred eec
Q 008201 556 RWQ 558 (574)
Q Consensus 556 r~~ 558 (574)
-..
T Consensus 181 ~~~ 183 (418)
T KOG1167|consen 181 QRY 183 (418)
T ss_pred HHH
Confidence 843
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.6e-16 Score=157.52 Aligned_cols=146 Identities=23% Similarity=0.388 Sum_probs=120.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC--CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
..+|..+..+|.|.- .|..+. .-.++.||+|.+... .....+...+|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777888998887 555454 345889999976533 2334467889999999999999999999997543
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||| ..+|...+. ..++-..+..|..|++.|++|||+. ||+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhh
Confidence 569999999 788888775 3467788889999999999999999 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 166 r~e~~ 170 (369)
T KOG0665|consen 166 RTEDT 170 (369)
T ss_pred cccCc
Confidence 96544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=146.73 Aligned_cols=136 Identities=18% Similarity=0.165 Sum_probs=105.1
Q ss_pred eeee-ccCcEEEEEEEeCCCCEEEEEEeecCCC-------------cchhHHHHHHHHHHhcCCCCe--eEEEEEEEeCC
Q 008201 412 NFLA-EGGFGSVHRGVLPDGQAVAVKQHKLASS-------------QGDHEFCSEVEVLSCAQHRNV--VMLIGFCIEDR 475 (574)
Q Consensus 412 ~~LG-~G~fG~Vy~a~~~~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~iL~~L~HpNI--V~L~g~~~~~~ 475 (574)
..|| .|+.|+||.+... +..++||.+..... .....+.+|++++..+.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 7888999988874 67889987753210 122457889999999998875 67777654322
Q ss_pred ----eEEEEEEecCC-CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 476 ----RRLLVYEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 476 ----~~~LVmEy~~g-gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
..++||||++| .+|.+++.. ..++.. .+.+|+.+|.+||+. ||+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999987 689888752 345543 356899999999999 99999999999999998999999
Q ss_pred eecceeecC
Q 008201 551 DFGLARWQP 559 (574)
Q Consensus 551 DFGLAr~~~ 559 (574)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.8e-14 Score=162.05 Aligned_cols=150 Identities=23% Similarity=0.295 Sum_probs=120.5
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC---CCCeeEEEEEEEeC
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIED 474 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~ 474 (574)
..++++....|.+.+.||+|+||.||+|...+|+.||+|+-+....-. |.-=.+++.+|+ -+.|..+...+...
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 345566677899999999999999999997779999999877654432 222233444444 24455555666667
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-------CCcE
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-------DFEP 547 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-------~~~v 547 (574)
+.-+||+||.+-|+|.+++. ..+.++|...+.++.|++..++.||.. +|||+||||+|+||.. ...+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccce
Confidence 78899999999999999997 677899999999999999999999999 9999999999999953 3468
Q ss_pred EEeeeccee
Q 008201 548 LVGDFGLAR 556 (574)
Q Consensus 548 KLsDFGLAr 556 (574)
+|+|||-+-
T Consensus 841 ~lIDfG~si 849 (974)
T KOG1166|consen 841 YLIDFGRSI 849 (974)
T ss_pred EEEecccce
Confidence 999999985
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.2e-13 Score=146.66 Aligned_cols=142 Identities=25% Similarity=0.254 Sum_probs=100.2
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcch----------------------------------------hHHH
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD----------------------------------------HEFC 450 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~----------------------------------------~~f~ 450 (574)
.+.||.|++|.||+|++.+|+.||||+.+..-.... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 357999999999999999999999998765321000 0245
Q ss_pred HHHHHHHhcC----CCCeeEEEEEE-EeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHH-HHHHHHhhC
Q 008201 451 SEVEVLSCAQ----HRNVVMLIGFC-IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR-GLRYLHEEC 524 (574)
Q Consensus 451 ~Ei~iL~~L~----HpNIV~L~g~~-~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~-gL~yLHs~~ 524 (574)
+|...+.++. |.+-+.+-.++ ......+|||||++|++|.++..... .... ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhC-
Confidence 5666555542 32223322222 22345799999999999988764211 1122 3456666655 47888988
Q ss_pred cCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 525 ~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|++|+|++|.||+++.++.++++|||+++.+..
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.3e-13 Score=138.69 Aligned_cols=162 Identities=25% Similarity=0.346 Sum_probs=132.2
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeCC------CCEEEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEE
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLPD------GQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGF 470 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~ 470 (574)
..++.+...+++...++-+|.||.||+|.+.+ .+.|-+|.++... .-+...+..|..+|..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45677778889999999999999999996532 3456667665433 2334568899999999999999999999
Q ss_pred EEeC-CeEEEEEEecCCCChHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC
Q 008201 471 CIED-RRRLLVYEYICNGSLDSHLYGCH------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (574)
Q Consensus 471 ~~~~-~~~~LVmEy~~ggsL~~~L~~~~------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~ 543 (574)
+.+. ...+.++.++.-|+|..||..++ .+.+...+...++.|++.|++|||.+ +|||.||..+|++|++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDD 431 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----Ccccchhhhhcceehh
Confidence 8764 46788999998999999997332 23456667778999999999999999 9999999999999999
Q ss_pred CCcEEEeeecceeecCCCCC
Q 008201 544 DFEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 544 ~~~vKLsDFGLAr~~~~~~~ 563 (574)
..++||+|=.|+|-+-+++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DY 451 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDY 451 (563)
T ss_pred heeEEeccchhccccCcccc
Confidence 99999999999997655443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7e-12 Score=117.31 Aligned_cols=133 Identities=20% Similarity=0.095 Sum_probs=97.5
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
.+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.++ .+++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999864 77899998754321 22346789999998865554 4555543 3345899999999887
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCc-CCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 490 DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR-VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 490 ~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~-~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
.... . ....++.+++++|..||.... ..+++|+|++|.||+++ ++.++++|||.+..-
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 6431 0 112456789999999999721 12369999999999999 678999999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-12 Score=145.54 Aligned_cols=145 Identities=23% Similarity=0.271 Sum_probs=111.9
Q ss_pred EEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC--CCcchh----HHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 410 QANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDH----EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~--~~~~~~----~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
....+|.|+||.|+... ....+.++.|..... ...... .+..|+.+-..+.|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 35679999999887776 333444555543311 111111 24557777778899999888777766666666699
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||++ +|..++. ....+....+..++.|++.|++|||.. ||.|||||++|+|++..|.+||+|||.+..+.-+
T Consensus 402 ~~~~-Dlf~~~~--~~~~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVM--SNGKLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHh--cccccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9998 9999886 345788889999999999999999999 9999999999999999999999999999877543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.5e-12 Score=142.16 Aligned_cols=142 Identities=18% Similarity=0.192 Sum_probs=94.0
Q ss_pred CeeEEeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCCc--------------------------c--------hh----
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQ--------------------------G--------DH---- 447 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~--------------------------~--------~~---- 447 (574)
.|.. +.||.|++|.||+|++.+ |+.||||+.++.-.. . .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4655 689999999999999877 999999998754110 0 01
Q ss_pred --HHHHHHHHHHhcC----CCCeeEEEEEEEe-CCeEEEEEEecCCCChHHHHhccCCC----CCCHHHHHHHHHHHHHH
Q 008201 448 --EFCSEVEVLSCAQ----HRNVVMLIGFCIE-DRRRLLVYEYICNGSLDSHLYGCHQE----PLEWSARQKIAVGAARG 516 (574)
Q Consensus 448 --~f~~Ei~iL~~L~----HpNIV~L~g~~~~-~~~~~LVmEy~~ggsL~~~L~~~~~~----~Ls~~~~~~Ia~qIa~g 516 (574)
++.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.+.++-.-...+ .+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 2445555444442 4444443333332 34678999999999997743211111 12222222333333
Q ss_pred HHHHHhhCcCCCeEeeCCCCCCeEEcCCC----cEEEeeecceeecCC
Q 008201 517 LRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFGLARWQPD 560 (574)
Q Consensus 517 L~yLHs~~~~~gIIHRDLKP~NILLd~~~----~vKLsDFGLAr~~~~ 560 (574)
+.. |++|+|++|.||+++.++ .++++|||++..+..
T Consensus 277 ----f~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 899999999999999888 999999999998754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.9e-12 Score=148.46 Aligned_cols=90 Identities=16% Similarity=0.117 Sum_probs=70.4
Q ss_pred hcCC-CCeeEEEEEE-------EeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCe
Q 008201 458 CAQH-RNVVMLIGFC-------IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529 (574)
Q Consensus 458 ~L~H-pNIV~L~g~~-------~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gI 529 (574)
.+.| +||.+++++| .....+++++||+ +++|.++|.. ....+++..++.|+.||+.||.|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ----GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC----Ce
Confidence 3455 6888888887 2334567888987 7799999964 345699999999999999999999998 99
Q ss_pred EeeCCCCCCeEEcCCCcEEEeeec
Q 008201 530 VHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 530 IHRDLKP~NILLd~~~~vKLsDFG 553 (574)
+||||||+||||+..+.+|++|||
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESA 125 (793)
T ss_pred eeccCCchhEEEcccCcEEEeecc
Confidence 999999999999654444433333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-10 Score=112.27 Aligned_cols=144 Identities=21% Similarity=0.206 Sum_probs=110.7
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCC--CCeeEEEEEEEeC---CeEEEEEEecC
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQH--RNVVMLIGFCIED---RRRLLVYEYIC 485 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~---~~~~LVmEy~~ 485 (574)
+.|+.|.++.||++...+|..+++|....... .....+..|++++..+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999976678999998764332 134568899999999875 4467777776653 25689999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC-----------------------------------------
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----------------------------------------- 524 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~----------------------------------------- 524 (574)
|.++...+. ...++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 988876552 135677777788888888888888521
Q ss_pred -----------cCCCeEeeCCCCCCeEEcC--CCcEEEeeecceeec
Q 008201 525 -----------RVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQ 558 (574)
Q Consensus 525 -----------~~~gIIHRDLKP~NILLd~--~~~vKLsDFGLAr~~ 558 (574)
....++|+|+.+.|||++. ++.+.|+||+.+.+-
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 0236899999999999998 667899999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-10 Score=112.24 Aligned_cols=136 Identities=16% Similarity=0.134 Sum_probs=99.3
Q ss_pred eeeeccCcEEEEEEEeCC-------CCEEEEEEeecCCCc----------c------------hhHH----HHHHHHHHh
Q 008201 412 NFLAEGGFGSVHRGVLPD-------GQAVAVKQHKLASSQ----------G------------DHEF----CSEVEVLSC 458 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~-------g~~VAVK~l~~~~~~----------~------------~~~f----~~Ei~iL~~ 458 (574)
..||.|.-+.||.|...+ +..+|||+.+..... . .+.+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999986542110 0 1122 379999998
Q ss_pred cCC--CCeeEEEEEEEeCCeEEEEEEecCCCChHH-HHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhhCcCCCeEeeCC
Q 008201 459 AQH--RNVVMLIGFCIEDRRRLLVYEYICNGSLDS-HLYGCHQEPLEWSARQKIAVGAARGLRYL-HEECRVGCIVHRDM 534 (574)
Q Consensus 459 L~H--pNIV~L~g~~~~~~~~~LVmEy~~ggsL~~-~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yL-Hs~~~~~gIIHRDL 534 (574)
+.. -++.+++++ ...+|||||+.+..+.. .+. ...++......+..+++.+|.+| |.. ||+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~----glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC----NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence 863 466677764 46789999996654422 232 22355556677889999999999 777 9999999
Q ss_pred CCCCeEEcCCCcEEEeeecceeecC
Q 008201 535 RPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 535 KP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++.|||+. ++.+.|+|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999988664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-12 Score=141.04 Aligned_cols=145 Identities=22% Similarity=0.208 Sum_probs=121.4
Q ss_pred eeeccCcEEEEEEEe----CCCCEEEEEEeecCCCcch--hHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 413 FLAEGGFGSVHRGVL----PDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~~~~~--~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.+|+|.||.|++++. ..|..+|+|.++....... .....|..++..++ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998872 3477889998775433221 14556888888887 9999999999999999999999999
Q ss_pred CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCC
Q 008201 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 486 ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~ 563 (574)
||.|...+. ....+.+.....+...++-+++++|.. +|+|||+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999988876 455677777788888999999999999 999999999999999999999999999997755443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=105.97 Aligned_cols=131 Identities=24% Similarity=0.292 Sum_probs=99.2
Q ss_pred eeeccCcEEEEEEEeCCCCEEEEEEeecCCC---cc-----hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASS---QG-----DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~---~~-----~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.+++|+-+.+|.+.+. |..+++|.-..... .- .....+|+.+|.++.--.|...+-+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999998763 44466674322211 11 134678999999887666665566666778889999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+|..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++||||+.+-
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999998888632 245666777778889999 999999999999997765 899999999854
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=104.49 Aligned_cols=144 Identities=20% Similarity=0.279 Sum_probs=107.8
Q ss_pred EEeeeeccCcEEEEEEEeCCCCEEEEEEeecCC--------CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS--------SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~--------~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
...+|-+|+-+.|+++.+ .|+...||.-.... .-..++..+|+.+|.++.--.|.-..-++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567889999999999987 57777888432211 112246788999999887666666666777777889999
Q ss_pred EecCC-CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC---cEEEeeecceee
Q 008201 482 EYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPLVGDFGLARW 557 (574)
Q Consensus 482 Ey~~g-gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~---~vKLsDFGLAr~ 557 (574)
||++| .++.+++...............++..|-+.+.-||.+ +|||+||..+||+|..++ .+.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 4777877643333333333367888889999999999 999999999999997654 457999999875
Q ss_pred c
Q 008201 558 Q 558 (574)
Q Consensus 558 ~ 558 (574)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=99.58 Aligned_cols=126 Identities=25% Similarity=0.225 Sum_probs=83.3
Q ss_pred EEEEEEeCCCCEEEEEEeecCCCc---------------------ch-----hHHHHHHHHHHhcCCC--CeeEEEEEEE
Q 008201 421 SVHRGVLPDGQAVAVKQHKLASSQ---------------------GD-----HEFCSEVEVLSCAQHR--NVVMLIGFCI 472 (574)
Q Consensus 421 ~Vy~a~~~~g~~VAVK~l~~~~~~---------------------~~-----~~f~~Ei~iL~~L~Hp--NIV~L~g~~~ 472 (574)
.||.|...+|..+|+|+.+..... .. ....+|+..|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999889999999987642110 00 2357899999999865 567776553
Q ss_pred eCCeEEEEEEecC--CCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 473 EDRRRLLVYEYIC--NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY-LHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 473 ~~~~~~LVmEy~~--ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~y-LHs~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
..+|||||++ |..+..+... .++......++.+++..+.. +|.. ||+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-eEEE
Confidence 4579999998 5555544321 11133445677777775555 4676 99999999999999887 9999
Q ss_pred eeecceeecC
Q 008201 550 GDFGLARWQP 559 (574)
Q Consensus 550 sDFGLAr~~~ 559 (574)
+|||.|....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999998664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.4e-08 Score=101.57 Aligned_cols=141 Identities=18% Similarity=0.114 Sum_probs=100.0
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc-----------chhHHHHHHHHHHhcCCCC--eeEEEEEEEe-----
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-----------GDHEFCSEVEVLSCAQHRN--VVMLIGFCIE----- 473 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~----- 473 (574)
+.+-......|++..+ +|+.+.||........ ....+.+|...+..+..-+ .+.+++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444455667655 6778999966432210 1114778999888775333 3444555543
Q ss_pred CCeEEEEEEecCCC-ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-------CC
Q 008201 474 DRRRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-------DF 545 (574)
Q Consensus 474 ~~~~~LVmEy~~gg-sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-------~~ 545 (574)
....+||+|++++. +|.+++......+.+......++.+++..+.-||.. ||+|+||++.|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999875 898887532234556667778999999999999999 9999999999999975 46
Q ss_pred cEEEeeecceee
Q 008201 546 EPLVGDFGLARW 557 (574)
Q Consensus 546 ~vKLsDFGLAr~ 557 (574)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 889999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.5e-08 Score=104.92 Aligned_cols=148 Identities=24% Similarity=0.337 Sum_probs=93.5
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcC----------CCCeeEEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQ----------HRNVVMLIGFCI 472 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~----------HpNIV~L~g~~~ 472 (574)
.+.....||.|+|+.||.+.. .+|+.+|+|++...... ..+.+.+|.-....+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456788999999999999995 46999999987755422 2234555554333322 112222222221
Q ss_pred e---------C---C-----eEEEEEEecCCCChHHHHh---ccCCC--CCCHHHHHHHHHHHHHHHHHHHhhCcCCCeE
Q 008201 473 E---------D---R-----RRLLVYEYICNGSLDSHLY---GCHQE--PLEWSARQKIAVGAARGLRYLHEECRVGCIV 530 (574)
Q Consensus 473 ~---------~---~-----~~~LVmEy~~ggsL~~~L~---~~~~~--~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gII 530 (574)
. . + +.+++|+-+ -++|.+++. ..... .+....++.+..|+++.+++||.. ||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY----GLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc----ceE
Confidence 1 1 1 236677776 678877753 21121 233444556778999999999999 999
Q ss_pred eeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 531 HRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 531 HRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+||+|+|++++.+|.++|+||+.....+
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecC
Confidence 99999999999999999999999877543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6e-09 Score=110.01 Aligned_cols=89 Identities=26% Similarity=0.408 Sum_probs=71.8
Q ss_pred CCCCeeEEEEEEEeC---------------------------CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHH
Q 008201 460 QHRNVVMLIGFCIED---------------------------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG 512 (574)
Q Consensus 460 ~HpNIV~L~g~~~~~---------------------------~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~q 512 (574)
.|||||++.++|.+. ..+|+||... ..+|..++.. ...+......|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHH
Confidence 599999999888642 2468999876 6789998853 34555667778899
Q ss_pred HHHHHHHHHhhCcCCCeEeeCCCCCCeEEc--CCC--cEEEeeeccee
Q 008201 513 AARGLRYLHEECRVGCIVHRDMRPNNILLT--HDF--EPLVGDFGLAR 556 (574)
Q Consensus 513 Ia~gL~yLHs~~~~~gIIHRDLKP~NILLd--~~~--~vKLsDFGLAr 556 (574)
+++|+.|||.+ ||.|||||.+||||. +|+ .+.|+|||.+-
T Consensus 350 lLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 350 LLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 99999999999 999999999999993 443 46789999764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-09 Score=125.85 Aligned_cols=142 Identities=21% Similarity=0.213 Sum_probs=114.5
Q ss_pred CeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCC-CcchhHHHHHHHH--HHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS-SQGDHEFCSEVEV--LSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~i--L~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
+|...+.||.+.|=+|.+|+...|. |+||++-... .-....|.++++- ...++|||.+.+.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999988887 8899876554 2333444444333 4456899999988877777778899999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
+ ..+|++.|.. ..-+...+.+-|+.|++.||.-+|.. ||+|+|||.+||||+.-+=+.|+||.--|
T Consensus 103 v-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 103 V-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred H-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccC
Confidence 8 6789888852 33456667778999999999999999 99999999999999998889999998766
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.5e-08 Score=99.27 Aligned_cols=135 Identities=27% Similarity=0.215 Sum_probs=99.2
Q ss_pred eeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc----------------------hhHHHHHHHHHHhcCCC--C
Q 008201 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG----------------------DHEFCSEVEVLSCAQHR--N 463 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~----------------------~~~f~~Ei~iL~~L~Hp--N 463 (574)
+.+.+.||-|.-+.||.|..+.|.++|||..+...... .....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678899999999999999899999999765432110 12357899999998754 6
Q ss_pred eeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC
Q 008201 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (574)
Q Consensus 464 IV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~ 543 (574)
+.+.+++ +...+||||++|-.|...- +.....-.++..|++-+.-+-.. ||||+|+.+-|||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchheEEEec
Confidence 6666654 5778999999886664421 12333344555555555555555 9999999999999999
Q ss_pred CCcEEEeeecceee
Q 008201 544 DFEPLVGDFGLARW 557 (574)
Q Consensus 544 ~~~vKLsDFGLAr~ 557 (574)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.7e-08 Score=110.99 Aligned_cols=99 Identities=25% Similarity=0.410 Sum_probs=90.6
Q ss_pred HHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCe-EeeCC
Q 008201 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI-VHRDM 534 (574)
Q Consensus 456 L~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gI-IHRDL 534 (574)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++++|+.||.|||.. .| .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s----~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS----PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC----cceeeeee
Confidence 3568899999999999999999999999999999999975 567789999999999999999999997 34 99999
Q ss_pred CCCCeEEcCCCcEEEeeecceeecC
Q 008201 535 RPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 535 KP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+..|++++..+.+||+|||+.....
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred ccccceeeeeEEEEechhhhccccc
Confidence 9999999999999999999988764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.6e-09 Score=108.03 Aligned_cols=137 Identities=20% Similarity=0.310 Sum_probs=113.5
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCC
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGS 488 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggs 488 (574)
...|.+...|..|+|++.. ..+++|+++..... ..++|..|.-.|+-+.||||..+++.|..+.++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3457888899999999854 45666777654332 23579999999999999999999999999999999999999999
Q ss_pred hHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 489 LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 489 L~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
|+..|+....-..+..++.+++.++++|+.|||+..+ -|.--.|....++||++.+.+|+
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhhee
Confidence 9999987656667888999999999999999999854 24455789999999999887763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-09 Score=122.33 Aligned_cols=150 Identities=25% Similarity=0.316 Sum_probs=117.9
Q ss_pred CeeEEeeeeccCcEEEEEEEeCC--CCEEEEEEeecCC--CcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPD--GQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm 481 (574)
.|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35666779999999998877433 4456666655433 111223445777666776 999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH-EECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLH-s~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~ 559 (574)
+|..++++...+........+...+..++.|+..++.|+| .. ++.|||+||+|.+++..+ .++++|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999988773212225666778889999999999999 76 899999999999999999 99999999998776
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 177 ~ 177 (601)
T KOG0590|consen 177 N 177 (601)
T ss_pred c
Confidence 5
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-07 Score=104.60 Aligned_cols=122 Identities=20% Similarity=0.217 Sum_probs=101.5
Q ss_pred eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHH
Q 008201 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR 506 (574)
Q Consensus 427 ~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~ 506 (574)
..++..|.|...+...........+-++-|+.++||||++|+..+...+..|||.|.+ ..|..++.. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHH
Confidence 5568888888887665533345777889999999999999999999999999999987 366767753 235556
Q ss_pred HHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 507 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 507 ~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
..-+.||+.||.|||+.| +++|++|.-..|+++..|+.||++|-++.-.
T Consensus 107 ~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 677899999999999886 8999999999999999999999999987543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-06 Score=86.65 Aligned_cols=107 Identities=24% Similarity=0.281 Sum_probs=83.9
Q ss_pred hHHHHHHHHHHhcCCC--CeeEEEEEEEeCC----eEEEEEEecCCC-ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHH
Q 008201 447 HEFCSEVEVLSCAQHR--NVVMLIGFCIEDR----RRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519 (574)
Q Consensus 447 ~~f~~Ei~iL~~L~Hp--NIV~L~g~~~~~~----~~~LVmEy~~gg-sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~y 519 (574)
....+|...+..|... .+++.+++..... ..+||+|++++. +|.+++... ..++......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--EQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--cccchhhHHHHHHHHHHHHHH
Confidence 4578888888777533 3456666665422 458999999874 799988631 225666778899999999999
Q ss_pred HHhhCcCCCeEeeCCCCCCeEEcCCC---cEEEeeecceeecC
Q 008201 520 LHEECRVGCIVHRDMRPNNILLTHDF---EPLVGDFGLARWQP 559 (574)
Q Consensus 520 LHs~~~~~gIIHRDLKP~NILLd~~~---~vKLsDFGLAr~~~ 559 (574)
||+. ||+|+|+++.|||++.+. .+.++||+-++...
T Consensus 134 lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999 999999999999999887 89999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9.1e-08 Score=111.03 Aligned_cols=109 Identities=29% Similarity=0.431 Sum_probs=77.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.+|..++.|..|+||.||..+.+ +.+.+|+|+-+ .. .+.+- +|....+|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee-------------------
Confidence 47888999999999999999854 57888885322 11 11111 33344445444
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+-...+. .-++++.. .+.+++|||.. ||+|||+||+|+||+.-|++|+.||||++.
T Consensus 136 --gDc~tllk--~~g~lPvd--------mvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 --GDCATLLK--NIGPLPVD--------MVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred --chhhhhcc--cCCCCcch--------hhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhh
Confidence 44444443 22334332 26789999999 999999999999999999999999999974
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.8e-06 Score=94.48 Aligned_cols=139 Identities=17% Similarity=0.159 Sum_probs=111.0
Q ss_pred EEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEEEEEecCC-CChHHHH
Q 008201 420 GSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRLLVYEYICN-GSLDSHL 493 (574)
Q Consensus 420 G~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LVmEy~~g-gsL~~~L 493 (574)
.+.|++. ..+|..|++|+++....+.......-+++++++.|.|||.+.++|.. +..++|||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 4678998 56899999999965544444344556889999999999999999873 4468999999875 5776654
Q ss_pred hcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 494 YGC-------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 494 ~~~-------------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
... .+...++..++.++.|+..||.++|+. |+.-+-|.|.+||++.+.+++|+..|..-++..
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 211 233467788999999999999999999 999999999999999999999999988877755
Q ss_pred CC
Q 008201 561 GD 562 (574)
Q Consensus 561 ~~ 562 (574)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 44
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1e-07 Score=105.15 Aligned_cols=149 Identities=21% Similarity=0.240 Sum_probs=119.8
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe--CCCCEEEEEEeecCCCcchhH--HHHHHHHHHhcC-CCCeeEEEEEEEeCCe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGDHE--FCSEVEVLSCAQ-HRNVVMLIGFCIEDRR 476 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~VAVK~l~~~~~~~~~~--f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~ 476 (574)
-..+.+|..+..||.|.|+.|+.+.. .++..|++|.+.........+ -..|+.+...+. |.+++.++..+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34566788999999999999998874 468899999776544333322 345666666664 8899998888877778
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeecce
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLA 555 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFGLA 555 (574)
.|+-.|||.++++...+. -...+.....+.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||++
T Consensus 341 ~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccc
Confidence 889999999998877663 345577788889999999999999998 89999999999999886 78889999988
Q ss_pred e
Q 008201 556 R 556 (574)
Q Consensus 556 r 556 (574)
.
T Consensus 415 t 415 (524)
T KOG0601|consen 415 T 415 (524)
T ss_pred c
Confidence 6
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.5e-07 Score=98.47 Aligned_cols=141 Identities=24% Similarity=0.274 Sum_probs=94.4
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc---------------------c-----h--------------hHHHH
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ---------------------G-----D--------------HEFCS 451 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~---------------------~-----~--------------~~f~~ 451 (574)
..|+.++-|.||+|++.+|+.||||+.+++-.. . . -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 578999999999999999999999986643110 0 0 02445
Q ss_pred HHHHHHhcC-----CCCeeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHH-HHHHHhhCc
Q 008201 452 EVEVLSCAQ-----HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG-LRYLHEECR 525 (574)
Q Consensus 452 Ei~iL~~L~-----HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~g-L~yLHs~~~ 525 (574)
|...+.++. .++|.=..=|..-.+...|+|||+.|..+.+.... ....++...+ +..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~i---a~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRKEL---AELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHHHH---HHHHHHHHHHHHHhc--
Confidence 665555442 34433222233334677899999999999887532 2244553333 2222222 2333334
Q ss_pred CCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 526 ~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|++|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.41 E-value=7e-07 Score=83.87 Aligned_cols=61 Identities=28% Similarity=0.266 Sum_probs=54.2
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+|.+++.. ...++++..+..|+.|++.||.|||+. + ||+|||++.++.+++ ||+++....
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecc
Confidence 688998864 356799999999999999999999998 5 999999999999999 999997644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.9e-06 Score=82.75 Aligned_cols=139 Identities=19% Similarity=0.159 Sum_probs=101.4
Q ss_pred eeccCcEEEEEEEeCCCCEEEEEEeecC------CCcchhHHHHHHHHHHhcCCC--CeeEEEEEEE-e--C--CeEEEE
Q 008201 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLA------SSQGDHEFCSEVEVLSCAQHR--NVVMLIGFCI-E--D--RRRLLV 480 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~~g~~VAVK~l~~~------~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~-~--~--~~~~LV 480 (574)
-|.||.+-|++-.+ +|+.+-+|.-... -+.....|.+|+..|..+..- .+.++. ++. . + -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36788888988776 3446888865411 123455799999999888632 244444 332 1 1 246799
Q ss_pred EEecCC-CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc--EEEeeecceee
Q 008201 481 YEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--PLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~g-gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~--vKLsDFGLAr~ 557 (574)
+|-+.| .+|.+++......+.+......++.+++..+.-||.. |+.|+|+.+.|||++.++. +.++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998743 6888888543334567777789999999999999999 9999999999999986666 99999987764
Q ss_pred c
Q 008201 558 Q 558 (574)
Q Consensus 558 ~ 558 (574)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.4e-05 Score=80.18 Aligned_cols=141 Identities=14% Similarity=0.122 Sum_probs=87.0
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC--eeEEEEEEEeCCeEEEEEEecCCCC-
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGFCIEDRRRLLVYEYICNGS- 488 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~~~~~LVmEy~~ggs- 488 (574)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 24467788776432 3346789999998886433 4677888877778889999998863
Q ss_pred hHHHH--------------h----ccCC---CCCCHHHHH-HHHH----------HHHH-HHHHHHhhCcCCCeEeeCCC
Q 008201 489 LDSHL--------------Y----GCHQ---EPLEWSARQ-KIAV----------GAAR-GLRYLHEECRVGCIVHRDMR 535 (574)
Q Consensus 489 L~~~L--------------~----~~~~---~~Ls~~~~~-~Ia~----------qIa~-gL~yLHs~~~~~gIIHRDLK 535 (574)
+...+ . .-+. ......... .+.. .+.. ...+|........++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 0 0011 111111111 1100 0111 12233222112357899999
Q ss_pred CCCeEEcCCCcEEEeeecceeec
Q 008201 536 PNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 536 P~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|.||+++.++ +.|+||+.+.+-
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCcC
Confidence 9999999888 999999988743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-05 Score=78.57 Aligned_cols=145 Identities=22% Similarity=0.186 Sum_probs=86.6
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCC--CeeEEEEEEEe---CCeEEEEEEecC
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR--NVVMLIGFCIE---DRRRLLVYEYIC 485 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~~~~---~~~~~LVmEy~~ 485 (574)
++.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999866 58999986543 3445788899998887533 35677765433 335789999999
Q ss_pred CCChHH----------------HHh---cc--CCCCCCHHHH--H-------HH------------HHHHHH-HHHHHHh
Q 008201 486 NGSLDS----------------HLY---GC--HQEPLEWSAR--Q-------KI------------AVGAAR-GLRYLHE 522 (574)
Q Consensus 486 ggsL~~----------------~L~---~~--~~~~Ls~~~~--~-------~I------------a~qIa~-gL~yLHs 522 (574)
|..+.. .+. .. ...++..... . .. ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887777 111 11 1111111110 0 00 011222 3444443
Q ss_pred hC---cCCCeEeeCCCCCCeEEc-CCCcEEEeeecceeec
Q 008201 523 EC---RVGCIVHRDMRPNNILLT-HDFEPLVGDFGLARWQ 558 (574)
Q Consensus 523 ~~---~~~gIIHRDLKP~NILLd-~~~~vKLsDFGLAr~~ 558 (574)
.. ....++|+|+.|.|||++ .++.+.|+||+.+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 21 123699999999999999 6666789999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.1e-07 Score=99.17 Aligned_cols=151 Identities=24% Similarity=0.186 Sum_probs=120.2
Q ss_pred CeeEEeeeec--cCcEEEEEEEe---CCCCEEEEEEeec--CCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEE
Q 008201 407 GFSQANFLAE--GGFGSVHRGVL---PDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 407 ~y~~~~~LG~--G~fG~Vy~a~~---~~g~~VAVK~l~~--~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~ 478 (574)
.|.....+|. |.+|.||.+.. .++..+|+|.-+. ........=.+|+...++++ |+|.++.+..+...+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999885 4588899987433 22233334456777667775 999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR----GLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFG 553 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~----gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFG 553 (574)
+-.|++ +.+|..+... ...-++....+.+..+... ||.++|.. +|+|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheecccccceeecCCcc
Confidence 999997 6888887764 2334677777888888888 99999998 89999999999999999 889999999
Q ss_pred ceeecCCCCC
Q 008201 554 LARWQPDGDM 563 (574)
Q Consensus 554 LAr~~~~~~~ 563 (574)
+...+.++..
T Consensus 269 ~v~~i~~~~~ 278 (524)
T KOG0601|consen 269 LVSKISDGNF 278 (524)
T ss_pred eeEEccCCcc
Confidence 9998876653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.2e-05 Score=80.47 Aligned_cols=140 Identities=14% Similarity=0.142 Sum_probs=94.6
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchh---------HHHHHHHHHHhcCCC---CeeEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH---------EFCSEVEVLSCAQHR---NVVMLIG 469 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~---------~f~~Ei~iL~~L~Hp---NIV~L~g 469 (574)
.+..++|...+++-......|.+-.. +|+.+++|..+.......+ ...+++..+..++.. .+..++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45678899999999888888877766 5788999987654322111 123444444444322 2222222
Q ss_pred EEE-----eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 470 FCI-----EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 470 ~~~-----~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+.. .....+|+|||++|..|.++.. ++. .++..+.+++.-||.. |+.|+|..|.|++++.+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECC
Confidence 221 1234569999999988876542 222 2445677889999999 99999999999999865
Q ss_pred CcEEEeeecceee
Q 008201 545 FEPLVGDFGLARW 557 (574)
Q Consensus 545 ~~vKLsDFGLAr~ 557 (574)
+ ++++||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 4 89999988764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.6e-05 Score=72.93 Aligned_cols=132 Identities=17% Similarity=0.280 Sum_probs=94.7
Q ss_pred EEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHHH
Q 008201 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (574)
Q Consensus 22 ~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (574)
+|||++|.| +.+..||.||+...-..|+.|+||-|.+....... . .+ .. ....+...+..+.-.
T Consensus 1 ~ILVavD~S-~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~--~----~~-----~~----~~~~~~~~~~~~~~~ 64 (146)
T cd01989 1 SVAVAVDKD-KKSKNALKWALDNLATKGQTIVLVHVHPPITSIPS--S----SG-----KL----EVASAYKQEEDKEAK 64 (146)
T ss_pred CEEEEecCc-cccHHHHHHHHHhccCCCCcEEEEEeccCcccCCC--C----cc-----ch----HHHHHHHHHHHHHHH
Confidence 489999997 57999999999988788999999988876332111 0 00 00 011122233344446
Q ss_pred HHHHHHHhhcCCCCceEEEEEEec-CCCchhhHHhhhcCccEEEeccccch----------hhhhhhhccc--eeEEEEe
Q 008201 102 QMILQLHDVYDPNKINFKIKIVSG-SPCGAVAAEAKKAQAGWVVLDKQLKH----------EEKCCMEELQ--CNIVVMK 168 (574)
Q Consensus 102 ~~~~~l~~~~~~~~i~~~ikv~~g-~~~~~va~eak~~~a~wvvlDr~lk~----------e~k~~~~~l~--cniv~~~ 168 (574)
+++.+..+.|...++.+...++.| .|...|..+|++.+|.=||+=+|=+. =..+++++-+ |-|.|++
T Consensus 65 ~~l~~~~~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~ 144 (146)
T cd01989 65 ELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVS 144 (146)
T ss_pred HHHHHHHHHHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEe
Confidence 667777777878899999999987 77778887899999999999988333 3346677888 8888887
Q ss_pred c
Q 008201 169 R 169 (574)
Q Consensus 169 ~ 169 (574)
+
T Consensus 145 ~ 145 (146)
T cd01989 145 K 145 (146)
T ss_pred C
Confidence 5
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=80.79 Aligned_cols=137 Identities=27% Similarity=0.254 Sum_probs=96.9
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcch-------------------h-----HHHHHHHHHHhcC--CCCee
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD-------------------H-----EFCSEVEVLSCAQ--HRNVV 465 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~-------------------~-----~f~~Ei~iL~~L~--HpNIV 465 (574)
..|..|.-+.||+|...++..+|+|+++....... + -...|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35778888899999988899999998875432111 1 1345777777764 34455
Q ss_pred EEEEEEEeCCeEEEEEEecCCC-ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 466 MLIGFCIEDRRRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 466 ~L~g~~~~~~~~~LVmEy~~gg-sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+.+++. ...|||||+... .-.-.| ..-++....+..+..++++.+.-|...+ ++||+||..-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE-C
Confidence 556554 457999999533 112222 2233444467778888888888887743 899999999999999 8
Q ss_pred CcEEEeeecceeecC
Q 008201 545 FEPLVGDFGLARWQP 559 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~ 559 (574)
+.+.|+|||-|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999887654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.8e-07 Score=99.54 Aligned_cols=148 Identities=20% Similarity=0.195 Sum_probs=98.7
Q ss_pred eeEEeeeeccCcEEEEEEEeCC----CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEE-------EEE----
Q 008201 408 FSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG-------FCI---- 472 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g-------~~~---- 472 (574)
+.+.+..+..+++.++...... .+.+..+..+...........+++-.+....|-+..-+.+ .+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 3444556667777766655222 3344444444333222233344454444444433332222 111
Q ss_pred -eCCeEEEEEEecCCCChHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 473 -EDRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 473 -~~~~~~LVmEy~~ggsL~~~L~~~-~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
...++|+.|++|...+|.+||.++ .....++...+.++.|++.|++| + +.+|||+||.||+...+..+||.
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhh
Confidence 123578999999999999999643 34567888899999999999999 5 89999999999999999999999
Q ss_pred eecceeecCCCC
Q 008201 551 DFGLARWQPDGD 562 (574)
Q Consensus 551 DFGLAr~~~~~~ 562 (574)
||||........
T Consensus 399 DFgl~ts~~~~~ 410 (516)
T KOG1033|consen 399 DFGLVTSQDKDE 410 (516)
T ss_pred hhhheeecccCC
Confidence 999988665444
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.2e-05 Score=77.37 Aligned_cols=142 Identities=18% Similarity=0.055 Sum_probs=86.6
Q ss_pred eeeccCc-EEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEEecCCCChH
Q 008201 413 FLAEGGF-GSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYEYICNGSLD 490 (574)
Q Consensus 413 ~LG~G~f-G~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmEy~~ggsL~ 490 (574)
.|..|.. ..||+.... +..+.+|...... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455655 678988764 4678888765432 345778999988874 344667888877666789999999988776
Q ss_pred HHH-------------------hccC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHHhhC---
Q 008201 491 SHL-------------------YGCH--QEPLEWS--ARQKIAV--------------------GAARGLRYLHEEC--- 524 (574)
Q Consensus 491 ~~L-------------------~~~~--~~~Ls~~--~~~~Ia~--------------------qIa~gL~yLHs~~--- 524 (574)
... +... ..++... ....... .+...+..|-...
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 1100 0011100 0000000 0111122222111
Q ss_pred cCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 525 ~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
....++|+|+.|.|||++.++.+.|+||+.|.+-
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 1236999999999999999877889999988743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00022 Score=70.61 Aligned_cols=125 Identities=23% Similarity=0.367 Sum_probs=89.1
Q ss_pred CCeeEEeeeeccCc-EEEEEEEeCCCCEEEEEEeec---CCC------------------cchhHHHHHHHHHHhcC---
Q 008201 406 GGFSQANFLAEGGF-GSVHRGVLPDGQAVAVKQHKL---ASS------------------QGDHEFCSEVEVLSCAQ--- 460 (574)
Q Consensus 406 ~~y~~~~~LG~G~f-G~Vy~a~~~~g~~VAVK~l~~---~~~------------------~~~~~f~~Ei~iL~~L~--- 460 (574)
..++.++.||.|.- |.||++++ +|+.+|+|.++. ... .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67899999999999 99999998 677999998332 111 01124777877776664
Q ss_pred CCCe--eEEEEEEEeC------------------CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 008201 461 HRNV--VMLIGFCIED------------------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520 (574)
Q Consensus 461 HpNI--V~L~g~~~~~------------------~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yL 520 (574)
+.++ |+.+||..-. ....||.||++... .+. ..-+.++.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 5566 8999998422 12357777765433 122 23345677788899
Q ss_pred HhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 521 Hs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~----gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL----GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC----CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999987 4579999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00011 Score=72.44 Aligned_cols=135 Identities=21% Similarity=0.253 Sum_probs=95.4
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCC----------------CcchhHHHHHHHHHHhcC------CCCeeEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS----------------SQGDHEFCSEVEVLSCAQ------HRNVVMLI 468 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~iL~~L~------HpNIV~L~ 468 (574)
...||+|+.-.||. .++.....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45699999998885 4455667888877655 122356677777666655 78999999
Q ss_pred EEEEeCCeEEEEEEecCC------CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc
Q 008201 469 GFCIEDRRRLLVYEYICN------GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (574)
Q Consensus 469 g~~~~~~~~~LVmEy~~g------gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd 542 (574)
|+..++-..-+|+|.+.+ .+|.+++. .+.++. . +...+-+-.+||-++ +|+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~---~~~~L~~f~~~l~~~----~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-E---LRQALDEFKRYLLDH----HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-H---HHHHHHHHHHHHHHc----CCeecCCCcccEEEE
Confidence 999999889999998743 36777774 344554 2 233334456677777 899999999999996
Q ss_pred CC--C--cEEEee-ecceeec
Q 008201 543 HD--F--EPLVGD-FGLARWQ 558 (574)
Q Consensus 543 ~~--~--~vKLsD-FGLAr~~ 558 (574)
.. + .+.|+| ||-..++
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~i 173 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKELI 173 (199)
T ss_pred ecCCCceEEEEEeCCCCcccc
Confidence 43 2 577787 6655543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.01 E-value=8.6e-05 Score=87.75 Aligned_cols=147 Identities=16% Similarity=0.212 Sum_probs=93.1
Q ss_pred EeeeeccCcEEEEEEEeCCC---CEEEEEEeecCCC-cchhHHHHHHHHHHhcC-CCCe--eEEEEEEEeC---CeEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPDG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQ-HRNV--VMLIGFCIED---RRRLLV 480 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~-HpNI--V~L~g~~~~~---~~~~LV 480 (574)
...|+.|.++.+|+....++ ..+++|+...... .....+.+|+.+|+.+. |.+| .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876553 3677776543321 23357889999999996 6665 7888887654 467999
Q ss_pred EEecCCCChHH--------------------HH---hccCC---------CCCCH--HHHHHHHH---------------
Q 008201 481 YEYICNGSLDS--------------------HL---YGCHQ---------EPLEW--SARQKIAV--------------- 511 (574)
Q Consensus 481 mEy~~ggsL~~--------------------~L---~~~~~---------~~Ls~--~~~~~Ia~--------------- 511 (574)
|||++|..+.+ .| +.... .+..+ ..+..+..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 11 11000 01111 11111111
Q ss_pred HHHHHHHHHHhhCcC-------CCeEeeCCCCCCeEEcCC-Cc-EEEeeecceee
Q 008201 512 GAARGLRYLHEECRV-------GCIVHRDMRPNNILLTHD-FE-PLVGDFGLARW 557 (574)
Q Consensus 512 qIa~gL~yLHs~~~~-------~gIIHRDLKP~NILLd~~-~~-vKLsDFGLAr~ 557 (574)
.+...+.+|..+.+. ..+||+|+++.|||++.+ .. .-|.||+++.+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 123346777665543 259999999999999853 33 46899998864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.8e-05 Score=86.95 Aligned_cols=140 Identities=21% Similarity=0.197 Sum_probs=89.8
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc-------------------------------------hhHHHHHHH
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-------------------------------------DHEFCSEVE 454 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~-------------------------------------~~~f~~Ei~ 454 (574)
+.||.-+.|.||+|++++|+.||||+-++.-... .-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5689999999999999999999999855431110 012444554
Q ss_pred HHHh----cCCCC------eeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC
Q 008201 455 VLSC----AQHRN------VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524 (574)
Q Consensus 455 iL~~----L~HpN------IV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~ 524 (574)
-..+ +.|-+ |.++|-.+ .....|+||||+|..+.+.-.- ....++...+...+.++.. +-+-..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf~~- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIFKT- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHHhc-
Confidence 3333 33444 33333332 3467899999999887765432 2334555444333333221 112223
Q ss_pred cCCCeEeeCCCCCCeEEcC----CCcEEEeeecceeecCC
Q 008201 525 RVGCIVHRDMRPNNILLTH----DFEPLVGDFGLARWQPD 560 (574)
Q Consensus 525 ~~~gIIHRDLKP~NILLd~----~~~vKLsDFGLAr~~~~ 560 (574)
|++|.|-.|.||++.. ++.+.+-|||+.+.+..
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999983 67899999999886643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.3e-05 Score=72.69 Aligned_cols=104 Identities=25% Similarity=0.254 Sum_probs=81.0
Q ss_pred HHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEEecCCCChHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCC
Q 008201 450 CSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527 (574)
Q Consensus 450 ~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~-~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~ 527 (574)
..|.-+|+.+++ +++++++|+| ..+++.||...+++...... ......+|..+.+|+.++++.+.+|+... .+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~-~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP-LG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC-CC
Confidence 358888998986 6999999999 34678999976655321000 01124689999999999999999999853 33
Q ss_pred CeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 528 gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
.+.-.|++++|+-+++++++|++|...+-..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5777999999999999999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00017 Score=72.08 Aligned_cols=73 Identities=16% Similarity=0.119 Sum_probs=45.7
Q ss_pred eeeeccCcE-EEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCC---CeeEEEEEEEeC---CeEEEEEEec
Q 008201 412 NFLAEGGFG-SVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR---NVVMLIGFCIED---RRRLLVYEYI 484 (574)
Q Consensus 412 ~~LG~G~fG-~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~~~---~~~~LVmEy~ 484 (574)
+.|+.|+.. .||+. +..+++|..... .....+.+|.++|..+... -+..+++..... ...|++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 48865 235677765432 2344788999999887532 344555444332 2458999999
Q ss_pred CCCChH
Q 008201 485 CNGSLD 490 (574)
Q Consensus 485 ~ggsL~ 490 (574)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=2.4e-05 Score=81.76 Aligned_cols=95 Identities=25% Similarity=0.362 Sum_probs=78.3
Q ss_pred HHHHhcCCCCeeEEEEEEEeCC-----eEEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcC
Q 008201 454 EVLSCAQHRNVVMLIGFCIEDR-----RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRV 526 (574)
Q Consensus 454 ~iL~~L~HpNIV~L~g~~~~~~-----~~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~ 526 (574)
.-|-.+-|.|||+++.|+.+.. ...++.||+..|+|..+|++. ....+....-.+|+-||+.||.|||+..|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P- 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP- 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC-
Confidence 3344566999999999886543 467899999999999999754 34556677777999999999999999755
Q ss_pred CCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 527 GCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 527 ~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
.|+|+++..+-|++..+|-+|+.
T Consensus 198 -piihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 198 -PIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred -ccccCCcchhheeecCCceEEec
Confidence 69999999999999999988873
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00068 Score=67.19 Aligned_cols=143 Identities=16% Similarity=0.115 Sum_probs=83.0
Q ss_pred EeeeeccCcEEEEEEEeCC--CCEEEEEEeecCCCcchhHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEEecCCC
Q 008201 411 ANFLAEGGFGSVHRGVLPD--GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmEy~~gg 487 (574)
.+.|..|-...+|+....+ ++.|++|+...... ..-...+|+.++..+.. .-.+++++.+. -.++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788888999998654 67888997654322 11234578888888853 33445554432 24899999887
Q ss_pred ChHHH--------------Hh---ccC-CC--------CC-CHHHHHHHHHH----------------------HHHHHH
Q 008201 488 SLDSH--------------LY---GCH-QE--------PL-EWSARQKIAVG----------------------AARGLR 518 (574)
Q Consensus 488 sL~~~--------------L~---~~~-~~--------~L-s~~~~~~Ia~q----------------------Ia~gL~ 518 (574)
++... +. ... .. .. .+..+..+... +...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65311 11 100 00 11 12222222111 111112
Q ss_pred HHHh----hCcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeec
Q 008201 519 YLHE----ECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQ 558 (574)
Q Consensus 519 yLHs----~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~ 558 (574)
.|-. ......++|+|+.+.|||++. ++.+.|+||..|.+-
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 2211 111126999999999999998 578999999988743
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00072 Score=59.01 Aligned_cols=103 Identities=21% Similarity=0.330 Sum_probs=79.2
Q ss_pred EEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHHH
Q 008201 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (574)
Q Consensus 22 ~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (574)
.|+|++|. .+.+..+|.||+.-.-+.+..|++|-|.+....... +..........
T Consensus 1 ~ilv~i~~-~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~------------------------~~~~~~~~~~~ 55 (130)
T cd00293 1 RILVAVDG-SEESERALRWAARLARRLGAELVLLHVVDPPPSSAA------------------------ELAELLEEEAR 55 (130)
T ss_pred CEEEEeCC-CHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch------------------------hHHHHHHHHHH
Confidence 38999996 556788999999998888999999999875332110 11222333345
Q ss_pred HHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEecccc
Q 008201 102 QMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQL 149 (574)
Q Consensus 102 ~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~l 149 (574)
+++.++...|+..++.+...+..|.+...+..+++..++..||+..+-
T Consensus 56 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dlvvig~~~ 103 (130)
T cd00293 56 ALLEALREALAEAGVKVETVVLEGDPAEAILEAAEELGADLIVMGSRG 103 (130)
T ss_pred HHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHcCCCEEEEcCCC
Confidence 677788877778899999999999997788888999999999999873
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00057 Score=66.40 Aligned_cols=130 Identities=21% Similarity=0.209 Sum_probs=88.4
Q ss_pred eEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCee-EEEEEEEeCCeEEEEEEecCCC
Q 008201 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVV-MLIGFCIEDRRRLLVYEYICNG 487 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV-~L~g~~~~~~~~~LVmEy~~gg 487 (574)
...+.|++|.+|.||+|.+. |..+|+|+-+.++ ....+..|+++|..+.--++. ++|.|. ..++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34567999999999999985 4578888765433 345789999999998866654 455553 334569999888
Q ss_pred ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCC-CCCeEEcCCCcEEEeeecceeec
Q 008201 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR-PNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 488 sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLK-P~NILLd~~~~vKLsDFGLAr~~ 558 (574)
.|.++-.. .+..+. ..+++.---|-.. ||-|..|. |..++|..++.+.|+||.-|++.
T Consensus 98 ~L~~~~~~-----~~rk~l----~~vlE~a~~LD~~----GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG-----GDRKHL----LRVLEKAYKLDRL----GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc-----ccHHHH----HHHHHHHHHHHHh----ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 98876532 122232 3334442223333 88888885 45555556669999999999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00048 Score=70.81 Aligned_cols=144 Identities=16% Similarity=0.041 Sum_probs=86.0
Q ss_pred EEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC--eeEEEEE------EEeCCeEEEEE
Q 008201 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGF------CIEDRRRLLVY 481 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~------~~~~~~~~LVm 481 (574)
..+.|..|....+|+....++ .+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 356677787789998876444 688887653 23345677888888775332 4454431 22345678999
Q ss_pred EecCCCChHH-----------HH---hcc----CC-----CCCCHHHHH----------HHHHHHHHHHHHHHhh---Cc
Q 008201 482 EYICNGSLDS-----------HL---YGC----HQ-----EPLEWSARQ----------KIAVGAARGLRYLHEE---CR 525 (574)
Q Consensus 482 Ey~~ggsL~~-----------~L---~~~----~~-----~~Ls~~~~~----------~Ia~qIa~gL~yLHs~---~~ 525 (574)
+|++|..+.. .+ +.. .. ....|.... .....+..++.++... ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876532 11 100 00 011221111 0111123345555431 11
Q ss_pred CCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 526 ~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
+.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23799999999999999987778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0011 Score=60.40 Aligned_cols=132 Identities=13% Similarity=0.257 Sum_probs=88.3
Q ss_pred eEEEEEEeCCCC-CCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 21 EKVVVAVKASKE-IPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 21 ~~Vvv~~dasr~-i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
+.|||++|.|.. .+..|+.||+.---+.|..|+||-|++...... ..+ +. .. ... ...++..+.
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~-~~~---~~------~~----~~~-~~~~~~~~~ 67 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYA-SLG---LA------YS----AEL-PAMDDLKAE 67 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccc-ccc---cc------cc----ccc-hHHHHHHHH
Confidence 569999999986 478999999987777889999998887533110 000 00 00 000 011122222
Q ss_pred HHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEEEEe
Q 008201 100 CSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMK 168 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv~~~ 168 (574)
-.+.+.++.+.+...++.+++.+..|.|...|...|++.+|.=||+-.| +.. ..+++.+..|-|.+++
T Consensus 68 ~~~~l~~~~~~~~~~~~~~~~~v~~G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~llGS~a~~vl~~a~cpVlvVr 144 (144)
T PRK15005 68 AKSQLEEIIKKFKLPTDRVHVHVEEGSPKDRILELAKKIPADMIIIASH-RPDITTYLLGSNAAAVVRHAECSVLVVR 144 (144)
T ss_pred HHHHHHHHHHHhCCCCCceEEEEeCCCHHHHHHHHHHHcCCCEEEEeCC-CCCchheeecchHHHHHHhCCCCEEEeC
Confidence 2344555555566677888999999999888887799999999999988 432 3456677777777663
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0027 Score=66.29 Aligned_cols=79 Identities=13% Similarity=0.052 Sum_probs=57.5
Q ss_pred eeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC---CCeeEEEEEEEe---CCeEEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH---RNVVMLIGFCIE---DRRRLLVY 481 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~---~~~~~LVm 481 (574)
....+.||.|..+.||+....+++ +.+|..+. ......+..|...|+.+.- -.+.++++++.. .+..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344567999999999998765564 66676432 1123478899999998853 367888888754 36689999
Q ss_pred EecCCCCh
Q 008201 482 EYICNGSL 489 (574)
Q Consensus 482 Ey~~ggsL 489 (574)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99988754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0049 Score=67.15 Aligned_cols=76 Identities=20% Similarity=0.171 Sum_probs=54.5
Q ss_pred EeeeeccCcEEEEEEEeCCC-CEEEEEEeecC-----C--CcchhHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPDG-QAVAVKQHKLA-----S--SQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g-~~VAVK~l~~~-----~--~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~L 479 (574)
.+.||.|.++.||++...+| +.++||.-... . ......+..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998776 58999974321 1 123456778888888763 3467778777 3456789
Q ss_pred EEEecCCCC
Q 008201 480 VYEYICNGS 488 (574)
Q Consensus 480 VmEy~~ggs 488 (574)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0036 Score=63.28 Aligned_cols=138 Identities=15% Similarity=0.059 Sum_probs=78.2
Q ss_pred eeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCChHH-
Q 008201 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYICNGSLDS- 491 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~ggsL~~- 491 (574)
+..|-.+.+|+... ++..+++|..........-...+|..+|+.+...++ .+++..+ . .++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45677778888773 566788887543322211235789999988864333 3444443 2 368999998876532
Q ss_pred -------------HHhccC-----CCCCCHHH-HHHHHHHH---------HHHHHHHHhhC----cCCCeEeeCCCCCCe
Q 008201 492 -------------HLYGCH-----QEPLEWSA-RQKIAVGA---------ARGLRYLHEEC----RVGCIVHRDMRPNNI 539 (574)
Q Consensus 492 -------------~L~~~~-----~~~Ls~~~-~~~Ia~qI---------a~gL~yLHs~~----~~~gIIHRDLKP~NI 539 (574)
.+..-+ ..+++... ...+..++ ...+..+-... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111111 11222211 11221111 11122221110 112589999999999
Q ss_pred EEcCCCcEEEeeecceee
Q 008201 540 LLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 540 LLd~~~~vKLsDFGLAr~ 557 (574)
|++.++ +.|+||..|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0035 Score=57.50 Aligned_cols=131 Identities=18% Similarity=0.226 Sum_probs=86.6
Q ss_pred eEEEEEEeCCC-CCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 21 EKVVVAVKASK-EIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 21 ~~Vvv~~dasr-~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
++|+|++|.|. +.+..|+.||+.-- +.+..|.||-|++..... .. ..+. . ...+..++..+.
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~la-~~~~~l~llhv~~~~~~~-~~---~~~~-------~-----~~~~~~~~~~~~ 65 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFLA-QDDGVIHLLHVLPGSASL-SL---HRFA-------A-----DVRRFEEHLQHE 65 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHHH-hcCCeEEEEEEecCcccc-cc---cccc-------c-----chhhHHHHHHHH
Confidence 57999999996 89999999999753 335678888787753210 00 0000 0 011222233333
Q ss_pred HHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchh--------hhhhhhccceeEEEEe
Q 008201 100 CSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE--------EKCCMEELQCNIVVMK 168 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e--------~k~~~~~l~cniv~~~ 168 (574)
-.+.+.++.+.++..++.++..+..|.|...|...|++.+|-=||+=.|=+.- ..+.+.+..|.|.|++
T Consensus 66 ~~~~l~~~~~~~~~~~~~v~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~llGS~a~~v~~~a~~pVLvV~ 142 (142)
T PRK15456 66 AEERLQTMVSHFTIDPSRIKQHVRFGSVRDEVNELAEELGADVVVIGSRNPSISTHLLGSNASSVIRHANLPVLVVR 142 (142)
T ss_pred HHHHHHHHHHHhCCCCcceEEEEcCCChHHHHHHHHhhcCCCEEEEcCCCCCccceecCccHHHHHHcCCCCEEEeC
Confidence 34456666666766788899999999998888766999999999998874431 1245566677766653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0071 Score=62.50 Aligned_cols=141 Identities=21% Similarity=0.224 Sum_probs=82.8
Q ss_pred eeeeccCcEEEEEEEeCC-------CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEEEEe
Q 008201 412 NFLAEGGFGSVHRGVLPD-------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LVmEy 483 (574)
+.|..|--..+|+....+ ++.+++|+..... .......+|..++..+...+ ..++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456667777899888654 5789999866433 22235678888888775333 345555553 2 368999
Q ss_pred cCCCChHHH--------------H---hccCCC-------CCC--HHHHHHH--------------------------HH
Q 008201 484 ICNGSLDSH--------------L---YGCHQE-------PLE--WSARQKI--------------------------AV 511 (574)
Q Consensus 484 ~~ggsL~~~--------------L---~~~~~~-------~Ls--~~~~~~I--------------------------a~ 511 (574)
++|..+... + +..... ..+ +.....+ ..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766321 1 110000 111 1111111 11
Q ss_pred HHHHHHHHHHhhC-----cCCCeEeeCCCCCCeEEcCC----CcEEEeeecceee
Q 008201 512 GAARGLRYLHEEC-----RVGCIVHRDMRPNNILLTHD----FEPLVGDFGLARW 557 (574)
Q Consensus 512 qIa~gL~yLHs~~-----~~~gIIHRDLKP~NILLd~~----~~vKLsDFGLAr~ 557 (574)
.+...+.+|-... ....++|+|+.+.|||++.+ +.+.++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 1222333443210 12269999999999999985 8899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.013 Score=61.13 Aligned_cols=143 Identities=15% Similarity=0.091 Sum_probs=77.6
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCC--CeeEEEE------EEEeCCeEEEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR--NVVMLIG------FCIEDRRRLLVYE 482 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g------~~~~~~~~~LVmE 482 (574)
.+.|+.|....+|+....+| .+++|++. . .....+..|+.++..|... .+.+.+. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34567777788999886555 67888775 2 1233444566666655321 2334332 1223556789999
Q ss_pred ecCCCChH-----------HHHh---ccCC---------CCCCH-HHHH-HH-----------HHH-HHHHHHHHHhh--
Q 008201 483 YICNGSLD-----------SHLY---GCHQ---------EPLEW-SARQ-KI-----------AVG-AARGLRYLHEE-- 523 (574)
Q Consensus 483 y~~ggsL~-----------~~L~---~~~~---------~~Ls~-~~~~-~I-----------a~q-Ia~gL~yLHs~-- 523 (574)
|++|..+. ..|. .... ..+.| .... .+ +.+ +...+.++...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99887431 1111 1000 01111 1111 11 111 11122222211
Q ss_pred -CcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 524 -CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 524 -~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
.-+.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 0123799999999999998765567999998863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0078 Score=62.62 Aligned_cols=144 Identities=18% Similarity=0.099 Sum_probs=82.9
Q ss_pred EEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC--eeEEEEE------EEeCCeEEEEE
Q 008201 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGF------CIEDRRRLLVY 481 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~------~~~~~~~~LVm 481 (574)
....++.|....+|+....+| .+++|+..... ....+..|++++..|...+ +++++.. ....+..++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 355677777788998876555 57788765422 2335566777777764222 4444432 12245678999
Q ss_pred EecCCCChH-----------HHH---hccCC---C-------CCCHHHHH------------HHHHHHHHHHHHHHhh--
Q 008201 482 EYICNGSLD-----------SHL---YGCHQ---E-------PLEWSARQ------------KIAVGAARGLRYLHEE-- 523 (574)
Q Consensus 482 Ey~~ggsL~-----------~~L---~~~~~---~-------~Ls~~~~~------------~Ia~qIa~gL~yLHs~-- 523 (574)
+|++|..+. ..+ +.... . .-.|.... .....+...++++...
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885432 111 11000 0 01111100 0011233345555431
Q ss_pred -CcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 524 -CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 524 -~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
..+.+++|+|+.+.||+++.++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112379999999999999988877899999985
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0054 Score=65.81 Aligned_cols=138 Identities=21% Similarity=0.247 Sum_probs=97.3
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC---------cc-------------hh----HHHHHHHHHHhcCCCCe
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS---------QG-------------DH----EFCSEVEVLSCAQHRNV 464 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~---------~~-------------~~----~f~~Ei~iL~~L~HpNI 464 (574)
-..|..|.-+.||.+...+|..+|||+++..-. .. .+ ....|+.-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 456889999999999988999999998653100 00 01 13457777887776555
Q ss_pred eEEEEEEEeCCeEEEEEEecCC-CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC
Q 008201 465 VMLIGFCIEDRRRLLVYEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (574)
Q Consensus 465 V~L~g~~~~~~~~~LVmEy~~g-gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~ 543 (574)
.-.--... ....|||+|+.. |-..-.| ....++...+..+-.+++.-+.-|...| ++||.||.-=|+|+ .
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c---~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC---RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh---ceeccchhhhhheE-E
Confidence 43222222 135799999842 1122223 3456777788888899999999999988 79999999999998 5
Q ss_pred CCcEEEeeecceee
Q 008201 544 DFEPLVGDFGLARW 557 (574)
Q Consensus 544 ~~~vKLsDFGLAr~ 557 (574)
+|.+.|+|-+-+..
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 67899999876653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00012 Score=85.87 Aligned_cols=144 Identities=23% Similarity=0.255 Sum_probs=102.2
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|.+.+-+-.|.|+.++.+.-. .|...++|...... ....+....+-.++-...||.++....-+......+|+++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 4555666778888888877632 35444444433221 1122233444444444456777766655556678899999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
|+.+++|...|+ ..++.+.+-+..++..+.++++|||.. .++|||++|.|+|+..++..+++|||+..
T Consensus 885 ~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 885 YLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred HhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCcccccc
Confidence 999999999887 344566666667777889999999997 68999999999999999999999999554
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.00065 Score=71.56 Aligned_cols=132 Identities=17% Similarity=0.108 Sum_probs=92.0
Q ss_pred CeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc----------------------hhHHHHHHHHHHhcCC-C-
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG----------------------DHEFCSEVEVLSCAQH-R- 462 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~----------------------~~~f~~Ei~iL~~L~H-p- 462 (574)
-+...+.||-|.-+.||.+-..+|+..++|..++..... .-...+|+..|+.|.- .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367789999999999999999899999999654422100 0134678888888853 2
Q ss_pred CeeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc
Q 008201 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (574)
Q Consensus 463 NIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd 542 (574)
-+.+.+++ +..++|||++.|-.|.+.-+ ...... +...+..-+.-|-.+ |+||+|..-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~---ly~~lm~~Iv~la~~----GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPT---LYDDLMGLIVRLANH----GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee-----cCChHH---HHHHHHHHHHHHHHc----CceecccchheeEEe
Confidence 23444443 47899999998888865432 112222 222333334445566 999999999999999
Q ss_pred CCCcEEEeeecc
Q 008201 543 HDFEPLVGDFGL 554 (574)
Q Consensus 543 ~~~~vKLsDFGL 554 (574)
+++.++++||--
T Consensus 237 dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 237 DDDKIVVIDFPQ 248 (465)
T ss_pred cCCCEEEeechH
Confidence 999999999963
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.016 Score=62.45 Aligned_cols=73 Identities=18% Similarity=0.091 Sum_probs=48.4
Q ss_pred eeeccCcEEEEEEEeCCC-CEEEEEEeec-------CCCcchhHHHHHHHHHHhcC--CC-CeeEEEEEEEeCCeEEEEE
Q 008201 413 FLAEGGFGSVHRGVLPDG-QAVAVKQHKL-------ASSQGDHEFCSEVEVLSCAQ--HR-NVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g-~~VAVK~l~~-------~~~~~~~~f~~Ei~iL~~L~--Hp-NIV~L~g~~~~~~~~~LVm 481 (574)
.||.|....||++...+| +.|+||.-.. .-.....+...|.+.|+... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 6899996331 11223345667888887654 24 45555544 455667999
Q ss_pred EecCCC
Q 008201 482 EYICNG 487 (574)
Q Consensus 482 Ey~~gg 487 (574)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0055 Score=53.83 Aligned_cols=129 Identities=22% Similarity=0.280 Sum_probs=86.6
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
+.|+|++|.+ +.+..|+.||+...-+.|..|++|-|++....... . . . .............
T Consensus 3 ~~Ilv~~d~~-~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~--~----~------~------~~~~~~~~~~~~~ 63 (140)
T PF00582_consen 3 KRILVAIDGS-EESRRALRFALELAKRSGAEITLLHVIPPPPQYSF--S----A------A------EDEESEEEAEEEE 63 (140)
T ss_dssp SEEEEEESSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHH--H----H------H------HHHHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHHhhCCeEEEEEeecccccccc--c----c------c------cccccccccchhh
Confidence 6799999954 45569999999988779999999999997441110 0 0 0 0001111111111
Q ss_pred HHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccc---------hhhhhhhhccceeEEEEe
Q 008201 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLK---------HEEKCCMEELQCNIVVMK 168 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk---------~e~k~~~~~l~cniv~~~ 168 (574)
...............+...+.+..|.+...+..+|+..++.=||+-++=+ .--.+++.+.+|-|.+++
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~~pVlvv~ 140 (140)
T PF00582_consen 64 QARQAEAEEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAPCPVLVVP 140 (140)
T ss_dssp HHHHHHHHHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTSSEEEEEE
T ss_pred hhhhHHHHHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCCCCEEEeC
Confidence 11111112233345788999999999988999889999999999988742 345678999999998875
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.025 Score=52.16 Aligned_cols=127 Identities=11% Similarity=0.108 Sum_probs=85.3
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCC-CcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSS-GRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
++++|++|.|. -+..|+.||+...-+.|-.|+||-|++..+. ....|. ....+..+.+.+.
T Consensus 4 k~ILvavD~S~-~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~ 65 (142)
T PRK09982 4 KHIGVAISGNE-EDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYF-----------------PATEDILQLLKNK 65 (142)
T ss_pred eEEEEEecCCc-chHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhc-----------------cchHHHHHHHHHH
Confidence 67999999875 5689999999987778899999988765331 000000 0011222333333
Q ss_pred HHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchhhhhh-------hhccceeEEEEe
Q 008201 100 CSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCC-------MEELQCNIVVMK 168 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e~k~~-------~~~l~cniv~~~ 168 (574)
-.+.+.++....+. ..+++.|+.|.|...|...|++.+|-=||+=.| ++..+++ +.+.+|-|.+++
T Consensus 66 ~~~~l~~~~~~~~~--~~~~~~v~~G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~~va~~V~~~s~~pVLvv~ 138 (142)
T PRK09982 66 SDNKLYKLTKNIQW--PKTKLRIERGEMPETLLEIMQKEQCDLLVCGHH-HSFINRLMPAYRGMINKMSADLLIVP 138 (142)
T ss_pred HHHHHHHHHHhcCC--CcceEEEEecCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHHHHHHHHHhcCCCCEEEec
Confidence 33445555554442 357788889999999998899999999999988 6666655 355566666654
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.024 Score=51.86 Aligned_cols=128 Identities=13% Similarity=0.154 Sum_probs=79.8
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
.++|+|++|.|.. +..||.||+.-.-..|..|+||-|.+.... .+. .+. .. ...+..+++.+
T Consensus 3 ~~~ILvavD~S~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~---~~~--~~~------~~-----~~~~~~~~~~~- 64 (144)
T PRK15118 3 YKHILIAVDLSPE-SKVLVEKAVSMARPYNAKVSLIHVDVNYSD---LYT--GLI------DV-----NLGDMQKRISE- 64 (144)
T ss_pred ceEEEEEccCChh-HHHHHHHHHHHHHhhCCEEEEEEEccChhh---hhh--hhh------hc-----chHHHHHHHHH-
Confidence 3679999999885 788999999865556788999877432211 000 000 00 01111122222
Q ss_pred HHHHHHHHHhhcCCCCceEE-EEEEecCCCchhhHHhhhcCccEEEeccccchhh-------hhhhhccceeEEEEe
Q 008201 100 CSQMILQLHDVYDPNKINFK-IKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEE-------KCCMEELQCNIVVMK 168 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~-ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e~-------k~~~~~l~cniv~~~ 168 (574)
+...+|..+.+..++.+. +.+..|.|...|..+|++.+|.=||+-.| .+-. .+.+.+..|-|.+++
T Consensus 65 --~~~~~l~~~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~lgSva~~v~~~a~~pVLvv~ 138 (144)
T PRK15118 65 --ETHHALTELSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHH-QDFWSKLMSSARQLINTVHVDMLIVP 138 (144)
T ss_pred --HHHHHHHHHHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCc-ccHHHHHHHHHHHHHhhCCCCEEEec
Confidence 122334444455677754 44557999888888899999999999888 3322 245677777777776
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.019 Score=59.38 Aligned_cols=31 Identities=29% Similarity=0.446 Sum_probs=26.3
Q ss_pred CeEeeCCCCCCeEEcCCCc-EEEeeecceeec
Q 008201 528 CIVHRDMRPNNILLTHDFE-PLVGDFGLARWQ 558 (574)
Q Consensus 528 gIIHRDLKP~NILLd~~~~-vKLsDFGLAr~~ 558 (574)
.++|+|+.+.|||++.++. .-|+||+.+.+-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5899999999999997555 459999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.044 Score=58.08 Aligned_cols=129 Identities=23% Similarity=0.297 Sum_probs=73.7
Q ss_pred CCEEEEEEee-cCCCcchhHHHHHHHHHHhcCC--CCeeEEEEEEEeCC--eEEEEEEecCCCChHH-------------
Q 008201 430 GQAVAVKQHK-LASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDR--RRLLVYEYICNGSLDS------------- 491 (574)
Q Consensus 430 g~~VAVK~l~-~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~--~~~LVmEy~~ggsL~~------------- 491 (574)
++.+++.... ...........+|..+|+.+.- --+...+++|..+. ..|.||+|++|..+..
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 7777777221 1122233456788888887753 23345566676655 6799999998743221
Q ss_pred -----HHhccC-----------------CCCC-CHHHHHHHH--------HHHHHHHHHHHhhCc----CCCeEeeCCCC
Q 008201 492 -----HLYGCH-----------------QEPL-EWSARQKIA--------VGAARGLRYLHEECR----VGCIVHRDMRP 536 (574)
Q Consensus 492 -----~L~~~~-----------------~~~L-s~~~~~~Ia--------~qIa~gL~yLHs~~~----~~gIIHRDLKP 536 (574)
+|...+ ...+ .|......+ -....-..||+.+.+ ...++|+|+++
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 111000 0000 011111000 012223456655533 23699999999
Q ss_pred CCeEEcCCCcEEEeeecceeec
Q 008201 537 NNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 537 ~NILLd~~~~vKLsDFGLAr~~ 558 (574)
.||+++.++.+=|.||+++.+-
T Consensus 208 gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCEEEeCCCeeEEEeccccccC
Confidence 9999999888889999999854
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.072 Score=56.83 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=82.6
Q ss_pred EeeeeccCcEEEEEEEeCC-----CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEec
Q 008201 411 ANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~ 484 (574)
...|-.|-...+|+....+ ++.|++|+........ -.-.+|..++..+..-++ .++++.+..+ .|+||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455557778899987532 3678899776543222 223678888887764333 3556665322 589999
Q ss_pred CCCChHHH-----------------HhccC----CCCCCHHHHHHHHHHH-----------------HHHHHHHHhh---
Q 008201 485 CNGSLDSH-----------------LYGCH----QEPLEWSARQKIAVGA-----------------ARGLRYLHEE--- 523 (574)
Q Consensus 485 ~ggsL~~~-----------------L~~~~----~~~Ls~~~~~~Ia~qI-----------------a~gL~yLHs~--- 523 (574)
++.+|... ++... .....+..+..+..++ ...+..|...
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 11110 0111233333332221 1122222221
Q ss_pred -CcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeec
Q 008201 524 -CRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQ 558 (574)
Q Consensus 524 -~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~ 558 (574)
.....++|+|+++.|||+++ ++.+.++||..|..-
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 11226899999999999986 468999999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.088 Score=57.66 Aligned_cols=73 Identities=15% Similarity=0.059 Sum_probs=50.0
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecC----CC---cchhHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA----SS---QGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~----~~---~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LV 480 (574)
.+.||.|....||+.... +..++||+-... .. ....+-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998864 456889964421 11 12334455677776554 357888888876 446789
Q ss_pred EEecCC
Q 008201 481 YEYICN 486 (574)
Q Consensus 481 mEy~~g 486 (574)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.054 Score=55.88 Aligned_cols=30 Identities=33% Similarity=0.354 Sum_probs=26.1
Q ss_pred CCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 527 ~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
.+++|+|+.+.|||++. +.+.|+||+.+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 37999999999999987 6788999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.0012 Score=74.33 Aligned_cols=134 Identities=18% Similarity=0.075 Sum_probs=92.8
Q ss_pred eeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEEEEecCCC-ChH
Q 008201 413 FLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLVYEYICNG-SLD 490 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LVmEy~~gg-sL~ 490 (574)
-+++|+++.+|+.+-...+.+..+.+... ....-++++|.+++||| .+.+++-+..+.+.+++++|+.++ +..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 35889999999888322333335554432 34567899999999999 778888888888999999999766 222
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 491 SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 491 ~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
..+.. ....+.......+.+.-+++|+|||+. .-+||| |||..+ +..+..||+.+..+...
T Consensus 324 ~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 324 LEMTV-SEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred ccCCh-hhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCcc
Confidence 22210 122233334445666677899999987 458998 777655 67889999998877554
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.056 Score=47.93 Aligned_cols=96 Identities=10% Similarity=0.098 Sum_probs=65.4
Q ss_pred EEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHHH
Q 008201 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (574)
Q Consensus 22 ~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (574)
+|+|++|.+. -++.||.||....-+.|..|.||-|.+.... . ..++. .
T Consensus 1 ~Ilv~vd~s~-~s~~al~~a~~la~~~~~~l~ll~v~~~~~~------------------~------~~~~~-------~ 48 (124)
T cd01987 1 RILVCISGGP-NAERLIRRAARLADRLKAPWYVVYVETPRLN------------------R------LSEAE-------R 48 (124)
T ss_pred CEEEEECCCc-chHHHHHHHHHHHHHhCCCEEEEEEecCccc------------------c------CCHHH-------H
Confidence 4899999874 6899999999887778899999998874211 0 11111 1
Q ss_pred HHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccc
Q 008201 102 QMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLK 150 (574)
Q Consensus 102 ~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk 150 (574)
++++++.+.++..++.+. -+..|.+...+..+|++.++.-||+-.|-+
T Consensus 49 ~~l~~~~~~~~~~~~~~~-~~~~~~~~~~I~~~~~~~~~dllviG~~~~ 96 (124)
T cd01987 49 RRLAEALRLAEELGAEVV-TLPGDDVAEAIVEFAREHNVTQIVVGKSRR 96 (124)
T ss_pred HHHHHHHHHHHHcCCEEE-EEeCCcHHHHHHHHHHHcCCCEEEeCCCCC
Confidence 223333344443455443 344567767777779999999999999855
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.047 Score=57.04 Aligned_cols=76 Identities=22% Similarity=0.263 Sum_probs=49.0
Q ss_pred eeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEEec
Q 008201 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
....+.|+.|....+|+.. .+++.+-||.-. ......|..|.+-|+.|. --.+++.+++....+..||+|||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456778989999999877 567889999765 223346888998888873 456789999988877889999999
Q ss_pred CCC
Q 008201 485 CNG 487 (574)
Q Consensus 485 ~gg 487 (574)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.097 Score=55.79 Aligned_cols=139 Identities=24% Similarity=0.270 Sum_probs=82.7
Q ss_pred eeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC------eeEEEEEE--EeCC--eEEEEEEe
Q 008201 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN------VVMLIGFC--IEDR--RRLLVYEY 483 (574)
Q Consensus 414 LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~L~g~~--~~~~--~~~LVmEy 483 (574)
|.. .-..+|+....+|.. ++|+.... ....++..|.+.|..|.-.+ |..+-|-. .-.. +.+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456788888777766 88887765 34456677788777663222 22222221 1123 77889999
Q ss_pred cCCCChHH------------HH---h----cc---C---CCCCCHHH----H---------HHHHHHHHHHHHHHHhhC-
Q 008201 484 ICNGSLDS------------HL---Y----GC---H---QEPLEWSA----R---------QKIAVGAARGLRYLHEEC- 524 (574)
Q Consensus 484 ~~ggsL~~------------~L---~----~~---~---~~~Ls~~~----~---------~~Ia~qIa~gL~yLHs~~- 524 (574)
++|..+.. ++ + +. + .....|.. . .....++...+..+.+.-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99887762 11 1 00 0 01233431 0 112333444555555432
Q ss_pred ---cCCC--eEeeCCCCCCeEEcCCCc-EEEeeeccee
Q 008201 525 ---RVGC--IVHRDMRPNNILLTHDFE-PLVGDFGLAR 556 (574)
Q Consensus 525 ---~~~g--IIHRDLKP~NILLd~~~~-vKLsDFGLAr 556 (574)
+..+ +||+|+.|.|||++.+.. +.++|||-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2223 999999999999998885 8899999886
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.12 Score=53.83 Aligned_cols=31 Identities=16% Similarity=0.222 Sum_probs=28.4
Q ss_pred CCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 527 ~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
.+++|+|+.+.|+|++.++.+.++||..+.+
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.074 Score=58.03 Aligned_cols=74 Identities=19% Similarity=0.133 Sum_probs=50.1
Q ss_pred EeeeeccCcEEEEEEEeCC-CCEEEEEEeec----C--CCcchhHHHHHHHHHHhcC--CC-CeeEEEEEEEeCCeEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPD-GQAVAVKQHKL----A--SSQGDHEFCSEVEVLSCAQ--HR-NVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~----~--~~~~~~~f~~Ei~iL~~L~--Hp-NIV~L~g~~~~~~~~~LV 480 (574)
.+.||.|.-..||++...+ ++.|+||.-.. . -.-..++...|.+.|+.+. -| .++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999743 56899996321 1 1223456777888888664 24 45566554 44566789
Q ss_pred EEecCC
Q 008201 481 YEYICN 486 (574)
Q Consensus 481 mEy~~g 486 (574)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.13 Score=53.01 Aligned_cols=134 Identities=17% Similarity=0.211 Sum_probs=86.2
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
+++||++|.|.. +..||.||+.---+.|..|+||-+++..+... .+ .+. .. ...+.++++.+.-
T Consensus 4 ~~ILv~~D~s~~-~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~--~~--~~~----~~-------~~~~~~~~~~~~~ 67 (305)
T PRK11175 4 QNILVVIDPNQD-DQPALRRAVYLAQRNGGKITAFLPIYDFSYEM--TT--LLS----PD-------EREAMRQGVISQR 67 (305)
T ss_pred ceEEEEcCCCcc-ccHHHHHHHHHHHhcCCCEEEEEeccCchhhh--hc--ccc----hh-------HHHHHHHHHHHHH
Confidence 579999999885 78899999986555667888876665432110 00 000 00 0011111122212
Q ss_pred HHHHHHHHhhcCCCCceEEEEEE-ecCCCchhhHHhhhcCccEEEeccccch-hh--------hhhhhccceeEEEEecC
Q 008201 101 SQMILQLHDVYDPNKINFKIKIV-SGSPCGAVAAEAKKAQAGWVVLDKQLKH-EE--------KCCMEELQCNIVVMKRS 170 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~~ikv~-~g~~~~~va~eak~~~a~wvvlDr~lk~-e~--------k~~~~~l~cniv~~~~~ 170 (574)
.+.+.++...+...++.+...+. .|.|...|...|++.++-=||+..|-+. -. .+.+.+..|-|.+++..
T Consensus 68 ~~~l~~~~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~~pvlvv~~~ 147 (305)
T PRK11175 68 TAWIREQAKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCPCPVLMVKDQ 147 (305)
T ss_pred HHHHHHHHHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCCCCEEEeccc
Confidence 23344444455566888888887 5888777887799999999999988432 11 35788899999999863
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.21 Score=52.97 Aligned_cols=141 Identities=16% Similarity=0.187 Sum_probs=79.4
Q ss_pred eeeeccCcEEEEEEEeCC----CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.|..|--..+|+....+ +..|++|+...... ..-.-.+|..+++.+..-++ .++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445456667788887433 23788887754332 22234678888888865444 45666652 22 58899977
Q ss_pred CChHH--------------HHhccCCC-------CCCHHHHHHHHHHH----------------------HHHHHHHHhh
Q 008201 487 GSLDS--------------HLYGCHQE-------PLEWSARQKIAVGA----------------------ARGLRYLHEE 523 (574)
Q Consensus 487 gsL~~--------------~L~~~~~~-------~Ls~~~~~~Ia~qI----------------------a~gL~yLHs~ 523 (574)
..|.. .|...+.. +-.|..+..+..++ ..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66521 11111111 11233333332222 1112222211
Q ss_pred C----cCCCeEeeCCCCCCeEEcC-CCcEEEeeecceee
Q 008201 524 C----RVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARW 557 (574)
Q Consensus 524 ~----~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~ 557 (574)
+ .+.-++|.||-+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1114799999999999975 57899999998874
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.24 Score=43.80 Aligned_cols=122 Identities=15% Similarity=0.125 Sum_probs=82.1
Q ss_pred EEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHHH
Q 008201 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSCS 101 (574)
Q Consensus 22 ~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 101 (574)
.|+|++|.+ +-+..||.||..-.-+.+-.|+||-+.+.... +.+ . . ..+..+.-.
T Consensus 1 ~ILv~vd~s-~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~----~~~---------~--------~---~~~~~~~~~ 55 (132)
T cd01988 1 RILVPVANP-NTARDLLELAAALARAQNGEIIPLNVIEVPNH----SSP---------S--------Q---LEVNVQRAR 55 (132)
T ss_pred CEEEecCCc-hhHHHHHHHHHHHhhcCCCeEEEEEEEecCCC----CCc---------c--------h---hHHHHHHHH
Confidence 389999987 67888999999876667778889988875331 110 0 0 011122235
Q ss_pred HHHHHHHhhcCCCCceEEEEEEe-cCCCchhhHHhhhcCccEEEeccccch---------hhhhhhhccceeEEEEe
Q 008201 102 QMILQLHDVYDPNKINFKIKIVS-GSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (574)
Q Consensus 102 ~~~~~l~~~~~~~~i~~~ikv~~-g~~~~~va~eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cniv~~~ 168 (574)
+++..+.+.....++.++..+.. |.+.+.|..-|...++.-||+=.|-+. --.+.+++.+|-|.++|
T Consensus 56 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~~pvlvv~ 132 (132)
T cd01988 56 KLLRQAERIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAPCDVAVVK 132 (132)
T ss_pred HHHHHHHHHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCCCCEEEeC
Confidence 66777777777778888877765 777777776688999999998777332 22345566667666653
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.29 Score=44.39 Aligned_cols=129 Identities=14% Similarity=0.138 Sum_probs=81.7
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
...++|++|.+-. +..||.+|+.---+-|..|+||-+++..... .. +.. ....+..+...
T Consensus 3 ~~~ILv~~D~s~~-s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~---~~---~~~-----------~~~~~~~~~~~-- 62 (142)
T PRK10116 3 YSNILVAVAVTPE-SQQLLAKAVSIARPVNGKISLITLASDPEMY---NQ---FAA-----------PMLEDLRSVMQ-- 62 (142)
T ss_pred CceEEEEccCCcc-hHHHHHHHHHHHHHhCCEEEEEEEccCcccc---hh---hhH-----------HHHHHHHHHHH--
Confidence 3679999998875 5779999987644457789998887653210 00 000 00111222221
Q ss_pred HHHHHHHHHhhcCCCCceE-EEEEEecCCCchhhHHhhhcCccEEEeccccchhh-------hhhhhccceeEEEEec
Q 008201 100 CSQMILQLHDVYDPNKINF-KIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEE-------KCCMEELQCNIVVMKR 169 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~-~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e~-------k~~~~~l~cniv~~~~ 169 (574)
.+....|..+.+..++.+ .+.+..|.|...|...|++.++-=||+-.|=+... .+++.+..|-|.+++.
T Consensus 63 -~~~~~~l~~~~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~s~a~~v~~~~~~pVLvv~~ 139 (142)
T PRK10116 63 -EETQSFLDKLIQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRASCSAKRVIASSEVDVLLVPL 139 (142)
T ss_pred -HHHHHHHHHHHHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHHHHHHHHHhcCCCCEEEEeC
Confidence 122233444445556655 46778899988888789999999999987744322 3567777888887763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.097 Score=56.41 Aligned_cols=76 Identities=16% Similarity=0.117 Sum_probs=57.3
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
..+.|++|++- |++|... ..-.+.++..++.+.+..+.-+.... ..-||||.-.||||+ +|++-|+||-
T Consensus 298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf---~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKF---PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcC---Ccccccccccceeee-cCceEEEEee
Confidence 34678888885 6666432 22457778888888777776666654 578999999999999 9999999999
Q ss_pred ceeecCC
Q 008201 554 LARWQPD 560 (574)
Q Consensus 554 LAr~~~~ 560 (574)
++|....
T Consensus 367 lsRl~~~ 373 (488)
T COG5072 367 LSRLSYS 373 (488)
T ss_pred eeecccC
Confidence 9995433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.58 Score=49.44 Aligned_cols=72 Identities=15% Similarity=0.033 Sum_probs=44.9
Q ss_pred cCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC--eeEEE---E--EEEeCCeEEEEEEecCCCCh
Q 008201 417 GGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLI---G--FCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 417 G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~---g--~~~~~~~~~LVmEy~~ggsL 489 (574)
+.-..||+....+|..+++|+.+... .....+..|++.+..|.... ++... | +...++..+.++++++|..+
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 34467899888788889999876332 23456777888777663211 22211 1 12235677889999987643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 574 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-38 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-105
Identities = 90/185 (48%), Positives = 119/185 (64%), Gaps = 4/185 (2%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-DHEFCS 451
+ FS EL++A+ FS N L GGFG V++G L DG VAVK+ K +QG + +F +
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKI 509
EVE++S A HRN++ L GFC+ RLLVY Y+ NGS+ S L Q PL+W RQ+I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A+G+ARGL YLH+ C I+HRD++ NILL +FE +VGDFGLA+ D V T V
Sbjct: 137 ALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195
Query: 570 IGTFG 574
GT G
Sbjct: 196 RGTIG 200
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 1e-89
Identities = 76/184 (41%), Positives = 105/184 (57%), Gaps = 7/184 (3%)
Query: 394 RWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEV 453
+LE AT F + G FG V++GVL DG VA+K+ SSQG EF +E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 454 EVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAV 511
E LS +H ++V LIGFC E +L+Y+Y+ NG+L HLYG + W R +I +
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-VETRVI 570
GAARGL YLH I+HRD++ NILL +F P + DFG+++ + D + T V
Sbjct: 147 GAARGLHYLHT----RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 571 GTFG 574
GT G
Sbjct: 203 GTLG 206
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 2e-86
Identities = 68/194 (35%), Positives = 99/194 (51%), Gaps = 17/194 (8%)
Query: 393 PRWFSYAELELATGGFSQ------ANFLAEGGFGSVHRGVLPDGQAVAVKQ----HKLAS 442
FS+ EL+ T F + N + EGGFG V++G + + VAVK+ + +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 443 SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH-QEPL 501
+ +F E++V++ QH N+V L+GF + LVY Y+ NGSL L PL
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 502 EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
W R KIA GAA G+ +LHE +HRD++ NILL F + DFGLAR
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 562 DMG-VETRVIGTFG 574
+ +R++GT
Sbjct: 187 AQTVMTSRIVGTTA 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 50/192 (26%), Positives = 72/192 (37%), Gaps = 20/192 (10%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
L + A G FG V + + VAVK Q + +E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVK--IF-PIQDKQSWQNEYEV 69
Query: 456 --LSCAQHRNVVMLIGFCIEDR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKI 509
L +H N++ IG L+ + GSL L + W+ I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHI 126
Query: 510 AVGAARGLRYLHEECRVG------CIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGD 562
A ARGL YLHE+ I HRD++ N+LL ++ + DFGLA ++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 563 MGVETRVIGTFG 574
G +GT
Sbjct: 187 AGDTHGQVGTRR 198
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-43
Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
+ +E L + G +G+V++G L D + VAVK + S F +E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK---VFSFANRQNFINEKNI 58
Query: 456 --LSCAQHRNVVMLIGFCIED-----RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQK 508
+ +H N+ I LLV EY NGSL +L +W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCR 115
Query: 509 IAVGAARGLRYLHEECRVG-----CIVHRDMRPNNILLTHDFEPLVGDFGLAR------- 556
+A RGL YLH E G I HRD+ N+L+ +D ++ DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 557 WQPDGDMGVETRVIGTFG 574
+P + +GT
Sbjct: 176 VRPGEEDNAAISEVGTIR 193
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 12/162 (7%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG V + + VA+K ++ S F E+ LS H N+V L G C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEP-LEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
LV EY GSL + L+G P + + ++G+ YLH ++HR
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHR 129
Query: 533 DMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVETRVIGTF 573
D++P N+LL L + DFG A M T G+
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDI-QTHM---TNNKGSA 167
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 7/163 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
+ G FG+VHR G VAVK + EF EV ++ +H N+V+ +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
+ +V EY+ GSL L+ E L+ R +A A+G+ YLH IV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP--IV 161
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
HR+++ N+L+ + V DFGL+R + + GT
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTP 203
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 6/161 (3%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG + G+ + +K+ + F EV+V+ C +H NV+ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+D+R + EYI G+L + WS R A A G+ YLH I+HR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM----NIIHR 132
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
D+ +N L+ + +V DFGLAR D E
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 50/172 (29%), Positives = 74/172 (43%), Gaps = 20/172 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ GGFG V+R G VAVK SQ E ++ + +H N++ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C+++ LV E+ G L+ L + + AV ARG+ YLH+E V I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVP-I 129
Query: 530 VHRDMRPNNILLTHDFEPL--------VGDFGLARWQPDGDMGVETRVIGTF 573
+HRD++ +NIL+ E + DFGLAR G +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAY 178
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH-------EFCSEVEVLSCAQHRNVV 465
+ +GGFG VH+G + D VA+K L S+G+ EF EV ++S H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L G R +V E++ G L L P++WS + ++ + A G+ Y+ +
Sbjct: 87 KLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ--NQ 141
Query: 526 VGCIVHRDMRPNNILLTHDFEPL-----VGDFGLARWQPDGDMGVETRVIGTF 573
IVHRD+R NI L E V DFGL++ G ++G F
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----LLGNF 190
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 34/156 (21%), Positives = 61/156 (39%), Gaps = 8/156 (5%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
L E G + +G G + VK K+ +F E L H NV+ ++G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 472 IE--DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
L+ ++ GSL + L+ ++ S K A+ ARG+ +LH + I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL--I 134
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMG 564
+ ++++ D + + +Q G M
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY 170
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 20/173 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV--LSCAQHRNVVMLIGFC 471
+ +G +G V G G+ VAVK + + + + E E+ +H N++ I
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 472 IEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
I+ L+ +Y NGSL +L L+ + K+A + GL +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 528 ----CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---TRVIGTF 573
I HRD++ NIL+ + + D GLA V+ +GT
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 17/171 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV--LSCAQHRNVVMLIGFC 471
+ +G +G V RG G+ VAVK SS+ + + E E+ +H N++ I
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 472 IEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ R L+ Y GSL +L L+ + +I + A GL +LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 528 ----CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
I HRD++ NIL+ + + + D GLA ++ G
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV--LSCAQHRNVVMLIGFC 471
+ +G FG V RG G+ VAVK + SS+ + + E E+ +H N++ I
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 472 IEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+D LV +Y +GSL +L ++ + K+A+ A GL +LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 528 ----CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
I HRD++ NIL+ + + D GLA ++ G
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 37/166 (22%), Positives = 69/166 (41%), Gaps = 14/166 (8%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
+ +G FG V+ G G+ VA++ + D F EV +H NVV+ +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ ++ +L S + + L+ + ++IA +G+ YLH + I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK----GILH 153
Query: 532 RDMRPNNILLTHDFEPLVGDFGLAR----WQPDGDMGVETRVIGTF 573
+D++ N+ + + ++ DFGL Q G
Sbjct: 154 KDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFC 471
+ G FG+V++G G VAVK + + F +EV VL +H N+++ +G+
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ +V ++ SL HL+ + E IA ARG+ YLH + I+H
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS----IIH 143
Query: 532 RDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGT 572
RD++ NNI L D +GDFGLA ++ G+
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 48/197 (24%), Positives = 71/197 (36%), Gaps = 17/197 (8%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
P + P +W L + G FG V G L
Sbjct: 86 LSTQQPLTKKSGVVLHRAVP----KDKW------VLNHEDLVLGEQIGRGNFGEVFSGRL 135
Query: 428 -PDGQAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485
D VAVK + +F E +L H N+V LIG C + + +V E +
Sbjct: 136 RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195
Query: 486 NGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545
G + L L ++ AA G+ YL + C +HRD+ N L+T
Sbjct: 196 GGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKN 250
Query: 546 EPLVGDFGLARWQPDGD 562
+ DFG++R + DG
Sbjct: 251 VLKISDFGMSREEADGV 267
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 10/195 (5%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S++A L ++C P + + E+ L +G FG V G
Sbjct: 150 SKHADGLCHRLTTVCPTSKP----QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VA+K K + F E +V+ +H +V L E+ +V EY+ G
Sbjct: 206 NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKG 263
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SL L G + L +A A G+ Y+ VHRD+R NIL+ +
Sbjct: 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVC 319
Query: 548 LVGDFGLARWQPDGD 562
V DFGLAR D +
Sbjct: 320 KVADFGLARLIEDNE 334
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 6/167 (3%)
Query: 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEV 455
Y E+ + L G FG V G VA+K K S D EF E +V
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKV 72
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
+ H +V L G C + R ++ EY+ NG L ++L + + ++
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCE 131
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+ YL E + +HRD+ N L+ V DFGL+R+ D +
Sbjct: 132 AMEYL-ESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 44/194 (22%), Positives = 81/194 (41%), Gaps = 7/194 (3%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S A L + +Y + E+ + + L G +G V+ GV
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSP-NYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 428 -PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486
VAVK K + + + EF E V+ +H N+V L+G C + ++ E++
Sbjct: 242 KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
G+L +L C+++ + +A + + YL ++ +HR++ N L+ +
Sbjct: 301 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHL 356
Query: 547 PLVGDFGLARWQPD 560
V DFGL+R
Sbjct: 357 VKVADFGLSRLMTG 370
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 10/190 (5%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
+ +A L + V + F + L + +G FG V G
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDE--FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYICN 486
G VAVK K ++ F +E V++ +H N+V L+G +E++ L +V EY+
Sbjct: 215 -RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271
Query: 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546
GSL +L + L K ++ + YL VHRD+ N+L++ D
Sbjct: 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNV 327
Query: 547 PLVGDFGLAR 556
V DFGL +
Sbjct: 328 AKVSDFGLTK 337
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 44/195 (22%), Positives = 69/195 (35%), Gaps = 11/195 (5%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
+ L C KP + + E+ L G FG V
Sbjct: 155 KKGNDGLCQKLSVPCMSS-----KPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATY 209
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VAVK K S + F +E V+ QH +V L ++ ++ E++ G
Sbjct: 210 NKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKG 267
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SL L + A G+ ++ + +HRD+R NIL++
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRDLRAANILVSASLVC 323
Query: 548 LVGDFGLARWQPDGD 562
+ DFGLAR D +
Sbjct: 324 KIADFGLARVIEDNE 338
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G FGSV G+ VAVK+ + ++ + +F E+E+L QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 469 GFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G C RR L+ EY+ GSL +L H+E ++ + +G+ YL R
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-GTKR- 134
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+HRD+ NIL+ ++ +GDFGL + P
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 47/149 (31%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K S D EF E + + H +V G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ +V EYI NG L ++L H + LE S ++ G+ +L E + +HRD
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFL-ESHQF---IHRD 129
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+ N L+ D V DFG+ R+ D
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 6/148 (4%)
Query: 414 LAEGGFGSVHRGVLPDG-QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G +G V+ GV VAVK K + + + EF E V+ +H N+V L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ ++ E++ G+L +L C+++ + +A + + YL ++ +HR
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHR 135
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPD 560
D+ N L+ + V DFGL+R
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG 163
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-25
Identities = 52/195 (26%), Positives = 77/195 (39%), Gaps = 10/195 (5%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL 427
S++A L ++C P + + E+ L +G FG V G
Sbjct: 233 SKHADGLCHRLTTVCPTSKP----QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 428 PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VA+K K + F E +V+ +H +V L E+ +V EY+ G
Sbjct: 289 NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKG 346
Query: 488 SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
SL L G + L +A A G+ Y+ VHRD+R NIL+ +
Sbjct: 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVC 402
Query: 548 LVGDFGLARWQPDGD 562
V DFGLAR D +
Sbjct: 403 KVADFGLARLIEDNE 417
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G FGSV G+ VAVK+ + ++ + +F E+E+L QH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 469 GFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G C RR L+ EY+ GSL +L H+E ++ + +G+ YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+HRD+ NIL+ ++ +GDFGL + P
Sbjct: 165 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G FGSV G VAVKQ + + +F E+++L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 469 GFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
G R+ LV EY+ +G L L H+ L+ S + +G+ YL R
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL-GSRR- 147
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ NIL+ + + DFGLA+ P
Sbjct: 148 --CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 414 LAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ P+G+ VA+K+ + A+S E E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ L+ + + G L ++ H++ + V A+G+ YL E+ R
Sbjct: 83 LGICLTSTV-QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+VHRD+ N+L+ + DFGLA+ +
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 21/167 (12%)
Query: 414 LAEGGFGSVHRGVL--------PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L +G F + +GV V +K A F ++S H+++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ G C+ +LV E++ GSLD++L ++ + + ++A A + +L EE
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 526 VGCIVHRDMRPNNILLTHDFEPL--------VGDFGLARWQPDGDMG 564
+ +H ++ NILL + + + D G++ D+
Sbjct: 134 L---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K S D F +E ++ QH+ +V L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ ++ EY+ NGSL L L + +A A G+ ++ EE +HRD
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY---IHRD 134
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+R NIL++ + DFGLAR D +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 414 LAEGGFGSVHRGVLP-----DGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVML 467
L EG FG V G+ VAVK K S + E+E+L H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 468 IGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G C ED L+ E++ +GSL +L ++ + + K AV +G+ YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYL-GSRQ 146
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ N+L+ + + +GDFGL +
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG VH G + VA+K + + + +F E EV+ H +V L G C+E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
LV E++ +G L +L + + + G+ YL EE V +HRD
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYL-EEACV---IHRD 129
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+ N L+ + V DFG+ R+ D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ +G FG V G G VAVK K ++ F +E V++ +H N+V L+G +E
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 474 DRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ L +V EY+ GSL +L + L K ++ + YL VHR
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHR 141
Query: 533 DMRPNNILLTHDFEPLVGDFGLAR 556
D+ N+L++ D V DFGL +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 47/162 (29%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + VAVK K AS +F E E+L+ QH+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ-------------KIAVGAA 514
G C E R L+V+EY+ +G L+ L + + + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G+ YL VHRD+ N L+ +GDFG++R
Sbjct: 169 AGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQ---AVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIG 469
L G FGSV +GV + VA+K K + + D E E +++ + +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C + +LV E G L L G +E + S ++ + G++YL EE
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYL-EEKN---F 131
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
VHRD+ N+LL + + DFGL++ D R G +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 11/161 (6%)
Query: 414 LAEGGFGSVHRGVL--PDGQA---VAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVML 467
+ G FG V++G+L G+ VA+K K + + +F E ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
G + + +++ EY+ NG+LD L + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
VHRD+ NIL+ + V DFGL+R D T
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 14/167 (8%)
Query: 414 LAEGGFGSVHRGVLP----DGQAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V G L +VA+K K+ + + +F E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECRV 526
G + + ++V EY+ NGSLDS L + +++ Q + G A G++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL-SDMGY 168
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
VHRD+ NIL+ + V DFGL R D T G
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 47/158 (29%), Positives = 67/158 (42%), Gaps = 19/158 (12%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L G FG V+ G + VAVK S+ D +F E ++S H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQ--KIAVGAARGLRYLH 521
IG ++ R ++ E + G L S L +P + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV---GDFGLAR 556
E +HRD+ N LLT V GDFG+AR
Sbjct: 199 EN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 14/167 (8%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ G G V G L VA+K K + + +F SE ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECRV 526
G R ++V EY+ NGSLD+ L +++ Q + G G+RYL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYL-SDLGY 172
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
VHRD+ N+L+ + V DFGL+R D T G
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 15/157 (9%)
Query: 414 LAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVML 467
L EG FG V G+ VAVK K + + E+++L H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 468 IGFCIEDRRR--LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G C + LV EY+ GSL +L + + + A G+ YL
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYL-HAQH 154
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+HRD+ N+LL +D +GDFGLA+ P+G
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 48/158 (30%), Positives = 68/158 (43%), Gaps = 19/158 (12%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L G FG V+ G + P VAVK S+ D +F E ++S H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQ--KIAVGAARGLRYLH 521
IG ++ R ++ E + G L S L +P + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV---GDFGLAR 556
E +HRD+ N LLT V GDFG+AR
Sbjct: 158 EN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 23/162 (14%)
Query: 414 LAEGGFGSVHRGVLPDG---QAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHRNVVMLI 468
+ EG FG V + + A+K+ K +S+ DH +F E+EVL H N++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHL------------YGCHQEPLEWSARQ--KIAVGAA 514
G C L EY +G+L L + S++Q A A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RG+ YL ++ I HRD+ NIL+ ++ + DFGL+R
Sbjct: 153 RGMDYLSQK---QFI-HRDLAARNILVGENYVAKIADFGLSR 190
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FG V + VAVK K + +F E E+L+ QH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KIAVGA 513
G C + ++V+EY+ +G L+ L + + Q IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A G+ YL VHRD+ N L+ + +GDFG++R
Sbjct: 143 ASGMVYL-ASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 51/164 (31%), Positives = 71/164 (43%), Gaps = 19/164 (11%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQHRNVVML 467
L EG FGSV G L VAVK KL +S + EF SE + H NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 468 IGFCIEDR-----RRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQ--KIAVGAARGLR 518
+G CIE + +++ ++ G L ++L P + K V A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
YL +HRD+ N +L D V DFGL++ GD
Sbjct: 162 YLSNR----NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 414 LAEGGFGSVHRGVL-PDGQ----AVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVML 467
L G FG+V++G+ P+G+ VA+K+ + A+S E E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C+ L+ + + G L ++ H++ + V A+G+ YL E+ R
Sbjct: 83 LGICLTSTV-QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+VHRD+ N+L+ + DFGLA+ +
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 19/164 (11%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVM 466
L +G FG V+ GV VA+K A+S + EF +E V+ +VV
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------KIAVGAARGLR 518
L+G + + L++ E + G L S+L ++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
YL+ VHRD+ N ++ DF +GDFG+ R + D
Sbjct: 153 YLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 414 LAEGGFGSVHRGVL--PDGQ--AVAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ EG FG VH+G+ P+ AVA+K K S +F E + H ++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G E+ ++ E G L S L + L+ ++ A + L YL E R
Sbjct: 83 GVITENPV-WIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYL-ESKR--- 136
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ N+L++ + +GDFGL+R+ D
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 11/174 (6%)
Query: 390 GKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE 448
G+ +F + + + L EGGF V L DG A+K+ Q E
Sbjct: 13 GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE 72
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCIEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWS 504
E ++ H N++ L+ +C+ +R L+ + G+L + + + +
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 505 ARQ--KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
Q + +G RGL +H + HRD++P NILL + +P++ D G
Sbjct: 133 EDQILWLLLGICRGLEAIHAKG----YAHRDLKPTNILLGDEGQPVLMDLGSMN 182
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 43/164 (26%), Positives = 63/164 (38%), Gaps = 25/164 (15%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVM 466
L E FG V++G L QAVA+K K A EF E + + QH NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KIAVG 512
L+G +D+ +++ Y +G L L S +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A G+ YL +VH+D+ N+L+ + D GL R
Sbjct: 137 IAAGMEYL-SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 11/163 (6%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
G F V+R L DG VA+K+ L ++ + E+++L H NV+
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101
Query: 472 IEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
IED +V E G L + + + + K V L ++H +
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR----V 157
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+HRD++P N+ +T +GD GL R ++GT
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGT 199
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 53/156 (33%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 414 LAEGGFGSVHRGVL--PDGQA--VAVKQHK---LASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V RG P G+ VAVK K L+ + +F EV + HRN++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L G + +V E GSL L HQ + AV A G+ YL E R
Sbjct: 86 LYGVVLTP-PMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYL-ESKR- 141
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+HRD+ N+LL +GDFGL R P D
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 414 LAEGGFGSVHRGVL-PDGQA----VAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVML 467
L G FG+VH+GV P+G++ V +K + S + + + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+G C LV +Y+ GSL H+ H+ L V A+G+ YL EE
Sbjct: 81 LGLCPGSSL-QLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYL-EEHG-- 135
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+VHR++ N+LL + V DFG+A P D
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 44/165 (26%), Positives = 66/165 (40%), Gaps = 20/165 (12%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKL-ASSQGDHE-FCSEVEVLSCAQHRNVVML 467
L +G FGSV L VAVK K + D E F E + H +V L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 468 IGFCIEDRRR------LLVYEYICNGSLDSHLYGC--HQEPLEWSARQ--KIAVGAARGL 517
+G + R + +++ ++ +G L + L + P + + V A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
YL +HRD+ N +L D V DFGL+R GD
Sbjct: 151 EYL-SSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 414 LAEGGFGSVHRGVLPDGQA---VAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLIG 469
L G FGSV +GV + VA+K K + + D E E +++ + +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
C + +LV E G L L G +E + S ++ + G++YL EE
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYL-EEKN---F 457
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
VHR++ N+LL + + DFGL++ D R G +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 12/165 (7%)
Query: 414 LAEGGFGSVHRGVLPDGQA---VAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLI 468
L G FG+V +G + VAVK K ++ E +E V+ + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G C + +LV E G L+ +L ++ ++ + G++YL EE
Sbjct: 85 GICEAESW-MLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYL-EESN--- 137
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
VHRD+ N+LL + DFGL++ + + + G +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 15/157 (9%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
+ +G FG V+ G D A+K + F E ++ H NV+ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 469 GFCI-EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECR 525
G + + ++ Y+C+G L + + P + + + ARG+ YL E +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP---TVKDLISFGLQVARGMEYL-AEQK 144
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ N +L F V DFGLAR D +
Sbjct: 145 ---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 469 GFCIEDRR-RLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECR 525
G C+ L+V Y+ +G L + + E + + + A+G++YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ N +L F V DFGLAR D +
Sbjct: 148 -KF-VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 49/163 (30%), Positives = 68/163 (41%), Gaps = 24/163 (14%)
Query: 414 LAEGGFGSVHRGVLPD------GQAVAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRNVV 465
L G FG V VAVK K A + SE++++S QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHL----------YGCHQEPLEWSARQ--KIAVGA 513
L+G C L++ EY C G L + L S R +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A+G+ +L + CI HRD+ N+LLT+ +GDFGLAR
Sbjct: 174 AQGMAFLASK---NCI-HRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-22
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 414 LAEGGFGSVHRGVL--PDGQ--AVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
L EG FG V+ GV G+ VAVK K + + +F SE ++ H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G E+ ++ E G L +L ++ L+ ++ + + YL E
Sbjct: 80 GIIEEEPT-WIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYL-ESINC-- 134
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ NIL+ +GDFGL+R+ D D
Sbjct: 135 -VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 8e-22
Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 414 LAEGGFGSVHRGVL--PDGQA--VAVKQHKL-ASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ EG FG VH+G+ P+ A VA+K K S +F E + H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G E+ ++ E G L S L + L+ ++ A + L YL E R
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYL-ESKR--- 511
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ N+L++ + +GDFGL+R+ D
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 414 LAEGGFGSVHRGVLPDG----QAVAVKQHKLASSQGDH-EFCSEVEVLSCAQHRNVVMLI 468
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 469 GFCIEDRR-RLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHEECR 525
G C+ L+V Y+ +G L + + E + + + A+G+++L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL-ASKK 212
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
VHRD+ N +L F V DFGLAR D +
Sbjct: 213 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 41/248 (16%)
Query: 334 LEKFSRLDRDAGVGMSSYRTDLEFSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPP 393
L K L R V S + + VR I+ ++ P L + +++ P + P
Sbjct: 20 LTKRIPLRRQVTVSAESSSSMNSNTPLVR--ITTRLSSTADTPMLAGVSEYELP---EDP 74
Query: 394 RW-FSYAELELATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHK-LASS 443
+W F +L L L EG FG V + VAVK K A+
Sbjct: 75 KWEFPRDKLTLG-------KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 444 QGDHEFCSEVEVLSC-AQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLE 502
+ + SE+E++ +H+N++ L+G C +D ++ EY G+L +L +E
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 503 WSARQ--------------KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548
+S ARG+ YL + +HRD+ N+L+T +
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYL-ASQK---CIHRDLAARNVLVTENNVMK 243
Query: 549 VGDFGLAR 556
+ DFGLAR
Sbjct: 244 IADFGLAR 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 28/167 (16%)
Query: 414 LAEGGFGSVHRGVLPD--------GQAVAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRN 463
L EG FG V VAVK K A+ + + SE+E++ +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KI 509
++ L+G C +D ++ EY G+L +L LE+S
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A ARG+ YL + +HRD+ N+L+T D + DFGLAR
Sbjct: 197 AYQVARGMEYL-ASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 49/167 (29%), Positives = 67/167 (40%), Gaps = 28/167 (16%)
Query: 414 LAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQGD-HEFCSEVEVLSC-AQHRNVV 465
L G FG V VAVK K ++ + SE++VLS H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHL--------------YGCHQEPLEWSARQ--KI 509
L+G C L++ EY C G L + L + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ A+G+ +L + CI HRD+ NILLTH + DFGLAR
Sbjct: 151 SYQVAKGMAFLASK---NCI-HRDLAARNILLTHGRITKICDFGLAR 193
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 8/160 (5%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVMLIGFCI 472
EG FG DG+ +K+ ++ S + E EV VL+ +H N+V
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
E+ +V +Y G L + + V L+++H+ I+HR
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHR 149
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
D++ NI LT D +GDFG+AR + + + IGT
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGT 188
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 28/167 (16%)
Query: 414 LAEGGFGSVHRGVLPD--------GQAVAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRN 463
L EG FG V VAVK K A+ + + SE+E++ +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ--------------KI 509
++ L+G C +D ++ EY G+L +L +E+S
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
ARG+ YL + +HRD+ N+L+T + + DFGLAR
Sbjct: 163 TYQLARGMEYL-ASQK---CIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 7e-21
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L +G F V+R + G VA+K + + + +EV++ +H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
ED + LV E NG ++ +L + E AR + G+ YLH
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSHG--- 132
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDM 563
I+HRD+ +N+LLT + + DFGLA + + +
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 46/203 (22%), Positives = 72/203 (35%), Gaps = 18/203 (8%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV- 426
P AP + P + + + FL +GGF
Sbjct: 6 DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISD 62
Query: 427 LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYE 482
+ A K + L + E+ + H++VV G ED + +V E
Sbjct: 63 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLE 121
Query: 483 YICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541
SL ++ L E AR G +YLH ++HRD++ N+ L
Sbjct: 122 LCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRNR----VIHRDLKLGNLFL 174
Query: 542 THDFEPLVGDFGLA-RWQPDGDM 563
D E +GDFGLA + + DG+
Sbjct: 175 NEDLEVKIGDFGLATKVEYDGER 197
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 37/174 (21%)
Query: 414 LAEGGFGSVHRGVLPDG------QAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ EG FG V + P VAVK K AS+ +F E +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ------------------- 507
L+G C + L++EY+ G L+ L + +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 508 ---KIAVGAARGLRYLHEECRVGCIVHRDM--RPNNILLTHDFEPLVGDFGLAR 556
IA A G+ YL E VHRD+ R N L+ + + DFGL+R
Sbjct: 175 EQLCIARQVAAGMAYLSER----KFVHRDLATR--NCLVGENMVVKIADFGLSR 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G +G V+ G L + +A+K+ S+ E+ + +H+N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWS-------ARQKIAVGAARGLRYLHEEC 524
E+ + E + GSL S L PL+ + +Q + GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN- 141
Query: 525 RVGCIVHRDMRPNNILL-THDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
IVHRD++ +N+L+ T+ + DFG ++ + G GT
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGT 186
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 55/211 (26%), Positives = 75/211 (35%), Gaps = 44/211 (20%)
Query: 376 PPLCSICQHKAPVFGKPPRW-FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDG---- 430
P S+ K P+W F L L L EG FG V +
Sbjct: 2 PLSLSVDAFKILE---DPKWEFPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRA 51
Query: 431 --QAVAVKQHK-LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNG 487
VAVK K AS + SE VL H +V+ L G C +D LL+ EY G
Sbjct: 52 GYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 488 SLDSHLYGCHQEPLEWSARQ----------------------KIAVGAARGLRYLHEECR 525
SL L + + A ++G++YL
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEM 169
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+VHRD+ NIL+ + + DFGL+R
Sbjct: 170 --KLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 43/174 (24%), Positives = 65/174 (37%), Gaps = 23/174 (13%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
+ + G FG VHR G AVK+ +L + + E+ + +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVP 114
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPL-EWSARQKIAVGAARGLRYLHEE 523
L G E + E + GSL + GC E + Q A GL YLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ-----ALEGLEYLHTR 169
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL-VGDFG----LARWQPDGDMGVETRVIGT 572
I+H D++ +N+LL+ D + DFG L + + GT
Sbjct: 170 ----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 17/159 (10%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
FL +GGF + A K + L + E+ + H++VV
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
G ED + +V E SL EP AR G +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---AR-YYLRQIVLGCQYLHRNR- 135
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDM 563
++HRD++ N+ L D E +GDFGLA + + DG+
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 41/166 (24%), Positives = 64/166 (38%), Gaps = 27/166 (16%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHK-LASSQGDHEFCSEVEVLS-CAQHRNVV 465
L G FG V + VAVK K A+ SE+++L H NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 466 MLIGFC-IEDRRRLLVYEYICNGSLDSHL------------YGCHQEPLEWSARQ--KIA 510
L+G C +++ E+ G+L ++L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A+G+ +L + +HRD+ NILL+ + DFGLAR
Sbjct: 155 FQVAKGMEFL-ASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 47/172 (27%), Positives = 67/172 (38%), Gaps = 33/172 (19%)
Query: 414 LAEGGFGSVHRGVLPDGQA------VAVKQHK-LASSQGDHEFCSEVEVLSC-AQHRNVV 465
L G FG V VAVK K A S SE+++++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ------------------ 507
L+G C L++EY C G L ++L ++ E
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 508 ---KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A A+G+ +L E VHRD+ N+L+TH + DFGLAR
Sbjct: 173 DLLCFAYQVAKGMEFL-EFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 12/152 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG+V+ +A+K + +L + +H+ EVE+ S +H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ D R+ L+ EY G++ L + E A L Y H +
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTA-TYITELANALSYCHSKR---- 129
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560
++HRD++P N+LL E + DFG + P
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQH--RNVVML 467
+ GG V + + Q A+K L A +Q + +E+ L+ Q ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL-EWSAR---QKIAVGAARGLRYLHEE 523
+ I D+ +V E N L+S L ++ + W + + + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNM----LEAVHTIHQH 127
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGT 572
IVH D++P N L+ + DFG+A QPD V+ +GT
Sbjct: 128 ----GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 45/186 (24%), Positives = 71/186 (38%), Gaps = 30/186 (16%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFC-SEVEVLSCAQHRNVVMLIGF 470
L GGFG V D A+K+ +L + + E EV+ L+ +H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 471 CIED---------RRRLLVY---EYICNGSLDSHL-YGCHQEPLEWSARQKIAVGAARGL 517
+E ++ +Y + +L + C E E S I + A +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-----------WQPDGDMGVE 566
+LH + ++HRD++P+NI T D VGDFGL P
Sbjct: 132 EFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 567 TRVIGT 572
T +GT
Sbjct: 188 TGQVGT 193
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 21/170 (12%)
Query: 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRN--VVML 467
+ GG V + + Q A+K L + + +E+ L+ Q + ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL-EWSAR---QKIAVGAARGLRYLHEE 523
+ I D+ +V E N L+S L ++ + W + + + + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNM----LEAVHTIHQH 146
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGT 572
IVH D++P N L+ + DFG+A QPD V+ +GT
Sbjct: 147 ----GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 37/153 (24%), Positives = 63/153 (41%), Gaps = 12/153 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFC 471
LAEGGF V+ + G+ A+K+ + + EV + + H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 472 IEDRRR-------LLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEE 523
+ L+ +C G L L + PL KI R ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-- 153
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ I+HRD++ N+LL++ + DFG A
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 28/175 (16%)
Query: 392 PPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--E 448
R+ + + G F +V++G+ VA + +
Sbjct: 24 DGRFLKFDIE------------IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR 71
Query: 449 FCSEVEVLSCAQHRNVVMLIGFCI---EDRRRLLVY-EYICNGSLDSHL--YGCHQEPLE 502
F E E+L QH N+V + ++ +++ E + +G+L ++L + ++
Sbjct: 72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMK 127
Query: 503 WSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLAR 556
+ +GL++LH R I+HRD++ +NI +T +GD GLA
Sbjct: 128 IKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 9/165 (5%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVMLIG-FC 471
G +G + DG+ + K+ S ++ + + SEV +L +H N+V
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 472 IEDRRRL-LVYEYICNGSLDSHLYGCHQ--EPLEWSARQKIAVGAARGLRYLHEECRVGC 528
L +V EY G L S + + + L+ ++ L+ H G
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 529 -IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
++HRD++P N+ L +GDFGLAR + D +GT
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGT 179
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 33/174 (18%), Positives = 67/174 (38%), Gaps = 29/174 (16%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVK-----------------QHKLASSQGDHEFCSEVEVL 456
L +G F + D + A+K K++ +F +E++++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 457 SCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA-- 513
+ ++ + G I + + ++YEY+ N S+ ++ I V
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 514 ----ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
Y+H E I HRD++P+NIL+ + + DFG + + D +
Sbjct: 157 IKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQH--RNVVML 467
+ GG V + + Q A+K L A +Q + +E+ L+ Q ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL-EWSAR---QKIAVGAARGLRYLHEE 523
+ I D+ +V E N L+S L ++ + W + + + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNM----LEAVHTIHQH 174
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGT 572
IVH D++P N L+ D + DFG+A QPD V+ +G
Sbjct: 175 ----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 41/179 (22%), Positives = 72/179 (40%), Gaps = 29/179 (16%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ GGFG V + DG+ +K+ K + + EV+ L+ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72
Query: 471 CIEDRRRL----------------LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
+ E+ G+L+ + E L+ ++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGT 572
+G+ Y+H + +++RD++P+NI L + +GDFGL + DG TR GT
Sbjct: 133 KGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGT 184
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 40/150 (26%), Positives = 53/150 (35%), Gaps = 16/150 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVL-SCAQHRNVVMLIG 469
L G +G V + DG+ AVK+ + +EV QH V L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 470 FCIEDRRRLLVYEYICNGSLDSHL--YGCH-QEPLEWSARQKIAVGAARGLRYLHEECRV 526
E L E C SL H +G E W L +LH +
Sbjct: 125 AWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQG-- 177
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+VH D++P NI L +GDFGL
Sbjct: 178 --LVHLDVKPANIFLGPRGRCKLGDFGLLV 205
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 18/176 (10%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSC-AQHRN 463
F + + G FGSV + V DG A+K+ K A S + EV + QH +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLH 521
VV ED L+ EY GSL + + + + + + RGLRY+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD--------GDMGVETRV 569
+VH D++P+NI ++ P GD+G TR+
Sbjct: 133 SMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 39/164 (23%), Positives = 62/164 (37%), Gaps = 23/164 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G +V RG G A+K + ++ + E EVL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 472 IEDRRRLLVY---EYICNGSLDSHL--YGCHQEPLEWSAR---QKIAVGAARGLRYLHEE 523
E+ E+ GSL + L E + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMNHLREN 131
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLARWQPDGDM 563
IVHR+++P NI+ + + DFG AR D +
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG+V+ + +A+K + +L +H+ E+E+ S +H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ DR+R+ L+ E+ G L L + E + + A L Y HE
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFME-ELADALHYCHERK---- 134
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561
++HRD++P N+L+ + E + DFG + P
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 26/160 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V + D + A+K+ + + SEV +L+ H+ VV +
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASLNHQYVVRYYAAWL 72
Query: 473 EDRRRL-------------LVYEYICNGSLDSHL--YGCHQEPLE-WSARQKIAVGAARG 516
E R + + EY NG+L + +Q+ E W ++I
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EA 128
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
L Y+H + I+HRD++P NI + +GDFGLA+
Sbjct: 129 LSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAK 164
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 7/160 (4%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ G A K + S + ++ E+E+L+ H +V L+G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
D + ++ E+ G++D+ + L Q + L +LH + I HR
Sbjct: 87 HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RII-HR 141
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
D++ N+L+T + + + DFG++ + + IGT
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGT 180
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 39/164 (23%), Positives = 62/164 (37%), Gaps = 23/164 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
L +G +V RG G A+K + ++ + E EVL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 472 IEDRRRLLVY---EYICNGSLDSHL--YGCHQEPLEWSAR---QKIAVGAARGLRYLHEE 523
E+ E+ GSL + L E + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMNHLREN 131
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLARWQPDGDM 563
IVHR+++P NI+ + + DFG AR D +
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 28/147 (19%), Positives = 54/147 (36%), Gaps = 13/147 (8%)
Query: 417 GGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGFCIE 473
+V+ P G+ V V++ L + + E+ V H N+V I
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGCIV 530
D +V ++ GS + + + IA G + L Y+H G +
Sbjct: 98 DNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALDYIHHM---GYV- 150
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARW 557
HR ++ ++IL++ D + +
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLS 177
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 2e-17
Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L GGFG V R + G+ VA+KQ + S + E +C E++++ H NVV
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 80
Query: 472 IEDRRRL-------LVYEYICNGSLDSHL--YGCHQEPLEWSAR---QKIAVGAARGLRY 519
+ ++L L EY G L +L + E R I+ LRY
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS----SALRY 136
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPL---VGDFGLARWQPDGDM 563
LHE I+HRD++P NI+L + L + D G A+ G++
Sbjct: 137 LHENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 43/170 (25%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQ-HKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGFC 471
L G G++ + D + VAVK+ S D E V++L +H NV+
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQLLRESDEHPNVIRYFCTE 87
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+ + + + E C +L ++ L + GL +LH IVH
Sbjct: 88 KDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLN----IVH 141
Query: 532 RDMRPNNILLTHDFE-----PLVGDFGLARWQPDGDMGVETR--VIGTFG 574
RD++P+NIL++ ++ DFGL + G R V GT G
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
F Q L G + +V++G+ G VA+K+ KL S +G S E+ ++ +H
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHE 63
Query: 463 NVVMLIGFCIEDRRRLLVYEYICN---GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
N+V L + + LV+E++ N +DS G LE + + +GL +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
HE I+HRD++P N+L+ + +GDFGLAR
Sbjct: 124 CHE----NKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIG-- 469
+ G +G V++G + GQ A+K + + + E E+ +L + HRN+ G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 470 ----FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHE 522
D + LV E+ GS+ + L+ + IA RGL +LH+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREILRGLSHLHQ 147
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
++HRD++ N+LLT + E + DFG++ Q D +G IGT
Sbjct: 148 HK----VIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGT 192
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 9e-17
Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 15/147 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFC 471
+ +G FG V +G+ + VA+K L ++ + + E+ VLS V G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEECRVGC 528
++D + ++ EY+ GS L PL+ +IA +GL YLH E
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLL--EPGPLD---ETQIATILREILKGLDYLHSE---KK 140
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLA 555
I HRD++ N+LL+ E + DFG+A
Sbjct: 141 I-HRDIKAANVLLSEHGEVKLADFGVA 166
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 21/172 (12%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRN 463
FS + G FG+V+ + + + VA+K+ + Q + ++ EV L +H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYL 520
+ G + + LV EY C GS S L H++PL+ +IA GA +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEY-CLGSA-SDLLEVHKKPLQ---EVEIAAVTHGALQGLAYL 170
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
H ++HRD++ NILL+ +GDFG A M +GT
Sbjct: 171 HSHN----MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGT 213
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 33/220 (15%), Positives = 71/220 (32%), Gaps = 30/220 (13%)
Query: 357 FSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAE 416
+ + + LS + P + + + + P E +L + + L E
Sbjct: 22 WDDKLIFKL-LSGLSKP-VSSYPNTFEWQCKL----PAIKPKTEFQLGSKLVYVHHLLGE 75
Query: 417 GGFGSVHRGV------LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
G F V+ + Q +K K A+ + +E L + +
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135
Query: 471 CIEDRRRLLVYEYICNGSLDSHL---YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ +LV E G+L + + ++ + A+ + +H+
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD----C 191
Query: 528 CIVHRDMRPNNILLTHDFEPLVG-----------DFGLAR 556
I+H D++P+N +L + F D G +
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCA 459
F + + EG +G V++ G+ VA+K+ +L D E S E+ +L
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-----DTETEGVPSTAIREISLLKEL 59
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
H N+V L+ + + LV+E+ + L + + + +GL +
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H ++HRD++P N+L+ + + DFGLAR
Sbjct: 119 CHSHR----VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA++Q L +E+ V+ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+V EY+ GSL + + ++ + + L +LH ++HR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ----VIHR 140
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
D++ +NILL D + DFG Q + + ++GT
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGT 179
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 43/167 (25%), Positives = 64/167 (38%), Gaps = 14/167 (8%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFCIE 473
G V P + VA+K+ L Q E E++ +S H N+V +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAV---GAARGLRYLHEECRV 526
LV + + GS+ + E + IA GL YLH+
Sbjct: 85 KDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--- 140
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
G I HRD++ NILL D + DFG++ + G +V TF
Sbjct: 141 GQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
+ + + L EG + +V++G VA+K+ +L +G EV +L +H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHA 60
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRY 519
N+V L ++ LV+EY LD L + + RGL Y
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H + ++HRD++P N+L+ E + DFGLAR
Sbjct: 116 CHRQK----VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 9/160 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG G V G+ VAVK L Q +EV ++ QH NVV + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ E++ G+L + Q L + + L YLH + ++HR
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ----GVIHR 165
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
D++ ++ILLT D + DFG Q D+ ++GT
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCA-QISKDVPKRKSLVGT 204
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ-GDHEFCS----EVEVL---SC 458
+ + G +G+V++ G VA+K ++ + G EV +L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 459 AQHRNVVMLIGFCIEDRRRL-----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA 513
+H NVV L+ C R LV+E+ + L ++L L + +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 514 ARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RGL +LH C IVHRD++P NIL+T + DFGLAR
Sbjct: 130 LRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 23/194 (11%), Positives = 48/194 (24%), Gaps = 39/194 (20%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE------------------------ 448
L + + G++ V +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 449 ----FCSEVEVLSCAQHRNVVMLIG----FCIEDRRRLLVYEYICNGSLDSHL--YGCHQ 498
F +++ Q + ++ + + R L + L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 499 EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558
+ L AR ++ + R L LH +VH +RP +I+L + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 559 PDGDMGVETRVIGT 572
+ R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
F L EG +GSV++ + GQ VA+KQ + E E+ ++ +VV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV---GAARGLRYLHEE 523
G ++ +V EY GS+ + + L +IA +GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLT---EDEIATILQSTLKGLEYLHFM 144
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+HRD++ NILL + + DFG+A Q M VIGT
Sbjct: 145 R----KIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGT 188
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 42/184 (22%), Positives = 69/184 (37%), Gaps = 32/184 (17%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGFCI 472
L G G+V G+ VAVK+ + E+++L+ H NV+
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCS-E 78
Query: 473 EDRRRL-LVYEYICNGSLD-----SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
R L + E CN +L ++ + + + + A G+ +LH
Sbjct: 79 TTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-- 135
Query: 527 GCIVHRDMRPNNILLTH-------------DFEPLVGDFGLARWQPDGDMGVETR---VI 570
I+HRD++P NIL++ + L+ DFGL + G T
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 571 GTFG 574
GT G
Sbjct: 194 GTSG 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 24/159 (15%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCAQ 460
+ + + EG +G V++ G+ VA+K+ +L D E S E+ +L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL-----DAEDEGIPSTAIREISLLKELH 77
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGL 517
H N+V LI +R LV+E+ ++ L ++ L+ S + RG+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ H+ I+HRD++P N+L+ D + DFGLAR
Sbjct: 133 AHCHQHR----ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 57/282 (20%), Positives = 96/282 (34%), Gaps = 48/282 (17%)
Query: 306 HHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSGNVREAI 365
HH H + + + + + + A+
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSAL 62
Query: 366 SLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRG 425
++ APP P + + V Y S+ L G FG VH+
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVNSF------YT--------VSKTEILGGGRFGQVHKC 108
Query: 426 V-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEY 483
G +A K K + E +E+ V++ H N++ L E + + LV EY
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEY 167
Query: 484 ICNGSL------DSHLYGCHQEPLEWSA----RQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ G L +S+ E +Q G+R++H+ I+H D
Sbjct: 168 VDGGELFDRIIDESYNLT------ELDTILFMKQ-----ICEGIRHMHQM----YILHLD 212
Query: 534 MRPNNILLTHDFEPLV--GDFGLAR-WQPDGDMGVETRVIGT 572
++P NIL + + DFGLAR ++P + V GT
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGT 251
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 20/178 (11%), Positives = 38/178 (21%), Gaps = 40/178 (22%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G V + + A+K S + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 470 FC-----------------------IEDRR---RLLVYEYICNGSLDS-----HLYGCHQ 498
+D LL+ + L+ +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFR 188
Query: 499 EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
A + R L + +VH P+N+ + D ++GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALW 242
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCS----EVEVLSCAQH 461
+ + +FL EG F +V++ Q VA+K+ KL + E+++L H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLR 518
N++ L+ LV+++ +++ L + L S + + +GL
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
YLH+ I+HRD++PNN+LL + + DFGLA+
Sbjct: 127 YLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 24/159 (15%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCAQ 460
+ + EG +G V++ G+ A+K+ +L + E S E+ +L +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELK 58
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGL 517
H N+V L +R +LV+E+ LD L + LE + + G+
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
Y H+ ++HRD++P N+L+ + E + DFGLAR
Sbjct: 114 AYCHDRR----VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 35/167 (20%), Positives = 65/167 (38%), Gaps = 22/167 (13%)
Query: 414 LAEGGFGSVHRGV--LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
+A GG G ++ + +G+ V +K + +E + L+ H ++V + F
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 471 CIEDRRRL-----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
R +V EY+ SL + L + + L YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH---S 200
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+G +V+ D++P NI+LT + + + D G + + GT
Sbjct: 201 IG-LVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFGYLYGT 240
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCA 459
+ + + EG +G+V + + VA+K+ +L D + S E+ +L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKEL 58
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARG 516
+H+N+V L D++ LV+E+ D L L+ + +G
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
L + H ++HRD++P N+L+ + E + +FGLAR
Sbjct: 114 LGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEV-LSCAQHRNVVMLIGF 470
+ G +GSV++ V P GQ +AVK+ + + + + +++V + + +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 471 CIEDRRRLLVYEYICNGSLDS---HLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ + E + S D ++Y + + KI + + L +L E +
Sbjct: 90 LFREGDCWICMEL-MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFG 553
I+HRD++P+NILL + DFG
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 17/156 (10%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS---EVEVLSCAQHRN 463
+ + + EG +G V + GQ VA+K+ S E+ +L +H N
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE-SEDDPVIKKIALREIRMLKQLKHPN 63
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYL 520
+V L+ RR LV+EY D + +Q + + I + + +
Sbjct: 64 LVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H+ +HRD++P NIL+T + DFG AR
Sbjct: 119 HKHN----CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 47/172 (27%), Positives = 69/172 (40%), Gaps = 27/172 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G F V G+ A+K K + + D +E+ VL +H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-Y 75
Query: 473 EDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
E LV + + G L D E A I ++YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYT-------EKDASLVIQQ-VLSAVKYLHENG- 126
Query: 526 VGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFG 574
IVHRD++P N+L E + + DFGL++ + +G M + GT G
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPG 172
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 46/169 (27%), Positives = 64/169 (37%), Gaps = 21/169 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG V GQ AVK ++ EV++L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
F ED+ LV E G L + E +I G+ Y+H+
Sbjct: 94 FF-EDKGYFYLVGEVYTGGELFDEIISRKRFSE----VDAARIIRQVLSGITYMHKNK-- 146
Query: 527 GCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGT 572
IVHRD++P N+LL D + DFGL+ IGT
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGT 191
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 34/147 (23%), Positives = 64/147 (43%), Gaps = 9/147 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEV-LSCAQHRNVVMLIGF 470
L G +G V + +P GQ +AVK+ +SQ ++++ + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 471 CIEDRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ + E + SLD + + KIAV + L +LH +
Sbjct: 75 LFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--- 130
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLA 555
++HRD++P+N+L+ + + DFG++
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 19/149 (12%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
EG +G V + G+ VA+K+ S D E+++L +H N+V L+
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIKKFLE--SDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
C + +R LV+E+ +D + L++ QK G+ + H
Sbjct: 93 CKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
I+HRD++P NIL++ + DFG AR
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 16/166 (9%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQ--HRNVVM 466
L GG +V+ D VA+K + E E EV + +Q H+N+V
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+I ED LV EYI +L ++ PL G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
IVHRD++P NIL+ + + DFG+A+ + + V+GT
Sbjct: 131 R-IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 29/164 (17%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCA 459
+ + L EG +G V++ + + VA+K+ +L +HE EV +L
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLKEL 90
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGL 517
QHRN++ L + R L++EY ++ L + + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG-----DFGLAR 556
+ H +HRD++P N+LL+ DFGLAR
Sbjct: 146 NFCHSRR----CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 48/167 (28%), Positives = 66/167 (39%), Gaps = 18/167 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L G +G V A+K K + S + EV VL H N++ L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 471 CIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLRYLHEECRVGC 528
ED+R LV E G L + H+ E A I G+ YLH+
Sbjct: 105 F-EDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAA-VIIKQVLSGVTYLHKHN---- 156
Query: 529 IVHRDMRPNNILLT---HDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
IVHRD++P N+LL D + DFGL+ + +GT
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGT 201
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 30/157 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR V G+ K + +E+ +++ H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-F 117
Query: 473 EDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYLH 521
ED+ + L+ E++ G L + + + + R GL+++H
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMS-----------EAEVINYMRQACEGLKHMH 166
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLV--GDFGLAR 556
E IVH D++P NI+ V DFGLA
Sbjct: 167 EH----SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 48/154 (31%), Positives = 66/154 (42%), Gaps = 23/154 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFC 471
L EG V + L Q AVK + EVE+L C HRNV+ LI F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 472 IEDRRRLLVYEYICNGSLDSHLY--GCHQEPLEWSARQKIAVGAAR----GLRYLHEECR 525
E+ R LV+E + GS+ SH++ E A + L +LH +
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNE--------LEASVVVQDVASALDFLHNK-- 130
Query: 526 VGCIVHRDMRPNNILLTHDFE--PL-VGDFGLAR 556
I HRD++P NIL H + P+ + DF L
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 48/236 (20%), Positives = 74/236 (31%), Gaps = 75/236 (31%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVV 465
F + GGFG V D A+K+ +L + + E EV+ L+ +H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 466 MLIGFCIEDRRRLLVYE-----------------------------------------YI 484
+E E +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 485 CNGSLDSHLY----GCHQEPL-EWSARQK------------IAVGAARGLRYLHEECRVG 527
S +LY C +E L +W R+ I + A + +LH +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---- 183
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR-----------WQPDGDMGVETRVIGT 572
++HRD++P+NI T D VGDFGL P T +GT
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 7/144 (4%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLIGFC 471
L G G V + P G +A K L ++ E++VL +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
D + E++ GSLD L + P + K+++ +GL YL E+ + I+H
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKGLTYLREKHK---IMH 155
Query: 532 RDMRPNNILLTHDFEPLVGDFGLA 555
RD++P+NIL+ E + DFG++
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVS 179
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 41/167 (24%), Positives = 64/167 (38%), Gaps = 18/167 (10%)
Query: 414 LAEGGFGSVHRG---VLPDGQAVAVKQHKLASS-QGDHEFCS--EVEVLSCA--QHRNVV 465
+ GG G V+ V + VA+K ++ + D F + + E + Q +VV
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKL--MSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ F D + + I L + L Q PL I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAH---A 152
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
G HRD++P NIL++ D + DFG+A D + +GT
Sbjct: 153 AG-ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 21/195 (10%), Positives = 47/195 (24%), Gaps = 44/195 (22%)
Query: 413 FLAEGGFGSVHRGV-LPDGQAVAVK----------------------------QHKLASS 443
L + + G++ V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 444 QGDHEFCSEVEVLSCAQHRNVVMLIG-FCIEDRRRLLVYEYICNGSLDSHL-----YGCH 497
+ F +++ Q + ++ + +L + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 498 QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557
+ L AR ++ + R L LH +VH +RP +I+L + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 558 QPDGDMGVETRVIGT 572
G +
Sbjct: 255 ----RDGARVVSSVS 265
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 32/168 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK--------QHKLASSQGDHEFCSEVEVLSCAQHRNV 464
L G FG V V + V VK + + E+ +LS +H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGS-----LDSHLYGCHQEPLEWSAR---QKIAVGAAR 515
+ ++ E++ LV E +G +D H EPL A +++
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPL---ASYIFRQLV----S 141
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
+ YL I+HRD++ NI++ DF + DFG A + G +
Sbjct: 142 AVGYLRL----KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 408 FSQANFLAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHE---FCS----EVEVL-- 456
+ + EG +G V + + G+ VA+K+ ++ EV VL
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRH 67
Query: 457 -SCAQHRNVVMLIGFCIEDRRRL-----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA 510
+H NVV L C R LV+E+ + L ++L + + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
RGL +LH +VHRD++P NIL+T + + DFGLAR
Sbjct: 127 FQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 49/173 (28%), Positives = 70/173 (40%), Gaps = 30/173 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G FG V + Q AVK +K ++ D EVE+L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 471 CIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
ED +V E G L E A +I G+ Y+H+
Sbjct: 90 L-EDSSSFYIVGELYTGGELFDEIIKRKRFS-------EHDAA-RIIKQVFSGITYMHKH 140
Query: 524 CRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLAR-WQPDGDMGVETRVIGT 572
IVHRD++P NILL + + + DFGL+ +Q + M IGT
Sbjct: 141 ----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 33/145 (22%), Positives = 64/145 (44%), Gaps = 8/145 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVL-SCAQHRNVVMLIGF 470
+ G G V + G +AVKQ + + ++ +++ +++V+ +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
I + + E + L Q P+ K+ V + L YL E+ ++
Sbjct: 93 FITNTDVFIAMEL-MGTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VI 147
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLA 555
HRD++P+NILL + + DFG++
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS 172
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 43/182 (23%), Positives = 66/182 (36%), Gaps = 43/182 (23%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGD---HEFCSEVEVLSCAQHRNVVM 466
L G F V + G A K + +S+ E EV +L H NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E+R + L+ E + G L L ++ A +
Sbjct: 80 LHDV-YENRTDVVLILELVSGGELFDFLAQKESL------------SEEEATSFIKQILD 126
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH + I H D++P NI+L P+ + DFGLA + + +
Sbjct: 127 GVNYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179
Query: 571 GT 572
GT
Sbjct: 180 GT 181
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 20/149 (13%), Positives = 39/149 (26%), Gaps = 16/149 (10%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQ--HKLASSQGDHE-FCSEVEVLSCAQHRNVVML 467
+ + D + VA+ + + S LS V +
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 468 IGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ L+V E+I GSL + A H R G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ P+ + ++ D + ++
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 41/163 (25%), Positives = 64/163 (39%), Gaps = 28/163 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG V G G VAVK + K+ S + E++ L +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
I +V EY+ G L ++ ++ AR + Y
Sbjct: 79 -VISTPTDFFMVMEYVSGGELFDYI----------CKHGRVEEMEARRLFQQILSAVDYC 127
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
H +VHRD++P N+LL + DFGL+ DG+
Sbjct: 128 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 20/162 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLI 468
L EG +G V + AVK + KL E+++L +H+NV+ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 469 G-FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSAR----QKIAVGAARGLRYLHE 522
E+++++ +V EY G + + A Q I GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----GLEYLHS 127
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564
+ IVH+D++P N+LLT + G+A
Sbjct: 128 QG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 33/171 (19%), Positives = 62/171 (36%), Gaps = 37/171 (21%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGD-----HEFCSEVEVLSCAQHRNV 464
L G G V + VA++ K A +E+E+L H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEW-SARQKIAVGAAR-------- 515
+ + F + +V E + G L + +++ +
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGEL-----------FDKVVGNKRLKEATCKLYFYQMLL 250
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL---VGDFGLARWQPDGDM 563
++YLHE I+HRD++P N+LL+ E + DFG ++ + +
Sbjct: 251 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 45/179 (25%), Positives = 71/179 (39%), Gaps = 34/179 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQG-DHE-FCSEVEVLSCAQHRNVVML 467
+ +G F V R + GQ AVK K SS G E E + +H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 468 IGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR----G 516
+ L +V+E++ L + + E +A R
Sbjct: 92 LETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------AVASHYMRQILEA 142
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGT 572
LRY H+ I+HRD++P+ +LL P+ +G FG+A + + RV GT
Sbjct: 143 LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 39/182 (21%), Positives = 64/182 (35%), Gaps = 43/182 (23%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK-----QHKLASSQGDHE-FCSEVEVLSCAQHRNVVM 466
L G F V + G+ A K + + E EV +L +H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E++ + L+ E + G L L + A +
Sbjct: 73 LHDIF-ENKTDVVLILELVSGGELFDFLAEKESLT------------EDEATQFLKQILD 119
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH + I H D++P NI+L P + DFG+A + + +
Sbjct: 120 GVHYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIF 172
Query: 571 GT 572
GT
Sbjct: 173 GT 174
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 44/168 (26%), Positives = 71/168 (42%), Gaps = 33/168 (19%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCS----EVEVLSCA 459
+ + + +G FG V + GQ VA+K+ + ++E F E+++L
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-----ENEKEGFPITALREIKILQLL 73
Query: 460 QHRNVVMLIGFCIEDRRRL--------LVYEYICNGSLDSHLYG---CHQEPLEWSARQK 508
+H NVV LI C LV+++ + L G S ++
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIKR 128
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ GL Y+H I+HRDM+ N+L+T D + DFGLAR
Sbjct: 129 VMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 43/182 (23%), Positives = 64/182 (35%), Gaps = 43/182 (23%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFC-----SEVEVLSCAQHRNVVM 466
L G F V + G A K K S C EV +L H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E+R + L+ E + G L L ++ A +
Sbjct: 80 LHDV-YENRTDVVLILELVSGGELFDFLAQKESLS------------EEEATSFIKQILD 126
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH + I H D++P NI+L P+ + DFGLA + + +
Sbjct: 127 GVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179
Query: 571 GT 572
GT
Sbjct: 180 GT 181
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 39/208 (18%), Positives = 63/208 (30%), Gaps = 52/208 (25%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHK----LASSQGDHE-FCSEVEVLSCAQHRNVVML 467
+ +G +G V + A+K + D E +EV ++ H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 468 IGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVG-------- 512
ED + + LV E G L +
Sbjct: 94 YE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 513 -----------------AAR-------GLRYLHEECRVGCIVHRDMRPNNILLTHD--FE 546
+ L YLH + G I HRD++P N L + + FE
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G-ICHRDIKPENFLFSTNKSFE 208
Query: 547 PLVGDFGLARWQPDGDMGVETRVIGTFG 574
+ DFGL++ + G + G
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 42/175 (24%), Positives = 58/175 (33%), Gaps = 31/175 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L G FG VH G +K SQ E +E+EVL H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 472 IEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYL 520
ED + +V E G L E + L Y
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSE--------GYVAELMKQMMNALAYF 140
Query: 521 HEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
H + +VH+D++P NIL + DFGLA + T GT
Sbjct: 141 HSQ---H-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGT 189
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 40/154 (25%), Positives = 59/154 (38%), Gaps = 24/154 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR G A K E++ +S +H +V L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 473 EDRRRL-LVYEYICNGSL-D--SHLYGCHQEPLEWSARQKIAVGAAR----GLRYLHEEC 524
ED + ++YE++ G L + + + E AV R GL ++HE
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSE--------DEAVEYMRQVCKGLCHMHEN- 274
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLV--GDFGLAR 556
VH D++P NI+ T + DFGL
Sbjct: 275 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 36/171 (21%), Positives = 64/171 (37%), Gaps = 37/171 (21%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHE-----FCSEVEVLSCAQHRNV 464
L G G V + VA+K K A +E+E+L H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSL------DSHLYGCHQEPLEWSAR---QKIAVGAAR 515
+ + F + +V E + G L + L E + + ++
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLK-------EATCKLYFYQML----L 125
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL---VGDFGLARWQPDGDM 563
++YLHE I+HRD++P N+LL+ E + DFG ++ + +
Sbjct: 126 AVQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 29/163 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ +G F V + G+ VA+K + +L + F EV ++ H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
IE + L L+ EY G + +L A ++ AR ++Y
Sbjct: 82 -VIETEKTLYLIMEYASGGEVFDYL----------VAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
H++ IVHRD++ N+LL D + DFG + G
Sbjct: 131 HQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/168 (27%), Positives = 66/168 (39%), Gaps = 20/168 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G FG V + Q AVK +K ++ D EVE+L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 471 CIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
ED +V E G L + E +I G+ Y+H+
Sbjct: 90 L-EDSSSFYIVGELYTGGELFDEIIKRKRFSE----HDAARIIKQVFSGITYMHKH---- 140
Query: 528 CIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGT 572
IVHRD++P NILL D + + DFGL+ IGT
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGT 186
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 46/171 (26%), Positives = 73/171 (42%), Gaps = 29/171 (16%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVL-SCAQHRNVVMLI 468
L EG F + V QA AVK A++Q E+ L C H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKLH 72
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQ--KIAVGAARGLRYLHEEC 524
D+ LV E + G L + ++ E A + V A + ++H+
Sbjct: 73 EVF-HDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSA---VSHMHDVG 126
Query: 525 RVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGT 572
+VHRD++P N+L T + + + + DFG AR +P + ++T T
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FT 172
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 43/182 (23%), Positives = 63/182 (34%), Gaps = 43/182 (23%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK-----QHKLASSQGDHE-FCSEVEVLSCAQHRNVVM 466
L G F V + G A K + K + E EV +L QH NV+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 467 LIGFCIEDRRRL-LVYEYICNGSL------DSHLYGCHQEPLEWSARQKIAVGAAR---- 515
L E++ + L+ E + G L L ++ A +
Sbjct: 79 LHEV-YENKTDVILILELVAGGELFDFLAEKESLT------------EEEATEFLKQILN 125
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR-WQPDGDMGVETRVI 570
G+ YLH I H D++P NI+L P + DFGLA + +
Sbjct: 126 GVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 571 GT 572
GT
Sbjct: 179 GT 180
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 40/176 (22%), Positives = 66/176 (37%), Gaps = 31/176 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQH-KLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G F V R V + GQ A S DH+ E + +H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 471 CIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQ--KIAVGAARGLRYLH 521
I + L+++ + G L + + E A + + A + + H
Sbjct: 79 -ISEEGHHYLIFDLVTGGELFEDIVAREYYS-------EADASHCIQQILEA---VLHCH 127
Query: 522 EECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFG 574
+ +VHR+++P N+LL + + + DFGLA GT G
Sbjct: 128 QMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 33/163 (20%), Positives = 66/163 (40%), Gaps = 31/163 (19%)
Query: 414 LAEGGFGSVHRGV---LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G +G V++ D + A+K ++ + C E+ +L +H NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 86
Query: 471 CIE--DRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAA----------RGL 517
+ DR+ L+++Y + L+ + ++ + + G+
Sbjct: 87 FLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 518 RYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLAR 556
YLH ++HRD++P NIL+ + + D G AR
Sbjct: 142 HYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 40/179 (22%), Positives = 63/179 (35%), Gaps = 31/179 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCS----------EVEVLSCA 459
L G +G V A+K + + + + E+ +L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 460 QHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARG 516
H N++ L ED++ LV E+ G L + E I G
Sbjct: 104 DHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDE----CDAANIMKQILSG 158
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+ YLH+ IVHRD++P NILL + + DFGL+ + +GT
Sbjct: 159 ICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGT 211
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 37/166 (22%), Positives = 61/166 (36%), Gaps = 29/166 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCS---EVEVL----SCAQHR 462
L +GGFG+V G L D VA+K +++ + + EV +L + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 463 NVVMLIGFCIEDRRRL-LVYEYICNGS-----LDSHLYGCHQEPLEWSARQKIAVGAARG 516
V+ L+ + E + LV E + G E +R
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGP---SR-CFFGQVVAA 151
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDG 561
+++ H +VHRD++ NIL+ + DFG D
Sbjct: 152 IQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 23/153 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFC-SEVEVLSCAQHRNVVMLIGFC 471
L G FG VHR V + K + D E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF--VKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 472 IEDRRRL-LVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYLHEECR 525
E L +++E+I + + + E + R+ V L++LH
Sbjct: 71 -ESMEELVMIFEFISGLDIFER----INTSAFELNERE--IVSYVHQVCEALQFLHSH-- 121
Query: 526 VGCIVHRDMRPNNILLTHDFEPLV--GDFGLAR 556
I H D+RP NI+ + +FG AR
Sbjct: 122 -N-IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 42/174 (24%), Positives = 65/174 (37%), Gaps = 32/174 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G F V R V G A K + S D + E + QH N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 471 CIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQ--KIAVGAARGLRYLH 521
I++ LV++ + G L + E A + + + + Y H
Sbjct: 97 -IQEESFHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQILES---IAYCH 145
Query: 522 EECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGT 572
IVHR+++P N+LL + + + DFGLA D + GT
Sbjct: 146 SNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGT 193
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQGDHEFCS--EVEVLSCAQ--HRNVVM 466
L GG VH D + VAVK + A D F E + A H +V
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 467 L--IGFCIEDRRRL--LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
+ G L +V EY+ +L ++ + P+ ++ A + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH- 133
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ G I+HRD++P NI+++ V DFG+AR
Sbjct: 134 --QNG-IIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 35/177 (19%)
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCS-------------EVEVLSCAQHR 462
G +G+V GV +G VA+K ++ ++ D + E+ +L+ H
Sbjct: 32 SGSYGAVCAGVDSEGIPVAIK--RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 463 NVVMLIGFCIEDRRRL-----LVYEYICNGSLDSHLY---GCHQEPLEWSARQKIAVGAA 514
N++ L + LV E + + L + + Q
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMG--VETR 568
GL LHE +VHRD+ P NILL + + + DF LAR D + V R
Sbjct: 145 LGLHVLHE----AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 28/163 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG V G G VAVK + K+ S + E++ L +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
I + +V EY+ G L ++ ++ +R G+ Y
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYI----------CKNGRLDEKESRRLFQQILSGVDYC 132
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
H +VHRD++P N+LL + DFGL+ DG+
Sbjct: 133 HRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 40/159 (25%), Positives = 61/159 (38%), Gaps = 29/159 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHR-NVVMLIG 469
L G F V + + GQ A K K Q E+ VL A+ V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 470 FCIEDRRRL-LVYEYICNGSL----DSHLYGCHQEPLEWSARQKIAVGAAR----GLRYL 520
E+ + L+ EY G + L E + + G+ YL
Sbjct: 97 V-YENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYL 147
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLAR 556
H+ IVH D++P NILL+ + + + DFG++R
Sbjct: 148 HQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 39/186 (20%), Positives = 64/186 (34%), Gaps = 35/186 (18%)
Query: 407 GFSQANF---------LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL 456
G ++ + + G +G V V A K+ + F E+E++
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 457 SCAQHRNVVMLIGFCIEDRRRL-LVYEYICNGSL-DSHL-YGCHQEPLEWSARQKIAVGA 513
H N++ L ED + LV E G L + + +E A
Sbjct: 61 KSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVFRE--------SDAARI 111
Query: 514 AR----GLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVE 566
+ + Y H+ + HRD++P N L D + DFGLA G +
Sbjct: 112 MKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MM 165
Query: 567 TRVIGT 572
+GT
Sbjct: 166 RTKVGT 171
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 40/163 (24%), Positives = 63/163 (38%), Gaps = 29/163 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG FG V Q VA+K + L S E+ L +H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRYL 520
I + +V EY G L ++ ++++ R + Y
Sbjct: 77 V-ITTPTDIVMVIEY-AGGELFDYI----------VEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
H IVHRD++P N+LL + + DFGL+ DG+
Sbjct: 125 HRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 42/165 (25%), Positives = 63/165 (38%), Gaps = 32/165 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGF 470
L +G F V R V G A K + S D + E + QH N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 471 CIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSAR---QKIAVGAARGLRYL 520
I++ LV++ + G L + E A Q+I + Y
Sbjct: 74 -IQEESFHYLVFDLVTGGELFEDIVAREFYS-------EADASHCIQQIL----ESIAYC 121
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGD 562
H IVHR+++P N+LL + + + DFGLA D +
Sbjct: 122 HSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 44/163 (26%), Positives = 66/163 (40%), Gaps = 20/163 (12%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L EG F +V + A+K +H + ++ + E +V+S H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT-RERDVMSRLDHPFFVKLY 96
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHL--YGCHQEPLEWSARQKIA-VGAARGLRYLHEEC 524
F +D +L Y NG L ++ G E R A + +A L YLH +
Sbjct: 97 -FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYLHGKG 150
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVET 567
I+HRD++P NILL D + DFG A+
Sbjct: 151 ----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 15/166 (9%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ G G V + VA+K KL+ + E+ ++ C H+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 467 LIG-FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L+ F + Y+ +D++L Q L+ + G+++LH
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--- 182
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG---VETR 568
I+HRD++P+NI++ D + DFGLAR M V TR
Sbjct: 183 -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 25/170 (14%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ G +GSV + G+ VA+K KL+ F E+ +L QH NV+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHENVIG 87
Query: 467 LIGFCIEDRRRL------LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
L+ LV + + + L Q + +GL+Y+
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETR 568
H +VHRD++P N+ + D E + DFGLAR D +M V TR
Sbjct: 143 HS----AGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTR 187
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 42/168 (25%), Positives = 60/168 (35%), Gaps = 31/168 (18%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---------QHKLASSQGDHEFCSEVEVL-SCAQHR 462
L G V R + P + AVK + EV++L + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 463 NVVMLIGFCIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQKIAVGAAR 515
N++ L E LV++ + G L D L E R KI
Sbjct: 85 NIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLS-------EKETR-KIMRALLE 135
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
+ LH+ IVHRD++P NILL D + DFG + G+
Sbjct: 136 VICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 21/167 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFC 471
+ G + R + AVK + S+ D E+E+L QH N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKI--IDKSKRDPT--EEIEILLRYGQHPNIITLKDVY 85
Query: 472 IEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLRYLHEECRVGCI 529
+D + + +V E + G L + Q+ E A + + + YLH + +
Sbjct: 86 -DDGKYVYVVTELMKGGELLDKI--LRQKFFSEREAS-AVLFTITKTVEYLHAQG----V 137
Query: 530 VHRDMRPNNILLTH---DFEPL-VGDFGLARWQPDGDMGVETRVIGT 572
VHRD++P+NIL + E + + DFG A+ + + T T
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 42/167 (25%), Positives = 60/167 (35%), Gaps = 30/167 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHE-----FCSEVEVL-SCAQHRN 463
+ G V R V G AVK S E E +L A H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 464 VVMLIGFCIEDRRRL-LVYEYICNGSL-D-----SHLYGCHQEPLEWSARQKIAVGAARG 516
++ LI E + LV++ + G L D L E R I
Sbjct: 162 IITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALS-------EKETR-SIMRSLLEA 212
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
+ +LH IVHRD++P NILL + + + DFG + G+
Sbjct: 213 VSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK 255
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 49/218 (22%), Positives = 77/218 (35%), Gaps = 28/218 (12%)
Query: 368 SRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGV- 426
+ N + P W + + + F + L G V+R
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 427 LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL-LVYEYIC 485
+ A+K L + +E+ VL H N++ L E + LV E +
Sbjct: 75 KGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVT 131
Query: 486 NGSLDSHL--YGCHQEPLEWSARQKIAVGAAR----GLRYLHEECRVGCIVHRDMRPNNI 539
G L + G + E + A A + + YLHE IVHRD++P N+
Sbjct: 132 GGELFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG----IVHRDLKPENL 179
Query: 540 LLTHDFE--PL-VGDFGLARWQPDGDMGVETRVIGTFG 574
L PL + DFGL++ + V GT G
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPG 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 19/151 (12%)
Query: 416 EGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIE 473
G FG V++ L G+ VA+K+ D F + E++++ H N+V L F
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYS 118
Query: 474 DRRRL------LVYEYI-CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ LV +Y+ + Y ++ L + R L Y+H
Sbjct: 119 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---- 174
Query: 527 GCIVHRDMRPNNILLTHDFEPL-VGDFGLAR 556
I HRD++P N+LL D L + DFG A+
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 34/162 (20%), Positives = 60/162 (37%), Gaps = 24/162 (14%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGF 470
L G G V GQ A+K + ++ EV+ + ++V ++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR------QEVDHHWQASGGPHIVCILDV 90
Query: 471 CIEDRRR-----LLVYEYICNGSL-DSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
E+ L++ E + G L Q E A + + +++LH
Sbjct: 91 Y-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD-IGTAIQFLHSHN 148
Query: 525 RVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLARWQPDGDM 563
I HRD++P N+L T + L + DFG A+ +
Sbjct: 149 ----IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 19/169 (11%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQ-HKLASSQGDHEFCSEVE--VLSCAQHRNVVM 466
L GGFG V + G+ A K+ +K + + VE +L+ R +V
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 467 LIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGA--ARGLRYLHEE 523
L + E + L LV + G + H+Y ++ + + I A GL +LH+
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
I++RD++P N+LL D + D GLA G + GT
Sbjct: 309 N----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GT 352
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 15/170 (8%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHR 462
+ + G G V + VA+K KL+ + E+ ++ C H+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 463 NVVMLIG-FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
N++ L+ F + YI +D++L Q L+ + G+++LH
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG---VETR 568
I+HRD++P+NI++ D + DFGLAR M V TR
Sbjct: 145 S----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 49/231 (21%), Positives = 76/231 (32%), Gaps = 45/231 (19%)
Query: 348 MSSYRTDLEFSGNVREAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGG 407
M S S + S + + K P+ + Y L
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQ------YQVGPL---- 50
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCS---EVEVLSCAQ 460
L GGFGSV+ G+ + D VA+K +++ EV +L
Sbjct: 51 ------LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 461 HR--NVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLY------GCHQEPLEWSARQKIAV 511
V+ L+ + E L+ E D L+ G QE L AR
Sbjct: 105 SGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEEL---AR-SFFW 156
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDG 561
+R+ H ++HRD++ NIL+ + L + DFG D
Sbjct: 157 QVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 49/169 (28%), Positives = 71/169 (42%), Gaps = 26/169 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLI 468
+ G +G+V V G VA+K KL F E+ +L +H NV+ L+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 469 GFCIEDRRRL------LVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLH 521
D LV + + + L E L Q + +GLRY+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETR 568
I+HRD++P N+ + D E + DFGLAR Q D +M V TR
Sbjct: 146 A----AGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVVTR 189
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 44/159 (27%), Positives = 63/159 (39%), Gaps = 24/159 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG +G V V +AVAVK + + + E+ + H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSAR----QKIAVGAARGLRYLHEE 523
+ L EY G L + + E A+ Q +A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA-----GVVYLH-- 122
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+G I HRD++P N+LL + DFGLA +
Sbjct: 123 -GIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 40/192 (20%), Positives = 70/192 (36%), Gaps = 54/192 (28%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCS------------------ 451
+ +G +G V D A+K + KL G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 452 -----EVEVLSCAQHRNVVMLIGFCIED--RRRL-LVYEYICNGSLDSHLYGCHQEPLEW 503
E+ +L H NVV L+ ++D L +V+E + G + +E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV-----------MEV 128
Query: 504 SARQKIAVGAAR--------GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+ ++ AR G+ YLH + I+HRD++P+N+L+ D + DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 556 RWQPDGDMGVET 567
D +
Sbjct: 185 NEFKGSDALLSN 196
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 47/168 (27%), Positives = 65/168 (38%), Gaps = 25/168 (14%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G F V + GQ A+K L + F E +VL R + L
Sbjct: 72 GAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLH 127
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECR 525
F +D L LV EY G L + L + AR +A V A + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA---IDSVHRLG- 182
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGT 572
VHRD++P+NILL + DFG + + DG + V GT
Sbjct: 183 ---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GT 226
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 44/159 (27%), Positives = 63/159 (39%), Gaps = 24/159 (15%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG +G V V +AVAVK + + + E+ + H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSAR----QKIAVGAARGLRYLHEE 523
+ L EY G L + + E A+ Q +A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMA-----GVVYLH-- 122
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
+G I HRD++P N+LL + DFGLA +
Sbjct: 123 -GIG-ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 36/159 (22%)
Query: 416 EGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCS-EVEVLSCAQHRNVVMLIGFCIED 474
G FG V + L + VA+K+ D F + E++++ +H NVV L F +
Sbjct: 50 NGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSN 104
Query: 475 RRRL------LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA----------RGLR 518
+ LV EY + +Y A+ K + R L
Sbjct: 105 GDKKDEVFLNLVLEY-----VPETVY----RASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLAR 556
Y+H +G I HRD++P N+LL L + DFG A+
Sbjct: 156 YIH---SIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 7e-10
Identities = 38/238 (15%), Positives = 65/238 (27%), Gaps = 63/238 (26%)
Query: 380 SICQHKAPVFGKPPRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVK--- 436
C K PV FS+ L T + + EG FG V + + D VA+K
Sbjct: 3 GECSQKGPV------PFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIA 52
Query: 437 -----QHKLASSQGDHEFCSEVEVL---------SCAQHRNVVMLIGFCI---------- 472
+ + E E+ + C + + L
Sbjct: 53 IEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL 112
Query: 473 --------------------EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVG 512
+D + +V E+ G +D L + + + I
Sbjct: 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEF-EFGGID--LEQMRTKLSSLATAKSILHQ 169
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVI 570
L R HRD+ N+LL + + G++ +I
Sbjct: 170 LTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 38/178 (21%), Positives = 62/178 (34%), Gaps = 40/178 (22%)
Query: 416 EGGFGSVHRGVL-PDGQAVAVK---QHKLASSQGDHEFC----SEVEVLSCAQHRNVVML 467
+G FG+V G G +VA+K Q F ++ L+ H N+V L
Sbjct: 33 QGTFGTVQLGKEKSTGMSVAIKKVIQDP--------RFRNRELQIMQDLAVLHHPNIVQL 84
Query: 468 IGFCIEDRRR-------LLVYEYICNGSLDSH----LYGCHQEPLEWSARQKIAVGAARG 516
+ R +V EY+ H Y Q + R
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYV---PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141
Query: 517 LRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQPDGDMGVE---TR 568
+ LH + HRD++P+N+L+ + + DFG A+ + V +R
Sbjct: 142 IGCLHLPSV--NVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKLSPSEPNVAYICSR 195
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 26/171 (15%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+ + G +GSV G VAVK KL+ E+ +L +H NV+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 467 LIGFCIEDRRRL------LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRY 519
L+ R LV + + L + L Q + RGL+Y
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG--VETR 568
+H I+HRD++P+N+ + D E + DFGLAR +M V TR
Sbjct: 148 IHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATR 193
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 46/211 (21%), Positives = 77/211 (36%), Gaps = 33/211 (15%)
Query: 371 APPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGGFSQ-----ANFLAEGGFGSVHRG 425
PP P Q P + P++ + L++ + L G G V +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 426 V-LPDGQAVAVKQHKLASSQGDHEFCS-EVEVL-SCAQHRNVVMLIGFCIEDRRR----- 477
+ A+K + D EVE+ +Q ++V ++ E+
Sbjct: 82 FNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVY-ENLYAGRKCL 134
Query: 478 LLVYEYICNGSLDSHLYGCHQEPL-EWSARQ--KIAVGAARGLRYLHEECRVGCIVHRDM 534
L+V E + G L S + + E A + K A ++YLH I HRD+
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHSIN----IAHRDV 187
Query: 535 RPNNILLTHDFE--PL-VGDFGLARWQPDGD 562
+P N+L T L + DFG A+ +
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 36/162 (22%), Positives = 54/162 (33%), Gaps = 28/162 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
+ G FG + VAVK + E+ +H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83
Query: 470 FCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSAR----QKIAVGAARGLRYLHEE 523
I L ++ EY G L + C+ E AR Q ++ G+ Y H
Sbjct: 84 -VILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLS-----GVSYCHSM 135
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPL--VGDFGLARWQPDGDM 563
I HRD++ N LL P + DFG ++
Sbjct: 136 Q----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 35/156 (22%), Positives = 70/156 (44%), Gaps = 23/156 (14%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVM 466
+++ EG +G V + VA+K K++ + +C E+++L +H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFE-HQTYCQRTLREIKILLRFRHENIIG 89
Query: 467 LIG-FCIEDRRRL----LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYL 520
+ ++ +V + +++ LY + L RGL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H ++HRD++P+N+LL + + DFGLAR
Sbjct: 145 HS----ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 56/174 (32%), Positives = 73/174 (41%), Gaps = 20/174 (11%)
Query: 408 FSQANFLAEGGFGSV----HRGVLPDGQAVAVKQ-HKLASSQGDHEFCSEVE--VLSCAQ 460
F Q L +GGFG V R G+ A K+ K + E + E +L
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 461 HRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPL-EWSARQKIAVGAARGLR 518
R VV L + E + L LV + G L H+Y Q E A A GL
Sbjct: 243 SRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLE 300
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
LH E IV+RD++P NILL + D GLA P+G ++ RV GT
Sbjct: 301 DLHRER----IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GT 348
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 44/168 (26%), Positives = 69/168 (41%), Gaps = 19/168 (11%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAV----KQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V L + + A+ K L ++ F E +VL + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWITTLH 140
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA--VGAARGLRYLHEECR 525
+ +D L LV +Y G L + L E AR +A V A + +H+
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA---IDSVHQLH- 195
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGT 572
VHRD++P+NIL+ + + DFG + DG + V GT
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GT 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 38/156 (24%), Positives = 60/156 (38%), Gaps = 29/156 (18%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
G +G V + + VA+K K+ D C E+ +L+ H +VV ++
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 471 CIEDRRRL-----LVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYL 520
I +V E DS + L + + G++Y+
Sbjct: 121 VIPKDVEKFDELYVVLEI-----ADSDF---KKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
H I+HRD++P N L+ D V DFGLAR
Sbjct: 173 HS----AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 35/156 (22%), Positives = 55/156 (35%), Gaps = 28/156 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ-HKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGF 470
L G G V + + A+K ++ EVE+ +Q ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVRIVDV 79
Query: 471 CIEDRRRLLVYEYI----CNGS--LDSHLYGCHQEPLEWSARQ--KIAVGAARGLRYLHE 522
E+ I +G Q E A + K A ++YLH
Sbjct: 80 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHS 135
Query: 523 ECRVGCIVHRDMRPNNILLTHDFE--PL-VGDFGLA 555
I HRD++P N+L T L + DFG A
Sbjct: 136 I---N-IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 41/174 (23%), Positives = 67/174 (38%), Gaps = 39/174 (22%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G FG V H+ + A+K + S F E ++++ A VV L
Sbjct: 80 GAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQLF 135
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLRY 519
+ +D R L +V EY+ G L + + + AR L
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALDA 183
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA-RWQPDGDMGVETRVIGT 572
+H +HRD++P+N+LL + DFG + +G + +T V GT
Sbjct: 184 IHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 42/149 (28%), Positives = 61/149 (40%), Gaps = 16/149 (10%)
Query: 414 LAEGGFGSVHRGVL-PDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
L G FG V G A+K Q + Q +H +E +L +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVNFPFLVKLE 107
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA-VGAARGLRYLHEECRV 526
F +D L +V EY+ G + SHL + E AR A + YLH
Sbjct: 108 -FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLT--FEYLHSLD-- 161
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+++RD++P N+L+ V DFG A
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 40/156 (25%), Positives = 59/156 (37%), Gaps = 29/156 (18%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
G +G V+ + VA+K K+ D C E+ +L+ + ++ L
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 471 CIEDRRRL-----LVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYL 520
I D +V E DS L + L + I G ++
Sbjct: 94 IIPDDLLKFDELYIVLEI-----ADSDL---KKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
HE I+HRD++P N LL D V DFGLAR
Sbjct: 146 HE----SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 36/159 (22%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L G FG VH L +G+ A+K + + Q +H E +LS H ++
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN-DERLMLSIVTHPFII 69
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLY--GCHQEPLEWSARQKIA-VGAARGLRYLH 521
+ +D +++ ++ +YI G L S L P+ A+ A V A L YLH
Sbjct: 70 RMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAEVCLA--LEYLH 123
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVG-----DFGLA 555
+ I++RD++P NILL + G DFG A
Sbjct: 124 SKD----IIYRDLKPENILLDKN-----GHIKITDFGFA 153
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 34/162 (20%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSCAQHRNVVMLIGF 470
GG G V V + VA+K K+ + D + E++++ H N+V +
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIK--KIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 471 CIEDRRRL--------------LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAAR 515
+L +V EY +++ L Q PL + R
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILL-THDFEPLVGDFGLAR 556
GL+Y+H ++HRD++P N+ + T D +GDFGLAR
Sbjct: 132 GLKYIHS----ANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 20/150 (13%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCS----EVEVLSC-AQHRNVVMLIG 469
+G +G V + + G+ VAVK K+ + + E+ +L+ + H N+V L+
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 470 -FCIEDRRRL-LVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRV 526
++ R + LV++Y +++ L+ LE +Q + + ++YLH
Sbjct: 77 VLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS---- 127
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G ++HRDM+P+NILL + V DFGL+R
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSR 157
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 22/156 (14%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVVMLI 468
G FG V + A+K Q + ++ + F E++++ +H +V L
Sbjct: 26 GSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVF-KELQIMQGLEHPFLVNLW 81
Query: 469 GFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIA-VGAARGLRYLHEECRV 526
+ +D + +V + + G L HL E + + I + A L YL +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETVKLFICELVMA--LDYLQNQR-- 135
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
I+HRDM+P+NILL + DF +A P
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 4/42 (9%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
R ++ LH ++HRD++P+N+L+ + + V DFGLAR
Sbjct: 123 RAVKVLHG----SNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 35/163 (21%), Positives = 67/163 (41%), Gaps = 24/163 (14%)
Query: 416 EGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFCI- 472
G + V + + + + V VK K + + E+++L + N++ L I
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLA--DIV 100
Query: 473 ---EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
R LV+E++ N + L + + L Y H I
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS----MGI 151
Query: 530 VHRDMRPNNILLTHDFEPL-VGDFGLAR-WQPDGDMGVE--TR 568
+HRD++P+N+++ H+ L + D+GLA + P + V +R
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 43/173 (24%), Positives = 63/173 (36%), Gaps = 18/173 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQ-HKLASSQGDHEFCSEVE--VL---SCAQ 460
FS + GGFG V+ D G+ A+K K E + E +L S
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 461 HRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
+V + + +L + + + G L HL E R A GL +
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAA-EIILGLEH 307
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+H +V+RD++P NILL + D GLA V GT
Sbjct: 308 MHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASV-GT 353
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 50/209 (23%), Positives = 74/209 (35%), Gaps = 26/209 (12%)
Query: 363 EAISLSRNAPPGPPPLCSICQHKAPVFGKPPRWFSYAELELATGG--FSQANF-----LA 415
E + + G + E+ LA + F L
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLG 157
Query: 416 EGGFGSV----HRGVLPDGQAVAVKQHK----LASSQGDHEFCSEVEVLSCAQHRNVVML 467
+G FG V + G+ A+K K +A + H E VL ++H + L
Sbjct: 158 KGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTAL 213
Query: 468 IGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ + RL V EY G L HL E AR A + L YLH E
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS-EDRARFYGAEIVS-ALDYLHSEKN- 269
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+V+RD++ N++L D + DFGL
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 27/89 (30%), Positives = 41/89 (46%), Gaps = 9/89 (10%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDH-EFCSEVEVLSCA-QHRNVV 465
L G FG V + VAVK K ++ +H SE+++L H NVV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 466 MLIGFCIEDRRRLLV-YEYICNGSLDSHL 493
L+G C + L+V E+ G+L ++L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 22/109 (20%), Positives = 41/109 (37%), Gaps = 4/109 (3%)
Query: 448 EFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQ 507
+ V + R + + + + + + + +++ L
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 508 KIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
+ A+G+ +L R CI HRD+ NILL+ + DFGLAR
Sbjct: 197 CYSFQVAKGMEFL--ASR-KCI-HRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 32/159 (20%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVE--VLSCAQHRNVV 465
L +GG+G V G+ A+K K A ++ E +L +H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------G 516
LI + + +L L+ EY+ G L L + A
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT----------ACFYLAEISMA 133
Query: 517 LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
L +LH++ I++RD++P NI+L H + DFGL
Sbjct: 134 LGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 37/157 (23%), Positives = 60/157 (38%), Gaps = 30/157 (19%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS-SQGDHEFC-SEVEVLSCAQHRNVVML 467
L +G FG V Q A+K K A+ D E ++L H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 468 IGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR--------GLR 518
+ + +L L+ +++ G L + L E + L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----------VKFYLAELALALD 140
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+LH I++RD++P NILL + + DFGL+
Sbjct: 141 HLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 32/169 (18%), Positives = 65/169 (38%), Gaps = 33/169 (19%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVK---QHKLASSQGDHEFCSEVEVLSC----------- 458
L G F +V + + VA+K K+ + + E +++L
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKEDS 82
Query: 459 AQHRNVVMLIG-FCIEDRRRL---LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
+++ L+ F + + +V+E + +L + + + ++I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL------VGDFGLARW 557
GL Y+H C I+H D++P N+L+ P + D G A W
Sbjct: 142 LGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 62/458 (13%), Positives = 113/458 (24%), Gaps = 148/458 (32%)
Query: 33 IPRTALVWALTHVV---QPGDCITL----------LVV-------VPSHSSGRRFWVFPR 72
+ R L + +P + + + + V + FW+
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL--N 188
Query: 73 FAGDCASGH-------------------RKSFSGTISEQRGDITDSCSQMILQ------- 106
+C S R S I + I +++
Sbjct: 189 L-KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 107 --LHDVYDPNKIN-FKI--KIVSGSPCGAVAAEAKKAQAGWVVLDKQ---LKHEEKCCME 158
L +V + N F + KI+ + V A + LD L +E ++
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE---VK 304
Query: 159 ELQCNIVVMK----RSQAKV---LRLNLVGASKKEAGVACPLPSDPDESFEKDPKNK--D 209
L + + + RL+++ S ++ D + D +
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG----LATWDNWKHVNCDKLTTIIE 360
Query: 210 SS-----SGSIRG--------PVVTPISSPELG----------TPFTATEAGTSSVSSSD 246
SS R P I + L + S+
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 247 PGTSPFFISGINGDLKKESSVIREDRNLEDSSSDT-------DSENLSVSSASMRFQPWM 299
P S I I +LK + + + L S D DS++L F
Sbjct: 421 PKESTISIPSIYLELKVK---LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF---- 473
Query: 300 TEFLRSHHQSSHQMEEECSRRTNNKTQASTTKALLEKFSRLDRDAGVGMSSYRTDLEFSG 359
+ HH + + E + F + + D F
Sbjct: 474 YSHI-GHHLKNIEHPER-----------------MTLFRMV----------F-LDFRFLE 504
Query: 360 NVREAISLSRNAPPGPPPLCS--------ICQHKAPVF 389
S + NA IC + P +
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDND-PKY 541
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 21/153 (13%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQH-RNVVMLIGF 470
+ G FG + G L + VA+K L + E + + F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 471 CIEDRRRLLVYEYICNG-SLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ +V E + G SL+ C + L+ IA+ + Y+H +
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLM--IAIQLISRMEYVHSKN---- 125
Query: 529 IVHRDMRPNNILL----THDFEPL-VGDFGLAR 556
+++RD++P N L+ + + + DF LA+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 40/152 (26%), Positives = 59/152 (38%), Gaps = 22/152 (14%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L +G FG V + G+ A+K + +A + H E VL +H +
Sbjct: 13 LGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLT 68
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKI-AVGAARGLRYLHEE 523
L + + RL V EY G L HL E R + L YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSALEYLHSR 124
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+V+RD++ N++L D + DFGL
Sbjct: 125 D----VVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 33/160 (20%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVE--VLSCAQHRN-V 464
L G +G V G+ A+K K A+ + + E VL + +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR-------- 515
V L + + +L L+ +YI G L +HL + +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----------VQIYVGEIVL 170
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
L +LH+ G I++RD++ NILL + ++ DFGL+
Sbjct: 171 ALEHLHKL---G-IIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 16/58 (27%), Positives = 27/58 (46%), Gaps = 8/58 (13%)
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDMGVE---TR 568
R + ++H I HRD++P N+L+ L + DFG A+ + V +R
Sbjct: 152 RAVGFIHS----LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR 205
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 27/155 (17%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIG 469
+ G FG ++ G + G+ VA+K K Q E ++ Q + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGIPTIRW 72
Query: 470 FCIEDRRRLLVYEYICNG-SLDSHLYGCHQE-PLE---WSARQKIAVGAARGLRYLHEEC 524
E ++V E + G SL+ C ++ L+ A Q I+ + Y+H +
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISR-----IEYIHSKN 125
Query: 525 RVGCIVHRDMRPNNILL---THDFEPLVGDFGLAR 556
+HRD++P+N L+ + DFGLA+
Sbjct: 126 ----FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 37/144 (25%), Positives = 59/144 (40%), Gaps = 18/144 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC--------AQHRNV 464
L G F +V + + VA+K K A + E+ +L V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 465 VMLIG-FCIE---DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
V L+ F I +V+E + L + + + L +KI +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 521 HEECRVGCIVHRDMRPNNILLTHD 544
H +CR I+H D++P NILL+ +
Sbjct: 163 HTKCR---IIHTDIKPENILLSVN 183
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 36/152 (23%), Positives = 60/152 (39%), Gaps = 21/152 (13%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNV 464
L +G FG V +G + AVK + + E VL+ + +
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMV-EKRVLALPGKPPFL 83
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
L C + RL V EY+ G L H+ + A A A GL +L +
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAA-EIAIGLFFLQSK 140
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I++RD++ +N++L + + DFG+
Sbjct: 141 G----IIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 46/155 (29%), Positives = 63/155 (40%), Gaps = 27/155 (17%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLS-CAQHRNV 464
+ +G FG V H+ + AVK + L + H E VL +H +
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMS-ERNVLLKNVKHPFL 101
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSAR---QKIAVGAARGLRYL 520
V L F + +L V +YI G L HL AR +IA L YL
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASA----LGYL 155
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
H IV+RD++P NILL ++ DFGL
Sbjct: 156 HSLN----IVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 38/149 (25%), Positives = 59/149 (39%), Gaps = 21/149 (14%)
Query: 417 GGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNVVML 467
G + V + + A+K + D E V A H +V L
Sbjct: 20 GSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQT-EKHVFEQASNHPFLVGL 75
Query: 468 IGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
C + RL V EY+ G L H+ + P E AR A + L YLHE
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLALNYLHERG-- 130
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I++RD++ +N+LL + + D+G+
Sbjct: 131 --IIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 44/157 (28%), Positives = 64/157 (40%), Gaps = 31/157 (19%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNV 464
L +G FG V + Q A+K L + E VLS A +H +
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMV-EKRVLSLAWEHPFL 80
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ + + L V EY+ G L H+ CH+ L A A GL++LH +
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR-ATFYAA-EIILGLQFLHSK 137
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVG-----DFGLA 555
IV+RD++ +NILL D G DFG+
Sbjct: 138 G----IVYRDLKLDNILLDKD-----GHIKIADFGMC 165
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 21/152 (13%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA-QHRNV 464
+ G + V + + A++ + D E V A H +
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQT-EKHVFEQASNHPFL 115
Query: 465 VMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
V L C + RL V EY+ G L H+ + P E AR A + L YLHE
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLALNYLHER 172
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I++RD++ +N+LL + + D+G+
Sbjct: 173 G----IIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 24/157 (15%)
Query: 412 NFLA---EGGFGSV----HRGVLPDGQAVAVK----QHKLASSQGDHEFCSEVEVLSCA- 459
F+ +G FG V + G AVK L + E +LS A
Sbjct: 26 EFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMT-EKRILSLAR 81
Query: 460 QHRNVVMLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLR 518
H + L C + RL V E++ G L H+ + AR A L
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAA-EIISALM 138
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
+LH++ I++RD++ +N+LL H+ + DFG+
Sbjct: 139 FLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 35/151 (23%), Positives = 59/151 (39%), Gaps = 19/151 (12%)
Query: 414 LAEGGFGSV----HRGVLPDGQAVAV----KQHKLASSQGDHEFCSEVEVLSCAQHRNVV 465
L +G FG V +G + AV K + + E VL+ +
Sbjct: 349 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMV-EKRVLALPGKPPFL 404
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
+ C + RL V EY+ G L H+ + A A A GL +L +
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAA-EIAIGLFFLQSKG 462
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555
I++RD++ +N++L + + DFG+
Sbjct: 463 ----IIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 19/152 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFC 471
+ EG FG + G L + Q VA+K S + E + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 472 IEDRRRLLVYEYICNG-SLDSHLYGCHQE-PLEWSARQKIAVGAARGLRYLHEECRVGCI 529
E +LV + + G SL+ L C ++ ++ A A ++ +HE+ +
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS----L 127
Query: 530 VHRDMRPNNILLTHDFEP-----LVGDFGLAR 556
V+RD++P+N L+ V DFG+ +
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 32/172 (18%), Positives = 57/172 (33%), Gaps = 30/172 (17%)
Query: 414 LAEGGFGSVHRGV---------LPDGQAVAVK----------QHKLASSQGDHEFCSEVE 454
G ++ P Q ++K + ++ +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 455 VLSCAQHRNVVMLIGF-CIEDRRRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVG 512
L + +GF +D+ R LV + G SL S L + L + ++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 513 AARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV--GDFGLA-RWQPDG 561
L +LHE VH ++ NI + + + V +G A R+ P G
Sbjct: 168 LLDALEFLHENE----YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 574 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.98 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.98 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.98 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.94 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.94 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.94 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.94 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.94 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.93 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.93 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.93 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.93 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.93 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.93 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.93 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.93 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.93 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.93 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.93 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.93 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.93 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.93 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.93 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.93 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.93 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.93 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.92 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.92 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.92 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.92 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.92 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.92 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.92 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.92 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.92 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.92 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.92 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.92 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.92 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.92 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.92 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.92 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.92 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.92 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.92 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.92 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.92 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.92 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.92 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.92 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.92 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.92 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.91 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.91 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.91 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.91 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.91 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.91 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.91 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.91 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.91 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.91 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.91 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.91 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.91 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.91 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.91 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.91 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.91 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.91 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.91 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.91 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.91 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.9 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.9 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.9 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.9 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.9 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.9 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.9 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.9 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.9 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.9 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.9 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.9 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.89 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.89 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.89 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.89 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.86 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.94 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.73 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 97.72 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 97.61 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 97.59 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 97.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 97.42 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 97.41 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 97.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.15 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 97.14 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.09 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 97.02 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 96.87 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 96.87 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 96.59 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 96.31 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 96.3 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 96.23 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.18 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.08 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 95.82 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 95.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.64 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 95.4 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 95.38 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 94.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.97 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 89.3 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.46 Aligned_cols=161 Identities=24% Similarity=0.327 Sum_probs=145.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
..|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4699999999999999999995 579999999998766666677999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
+||+|.+++.. ..+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999863 5699999999999999999999999 999999999999999999999999999998754332
Q ss_pred ccceeeccCC
Q 008201 565 VETRVIGTFG 574 (574)
Q Consensus 565 ~~t~v~GT~G 574 (574)
..++++||+.
T Consensus 226 ~~~~~~GTp~ 235 (346)
T 4fih_A 226 RRKSLVGTPY 235 (346)
T ss_dssp CBCCCCSCGG
T ss_pred cccccccCcC
Confidence 3456899973
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.75 Aligned_cols=164 Identities=25% Similarity=0.306 Sum_probs=138.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|++++.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999994 57999999999765332 33578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
||+||+|.++|.......+++..++.|+.||+.||.|||++ |||||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999765566789999999999999999999999 99999999999999999999999999999774322
Q ss_pred CCccceeeccCC
Q 008201 563 MGVETRVIGTFG 574 (574)
Q Consensus 563 ~~~~t~v~GT~G 574 (574)
...+.++||++
T Consensus 180 -~~~~~~~GT~~ 190 (350)
T 4b9d_A 180 -ELARACIGTPY 190 (350)
T ss_dssp -HHHHHHHSCCT
T ss_pred -ccccccCCCcc
Confidence 22345789874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.71 Aligned_cols=163 Identities=25% Similarity=0.319 Sum_probs=145.0
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|++.+.||+|+||.||+|+ ..+|+.||||++... .....+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999999 457999999998753 2234467999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|||+||+|.+++.. .+.+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999973 46799999999999999999999999 9999999999999999999999999999987543
Q ss_pred C-CCccceeeccCC
Q 008201 562 D-MGVETRVIGTFG 574 (574)
Q Consensus 562 ~-~~~~t~v~GT~G 574 (574)
. .....+++||++
T Consensus 186 ~~~~~~~~~~GTp~ 199 (311)
T 4aw0_A 186 SKQARANSFVGTAQ 199 (311)
T ss_dssp TTCCCBCCCCSCGG
T ss_pred CCcccccCcccCcc
Confidence 3 334567899973
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.89 Aligned_cols=161 Identities=24% Similarity=0.332 Sum_probs=146.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
..|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4699999999999999999995 579999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
+||+|.+++. ...+++..+..|+.||+.||.|||++ |||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~---~~~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 9999999985 34699999999999999999999999 999999999999999999999999999998754332
Q ss_pred ccceeeccCC
Q 008201 565 VETRVIGTFG 574 (574)
Q Consensus 565 ~~t~v~GT~G 574 (574)
..+.++||+.
T Consensus 303 ~~~~~~GTp~ 312 (423)
T 4fie_A 303 RRKSLVGTPY 312 (423)
T ss_dssp CBCCCEECTT
T ss_pred cccccccCcC
Confidence 3457899974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=294.30 Aligned_cols=166 Identities=31% Similarity=0.431 Sum_probs=141.9
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
..++|.+.+.||+|+||.||+|++. ++..||||.++.......++|.+|+++|++++|||||+++|+|.+.+..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3467999999999999999999853 4788999999866555567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 478 LLVYEYICNGSLDSHLYGC-----------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~-----------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
|||||||++|+|.++|... ....++|..++.|+.||+.||.|||++ +||||||||+||||+.++.
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCc
Confidence 9999999999999999642 235799999999999999999999998 8999999999999999999
Q ss_pred EEEeeecceeecCCCCC-CccceeeccC
Q 008201 547 PLVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 547 vKLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
+||+|||+|+....... ......+||+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~ 194 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPI 194 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECG
T ss_pred EEECCcccceecCCCCceeecCceecCh
Confidence 99999999997654332 2233466775
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.05 Aligned_cols=166 Identities=32% Similarity=0.447 Sum_probs=135.7
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
...+|.+.+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3457889999999999999999853 4789999999866555567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 478 LLVYEYICNGSLDSHLYGCH-------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~-------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
|||||||++|+|.++|.... ..+++|..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCC
Confidence 99999999999999996431 34699999999999999999999998 89999999999999999
Q ss_pred CcEEEeeecceeecCCCC-CCccceeeccC
Q 008201 545 FEPLVGDFGLARWQPDGD-MGVETRVIGTF 573 (574)
Q Consensus 545 ~~vKLsDFGLAr~~~~~~-~~~~t~v~GT~ 573 (574)
+.+||+|||+|+.+.... ....+..+||+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp TEEEECCCC----------------CCCCG
T ss_pred CcEEEcccccceeccCCCcceecCcccccc
Confidence 999999999999775433 23345677876
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=290.31 Aligned_cols=166 Identities=28% Similarity=0.428 Sum_probs=137.7
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
|++..++|.+.+.||+|+||.||+|++.+ .||||+++.... ...+.|.+|+.+|++++|||||++++++.. +.+|
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 56677889999999999999999998643 599999875432 234579999999999999999999998854 5689
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
||||||++|+|.++|.. ...++++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+..
T Consensus 108 iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999974 456799999999999999999999998 9999999999999999999999999999977
Q ss_pred CCCC-CCccceeeccCC
Q 008201 559 PDGD-MGVETRVIGTFG 574 (574)
Q Consensus 559 ~~~~-~~~~t~v~GT~G 574 (574)
.... ....+..+||++
T Consensus 183 ~~~~~~~~~~~~~GT~~ 199 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVL 199 (307)
T ss_dssp -----------CCCCTT
T ss_pred ccCCcceeecccccCCC
Confidence 5432 223456789874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=281.55 Aligned_cols=160 Identities=24% Similarity=0.391 Sum_probs=128.0
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|++.+.||+|+||.||+|+ ..+|+.||||++.... ......+.+|+.+|+.++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 589999999999999999999 4579999999987543 223457899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+ +|+|.+++.. .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 998 7899999873 56799999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCCccceeeccCC
Q 008201 562 DMGVETRVIGTFG 574 (574)
Q Consensus 562 ~~~~~t~v~GT~G 574 (574)
. ..++.+||++
T Consensus 166 ~--~~~~~~GT~~ 176 (275)
T 3hyh_A 166 N--FLKTSCGSPN 176 (275)
T ss_dssp -----------CT
T ss_pred C--ccCCeeECcc
Confidence 3 2346789974
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=288.34 Aligned_cols=165 Identities=27% Similarity=0.351 Sum_probs=140.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
...+++.+.||+|+||.||+|.+. +++.||||.++.... ...++|.+|+.+|++++|||||+++|+|..++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 346788899999999999999852 467899999875433 3346799999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC
Q 008201 478 LLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~ 543 (574)
|||||||++|+|.++|.... ...++|..++.|+.||+.||.|||++ +||||||||+||||+.
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYD 180 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECC
Confidence 99999999999999996421 24689999999999999999999998 8999999999999999
Q ss_pred CCcEEEeeecceeecCCCC-CCccceeeccC
Q 008201 544 DFEPLVGDFGLARWQPDGD-MGVETRVIGTF 573 (574)
Q Consensus 544 ~~~vKLsDFGLAr~~~~~~-~~~~t~v~GT~ 573 (574)
++.+||+|||+|+.+...+ ....+..+||+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred CCCEEECCcccceeccCCCceeEecccccCC
Confidence 9999999999999765433 22344567775
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=289.70 Aligned_cols=159 Identities=26% Similarity=0.277 Sum_probs=136.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.+.|.+.+.||+|+||.||+|+. .+|+.||||+++.... ..+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34689999999999999999994 5699999999975432 24799999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeecCCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQPDGD 562 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~~~~ 562 (574)
|+||+|.++|.. .+.+++..+..|+.||+.||.|||++ +||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999973 46799999999999999999999999 999999999999999987 69999999999876543
Q ss_pred CC----ccceeeccCC
Q 008201 563 MG----VETRVIGTFG 574 (574)
Q Consensus 563 ~~----~~t~v~GT~G 574 (574)
.. ....++||++
T Consensus 206 ~~~~~~~~~~~~GT~~ 221 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTET 221 (336)
T ss_dssp --------CCCCCCGG
T ss_pred cccceecCCccccCcc
Confidence 22 2234789973
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=281.94 Aligned_cols=158 Identities=25% Similarity=0.333 Sum_probs=135.4
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRLLV 480 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LV 480 (574)
|+..+.||+|+||.||+|.. .++..||+|.+..... ...+.|.+|+.+|+.++|||||+++++|.. .+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36777899999999999995 5699999999875432 233569999999999999999999999875 3468999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC--eEeeCCCCCCeEEcC-CCcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTH-DFEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g--IIHRDLKP~NILLd~-~~~vKLsDFGLAr~ 557 (574)
||||+||+|.+++.. ...+++..+..|+.||+.||.|||++ + ||||||||+||||+. ++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~----~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999973 56799999999999999999999998 6 999999999999984 79999999999986
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
.... ..++++|||+
T Consensus 182 ~~~~---~~~~~~GTp~ 195 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPE 195 (290)
T ss_dssp CCTT---SBEESCSSCC
T ss_pred CCCC---ccCCcccCcc
Confidence 5332 3456899984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=281.43 Aligned_cols=165 Identities=26% Similarity=0.365 Sum_probs=128.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC--------
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-------- 475 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-------- 475 (574)
++|++++.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3599999999999999999994 57999999998765433 2356899999999999999999999997654
Q ss_pred ----eEEEEEEecCCCChHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 476 ----RRLLVYEYICNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 476 ----~~~LVmEy~~ggsL~~~L~~~~~-~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
.+|||||||++|+|.+++..... ...++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999974321 2356677889999999999999999 99999999999999999999999
Q ss_pred eecceeecCCCCCC-----------ccceeeccCC
Q 008201 551 DFGLARWQPDGDMG-----------VETRVIGTFG 574 (574)
Q Consensus 551 DFGLAr~~~~~~~~-----------~~t~v~GT~G 574 (574)
|||+|+.+...... ..+..+||++
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 195 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195 (299)
T ss_dssp CCCCC--------------------------CCCT
T ss_pred cCccceecCCCccccccccccccccccCCcccCcc
Confidence 99999987543221 2245689874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-33 Score=288.37 Aligned_cols=162 Identities=24% Similarity=0.250 Sum_probs=134.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
++|++.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.+|+.++|||||+++++|.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4699999999999999999984 2478999999875422 223468899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|||||+||+|.+++.. .+.+++..+..|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999973 56799999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCccceeeccCC
Q 008201 560 DGDMGVETRVIGTFG 574 (574)
Q Consensus 560 ~~~~~~~t~v~GT~G 574 (574)
.... ..++++||+.
T Consensus 178 ~~~~-~~~~~~GT~~ 191 (304)
T 3ubd_A 178 DHEK-KAYSFCGTVE 191 (304)
T ss_dssp ---C-CCCSCCCCGG
T ss_pred CCCc-cccccccCcc
Confidence 4332 3346789973
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.53 Aligned_cols=162 Identities=27% Similarity=0.335 Sum_probs=130.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHH--HHHHHHHHhcCCCCeeEEEEEEEeCC----eEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEF--CSEVEVLSCAQHRNVVMLIGFCIEDR----RRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f--~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~L 479 (574)
.+|.+.+.||+|+||.||+|++ +|+.||||++... ....+ ..|+..+..++|||||+++++|..++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4688999999999999999997 6899999998643 22333 34555667889999999999998754 5799
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC----cCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~----~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
|||||++|+|.++|.. .+++|..+..++.|++.||.|||+++ ..++||||||||+||||+.++.+||+|||+|
T Consensus 79 V~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999963 46999999999999999999999752 1127999999999999999999999999999
Q ss_pred eecCCCCCC---ccceeeccCC
Q 008201 556 RWQPDGDMG---VETRVIGTFG 574 (574)
Q Consensus 556 r~~~~~~~~---~~t~v~GT~G 574 (574)
+........ .....+||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ 177 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKR 177 (303)
T ss_dssp EEEETTTTEESCC-----CCGG
T ss_pred ccccCCCCceeeeccccccccc
Confidence 987554322 2335688863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=280.19 Aligned_cols=174 Identities=24% Similarity=0.305 Sum_probs=146.8
Q ss_pred cchhHHHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCC-CCeeEE
Q 008201 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQH-RNVVML 467 (574)
Q Consensus 396 fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~H-pNIV~L 467 (574)
+....|++..++|++.+.||+|+||.||+|.+. +++.||||.++..... ..+.|.+|+.+|+.++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 445678888999999999999999999999843 2468999998765433 23579999999999975 899999
Q ss_pred EEEEEeC-CeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEee
Q 008201 468 IGFCIED-RRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532 (574)
Q Consensus 468 ~g~~~~~-~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHR 532 (574)
+|+|... +.+|||||||++|+|.++|.... ...+++..++.|+.||+.||.|||++ +||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHR 209 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHR 209 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCS
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecC
Confidence 9999764 56899999999999999996421 34589999999999999999999999 99999
Q ss_pred CCCCCCeEEcCCCcEEEeeecceeecCCCCC-CccceeeccC
Q 008201 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 533 DLKP~NILLd~~~~vKLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
||||+|||++.++.+||+|||+|+.+..... ...+..+||+
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 9999999999999999999999997754433 3345677886
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=280.02 Aligned_cols=163 Identities=23% Similarity=0.361 Sum_probs=138.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEe------CC
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIE------DR 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~ 475 (574)
.++|.+++.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999994 57999999998754322 23568899999999999999999999864 35
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
.+||||||| +|+|.+++. ..+++++..+..|+.||+.||.|||++ |||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~-~g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECC-SEEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCC-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeeccee
Confidence 789999999 578999986 467899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC---CCccceeeccCC
Q 008201 556 RWQPDGD---MGVETRVIGTFG 574 (574)
Q Consensus 556 r~~~~~~---~~~~t~v~GT~G 574 (574)
+.+.... ....+.++||+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~ 227 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRW 227 (398)
T ss_dssp BCC-------CCCCCSSCCCCT
T ss_pred eecccCccccccccccceeChH
Confidence 9774332 223456789873
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=282.51 Aligned_cols=162 Identities=23% Similarity=0.338 Sum_probs=143.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||+|+++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 35799999999999999999994 57999999999866555556789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC--CcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD--FEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~--~~vKLsDFGLAr~~~~~ 561 (574)
|+||+|.++|.. ....+++..+..|+.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999864 346799999999999999999999999 99999999999999854 89999999999988654
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
. .....+||+
T Consensus 311 ~--~~~~~~GT~ 320 (573)
T 3uto_A 311 Q--SVKVTTGTA 320 (573)
T ss_dssp S--EEEEECSSG
T ss_pred C--ceeeeEECc
Confidence 3 234578886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=266.23 Aligned_cols=147 Identities=22% Similarity=0.301 Sum_probs=131.5
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 477 (574)
...+.|++.+.||+|+||.||+|+. .+++.||+|.+... .....+.+|+++|+.+ +||||++++++|.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3567899999999999999999983 24788999988643 3345688999999988 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeeccee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLAR 556 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFGLAr 556 (574)
||||||+++++|.+++. .+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999884 489999999999999999999999 99999999999999877 899999999999
Q ss_pred ecCC
Q 008201 557 WQPD 560 (574)
Q Consensus 557 ~~~~ 560 (574)
...+
T Consensus 167 ~~~~ 170 (361)
T 4f9c_A 167 GTHD 170 (361)
T ss_dssp ECTT
T ss_pred ccCC
Confidence 7654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=287.51 Aligned_cols=161 Identities=24% Similarity=0.303 Sum_probs=138.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHH---HHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSE---VEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ......+.+| +.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 45799999999999999999994 569999999987432 1222334444 5566677899999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|||||||+||+|..+|.. .+.+++..+..|+.||+.||.|||++ |||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999973 56799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
+.... ..+++|||+
T Consensus 342 ~~~~~---~~t~~GTp~ 355 (689)
T 3v5w_A 342 FSKKK---PHASVGTHG 355 (689)
T ss_dssp CSSCC---CCSCCSCGG
T ss_pred cCCCC---CCCccCCcC
Confidence 75543 245789974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=262.29 Aligned_cols=173 Identities=21% Similarity=0.242 Sum_probs=149.8
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEE
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 472 (574)
.+.++.+..++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+|..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44566677889999999999999999999965 58899999987421 122335889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
+.+..||||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999974 356799999999999999999999998 9999999999999999999999999
Q ss_pred cceeecCCCCCCccceeeccCC
Q 008201 553 GLARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 553 GLAr~~~~~~~~~~t~v~GT~G 574 (574)
|+|+..........+..+||++
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~ 241 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPD 241 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGG
T ss_pred hhhhhcccCCCcccccccCCcC
Confidence 9999876555444455788863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=242.88 Aligned_cols=152 Identities=30% Similarity=0.522 Sum_probs=137.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+|+.++||||+++++++...+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 45799999999999999999995 46999999988665555566799999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999999975 356799999999999999999999999 9999999999999999999999999999976543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=241.30 Aligned_cols=161 Identities=22% Similarity=0.358 Sum_probs=142.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+|. ..+|+.||+|.+........+.+.+|+.+|+.++||||++++++|...+..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4579999999999999999999 457999999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~ 563 (574)
+++++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999964 3689999999999999999999999 999999999999999999999999999997754432
Q ss_pred CccceeeccC
Q 008201 564 GVETRVIGTF 573 (574)
Q Consensus 564 ~~~t~v~GT~ 573 (574)
.....+||+
T Consensus 172 -~~~~~~gt~ 180 (297)
T 3fxz_A 172 -KRSTMVGTP 180 (297)
T ss_dssp -CBCCCCSCG
T ss_pred -ccCCccCCc
Confidence 233456664
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=258.43 Aligned_cols=170 Identities=21% Similarity=0.250 Sum_probs=146.7
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 473 (574)
+.++.+..++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+|+.++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455667789999999999999999999954 68999999986421 2233458899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
.+..||||||++||+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999863 4689999999999999999999999 99999999999999999999999999
Q ss_pred ceeecCCCCCCccceeeccCC
Q 008201 554 LARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~G 574 (574)
+|+.............+||++
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~ 234 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPD 234 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGG
T ss_pred eeEeeccCCcccccCCcCCcc
Confidence 999876544333446778863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=246.16 Aligned_cols=180 Identities=49% Similarity=0.820 Sum_probs=155.3
Q ss_pred CCccchhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEE
Q 008201 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFC 471 (574)
Q Consensus 393 ~~~fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 471 (574)
.+.|++.++....++|.+.+.||+|+||.||+|...+|+.||||++...... ....+.+|+.+|+.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4568899999999999999999999999999999878999999998764332 234689999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~--~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
...+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+.. +|+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSS-CEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999997542 34599999999999999999999997533 7999999999999999999999
Q ss_pred eeecceeecCCCCCCccceeeccC
Q 008201 550 GDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 550 sDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
+|||+++..............||+
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~ 199 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTI 199 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCG
T ss_pred ccCccccccCcccccccccccCCc
Confidence 999999987655544455556765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-28 Score=257.75 Aligned_cols=173 Identities=23% Similarity=0.219 Sum_probs=148.6
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEE
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 472 (574)
.+.+..+..++|.+.+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.+|..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4455667778999999999999999999995 479999999987432 122345889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
+.+..||||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999964 234799999999999999999999998 9999999999999999999999999
Q ss_pred cceeecCCCCCCccceeeccCC
Q 008201 553 GLARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 553 GLAr~~~~~~~~~~t~v~GT~G 574 (574)
|+|+.............+||++
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~ 228 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPD 228 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGG
T ss_pred hhheeccCCCccccceeccccC
Confidence 9999876544333345678863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=244.39 Aligned_cols=174 Identities=43% Similarity=0.749 Sum_probs=149.5
Q ss_pred cchhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 396 fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
+++.++...+++|...+.||+|+||.||+|...+|+.||||.+........+.+.+|+.+|+.++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445566788999999999999999999998889999999988766556678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 476 RRLLVYEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~--~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999986432 24689999999999999999999998 99999999999999999999999999
Q ss_pred ceeecCCCC-CCccceeeccC
Q 008201 554 LARWQPDGD-MGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~-~~~~t~v~GT~ 573 (574)
+++...... ....+...||+
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~ 205 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTL 205 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEET
T ss_pred cccccccccccccccccCCCc
Confidence 998764322 22234455665
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=246.87 Aligned_cols=163 Identities=21% Similarity=0.328 Sum_probs=142.2
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
...++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++...+..|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456899999999999999999995 6799999999875432 234568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999863 45799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
.+.. .+..+||+
T Consensus 166 ~~~~--~~~~~gt~ 177 (328)
T 3fe3_A 166 VGGK--LDAFCGAP 177 (328)
T ss_dssp SSCG--GGTTSSSG
T ss_pred CCCc--cccccCCc
Confidence 4332 23456665
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=240.33 Aligned_cols=165 Identities=26% Similarity=0.339 Sum_probs=136.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
...++|.+.+.||+|+||.||+|+. .+++.||+|.+....... .+.+.+|+.+++.++||||+++++++...+..|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 3467899999999999999999994 469999999986543322 356889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ..++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999999999999974 45799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
...........+||+
T Consensus 162 ~~~~~~~~~~~~gt~ 176 (294)
T 4eqm_A 162 SETSLTQTNHVLGTV 176 (294)
T ss_dssp -------------CC
T ss_pred ccccccccCccccCc
Confidence 554433344566765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-26 Score=238.44 Aligned_cols=158 Identities=25% Similarity=0.323 Sum_probs=140.9
Q ss_pred eeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 408 FSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 788889999999999999965 7999999999877666667899999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCCcc
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE 566 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~ 566 (574)
++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 127 ~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 198 (321)
T 2c30_A 127 GALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 198 (321)
T ss_dssp CBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-cc
Confidence 99999985 45799999999999999999999998 999999999999999999999999999997754322 23
Q ss_pred ceeeccC
Q 008201 567 TRVIGTF 573 (574)
Q Consensus 567 t~v~GT~ 573 (574)
...+||+
T Consensus 199 ~~~~gt~ 205 (321)
T 2c30_A 199 KSLVGTP 205 (321)
T ss_dssp CCCCSCG
T ss_pred ccccCCc
Confidence 3456664
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=246.24 Aligned_cols=162 Identities=23% Similarity=0.257 Sum_probs=141.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||+|+++.. .......+.+|+.+|+.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 45799999999999999999995 46999999998753 223445788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999863 45789999999999999999999999 999999999999999999999999999986533
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
... .....+||+
T Consensus 158 ~~~-~~~~~~gt~ 169 (337)
T 1o6l_A 158 DGA-TMKTFCGTP 169 (337)
T ss_dssp TTC-CBCCCEECG
T ss_pred CCC-cccccccCh
Confidence 222 234567775
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=247.31 Aligned_cols=164 Identities=24% Similarity=0.315 Sum_probs=136.1
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 477 (574)
+..++|.+.+.||+|+||.||+|+. .+|+.||||+++.. .......+.+|..+|..+ +||||+++++++...+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4456899999999999999999995 46999999998753 223345678999999988 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||||+++|+|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+.
T Consensus 100 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999973 46799999999999999999999999 999999999999999999999999999996
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
..... ......+||+
T Consensus 174 ~~~~~-~~~~~~~gt~ 188 (353)
T 3txo_A 174 GICNG-VTTATFCGTP 188 (353)
T ss_dssp SCC----------CCG
T ss_pred cccCC-ccccccCCCc
Confidence 43322 2334567876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-27 Score=232.12 Aligned_cols=156 Identities=30% Similarity=0.448 Sum_probs=140.2
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+++..++|.+.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+|..++||||+++++++...+..++|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 345667899999999999999999998888899999987543 3456799999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 82 TEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEccCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999999964 344699999999999999999999999 999999999999999999999999999997755
Q ss_pred CC
Q 008201 561 GD 562 (574)
Q Consensus 561 ~~ 562 (574)
..
T Consensus 157 ~~ 158 (268)
T 3sxs_A 157 DQ 158 (268)
T ss_dssp TC
T ss_pred hh
Confidence 43
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=235.94 Aligned_cols=152 Identities=24% Similarity=0.366 Sum_probs=131.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC--------
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-------- 475 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-------- 475 (574)
++|.+.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.+|+.++||||++++++|.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46999999999999999999965 7999999998754432 3467999999999999999999999986643
Q ss_pred -------------------------------------------------eEEEEEEecCCCChHHHHhccC-CCCCCHHH
Q 008201 476 -------------------------------------------------RRLLVYEYICNGSLDSHLYGCH-QEPLEWSA 505 (574)
Q Consensus 476 -------------------------------------------------~~~LVmEy~~ggsL~~~L~~~~-~~~Ls~~~ 505 (574)
..++||||+++++|.+++.... ....++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3899999999999999997532 23456777
Q ss_pred HHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 506 RQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 506 ~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 166 ~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 899999999999999998 9999999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=242.71 Aligned_cols=161 Identities=27% Similarity=0.321 Sum_probs=140.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.+.|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.+|+.++||||++++++|...+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45799999999999999999995 46999999998765332 235789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC----cEEEeeec
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~----~vKLsDFG 553 (574)
|+||||+++++|.+++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999996 456799999999999999999999999 999999999999998876 79999999
Q ss_pred ceeecCCCCCCccceeeccC
Q 008201 554 LARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~ 573 (574)
+++....+.. ....+||+
T Consensus 165 ~a~~~~~~~~--~~~~~gt~ 182 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTP 182 (361)
T ss_dssp SCEECCTTCC--CCCCCSCG
T ss_pred CceEcCCCCc--cccCCCCc
Confidence 9998765432 23456775
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=239.99 Aligned_cols=160 Identities=27% Similarity=0.351 Sum_probs=140.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||+|+++... ....+.+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 35799999999999999999995 469999999987532 23345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999973 46799999999999999999999998 999999999999999999999999999997653
Q ss_pred CCCCccceeeccCC
Q 008201 561 GDMGVETRVIGTFG 574 (574)
Q Consensus 561 ~~~~~~t~v~GT~G 574 (574)
. ....+||++
T Consensus 159 ~----~~~~~gt~~ 168 (318)
T 1fot_A 159 V----TYTLCGTPD 168 (318)
T ss_dssp C----BCCCCSCTT
T ss_pred c----cccccCCcc
Confidence 2 234567763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=234.34 Aligned_cols=153 Identities=27% Similarity=0.486 Sum_probs=138.4
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.+..++|.+.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.+|+.++||||+++++++...+..++||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 44556899999999999999999998888899999987543 34567999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 85 EFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp ECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999964 455799999999999999999999999 999999999999999999999999999986543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=238.87 Aligned_cols=163 Identities=26% Similarity=0.350 Sum_probs=138.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 358999999999999999999954 7999999998754332 23568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|+++++|.+++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999986 456799999999999999999999998 99999999999999999999999999998764322
Q ss_pred -CCccceeeccC
Q 008201 563 -MGVETRVIGTF 573 (574)
Q Consensus 563 -~~~~t~v~GT~ 573 (574)
.......+||+
T Consensus 160 ~~~~~~~~~gt~ 171 (323)
T 3tki_A 160 RERLLNKMCGTL 171 (323)
T ss_dssp EECCBCSCCSCG
T ss_pred cccccCCCccCc
Confidence 12223456664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-27 Score=243.68 Aligned_cols=165 Identities=27% Similarity=0.340 Sum_probs=140.6
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 476 (574)
.+..++|.+.+.||+|+||.||+|+. .+|+.||+|+++... ......+..|..+|..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999995 468999999987532 23345678899999877 89999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+||||+++|+|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999973 45799999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccceeeccC
Q 008201 557 WQPDGDMGVETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~ 573 (574)
....+.. .....+||+
T Consensus 167 ~~~~~~~-~~~~~~gt~ 182 (345)
T 1xjd_A 167 ENMLGDA-KTNTFCGTP 182 (345)
T ss_dssp CCCCTTC-CBCCCCSCG
T ss_pred hcccCCC-cccCCCCCc
Confidence 6543322 234567775
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=248.59 Aligned_cols=163 Identities=22% Similarity=0.254 Sum_probs=139.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 479 (574)
.++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+..|..+|..+ +||||++++++|.+.+..||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999999999999954 688999999875422 2334688999999877 89999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999873 46799999999999999999999999 99999999999999999999999999999643
Q ss_pred CCCCCccceeeccCC
Q 008201 560 DGDMGVETRVIGTFG 574 (574)
Q Consensus 560 ~~~~~~~t~v~GT~G 574 (574)
.... ....++||++
T Consensus 205 ~~~~-~~~~~~gt~~ 218 (396)
T 4dc2_A 205 RPGD-TTSTFCGTPN 218 (396)
T ss_dssp CTTC-CBCCCCBCGG
T ss_pred cCCC-ccccccCCcc
Confidence 3222 3455788863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=242.49 Aligned_cols=168 Identities=18% Similarity=0.183 Sum_probs=141.8
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEE------eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC---CCCeeEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGV------LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGF 470 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~------~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~ 470 (574)
++++..++|.+.+.||+|+||.||+|. ..+++.||+|++... ...++..|+.++..++ |+||+.++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 345567789999999999999999994 456899999998643 3557888999999887 8999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC----
Q 008201 471 CIEDRRRLLVYEYICNGSLDSHLYGC---HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---- 543 (574)
Q Consensus 471 ~~~~~~~~LVmEy~~ggsL~~~L~~~---~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---- 543 (574)
+...+..||||||+++|+|.+++... ....+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccC
Confidence 99999999999999999999999642 356799999999999999999999998 9999999999999998
Q ss_pred -------CCcEEEeeecceeecCC-CCCCccceeeccCC
Q 008201 544 -------DFEPLVGDFGLARWQPD-GDMGVETRVIGTFG 574 (574)
Q Consensus 544 -------~~~vKLsDFGLAr~~~~-~~~~~~t~v~GT~G 574 (574)
++.+||+|||+|+.+.. ......+..+||++
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~ 250 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTS
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCC
Confidence 89999999999987542 22223345677764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=233.75 Aligned_cols=162 Identities=22% Similarity=0.338 Sum_probs=134.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--------------------------chhHHHHHHHHH
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--------------------------GDHEFCSEVEVL 456 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--------------------------~~~~f~~Ei~iL 456 (574)
..++|.+.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 456899999999999999999984 56899999998754311 124688999999
Q ss_pred HhcCCCCeeEEEEEEEe--CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCC
Q 008201 457 SCAQHRNVVMLIGFCIE--DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDM 534 (574)
Q Consensus 457 ~~L~HpNIV~L~g~~~~--~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDL 534 (574)
+.++||||+++++++.. .+..|+||||+++++|.+++ ....+++..+..++.||+.||.|||+. +|+||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dl 163 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDI 163 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCC
Confidence 99999999999999986 56899999999999998865 356799999999999999999999999 9999999
Q ss_pred CCCCeEEcCCCcEEEeeecceeecCCCCCCccceeeccC
Q 008201 535 RPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 535 KP~NILLd~~~~vKLsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
||+|||++.++.+||+|||+++.+..... ......||+
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~ 201 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTP 201 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCG
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCc
Confidence 99999999999999999999997754332 222345554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-27 Score=247.35 Aligned_cols=162 Identities=22% Similarity=0.293 Sum_probs=142.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+|+.++||||++++++|.+.+..|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 345799999999999999999995 468999999986432 2344678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+.+|+|..++. ....+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||+|+.+.
T Consensus 93 v~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999997 456799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
... ..+..+||+
T Consensus 167 ~~~--~~~~~~gt~ 178 (384)
T 4fr4_A 167 RET--QITTMAGTK 178 (384)
T ss_dssp TTC--CBCCCCSCG
T ss_pred CCC--ceeccCCCc
Confidence 433 234567775
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=235.74 Aligned_cols=161 Identities=23% Similarity=0.270 Sum_probs=140.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+|+.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46899999999999999999995 468999999987442 3345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC--CCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~--~~~vKLsDFGLAr~~~~~ 561 (574)
+++++|.+++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||+++.+..+
T Consensus 83 ~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999964 345799999999999999999999999 9999999999999987 789999999999987554
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
. ......||+
T Consensus 158 ~--~~~~~~gt~ 167 (321)
T 1tki_A 158 D--NFRLLFTAP 167 (321)
T ss_dssp C--EEEEEESCG
T ss_pred C--ccccccCCh
Confidence 3 234456665
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=239.64 Aligned_cols=163 Identities=25% Similarity=0.310 Sum_probs=130.3
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCC----CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
..++|.+.+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+.+|+.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 345799999999999999999985 478999999987542 123345788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999963 45689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+....... .....+||+
T Consensus 169 ~~~~~~~~-~~~~~~gt~ 185 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTI 185 (327)
T ss_dssp -----------CTTSSCC
T ss_pred cccccCCc-cccccCCCc
Confidence 86533221 223345664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=230.20 Aligned_cols=149 Identities=23% Similarity=0.378 Sum_probs=131.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+|+.+|+.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999995 469999999987654322 3568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+.+ +|..++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9964 66665543 456799999999999999999999999 999999999999999999999999999997653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=233.81 Aligned_cols=152 Identities=27% Similarity=0.353 Sum_probs=133.4
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
...++|.+.+.||+|+||.||+|+..+|+.||+|++...... ....+.+|+.+|+.++||||+++++++...+..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345689999999999999999999888999999998754322 235688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||++ ++|.+++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|+....
T Consensus 98 ~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCS-EEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCC-CCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99996 588887764 445699999999999999999999999 999999999999999999999999999997753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=241.66 Aligned_cols=162 Identities=23% Similarity=0.254 Sum_probs=139.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 479 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||+|++...... ....+.+|+.+|..+ +||||+++++++...+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35799999999999999999995 46899999998754322 234578899999987 89999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|..++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 88 v~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999863 45799999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
.... .....+||+
T Consensus 162 ~~~~-~~~~~~gt~ 174 (345)
T 3a8x_A 162 RPGD-TTSTFCGTP 174 (345)
T ss_dssp CTTC-CBCCCCSCG
T ss_pred CCCC-cccccCCCc
Confidence 3222 234567775
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=237.69 Aligned_cols=154 Identities=29% Similarity=0.457 Sum_probs=135.7
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
+..++|.+.+.||+|+||.||+|... .+..||||.++.... ...+.+.+|+.+|+.++||||+++++++...+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44568999999999999999999953 345699999875432 2345789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999964 446799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
....
T Consensus 201 ~~~~ 204 (325)
T 3kul_A 201 LEDD 204 (325)
T ss_dssp CC--
T ss_pred cccC
Confidence 7543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=241.37 Aligned_cols=158 Identities=23% Similarity=0.258 Sum_probs=139.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 469999999986532 234457889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999974 35699999999999999999999998 9999999999999999999999999999977543
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
....+||+
T Consensus 195 ----~~~~~gt~ 202 (350)
T 1rdq_E 195 ----TWTLCGTP 202 (350)
T ss_dssp ----BCCCEECG
T ss_pred ----cccccCCc
Confidence 23457775
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-26 Score=232.98 Aligned_cols=160 Identities=26% Similarity=0.324 Sum_probs=139.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
++|.+.+.||+|+||.||+|.. .+|+.||+|.+...... ..+.+.+|+.+|+.++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4699999999999999999995 46999999998764322 2457899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC----cEEEeeecc
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFGL 554 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~----~vKLsDFGL 554 (574)
+||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999996 456799999999999999999999998 999999999999999887 899999999
Q ss_pred eeecCCCCCCccceeeccC
Q 008201 555 ARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 555 Ar~~~~~~~~~~t~v~GT~ 573 (574)
++....... ....+||+
T Consensus 165 a~~~~~~~~--~~~~~gt~ 181 (326)
T 2y0a_A 165 AHKIDFGNE--FKNIFGTP 181 (326)
T ss_dssp CEECCTTSC--CCCCCSCT
T ss_pred CeECCCCCc--cccccCCc
Confidence 998754332 23456665
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=233.77 Aligned_cols=155 Identities=27% Similarity=0.423 Sum_probs=136.7
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.+++..++|.+.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+.+|..++||||+++++++...+..|+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 3455667899999999999999999998888899999987543 345679999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999964 245699999999999999999999999 99999999999999999999999999998654
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 172 ~ 172 (283)
T 3gen_A 172 D 172 (283)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.9e-27 Score=233.46 Aligned_cols=159 Identities=26% Similarity=0.414 Sum_probs=142.7
Q ss_pred hHHHhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 399 AELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 399 ~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
..+++..++|.+.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+|+.++||||+++++++...+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 456677889999999999999999999954 5889999998743 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+.+++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999999865667799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC
Q 008201 558 QPDGD 562 (574)
Q Consensus 558 ~~~~~ 562 (574)
.....
T Consensus 161 ~~~~~ 165 (288)
T 3kfa_A 161 MTGDT 165 (288)
T ss_dssp SCSSS
T ss_pred ccCCc
Confidence 65443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=241.55 Aligned_cols=155 Identities=28% Similarity=0.437 Sum_probs=135.4
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe--------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 472 (574)
+..++|.+.+.||+|+||.||+|+. .++..||||+++..... ..+.+.+|+.+|+.+ +||||++++++|.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3456899999999999999999984 23567999998754322 235689999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCC
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNN 538 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~N 538 (574)
..+..|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~N 233 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARN 233 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGG
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----Ceeccccchhh
Confidence 9999999999999999999997532 24589999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeecceeecCCC
Q 008201 539 ILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 539 ILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||++.++.+||+|||+|+.+...
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNI 256 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCC
T ss_pred EEECCCCCEEEccccCCcccCcc
Confidence 99999999999999999977543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=228.97 Aligned_cols=156 Identities=29% Similarity=0.415 Sum_probs=138.5
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
++++..++|.+.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++|+.++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 4667778999999999999999999998888899999987543 34567999999999999999999999986 456899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999643233699999999999999999999999 99999999999999999999999999999775
Q ss_pred CC
Q 008201 560 DG 561 (574)
Q Consensus 560 ~~ 561 (574)
..
T Consensus 161 ~~ 162 (279)
T 1qpc_A 161 DN 162 (279)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-26 Score=237.05 Aligned_cols=164 Identities=22% Similarity=0.320 Sum_probs=138.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC-----CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS-----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
.+.|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++...+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999985 569999999986421 123567999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc---EEEeeec
Q 008201 479 LVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFG 553 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~---vKLsDFG 553 (574)
+||||+++++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999998877532 344689999999999999999999999 9999999999999986654 9999999
Q ss_pred ceeecCCCCCCccceeeccC
Q 008201 554 LARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~ 573 (574)
+++....... .....+||+
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~ 197 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTP 197 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCG
T ss_pred ceeEecCCCe-eecCCcCCc
Confidence 9998765332 223456665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=235.52 Aligned_cols=168 Identities=29% Similarity=0.468 Sum_probs=132.4
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.+++..++|.+.+.||+|+||.||+|+. +|+.||||++...... ..+.+.+|+.+|+.++||||+++++++...+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3445567899999999999999999987 6889999998755432 234688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC--eEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 478 LLVYEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~-~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g--IIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
++||||+++++|.+++.... ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997421 12389999999999999999999998 8 99999999999999999999999999
Q ss_pred eeecCCCCCCccceeeccC
Q 008201 555 ARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 555 Ar~~~~~~~~~~t~v~GT~ 573 (574)
++....... ......||+
T Consensus 186 a~~~~~~~~-~~~~~~gt~ 203 (309)
T 3p86_A 186 SRLKASTFL-SSKSAAGTP 203 (309)
T ss_dssp -----------------CC
T ss_pred Ccccccccc-ccccCCCCc
Confidence 986543322 223455664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=236.71 Aligned_cols=162 Identities=22% Similarity=0.267 Sum_probs=143.0
Q ss_pred CCccchhHHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-----CCCeeE
Q 008201 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----HRNVVM 466 (574)
Q Consensus 393 ~~~fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----HpNIV~ 466 (574)
...+++.+.....++|.+.+.||+|+||.||+|+. .+++.||||++... ......+..|+.+|+.+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34567777788889999999999999999999995 56899999998632 233456788999999987 999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---
Q 008201 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--- 543 (574)
Q Consensus 467 L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~--- 543 (574)
+++++...+..|+||||+ +++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccc
Confidence 999999999999999999 99999999765556799999999999999999999998 9999999999999975
Q ss_pred ----------------------CCcEEEeeecceeecCC
Q 008201 544 ----------------------DFEPLVGDFGLARWQPD 560 (574)
Q Consensus 544 ----------------------~~~vKLsDFGLAr~~~~ 560 (574)
++.+||+|||+|+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999997644
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=245.71 Aligned_cols=164 Identities=26% Similarity=0.294 Sum_probs=132.4
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEV-LSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~i-L~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..++|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+..|..+ ++.++||||++++++|...+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3457999999999999999999954 689999999875432 223456677776 56789999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999973 45789999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCCccceeeccCC
Q 008201 559 PDGDMGVETRVIGTFG 574 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~G 574 (574)
..... ....++||++
T Consensus 190 ~~~~~-~~~~~~gt~~ 204 (373)
T 2r5t_A 190 IEHNS-TTSTFCGTPE 204 (373)
T ss_dssp BCCCC-CCCSBSCCCC
T ss_pred ccCCC-ccccccCCcc
Confidence 33222 3345778763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=241.54 Aligned_cols=164 Identities=22% Similarity=0.229 Sum_probs=140.0
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~ 477 (574)
+..++|.+.+.||+|+||.||+|+.. +|+.||+|+++... ....+.+..|..+|..+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34568999999999999999999965 58899999987542 23345688999999887 799999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||++||+|..++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|+.
T Consensus 97 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999973 35799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
...... .....+||+
T Consensus 171 ~~~~~~-~~~~~~gt~ 185 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTP 185 (353)
T ss_dssp CCCTTC-CBCCCCSCG
T ss_pred cccCCc-ccccccCCc
Confidence 433222 234567775
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-26 Score=242.42 Aligned_cols=157 Identities=22% Similarity=0.239 Sum_probs=125.8
Q ss_pred CCeeEE-eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHH-hcCCCCeeEEEEEEEe----CCeEE
Q 008201 406 GGFSQA-NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGFCIE----DRRRL 478 (574)
Q Consensus 406 ~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~-~L~HpNIV~L~g~~~~----~~~~~ 478 (574)
++|.+. +.||+|+||.||+|.. .+|+.||||++.. ...+.+|+.++. ..+||||++++++|.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 457665 7899999999999995 4699999999863 246778998874 5589999999999875 56789
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecce
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLA 555 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGLA 555 (574)
|||||+.+|+|.+++.......+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999764456799999999999999999999998 9999999999999997 789999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+...... ..+..+||+
T Consensus 212 ~~~~~~~--~~~~~~gt~ 227 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTP 227 (400)
T ss_dssp EECC-------------C
T ss_pred cccCCCC--ccccCCCCC
Confidence 9765332 223456665
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=231.33 Aligned_cols=163 Identities=27% Similarity=0.289 Sum_probs=138.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--RRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV 480 (574)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++|+.++||||+++++++...+ ..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457999999999999999999954 599999999875432 33467889999999999999999999998765 78999
Q ss_pred EEecCCCChHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE----cCCCcEEEeeecce
Q 008201 481 YEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGLA 555 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~-~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL----d~~~~vKLsDFGLA 555 (574)
|||+++++|.+++.... ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+|
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997532 23499999999999999999999999 99999999999999 77888999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+....... .....||+
T Consensus 164 ~~~~~~~~--~~~~~gt~ 179 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTE 179 (319)
T ss_dssp EECCTTCC--BCCCCSCG
T ss_pred eecCCCCc--eeecccCC
Confidence 98755432 12344554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-27 Score=251.78 Aligned_cols=155 Identities=26% Similarity=0.371 Sum_probs=138.8
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.+++..++|.+.+.||+|+||.||+|...++..||||.++... ...+.|.+|+.+|+.++||||+++++++. .+..|+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3566778899999999999999999998888899999988543 45678999999999999999999999986 567899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++|+|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999743334688999999999999999999999 99999999999999999999999999998764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 336 ~ 336 (454)
T 1qcf_A 336 D 336 (454)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=238.47 Aligned_cols=163 Identities=25% Similarity=0.314 Sum_probs=140.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 345799999999999999999995 46999999998765332 235688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC---CcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~---~~vKLsDFGLAr~ 557 (574)
|||+.+++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999886 456799999999999999999999999 99999999999999865 4599999999997
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
...... ....+||++
T Consensus 181 ~~~~~~--~~~~~gt~~ 195 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPG 195 (362)
T ss_dssp CTTCCS--CCCSCSCTT
T ss_pred ecCCcc--cccCCCCcc
Confidence 754332 234567753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-27 Score=251.34 Aligned_cols=163 Identities=24% Similarity=0.256 Sum_probs=130.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+|+.++||||++++++|...+..||
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 345799999999999999999994 56999999998753 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
||||+++++|..++.. ...+++..+..++.||+.||.|||+ . ||+||||||+||||+.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999863 4579999999999999999999998 6 8999999999999999999999999999864
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
..... .....+||+
T Consensus 300 ~~~~~-~~~~~~gt~ 313 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTP 313 (446)
T ss_dssp CC------CCSSSCG
T ss_pred cCCCc-ccccccCCc
Confidence 43322 234467775
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-26 Score=233.67 Aligned_cols=162 Identities=19% Similarity=0.235 Sum_probs=139.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVm 481 (574)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.+|+.+ +||||+++++++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 346899999999999999999994 679999999987543 234688999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc-----EEEeeeccee
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-----PLVGDFGLAR 556 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~-----vKLsDFGLAr 556 (574)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+|+
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 9999999975 356899999999999999999999999 9999999999999998887 9999999999
Q ss_pred ecCCCCCC------ccceeeccC
Q 008201 557 WQPDGDMG------VETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~------~~t~v~GT~ 573 (574)
.+...... .....+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~ 181 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTA 181 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCT
T ss_pred eeecCCCCccccccccCCcCCCc
Confidence 77543321 124566775
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=238.67 Aligned_cols=174 Identities=24% Similarity=0.315 Sum_probs=143.3
Q ss_pred cchhHHHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEE
Q 008201 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVML 467 (574)
Q Consensus 396 fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L 467 (574)
+....+++..++|.+.+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|+.+|..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 45677888899999999999999999999973 34689999999754332 235689999999999 78999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCChHHHHhccCC------------------------------------------------
Q 008201 468 IGFCIEDR-RRLLVYEYICNGSLDSHLYGCHQ------------------------------------------------ 498 (574)
Q Consensus 468 ~g~~~~~~-~~~LVmEy~~ggsL~~~L~~~~~------------------------------------------------ 498 (574)
+++|...+ ..++||||+.+|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 48999999999999999975321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 499 ----------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 499 ----------------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288999999999999999999999 99999999999999999999999999998764432
Q ss_pred C-CccceeeccC
Q 008201 563 M-GVETRVIGTF 573 (574)
Q Consensus 563 ~-~~~t~v~GT~ 573 (574)
. ...+...||+
T Consensus 248 ~~~~~~~~~~t~ 259 (359)
T 3vhe_A 248 DYVRKGDARLPL 259 (359)
T ss_dssp TCEEC--CEECG
T ss_pred cchhccccCCCc
Confidence 2 2233345553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-26 Score=225.01 Aligned_cols=161 Identities=24% Similarity=0.314 Sum_probs=140.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+.+|+.++||||+++++++...+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356999999999999999999954 5889999998876556667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE---cCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL---d~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.++|+|||+++....
T Consensus 88 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998863 45689999999999999999999999 99999999999999 7889999999999987754
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
... .....||+
T Consensus 162 ~~~--~~~~~~t~ 172 (277)
T 3f3z_A 162 GKM--MRTKVGTP 172 (277)
T ss_dssp TSC--BCCCCSCT
T ss_pred ccc--hhccCCCC
Confidence 332 22345554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=252.44 Aligned_cols=157 Identities=25% Similarity=0.414 Sum_probs=141.9
Q ss_pred hHHHhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 399 AELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 399 ~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
..+++...+|.+.+.||+|+||.||+|... ++..||||.++... ...+.|.+|+.+|+.++||||++++++|...+..
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 345667778999999999999999999965 48899999987543 3456899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||||+++|+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeeccccee
Confidence 9999999999999999765566799999999999999999999999 999999999999999999999999999997
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
...
T Consensus 368 ~~~ 370 (495)
T 1opk_A 368 MTG 370 (495)
T ss_dssp CTT
T ss_pred ccC
Confidence 654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=248.86 Aligned_cols=156 Identities=30% Similarity=0.414 Sum_probs=136.3
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.+++..++|.+.+.||+|+||.||+|...++..||||.++... ...+.|.+|+.+|+.++||||+++++++.. +..|+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3556677899999999999999999998878889999987543 345679999999999999999999999866 67899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++|+|.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999999653445689999999999999999999999 99999999999999999999999999999765
Q ss_pred CC
Q 008201 560 DG 561 (574)
Q Consensus 560 ~~ 561 (574)
..
T Consensus 332 ~~ 333 (452)
T 1fmk_A 332 DN 333 (452)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=236.89 Aligned_cols=158 Identities=30% Similarity=0.445 Sum_probs=139.0
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEE
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGF 470 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~ 470 (574)
+..+++..++|.+.+.||+|+||.||+|+.. +++.||+|.++..... ..+.+.+|+.+|+.++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445667889999999999999999999953 3588999998754332 23568999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC
Q 008201 471 CIEDRRRLLVYEYICNGSLDSHLYGCH----------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (574)
Q Consensus 471 ~~~~~~~~LVmEy~~ggsL~~~L~~~~----------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g 528 (574)
+...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++ +
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ 194 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----K 194 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----C
Confidence 999999999999999999999997532 25799999999999999999999999 9
Q ss_pred eEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 529 IIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+||||||+|||++.++.+||+|||+++...
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 225 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccc
Confidence 9999999999999999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=229.14 Aligned_cols=148 Identities=26% Similarity=0.392 Sum_probs=133.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||+|...+|+.||+|++...... ....+.+|+.+|+.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999878999999998754322 235788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|.+++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LD-QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CS-EEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 96 589988864 346799999999999999999999999 99999999999999999999999999998664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=238.11 Aligned_cols=160 Identities=24% Similarity=0.367 Sum_probs=139.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+|+.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999994 679999999986431 22345789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+ +|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7899888863 45799999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
+.. ....+||+
T Consensus 161 ~~~--~~~~~gt~ 171 (336)
T 3h4j_B 161 GNF--LKTSCGSP 171 (336)
T ss_dssp SBT--TCCCTTST
T ss_pred Ccc--cccccCCc
Confidence 432 23456665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=239.41 Aligned_cols=161 Identities=22% Similarity=0.303 Sum_probs=140.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
++|.+.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+.+|+.++||||+++++++...+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 5799999999999999999995 469999999987655444567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC--CCcEEEeeecceeecCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~--~~~vKLsDFGLAr~~~~~~ 562 (574)
.+++|.+++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++. .+.+||+|||+|+......
T Consensus 131 ~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 131 SGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999864 345799999999999999999999999 9999999999999974 4789999999999875433
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
. ....+||+
T Consensus 206 ~--~~~~~gt~ 214 (387)
T 1kob_A 206 I--VKVTTATA 214 (387)
T ss_dssp C--EEEECSSG
T ss_pred c--eeeeccCC
Confidence 2 23446664
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=240.14 Aligned_cols=162 Identities=25% Similarity=0.275 Sum_probs=139.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCC----CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 476 (574)
++|.+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.+|+.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999996 368999999986432 22345677899999999 69999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.||||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999974 35799999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCCCccceeeccC
Q 008201 557 WQPDGDMGVETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~ 573 (574)
.+...........+||+
T Consensus 208 ~~~~~~~~~~~~~~gt~ 224 (355)
T 1vzo_A 208 EFVADETERAYDFCGTI 224 (355)
T ss_dssp ECCGGGGGGGCGGGSCC
T ss_pred ecccCCCCcccCcccCc
Confidence 76543333334456765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=246.87 Aligned_cols=148 Identities=22% Similarity=0.339 Sum_probs=122.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC-----Ce
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 476 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 35799999999999999999984 4799999998865322 2335788999999999999999999999543 56
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+||||+ +++|..++. ....+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999997 689999886 456799999999999999999999999 99999999999999999999999999999
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
...
T Consensus 205 ~~~ 207 (458)
T 3rp9_A 205 TVD 207 (458)
T ss_dssp CTT
T ss_pred hcc
Confidence 764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=232.30 Aligned_cols=153 Identities=30% Similarity=0.495 Sum_probs=133.1
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--C
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--R 475 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~ 475 (574)
+..++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.+|+.++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 3456899999999999999999984 35889999998865555556799999999999999999999998653 4
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 68999999999999999975 344699999999999999999999998 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 162 ~~~~~ 166 (295)
T 3ugc_A 162 KVLPQ 166 (295)
T ss_dssp C----
T ss_pred ccccC
Confidence 97654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=227.17 Aligned_cols=163 Identities=40% Similarity=0.632 Sum_probs=144.4
Q ss_pred CCccchhHHHhhcCCeeEE------eeeeccCcEEEEEEEeCCCCEEEEEEeecCC----CcchhHHHHHHHHHHhcCCC
Q 008201 393 PRWFSYAELELATGGFSQA------NFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHR 462 (574)
Q Consensus 393 ~~~fs~~~le~~~~~y~~~------~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~Hp 462 (574)
...|++.++...+++|... +.||+|+||.||+|.. +++.||+|.+.... ....+.+.+|+.+|+.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567888999999988877 8999999999999986 68899999886532 12245789999999999999
Q ss_pred CeeEEEEEEEeCCeEEEEEEecCCCChHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE
Q 008201 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (574)
Q Consensus 463 NIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~-~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL 541 (574)
||+++++++...+..++||||+++++|.+++... ...++++..+..++.|++.||.|||+. +|+||||||+|||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 245799999999999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecceeecCC
Q 008201 542 THDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 542 d~~~~vKLsDFGLAr~~~~ 560 (574)
+.++.+||+|||+++....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEK 185 (307)
T ss_dssp CTTCCEEECCCTTCEECCS
T ss_pred cCCCcEEEeeccccccccc
Confidence 9999999999999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-26 Score=227.39 Aligned_cols=147 Identities=27% Similarity=0.410 Sum_probs=128.9
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHh--cCCCCeeEEEEEEEeC----CeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC--AQHRNVVMLIGFCIED----RRR 477 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~----~~~ 477 (574)
..++|.+.+.||+|+||.||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 456899999999999999999987 7899999998643 34566778888877 7899999999997653 468
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH--------EECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLH--------s~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
|+||||+++++|.+++. ...+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999994 457999999999999999999999 76 8999999999999999999999
Q ss_pred eeecceeecCCC
Q 008201 550 GDFGLARWQPDG 561 (574)
Q Consensus 550 sDFGLAr~~~~~ 561 (574)
+|||+|+.....
T Consensus 155 ~Dfg~a~~~~~~ 166 (301)
T 3q4u_A 155 ADLGLAVMHSQS 166 (301)
T ss_dssp CCCTTCEEEETT
T ss_pred eeCCCeeecccc
Confidence 999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=251.99 Aligned_cols=165 Identities=29% Similarity=0.371 Sum_probs=143.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
+..++|.+.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4556799999999999999999995 479999999986532 233456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|||||++||+|..++.......+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+..
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999999764455699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
..+.. .+..+||+
T Consensus 337 ~~~~~--~~~~~GT~ 349 (576)
T 2acx_A 337 PEGQT--IKGRVGTV 349 (576)
T ss_dssp CTTCC--EECCCSCG
T ss_pred ccCcc--ccccCCCc
Confidence 65432 23457776
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8e-26 Score=236.86 Aligned_cols=160 Identities=19% Similarity=0.225 Sum_probs=131.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457999999999999999999954 79999999987543 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc--EEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--PLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~--vKLsDFGLAr~~~~~ 561 (574)
+.+++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++. +||+|||+|+.....
T Consensus 98 ~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999863 45799999999999999999999998 9999999999999987765 999999999854322
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
. .....+||+
T Consensus 172 ~--~~~~~~gt~ 181 (361)
T 3uc3_A 172 S--QPKSTVGTP 181 (361)
T ss_dssp -----------C
T ss_pred C--CCCCCcCCC
Confidence 2 123345665
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=238.48 Aligned_cols=160 Identities=26% Similarity=0.336 Sum_probs=132.7
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
|...+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|+.+|+.++||||++++++|...+..+|||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 34467899999999999985 56999999999876555566899999999999999999999999999999999999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE--cCCCcEEEeeecceeecCCCCCC
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL--THDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL--d~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 171 ~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 171 GELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp CEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999998864 345689999999999999999999999 99999999999999 5678999999999998754432
Q ss_pred ccceeeccCC
Q 008201 565 VETRVIGTFG 574 (574)
Q Consensus 565 ~~t~v~GT~G 574 (574)
....+||++
T Consensus 245 -~~~~~gt~~ 253 (373)
T 2x4f_A 245 -LKVNFGTPE 253 (373)
T ss_dssp -CCCCCSSCT
T ss_pred -cccccCCCc
Confidence 223456653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=236.90 Aligned_cols=162 Identities=24% Similarity=0.276 Sum_probs=125.1
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
....++|.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.+|+.++||||++++++|...+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999999999999964 58899999987542 345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGLAr~ 557 (574)
|||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999986 456799999999999999999999999 9999999999999975 88999999999997
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
..... .....+||+
T Consensus 201 ~~~~~--~~~~~~gt~ 214 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTP 214 (349)
T ss_dssp --------------CG
T ss_pred cCccc--ccccccCCC
Confidence 64332 123455664
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-26 Score=230.69 Aligned_cols=162 Identities=24% Similarity=0.181 Sum_probs=132.4
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc--chhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|++.+.||+|+||.||+|... +|+.||||++...... ....+..|+..+..+ +||||++++++|...+..|+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3457999999999999999999965 7999999987654322 223455666666555 89999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+ +++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 7899988865 345799999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
.... .+...||+
T Consensus 209 ~~~~--~~~~~gt~ 220 (311)
T 3p1a_A 209 TAGA--GEVQEGDP 220 (311)
T ss_dssp --------CCCCCG
T ss_pred cCCC--CcccCCCc
Confidence 4322 23345664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=226.60 Aligned_cols=152 Identities=26% Similarity=0.464 Sum_probs=137.8
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.+..++|.+.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 34556899999999999999999998888899999987543 34467999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 83 EFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp CCCTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred eCCCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEcccccccccc
Confidence 99999999999965 345789999999999999999999999 99999999999999999999999999998654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=226.34 Aligned_cols=149 Identities=26% Similarity=0.351 Sum_probs=133.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|.+.+.||+|+||.||+|... +|+.||+|++....... .+.+.+|+.+|+.++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999954 59999999886543322 3468899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+++++|..++. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999998876 456799999999999999999999999 999999999999999999999999999997653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=241.12 Aligned_cols=155 Identities=28% Similarity=0.449 Sum_probs=137.2
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
+.+..++|.+.+.||+|+||.||+|... +++.||||.++.... .....|.+|+.+|+.++||||+++++++...+..|
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3455678999999999999999999965 799999999875432 22346889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 189 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999964 344689999999999999999999999 9999999999999999999999999999875
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 264 ~~ 265 (377)
T 3cbl_A 264 AD 265 (377)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-26 Score=232.33 Aligned_cols=158 Identities=29% Similarity=0.424 Sum_probs=135.7
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
++++..++|.+.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+|..+ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4566778999999999999999999984 246689999987543 23446799999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeE
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCHQ---------------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~~---------------------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gII 530 (574)
...+..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||+. ||+
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iv 194 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCV 194 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----Ccc
Confidence 999999999999999999999975322 3489999999999999999999999 999
Q ss_pred eeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 531 HRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||||||+|||++.++.+||+|||+++.....
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~ 225 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSD 225 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccC
Confidence 9999999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=235.84 Aligned_cols=150 Identities=19% Similarity=0.251 Sum_probs=135.9
Q ss_pred cCCeeEEeeeecc--CcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 405 TGGFSQANFLAEG--GFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G--~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.++|.+.+.||+| +||.||+|+.. +|+.||||++..... .....+.+|+.+|+.++||||++++++|...+..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 99999999954 699999999876432 223568889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
||||+++++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999765557799999999999999999999999 9999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=242.69 Aligned_cols=154 Identities=31% Similarity=0.489 Sum_probs=129.3
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
+...+|.+.+.||+|+||.||+|+.. ++..||||.++.... ...+.|.+|+.+|+.++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34567999999999999999999854 577899999876432 2345799999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999999999999974 345799999999999999999999998 999999999999999999999999999997
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
....
T Consensus 197 ~~~~ 200 (373)
T 2qol_A 197 LEDD 200 (373)
T ss_dssp ----
T ss_pred cccC
Confidence 7543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=234.69 Aligned_cols=156 Identities=20% Similarity=0.229 Sum_probs=131.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC--------cchhHHHHHHHHHHhcC---------CCCeeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--------QGDHEFCSEVEVLSCAQ---------HRNVVM 466 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~---------HpNIV~ 466 (574)
..++|.+.+.||+|+||.||+|+. +|+.||||++..... ...+.+.+|+.+|+.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345788999999999999999997 789999999886532 12367899999999886 888888
Q ss_pred EEEEEE------------------------------eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHH
Q 008201 467 LIGFCI------------------------------EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARG 516 (574)
Q Consensus 467 L~g~~~------------------------------~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~g 516 (574)
+++++. ..+..||||||+++|++.+.+. ...+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHH
Confidence 888754 2678999999999997766663 3578999999999999999
Q ss_pred HHHHH-hhCcCCCeEeeCCCCCCeEEcCCC--------------------cEEEeeecceeecCCCCCCccceeeccC
Q 008201 517 LRYLH-EECRVGCIVHRDMRPNNILLTHDF--------------------EPLVGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 517 L~yLH-s~~~~~gIIHRDLKP~NILLd~~~--------------------~vKLsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
|.||| +. +|+||||||+||||+.++ .+||+|||+|+..... ..+||+
T Consensus 174 L~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 174 LAVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999 88 999999999999999887 8999999999977532 346665
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=234.29 Aligned_cols=164 Identities=24% Similarity=0.339 Sum_probs=131.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCC----
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDR---- 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~---- 475 (574)
..++|.+.+.||+|+||.||+|+. .+++.||||++....... ...+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346899999999999999999994 679999999987653332 246889999999999999999999987654
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 34999999999999999973 45799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--CccceeeccC
Q 008201 556 RWQPDGDM--GVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~--~~~t~v~GT~ 573 (574)
+.+..... ......+||+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~ 183 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTA 183 (311)
T ss_dssp ------------------CC
T ss_pred ccccccccccccccccCcCc
Confidence 87654322 1223355665
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=225.59 Aligned_cols=152 Identities=30% Similarity=0.453 Sum_probs=132.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--Ce
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RR 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~ 476 (574)
...|++.+.||+|+||.||+|++ .+++.||+|++..... .....+.+|+.+|+.++||||+++++++... +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34699999999999999999983 4689999999875432 3346789999999999999999999999876 67
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccc
Confidence 8999999999999999954 345699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCC
Q 008201 557 WQPDG 561 (574)
Q Consensus 557 ~~~~~ 561 (574)
.....
T Consensus 175 ~~~~~ 179 (302)
T 4e5w_A 175 AIETD 179 (302)
T ss_dssp ECCTT
T ss_pred cccCC
Confidence 77544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=229.08 Aligned_cols=155 Identities=28% Similarity=0.425 Sum_probs=126.5
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
+++..++|.+.+.||+|+||.||+|... .+..||+|.+...... ..+.+.+|+.+|+.++||||+++++++ ..+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TEN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccC
Confidence 3456678999999999999999999853 2557999988754322 235689999999999999999999998 456
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred ccEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccc
Confidence 78999999999999999974 345799999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCC
Q 008201 556 RWQPDG 561 (574)
Q Consensus 556 r~~~~~ 561 (574)
+.....
T Consensus 164 ~~~~~~ 169 (281)
T 1mp8_A 164 RYMEDS 169 (281)
T ss_dssp ------
T ss_pred cccCcc
Confidence 876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=241.33 Aligned_cols=149 Identities=23% Similarity=0.320 Sum_probs=131.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC-----Ce
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 476 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999994 5689999999875322 2335789999999999999999999999876 57
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+||||+ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIA-DSDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecC-CcCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 89999998 569999997 456799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCC
Q 008201 557 WQPD 560 (574)
Q Consensus 557 ~~~~ 560 (574)
....
T Consensus 178 ~~~~ 181 (432)
T 3n9x_A 178 TINS 181 (432)
T ss_dssp EC--
T ss_pred cccc
Confidence 7754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=230.03 Aligned_cols=151 Identities=28% Similarity=0.412 Sum_probs=120.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.++|++.+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|+.+|+.++||||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35799999999999999999994 4699999999876543 234678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~----~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|+. ++|.+++... ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 996 6999888542 224689999999999999999999998 9999999999999999999999999999976
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 159 ~~ 160 (317)
T 2pmi_A 159 GI 160 (317)
T ss_dssp TS
T ss_pred CC
Confidence 53
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=243.78 Aligned_cols=163 Identities=21% Similarity=0.264 Sum_probs=138.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
..++|.+.+.||+|+||.||+|. ..+|+.+|+|++...... ..+.+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 34579999999999999999998 457999999998764432 234688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc---CCCcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd---~~~~vKLsDFGLAr~ 557 (574)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998874 46799999999999999999999999 999999999999998 467899999999987
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
...... .....+||+
T Consensus 163 ~~~~~~-~~~~~~gt~ 177 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTP 177 (444)
T ss_dssp CCTTCC-BCCCSCSCG
T ss_pred ecCCCc-eeecccCCc
Confidence 654332 223456775
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-26 Score=237.39 Aligned_cols=155 Identities=31% Similarity=0.437 Sum_probs=136.1
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC--------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
++..++|.+.+.||+|+||.||+|+.. .+..||||++...... ....+.+|+++|+.+ +||||++++++|
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 455678999999999999999999842 2457999998755332 235689999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
...+..++||||+++++|.+++.... ...+++..++.|+.||+.||.|||+. +|+||||||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~ 220 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAAR 220 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcc
Confidence 99999999999999999999997532 24699999999999999999999999 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecCC
Q 008201 538 NILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||++.++.+||+|||+|+....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~ 243 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHH 243 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSC
T ss_pred eEEEcCCCcEEEcccCccccccc
Confidence 99999999999999999997654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=245.50 Aligned_cols=162 Identities=25% Similarity=0.406 Sum_probs=142.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+|+.++||||+++++++...+..|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4568999999999999999999954 79999999987532 2234578999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999996 456799999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
.+.. ....+||+
T Consensus 168 ~~~~--~~~~~gt~ 179 (476)
T 2y94_A 168 DGEF--LRTSCGSP 179 (476)
T ss_dssp TTCC--BCCCCSCS
T ss_pred cccc--ccccCCCc
Confidence 5432 23456775
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=227.27 Aligned_cols=158 Identities=31% Similarity=0.445 Sum_probs=138.7
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
.+++..++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+|+.+ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3556677899999999999999999984 3478899999875543 2345789999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccCC----------------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCC
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCHQ----------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR 535 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~~----------------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLK 535 (574)
...+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+. +|+|||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlk 172 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLA 172 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCS
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCc
Confidence 999999999999999999999975322 2589999999999999999999999 99999999
Q ss_pred CCCeEEcCCCcEEEeeecceeecCCC
Q 008201 536 PNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 536 P~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|+|||++.++.+||+|||+++.....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 198 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKND 198 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSC
T ss_pred cceEEEcCCCCEEEcccccccccccc
Confidence 99999999999999999999977543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=247.68 Aligned_cols=166 Identities=25% Similarity=0.325 Sum_probs=144.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|.+.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.+|+.++||||++++++|...+..|+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 346799999999999999999996 469999999987532 2334568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 480 VYEYICNGSLDSHLYGCH--QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~--~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||++||+|..++.... ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++.
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999999987532 45799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
+..... .....+||++
T Consensus 339 ~~~~~~-~~~~~~GT~~ 354 (543)
T 3c4z_A 339 LKAGQT-KTKGYAGTPG 354 (543)
T ss_dssp CCTTCC-CBCCCCSCTT
T ss_pred ccCCCc-ccccccCCcc
Confidence 765432 2344688864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-26 Score=228.24 Aligned_cols=158 Identities=31% Similarity=0.421 Sum_probs=137.5
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~ 472 (574)
.+++..++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 3455667899999999999999999984 2457899999875432 23357889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeE
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCHQ----------------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~~----------------------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gII 530 (574)
..+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||++ +|+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~iv 172 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLV 172 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCc
Confidence 99999999999999999999975322 3489999999999999999999999 999
Q ss_pred eeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 531 HRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||||||+|||++.++.+||+|||+++.....
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTT
T ss_pred ccccchheEEEcCCCCEEEcccccccccccc
Confidence 9999999999999999999999999977543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=241.30 Aligned_cols=153 Identities=29% Similarity=0.431 Sum_probs=137.2
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR-RRL 478 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~-~~~ 478 (574)
.+++..++|.+.+.||+|+||.||+|... |+.||||.++... ..+.|.+|+.+|+.++||||+++++++...+ ..|
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 45566778999999999999999999974 7899999987543 4567999999999999999999999987765 799
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999999999765455689999999999999999999999 9999999999999999999999999999865
Q ss_pred C
Q 008201 559 P 559 (574)
Q Consensus 559 ~ 559 (574)
.
T Consensus 340 ~ 340 (450)
T 1k9a_A 340 S 340 (450)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=225.21 Aligned_cols=164 Identities=30% Similarity=0.423 Sum_probs=134.2
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-----cchhHHHHHHHHHHhcC---CCCeeEEEEEEEe
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-----QGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIE 473 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-----~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~ 473 (574)
...++|.+.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|+.+++.++ ||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567899999999999999999994 5799999999875332 12346778888887765 9999999999987
Q ss_pred CC-----eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEE
Q 008201 474 DR-----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (574)
Q Consensus 474 ~~-----~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vK 548 (574)
.. ..++||||+. ++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEE
Confidence 65 5799999995 6999999765555699999999999999999999999 999999999999999999999
Q ss_pred EeeecceeecCCCCCCccceeeccC
Q 008201 549 VGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 549 LsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
|+|||+|+....... .+..+||+
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~gt~ 183 (308)
T 3g33_A 161 LADFGLARIYSYQMA--LTPVVVTL 183 (308)
T ss_dssp ECSCSCTTTSTTCCC--SGGGGCCC
T ss_pred EeeCccccccCCCcc--cCCccccc
Confidence 999999987643322 23455664
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=221.00 Aligned_cols=153 Identities=27% Similarity=0.396 Sum_probs=133.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..+ +||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457999999999999999999954 799999999876432 2345688999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---------------
Q 008201 481 YEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--------------- 543 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~--------------- 543 (574)
|||+++++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999643 236799999999999999999999999 9999999999999984
Q ss_pred ----CCcEEEeeecceeecCCC
Q 008201 544 ----DFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 544 ----~~~vKLsDFGLAr~~~~~ 561 (574)
...+||+|||+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS
T ss_pred ccCCceEEEEcccccccccCCc
Confidence 447999999999977543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.47 Aligned_cols=161 Identities=25% Similarity=0.311 Sum_probs=139.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc--------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~--------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
.++|.+.+.||+|+||.||+|. ..+++.||||++...... ....+.+|+.+|+.++||||++++++|...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4579999999999999999998 457999999998765321 2235788999999999999999999999999
Q ss_pred eEEEEEEecCCC-ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 476 RRLLVYEYICNG-SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 476 ~~~LVmEy~~gg-sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
..++||||+.+| +|..++. ....+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999766 9999987 456799999999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCCCccceeeccC
Q 008201 555 ARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 555 Ar~~~~~~~~~~t~v~GT~ 573 (574)
++....... ....+||+
T Consensus 177 a~~~~~~~~--~~~~~gt~ 193 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTI 193 (335)
T ss_dssp CEECCTTCC--BCEECSCG
T ss_pred ceECCCCCc--eeccCCCc
Confidence 998765432 23456665
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=232.90 Aligned_cols=164 Identities=23% Similarity=0.282 Sum_probs=135.7
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~ 478 (574)
+..++|.+.+.||+|+||.||++...+++.||||++...... ..+.+.+|+.+|..++| +||+++++++...+..|
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 445679999999999999999999888999999998755332 23568999999999986 99999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
||||| .+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+|+.+
T Consensus 86 lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99995 58899999974 56799999999999999999999999 999999999999997 678999999999977
Q ss_pred CCCCC-CccceeeccCC
Q 008201 559 PDGDM-GVETRVIGTFG 574 (574)
Q Consensus 559 ~~~~~-~~~t~v~GT~G 574 (574)
..... ...+..+||++
T Consensus 158 ~~~~~~~~~~~~~gt~~ 174 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVN 174 (343)
T ss_dssp ------------CCCCS
T ss_pred CcccccccCCCCcCCcC
Confidence 54332 22345667763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-26 Score=232.62 Aligned_cols=156 Identities=22% Similarity=0.259 Sum_probs=133.1
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC-----CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA-----SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~-----~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 473 (574)
.+....++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3455667899999999999999999995 56899999998643 22344679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGC--------------------------------------HQEPLEWSARQKIAVGAAR 515 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~--------------------------------------~~~~Ls~~~~~~Ia~qIa~ 515 (574)
.+..++||||+++++|.+++... ....+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988421 0122356778899999999
Q ss_pred HHHHHHhhCcCCCeEeeCCCCCCeEEcCCC--cEEEeeecceeecC
Q 008201 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDF--EPLVGDFGLARWQP 559 (574)
Q Consensus 516 gL~yLHs~~~~~gIIHRDLKP~NILLd~~~--~vKLsDFGLAr~~~ 559 (574)
||.|||+. +|+||||||+|||++.++ .+||+|||+++.+.
T Consensus 180 ~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~ 221 (345)
T 3hko_A 180 ALHYLHNQ----GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221 (345)
T ss_dssp HHHHHHHT----TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred HHHHHHHC----CccccCCChhhEEEecCCCceEEEeecccccccc
Confidence 99999999 999999999999998776 89999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=221.86 Aligned_cols=150 Identities=26% Similarity=0.385 Sum_probs=134.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5799999999999999999995 579999999986432 123357899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999974 346799999999999999999999999 999999999999999999999999999997653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-25 Score=225.54 Aligned_cols=151 Identities=28% Similarity=0.349 Sum_probs=135.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||+|.+...... ..+.+.+|+.+|+.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35699999999999999999995 46999999998764332 245799999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC----cEEEeeec
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~----~vKLsDFG 553 (574)
++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997 456789999999999999999999999 999999999999999887 79999999
Q ss_pred ceeecCCC
Q 008201 554 LARWQPDG 561 (574)
Q Consensus 554 LAr~~~~~ 561 (574)
+++.....
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99977543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=226.41 Aligned_cols=148 Identities=30% Similarity=0.401 Sum_probs=131.2
Q ss_pred CCeeEE-eeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQA-NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~-~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+.|.+. +.||+|+||.||+|. ..+++.||||++..........+.+|+.+|..+ +||||+++++++...+..|+|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 468874 789999999999999 457999999999866555567899999999885 79999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc---EEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~---vKLsDFGLAr~~~ 559 (574)
|+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999974 35789999999999999999999999 9999999999999998765 9999999998654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-26 Score=225.71 Aligned_cols=150 Identities=23% Similarity=0.351 Sum_probs=133.9
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CC-------CEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DG-------QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-------~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
..++|.+.+.||+|+||.||+|... ++ ..||+|.+........+.+.+|+.+|+.++||||+++++++...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4568999999999999999999843 34 479999987665555678999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc--------E
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--------P 547 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~--------v 547 (574)
..++||||+.+++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999975 334589999999999999999999999 9999999999999998887 9
Q ss_pred EEeeecceeec
Q 008201 548 LVGDFGLARWQ 558 (574)
Q Consensus 548 KLsDFGLAr~~ 558 (574)
||+|||+++..
T Consensus 161 kl~Dfg~~~~~ 171 (289)
T 4fvq_A 161 KLSDPGISITV 171 (289)
T ss_dssp EECCCCSCTTT
T ss_pred eeccCcccccc
Confidence 99999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=230.03 Aligned_cols=162 Identities=23% Similarity=0.298 Sum_probs=139.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457999999999999999999954 588999999875422 2335688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998863 45799999999999999999999999 999999999999999999999999999997753
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
... ......||+
T Consensus 194 ~~~-~~~~~~gt~ 205 (335)
T 2owb_A 194 DGE-RKKVLCGTP 205 (335)
T ss_dssp TTC-CBCCCCSCC
T ss_pred Ccc-cccccCCCc
Confidence 322 123345554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-25 Score=222.98 Aligned_cols=162 Identities=23% Similarity=0.298 Sum_probs=138.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357999999999999999999954 588999999875432 2335688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998863 45799999999999999999999999 999999999999999999999999999997653
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
... ......||+
T Consensus 168 ~~~-~~~~~~~~~ 179 (294)
T 2rku_A 168 DGE-RKKVLCGTP 179 (294)
T ss_dssp TTC-CBCCCCSCC
T ss_pred Ccc-ccccccCCC
Confidence 322 123345554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=252.50 Aligned_cols=157 Identities=29% Similarity=0.398 Sum_probs=140.1
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
....+++..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|+.++|+||+++++++.. +.
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 3445677788899999999999999999998888889999988543 345679999999999999999999999866 67
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.||||||+.+|+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 89999999999999999653345689999999999999999999999 99999999999999999999999999998
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
...
T Consensus 412 ~~~ 414 (535)
T 2h8h_A 412 LIE 414 (535)
T ss_dssp TCC
T ss_pred ecC
Confidence 664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=233.25 Aligned_cols=168 Identities=29% Similarity=0.404 Sum_probs=137.5
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC----e
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----R 476 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~ 476 (574)
+.+..++|++.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.+|+.++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3445568999999999999999999874 7899999986542 22335667899999999999999999998754 4
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC------cCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC------RVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~------~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ +..+|+||||||+|||++.++.+||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 7999999999999999963 45999999999999999999999851 11269999999999999999999999
Q ss_pred eecceeecCCCCCC-ccceeeccC
Q 008201 551 DFGLARWQPDGDMG-VETRVIGTF 573 (574)
Q Consensus 551 DFGLAr~~~~~~~~-~~t~v~GT~ 573 (574)
|||+|+.+...... .....+||+
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~ 197 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTR 197 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCG
T ss_pred cCCcccccccccCccccccCccCc
Confidence 99999877543321 223355664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=221.69 Aligned_cols=150 Identities=31% Similarity=0.487 Sum_probs=125.0
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC----cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS----QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~----~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
+..++|.+.+.||+|+||.||+|.. .|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 3457899999999999999999997 488999999875432 22357899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC---eEeeCCCCCCeEEcC--------CCcE
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC---IVHRDMRPNNILLTH--------DFEP 547 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g---IIHRDLKP~NILLd~--------~~~v 547 (574)
+||||+++++|.+++. ...+++..+..++.|++.||.|||+. + |+||||||+|||++. ++.+
T Consensus 83 lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcce
Confidence 9999999999999984 56799999999999999999999998 6 999999999999986 6789
Q ss_pred EEeeecceeecCC
Q 008201 548 LVGDFGLARWQPD 560 (574)
Q Consensus 548 KLsDFGLAr~~~~ 560 (574)
||+|||+++....
T Consensus 156 kl~Dfg~~~~~~~ 168 (271)
T 3dtc_A 156 KITDFGLAREWHR 168 (271)
T ss_dssp EECCCCC------
T ss_pred EEccCCccccccc
Confidence 9999999986643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=220.70 Aligned_cols=149 Identities=24% Similarity=0.424 Sum_probs=133.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe----------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE---------- 473 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~---------- 473 (574)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ..+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457999999999999999999964 79999999987542 457889999999999999999999864
Q ss_pred ------CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcE
Q 008201 474 ------DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547 (574)
Q Consensus 474 ------~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~v 547 (574)
....++||||+++++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCCE
Confidence 34589999999999999999765556899999999999999999999999 99999999999999999999
Q ss_pred EEeeecceeecCCC
Q 008201 548 LVGDFGLARWQPDG 561 (574)
Q Consensus 548 KLsDFGLAr~~~~~ 561 (574)
||+|||+++.....
T Consensus 162 kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 162 KIGDFGLVTSLKND 175 (284)
T ss_dssp EECCCTTCEESSCC
T ss_pred EECcchhheecccc
Confidence 99999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.18 Aligned_cols=149 Identities=29% Similarity=0.421 Sum_probs=123.1
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCC--e
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDR--R 476 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~--~ 476 (574)
...++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+|..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999984 579999999886432 223356889999999997 999999999998654 6
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+||||+. ++|..++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999995 689998863 5789999999999999999999999 99999999999999999999999999999
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
.+.
T Consensus 158 ~~~ 160 (388)
T 3oz6_A 158 SFV 160 (388)
T ss_dssp ESS
T ss_pred ccc
Confidence 764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-25 Score=220.76 Aligned_cols=149 Identities=29% Similarity=0.429 Sum_probs=135.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
..|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+|+.++||||+++++++...+..|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4699999999999999999984 5699999999876543 3346799999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
+++++|.+++. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 102 LGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999984 46799999999999999999999999 9999999999999999999999999999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-25 Score=219.53 Aligned_cols=151 Identities=21% Similarity=0.280 Sum_probs=134.3
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
+..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++..+ +|+||+++++++......++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 4557899999999999999999994 679999999886432 334688999999999 799999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc-----EEEeeecce
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-----PLVGDFGLA 555 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~-----vKLsDFGLA 555 (574)
|||+ +++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+|
T Consensus 85 ~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 85 IDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999 9999999975 345699999999999999999999998 9999999999999987766 999999999
Q ss_pred eecCCC
Q 008201 556 RWQPDG 561 (574)
Q Consensus 556 r~~~~~ 561 (574)
+.....
T Consensus 159 ~~~~~~ 164 (298)
T 1csn_A 159 KFYRDP 164 (298)
T ss_dssp EESBCT
T ss_pred cccccc
Confidence 977543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-25 Score=219.42 Aligned_cols=151 Identities=25% Similarity=0.332 Sum_probs=133.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 56899999999999999999995 46999999998754322 2356889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc---EEEeeecceeec
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFGLARWQ 558 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~---vKLsDFGLAr~~ 558 (574)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999988863 45799999999999999999999999 9999999999999986655 999999999876
Q ss_pred CCC
Q 008201 559 PDG 561 (574)
Q Consensus 559 ~~~ 561 (574)
...
T Consensus 159 ~~~ 161 (284)
T 3kk8_A 159 NDS 161 (284)
T ss_dssp CSS
T ss_pred ccC
Confidence 543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=223.98 Aligned_cols=150 Identities=27% Similarity=0.386 Sum_probs=133.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 345799999999999999999985 458899999986432 1234568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999864 35689999999999999999999998 99999999999999999999999999997554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=226.77 Aligned_cols=158 Identities=27% Similarity=0.413 Sum_probs=137.2
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEe-
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIE- 473 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~- 473 (574)
.+..+....++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3444555678899999999999999999995 579999999987543 3456789999999999 79999999999987
Q ss_pred -----CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEE
Q 008201 474 -----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (574)
Q Consensus 474 -----~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vK 548 (574)
.+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEE
Confidence 46889999999999999999764456799999999999999999999999 999999999999999999999
Q ss_pred EeeecceeecC
Q 008201 549 VGDFGLARWQP 559 (574)
Q Consensus 549 LsDFGLAr~~~ 559 (574)
|+|||+++...
T Consensus 170 l~Dfg~~~~~~ 180 (326)
T 2x7f_A 170 LVDFGVSAQLD 180 (326)
T ss_dssp ECCCTTTC---
T ss_pred EeeCcCceecC
Confidence 99999998664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=227.29 Aligned_cols=151 Identities=25% Similarity=0.261 Sum_probs=130.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46899999999999999999995 468999999987543322 35688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999973 45799999999999999999999999 999999999999999999999999999987654
Q ss_pred C
Q 008201 561 G 561 (574)
Q Consensus 561 ~ 561 (574)
.
T Consensus 187 ~ 187 (309)
T 2h34_A 187 E 187 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=227.65 Aligned_cols=156 Identities=28% Similarity=0.447 Sum_probs=134.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe--------CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL--------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~--------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
++..++|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.+|+.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 34456899999999999999999985 3477899999875432 2335688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCC
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPN 537 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~ 537 (574)
...+..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~ 186 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAAR 186 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccc
Confidence 99999999999999999999997532 13489999999999999999999999 9999999999
Q ss_pred CeEEcCCCcEEEeeecceeecCCC
Q 008201 538 NILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 538 NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|||++.++.+||+|||+++.....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTT
T ss_pred eEEEcCCCCEEEcccccccccccc
Confidence 999999999999999999977543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=223.34 Aligned_cols=151 Identities=24% Similarity=0.322 Sum_probs=132.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||+|.. .++..+|+|.+..... ...+.+.+|+.+|+.++||||+++++++...+..|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4699999999999999999995 4689999999876543 3446799999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE---cCCCcEEEeeecceeec
Q 008201 484 ICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQ 558 (574)
Q Consensus 484 ~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL---d~~~~vKLsDFGLAr~~ 558 (574)
+++++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999988532 346799999999999999999999999 99999999999999 45688999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 178 ~~ 179 (285)
T 3is5_A 178 KS 179 (285)
T ss_dssp --
T ss_pred CC
Confidence 54
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=252.45 Aligned_cols=166 Identities=22% Similarity=0.228 Sum_probs=141.7
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~ 476 (574)
.+..++|.+.+.||+|+||.||+|+. .+++.||||+++.. .....+.+..|..+|..+ +||||+.+++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34567899999999999999999995 46899999998753 223445688899999887 69999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
+||||||+++|+|..++.. ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+
T Consensus 417 ~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999999974 35799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCCccceeeccCC
Q 008201 557 WQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~G 574 (574)
....... ....++||++
T Consensus 491 ~~~~~~~-~~~~~~GT~~ 507 (674)
T 3pfq_A 491 ENIWDGV-TTKTFCGTPD 507 (674)
T ss_dssp ECCCTTC-CBCCCCSCSS
T ss_pred ccccCCc-ccccccCCCc
Confidence 6543332 3456788864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=219.97 Aligned_cols=148 Identities=28% Similarity=0.366 Sum_probs=134.3
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 57999999999999999999954 699999999875433 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 87 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999886 456799999999999999999999998 99999999999999999999999999998664
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=228.31 Aligned_cols=157 Identities=25% Similarity=0.327 Sum_probs=128.1
Q ss_pred CeeEE---eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 008201 407 GFSQA---NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 407 ~y~~~---~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm 481 (574)
+|.+. +.||+|+||.||+|.. .+|+.||||++... ....+.+|+.+|..+. ||||+++++++.+.+..|+||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 35553 7899999999999995 46999999998643 3456889999999997 999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC---cEEEeeecceeec
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EPLVGDFGLARWQ 558 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~---~vKLsDFGLAr~~ 558 (574)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 86 ELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999974 56799999999999999999999999 999999999999998765 8999999999976
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
...... ....+||+
T Consensus 160 ~~~~~~-~~~~~~t~ 173 (325)
T 3kn6_A 160 PPDNQP-LKTPCFTL 173 (325)
T ss_dssp CC-------------
T ss_pred CCCCCc-ccccCCCc
Confidence 543322 23345554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=234.71 Aligned_cols=163 Identities=27% Similarity=0.289 Sum_probs=137.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--RRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~~LV 480 (574)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++|+.++||||+++++++...+ ..|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999954 599999999875432 33456889999999999999999999998765 78999
Q ss_pred EEecCCCChHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE----cCCCcEEEeeecce
Q 008201 481 YEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLVGDFGLA 555 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~-~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL----d~~~~vKLsDFGLA 555 (574)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+|
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999996432 23499999999999999999999999 99999999999999 77788999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+....... ....+||+
T Consensus 164 ~~~~~~~~--~~~~~gt~ 179 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTE 179 (396)
T ss_dssp EECCCGGG--SSCSSSCC
T ss_pred eEccCCCc--cccccCCc
Confidence 98754332 22345664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=227.18 Aligned_cols=152 Identities=28% Similarity=0.407 Sum_probs=135.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEE--eCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI--EDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~--~~~~~ 477 (574)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|+.+|+.++||||+++++++. ..+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 45799999999999999999983 468899999988665555567999999999999999999999987 45678
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999964 234699999999999999999999998 999999999999999999999999999997
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
....
T Consensus 177 ~~~~ 180 (327)
T 3lxl_A 177 LPLD 180 (327)
T ss_dssp CCTT
T ss_pred cccC
Confidence 7543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-25 Score=219.26 Aligned_cols=150 Identities=25% Similarity=0.333 Sum_probs=134.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCc------chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.++|.+.+.||+|+||.||+|... +|+.||+|.+...... ..+.+.+|+.+|+.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356999999999999999999965 6999999998754321 246789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC----cEEEeeec
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~----~vKLsDFG 553 (574)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999963 45789999999999999999999999 999999999999998877 89999999
Q ss_pred ceeecCC
Q 008201 554 LARWQPD 560 (574)
Q Consensus 554 LAr~~~~ 560 (574)
+++....
T Consensus 158 ~~~~~~~ 164 (283)
T 3bhy_A 158 IAHKIEA 164 (283)
T ss_dssp TCEECC-
T ss_pred cceeccC
Confidence 9997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=242.19 Aligned_cols=161 Identities=25% Similarity=0.335 Sum_probs=134.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
.++|.+.+.||+|+||.||+|+. .++..||+|++.... ......+.+|+.+|+.++||||++++++|...+..|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 44699999999999999999995 468999999987543 233567899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC---CcEEEeeecceeec
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDFGLARWQ 558 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~---~~vKLsDFGLAr~~ 558 (574)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.. +.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999988863 45799999999999999999999999 99999999999999764 55999999999987
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
..... ....+||+
T Consensus 190 ~~~~~--~~~~~gt~ 202 (494)
T 3lij_A 190 ENQKK--MKERLGTA 202 (494)
T ss_dssp BTTBC--BCCCCSCT
T ss_pred CCCcc--ccccCCCc
Confidence 54332 23456775
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=230.39 Aligned_cols=163 Identities=26% Similarity=0.372 Sum_probs=131.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc-----hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG-----DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~-----~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
..++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+|+.+|+.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 456899999999999999999995 469999999987543211 24688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++||||+.+ +|..++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999965 88888864 345688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
+..... ..+..+||+
T Consensus 162 ~~~~~~-~~~~~~~t~ 176 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTR 176 (346)
T ss_dssp TTSCCC-CCCCSCCCC
T ss_pred ccCCcc-cCCcccccc
Confidence 643322 223345554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=237.57 Aligned_cols=163 Identities=20% Similarity=0.284 Sum_probs=130.5
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--------cchhHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--------QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 473 (574)
...++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3467899999999999999999984 5689999999875321 11235889999999999999999999985
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC---CcEEEe
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVG 550 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~---~~vKLs 550 (574)
.+..|+||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999999886 456799999999999999999999998 99999999999999754 459999
Q ss_pred eecceeecCCCCCCccceeeccCC
Q 008201 551 DFGLARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 551 DFGLAr~~~~~~~~~~t~v~GT~G 574 (574)
|||+|+...... .....+||++
T Consensus 285 DFG~a~~~~~~~--~~~~~~gt~~ 306 (419)
T 3i6u_A 285 DFGHSKILGETS--LMRTLCGTPT 306 (419)
T ss_dssp CSSTTTSCC-------------CT
T ss_pred ecccceecCCCc--cccccCCCCC
Confidence 999999765432 2344667753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=239.77 Aligned_cols=162 Identities=24% Similarity=0.341 Sum_probs=136.9
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-------------cchhHHHHHHHHHHhcCCCCeeEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-------------QGDHEFCSEVEVLSCAQHRNVVMLIG 469 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~iL~~L~HpNIV~L~g 469 (574)
..++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456899999999999999999995 4689999999875431 22357899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC---c
Q 008201 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---E 546 (574)
Q Consensus 470 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~---~ 546 (574)
+|...+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998863 45799999999999999999999999 999999999999998775 6
Q ss_pred EEEeeecceeecCCCCCCccceeeccC
Q 008201 547 PLVGDFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 547 vKLsDFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
+||+|||+|+.+..... ....+||+
T Consensus 188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~ 212 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK--LRDRLGTA 212 (504)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCSCT
T ss_pred EEEEECCCCEEcCCCCc--cccccCCc
Confidence 99999999998754332 23456665
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=228.61 Aligned_cols=158 Identities=28% Similarity=0.458 Sum_probs=123.6
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCC-C---CEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPD-G---QAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g---~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 473 (574)
++.+..++|.+.+.||+|+||.||+|.... + ..||||.+.... ....+.+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 445667789999999999999999999543 3 279999987542 2334679999999999999999999999987
Q ss_pred CCeE------EEEEEecCCCChHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC
Q 008201 474 DRRR------LLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH 543 (574)
Q Consensus 474 ~~~~------~LVmEy~~ggsL~~~L~~~----~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~ 543 (574)
.... ++||||+++++|.+++... ....+++..+..++.||+.||.|||+. ||+||||||+|||++.
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAE 172 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcC
Confidence 7655 9999999999999998532 123689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecceeecCCC
Q 008201 544 DFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 544 ~~~vKLsDFGLAr~~~~~ 561 (574)
++.+||+|||+|+.....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSG 190 (323)
T ss_dssp TSCEEECCCCC-------
T ss_pred CCCEEEeecccccccccc
Confidence 999999999999876443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=231.46 Aligned_cols=152 Identities=18% Similarity=0.217 Sum_probs=126.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCC------CCEEEEEEeecCCCcch-----------hHHHHHHHHHHhcCCCCee
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQGD-----------HEFCSEVEVLSCAQHRNVV 465 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~VAVK~l~~~~~~~~-----------~~f~~Ei~iL~~L~HpNIV 465 (574)
...++|.+.+.||+|+||.||+|.... ++.||||++........ ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345689999999999999999998643 47899999875432111 1234455666777899999
Q ss_pred EEEEEEEeC----CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE
Q 008201 466 MLIGFCIED----RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL 541 (574)
Q Consensus 466 ~L~g~~~~~----~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL 541 (574)
++++++... ...||||||+ +++|.+++.. ....+++..++.|+.||+.||.|||+. +|+||||||+|||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill 185 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLL 185 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEE
Confidence 999999764 4589999999 9999999975 456799999999999999999999999 99999999999999
Q ss_pred c--CCCcEEEeeecceeecCC
Q 008201 542 T--HDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 542 d--~~~~vKLsDFGLAr~~~~ 560 (574)
+ .++.+||+|||+|+.+..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~ 206 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCP 206 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSG
T ss_pred ecCCCCeEEEEECCcceeccc
Confidence 9 889999999999987754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=228.66 Aligned_cols=162 Identities=29% Similarity=0.449 Sum_probs=132.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCE----EEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQA----VAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
.++|.+.+.||+|+||.||+|.. .+++. ||+|.+.... ......+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 45799999999999999999984 34554 7888775433 233356788999999999999999999986 55789
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 91 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999964 345789999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCC-Cccceeecc
Q 008201 559 PDGDM-GVETRVIGT 572 (574)
Q Consensus 559 ~~~~~-~~~t~v~GT 572 (574)
..... ...+...||
T Consensus 166 ~~~~~~~~~~~~~~~ 180 (325)
T 3kex_A 166 PPDDKQLLYSEAKTP 180 (325)
T ss_dssp CCCTTCCC-----CC
T ss_pred CcccccccccCCCCc
Confidence 54432 222334454
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=224.19 Aligned_cols=150 Identities=25% Similarity=0.378 Sum_probs=132.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||+|.+..........+.+|+.+|+.++||||+++++++...+..|+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45799999999999999999995 47999999999865544556789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE---cCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL---d~~~~vKLsDFGLAr~~~~ 560 (574)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998863 45789999999999999999999999 99999999999999 7789999999999986543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=220.55 Aligned_cols=149 Identities=35% Similarity=0.588 Sum_probs=130.3
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcch-------hHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGD-------HEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~-------~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
..++|.+.+.||+|+||.||+|.. .+++.||+|.+........ +.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346899999999999999999995 5799999999875443221 57899999999999999999999986654
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC--eEeeCCCCCCeEEcCCCc-----EE
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFE-----PL 548 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g--IIHRDLKP~NILLd~~~~-----vK 548 (574)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++. +|
T Consensus 97 --~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred --eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999988864 456799999999999999999999998 8 999999999999988776 99
Q ss_pred EeeecceeecC
Q 008201 549 VGDFGLARWQP 559 (574)
Q Consensus 549 LsDFGLAr~~~ 559 (574)
|+|||+++...
T Consensus 170 l~Dfg~~~~~~ 180 (287)
T 4f0f_A 170 VADFGLSQQSV 180 (287)
T ss_dssp ECCCTTCBCCS
T ss_pred eCCCCcccccc
Confidence 99999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-26 Score=237.21 Aligned_cols=152 Identities=30% Similarity=0.421 Sum_probs=131.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
+..++|.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.+|+.++||||+++++++...+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34567999999999999999999842 467899999864422 33346889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC---cE
Q 008201 476 RRLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF---EP 547 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~-----~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~---~v 547 (574)
..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999996532 24689999999999999999999999 999999999999999554 59
Q ss_pred EEeeecceeec
Q 008201 548 LVGDFGLARWQ 558 (574)
Q Consensus 548 KLsDFGLAr~~ 558 (574)
||+|||+|+..
T Consensus 224 kL~DFG~a~~~ 234 (367)
T 3l9p_A 224 KIGDFGMARDI 234 (367)
T ss_dssp EECCCHHHHHH
T ss_pred EECCCcccccc
Confidence 99999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=220.85 Aligned_cols=150 Identities=24% Similarity=0.375 Sum_probs=134.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999954 68899999986432 22345789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999874 35689999999999999999999998 999999999999999999999999999986643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=229.45 Aligned_cols=152 Identities=20% Similarity=0.304 Sum_probs=136.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcch-----------------hHHHHHHHHHHhcCCCCeeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGD-----------------HEFCSEVEVLSCAQHRNVVM 466 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~-----------------~~f~~Ei~iL~~L~HpNIV~ 466 (574)
..++|.+.+.||+|+||.||+|.. +|+.||+|.+........ ..+.+|+.+|+.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999999999 999999999875422111 67999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCChHHH------HhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCe
Q 008201 467 LIGFCIEDRRRLLVYEYICNGSLDSH------LYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNI 539 (574)
Q Consensus 467 L~g~~~~~~~~~LVmEy~~ggsL~~~------L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NI 539 (574)
+++++...+..|+||||+++++|.++ +.......+++..+..++.||+.||.|||+ . ||+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhE
Confidence 99999999999999999999999998 654336789999999999999999999999 7 999999999999
Q ss_pred EEcCCCcEEEeeecceeecCC
Q 008201 540 LLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 540 LLd~~~~vKLsDFGLAr~~~~ 560 (574)
|++.++.+||+|||+++....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp EECTTSCEEECCCTTCEECBT
T ss_pred EEcCCCcEEEecccccccccc
Confidence 999999999999999997644
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=228.65 Aligned_cols=158 Identities=22% Similarity=0.311 Sum_probs=134.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .+.+|+++|.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45799999999999999999995 4689999999875432 345788888887 79999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC----CcEEEeeecceeec
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD----FEPLVGDFGLARWQ 558 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~----~~vKLsDFGLAr~~ 558 (574)
|+.+|+|.+++. ....+++..+..++.||+.||.|||+. ||+||||||+|||+... +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999987 456799999999999999999999999 99999999999998543 35999999999977
Q ss_pred CCCCCCccceeeccC
Q 008201 559 PDGDMGVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~ 573 (574)
..... .....+||+
T Consensus 171 ~~~~~-~~~~~~gt~ 184 (342)
T 2qr7_A 171 RAENG-LLMTPCYTA 184 (342)
T ss_dssp BCTTC-CBCCSSCCS
T ss_pred cCCCC-ceeccCCCc
Confidence 54332 233456665
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=219.11 Aligned_cols=153 Identities=24% Similarity=0.388 Sum_probs=137.0
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.+..++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345678999999999999999999964 79999999987532 23345789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccc
Confidence 999999999999999964 35689999999999999999999999 999999999999999999999999999987
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
...
T Consensus 161 ~~~ 163 (276)
T 2h6d_A 161 MSD 163 (276)
T ss_dssp CCC
T ss_pred cCC
Confidence 654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-25 Score=219.50 Aligned_cols=151 Identities=26% Similarity=0.329 Sum_probs=134.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---------chhHHHHHHHHHHhcC-CCCeeEEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---------GDHEFCSEVEVLSCAQ-HRNVVMLIGFCIE 473 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---------~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~ 473 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.+|+.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999995 46899999998765321 1245789999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999974 45789999999999999999999999 99999999999999999999999999
Q ss_pred ceeecCCC
Q 008201 554 LARWQPDG 561 (574)
Q Consensus 554 LAr~~~~~ 561 (574)
+++.....
T Consensus 170 ~~~~~~~~ 177 (298)
T 1phk_A 170 FSCQLDPG 177 (298)
T ss_dssp TCEECCTT
T ss_pred chhhcCCC
Confidence 99977543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=229.20 Aligned_cols=149 Identities=30% Similarity=0.430 Sum_probs=132.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
..|...+.||+|+||.||+|+. .+|+.||||++....... .+.+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999994 579999999987543322 246889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 688887753 346799999999999999999999999 999999999999999999999999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=230.17 Aligned_cols=149 Identities=26% Similarity=0.411 Sum_probs=128.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
..++|.+.+.||+|+||.||+|. ..+|+.||||++....... ...+.+|+.+|+.++||||+++++++...+..|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 34579999999999999999998 4579999999987543322 34678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc-----CCCcEEEeeecce
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-----HDFEPLVGDFGLA 555 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd-----~~~~vKLsDFGLA 555 (574)
|||+. ++|.+++.. ...+++..+..|+.||+.||.|||+. +|+||||||+|||++ ..+.+||+|||+|
T Consensus 112 ~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99996 599999873 45699999999999999999999999 999999999999994 4556999999999
Q ss_pred eecC
Q 008201 556 RWQP 559 (574)
Q Consensus 556 r~~~ 559 (574)
+.+.
T Consensus 185 ~~~~ 188 (329)
T 3gbz_A 185 RAFG 188 (329)
T ss_dssp HHHC
T ss_pred cccC
Confidence 8764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=228.56 Aligned_cols=157 Identities=28% Similarity=0.387 Sum_probs=133.7
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc-----------hhHHHHHHHHHHhcCCCCee
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG-----------DHEFCSEVEVLSCAQHRNVV 465 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~-----------~~~f~~Ei~iL~~L~HpNIV 465 (574)
.+.++....++|.+.+.||+|+||.||+|...+|+.||||++....... .+.+.+|+.+|+.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567788899999999999999999999998789999999886533221 15789999999999999999
Q ss_pred EEEEEEEe-----CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeE
Q 008201 466 MLIGFCIE-----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 540 (574)
Q Consensus 466 ~L~g~~~~-----~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NIL 540 (574)
++++++.. ....|+||||+. ++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEE
Confidence 99999854 236899999996 688888864 455799999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeecceeecC
Q 008201 541 LTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 541 Ld~~~~vKLsDFGLAr~~~ 559 (574)
++.++.+||+|||+++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~ 185 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDT 185 (362)
T ss_dssp ECTTCCEEECCTTC-----
T ss_pred EcCCCCEEEEecCcccccc
Confidence 9999999999999998554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=228.60 Aligned_cols=151 Identities=26% Similarity=0.484 Sum_probs=127.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCE----EEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQA----VAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
.++|++.+.||+|+||.||+|+. .+++. ||+|.+.... ....+.+.+|+.+|+.++||||++++++|...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 45799999999999999999994 34544 5888775433 234567999999999999999999999998764 78
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+|+||+++|+|.+++.. ....+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999975 456799999999999999999999999 9999999999999999999999999999977
Q ss_pred CCC
Q 008201 559 PDG 561 (574)
Q Consensus 559 ~~~ 561 (574)
...
T Consensus 168 ~~~ 170 (327)
T 3poz_A 168 GAE 170 (327)
T ss_dssp TTT
T ss_pred cCC
Confidence 543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=228.70 Aligned_cols=148 Identities=28% Similarity=0.430 Sum_probs=129.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+|+.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999954 79999999987543222 22456799999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
+. ++|.+++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 95 689888865 355799999999999999999999999 99999999999999999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=228.25 Aligned_cols=165 Identities=23% Similarity=0.328 Sum_probs=141.9
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcc--------hhHHHHHHHHHHhc-CCCCeeEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCA-QHRNVVMLIGF 470 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L-~HpNIV~L~g~ 470 (574)
.....++|.+.+.||+|+||.||+|... +|+.||||++....... .+.+.+|+.+|+.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445568999999999999999999964 79999999987653211 24578999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 471 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
+...+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999963 45799999999999999999999998 99999999999999999999999
Q ss_pred eecceeecCCCCCCccceeeccC
Q 008201 551 DFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 551 DFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
|||++..+..... ....+||+
T Consensus 243 DfG~~~~~~~~~~--~~~~~gt~ 263 (365)
T 2y7j_A 243 DFGFSCHLEPGEK--LRELCGTP 263 (365)
T ss_dssp CCTTCEECCTTCC--BCCCCSCG
T ss_pred ecCcccccCCCcc--cccCCCCC
Confidence 9999998764432 23456664
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=226.92 Aligned_cols=157 Identities=29% Similarity=0.439 Sum_probs=136.5
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeC-CC-----CEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLP-DG-----QAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-----~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
.+++..++|.+.+.||+|+||.||+|... ++ ..||+|.+..... ...+.+.+|+.+|+.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35666789999999999999999999843 23 4799999875433 2345689999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCe
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 539 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NI 539 (574)
...+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||+. +|+||||||+||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NI 195 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNV 195 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGC
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceE
Confidence 99999999999999999999986421 35689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeecceeecCC
Q 008201 540 LLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 540 LLd~~~~vKLsDFGLAr~~~~ 560 (574)
|++.++.+||+|||+++....
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~ 216 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMN 216 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGG
T ss_pred EECCCCeEEECcccccccccc
Confidence 999999999999999986643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=221.49 Aligned_cols=152 Identities=24% Similarity=0.358 Sum_probs=127.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+|+.++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999994 5799999999875332 2235688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 481 YEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|||+.+++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999988532 356789999999999999999999999 9999999999999999999999999999876
Q ss_pred CC
Q 008201 559 PD 560 (574)
Q Consensus 559 ~~ 560 (574)
..
T Consensus 187 ~~ 188 (310)
T 2wqm_A 187 SS 188 (310)
T ss_dssp --
T ss_pred cC
Confidence 44
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=223.78 Aligned_cols=153 Identities=24% Similarity=0.354 Sum_probs=133.9
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe----CCe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRR 476 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~ 476 (574)
.+..++|.+.+.||+|+||.||++.. .+|+.||||++........+.+.+|+.+++.++||||+++++++.. .+.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 34556899999999999999999995 6799999999876555555679999999999999999999999973 347
Q ss_pred EEEEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 477 RLLVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
.|+||||+.+++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 89999999999999988642 356799999999999999999999999 999999999999999999999999999
Q ss_pred eeec
Q 008201 555 ARWQ 558 (574)
Q Consensus 555 Ar~~ 558 (574)
++..
T Consensus 181 ~~~~ 184 (317)
T 2buj_A 181 MNQA 184 (317)
T ss_dssp CEES
T ss_pred chhc
Confidence 8865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-25 Score=225.87 Aligned_cols=149 Identities=26% Similarity=0.451 Sum_probs=130.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|.+.+.||+|+||.||+|+.. +|+.||+|++....... .+.+.+|+.+|+.++||||+++++++...+..|+|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 47999999999999999999954 59999999886543322 3457899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|+.+++|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999998888765 456799999999999999999999999 999999999999999999999999999986643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=241.38 Aligned_cols=162 Identities=27% Similarity=0.362 Sum_probs=139.9
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+|+.++||||++++++|...+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457999999999999999999954 79999999987543 2344679999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE---cCCCcEEEeeeccee
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLAR 556 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL---d~~~~vKLsDFGLAr 556 (574)
||||+.+++|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+|+
T Consensus 104 v~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999886 456799999999999999999999999 99999999999999 567899999999998
Q ss_pred ecCCCCCCccceeeccC
Q 008201 557 WQPDGDMGVETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~ 573 (574)
.+..... ....+||+
T Consensus 178 ~~~~~~~--~~~~~gt~ 192 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTA 192 (484)
T ss_dssp HBCCCCS--HHHHTTGG
T ss_pred Ecccccc--cccCCCCc
Confidence 7754432 22345554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=224.79 Aligned_cols=162 Identities=26% Similarity=0.367 Sum_probs=139.1
Q ss_pred cchhHHHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEE
Q 008201 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVML 467 (574)
Q Consensus 396 fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L 467 (574)
+....+++..++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.+|..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45567778889999999999999999999973 35789999998754332 234688999999999 68999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCChHHHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEee
Q 008201 468 IGFCIEDR-RRLLVYEYICNGSLDSHLYGCHQ--------------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532 (574)
Q Consensus 468 ~g~~~~~~-~~~LVmEy~~ggsL~~~L~~~~~--------------~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHR 532 (574)
++++...+ ..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+. +|+||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~ 172 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHR 172 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCS
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----Ccccc
Confidence 99998754 58999999999999999975322 2288999999999999999999999 99999
Q ss_pred CCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 533 DMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 533 DLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||||+|||++.++.+||+|||+++.....
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred cCccceEEECCCCCEEECCCccccccccC
Confidence 99999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=232.33 Aligned_cols=151 Identities=26% Similarity=0.333 Sum_probs=134.5
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
+..++|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++...+..|+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34567999999999999999999954 699999999876532 2235689999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp ECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999974 456899999999999999999999842 7999999999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=223.00 Aligned_cols=151 Identities=32% Similarity=0.516 Sum_probs=126.0
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
.++..++|.+.+.||+|+||.||+|... ..+|+|+++..... ..+.+.+|+.+|+.++||||+++++++ ..+..+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 4566788999999999999999999853 35999998755432 235689999999999999999999965 556789
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+||||+.+++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999864 456799999999999999999999999 9999999999999999999999999999865
Q ss_pred C
Q 008201 559 P 559 (574)
Q Consensus 559 ~ 559 (574)
.
T Consensus 171 ~ 171 (289)
T 3og7_A 171 S 171 (289)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=220.19 Aligned_cols=151 Identities=28% Similarity=0.401 Sum_probs=130.5
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
....+|.+.+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34568999999999999999999954 59999999987542 4567899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+.+++|.+++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999863 356799999999999999999999999 999999999999999999999999999987654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=226.74 Aligned_cols=160 Identities=30% Similarity=0.430 Sum_probs=138.8
Q ss_pred cchhHHHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEE
Q 008201 396 FSYAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLI 468 (574)
Q Consensus 396 fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~ 468 (574)
+...++++..++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+|+.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344456777889999999999999999999843 377899999875432 2234688999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeE
Q 008201 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCH--------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNIL 540 (574)
Q Consensus 469 g~~~~~~~~~LVmEy~~ggsL~~~L~~~~--------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NIL 540 (574)
+++...+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+. ||+||||||+|||
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIl 170 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCM 170 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEE
Confidence 99999999999999999999999986421 25678999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeecceeecC
Q 008201 541 LTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 541 Ld~~~~vKLsDFGLAr~~~ 559 (574)
++.++.+||+|||+++...
T Consensus 171 i~~~~~~kl~Dfg~~~~~~ 189 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIY 189 (322)
T ss_dssp ECTTCCEEECCTTCCCGGG
T ss_pred EcCCCeEEECcCccccccc
Confidence 9999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=221.10 Aligned_cols=149 Identities=23% Similarity=0.387 Sum_probs=132.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
..++|++.+.||+|+||.||+|... +|+.||+|.+........+.+.+|+.+|+.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999964 589999999887666666789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+++++|..++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 9999999998864 345799999999999999999999999 999999999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-25 Score=220.89 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=131.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe----------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE---------- 473 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~---------- 473 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||.+... ......+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35799999999999999999995 57999999998643 2334578899999999999999999999865
Q ss_pred ---CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 474 ---DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 474 ---~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
.+..|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEe
Confidence 3568999999999999999975 345678899999999999999999999 99999999999999999999999
Q ss_pred eecceeecC
Q 008201 551 DFGLARWQP 559 (574)
Q Consensus 551 DFGLAr~~~ 559 (574)
|||+++...
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=218.28 Aligned_cols=150 Identities=23% Similarity=0.294 Sum_probs=131.2
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
.|.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556899999999999994 5689999999887655556789999999999999999999999999999999999999
Q ss_pred CCChHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeecceeecCC
Q 008201 486 NGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPD 560 (574)
Q Consensus 486 ggsL~~~L~~~~-~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFGLAr~~~~ 560 (574)
+++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999997532 34567888999999999999999999 9999999999999987 89999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=224.37 Aligned_cols=148 Identities=28% Similarity=0.414 Sum_probs=129.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEe--------C
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIE--------D 474 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------~ 474 (574)
++|.+.+.||+|+||.||+|+. .+|+.||+|++...... ....+.+|+.+|+.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999995 57999999988654332 23568899999999999999999999987 4
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
+..|+||||+. ++|...+.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccC-CCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 46899999996 577777754 345799999999999999999999999 999999999999999999999999999
Q ss_pred eeecC
Q 008201 555 ARWQP 559 (574)
Q Consensus 555 Ar~~~ 559 (574)
|+.+.
T Consensus 171 a~~~~ 175 (351)
T 3mi9_A 171 ARAFS 175 (351)
T ss_dssp CEECC
T ss_pred ccccc
Confidence 99765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=221.09 Aligned_cols=148 Identities=31% Similarity=0.476 Sum_probs=130.9
Q ss_pred eeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLL 479 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 479 (574)
|++.+.||+|+||.||++.+ .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 59999999999999999864 2588999999876532 2245689999999999999999999999874 67899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999963 4599999999999999999999999 99999999999999999999999999999876
Q ss_pred CCC
Q 008201 560 DGD 562 (574)
Q Consensus 560 ~~~ 562 (574)
...
T Consensus 186 ~~~ 188 (318)
T 3lxp_A 186 EGH 188 (318)
T ss_dssp TTC
T ss_pred ccc
Confidence 543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=247.14 Aligned_cols=155 Identities=29% Similarity=0.446 Sum_probs=133.6
Q ss_pred HHhhcCCeeEEe-eeeccCcEEEEEEEeC---CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 401 LELATGGFSQAN-FLAEGGFGSVHRGVLP---DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 401 le~~~~~y~~~~-~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
+.+...+|.+.+ .||+|+||.||+|.+. ++..||||+++.... ...+.|.+|+.+|+.++||||++++++|.. +
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 344556677766 8999999999999853 466799999986533 345679999999999999999999999976 5
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..||||||+++|+|.+++.. ....+++..+..|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 69999999999999999964 356799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCC
Q 008201 556 RWQPDG 561 (574)
Q Consensus 556 r~~~~~ 561 (574)
+.+...
T Consensus 484 ~~~~~~ 489 (613)
T 2ozo_A 484 KALGAD 489 (613)
T ss_dssp TTCC--
T ss_pred ccccCC
Confidence 876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=231.97 Aligned_cols=161 Identities=23% Similarity=0.281 Sum_probs=134.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcC--CCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQ--HRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~~~~LV 480 (574)
..+|.+.+.||+|+||.||+|...+++.||||++..... .....+.+|+.+|+.++ ||||+++++++...+..|||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 346999999999999999999977799999999876533 23357899999999997 59999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||+ .+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 135 ~E~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 MEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Eec-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 994 68999999974 45789999999999999999999998 999999999999995 58999999999997754
Q ss_pred CCC-CccceeeccC
Q 008201 561 GDM-GVETRVIGTF 573 (574)
Q Consensus 561 ~~~-~~~t~v~GT~ 573 (574)
... ......+||+
T Consensus 207 ~~~~~~~~~~~gt~ 220 (390)
T 2zmd_A 207 DTTSVVKDSQVGAV 220 (390)
T ss_dssp -------CCSCCCG
T ss_pred CCccccCCCCCcCC
Confidence 332 1234456775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=224.81 Aligned_cols=155 Identities=23% Similarity=0.259 Sum_probs=126.3
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc------chhHHHHHHHHHHhc----CCCCeeEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCA----QHRNVVMLIG 469 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L----~HpNIV~L~g 469 (574)
.+...++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++..+ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345567899999999999999999984 57899999998754322 223466799999998 8999999999
Q ss_pred EEEeCCeEEEEEEe-cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc-CCCcE
Q 008201 470 FCIEDRRRLLVYEY-ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEP 547 (574)
Q Consensus 470 ~~~~~~~~~LVmEy-~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd-~~~~v 547 (574)
++...+..++|||| +.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999974 45699999999999999999999999 999999999999999 88999
Q ss_pred EEeeecceeecCCC
Q 008201 548 LVGDFGLARWQPDG 561 (574)
Q Consensus 548 KLsDFGLAr~~~~~ 561 (574)
||+|||+++.....
T Consensus 180 kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 180 KLIDFGSGALLHDE 193 (312)
T ss_dssp EECCCSSCEECCSS
T ss_pred EEEEcchhhhcccC
Confidence 99999999977543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=224.03 Aligned_cols=156 Identities=23% Similarity=0.358 Sum_probs=121.2
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
+.+..++|.+.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.+|+.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 445677899999999999999999984 5789999998865432 23456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 479 LVYEYICNGSLDSHLYGC------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999988631 245689999999999999999999999 9999999999999999999999999
Q ss_pred cceeecCC
Q 008201 553 GLARWQPD 560 (574)
Q Consensus 553 GLAr~~~~ 560 (574)
|+++....
T Consensus 166 g~~~~~~~ 173 (303)
T 2vwi_A 166 GVSAFLAT 173 (303)
T ss_dssp HHHHHCC-
T ss_pred cchheecc
Confidence 99986643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.1e-25 Score=224.61 Aligned_cols=169 Identities=25% Similarity=0.283 Sum_probs=138.8
Q ss_pred hHHHhhcCCeeEE-eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcC-CCCeeEEEEEEEe
Q 008201 399 AELELATGGFSQA-NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIE 473 (574)
Q Consensus 399 ~~le~~~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~ 473 (574)
...+...+.|.+. +.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+|..+. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3345566678887 8999999999999995 4699999999875432 33467899999999995 6999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEe
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVG 550 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLs 550 (574)
.+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||+. ||+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999998654567899999999999999999999999 9999999999999987 7899999
Q ss_pred eecceeecCCCCCCccceeeccC
Q 008201 551 DFGLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 551 DFGLAr~~~~~~~~~~t~v~GT~ 573 (574)
|||+++....... ....+||+
T Consensus 177 Dfg~a~~~~~~~~--~~~~~gt~ 197 (327)
T 3lm5_A 177 DFGMSRKIGHACE--LREIMGTP 197 (327)
T ss_dssp CGGGCEEC-----------CCCG
T ss_pred eCccccccCCccc--cccccCCc
Confidence 9999997754322 22345554
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=228.43 Aligned_cols=152 Identities=22% Similarity=0.328 Sum_probs=126.6
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe------
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE------ 473 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------ 473 (574)
++...++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+.+|+.++||||++++++|..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 455678899999999999999999984 6799999998864432 23479999999999999999999854
Q ss_pred --------------------------------CCeEEEEEEecCCCChHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHH
Q 008201 474 --------------------------------DRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRY 519 (574)
Q Consensus 474 --------------------------------~~~~~LVmEy~~ggsL~~~L~~--~~~~~Ls~~~~~~Ia~qIa~gL~y 519 (574)
....++||||++ ++|.+.+.. .....+++..+..++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999996 588777653 246789999999999999999999
Q ss_pred HHhhCcCCCeEeeCCCCCCeEEc-CCCcEEEeeecceeecCCC
Q 008201 520 LHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 520 LHs~~~~~gIIHRDLKP~NILLd-~~~~vKLsDFGLAr~~~~~ 561 (574)
||+. ||+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 157 LH~~----gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 195 (383)
T 3eb0_A 157 IHSL----GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS 195 (383)
T ss_dssp HHTT----TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred HHHC----cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence 9998 999999999999998 6899999999999977543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=223.47 Aligned_cols=152 Identities=30% Similarity=0.481 Sum_probs=134.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-----CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-----PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR--RR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~--~~ 477 (574)
.++|.+.+.||+|+||.||+|++ .+|+.||+|++........+.+.+|+.+|+.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45799999999999999999983 368899999988665555567999999999999999999999987654 68
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999975 345699999999999999999999998 999999999999999999999999999998
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
....
T Consensus 195 ~~~~ 198 (326)
T 2w1i_A 195 LPQD 198 (326)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=219.72 Aligned_cols=145 Identities=22% Similarity=0.374 Sum_probs=130.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEe--CCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIE--DRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~--~~~~~LV 480 (574)
.++|++.+.||+|+||.||+|. ..+++.||+|++.. ...+.+.+|+.+|+.++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 4579999999999999999998 45799999999863 33567899999999997 9999999999987 6678999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeecC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQP 559 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~ 559 (574)
|||+.+++|.+++. .+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999884 388999999999999999999999 999999999999999776 89999999999775
Q ss_pred CC
Q 008201 560 DG 561 (574)
Q Consensus 560 ~~ 561 (574)
..
T Consensus 183 ~~ 184 (330)
T 3nsz_A 183 PG 184 (330)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=218.39 Aligned_cols=153 Identities=29% Similarity=0.464 Sum_probs=133.4
Q ss_pred hhcCCeeEEe-eeeccCcEEEEEEEeC---CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQAN-FLAEGGFGSVHRGVLP---DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~-~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
+..++|.+.+ .||+|+||.||+|... ++..||+|.++.... ...+.+.+|+.+|+.++||||+++++++ ..+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 4456787777 9999999999999843 578899999886533 2345789999999999999999999999 55679
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999999964 456799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
....
T Consensus 160 ~~~~ 163 (287)
T 1u59_A 160 LGAD 163 (287)
T ss_dssp CTTC
T ss_pred eccC
Confidence 7543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=239.30 Aligned_cols=160 Identities=22% Similarity=0.297 Sum_probs=128.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecC--CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLA--SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------ 474 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------ 474 (574)
..++|.+.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35789999999999999999998 456999999998754 222345788999999999999999999999754
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
...||||||+.+ +|.+.+. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 357999999954 5766664 2489999999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCCCccceeeccCC
Q 008201 555 ARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 555 Ar~~~~~~~~~~t~v~GT~G 574 (574)
|+...... ..+..+||++
T Consensus 211 a~~~~~~~--~~~~~~gt~~ 228 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRY 228 (464)
T ss_dssp C-----CC--CC----CCCT
T ss_pred eeecCCCc--ccCCCccccc
Confidence 99765432 2345677753
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=219.01 Aligned_cols=149 Identities=23% Similarity=0.399 Sum_probs=131.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57999999999999999999954 699999999875432 233578899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+. ++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 154 (299)
T 2r3i_A 83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154 (299)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence 996 6999999765556799999999999999999999999 99999999999999999999999999998664
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-25 Score=224.52 Aligned_cols=156 Identities=26% Similarity=0.314 Sum_probs=134.9
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEe----
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIE---- 473 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~---- 473 (574)
.+++...+|.+.+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+.+|..+. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 4455666899999999999999999995 479999999987655555567899999999996 9999999999953
Q ss_pred ----CCeEEEEEEecCCCChHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC--eEeeCCCCCCeEEcCCCc
Q 008201 474 ----DRRRLLVYEYICNGSLDSHLYGC-HQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 474 ----~~~~~LVmEy~~ggsL~~~L~~~-~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g--IIHRDLKP~NILLd~~~~ 546 (574)
....+++|||+ +|+|.+++... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.
T Consensus 102 ~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 102 SDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp STTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSC
T ss_pred cccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCC
Confidence 34579999998 57998888542 356799999999999999999999998 7 999999999999999999
Q ss_pred EEEeeecceeecCC
Q 008201 547 PLVGDFGLARWQPD 560 (574)
Q Consensus 547 vKLsDFGLAr~~~~ 560 (574)
+||+|||+++....
T Consensus 177 ~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 177 IKLCDFGSATTISH 190 (337)
T ss_dssp EEBCCCTTCBCCSS
T ss_pred EEEecCccceeccc
Confidence 99999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-25 Score=220.37 Aligned_cols=153 Identities=29% Similarity=0.398 Sum_probs=130.7
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCC----CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
+..++|.+.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.+|+.++||||+++++++.. +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 345689999999999999999998432 34699999875432 234578999999999999999999999865 457
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 899999999999999964 345689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
....
T Consensus 163 ~~~~ 166 (281)
T 3cc6_A 163 IEDE 166 (281)
T ss_dssp C---
T ss_pred cccc
Confidence 6543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=222.19 Aligned_cols=151 Identities=28% Similarity=0.384 Sum_probs=133.6
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHh--cCCCCeeEEEEEEEeCC---
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSC--AQHRNVVMLIGFCIEDR--- 475 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~--L~HpNIV~L~g~~~~~~--- 475 (574)
.....++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++...+
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 345567899999999999999999997 5899999998642 34568889999987 78999999999998876
Q ss_pred -eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 476 -RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH--------EECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 476 -~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLH--------s~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
..|+||||+++++|.+++.. ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECCCCC
Confidence 78999999999999999963 46899999999999999999999 66 8999999999999999999
Q ss_pred EEEeeecceeecCCCC
Q 008201 547 PLVGDFGLARWQPDGD 562 (574)
Q Consensus 547 vKLsDFGLAr~~~~~~ 562 (574)
+||+|||+++......
T Consensus 186 ~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 186 CCIADLGLAVRHDSAT 201 (342)
T ss_dssp EEECCCTTCEEEETTT
T ss_pred EEEEECCCceeccccc
Confidence 9999999998775443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=222.26 Aligned_cols=154 Identities=27% Similarity=0.353 Sum_probs=129.4
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhc--CCCCeeEEEEEEEeC----
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA--QHRNVVMLIGFCIED---- 474 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L--~HpNIV~L~g~~~~~---- 474 (574)
.....++|.+.+.||+|+||.||+|+.. |+.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445568999999999999999999874 899999998643 234456666666554 899999999999887
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC----cCCCeEeeCCCCCCeEEcCCCcEEEe
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILLTHDFEPLVG 550 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~----~~~gIIHRDLKP~NILLd~~~~vKLs 550 (574)
...|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ...+|+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999963 46999999999999999999999762 01279999999999999999999999
Q ss_pred eecceeecCCC
Q 008201 551 DFGLARWQPDG 561 (574)
Q Consensus 551 DFGLAr~~~~~ 561 (574)
|||+|+.+...
T Consensus 185 Dfg~a~~~~~~ 195 (337)
T 3mdy_A 185 DLGLAVKFISD 195 (337)
T ss_dssp CCTTCEECC--
T ss_pred eCCCceeeccc
Confidence 99999876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-25 Score=219.70 Aligned_cols=150 Identities=28% Similarity=0.419 Sum_probs=129.5
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCC----CCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEE-eCCeEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCI-EDRRRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~-~~~~~~L 479 (574)
.+|.+.+.||+|+||.||+|...+ +..+|+|.+..... ...+.+.+|+.+|+.++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468999999999999999998532 23589998875432 23356899999999999999999999865 4567899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999964 456789999999999999999999999 99999999999999999999999999998764
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 180 ~ 180 (298)
T 3f66_A 180 D 180 (298)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=218.46 Aligned_cols=154 Identities=27% Similarity=0.401 Sum_probs=132.2
Q ss_pred HhhcCCeeEEe-eeeccCcEEEEEEEe---CCCCEEEEEEeecCCCcc--hhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 402 ELATGGFSQAN-FLAEGGFGSVHRGVL---PDGQAVAVKQHKLASSQG--DHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 402 e~~~~~y~~~~-~LG~G~fG~Vy~a~~---~~g~~VAVK~l~~~~~~~--~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
.+...+|.+.+ .||+|+||.||+|.. .+++.||||++....... .+.+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456799888 999999999999963 347889999987543222 45789999999999999999999999 567
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 78999999999999999974 45699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC
Q 008201 556 RWQPDGD 562 (574)
Q Consensus 556 r~~~~~~ 562 (574)
+......
T Consensus 165 ~~~~~~~ 171 (291)
T 1xbb_A 165 KALRADE 171 (291)
T ss_dssp EECCTTC
T ss_pred eeeccCC
Confidence 9775443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=217.43 Aligned_cols=149 Identities=24% Similarity=0.313 Sum_probs=129.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRL 478 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~ 478 (574)
..|.+.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.+|+.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3488899999999999999985 5688999999875432 233568999999999999999999999875 35689
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC--eEeeCCCCCCeEEc-CCCcEEEeeecce
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLT-HDFEPLVGDFGLA 555 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g--IIHRDLKP~NILLd-~~~~vKLsDFGLA 555 (574)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999963 36789999999999999999999998 7 99999999999998 7899999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
.....
T Consensus 180 ~~~~~ 184 (290)
T 1t4h_A 180 TLKRA 184 (290)
T ss_dssp GGCCT
T ss_pred ccccc
Confidence 75543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.6e-25 Score=215.68 Aligned_cols=150 Identities=21% Similarity=0.270 Sum_probs=133.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED--RRRLL 479 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~--~~~~L 479 (574)
..++|.+.+.||+|+||.||+|+. +++.||+|++..... ...+.+.+|+.+|+.++||||+++++++... +..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 345799999999999999999997 488999999886532 2235689999999999999999999999877 78899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC--eEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g--IIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||+++++|.+++.......+++..+..++.||+.||.|||+. + |+||||||+|||++.++.++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999999864445799999999999999999999998 7 99999999999999999999999998765
Q ss_pred c
Q 008201 558 Q 558 (574)
Q Consensus 558 ~ 558 (574)
.
T Consensus 163 ~ 163 (271)
T 3kmu_A 163 F 163 (271)
T ss_dssp T
T ss_pred e
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=219.06 Aligned_cols=151 Identities=26% Similarity=0.400 Sum_probs=130.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC----CcchhHHHHHHHHHHhcCCCCeeEEEEEEE--eCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHRNVVMLIGFCI--EDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~--~~~~~ 477 (574)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+|+.++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999995 568999999987532 233457899999999999999999999984 44578
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+.++ |.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999766 77777655567899999999999999999999999 999999999999999999999999999997
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
...
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=219.51 Aligned_cols=147 Identities=29% Similarity=0.412 Sum_probs=125.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEE-----------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI----------- 472 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~----------- 472 (574)
.++|.+.+.||+|+||.||+|... +|+.||+|.+........+.+.+|+.+|+.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999965 59999999988665555567899999999999999999999874
Q ss_pred ---eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc-CCCcEE
Q 008201 473 ---EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEPL 548 (574)
Q Consensus 473 ---~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd-~~~~vK 548 (574)
..+..|+||||+. ++|.+++. ..++++..+..++.||+.||.|||+. ||+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeEE
Confidence 3467899999996 69999984 46799999999999999999999999 999999999999997 567999
Q ss_pred EeeecceeecC
Q 008201 549 VGDFGLARWQP 559 (574)
Q Consensus 549 LsDFGLAr~~~ 559 (574)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (320)
T 2i6l_A 162 IGDFGLARIMD 172 (320)
T ss_dssp ECCCTTCBCC-
T ss_pred EccCccccccC
Confidence 99999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=236.70 Aligned_cols=160 Identities=28% Similarity=0.370 Sum_probs=136.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+|+.++||||+++++++...+..|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 4699999999999999999995 479999999986432 2345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc---CCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd---~~~~vKLsDFGLAr~~~ 559 (574)
|+.+++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 102 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999998863 45799999999999999999999999 999999999999995 45689999999998664
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
.... ....+||+
T Consensus 176 ~~~~--~~~~~gt~ 187 (486)
T 3mwu_A 176 QNTK--MKDRIGTA 187 (486)
T ss_dssp CC------CCTTGG
T ss_pred CCCc--cCCCcCCC
Confidence 4322 22345654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=227.01 Aligned_cols=161 Identities=23% Similarity=0.322 Sum_probs=135.3
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~~ 477 (574)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.+|..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 45899999999999999999984 46889999998754322 235688999999999999999999999765 368
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999995 699998853 4699999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCC--CccceeeccC
Q 008201 558 QPDGDM--GVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~--~~~t~v~GT~ 573 (574)
...... ...+..+||+
T Consensus 178 ~~~~~~~~~~~~~~~gt~ 195 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATR 195 (364)
T ss_dssp CCGGGCBCCTTCCCCSCG
T ss_pred cCCCCCcccccccccccc
Confidence 753321 1123456664
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=220.03 Aligned_cols=149 Identities=22% Similarity=0.322 Sum_probs=128.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--------cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--------QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+|+.++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45799999999999999999995 4689999999865321 12235889999999999999999999997655
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc---EEEeee
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDF 552 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~---vKLsDF 552 (574)
.|+||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999886 456799999999999999999999999 9999999999999987654 999999
Q ss_pred cceeecCC
Q 008201 553 GLARWQPD 560 (574)
Q Consensus 553 GLAr~~~~ 560 (574)
|+++....
T Consensus 162 g~~~~~~~ 169 (322)
T 2ycf_A 162 GHSKILGE 169 (322)
T ss_dssp TTCEECCC
T ss_pred ccceeccc
Confidence 99997654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=246.41 Aligned_cols=159 Identities=23% Similarity=0.334 Sum_probs=133.8
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC--CCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe--
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP--DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR-- 476 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-- 476 (574)
++..++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.+|+.++||||++++++|...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 445689999999999999999999954 689999998865432 233468899999999999999999999987665
Q ss_pred ---EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 477 ---RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 477 ---~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
.||||||+++++|.+++. ..+++..++.|+.||+.||.|||++ ||+||||||+|||++.+ .+||+|||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecc
Confidence 799999999999998774 2799999999999999999999999 99999999999999885 89999999
Q ss_pred ceeecCCCCCCccceeeccCC
Q 008201 554 LARWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~G 574 (574)
+++..... +..+||++
T Consensus 227 ~a~~~~~~-----~~~~gt~~ 242 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPG 242 (681)
T ss_dssp TCEETTCC-----SCCCCCTT
T ss_pred cchhcccC-----CccCCCcc
Confidence 99977543 34567764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=224.15 Aligned_cols=154 Identities=28% Similarity=0.455 Sum_probs=131.1
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCC-----CCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPD-----GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
++...+|.+.+.||+|+||.||+|.... +..||+|.+...... ....+.+|+.+|+.++||||+++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3455689999999999999999998532 246999998754322 2346889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 99999999999999999965 456799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 195 ~~~~~ 199 (333)
T 1mqb_A 195 RVLED 199 (333)
T ss_dssp -----
T ss_pred hhhcc
Confidence 87654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=217.09 Aligned_cols=149 Identities=28% Similarity=0.401 Sum_probs=129.2
Q ss_pred CeeEEeeeeccCcEEEEEEEeC-CC---CEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE-EEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP-DG---QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR-LLV 480 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~-~g---~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~-~LV 480 (574)
.|...+.||+|+||.||+|... ++ ..+|+|.+..... ...+.+.+|+.+|+.++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4677899999999999999843 33 3799998875433 2335788999999999999999999999876655 999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999975 456789999999999999999999999 999999999999999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=230.72 Aligned_cols=148 Identities=27% Similarity=0.391 Sum_probs=124.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 56899999999999999999995 5799999999864322 22356889999999999999999999997653
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8999999863 5789999999999999999999999 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 97643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=217.41 Aligned_cols=155 Identities=22% Similarity=0.313 Sum_probs=123.1
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc-h-hHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG-D-HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~-~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
++..++|++.+.||+|+||.||+|.. .+|+.||+|++....... . +.+..+...++.++||||+++++++...+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 44567899999999999999999995 579999999987543222 2 23444555678889999999999999999999
Q ss_pred EEEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 479 LVYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
+||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ||+||||||+|||++.++.+||+|||+++
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 9999996 5887776432 4568999999999999999999999963 79999999999999999999999999998
Q ss_pred ecCC
Q 008201 557 WQPD 560 (574)
Q Consensus 557 ~~~~ 560 (574)
....
T Consensus 159 ~~~~ 162 (290)
T 3fme_A 159 YLVD 162 (290)
T ss_dssp ----
T ss_pred cccc
Confidence 7644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=216.07 Aligned_cols=147 Identities=22% Similarity=0.280 Sum_probs=129.7
Q ss_pred CCeeEE-eeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHH-HhcCCCCeeEEEEEEEe----CCeEE
Q 008201 406 GGFSQA-NFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVL-SCAQHRNVVMLIGFCIE----DRRRL 478 (574)
Q Consensus 406 ~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL-~~L~HpNIV~L~g~~~~----~~~~~ 478 (574)
++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....|
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 457776 8899999999999995 5799999999863 34678899988 66689999999999987 66789
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecce
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLA 555 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGLA 555 (574)
+||||+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999865556899999999999999999999999 9999999999999998 789999999999
Q ss_pred eecCCC
Q 008201 556 RWQPDG 561 (574)
Q Consensus 556 r~~~~~ 561 (574)
+.....
T Consensus 168 ~~~~~~ 173 (299)
T 3m2w_A 168 KETTGE 173 (299)
T ss_dssp EECTTC
T ss_pred cccccc
Confidence 976543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=218.73 Aligned_cols=145 Identities=14% Similarity=0.034 Sum_probs=127.9
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
+..++|.+.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|+.++..++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999954 58999999998654332 257899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
+||||++|++|.+++.. + .....+..|+.||+.||.|||++ ||+||||||+|||++.++.+||+++|..
T Consensus 108 lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999999842 3 35557889999999999999999 9999999999999999999999977654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=220.80 Aligned_cols=160 Identities=31% Similarity=0.465 Sum_probs=129.0
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEE
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFC 471 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~ 471 (574)
+.++.+..++|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+|+.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445566778999999999999999999843 3558999998755332 235689999999999999999999999
Q ss_pred EeCC-----eEEEEEEecCCCChHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc
Q 008201 472 IEDR-----RRLLVYEYICNGSLDSHLYGC----HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (574)
Q Consensus 472 ~~~~-----~~~LVmEy~~ggsL~~~L~~~----~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd 542 (574)
...+ ..++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~ 181 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLR 181 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEEC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEc
Confidence 8755 359999999999999998431 346799999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecceeecCCC
Q 008201 543 HDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 543 ~~~~vKLsDFGLAr~~~~~ 561 (574)
.++.+||+|||+++.....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp TTSCEEECSCSCC------
T ss_pred CCCcEEEeecCcceecccc
Confidence 9999999999999876443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=225.45 Aligned_cols=150 Identities=17% Similarity=0.206 Sum_probs=124.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCCc-----------chhHHHHHHHHHHhcCCCCeeEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ-----------GDHEFCSEVEVLSCAQHRNVVMLI 468 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~iL~~L~HpNIV~L~ 468 (574)
..++|.+.+.||+|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3568999999999999999999954 5788999988754321 113467888999999999999999
Q ss_pred EEEEe----CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC
Q 008201 469 GFCIE----DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD 544 (574)
Q Consensus 469 g~~~~----~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~ 544 (574)
+++.. ....|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccC
Confidence 99988 67899999999 9999999864 33799999999999999999999999 99999999999999988
Q ss_pred C--cEEEeeecceeecCC
Q 008201 545 F--EPLVGDFGLARWQPD 560 (574)
Q Consensus 545 ~--~vKLsDFGLAr~~~~ 560 (574)
+ .+||+|||+|+.+..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCP 205 (345)
T ss_dssp STTSEEECCCTTCEESSG
T ss_pred CCCcEEEEeCCCceeccc
Confidence 7 999999999987743
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=220.37 Aligned_cols=149 Identities=30% Similarity=0.510 Sum_probs=129.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEE--EEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAV--AVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~V--AVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
++|.+.+.||+|+||.||+|+. .+|..+ |+|.+.... ....+.+.+|+.+|+.+ +||||+++++++...+..|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5799999999999999999994 456654 899887432 23345789999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 481 YEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCe
Confidence 99999999999996422 24799999999999999999999999 9999999999999999999
Q ss_pred EEEeeecceeec
Q 008201 547 PLVGDFGLARWQ 558 (574)
Q Consensus 547 vKLsDFGLAr~~ 558 (574)
+||+|||+++..
T Consensus 181 ~kL~Dfg~~~~~ 192 (327)
T 1fvr_A 181 AKIADFGLSRGQ 192 (327)
T ss_dssp EEECCTTCEESS
T ss_pred EEEcccCcCccc
Confidence 999999999843
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=217.49 Aligned_cols=151 Identities=29% Similarity=0.432 Sum_probs=130.7
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe--CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhc---CCCCeeEEEEEEE----
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL--PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCA---QHRNVVMLIGFCI---- 472 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~---- 472 (574)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999996 4688999998875432 2234677888888766 8999999999997
Q ss_pred -eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEee
Q 008201 473 -EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551 (574)
Q Consensus 473 -~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsD 551 (574)
.....++||||+. ++|.+++.......+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999996 6999999765556799999999999999999999999 999999999999999999999999
Q ss_pred ecceeecC
Q 008201 552 FGLARWQP 559 (574)
Q Consensus 552 FGLAr~~~ 559 (574)
||+++...
T Consensus 164 fg~~~~~~ 171 (326)
T 1blx_A 164 FGLARIYS 171 (326)
T ss_dssp CCSCCCCC
T ss_pred Cccccccc
Confidence 99998664
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=232.49 Aligned_cols=150 Identities=16% Similarity=0.198 Sum_probs=124.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHH---HHHHhcCCCCeeEEE-------EE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEV---EVLSCAQHRNVVMLI-------GF 470 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei---~iL~~L~HpNIV~L~-------g~ 470 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+ .+|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45799999999999999999994 579999999987432 23346788999 455566899999998 77
Q ss_pred EEeCCe-----------------EEEEEEecCCCChHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC
Q 008201 471 CIEDRR-----------------RLLVYEYICNGSLDSHLYGCH-----QEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (574)
Q Consensus 471 ~~~~~~-----------------~~LVmEy~~ggsL~~~L~~~~-----~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g 528 (574)
+...+. .||||||+ +|+|.+++.... ...+++..+..|+.||+.||.|||+. +
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----G 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----C
Confidence 665532 78999999 789999996421 12334578889999999999999999 9
Q ss_pred eEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 529 IIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+||||||+|||++.++.+||+|||+|+...
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 9999999999999999999999999999643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=225.09 Aligned_cols=138 Identities=26% Similarity=0.360 Sum_probs=117.3
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC--------CCCeeEEEEEEE-
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ--------HRNVVMLIGFCI- 472 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~--------HpNIV~L~g~~~- 472 (574)
...++|.+.+.||+|+||.||+|+ ..+++.||||++... ....+.+.+|+.+|+.++ |+||++++++|.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 345789999999999999999998 456899999998743 233457889999999885 788999999997
Q ss_pred ---eCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC
Q 008201 473 ---EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (574)
Q Consensus 473 ---~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~ 545 (574)
.....||||||+ +++|.+++.......+++..++.|+.||+.||.|||+++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccc
Confidence 455789999999 677777776545567999999999999999999999964 799999999999999775
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-24 Score=227.93 Aligned_cols=151 Identities=21% Similarity=0.263 Sum_probs=132.2
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhc------CCCCeeEEEEEEEeCCe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA------QHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L------~HpNIV~L~g~~~~~~~ 476 (574)
...+|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+|+.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 456799999999999999999984 46899999998743 22335678899988877 57799999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc--EEEeeecc
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE--PLVGDFGL 554 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~--vKLsDFGL 554 (574)
.|+||||+ +++|.+++.......+++..+..|+.||+.||.|||+. +|+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999999 57999998765556799999999999999999999999 9999999999999999887 99999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
|+....
T Consensus 249 a~~~~~ 254 (429)
T 3kvw_A 249 SCYEHQ 254 (429)
T ss_dssp CEETTC
T ss_pred ceecCC
Confidence 987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=221.20 Aligned_cols=149 Identities=24% Similarity=0.396 Sum_probs=130.6
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC-----Ce
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 476 (574)
..++|.+.+.||+|+||.||+|.. .+|+.||||.+..... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 356899999999999999999995 4699999999864332 2234688999999999999999999998764 67
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999995 689998863 5799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCC
Q 008201 557 WQPD 560 (574)
Q Consensus 557 ~~~~ 560 (574)
....
T Consensus 161 ~~~~ 164 (353)
T 2b9h_A 161 IIDE 164 (353)
T ss_dssp ECC-
T ss_pred cccc
Confidence 7653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=217.59 Aligned_cols=152 Identities=24% Similarity=0.353 Sum_probs=132.8
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe--CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCC------CeeEEEEEEEeC
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL--PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR------NVVMLIGFCIED 474 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp------NIV~L~g~~~~~ 474 (574)
...++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+.+++.++|+ +|+++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 4557899999999999999999985 36889999998643 22345688999999988765 499999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-----------
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH----------- 543 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~----------- 543 (574)
+..|+||||+ +++|.+++......++++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 89999999765556799999999999999999999999 9999999999999987
Q ss_pred --------CCcEEEeeecceeecCC
Q 008201 544 --------DFEPLVGDFGLARWQPD 560 (574)
Q Consensus 544 --------~~~vKLsDFGLAr~~~~ 560 (574)
++.+||+|||+++....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccccCCCceEeeCcccccCcc
Confidence 66899999999997644
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-25 Score=244.60 Aligned_cols=152 Identities=19% Similarity=0.163 Sum_probs=118.1
Q ss_pred eeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc----------chhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 413 FLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ----------GDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 413 ~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~----------~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++.|++|.++.++ +-.|+.+++|.+...... ..++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35677777766655 446889999998754221 124699999999999 699999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||++|++|.++|. ..++++.. .|+.||+.||.|||++ |||||||||+||||+.+|.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999997 45677654 5889999999999999 999999999999999999999999999997754
Q ss_pred CCCCccceeeccCC
Q 008201 561 GDMGVETRVIGTFG 574 (574)
Q Consensus 561 ~~~~~~t~v~GT~G 574 (574)
... ..+.++||+|
T Consensus 392 ~~~-~~~t~vGTp~ 404 (569)
T 4azs_A 392 DCS-WPTNLVQSFF 404 (569)
T ss_dssp --C-CSHHHHHHHH
T ss_pred CCc-cccCceechh
Confidence 332 3345778863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-25 Score=226.91 Aligned_cols=146 Identities=20% Similarity=0.242 Sum_probs=128.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC---------CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeE---------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP---------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM--------- 466 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~---------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~--------- 466 (574)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+... ..+.+|+.+|+.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 357999999999999999999954 3789999998743 46889999999999999987
Q ss_pred ------EEEEEEe-CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCe
Q 008201 467 ------LIGFCIE-DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNI 539 (574)
Q Consensus 467 ------L~g~~~~-~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NI 539 (574)
+++++.. .+..|+||||+ +++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHE
Confidence 6778776 67899999999 99999999754357899999999999999999999999 999999999999
Q ss_pred EEcCCC--cEEEeeecceeecCC
Q 008201 540 LLTHDF--EPLVGDFGLARWQPD 560 (574)
Q Consensus 540 LLd~~~--~vKLsDFGLAr~~~~ 560 (574)
|++.++ .+||+|||+++.+..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSG
T ss_pred EEcCCCCceEEEecCcceeeccC
Confidence 999998 999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=212.66 Aligned_cols=152 Identities=24% Similarity=0.364 Sum_probs=131.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLL 479 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~L 479 (574)
.++|.+.+.||+|+||.||++.. .+|+.||+|.+..... ...+.+.+|+.+|+.++||||+++++++.. .+..|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35799999999999999999995 4699999999876432 233568999999999999999999998864 568999
Q ss_pred EEEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC-----eEeeCCCCCCeEEcCCCcEEEeee
Q 008201 480 VYEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECRVGC-----IVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g-----IIHRDLKP~NILLd~~~~vKLsDF 552 (574)
||||+++++|.+++... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999998642 345699999999999999999999998 7 999999999999999999999999
Q ss_pred cceeecCC
Q 008201 553 GLARWQPD 560 (574)
Q Consensus 553 GLAr~~~~ 560 (574)
|+++....
T Consensus 161 g~~~~~~~ 168 (279)
T 2w5a_A 161 GLARILNH 168 (279)
T ss_dssp CHHHHC--
T ss_pred chheeecc
Confidence 99987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-24 Score=211.68 Aligned_cols=150 Identities=21% Similarity=0.345 Sum_probs=125.9
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEE-EeCCeEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC-IEDRRRLLVY 481 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~-~~~~~~~LVm 481 (574)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.+++.++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346899999999999999999994 679999999866443 234588999999999987766665555 6677889999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE---cCCCcEEEeeecceeec
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQ 558 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL---d~~~~vKLsDFGLAr~~ 558 (574)
||+ +++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999864 355799999999999999999999999 99999999999999 78899999999999987
Q ss_pred CCC
Q 008201 559 PDG 561 (574)
Q Consensus 559 ~~~ 561 (574)
...
T Consensus 159 ~~~ 161 (296)
T 4hgt_A 159 RDA 161 (296)
T ss_dssp BCT
T ss_pred cCc
Confidence 554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=223.64 Aligned_cols=158 Identities=22% Similarity=0.289 Sum_probs=125.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999984 4689999999875432 22356889999999999999999999997665
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999995 57888875 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+...... ..+..+||+
T Consensus 175 ~~~~~~~--~~~~~~gt~ 190 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTR 190 (371)
T ss_dssp -----------------C
T ss_pred ccccccc--ccCCceecC
Confidence 8764322 123345554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.3e-25 Score=218.36 Aligned_cols=153 Identities=29% Similarity=0.424 Sum_probs=128.5
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC-CeEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED-RRRLL 479 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-~~~~L 479 (574)
+.+..++|.+.+.||+|+||.||++.. +|+.||+|.++.. ...+.+.+|+.+++.++||||+++++++... +..|+
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 344567899999999999999999987 4889999998743 2456789999999999999999999997654 47899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999999999753333488999999999999999999999 99999999999999999999999999998654
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 169 ~ 169 (278)
T 1byg_A 169 S 169 (278)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=228.39 Aligned_cols=149 Identities=28% Similarity=0.443 Sum_probs=122.9
Q ss_pred CeeEEeeeeccCcEEEEEEEeC--CC--CEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVLP--DG--QAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLLV 480 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~--~g--~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LV 480 (574)
.|...+.||+|+||.||+|... ++ ..||+|.++.... ...+.+.+|+.+|+.++||||+++++++.. .+..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4788899999999999999853 22 4689998865332 334679999999999999999999998754 5578999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999964 445689999999999999999999999 999999999999999999999999999986643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-23 Score=209.84 Aligned_cols=149 Identities=21% Similarity=0.347 Sum_probs=129.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEE-EeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFC-IEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~-~~~~~~~LVmE 482 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56899999999999999999994 679999999887543 234689999999999988766555554 66778899999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE---cCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL---d~~~~vKLsDFGLAr~~~ 559 (574)
|+ +++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999964 356799999999999999999999999 99999999999999 478999999999999876
Q ss_pred CC
Q 008201 560 DG 561 (574)
Q Consensus 560 ~~ 561 (574)
..
T Consensus 160 ~~ 161 (296)
T 3uzp_A 160 DA 161 (296)
T ss_dssp CT
T ss_pred cc
Confidence 54
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=228.13 Aligned_cols=147 Identities=27% Similarity=0.390 Sum_probs=116.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------C
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------R 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~ 475 (574)
.++|.+.+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++... +
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999998 45799999999865322 2335688999999999999999999999754 5
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+|+||+ +++|.+++. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999998 889999885 36799999999999999999999998 9999999999999999999999999999
Q ss_pred eecC
Q 008201 556 RWQP 559 (574)
Q Consensus 556 r~~~ 559 (574)
+...
T Consensus 180 ~~~~ 183 (367)
T 2fst_X 180 RHTA 183 (367)
T ss_dssp ----
T ss_pred cccc
Confidence 8754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=221.01 Aligned_cols=151 Identities=26% Similarity=0.485 Sum_probs=127.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCE----EEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQA----VAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~----VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
..++|.+.+.||+|+||.||+|.. .+++. ||+|.+.... ....+.+.+|+.+|+.++||||++++++|.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 356899999999999999999994 44554 5777765432 334567999999999999999999999998764 8
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++|+||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999999975 456799999999999999999999999 999999999999999999999999999987
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
...
T Consensus 167 ~~~ 169 (327)
T 3lzb_A 167 LGA 169 (327)
T ss_dssp ---
T ss_pred ccC
Confidence 643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=217.50 Aligned_cols=150 Identities=31% Similarity=0.470 Sum_probs=124.0
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHH--HhcCCCCeeEEEEEEEe-----CCe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVL--SCAQHRNVVMLIGFCIE-----DRR 476 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL--~~L~HpNIV~L~g~~~~-----~~~ 476 (574)
..++|.+.+.||+|+||.||+|.. +++.||||++.... ...+..|.+++ ..++||||+++++++.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 456899999999999999999976 68999999987432 33455555554 45899999999986643 225
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcC-----CCeEeeCCCCCCeEEcCCCcEEEee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV-----GCIVHRDMRPNNILLTHDFEPLVGD 551 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~-----~gIIHRDLKP~NILLd~~~~vKLsD 551 (574)
.|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+.. .+|+||||||+|||++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 7899999999999999953 3458999999999999999999986311 1799999999999999999999999
Q ss_pred ecceeecCC
Q 008201 552 FGLARWQPD 560 (574)
Q Consensus 552 FGLAr~~~~ 560 (574)
||+|+.+..
T Consensus 164 FG~a~~~~~ 172 (336)
T 3g2f_A 164 FGLSMRLTG 172 (336)
T ss_dssp CTTCEECSS
T ss_pred ccceeeccc
Confidence 999997754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=218.21 Aligned_cols=149 Identities=28% Similarity=0.397 Sum_probs=123.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.++|.+.+.||+|+||.||+|.. .++.||+|.+... ...+.+.+|+.+|+.++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 45799999999999999999987 4788999988632 34567899999999999999999999886 4579999999
Q ss_pred CCCChHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc-EEEeeecceeecC
Q 008201 485 CNGSLDSHLYGCHQ-EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE-PLVGDFGLARWQP 559 (574)
Q Consensus 485 ~ggsL~~~L~~~~~-~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~-vKLsDFGLAr~~~ 559 (574)
++++|.+++..... ..+++..++.++.|++.||.|||+... .+|+||||||+|||++.++. +||+|||+++...
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP-KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSS-SCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCC-CCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999974322 247889999999999999999999311 18999999999999998886 7999999998654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-24 Score=218.23 Aligned_cols=160 Identities=21% Similarity=0.264 Sum_probs=135.8
Q ss_pred CCccchhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcC--CCCeeEEE
Q 008201 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQ--HRNVVMLI 468 (574)
Q Consensus 393 ~~~fs~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~--HpNIV~L~ 468 (574)
.+.+.+..+.+..++|.+.+.||+|+||.||++...+++.||||++...... ....+.+|+.+|..++ |+||++++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 3455666677778889999999999999999999878999999998754332 3357899999999997 59999999
Q ss_pred EEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEE
Q 008201 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL 548 (574)
Q Consensus 469 g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vK 548 (574)
+++...+..|+|||+ .+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++ +.+|
T Consensus 95 ~~~~~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 95 DYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp EEEECSSEEEEEECC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEE
T ss_pred EEeecCCEEEEEEec-CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEE
Confidence 999999999999994 58999999974 45789999999999999999999999 9999999999999964 8999
Q ss_pred EeeecceeecCC
Q 008201 549 VGDFGLARWQPD 560 (574)
Q Consensus 549 LsDFGLAr~~~~ 560 (574)
|+|||+++....
T Consensus 167 L~Dfg~~~~~~~ 178 (313)
T 3cek_A 167 LIDFGIANQMQP 178 (313)
T ss_dssp ECCCSSSCC---
T ss_pred EeeccccccccC
Confidence 999999987644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=8.5e-24 Score=226.04 Aligned_cols=157 Identities=24% Similarity=0.303 Sum_probs=127.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------RRRL 478 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~~ 478 (574)
.+|.+.+.||+|+||.||+|+. .+|+.||||++.... ..+.+|+++|+.++||||++++++|... .+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3699999999999999999996 469999999886432 2244799999999999999999998642 2467
Q ss_pred EEEEecCCCChHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-CcEEEeeecce
Q 008201 479 LVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-FEPLVGDFGLA 555 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~--~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-~~vKLsDFGLA 555 (574)
+||||+++ +|..++.. .....+++..++.++.||+.||.|||+. +|+||||||+||||+.+ +.+||+|||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 99999964 66665532 2457899999999999999999999998 99999999999999965 67899999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+.+..+.. ....+||+
T Consensus 205 ~~~~~~~~--~~~~~~t~ 220 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSR 220 (420)
T ss_dssp EECCTTCC--CCSCCSCT
T ss_pred hhcccCCC--ceeeeeCC
Confidence 97754332 12345554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=219.74 Aligned_cols=154 Identities=23% Similarity=0.283 Sum_probs=134.0
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc------chhHHHHHHHHHHhcC--CCCeeEEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQ--HRNVVMLIGFC 471 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~L~g~~ 471 (574)
.+...++|.+.+.||+|+||.||+|. ..+++.||||.+...... ....+.+|+.+|+.++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34456789999999999999999998 457899999998764322 2245778999999996 59999999999
Q ss_pred EeCCeEEEEEEecCC-CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc-CCCcEEE
Q 008201 472 IEDRRRLLVYEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEPLV 549 (574)
Q Consensus 472 ~~~~~~~LVmEy~~g-gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd-~~~~vKL 549 (574)
...+..++||||+.+ ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999976 899999874 46789999999999999999999998 999999999999999 7899999
Q ss_pred eeecceeecCC
Q 008201 550 GDFGLARWQPD 560 (574)
Q Consensus 550 sDFGLAr~~~~ 560 (574)
+|||+++....
T Consensus 192 ~Dfg~~~~~~~ 202 (320)
T 3a99_A 192 IDFGSGALLKD 202 (320)
T ss_dssp CCCTTCEECCS
T ss_pred eeCcccccccc
Confidence 99999997754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=223.40 Aligned_cols=150 Identities=24% Similarity=0.319 Sum_probs=124.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------RRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------~~~ 478 (574)
..+|.+.+.||+|+||.||+|+...+..+|+|++..... ...+|+.+|+.++||||++++++|...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 456999999999999999999987766799998764322 2347999999999999999999996543 378
Q ss_pred EEEEecCCCChHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc-CCCcEEEeeeccee
Q 008201 479 LVYEYICNGSLDSHLY-GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLAR 556 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~-~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd-~~~~vKLsDFGLAr 556 (574)
+||||++++.+..... ......+++..+..++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 9999996644333321 12456899999999999999999999999 999999999999999 78999999999999
Q ss_pred ecCCCC
Q 008201 557 WQPDGD 562 (574)
Q Consensus 557 ~~~~~~ 562 (574)
.+..+.
T Consensus 191 ~~~~~~ 196 (394)
T 4e7w_A 191 ILIAGE 196 (394)
T ss_dssp ECCTTC
T ss_pred cccCCC
Confidence 875443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.68 Aligned_cols=153 Identities=22% Similarity=0.340 Sum_probs=131.2
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC-CC-CEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC------eeEEEEEEEe
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP-DG-QAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN------VVMLIGFCIE 473 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN------IV~L~g~~~~ 473 (574)
....++|.+.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.+|+.++|++ ++.+++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 344678999999999999999999953 44 68999998643 233456888999999987665 9999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE------------
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL------------ 541 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL------------ 541 (574)
.+..|+||||+ +++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 77787777654556799999999999999999999998 99999999999999
Q ss_pred -------cCCCcEEEeeecceeecCC
Q 008201 542 -------THDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 542 -------d~~~~vKLsDFGLAr~~~~ 560 (574)
+.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS
T ss_pred ccccccccCCCcEEEeecCccccccc
Confidence 5678999999999997543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-24 Score=218.90 Aligned_cols=153 Identities=31% Similarity=0.433 Sum_probs=129.6
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
+..++|.+.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.+|+.++||||+++++++...+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 4456899999999999999999983 3477899999864432 23457889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcE
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQ-----EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEP 547 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~-----~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~v 547 (574)
..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999975321 4589999999999999999999999 9999999999999984 4569
Q ss_pred EEeeecceeecC
Q 008201 548 LVGDFGLARWQP 559 (574)
Q Consensus 548 KLsDFGLAr~~~ 559 (574)
||+|||+++...
T Consensus 183 kl~Dfg~~~~~~ 194 (327)
T 2yfx_A 183 KIGDFGMARDIY 194 (327)
T ss_dssp EECCCHHHHHHH
T ss_pred EECccccccccc
Confidence 999999998553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=240.08 Aligned_cols=157 Identities=28% Similarity=0.423 Sum_probs=134.7
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeC----CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLP----DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 474 (574)
.+++..++|.+.+.||+|+||.||+|... .+..||+|.+...... ..+.+.+|+.+|+.++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44556678999999999999999999853 2567999988754332 2357899999999999999999999984 5
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
+..|+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCC
Confidence 678999999999999999974 345789999999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCC
Q 008201 555 ARWQPDGD 562 (574)
Q Consensus 555 Ar~~~~~~ 562 (574)
|+......
T Consensus 538 a~~~~~~~ 545 (656)
T 2j0j_A 538 SRYMEDST 545 (656)
T ss_dssp CCSCCC--
T ss_pred CeecCCCc
Confidence 99775443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7e-24 Score=239.05 Aligned_cols=147 Identities=27% Similarity=0.403 Sum_probs=127.6
Q ss_pred eeE-EeeeeccCcEEEEEEEe---CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 408 FSQ-ANFLAEGGFGSVHRGVL---PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 408 y~~-~~~LG~G~fG~Vy~a~~---~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
+.+ .+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.+|+.++||||++++++|.. +..+|||
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~ 448 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 448 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEE
Confidence 444 34799999999999964 3467899999875432 234679999999999999999999999964 5689999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++++|.+++. ....+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 449 E~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999996 356799999999999999999999999 9999999999999999999999999999977543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=217.71 Aligned_cols=156 Identities=22% Similarity=0.264 Sum_probs=119.9
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe--
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR-- 476 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~-- 476 (574)
......++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+..++.++||||++++++|...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3455678999999999999999999995 469999999886543 334467788889999999999999999976443
Q ss_pred -----EEEEEEecCCCChHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHH--hhCcCCCeEeeCCCCCCeEEcC-CCc
Q 008201 477 -----RLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLH--EECRVGCIVHRDMRPNNILLTH-DFE 546 (574)
Q Consensus 477 -----~~LVmEy~~ggsL~~~L~~--~~~~~Ls~~~~~~Ia~qIa~gL~yLH--s~~~~~gIIHRDLKP~NILLd~-~~~ 546 (574)
.++||||+.+ +|...+.. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTTE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCCc
Confidence 7899999965 55544432 24567899999999999999999999 77 9999999999999997 899
Q ss_pred EEEeeecceeecCCC
Q 008201 547 PLVGDFGLARWQPDG 561 (574)
Q Consensus 547 vKLsDFGLAr~~~~~ 561 (574)
+||+|||+++.....
T Consensus 171 ~kl~Dfg~a~~~~~~ 185 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPS 185 (360)
T ss_dssp EEECCCTTCBCCCTT
T ss_pred EEEeeCCCceecCCC
Confidence 999999999977543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=212.90 Aligned_cols=152 Identities=32% Similarity=0.455 Sum_probs=124.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC--CCC--EEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP--DGQ--AVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~--~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
..++|.+.+.||+|+||.||+|... +++ .||+|+++... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3457999999999999999999842 333 68999887542 223457899999999999999999999998765
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8899999999999999864 245689999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCC
Q 008201 557 WQPDG 561 (574)
Q Consensus 557 ~~~~~ 561 (574)
.....
T Consensus 170 ~~~~~ 174 (291)
T 1u46_A 170 ALPQN 174 (291)
T ss_dssp ECCC-
T ss_pred ccccc
Confidence 87543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-23 Score=214.69 Aligned_cols=147 Identities=23% Similarity=0.307 Sum_probs=122.1
Q ss_pred cCCeeEE-eeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHH-HHHHhcCCCCeeEEEEEEEe----CCeE
Q 008201 405 TGGFSQA-NFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEV-EVLSCAQHRNVVMLIGFCIE----DRRR 477 (574)
Q Consensus 405 ~~~y~~~-~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei-~iL~~L~HpNIV~L~g~~~~----~~~~ 477 (574)
.++|.+. +.||+|+||.||+|... +|+.||||++... ....+|+ ..++.++||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4578885 46999999999999954 6999999998642 1223333 34667899999999999976 4458
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecc
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGL 554 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGL 554 (574)
++||||+++++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999865556899999999999999999999999 9999999999999976 45699999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
++....
T Consensus 178 ~~~~~~ 183 (336)
T 3fhr_A 178 AKETTQ 183 (336)
T ss_dssp CEEC--
T ss_pred ceeccc
Confidence 987653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-24 Score=221.41 Aligned_cols=147 Identities=25% Similarity=0.384 Sum_probs=126.2
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE----
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR---- 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~---- 477 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+|+.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999984 56999999998754322 235688999999999999999999999877654
Q ss_pred --EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 478 --LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 478 --~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999995 78888773 3599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 192 ~~~~~ 196 (371)
T 4exu_A 192 RHADA 196 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 86543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=224.03 Aligned_cols=160 Identities=24% Similarity=0.328 Sum_probs=117.8
Q ss_pred CeeE-EeeeeccCcEEEEEEEeC---CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEE
Q 008201 407 GFSQ-ANFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLV 480 (574)
Q Consensus 407 ~y~~-~~~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV 480 (574)
.|.+ .+.||+|+||.||+|+.. +++.||||++... .....+.+|+.+|+.++||||++++++|.. ....|||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4665 457999999999999954 5789999998643 234578899999999999999999999965 6689999
Q ss_pred EEecCCCChHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE----cCCCcEEE
Q 008201 481 YEYICNGSLDSHLYGC-------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL----THDFEPLV 549 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~-------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL----d~~~~vKL 549 (574)
|||+. ++|.+++... ....+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 99985 6888777421 223599999999999999999999999 99999999999999 67789999
Q ss_pred eeecceeecCCCCC--CccceeeccC
Q 008201 550 GDFGLARWQPDGDM--GVETRVIGTF 573 (574)
Q Consensus 550 sDFGLAr~~~~~~~--~~~t~v~GT~ 573 (574)
+|||+|+.+..... ......+||+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~ 199 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTF 199 (405)
T ss_dssp CCTTCCC----------------CCC
T ss_pred EECCCceecCCCCcccccCCCceecC
Confidence 99999997654221 2233456665
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=209.11 Aligned_cols=151 Identities=26% Similarity=0.369 Sum_probs=133.7
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+|+.++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999954 69999999987543 23456789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC---CcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD---FEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~---~~vKLsDFGLAr~ 557 (574)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999988863 35789999999999999999999999 99999999999999754 4799999999986
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
...
T Consensus 174 ~~~ 176 (287)
T 2wei_A 174 FQQ 176 (287)
T ss_dssp BCC
T ss_pred ecC
Confidence 644
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-24 Score=221.02 Aligned_cols=147 Identities=12% Similarity=0.032 Sum_probs=111.3
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc---chhHHHHHHHHHHhc--CCCCeeEEE-------EEEEe
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCA--QHRNVVMLI-------GFCIE 473 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L--~HpNIV~L~-------g~~~~ 473 (574)
.|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 589999999999999999995 47999999999875432 234577885555444 699988865 45543
Q ss_pred C-----------------CeEEEEEEecCCCChHHHHhccCCCCCCHHHH------HHHHHHHHHHHHHHHhhCcCCCeE
Q 008201 474 D-----------------RRRLLVYEYICNGSLDSHLYGCHQEPLEWSAR------QKIAVGAARGLRYLHEECRVGCIV 530 (574)
Q Consensus 474 ~-----------------~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~------~~Ia~qIa~gL~yLHs~~~~~gII 530 (574)
. ...||||||++ ++|.+++... ...+++..+ ..++.||+.||.|||++ +|+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~iv 216 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK----GLV 216 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TEE
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CCc
Confidence 3 33799999997 8999999752 223455555 67789999999999999 999
Q ss_pred eeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 531 HRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 531 HRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||||+|||++.++.+||+|||+|+...
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~ 245 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVG 245 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETT
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecC
Confidence 99999999999999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-23 Score=224.87 Aligned_cols=149 Identities=21% Similarity=0.335 Sum_probs=130.8
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmE 482 (574)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.++| ++|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999994 5799999998775432 3458899999999987 667777777788889999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEE---cCCCcEEEeeecceeecC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILL---THDFEPLVGDFGLARWQP 559 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILL---d~~~~vKLsDFGLAr~~~ 559 (574)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999964 356799999999999999999999999 99999999999999 688999999999999876
Q ss_pred CC
Q 008201 560 DG 561 (574)
Q Consensus 560 ~~ 561 (574)
..
T Consensus 158 ~~ 159 (483)
T 3sv0_A 158 DT 159 (483)
T ss_dssp CT
T ss_pred CC
Confidence 54
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.3e-23 Score=217.65 Aligned_cols=156 Identities=22% Similarity=0.225 Sum_probs=131.3
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CC-----CeeEEEEEEEe
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HR-----NVVMLIGFCIE 473 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-Hp-----NIV~L~g~~~~ 473 (574)
.+...++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+..|+.++..++ |+ +|+.+++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 344567899999999999999999985 46889999998743 223456788999998885 45 49999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc--CCCcEEEee
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT--HDFEPLVGD 551 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd--~~~~vKLsD 551 (574)
.+..||||||+ +++|.+++.......+++..+..++.|++.||.|||.+. .+|+||||||+|||++ .++.+||+|
T Consensus 128 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE--LSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT--TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC--CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999 469999997655567999999999999999999999521 1899999999999995 478899999
Q ss_pred ecceeecCC
Q 008201 552 FGLARWQPD 560 (574)
Q Consensus 552 FGLAr~~~~ 560 (574)
||+|+....
T Consensus 205 FG~a~~~~~ 213 (382)
T 2vx3_A 205 FGSSCQLGQ 213 (382)
T ss_dssp CTTCEETTC
T ss_pred ccCceeccc
Confidence 999997754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=218.37 Aligned_cols=154 Identities=22% Similarity=0.391 Sum_probs=132.4
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIED 474 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~ 474 (574)
...++++..++|.+.+.||+|+||.||+|.... .+|+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 445667778899999999999999999998643 499998875432 2335678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
+..++||||+.+++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999964 345789999999999999999999999 999999999999998 67999999999
Q ss_pred eeec
Q 008201 555 ARWQ 558 (574)
Q Consensus 555 Ar~~ 558 (574)
++..
T Consensus 176 ~~~~ 179 (319)
T 2y4i_B 176 FSIS 179 (319)
T ss_dssp CC--
T ss_pred cccc
Confidence 8765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=216.82 Aligned_cols=146 Identities=25% Similarity=0.383 Sum_probs=126.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-----
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR----- 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~----- 476 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.+|+.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999995 46999999998754322 23568899999999999999999999987654
Q ss_pred -EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 477 -RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 477 -~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
.|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999995 68887763 3599999999999999999999999 9999999999999999999999999999
Q ss_pred eecC
Q 008201 556 RWQP 559 (574)
Q Consensus 556 r~~~ 559 (574)
+...
T Consensus 174 ~~~~ 177 (353)
T 3coi_A 174 RHAD 177 (353)
T ss_dssp TC--
T ss_pred cCCC
Confidence 8654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=212.51 Aligned_cols=155 Identities=23% Similarity=0.376 Sum_probs=128.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVE-VLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~-iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
.+..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+..|+. +++.++||||+++++++...+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 34557899999999999999999995 46999999998754322 2235666666 677789999999999999999999
Q ss_pred EEEEecCCCChHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 479 LVYEYICNGSLDSHLYG---CHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~---~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
+||||+. ++|.+++.. .....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 9999996 578777642 23578999999999999999999999963 7999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 174 ~~~~~ 178 (327)
T 3aln_A 174 GQLVD 178 (327)
T ss_dssp CC---
T ss_pred eeccc
Confidence 87643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=215.49 Aligned_cols=152 Identities=19% Similarity=0.310 Sum_probs=130.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-----------CCCeeEEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----------HRNVVMLIGFC 471 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~L~g~~ 471 (574)
..++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+|+.++ |+||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 346899999999999999999994 57999999998742 223456889999998886 89999999999
Q ss_pred EeCC----eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc-----
Q 008201 472 IEDR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT----- 542 (574)
Q Consensus 472 ~~~~----~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd----- 542 (574)
...+ ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+++ ||+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCC
Confidence 8654 789999999 999999997655667999999999999999999999953 799999999999994
Q ss_pred -CCCcEEEeeecceeecCC
Q 008201 543 -HDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 543 -~~~~vKLsDFGLAr~~~~ 560 (574)
..+.+||+|||+|+....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 445899999999997754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=225.05 Aligned_cols=164 Identities=24% Similarity=0.273 Sum_probs=127.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
.+...+|...+.||+|+||.||.....+|+.||||++.... ...+.+|+.+|+.+ +||||+++++++...+..|||
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 34455799999999999999765556689999999986432 23467899999999 799999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-----CCcEEEeeecce
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-----DFEPLVGDFGLA 555 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-----~~~vKLsDFGLA 555 (574)
|||+ +++|.+++... ...+.+..+..++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+|
T Consensus 97 ~E~~-~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELC-AATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECC-SEEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECC-CCCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999 46999999753 33445556678999999999999999 9999999999999953 346889999999
Q ss_pred eecCCCCC--CccceeeccCC
Q 008201 556 RWQPDGDM--GVETRVIGTFG 574 (574)
Q Consensus 556 r~~~~~~~--~~~t~v~GT~G 574 (574)
+.+..+.. ...+..+||++
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~ 191 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEG 191 (432)
T ss_dssp ECC------------CCSCTT
T ss_pred eeccCCCcceeeccccCCCcC
Confidence 97754322 22344567753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=208.35 Aligned_cols=153 Identities=22% Similarity=0.325 Sum_probs=118.7
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcc-h-hHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQG-D-HEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~-~-~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
....++|.+.+.||+|+||.||+|... +|+.||||++....... . +.+..+..+++.++||||+++++++...+..|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 344568999999999999999999964 69999999987653322 1 23444555788889999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-hCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE-ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs-~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
+||||+ ++.+..++.. ....+++..+..++.||+.||.|||+ + ||+||||||+|||++.++.+||+|||+++.
T Consensus 101 lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999 5555555432 35679999999999999999999998 5 899999999999999999999999999986
Q ss_pred cCC
Q 008201 558 QPD 560 (574)
Q Consensus 558 ~~~ 560 (574)
...
T Consensus 175 ~~~ 177 (318)
T 2dyl_A 175 LVD 177 (318)
T ss_dssp ---
T ss_pred ccC
Confidence 644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-23 Score=220.79 Aligned_cols=161 Identities=25% Similarity=0.260 Sum_probs=122.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|..+ +||||+++++++...+..||||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456778999999999998777678999999988643 234678999999876 8999999999999999999999999
Q ss_pred CCCChHHHHhccCCCC-----CCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC-------------Cc
Q 008201 485 CNGSLDSHLYGCHQEP-----LEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD-------------FE 546 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~-----Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~-------------~~ 546 (574)
+++|.+++....... ..+..+..++.||+.||.|||+. +|+||||||+|||++.+ +.
T Consensus 92 -~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 92 -NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp -SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred -CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCceE
Confidence 569999997432111 12234567999999999999998 99999999999999754 48
Q ss_pred EEEeeecceeecCCCCCC---ccceeeccCC
Q 008201 547 PLVGDFGLARWQPDGDMG---VETRVIGTFG 574 (574)
Q Consensus 547 vKLsDFGLAr~~~~~~~~---~~t~v~GT~G 574 (574)
+||+|||+|+....+... .....+||++
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~ 197 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197 (434)
T ss_dssp EEECCCTTCEECCC--------------CCT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCC
Confidence 999999999987654322 1234567753
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.8e-22 Score=200.76 Aligned_cols=142 Identities=15% Similarity=0.074 Sum_probs=114.6
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc------------------chhHHHHHHHHHHhcCCC
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ------------------GDHEFCSEVEVLSCAQHR 462 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~------------------~~~~f~~Ei~iL~~L~Hp 462 (574)
+......|.+.+.||+|+||.||+|...+|+.||+|.++..... ....+.+|+.+|+.++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 34445568888999999999999999977999999998653221 23458899999999984
Q ss_pred CeeEEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc
Q 008201 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (574)
Q Consensus 463 NIV~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd 542 (574)
+++++++.. +..|+||||++|++|.+ +. . .....++.|++.||.|||+. ||+||||||+|||++
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--~------~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VR--V------ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS 227 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--C------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cc--h------hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE
Confidence 555554433 56799999999999988 42 1 22457999999999999998 999999999999999
Q ss_pred CCCcEEEeeecceeecCC
Q 008201 543 HDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 543 ~~~~vKLsDFGLAr~~~~ 560 (574)
++.+||+|||+|+....
T Consensus 228 -~~~vkl~DFG~a~~~~~ 244 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEVGE 244 (282)
T ss_dssp -TTEEEECCCTTCEETTS
T ss_pred -CCcEEEEECCCCeECCC
Confidence 99999999999997643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-22 Score=221.75 Aligned_cols=135 Identities=15% Similarity=0.216 Sum_probs=107.7
Q ss_pred eEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcc--------hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQG--------DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~--------~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
...+.||+|+||.||+|.. .+..+++|......... .+.+.+|+++|+.++||||+.+..++...+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 57889999765432211 23478999999999999999666666677788999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999863 568999999999999999 9999999999999998 999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=229.73 Aligned_cols=162 Identities=30% Similarity=0.450 Sum_probs=133.7
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEe------CCeE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE------DRRR 477 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~~~ 477 (574)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5799999999999999999985 5699999998875422 234568999999999999999999999765 6678
Q ss_pred EEEEEecCCCChHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc---EEEeeec
Q 008201 478 LLVYEYICNGSLDSHLYGCH-QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE---PLVGDFG 553 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~-~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~---vKLsDFG 553 (574)
|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997532 33689999999999999999999998 9999999999999997664 9999999
Q ss_pred ceeecCCCCCCccceeeccC
Q 008201 554 LARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~ 573 (574)
+++....... .....||+
T Consensus 170 ~a~~~~~~~~--~~~~~gt~ 187 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTL 187 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCC
T ss_pred cccccccccc--cccccCCc
Confidence 9997754432 23345554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.84 E-value=3e-21 Score=205.80 Aligned_cols=150 Identities=17% Similarity=0.191 Sum_probs=115.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc---chhHHHHHHHHHHhcCC-CCe---------------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ---GDHEFCSEVEVLSCAQH-RNV--------------- 464 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~iL~~L~H-pNI--------------- 464 (574)
...|...+.||+|+||.||+|. ..+|+.||||++...... ..+.+.+|+.+++.++| .|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458889999999999999999 557999999998744332 24678999999999987 221
Q ss_pred ------eEEEEEEEe-----CCeEEEEEEecCCCChHHHHh-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC
Q 008201 465 ------VMLIGFCIE-----DRRRLLVYEYICNGSLDSHLY-----GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (574)
Q Consensus 465 ------V~L~g~~~~-----~~~~~LVmEy~~ggsL~~~L~-----~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g 528 (574)
..+..++.. ....+++|+++ +++|.+++. ......+++..++.++.||+.||.|||+. +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ 231 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----G 231 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----C
Confidence 111111211 12357777765 789998884 22345678889999999999999999999 9
Q ss_pred eEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 529 IIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
|+||||||+||||+.++.+||+|||+|+...
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~ 262 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecC
Confidence 9999999999999999999999999998654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.8e-20 Score=183.48 Aligned_cols=138 Identities=20% Similarity=0.147 Sum_probs=108.0
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCE--EEEEEeecCCCcc------------------------hhHHHHHHHHHHhcC
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQA--VAVKQHKLASSQG------------------------DHEFCSEVEVLSCAQ 460 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~--VAVK~l~~~~~~~------------------------~~~f~~Ei~iL~~L~ 460 (574)
|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 77889999999999999996 78989 9999876432110 125789999999998
Q ss_pred CCCe--eEEEEEEEeCCeEEEEEEecCC-C----ChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hhCcCCCeEee
Q 008201 461 HRNV--VMLIGFCIEDRRRLLVYEYICN-G----SLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH-EECRVGCIVHR 532 (574)
Q Consensus 461 HpNI--V~L~g~~~~~~~~~LVmEy~~g-g----sL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLH-s~~~~~gIIHR 532 (574)
|+++ +.++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| .. ||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~----givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA----ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS----CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC----CEEeC
Confidence 8754 444443 356899999942 3 66665432 224456789999999999999 77 99999
Q ss_pred CCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 533 DMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 533 DLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
||||+|||++. .++|+|||+|.....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCC
Confidence 99999999998 999999999997643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=7.1e-17 Score=172.17 Aligned_cols=136 Identities=13% Similarity=0.120 Sum_probs=101.9
Q ss_pred CeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc--------------chh--------HHHHHHHHHHhcCCCCe
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ--------------GDH--------EFCSEVEVLSCAQHRNV 464 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~--------------~~~--------~f~~Ei~iL~~L~HpNI 464 (574)
-|.+.+.||.|+||.||+|...+|+.||||+++..... ... ...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 49999999999999999999888999999987642110 000 12356777777755544
Q ss_pred e--EEEEEEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc
Q 008201 465 V--MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT 542 (574)
Q Consensus 465 V--~L~g~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd 542 (574)
. ..+++ . ..+|||||+.|++|..+.. . .....++.||+.+|.|||.. |||||||||.|||++
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH----GLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEe
Confidence 3 23322 2 3479999999888866542 1 13456889999999999998 999999999999998
Q ss_pred CCC----------cEEEeeecceeec
Q 008201 543 HDF----------EPLVGDFGLARWQ 558 (574)
Q Consensus 543 ~~~----------~vKLsDFGLAr~~ 558 (574)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3889999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2e-12 Score=127.77 Aligned_cols=147 Identities=13% Similarity=0.010 Sum_probs=115.5
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmE 482 (574)
...+|.....++.|+++.||++... +..+++|............+.+|+.+|+.+. +..+.++++++...+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3457988899999999999999853 6789999887532233446899999999885 6778899999999899999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC-------------------------------------- 524 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~-------------------------------------- 524 (574)
|++|.+|.+.+. +......++.+++++|..||...
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999987642 11223467889999999999810
Q ss_pred -----------------cCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 525 -----------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 525 -----------------~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
....++|+|++|.|||++++..+.|+||+.+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 0025999999999999987656679999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.5e-11 Score=118.36 Aligned_cols=139 Identities=18% Similarity=0.067 Sum_probs=103.1
Q ss_pred CeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC--eeEEEEEEEeCCeEEEEEEec
Q 008201 407 GFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~~~~~~~~~LVmEy~ 484 (574)
+|.+....+.|..+.||++...+|..+++|..... ....+.+|+.+|+.+.+.+ +.++++++...+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 45554444466669999998777888999987543 2346889999999886544 567899888888899999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCc---------------------------------------
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR--------------------------------------- 525 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~--------------------------------------- 525 (574)
+|.+|. ... .. ...++.+++..|..||....
T Consensus 98 ~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 998884 211 11 22566777788888886420
Q ss_pred ---------------CCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 526 ---------------VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 526 ---------------~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
..+++|+|++|.|||++.++.+.|+|||.|.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 113999999999999987766779999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.4e-10 Score=117.49 Aligned_cols=145 Identities=17% Similarity=0.211 Sum_probs=108.0
Q ss_pred eeEEeeeeccCcEEEEEEEeCCCCEEEEEEee--cCCC-cchhHHHHHHHHHHhcC--CCCeeEEEEEEEeC---CeEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHK--LASS-QGDHEFCSEVEVLSCAQ--HRNVVMLIGFCIED---RRRLL 479 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~--~~~~-~~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~---~~~~L 479 (574)
....+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|+.+|+.+. +..+++++.++.+. +..|+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3456789999999999988654 578888765 3221 22346889999999997 45688999988776 45899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCc----------------------------------
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR---------------------------------- 525 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~---------------------------------- 525 (574)
||||++|..+.+.. ...++......++.+++..|..||....
T Consensus 119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999988875421 2346788888999999999999997310
Q ss_pred --------------------CCCeEeeCCCCCCeEEcCCCc--EEEeeecceee
Q 008201 526 --------------------VGCIVHRDMRPNNILLTHDFE--PLVGDFGLARW 557 (574)
Q Consensus 526 --------------------~~gIIHRDLKP~NILLd~~~~--vKLsDFGLAr~ 557 (574)
...++|+|+++.|||++.++. +.|+||+++.+
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 136999999999999997753 68999999985
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.51 E-value=1.6e-07 Score=95.05 Aligned_cols=138 Identities=20% Similarity=0.180 Sum_probs=99.4
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCC--eeEEEEEEEeCC---eEEEEEEec
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRN--VVMLIGFCIEDR---RRLLVYEYI 484 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpN--IV~L~g~~~~~~---~~~LVmEy~ 484 (574)
.+.++.|.+..||+.. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3458999999999753 45888875422 23457899999998884 333 445555543333 348999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC----------------------------------------
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC---------------------------------------- 524 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~---------------------------------------- 524 (574)
+|.+|..... ..++......++.+++..|..||...
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875432 24677777888888888888888610
Q ss_pred --------------cCCCeEeeCCCCCCeEEcC--CCcEEEeeecceeec
Q 008201 525 --------------RVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQ 558 (574)
Q Consensus 525 --------------~~~gIIHRDLKP~NILLd~--~~~vKLsDFGLAr~~ 558 (574)
....++|+|++|.|||++. ...+.|+||+.+.+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 0125899999999999998 456789999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.3e-06 Score=88.97 Aligned_cols=138 Identities=20% Similarity=0.155 Sum_probs=95.5
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCC---CeeEEEEEEE-eCCeEEEEEEecCC
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR---NVVMLIGFCI-EDRRRLLVYEYICN 486 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp---NIV~L~g~~~-~~~~~~LVmEy~~g 486 (574)
...++.|....||+. |..+++|+.. .......+.+|+.+|..+.+. .+.+++.++. ..+..|+||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888998999987 5668888743 222345788999999998752 3567777764 45568899999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC------------------------------------------
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC------------------------------------------ 524 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~------------------------------------------ 524 (574)
..|..... ..++......++.+++..|..||...
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88876321 12344444555555555555555421
Q ss_pred --------------cCCCeEeeCCCCCCeEEcC---CCc-EEEeeecceeec
Q 008201 525 --------------RVGCIVHRDMRPNNILLTH---DFE-PLVGDFGLARWQ 558 (574)
Q Consensus 525 --------------~~~gIIHRDLKP~NILLd~---~~~-vKLsDFGLAr~~ 558 (574)
....++|+|+++.|||++. ++. +.|+||+.+.+-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1125799999999999987 455 479999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=2.9e-06 Score=83.64 Aligned_cols=143 Identities=17% Similarity=0.053 Sum_probs=99.1
Q ss_pred CCeeEEeeeeccCcE-EEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFG-SVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG-~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.+|+.. .+..|..| .||+.... ++..+.+|..... ....+.+|..+|+.+. +--+.++++++.+.+..|+|||
T Consensus 25 ~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 344433 34455554 68987743 4677889976532 3456889999998875 3346788999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC--------------------------------------
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC-------------------------------------- 524 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~-------------------------------------- 524 (574)
+++|.++.+.... .......+..+++..|.-||...
T Consensus 101 ~l~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999888765431 11122345556666666666420
Q ss_pred ----------------cCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 525 ----------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 525 ----------------~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
....++|+|+.+.|||++.++.+-|+||+.+.+-
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 0113799999999999998777779999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.1e-06 Score=90.55 Aligned_cols=82 Identities=9% Similarity=-0.059 Sum_probs=57.7
Q ss_pred eEEeee-eccCcEEEEEEEeC-------CCCEEEEEEeecCC---CcchhHHHHHHHHHHhcC-C--CCeeEEEEEEEeC
Q 008201 409 SQANFL-AEGGFGSVHRGVLP-------DGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQ-H--RNVVMLIGFCIED 474 (574)
Q Consensus 409 ~~~~~L-G~G~fG~Vy~a~~~-------~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~-H--pNIV~L~g~~~~~ 474 (574)
...+.| +.|..+.+|+.... ++..+++|...... ......+.+|+.+|+.+. + -.+.+++.++...
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88889999988754 26678888765332 112346788999998875 2 3577888887655
Q ss_pred ---CeEEEEEEecCCCChH
Q 008201 475 ---RRRLLVYEYICNGSLD 490 (574)
Q Consensus 475 ---~~~~LVmEy~~ggsL~ 490 (574)
+..|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.6e-05 Score=83.38 Aligned_cols=75 Identities=13% Similarity=0.005 Sum_probs=50.5
Q ss_pred EeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCC-------cchhHHHHHHHHHHhcCC--C-CeeEEEEEEEeCCeEEE
Q 008201 411 ANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASS-------QGDHEFCSEVEVLSCAQH--R-NVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~-------~~~~~f~~Ei~iL~~L~H--p-NIV~L~g~~~~~~~~~L 479 (574)
.+.||.|.++.||++... +++.++||....... .....+..|.++|+.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999753 468899997643211 123457889999987742 3 34566654 3455689
Q ss_pred EEEecCCC
Q 008201 480 VYEYICNG 487 (574)
Q Consensus 480 VmEy~~gg 487 (574)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=2.2e-05 Score=79.47 Aligned_cols=143 Identities=14% Similarity=0.165 Sum_probs=81.7
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC--CCeeEEEE------EEEeCCeEEEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIG------FCIEDRRRLLVYE 482 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g------~~~~~~~~~LVmE 482 (574)
...|+.|..+.||+....+| .+++|+... ....+..|+.++..|.. -.+.+++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45576677889999987555 488998764 12344456666655431 12333332 1234667899999
Q ss_pred ecCCCChH-----------HH---Hhcc-C----C-------CCCCHHHH------------------------------
Q 008201 483 YICNGSLD-----------SH---LYGC-H----Q-------EPLEWSAR------------------------------ 506 (574)
Q Consensus 483 y~~ggsL~-----------~~---L~~~-~----~-------~~Ls~~~~------------------------------ 506 (574)
|++|..+. .. ++.. . . ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99886542 11 1110 0 0 00122211
Q ss_pred -HHHHHHHHHHHHHHHh--------h-CcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 507 -QKIAVGAARGLRYLHE--------E-CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 507 -~~Ia~qIa~gL~yLHs--------~-~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
..+..++..++.+|+. . .....++|+|+.+.|||++.++.+.|+||+.+.+-
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 0111223446667763 1 01237999999999999988888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.94 E-value=5e-05 Score=76.11 Aligned_cols=81 Identities=19% Similarity=0.090 Sum_probs=60.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC---CCeeEEEEEEEeCCeEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH---RNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H---pNIV~L~g~~~~~~~~~LVm 481 (574)
.........+|.|..+.||+....+|+.|.+|+...........|..|+..|+.|.- --+++++++. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 345677888999999999999999999999998665444444568899999998842 2345555542 347899
Q ss_pred EecCCCCh
Q 008201 482 EYICNGSL 489 (574)
Q Consensus 482 Ey~~ggsL 489 (574)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99977653
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=97.73 E-value=7.1e-05 Score=66.06 Aligned_cols=127 Identities=15% Similarity=0.165 Sum_probs=93.7
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcc-cCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhH-H
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHV-VQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT-D 98 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~v-v~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 98 (574)
++|+|++|.|. .+..||.||+.-- -+.|..|+||-|.+...... + .+ ....+..+++. +
T Consensus 2 ~~ILv~~D~s~-~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~--~-----~~-----------~~~~~~~~~~~~~ 62 (138)
T 3idf_A 2 KKLLFAIDDTE-ACERAAQYILDMFGKDADCTLTLIHVKPEFMLYG--E-----AV-----------LAAYDEIEMKEEE 62 (138)
T ss_dssp EEEEEECCSSH-HHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCH--H-----HH-----------HHHHHHHHHHHHH
T ss_pred ceEEEEeCCCH-HHHHHHHHHHHHhccCCCCEEEEEEEecCCCccc--c-----cc-----------cCcHHHHHHHHHH
Confidence 57999999874 4888999999988 88999999999988643210 0 00 01123344444 5
Q ss_pred HHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchh--------hhhhhhccceeEEEEe
Q 008201 99 SCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE--------EKCCMEELQCNIVVMK 168 (574)
Q Consensus 99 ~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e--------~k~~~~~l~cniv~~~ 168 (574)
...+.+.++.+.+...++.++..|..|.|...|..+|+ +|.-||+-.|=+.. -.+++.+..|.|.+++
T Consensus 63 ~~~~~l~~~~~~~~~~g~~~~~~v~~g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 138 (138)
T 3idf_A 63 KAKLLTQKFSTFFTEKGINPFVVIKEGEPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAPIPVLIVK 138 (138)
T ss_dssp HHHHHHHHHHHHHHTTTCCCEEEEEESCHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHHHCCCCeEEEEecCChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCCCCEEEeC
Confidence 55667788888888889999999999999888887788 99999999873322 2456777788887764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00019 Score=73.93 Aligned_cols=140 Identities=16% Similarity=0.133 Sum_probs=92.5
Q ss_pred eEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEEecC
Q 008201 409 SQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ---HRNVVMLIGFCIEDRRRLLVYEYIC 485 (574)
Q Consensus 409 ~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~---HpNIV~L~g~~~~~~~~~LVmEy~~ 485 (574)
...+.|+.|.+..+|+... ++..+++|..... ....+..|...|+.|. ...+++++.++...+..|+||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456789999999999886 4678888976532 2456889999988774 3568889998888888999999999
Q ss_pred CCChH--------HH---HhccCC-C-------------------CCCHHHHH---HHHH----------------HHHH
Q 008201 486 NGSLD--------SH---LYGCHQ-E-------------------PLEWSARQ---KIAV----------------GAAR 515 (574)
Q Consensus 486 ggsL~--------~~---L~~~~~-~-------------------~Ls~~~~~---~Ia~----------------qIa~ 515 (574)
+..+. .. |+.... . .-+|.... ++.. .++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87652 11 221111 0 01354321 1111 1111
Q ss_pred H-HHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeec
Q 008201 516 G-LRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFG 553 (574)
Q Consensus 516 g-L~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFG 553 (574)
. ...|......+.++|+|+.+.|+|++.++ +.|+||+
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 12332222234799999999999999887 8899984
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00012 Score=65.09 Aligned_cols=131 Identities=17% Similarity=0.236 Sum_probs=98.3
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
.++|+|++|.|. -+..||.||+.---+.|..|+||-|.+....... . .+. ...+..++..+.
T Consensus 5 ~~~ILv~~D~s~-~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~--~----~~~-----------~~~~~~~~~~~~ 66 (146)
T 3s3t_A 5 YTNILVPVDSSD-AAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTP--A----LDP-----------VLSELLDAEAAH 66 (146)
T ss_dssp CCEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCG--G----GHH-----------HHHHHHHHHHHH
T ss_pred cceEEEEcCCCH-HHHHHHHHHHHHHHhcCCEEEEEEEecCcccccc--c----ccc-----------ccHHHHHHHHHH
Confidence 478999999875 4888999999877677899999999886442110 0 000 122334445555
Q ss_pred HHHHHHHHHhhcCCCCc-eEEEEEEecCCCchhhH-HhhhcCccEEEeccccch---------hhhhhhhccceeEEEEe
Q 008201 100 CSQMILQLHDVYDPNKI-NFKIKIVSGSPCGAVAA-EAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMK 168 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i-~~~ikv~~g~~~~~va~-eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cniv~~~ 168 (574)
-.+.+.++.+.+...+| .++..|..|.|...|.. .|++.+|.-||+-.|=+. -..+++.+..|-|.+++
T Consensus 67 ~~~~l~~~~~~~~~~g~~~~~~~~~~g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV~ 146 (146)
T 3s3t_A 67 AKDAMRQRQQFVATTSAPNLKTEISYGIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAPCNVIVIR 146 (146)
T ss_dssp HHHHHHHHHHHHTTSSCCCCEEEEEEECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCSSEEEEEC
T ss_pred HHHHHHHHHHHHHhcCCcceEEEEecCChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCCCCEEEeC
Confidence 56678888888888899 99999999999999998 799999999999877332 23567888899998874
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00014 Score=66.02 Aligned_cols=146 Identities=13% Similarity=0.160 Sum_probs=96.5
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCc-ccccccccccccccCCcccccccchhhhhhhHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGR-RFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (574)
.++|+|++|.|.. +..||.||+.-.-+.|..|+||-|.+...... ...++.. .+.+.. .. ......+..+++.+
T Consensus 5 ~~~ILv~vD~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~-~~~~~~-~~--~~~~~~~~~~~~~~ 79 (162)
T 1mjh_A 5 YKKILYPTDFSET-AEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLL-GVAGLN-KS--VEEFENELKNKLTE 79 (162)
T ss_dssp CCEEEEECCSCHH-HHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC---------------------CHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHH-HHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccc-cccccc-cc--hhhhHHHHHHHHHH
Confidence 3689999998765 77899999998777899999998887420000 0001000 000000 00 00001123344444
Q ss_pred HHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccch---------hhhhhhhccceeEEEEec
Q 008201 99 SCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKR 169 (574)
Q Consensus 99 ~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cniv~~~~ 169 (574)
...+.+.++.+.+...+|.++..|..|.|...|...|++.+|.-||+-.|=+. -..+++.+..|-|.+++.
T Consensus 80 ~~~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~~pVlvv~~ 159 (162)
T 1mjh_A 80 EAKNKMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLVVKR 159 (162)
T ss_dssp HHHHHHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEEECC
T ss_pred HHHHHHHHHHHHHHHcCCceEEEEcCCCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCCCCEEEEeC
Confidence 45556777777777779999999999999888888899999999999987332 245788999999999985
Q ss_pred C
Q 008201 170 S 170 (574)
Q Consensus 170 ~ 170 (574)
.
T Consensus 160 ~ 160 (162)
T 1mjh_A 160 K 160 (162)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00017 Score=76.45 Aligned_cols=74 Identities=15% Similarity=0.079 Sum_probs=46.2
Q ss_pred EEeeeeccCcEEEEEEEeCCCCEEEEEEeecC----CCc---chhHHHHHHHHHHhc---CCCCeeEEEEEEEeCCeEEE
Q 008201 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLA----SSQ---GDHEFCSEVEVLSCA---QHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~----~~~---~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~~~~~~L 479 (574)
..+.||.|..+.||++.. ++..++||..... ... .......|.+++..+ ....+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999964 5678999953321 111 112223344433322 334667777765 567799
Q ss_pred EEEec-CC
Q 008201 480 VYEYI-CN 486 (574)
Q Consensus 480 VmEy~-~g 486 (574)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00015 Score=66.53 Aligned_cols=142 Identities=11% Similarity=0.096 Sum_probs=93.0
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|||++|.+.. +..||.||+.-.-+.|..|+||-|.+........-+++.+.. . .. ....+..+++.+..
T Consensus 6 ~~ILv~vD~s~~-s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~---~--~~---~~~~~~~~~~~~~~ 76 (170)
T 2dum_A 6 RKVLFPTDFSEG-AYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYD---N--AE---IELKDIKEKLKEEA 76 (170)
T ss_dssp SEEEEECCSSHH-HHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC--------------------CCTTSHHHHHHHH
T ss_pred ceEEEEecCCHH-HHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccc---c--cc---ccHHHHHHHHHHHH
Confidence 679999998765 788999999988788999999988764321000000100000 0 00 00112223333334
Q ss_pred HHHHHHHHhhcCCCCceEEE--EEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEEEEec
Q 008201 101 SQMILQLHDVYDPNKINFKI--KIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMKR 169 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~~i--kv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv~~~~ 169 (574)
.+.+.++.+.++..+|.++. .+..|.|...|...|++.+|.-||+-.|=+.. ..+++.+..|-|.+++.
T Consensus 77 ~~~l~~~~~~~~~~g~~~~~~~~~~~g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~~PVlvv~~ 156 (170)
T 2dum_A 77 SRKLQEKAEEVKRAFRAKNVRTIIRFGIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTKKPVLIIKE 156 (170)
T ss_dssp HHHHHHHHHHHHHHTTCSEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCSSCEEEECC
T ss_pred HHHHHHHHHHHHHcCCceeeeeEEecCChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCCCCEEEEcc
Confidence 45555665555556787877 89999998888888999999999999884332 34678889999999985
Q ss_pred Cc
Q 008201 170 SQ 171 (574)
Q Consensus 170 ~~ 171 (574)
..
T Consensus 157 ~~ 158 (170)
T 2dum_A 157 VD 158 (170)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00021 Score=65.98 Aligned_cols=140 Identities=20% Similarity=0.283 Sum_probs=91.0
Q ss_pred ceEEEEEEeCCCC--------CCHHHHHHHhhcccC---CCCeEEEEEEecCCCCCcccccccccccccccCCccccccc
Q 008201 20 AEKVVVAVKASKE--------IPRTALVWALTHVVQ---PGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGT 88 (574)
Q Consensus 20 ~~~Vvv~~dasr~--------i~~~a~~wal~~vv~---~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (574)
..+|||++|.+.. .+..||.||+....+ .|..|+||-|.+....+ +..+ .. ... ....
T Consensus 5 ~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~--~~~~---~~----~~~--~~~~ 73 (175)
T 2gm3_A 5 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDG--FDDV---DS----IYA--SPED 73 (175)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC---------------C----CCC--SHHH
T ss_pred ccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeeccccc--cccc---cc----ccC--CHHH
Confidence 4789999999872 678899999997655 47789999777532211 1000 00 000 0001
Q ss_pred chhhhhhhHHHHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhc
Q 008201 89 ISEQRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEE 159 (574)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~ 159 (574)
..+..++..+.-.+.+.++.+.+...+|.++..|..|.|...|...|++.+|.-||+=.|=+.- ..+++.+
T Consensus 74 ~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~ 153 (175)
T 2gm3_A 74 FRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKH 153 (175)
T ss_dssp HHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhC
Confidence 1111222222233455555555655689999999999988888888999999999999884332 3568889
Q ss_pred cceeEEEEecC
Q 008201 160 LQCNIVVMKRS 170 (574)
Q Consensus 160 l~cniv~~~~~ 170 (574)
..|-|.+++..
T Consensus 154 a~~pVlvv~~~ 164 (175)
T 2gm3_A 154 AECPVMTIKRN 164 (175)
T ss_dssp CSSCEEEEECC
T ss_pred CCCCEEEEcCC
Confidence 99999999854
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00049 Score=60.82 Aligned_cols=129 Identities=14% Similarity=0.238 Sum_probs=85.5
Q ss_pred eEEEEEEeCCCC-CCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 21 EKVVVAVKASKE-IPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 21 ~~Vvv~~dasr~-i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
++|+|++|.|.. .+..||.||+.---+.|..|+||-|.+...... . +... .. ...+..++..
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~---~---~~~~----~~-----~~~~~~~~~~-- 64 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYA---S---LGMA----YT-----AELPGMDELR-- 64 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC-------------------------------CHHHHH--
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccc---c---cccc----cc-----chhhhHHHHH--
Confidence 579999998874 599999999887667889999999988643110 0 0000 00 0011112222
Q ss_pred HHHHHHHHHhhcCC---CCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEEEE
Q 008201 100 CSQMILQLHDVYDP---NKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVM 167 (574)
Q Consensus 100 ~~~~~~~l~~~~~~---~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv~~ 167 (574)
.+...+|..+++. .++.++..+..|.|...|..+|++.+|.-||+=+| +.. ..+++.+..|-|.++
T Consensus 65 -~~~~~~l~~~~~~~~~~~~~v~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~~~~Gs~~~~v~~~~~~pVlvv 142 (143)
T 3fdx_A 65 -EGSETQLKEIAKKFSIPEDRMHFHVAEGSPKDKILALAKSLPADLVIIASH-RPDITTYLLGSNAAAVVRHAECSVLVV 142 (143)
T ss_dssp -HHHHHHHHHHHTTSCCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEEESS-CTTCCSCSSCHHHHHHHHHCSSEEEEE
T ss_pred -HHHHHHHHHHHHHcCCCCCceEEEEEecChHHHHHHHHHHhCCCEEEEeCC-CCCCeeeeeccHHHHHHHhCCCCEEEe
Confidence 2333444444444 45678999999999888888899999999999988 433 246778888988876
Q ss_pred e
Q 008201 168 K 168 (574)
Q Consensus 168 ~ 168 (574)
+
T Consensus 143 ~ 143 (143)
T 3fdx_A 143 R 143 (143)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00068 Score=68.39 Aligned_cols=145 Identities=12% Similarity=0.047 Sum_probs=82.3
Q ss_pred EEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC--eeEEEEE------EEeCCeEEEEE
Q 008201 410 QANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN--VVMLIGF------CIEDRRRLLVY 481 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN--IV~L~g~------~~~~~~~~LVm 481 (574)
..+.|+.|....+|+....+| .+++|..... .....+..|+.++..+...+ +.+++.. ....+..+++|
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred EeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 355677888899999987666 5788887642 12345667888877664212 2333311 12346678999
Q ss_pred EecCCCChHH-----------H---Hhcc-C--CCC----C---CHHHHHH------------HHHHHHHHHHHHHhhC-
Q 008201 482 EYICNGSLDS-----------H---LYGC-H--QEP----L---EWSARQK------------IAVGAARGLRYLHEEC- 524 (574)
Q Consensus 482 Ey~~ggsL~~-----------~---L~~~-~--~~~----L---s~~~~~~------------Ia~qIa~gL~yLHs~~- 524 (574)
+|++|..+.. . ++.. . ..+ . .|..... +...+...+.++....
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998865321 0 1110 0 000 1 1222100 0112344566665432
Q ss_pred --cCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 525 --RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 525 --~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
.+.+++|+|+.+.|||++.+..+.|+||+.+.+
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 123799999999999998876668999998864
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00023 Score=65.50 Aligned_cols=133 Identities=10% Similarity=0.062 Sum_probs=88.7
Q ss_pred CcceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEE--EEecCCCCCcccccccccccccccCCcccccccchhhhhh
Q 008201 18 DVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLL--VVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGD 95 (574)
Q Consensus 18 ~~~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll--~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (574)
...++|||++|.|. -+..||.||+.-.- .|..|+|| -|++..... +++.. . . .+..++
T Consensus 15 ~~~~~ILv~vD~s~-~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~---~~~~~--~-----~--------~~~~~~ 74 (163)
T 1tq8_A 15 SAYKTVVVGTDGSD-SSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDAR---AADIL--K-----D--------ESYKVT 74 (163)
T ss_dssp CCCCEEEEECCSSH-HHHHHHHHHHHHHT-TTSEEEEEEECCC-------------------------------------
T ss_pred ccCCEEEEEcCCCH-HHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccc---ccccc--c-----c--------HHHHHH
Confidence 33588999999875 47889999998766 88999999 666542210 11110 0 0 011112
Q ss_pred hHHHHHHHHHHHHhhcCCCCce-EEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEE
Q 008201 96 ITDSCSQMILQLHDVYDPNKIN-FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIV 165 (574)
Q Consensus 96 ~~~~~~~~~~~l~~~~~~~~i~-~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv 165 (574)
+.+...+.+.++.+.+...+|. ++..|..|.|...|...|++.+|.-||+=.|=+.- ..+++.+.+|.|.
T Consensus 75 ~~~~~~~~l~~~~~~~~~~gv~~v~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~~PVl 154 (163)
T 1tq8_A 75 GTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDVL 154 (163)
T ss_dssp -CCTHHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEEE
T ss_pred HHHHHHHHHHHHHHHHHHcCCCeEEEEEecCCHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCCCCEE
Confidence 2223345566666666667898 99999999988888877999999999999883332 2467889999999
Q ss_pred EEecC
Q 008201 166 VMKRS 170 (574)
Q Consensus 166 ~~~~~ 170 (574)
+++..
T Consensus 155 vV~~~ 159 (163)
T 1tq8_A 155 IVHTT 159 (163)
T ss_dssp EECCC
T ss_pred EEeCC
Confidence 99754
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00016 Score=64.12 Aligned_cols=133 Identities=17% Similarity=0.206 Sum_probs=91.5
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|+|++|.|. -+..|+.||+.---+.|..|+||-|.+.... +.++..+. .. ....+..++..+.-
T Consensus 3 ~~ILv~vD~s~-~s~~al~~A~~la~~~~a~l~ll~v~~~~~~---~~~~~~~~------~~----~~~~~~~~~~~~~~ 68 (147)
T 3hgm_A 3 NRIMVPVDGSK-GAVKALEKGVGLQQLTGAELYILCVFKHHSL---LEASLSMA------RP----EQLDIPDDALKDYA 68 (147)
T ss_dssp SEEEEECCSBH-HHHHHHHHHHHHHHHHCCEEEEEEEECCHHH---HHHTBSSC------CC----GGGCCCTTHHHHHH
T ss_pred ceEEEEeCCCH-HHHHHHHHHHHHHHhcCCEEEEEEEecCccc---cccccccc------Ch----hhhhhHHHHHHHHH
Confidence 57999999874 5888999999977677999999999885321 11111100 00 01112233334444
Q ss_pred HHHHHHHHhhcCCCCceE---EEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEEEE
Q 008201 101 SQMILQLHDVYDPNKINF---KIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVM 167 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~---~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv~~ 167 (574)
.+.+.++.+.+...+|.+ +..+..|.|...|..+|++.+|.-||+-.|=+.- -.+++.+.+|-|.++
T Consensus 69 ~~~l~~~~~~~~~~g~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV 147 (147)
T 3hgm_A 69 TEIAVQAKTRATELGVPADKVRAFVKGGRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAHCPVLVV 147 (147)
T ss_dssp HHHHHHHHHHHHHTTCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCSSCEEEC
T ss_pred HHHHHHHHHHHHhcCCCccceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCCCCEEEC
Confidence 556677777777778887 9999999998888888999999999998773322 346677778887663
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00061 Score=60.81 Aligned_cols=134 Identities=14% Similarity=0.196 Sum_probs=86.7
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
.++|||++|.|.. +..||.||+.---+.|..|+||-|.+....... .+.+.- .....+..++..+.
T Consensus 6 ~~~ILv~vD~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~-----~~~~~~--------~~~~~~~~~~~~~~ 71 (150)
T 3tnj_A 6 YHHILLAVDFSSE-DSQVVQKVRNLASQIGARLSLIHVLDNIPMPDT-----PYGTAI--------PLDTETTYDAMLDV 71 (150)
T ss_dssp CSEEEEECCCSTT-HHHHHHHHHHHHHHHTCEEEEEEEEC-------------CTTCC--------CSSSCCCHHHHHHH
T ss_pred cceEEEEeCCCHH-HHHHHHHHHHHHhhcCCEEEEEEEEcCcccccc-----cccccc--------CcCHHHHHHHHHHH
Confidence 3689999998764 889999999987777899999998876432100 011100 00111223333333
Q ss_pred HHHHHHHHHhhcCCCCce-EEEEEEecCCCchhhHHhhhcCccEEEeccccchh--------hhhhhhccceeEEEEecC
Q 008201 100 CSQMILQLHDVYDPNKIN-FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE--------EKCCMEELQCNIVVMKRS 170 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~-~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e--------~k~~~~~l~cniv~~~~~ 170 (574)
..+.+.++.+-+ ++. ++..|..|.|...|..+|++.+|.-||+=+|=+.. ..+++.+..|-|.+++..
T Consensus 72 ~~~~l~~~~~~~---~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~~~ 148 (150)
T 3tnj_A 72 EKQKLSQIGNTL---GIDPAHRWLVWGEPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAKCDVLAVRLR 148 (150)
T ss_dssp HHHHHHHHHHHH---TCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCSSEEEEEECC
T ss_pred HHHHHHHHHHHc---CCCcceEEEecCCHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCCCCEEEEeCC
Confidence 344444444443 455 46788999999888888999999999999874332 356778999999998854
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0014 Score=66.79 Aligned_cols=142 Identities=14% Similarity=0.063 Sum_probs=73.7
Q ss_pred eeeeccCcEE-EEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEEEEecCCCC
Q 008201 412 NFLAEGGFGS-VHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRLLVYEYICNGS 488 (574)
Q Consensus 412 ~~LG~G~fG~-Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LVmEy~~ggs 488 (574)
+.|+.|.... +|+....+|..+++|...... ...+..|+.++..+.. -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4455554444 666665446777777544321 1345567777776642 23566776643333 78999997666
Q ss_pred hHHHHhcc---------------------CC---CCCCHHHHH-------H-HH------------HHHHHHHHHHHhh-
Q 008201 489 LDSHLYGC---------------------HQ---EPLEWSARQ-------K-IA------------VGAARGLRYLHEE- 523 (574)
Q Consensus 489 L~~~L~~~---------------------~~---~~Ls~~~~~-------~-Ia------------~qIa~gL~yLHs~- 523 (574)
+..++... .. ..+...... . +. ..+...+..|...
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433210 00 112211110 0 00 0111222333211
Q ss_pred -CcCCCeEeeCCCCCCeEEcCC----CcEEEeeecceeec
Q 008201 524 -CRVGCIVHRDMRPNNILLTHD----FEPLVGDFGLARWQ 558 (574)
Q Consensus 524 -~~~~gIIHRDLKP~NILLd~~----~~vKLsDFGLAr~~ 558 (574)
.....++|+|+.+.|||++.+ +.+.|+||+.+.+-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 112379999999999999875 67899999998864
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00045 Score=62.35 Aligned_cols=129 Identities=8% Similarity=0.114 Sum_probs=93.1
Q ss_pred ceEEEEEEe--CCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhH
Q 008201 20 AEKVVVAVK--ASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT 97 (574)
Q Consensus 20 ~~~Vvv~~d--asr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (574)
.++|+|++| .| +.+..||.||+.-.-+.|..|+||-|.+.... ..+.. ...+..++..
T Consensus 15 ~~~ILv~vD~~~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~----~~~~~---------------~~~~~~~~~~ 74 (156)
T 3fg9_A 15 YRRILLTVDEDDN-TSSERAFRYATTLAHDYDVPLGICSVLESEDI----NIFDS---------------LTPSKIQAKR 74 (156)
T ss_dssp CC-EEEECCSCCC-HHHHHHHHHHHHHHHHHTCCEEEEEEECCCCT----TCCCS---------------SHHHHHHHHH
T ss_pred CceEEEEECCCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCc----ccccc---------------CCHHHHHHHH
Confidence 478999999 65 56888999999876667889999999886431 01000 1113334444
Q ss_pred HHHHHHHHHHHhhcCCCCc-eEEEEEEe-cCCCchhhHH-hhhcCccEEEeccccchh--------hhhhhhccceeEEE
Q 008201 98 DSCSQMILQLHDVYDPNKI-NFKIKIVS-GSPCGAVAAE-AKKAQAGWVVLDKQLKHE--------EKCCMEELQCNIVV 166 (574)
Q Consensus 98 ~~~~~~~~~l~~~~~~~~i-~~~ikv~~-g~~~~~va~e-ak~~~a~wvvlDr~lk~e--------~k~~~~~l~cniv~ 166 (574)
+.-.+.+.++.+.++..+| .++..|.. |.|...|... |++.+|.-||+-.|=+.. -.+++.+.+|-|.+
T Consensus 75 ~~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~~PVlv 154 (156)
T 3fg9_A 75 KHVEDVVAEYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAPISVIV 154 (156)
T ss_dssp HHHHHHHHHHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCSSEEEE
T ss_pred HHHHHHHHHHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCCCCEEE
Confidence 4445566667666766788 59999999 9999999988 999999999998874332 35677888898887
Q ss_pred Ee
Q 008201 167 MK 168 (574)
Q Consensus 167 ~~ 168 (574)
++
T Consensus 155 V~ 156 (156)
T 3fg9_A 155 VR 156 (156)
T ss_dssp EC
T ss_pred eC
Confidence 64
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=66.92 Aligned_cols=143 Identities=14% Similarity=0.067 Sum_probs=82.9
Q ss_pred eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCC--CeeEEEEE-----EEeCCeEEEEEEec
Q 008201 412 NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHR--NVVMLIGF-----CIEDRRRLLVYEYI 484 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~Hp--NIV~L~g~-----~~~~~~~~LVmEy~ 484 (574)
..|+ |....||+....+|+.+++|...... .....+..|..++..+... .+++++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77789998877678789999876332 2345677788888776422 23444432 22355678999999
Q ss_pred CCCChH-----H------H---Hhcc-C------CCCCCHHHH----HHHH---------------HHHHHHHHHHHhhC
Q 008201 485 CNGSLD-----S------H---LYGC-H------QEPLEWSAR----QKIA---------------VGAARGLRYLHEEC 524 (574)
Q Consensus 485 ~ggsL~-----~------~---L~~~-~------~~~Ls~~~~----~~Ia---------------~qIa~gL~yLHs~~ 524 (574)
+|..+. . . ++.. . ...+.+... ..++ ..+...+..+....
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 1 1 1110 0 011222211 0010 01112233333221
Q ss_pred ---cCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 525 ---RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 525 ---~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
....++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 123689999999999999 4 8999999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00042 Score=69.76 Aligned_cols=139 Identities=12% Similarity=0.047 Sum_probs=76.7
Q ss_pred EeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEec-CCCC
Q 008201 411 ANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYI-CNGS 488 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~-~ggs 488 (574)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++++ ..+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577899999999998 45788876543211 1234568887776642222 455554 333457899999 6655
Q ss_pred hHHH---------------H---hccCC---CCCC-HHHHHHHHHH--------------HHHHHHHHHh----hCcCCC
Q 008201 489 LDSH---------------L---YGCHQ---EPLE-WSARQKIAVG--------------AARGLRYLHE----ECRVGC 528 (574)
Q Consensus 489 L~~~---------------L---~~~~~---~~Ls-~~~~~~Ia~q--------------Ia~gL~yLHs----~~~~~g 528 (574)
|... | +.... ..+. +.....+... +...+..|.. ......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5310 1 11000 0011 1111111111 1111222211 112235
Q ss_pred eEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 529 IIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
++|+|+.+.||| ..++.+.|+||..|.+-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56677899999988753
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0011 Score=58.46 Aligned_cols=132 Identities=12% Similarity=0.043 Sum_probs=89.0
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEe-cCCCCCcccccccccccccccCCcccccccchhhhhhhHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVV-PSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (574)
.++|+|++|.|.. +..||.||+.---+.|..|+||-|. +.... ...++...+.. . .+..+++.+
T Consensus 4 ~~~ILv~~D~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~~~~~~~~~~~----------~---~~~~~~~~~ 68 (138)
T 1q77_A 4 MKVLLVLTDAYSD-CEKAITYAVNFSEKLGAELDILAVLEDVYNL-ERANVTFGLPF----------P---PEIKEESKK 68 (138)
T ss_dssp CEEEEEEESTTCC-CHHHHHHHHHHHTTTCCEEEEEEECHHHHHH-HHHHHHHCCCC----------C---THHHHHHHH
T ss_pred ccEEEEEccCCHh-HHHHHHHHHHHHHHcCCeEEEEEEecccccc-cccccccCCCC----------C---hHHHHHHHH
Confidence 4689999998865 8899999998877788999999887 42000 00011000000 0 122233333
Q ss_pred HHHHHHHHHHhh--cCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchhhhhhhhccceeEEEEe
Q 008201 99 SCSQMILQLHDV--YDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVMK 168 (574)
Q Consensus 99 ~~~~~~~~l~~~--~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e~k~~~~~l~cniv~~~ 168 (574)
...+.+.++ +. ....+ .++..+..|.|...|...|++.+|.-||+-.|=+.--.+++.+..|-|.+++
T Consensus 69 ~~~~~l~~~-~~~~~~~~~-~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~g~sv~~~vl~~a~~PVlvv~ 138 (138)
T 1q77_A 69 RIERRLREV-WEKLTGSTE-IPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIVK 138 (138)
T ss_dssp HHHHHHHHH-HHHHHSCCC-CCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEECC
T ss_pred HHHHHHHHH-HHHhhccCC-cceEEEEcCCHHHHHHHHHHhcCCCEEEEeCCCCchHHHHHHhCCCceEeeC
Confidence 344555555 54 34555 6777788999888888889999999999998855566678888899888764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0052 Score=66.46 Aligned_cols=74 Identities=8% Similarity=-0.038 Sum_probs=48.4
Q ss_pred EeeeeccCcEEEEEEEeCC-CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEEecCCCC
Q 008201 411 ANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLVYEYICNGS 488 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LVmEy~~ggs 488 (574)
.+.|+.|-...+|++...+ +..+++|+...... ..-...+|..+|..|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998765 57888887643221 11123589999998875444 57777762 3 25999998754
Q ss_pred h
Q 008201 489 L 489 (574)
Q Consensus 489 L 489 (574)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00073 Score=59.64 Aligned_cols=129 Identities=14% Similarity=0.146 Sum_probs=83.3
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|+|++|.|.. +..||.||+.-.-+.|..|+||-|.+...... +.+... ...+..++..+.-
T Consensus 3 ~~ILv~~D~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-----~~~~~~-----------~~~~~~~~~~~~~ 65 (141)
T 1jmv_A 3 KHILVAVDLSEE-SPILLKKAVGIAKRHDAKLSIIHVDVNFSDLY-----TGLIDV-----------NMSSMQDRISTET 65 (141)
T ss_dssp SEEEEEECCSTT-HHHHHHHHHHHHHHHTCEEEEEEEEECCGGGC-----CCCEEH-----------HHHHHTTCCCCHH
T ss_pred ceEEEEecCchh-hHHHHHHHHHHHHhcCCEEEEEEEecCchhhh-----cccccc-----------chHHHHHHHHHHH
Confidence 579999998764 77899999987766789999998875422100 001000 0001111111111
Q ss_pred HHHHHHHHhhcCCCCceE-EEEEEecCCCchhhHHhhhcCccEEEeccccchhh-------hhhhhccceeEEEEecC
Q 008201 101 SQMILQLHDVYDPNKINF-KIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEE-------KCCMEELQCNIVVMKRS 170 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~-~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e~-------k~~~~~l~cniv~~~~~ 170 (574)
.+.+.++.+ ..++.+ +..+..|.|...|...|++.+|.-||+-.| +.-. .+++.+..|-|.+++..
T Consensus 66 ~~~l~~~~~---~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~vl~~~~~pVlvv~~~ 139 (141)
T 1jmv_A 66 QKALLDLAE---SVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIKIDMLVVPLR 139 (141)
T ss_dssp HHHHHHHHH---HSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCCSEEEEEECC
T ss_pred HHHHHHHHH---HcCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-CchhhhhcchHHHHHhcCCCCEEEeeCC
Confidence 222333322 235655 577888999888888899999999999998 6443 45778899999999753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0029 Score=67.69 Aligned_cols=74 Identities=15% Similarity=0.138 Sum_probs=50.5
Q ss_pred EEeeeeccCcEEEEEEEeCC--------CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEE
Q 008201 410 QANFLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-VMLIGFCIEDRRRLLV 480 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-V~L~g~~~~~~~~~LV 480 (574)
..+.|+.|....+|++...+ +..+++|+.... .....+..|..++..+...++ .++++.+. + .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 35678888889999998653 578999987421 122456689999888753333 56777653 2 389
Q ss_pred EEecCCCCh
Q 008201 481 YEYICNGSL 489 (574)
Q Consensus 481 mEy~~ggsL 489 (574)
+||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0024 Score=67.52 Aligned_cols=141 Identities=17% Similarity=0.179 Sum_probs=83.0
Q ss_pred eeeeccCcEEEEEEEeC--------CCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEE
Q 008201 412 NFLAEGGFGSVHRGVLP--------DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~--------~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVmE 482 (574)
+.|..|-...+|++... +++.+++|+.-.. ......+.+|..+++.|. +.-..++++++.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777788988864 2578899875322 223456778999998775 3223566766543 29999
Q ss_pred ecCCCChHH--------------HH---hcc---CCCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 008201 483 YICNGSLDS--------------HL---YGC---HQEPLE--WSARQKIAVGAA-------------------RGLRYLH 521 (574)
Q Consensus 483 y~~ggsL~~--------------~L---~~~---~~~~Ls--~~~~~~Ia~qIa-------------------~gL~yLH 521 (574)
|++|..|.. .| +.. ...... +..+.++..++. ..+.+|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998865531 11 111 011122 344445554432 1234443
Q ss_pred hh----CcCCCeEeeCCCCCCeEEcCC----CcEEEeeecceee
Q 008201 522 EE----CRVGCIVHRDMRPNNILLTHD----FEPLVGDFGLARW 557 (574)
Q Consensus 522 s~----~~~~gIIHRDLKP~NILLd~~----~~vKLsDFGLAr~ 557 (574)
.. .....++|+|+.+.|||++.+ +.+.|+||..|.+
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 122369999999999999876 7899999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.002 Score=66.78 Aligned_cols=74 Identities=14% Similarity=0.051 Sum_probs=44.7
Q ss_pred EeeeeccCcEEEEEEEeCC---------CCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPD---------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LV 480 (574)
...|+.|....+|+....+ +..+++|+...... .......|..+|..+...+ +.++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888888999988643 26888887654221 1123467888888775333 44666554 2 3689
Q ss_pred EEecCCCCh
Q 008201 481 YEYICNGSL 489 (574)
Q Consensus 481 mEy~~ggsL 489 (574)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0014 Score=59.67 Aligned_cols=121 Identities=12% Similarity=0.094 Sum_probs=85.5
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
...|+|++|..-+-+..||.||+.-.-+.|..|+||-|.+.... .. ++..+.
T Consensus 24 ~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~------------------------~~----~~~~~~ 75 (155)
T 3dlo_A 24 YMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR------------------------TK----DEDIIE 75 (155)
T ss_dssp CCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT------------------------SC----HHHHHH
T ss_pred cCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc------------------------cc----HHHHHH
Confidence 37899999993356888999999987777889999988874210 00 112222
Q ss_pred HHHHHHHHHhhcCCCCceEEEE--EEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEEEEe
Q 008201 100 CSQMILQLHDVYDPNKINFKIK--IVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMK 168 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ik--v~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv~~~ 168 (574)
-.+.+.++.+.+...++.+++. +..|.|...|..+|++.+|.-||+-.|=+.- ..+.+.+..|-|.++|
T Consensus 76 ~~~~l~~~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~~PVLvVr 155 (155)
T 3dlo_A 76 AKETLSWAVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKANKPVICIK 155 (155)
T ss_dssp HHHHHHHHHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCCCCEEEeC
Confidence 2444555555555567777765 4559998888888999999999998773332 3467788899988875
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=96.87 E-value=0.001 Score=58.59 Aligned_cols=125 Identities=12% Similarity=0.182 Sum_probs=81.4
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|+|++|.|. -+..||.||+.---+.|..|+||-|.+.... ++..+ . . .+..+++.+.-
T Consensus 3 ~~ILv~~D~s~-~s~~al~~a~~la~~~~a~l~ll~v~~~~~~-----~~~~~-----~-~--------~~~~~~~~~~~ 62 (137)
T 2z08_A 3 KTILLAYDGSE-HARRAAEVAKAEAEAHGARLIVVHAYEPVPD-----YLGEP-----F-F--------EEALRRRLERA 62 (137)
T ss_dssp SEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEEECC---------------------------------CHHHHHH
T ss_pred ceEEEEeCCCH-HHHHHHHHHHHHHhhcCCEEEEEEEecCCCc-----ccccc-----c-h--------HHHHHHHHHHH
Confidence 57999999875 4678999999876667899999988774221 11000 0 0 01112222323
Q ss_pred HHHHHHHHhhcCCCCc-eEEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEEEEe
Q 008201 101 SQMILQLHDVYDPNKI-NFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMK 168 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i-~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv~~~ 168 (574)
.+.+.++.+. .++ .++..+..|.|...|...|++.+|.-||+-.|=+.- ..+++.+..|-|.+++
T Consensus 63 ~~~l~~~~~~---~g~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 137 (137)
T 2z08_A 63 EGVLEEARAL---TGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLVR 137 (137)
T ss_dssp HHHHHHHHHH---HCCCGGGEEEEESSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHHHHH---cCCCccEEEEEecCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCCCCEEEeC
Confidence 3344444333 466 677778899998888888999999999998874322 3456788888888864
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.003 Score=63.03 Aligned_cols=131 Identities=9% Similarity=0.167 Sum_probs=94.8
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|||++|.|. -+..||.||+.---+.|..|+||-|.+..... .+. . + ....+..++..+..
T Consensus 23 ~~ILv~vD~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~----~~~--~-----~------~~~~~~~~~~~~~~ 84 (294)
T 3loq_A 23 NAMLLPTDLSE-NSFKVLEYLGDFKKVGVEEIGVLFVINLTKLS----TVS--G-----G------IDIDHYIDEMSEKA 84 (294)
T ss_dssp CEEEEECCSCT-GGGGGGGGHHHHHHTTCCEEEEECCEECTTC----------------C------CCTTHHHHHHHHHH
T ss_pred ccEEEecCCCH-HHHHHHHHHHHHHhhcCCEEEEEEEecCcccc----ccc--c-----c------ccHHHHHHHHHHHH
Confidence 78999999874 57889999999777778999999888764321 000 0 0 01223334444555
Q ss_pred HHHHHHHHhhcCCCCceEEE-EEE-ecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccceeEEEEec
Q 008201 101 SQMILQLHDVYDPNKINFKI-KIV-SGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCNIVVMKR 169 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~~i-kv~-~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cniv~~~~ 169 (574)
.+.+.++.+.+...+|.++. .|+ .|.|...| .|++.+|.-||+-++=+.. ..+++.+..|.|.+++.
T Consensus 85 ~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv~~ 162 (294)
T 3loq_A 85 EEVLPEVAQKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSKVPVYIFKH 162 (294)
T ss_dssp HHHHHHHHHHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCSSCEEEECC
T ss_pred HHHHHHHHHHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCCCCEEEecC
Confidence 66677777777778999998 888 89887777 8899999999999874433 34577888999999985
Q ss_pred Cc
Q 008201 170 SQ 171 (574)
Q Consensus 170 ~~ 171 (574)
..
T Consensus 163 ~~ 164 (294)
T 3loq_A 163 DM 164 (294)
T ss_dssp CT
T ss_pred cc
Confidence 43
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0088 Score=60.06 Aligned_cols=135 Identities=15% Similarity=0.154 Sum_probs=94.6
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
.++|||++|.|. -+..||.||+.---+.|-.|+||-|++..+. ....+. ......+..+++.+.
T Consensus 7 ~k~ILv~~D~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~-----~~~~~~----------~~~~~~~~~~~~~~~ 70 (319)
T 3olq_A 7 YQNLLVVIDPNQ-DDQPALRRAVYIVQRNGGRIKAFLPVYDLSY-----DMTTLL----------SPDERNAMRKGVINQ 70 (319)
T ss_dssp SCEEEEECCTTC-SCCHHHHHHHHHHHHHCCEEEEEEEECCGGG-----GCTTTS----------CHHHHHHHHHHHHHH
T ss_pred cceEEEEECCCc-ccHHHHHHHHHHHHHcCCeEEEEEEecccch-----hhcccc----------ChhhHHHHHHHHHHH
Confidence 368999999875 5677999998876667789999988764221 000000 000112222333444
Q ss_pred HHHHHHHHHhhcCCCCceEEEEEE-ecCCCchhhHHhhhcCccEEEeccccch---------hhhhhhhccceeEEEEec
Q 008201 100 CSQMILQLHDVYDPNKINFKIKIV-SGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKR 169 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ikv~-~g~~~~~va~eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cniv~~~~ 169 (574)
..+.+.++.+.+...+|.++..+. .|.|...|+.+|++.+|.-||+-+|=+. -....+.+..|-|.+++.
T Consensus 71 ~~~~l~~~~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv~~ 150 (319)
T 3olq_A 71 KTAWIKQQARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCPAPVWMVKD 150 (319)
T ss_dssp HHHHHHHHHHHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCSSCEEEEES
T ss_pred HHHHHHHHHHHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCCCCEEEecC
Confidence 455667777777678999999999 8999888888899999999999887432 344678899999999986
Q ss_pred C
Q 008201 170 S 170 (574)
Q Consensus 170 ~ 170 (574)
.
T Consensus 151 ~ 151 (319)
T 3olq_A 151 K 151 (319)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0057 Score=61.53 Aligned_cols=132 Identities=14% Similarity=0.163 Sum_probs=88.8
Q ss_pred cceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHH
Q 008201 19 VAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (574)
Q Consensus 19 ~~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (574)
..+.|||++|.|. -+..||.||+.---+.|..|+||-|.+.... -|....+ ..+..+++.+
T Consensus 18 ~~~~ILv~~D~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~---~~~~~~~---------------~~~~~~~~~~ 78 (309)
T 3cis_A 18 SSLGIIVGIDDSP-AAQVAVRWAARDAELRKIPLTLVHAVSPEVA---TWLEVPL---------------PPGVLRWQQD 78 (309)
T ss_dssp CTTEEEEECCSSH-HHHHHHHHHHHHHHHHTCCEEEEEECCCCCC---CTTCCCC---------------CHHHHHHHHH
T ss_pred CCCeEEEEECCCH-HHHHHHHHHHHHHHhcCCcEEEEEEecCccc---ccccCCC---------------CchhhHHHHH
Confidence 3588999999875 4778999999876677889999988763211 1210000 0112222333
Q ss_pred HHHHHHHHHHhhcCCC-----CceEEEEEEecCCCchhhHHhhhcCccEEEeccccch---------hhhhhhhccceeE
Q 008201 99 SCSQMILQLHDVYDPN-----KINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNI 164 (574)
Q Consensus 99 ~~~~~~~~l~~~~~~~-----~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cni 164 (574)
...+++.++.+.+... ++.++..+..|.|...|..+|+ +|.-||+-+|=+. -..+++.+..|.|
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PV 156 (309)
T 3cis_A 79 HGRHLIDDALKVVEQASLRAGPPTVHSEIVPAAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAHCPV 156 (309)
T ss_dssp HHHHHHHHHHHHHHHHCSSSCCSCEEEEEESSCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCSSCE
T ss_pred HHHHHHHHHHHHHHHhcccCCCceEEEEEecCCHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCCCCE
Confidence 3344445554444432 8899999999998888887786 8999999987432 2356788999999
Q ss_pred EEEecCc
Q 008201 165 VVMKRSQ 171 (574)
Q Consensus 165 v~~~~~~ 171 (574)
.+++...
T Consensus 157 lvv~~~~ 163 (309)
T 3cis_A 157 VIIHDED 163 (309)
T ss_dssp EEECTTC
T ss_pred EEEcCCc
Confidence 9998543
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0062 Score=60.74 Aligned_cols=115 Identities=20% Similarity=0.282 Sum_probs=86.3
Q ss_pred cceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHH
Q 008201 19 VAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITD 98 (574)
Q Consensus 19 ~~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (574)
..+.|+|++|.+. .+..||.||+.-.-+.|..|+||-|.+... .
T Consensus 169 ~~~~Ilv~~d~s~-~s~~al~~a~~la~~~~~~l~ll~v~~~~~-------------------~---------------- 212 (294)
T 3loq_A 169 LFDRVLVAYDFSK-WADRALEYAKFVVKKTGGELHIIHVSEDGD-------------------K---------------- 212 (294)
T ss_dssp TTSEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEECSSSC-------------------C----------------
T ss_pred cCCEEEEEECCCH-HHHHHHHHHHHHhhhcCCEEEEEEEccCch-------------------H----------------
Confidence 3588999999884 578899999987666788999998877421 0
Q ss_pred HHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccch---------hhhhhhhccceeEEEEec
Q 008201 99 SCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKR 169 (574)
Q Consensus 99 ~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cniv~~~~ 169 (574)
.+.+.++.+.+...++.++..|..|.+...+...|++.+|.-||+=.+=+. --.+.+.+..|.|.+++.
T Consensus 213 --~~~l~~~~~~l~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pvLvv~~ 290 (294)
T 3loq_A 213 --TADLRVMEEVIGAEGIEVHVHIESGTPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSPVPVFVCKR 290 (294)
T ss_dssp --HHHHHHHHHHHHHTTCCEEEEEECSCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCSSCEEEECS
T ss_pred --HHHHHHHHHHHHHcCCcEEEEEecCCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCCCCEEEECC
Confidence 222333333444458889999999988888887799999999999876332 235678899999999987
Q ss_pred Cc
Q 008201 170 SQ 171 (574)
Q Consensus 170 ~~ 171 (574)
..
T Consensus 291 ~~ 292 (294)
T 3loq_A 291 GD 292 (294)
T ss_dssp CT
T ss_pred CC
Confidence 54
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.023 Score=58.48 Aligned_cols=31 Identities=16% Similarity=0.305 Sum_probs=28.1
Q ss_pred CeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 528 gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
.++|+|+.+.|||++.++.+.|+||+.+.+-
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 6999999999999998888999999988754
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.019 Score=57.02 Aligned_cols=114 Identities=13% Similarity=0.163 Sum_probs=84.1
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
.++|+|++|.|. -+..||.||+.---+.|-.|+||-|.++ ...
T Consensus 7 ~~~ILv~~D~s~-~s~~al~~A~~la~~~~a~l~ll~v~~~-------------------~~~----------------- 49 (290)
T 3mt0_A 7 IRSILVVIEPDQ-LEGLALKRAQLIAGVTQSHLHLLVCEKR-------------------RDH----------------- 49 (290)
T ss_dssp CCEEEEECCSSC-SCCHHHHHHHHHHHHHCCEEEEEEECSS-------------------SCC-----------------
T ss_pred hceEEEEeCCCc-cchHHHHHHHHHHHhcCCeEEEEEeeCc-------------------HHH-----------------
Confidence 368999999874 5788999999876667788999988762 000
Q ss_pred HHHHHHHHHhhcCCCCceEEEEEE-ecCCCchhhHHhhhcCccEEEeccccch---------hhhhhhhccceeEEEEec
Q 008201 100 CSQMILQLHDVYDPNKINFKIKIV-SGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVMKR 169 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ikv~-~g~~~~~va~eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cniv~~~~ 169 (574)
.+.+.++.+.+...++.++..+. .|.|...|..+|++.+|.-||+-+|-+. -....+.+..|-|.+++.
T Consensus 50 -~~~l~~~~~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~~PVlvv~~ 128 (290)
T 3mt0_A 50 -SAALNDLAQELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAPCPVLMTKT 128 (290)
T ss_dssp -HHHHHHHHHHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCSSCEEEECC
T ss_pred -HHHHHHHHHHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCCCCEEEecC
Confidence 12233333333456899999998 5778888888899999999999987432 235678889999999985
Q ss_pred Cc
Q 008201 170 SQ 171 (574)
Q Consensus 170 ~~ 171 (574)
..
T Consensus 129 ~~ 130 (290)
T 3mt0_A 129 AR 130 (290)
T ss_dssp CS
T ss_pred CC
Confidence 43
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.022 Score=56.62 Aligned_cols=130 Identities=14% Similarity=0.185 Sum_probs=88.3
Q ss_pred cceEEEEEEeCCCC------CCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhh
Q 008201 19 VAEKVVVAVKASKE------IPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQ 92 (574)
Q Consensus 19 ~~~~Vvv~~dasr~------i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (574)
..++|+|++|.|.. ++..||.||+.-.-+.|..|+||-|.+....+.. . . .. +.
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~---~-----------~-----~~-~~ 192 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA---D-----------P-----TF-QL 192 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC----------------------------CH-HH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc---C-----------c-----hh-HH
Confidence 45899999999987 4899999999887777899999988875332110 0 0 00 22
Q ss_pred hhhhHHHHHHHHHHHHhhcCCCCc-eEEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccce
Q 008201 93 RGDITDSCSQMILQLHDVYDPNKI-NFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQC 162 (574)
Q Consensus 93 ~~~~~~~~~~~~~~l~~~~~~~~i-~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~c 162 (574)
.+++.+...+.+.++.+-+ ++ .+++.|..|.|...|...|++.+|.-||+=.|=+.- -.+.+.+..|
T Consensus 193 ~~~~~~~~~~~l~~~~~~~---g~~~~~~~v~~g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~~ 269 (290)
T 3mt0_A 193 SETIEARYREACRTFQAEY---GFSDEQLHIEEGPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLES 269 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TCCTTTEEEEESCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHHHHc---CCCcceEEEeccCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCCC
Confidence 2333333333344444333 55 356778899988888888999999999998773332 3567899999
Q ss_pred eEEEEecCc
Q 008201 163 NIVVMKRSQ 171 (574)
Q Consensus 163 niv~~~~~~ 171 (574)
-|.+++...
T Consensus 270 pVLvv~~~~ 278 (290)
T 3mt0_A 270 DVLVLKPDD 278 (290)
T ss_dssp EEEEECCHH
T ss_pred CEEEECCCC
Confidence 999998654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.64 E-value=0.055 Score=57.90 Aligned_cols=141 Identities=13% Similarity=0.051 Sum_probs=84.3
Q ss_pred EeeeeccCcEEEEEEEeCC--------CCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm 481 (574)
.+.|..|--..+|+....+ +..+++++..... ...-+..+|..+++.+. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4567777788899988653 5788998864332 12223467888888774 22245666543 2 37899
Q ss_pred EecCCCChHH--------------HH---hc--c---------CCCCCCHHHHHHHHHHH-------------------H
Q 008201 482 EYICNGSLDS--------------HL---YG--C---------HQEPLEWSARQKIAVGA-------------------A 514 (574)
Q Consensus 482 Ey~~ggsL~~--------------~L---~~--~---------~~~~Ls~~~~~~Ia~qI-------------------a 514 (574)
||++|..|.. .| +. . ...+.-+..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9998865421 01 00 0 01111244443443322 2
Q ss_pred HHHHHHHhhC--------------------cCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 515 RGLRYLHEEC--------------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 515 ~gL~yLHs~~--------------------~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
..+.+|.... .+..++|+|+.+.||| +.++.+.|+||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2334443221 1126899999999999 7888999999999874
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.022 Score=57.10 Aligned_cols=135 Identities=14% Similarity=0.135 Sum_probs=90.1
Q ss_pred ceEEEEEEeCCCC------CCHHHHHHHhhcccCC--CCeEEEEEEecCCCCCcccccccccccccccCCcccccccchh
Q 008201 20 AEKVVVAVKASKE------IPRTALVWALTHVVQP--GDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISE 91 (574)
Q Consensus 20 ~~~Vvv~~dasr~------i~~~a~~wal~~vv~~--gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (574)
.+.|||++|.+.+ .+..||.||+.-.-.. |..|+||-|.+...... |. .. ......+
T Consensus 156 ~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~--~~---~~----------~~~~~~~ 220 (319)
T 3olq_A 156 YGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINI--AI---EL----------PDFDPNL 220 (319)
T ss_dssp TCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSC--CT---TC----------TTCCHHH
T ss_pred CCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhh--hc---cC----------CcccHHH
Confidence 5889999999987 6899999998864443 88999998887644221 10 00 0001223
Q ss_pred hhhhhHHHHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhccce
Q 008201 92 QRGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQC 162 (574)
Q Consensus 92 ~~~~~~~~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~c 162 (574)
..++..+...+.+..+..-|.-. .+++.|..|.|...+...|++.+|.-||+=.|=+.- -.+.+.+.+|
T Consensus 221 ~~~~~~~~~~~~l~~~~~~~~~~--~~~~~v~~g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~~ 298 (319)
T 3olq_A 221 YNNALRGQHLIAMKELRQKFSIP--EEKTHVKEGLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIKC 298 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCC--GGGEEEEESCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCCS
T ss_pred HHHHHHHHHHHHHHHHHHHhCCC--cccEEEecCCcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCCC
Confidence 33344444444454444444322 345667889988888877999999999998873322 3467899999
Q ss_pred eEEEEecCc
Q 008201 163 NIVVMKRSQ 171 (574)
Q Consensus 163 niv~~~~~~ 171 (574)
-|.+++..+
T Consensus 299 pVLvv~~~~ 307 (319)
T 3olq_A 299 DLLAIKPDG 307 (319)
T ss_dssp EEEEECCTT
T ss_pred CEEEECCCC
Confidence 999998655
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=95.38 E-value=0.015 Score=56.81 Aligned_cols=135 Identities=13% Similarity=0.124 Sum_probs=90.6
Q ss_pred EEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhh----hhhhH
Q 008201 22 KVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQ----RGDIT 97 (574)
Q Consensus 22 ~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 97 (574)
+|+|++|.|. -+..||.||+.---+.|..|+||-|.+.... .+.+ ..+ ... ......+. .++..
T Consensus 2 ~ILv~vD~s~-~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~--~~~~---~~~---~~~---~~~~~~~~~~~~~~~~~ 69 (268)
T 3ab8_A 2 RILLATDGSP-QARGAEALAEWLAYKLSAPLTVLFVVDTRLA--RIPE---LLD---FGA---LTVPVPVLRTELERALA 69 (268)
T ss_dssp CEEEECCSCG-GGHHHHHHHHHHHHHHTCCEEEEEEEEHHHH--THHH---HC-------------CHHHHHHHHHHHHH
T ss_pred cEEEEcCCCH-HHHHHHHHHHHHHHHhCCcEEEEEEeccCCc--cccc---ccC---chH---HHHHHHHHHHHHHHHHH
Confidence 5899999875 4788999999876667889999988764221 0000 000 000 00011010 23344
Q ss_pred HHHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccch-h---------hhhhhhccceeEEEE
Q 008201 98 DSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH-E---------EKCCMEELQCNIVVM 167 (574)
Q Consensus 98 ~~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~-e---------~k~~~~~l~cniv~~ 167 (574)
+...+.+.++...+...++.++..+..|.|...|..+ +.+|.-||+-+|=+. . ..+++.+..|-|.++
T Consensus 70 ~~~~~~l~~~~~~~~~~g~~~~~~~~~g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~~PVlvv 147 (268)
T 3ab8_A 70 LRGEAVLERVRQSALAAGVAVEAVLEEGVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASPVPVLLA 147 (268)
T ss_dssp HHHHHHHHHHHHHHHHTTCCEEEEEEEECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHHHHHHHhCCCCeEEEEecCCHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCCCCEEEE
Confidence 4456667777777777799999999999988777644 889999999987443 2 356788899999999
Q ss_pred ecC
Q 008201 168 KRS 170 (574)
Q Consensus 168 ~~~ 170 (574)
+..
T Consensus 148 ~~~ 150 (268)
T 3ab8_A 148 PGE 150 (268)
T ss_dssp CSS
T ss_pred CCC
Confidence 854
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=94.89 E-value=0.056 Score=54.15 Aligned_cols=127 Identities=12% Similarity=0.154 Sum_probs=82.9
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
...|||++|.+.. +..||.||+.-.-+.|..|+||-|.+..... . +. . ....+..++..+.
T Consensus 171 ~~~Ilv~~D~s~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~----~---~~-----~------~~~~~~~~~~~~~ 231 (309)
T 3cis_A 171 QAPVLVGVDGSSA-SELATAIAFDEASRRNVDLVALHAWSDVDVS----E---WP-----G------IDWPATQSMAEQV 231 (309)
T ss_dssp CCCEEEECCSSHH-HHHHHHHHHHHHHHTTCCEEEEEESCSSCCT----T---CS-----S------CCHHHHHHHHHHH
T ss_pred CCeEEEEeCCChH-HHHHHHHHHHHHHhcCCEEEEEEEeeccccc----C---CC-----c------ccHHHHHHHHHHH
Confidence 4679999998754 6779999998776778899999887643210 0 00 0 0011122222222
Q ss_pred HHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccc---------hhhhhhhhccceeEEEEec
Q 008201 100 CSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLK---------HEEKCCMEELQCNIVVMKR 169 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk---------~e~k~~~~~l~cniv~~~~ 169 (574)
-.+.+..+...| .++.++..|..|.|...|...|+ +|.-||+=.|=+ .--.+.+.+..|-|.+++.
T Consensus 232 l~~~~~~~~~~~--~~~~~~~~~~~g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~~pVlvv~~ 306 (309)
T 3cis_A 232 LAERLAGWQERY--PNVAITRVVVRDQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLARTPVIVARE 306 (309)
T ss_dssp HHHHHTTHHHHC--TTSCEEEEEESSCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCSSCEEEECC
T ss_pred HHHHHHHHHhhC--CCCcEEEEEEcCCHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCCCCEEEeCC
Confidence 222233333222 47889999999998888876687 999999987732 2345678899999999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.97 E-value=1.4 Score=46.09 Aligned_cols=30 Identities=27% Similarity=0.479 Sum_probs=25.4
Q ss_pred CeEeeCCCCCCeEE------cCCCcEEEeeecceee
Q 008201 528 CIVHRDMRPNNILL------THDFEPLVGDFGLARW 557 (574)
Q Consensus 528 gIIHRDLKP~NILL------d~~~~vKLsDFGLAr~ 557 (574)
.++|+|+.+.|||+ +.+..+.++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4457799999999874
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=89.30 E-value=0.37 Score=46.78 Aligned_cols=110 Identities=10% Similarity=0.099 Sum_probs=73.2
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
.+.|+|++|.+.. +..||.||..-.-..|..|+||-|.+.. + +.
T Consensus 154 ~~~ilv~~d~s~~-~~~al~~a~~la~~~~a~l~ll~v~~~~-----------------------------~---~~--- 197 (268)
T 3ab8_A 154 LEGALLGYDASES-AVRALHALAPLARALGLGVRVVSVHEDP-----------------------------A---RA--- 197 (268)
T ss_dssp CCEEEEECCSCHH-HHHHHHHHHHHHHHHTCCEEEEEECSSH-----------------------------H---HH---
T ss_pred CCEEEEEECCCHH-HHHHHHHHHHhhhcCCCEEEEEEEcCcH-----------------------------H---HH---
Confidence 4689999998764 5678999876544567778888776531 0 00
Q ss_pred HHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccc-----hhhhhhhhccceeEEEEe
Q 008201 100 CSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLK-----HEEKCCMEELQCNIVVMK 168 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk-----~e~k~~~~~l~cniv~~~ 168 (574)
.+.+.++.+.....+|.+++.+..|.|...+...|++. .-||+=..++ .=-...+.+.+|-|.+++
T Consensus 198 -~~~l~~~~~~l~~~~~~~~~~~~~g~~~~~i~~~a~~~--dliV~G~~~~~~~~Gs~~~~vl~~~~~pvlvv~ 268 (268)
T 3ab8_A 198 -EAWALEAEAYLRDHGVEASALVLGGDAADHLLRLQGPG--DLLALGAPVRRLVFGSTAERVIRNAQGPVLTAR 268 (268)
T ss_dssp -HHHHHHHHHHHHHTTCCEEEEEECSCHHHHHHHHCCTT--EEEEEECCCSCCSSCCHHHHHHHHCSSCEEEEC
T ss_pred -HHHHHHHHHHHHHcCCceEEEEeCCChHHHHHHHHHhC--CEEEECCcccccEeccHHHHHHhcCCCCEEEeC
Confidence 12233333444445888999999998888887667776 7888765222 223556777888887763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 574 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-42 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-35 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-33 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-32 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-32 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-31 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-29 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-26 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-13 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 10/176 (5%)
Query: 401 LELATGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSC 458
+EL F + + L G G V + P G +A K L E++VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 459 AQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLR 518
+V G D + E++ GSLD L + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 118
Query: 519 YLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
YL E+ + I+HRD++P+NIL+ E + DFG++ D +GT
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRS 168
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-42
Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 7/176 (3%)
Query: 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCA 459
+ E+ G + + G FG+V++G AV + + Q F +EV VL
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 460 QHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRY 519
+H N+++ +G+ + +V ++ SL HL+ + E IA A+G+ Y
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDY 119
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE-TRVIGTFG 574
LH + I+HRD++ NNI L D +GDFGLA + + ++ G+
Sbjct: 120 LHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 6/161 (3%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VAVK K S F +E ++ QH+ +V L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
+ ++ EY+ NGSL L L + +A A G+ ++ E +HRD
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRD 134
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+R NIL++ + DFGLAR D +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 5e-40
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 6/161 (3%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
L G FG V G VA+K K S + EF E +V+ H +V L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
R ++ EY+ NG L ++L + + ++ + YL + +HRD
Sbjct: 71 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRD 125
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+ N L+ V DFGL+R+ D +
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 2e-38
Identities = 47/194 (24%), Positives = 78/194 (40%), Gaps = 20/194 (10%)
Query: 396 FSYAELELATGGFSQA---------NFLAEGGFGSVHRGVLP----DGQAVAVKQ-HKLA 441
F++ + A F++ + G FG V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 442 SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPL 501
+ + +F SE ++ H NV+ L G + +++ E++ NGSLD +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125
Query: 502 EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPD 560
+ G A G++YL + VHRD+ NIL+ + V DFGL+R+ + D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 561 GDMGVETRVIGTFG 574
T +G
Sbjct: 182 TSDPTYTSALGGKI 195
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 6e-38
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 15/171 (8%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRN 463
FS + G FG+V+ + + + VA+K+ + Q + + EV L +H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ G + + LV EY + D H++PL+ + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
++HRD++ NILL+ +GDFG A +GT
Sbjct: 135 ----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPY 176
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (348), Expect = 1e-37
Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 6/183 (3%)
Query: 393 PRWFSYAELELATGGFSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCS 451
P +Y + E+ + + L G +G V+ GV VAVK K + + + EF
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 62
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV 511
E V+ +H N+V L+G C + ++ E++ G+L +L C+++ + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG 571
+ + YL ++ +HRD+ N L+ + V DFGL+R
Sbjct: 123 QISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 572 TFG 574
Sbjct: 179 PIK 181
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 49/185 (26%), Positives = 69/185 (37%), Gaps = 7/185 (3%)
Query: 391 KPPRW-FSYAELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEF 449
KP + E+ L +G FG V G VA+K K + F
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAF 59
Query: 450 CSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKI 509
E +V+ +H +V L E+ +V EY+ GSL L G + L +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A A G+ Y+ VHRD+R NIL+ + V DFGLAR D +
Sbjct: 119 AAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
Query: 570 IGTFG 574
Sbjct: 175 KFPIK 179
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 49/182 (26%), Positives = 76/182 (41%), Gaps = 13/182 (7%)
Query: 400 ELELATGGFSQANF-LAEGGFGSVHRGVL---PDGQAVAVKQHKLASSQGD-HEFCSEVE 454
+L L A+ L G FGSV +GV VA+K K + + D E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 455 VLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAA 514
++ + +V LIG C + +LV E G L L G +E + S ++ +
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVS 119
Query: 515 RGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR--VIGT 572
G++YL E+ VHRD+ N+LL + + DFGL++ D R
Sbjct: 120 MGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 573 FG 574
Sbjct: 176 LK 177
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 5e-37
Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 6/157 (3%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L +G FG V++ + A K S + ++ E+++L+ H N+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ ++ E+ G++D+ + + PL S Q + L YLH+ I+HR
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN----KIIHR 134
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
D++ NIL T D + + DFG++ ++ +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 5e-37
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 6/161 (3%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ G FG VH G + VA+K + + + +F E EV+ H +V L G C+E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 474 DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533
LV+E++ +G L + + + + G+ YL E C++HRD
Sbjct: 72 QAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRD 126
Query: 534 MRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+ N L+ + V DFG+ R+ D T
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 4e-36
Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ +G FG V G G VAVK + + F +E V++ +H N+V L+G +E
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 474 DRRRL-LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ L +V EY+ GSL +L + L K ++ + YL VHR
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHR 127
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
D+ N+L++ D V DFGL + + V
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 16/172 (9%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473
+ +G FG V RG G+ VAVK + +E+ +H N++ I +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 474 DR----RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC- 528
D + LV +Y +GSL +L ++ + K+A+ A GL +LH E
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 529 ---IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVE---TRVIGTFG 574
I HRD++ NIL+ + + D GLA ++ +GT
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-35
Identities = 47/191 (24%), Positives = 71/191 (37%), Gaps = 34/191 (17%)
Query: 414 LAEGGFGSVHRGVLPD------GQAVAVKQHKLASSQGDHE-FCSEVEVLS-CAQHRNVV 465
L G FG V VAVK K + + E SE+++++ H N+V
Sbjct: 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQ---------------------EPLEWS 504
L+G C L++EY C G L ++L + L +
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 505 ARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDM 563
A A+G+ +L + VHRD+ N+L+TH + DFGLAR D +
Sbjct: 165 DLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 564 GVETRVIGTFG 574
V
Sbjct: 221 VVRGNARLPVK 231
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-35
Identities = 50/186 (26%), Positives = 73/186 (39%), Gaps = 29/186 (15%)
Query: 414 LAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQGDHE-FCSEVEVLS-CAQHRNVV 465
L G FG V VAVK K ++ + E SE++VLS H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH----------------QEPLEWSARQKI 509
L+G C L++ EY C G L + L + L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETR 568
+ A+G+ +L + +HRD+ NILLTH + DFGLAR + D + V+
Sbjct: 151 SYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 569 VIGTFG 574
Sbjct: 207 ARLPVK 212
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-34
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 13/165 (7%)
Query: 414 LAEGGFGSVHRGVLP-DGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG+V+ +A+K +L + +H+ EVE+ S +H N++ L G
Sbjct: 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ + R L+ EY G++ L + A L Y H + +
Sbjct: 74 YFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSK----RV 127
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+HRD++P N+LL E + DFG + P T + GT
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLD 169
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (321), Expect = 1e-33
Identities = 48/208 (23%), Positives = 72/208 (34%), Gaps = 34/208 (16%)
Query: 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQGDH-EF 449
LE + EG FG V + P VAVK K +S +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 450 CSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGC------------- 496
E +++ + N+V L+G C + L++EY+ G L+ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 497 ---------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEP 547
PL + + IA A G+ YL E VHRD+ N L+ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVV 179
Query: 548 LVGDFGLARWQPDGD-MGVETRVIGTFG 574
+ DFGL+R D +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIR 207
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-33
Identities = 36/151 (23%), Positives = 63/151 (41%), Gaps = 8/151 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G +G + DG+ + K+ + + SEV +L +H N+V
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 471 CIE--DRRRLLVYEYICNGSLDSHL--YGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
I+ + +V EY G L S + ++ L+ ++ L+ H
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 527 G-CIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
G ++HRD++P N+ L +GDFGLAR
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-33
Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 14/168 (8%)
Query: 414 LAEGGFGSVHRGVLPD---GQAVAVKQHKLASSQGD--HEFCSEVEVLSCAQHRNVVMLI 468
L G FG+V +G + VAVK K ++ E +E V+ + +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G C + +LV E G L+ +L ++ ++ + G++YL E
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---- 127
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR--VIGTFG 574
VHRD+ N+LL + DFGL++ + + +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-33
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 11/166 (6%)
Query: 414 LAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLI 468
+ EG FG VH+G+ AVA+K K +S E F E + H ++V LI
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
G + ++ E G L S L L+ ++ A + L YL +
Sbjct: 75 GVI-TENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKR---- 128
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
VHRD+ N+L++ + +GDFGL+R+ D ++
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-33
Identities = 44/164 (26%), Positives = 64/164 (39%), Gaps = 9/164 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L EG +G V V +AVAVK + + E E+ + H NVV G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
E + L EY G L + + Q+ G+ YLH I H
Sbjct: 73 REGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITH 126
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRVIGTFG 574
RD++P N+LL + DFGLA + + + ++ GT
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-32
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 8/157 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ +G G+V+ + + GQ VA++Q L +E+ V+ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+V EY+ GSL + + ++ + + L +LH ++HR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN----QVIHR 140
Query: 533 DMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
D++ +NILL D + DFG T V
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-32
Identities = 40/169 (23%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 414 LAEGGFGSVHRGVLPD-GQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G F +V++G+ + VA + + + F E E+L QH N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 471 CIEDRRR----LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
+ +LV E + +G+L ++L + ++ + +GL++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 527 GCIVHRDMRPNNILLTH-DFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
I+HRD++ +NI +T +GD GLA + VIGT
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPE 178
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-32
Identities = 48/170 (28%), Positives = 68/170 (40%), Gaps = 15/170 (8%)
Query: 414 LAEGGFGSVHRGVLP----DGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
L +G FG V RG +VAVK L+ + +F EV + HRN++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 467 LIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRV 526
L G + + +V E GSL HQ + AV A G+ YL +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESK--- 130
Query: 527 GCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD--MGVETRVIGTFG 574
+HRD+ N+LL +GDFGL R P D ++ F
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 43/167 (25%), Positives = 68/167 (40%), Gaps = 11/167 (6%)
Query: 414 LAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQGD-HEFCSEVEVLSCAQHRNVVMLI 468
+ G FG V+ G L D AVK + G+ +F +E ++ H NV+ L+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 469 GFCIE-DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
G C+ + L+V Y+ +G L + + A+G+++L +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 149
Query: 528 CIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
VHRD+ N +L F V DFGLAR D + G
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 47/186 (25%), Positives = 72/186 (38%), Gaps = 25/186 (13%)
Query: 408 FSQANFLAEGGFGSVHRGVLPDG---QAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHR 462
+ + EG FG V + + A+K+ K +S+ DH +F E+EVL H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQK 508
N++ L+G C L EY +G+L L L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 509 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETR 568
A ARG+ YL ++ +HRD+ NIL+ ++ + DFGL+R Q T
Sbjct: 132 FAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TM 185
Query: 569 VIGTFG 574
Sbjct: 186 GRLPVR 191
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 122 bits (308), Expect = 2e-31
Identities = 36/153 (23%), Positives = 57/153 (37%), Gaps = 8/153 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR G A K E++ +S +H +V L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+D +++YE++ G L + H + + +GL ++HE VH
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN----NYVHL 148
Query: 533 DMRPNNILLTHDFEPLV--GDFGLARWQPDGDM 563
D++P NI+ T + DFGL
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 3e-31
Identities = 40/166 (24%), Positives = 61/166 (36%), Gaps = 11/166 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L EG F +V L + A+K + E +V+S H V L
Sbjct: 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+D + Y NG L ++ + + + L YLH + I
Sbjct: 76 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK----GI 129
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFG 574
+HRD++P NILL D + DFG A+ P+ +GT
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 120 bits (303), Expect = 1e-30
Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 8/153 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR V G+ K + +E+ +++ H ++ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ +L+ E++ G L + + + A GL+++HE IVH
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH----SIVHL 151
Query: 533 DMRPNNILLTHDFEPLV--GDFGLARWQPDGDM 563
D++P NI+ V DFGLA ++
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 4e-30
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 393 PRWFSYAEL------ELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQ-HK 439
P +FS A++ E+A + + L +G FG V+ GV VA+K ++
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 440 LASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQ- 498
AS + EF +E V+ +VV L+G + + L++ E + G L S+L
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 499 -------EPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 551
P S ++A A G+ YL+ VHRD+ N ++ DF +GD
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGD 176
Query: 552 FGLARWQPDGD-MGVETRVIGTFG 574
FG+ R + D + +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVR 200
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-30
Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 11/174 (6%)
Query: 402 ELATGGFSQANFLAEGGFGSVHRGVLPDGQ-----AVAVKQHKLASSQGD-HEFCSEVEV 455
E+ ++ + G FG V++G+L VA+K K ++ +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 456 LSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAAR 515
+ H N++ L G + + +++ EY+ NG+ + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 516 GLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
G++YL VHRD+ NIL+ + V DFGL+R D T
Sbjct: 122 GMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 13/174 (7%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQ----AVAVKQ-HKLASSQGDHEFCSEVEVLSCAQH 461
F + L G FG+V++G+ +P+G+ VA+K+ + S + + E E V++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 462 RNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLH 521
+V L+G C+ + L+ + + G L + H++ + V A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 522 EECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR-WQPDGDMGVETRVIGTFG 574
+ +VHRD+ N+L+ + DFGLA+ +
Sbjct: 129 DR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (290), Expect = 5e-29
Identities = 37/163 (22%), Positives = 61/163 (37%), Gaps = 13/163 (7%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQ--- 460
FS + GGFG V+ D G+ A+K ++ QG+ +E +LS
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 461 HRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYL 520
+V + + + + + G L HL + + A GL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHM 123
Query: 521 HEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563
H +V+RD++P NILL + D GLA
Sbjct: 124 HNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 9e-29
Identities = 45/185 (24%), Positives = 72/185 (38%), Gaps = 28/185 (15%)
Query: 414 LAEGGFGSVHRGV------LPDGQAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHRNVV 465
L G FG V + VAVK K ++ +H SE+++L H NVV
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 466 MLIGFCIEDRRRL-LVYEYICNGSLDSHLYGC--------------HQEPLEWSARQKIA 510
L+G C + L ++ E+ G+L ++L +++ L +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 511 VGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW-QPDGDMGVETRV 569
A+G+ +L +HRD+ NILL+ + DFGLAR D D +
Sbjct: 141 FQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 570 IGTFG 574
Sbjct: 197 RLPLK 201
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 9/153 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G FG VHR V + K K+ + E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++++E+I + + L L++LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSH----NIGHF 126
Query: 533 DMRPNNILLTHDFEPLV--GDFGLARWQPDGDM 563
D+RP NI+ + +FG AR GD
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (279), Expect = 3e-28
Identities = 36/162 (22%), Positives = 69/162 (42%), Gaps = 8/162 (4%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFC 471
+ EG +G V++ G+ A+K+ +L E+ +L +H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
+R +LV+E++ + LE + + G+ Y H+ ++H
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR----RVLH 123
Query: 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
RD++P N+L+ + E + DFGLAR ++ +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 110 bits (277), Expect = 6e-28
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 19/172 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---------FCSEVEVLS-CAQHR 462
L G V R + P + AVK + EV++L + H
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 463 NVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
N++ L + LV++ + G L +L + L +KI + LH+
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVICALHK 128
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
IVHRD++P NILL D + DFG + G+ V GT
Sbjct: 129 LN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 174
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 6e-28
Identities = 38/166 (22%), Positives = 67/166 (40%), Gaps = 13/166 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIGFC 471
L G F V + VA+K + +G +E+ VL +H N+V L
Sbjct: 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76
Query: 472 IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531
L+ + + G L + + ++ ++YLH+ IVH
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL----GIVH 130
Query: 532 RDMRPNNILLTH---DFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
RD++P N+L D + ++ DFGL++ + G + + GT G
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPG 174
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 46/166 (27%), Positives = 65/166 (39%), Gaps = 12/166 (7%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE---FCSEVEVLSCA-QHRNVVMLI 468
L +G FG V Q A+K K D + E VLS A +H + +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 469 GFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
V EY+ G L H+ CH + S A GL++LH +
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK----G 123
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
IV+RD++ +NILL D + DFG+ + GD GT
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPD 168
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-27
Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 7/148 (4%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-FCSEVEVLSCAQHRNVVMLIG 469
+++ EG +G V + VA+K+ Q + E+++L +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYG-CHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
+ Y+ + + LY + L RGL+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA----N 129
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLAR 556
++HRD++P+N+LL + + DFGLAR
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLAR 157
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 9e-27
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 412 NFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE-----FCSEVEVLSCAQHRNVV 465
+FL EG F +V++ Q VA+K+ KL + E+++L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 466 MLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
L+ LV++++ + + L S + + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
I+HRD++PNN+LL + + DFGLA+ T + T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRW 165
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 9e-27
Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 28/180 (15%)
Query: 414 LAEGGFGSVHRGVLP--------DGQAVAVKQHKLASSQGDH-EFCSEVEVLS-CAQHRN 463
L EG FG V VAVK K +++ D + SE+E++ +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKI 509
++ L+G C +D ++ EY G+L +L +E L
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 510 AVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRV 569
A ARG+ YL + +HRD+ N+L+T D + DFGLAR D +T
Sbjct: 141 AYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (266), Expect = 4e-26
Identities = 38/151 (25%), Positives = 63/151 (41%), Gaps = 10/151 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG VH +G+ A+K + + E +LS H ++ + G
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
+ ++ ++ +Y G L Q A+ A L YLH + I
Sbjct: 72 TFQDAQQIFMIMDY-IEGGELFSLLRKSQRFPNPVAK-FYAAEVCLALEYLHSKD----I 125
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560
++RD++P NILL + + DFG A++ PD
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD 156
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 7e-26
Identities = 36/169 (21%), Positives = 70/169 (41%), Gaps = 8/169 (4%)
Query: 408 FSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKL--ASSQGDHEFCSEVEVLSCAQHRNV 464
F + + EG +G V++ G+ VA+K+ +L + E+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
V L+ + + LV+E+ + L + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTF 573
++HRD++P N+L+ + + DFGLAR V+ +
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 104 bits (260), Expect = 1e-25
Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 16/171 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGD---HEFCSEVEVLSCAQHRNVVMLIG 469
L GG VH L + VAVK + ++ F E + + H +V +
Sbjct: 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74
Query: 470 FCIEDRRRL----LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+ +V EY+ +L ++ + P+ ++ A + L + H+
Sbjct: 75 TGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN-- 130
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD--MGVETRVIGTFG 574
I+HRD++P NI+++ V DFG+AR D + VIGT
Sbjct: 131 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 4e-25
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 17/172 (9%)
Query: 414 LAEGGFGSVHRG--VLPDGQAVAVKQHKLASSQGDHEFCSEVEV-----LSCAQHRNVVM 466
+ EG +G V + + G+ VA+K+ ++ + + + EV L +H NVV
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 467 LIGFCIEDRRRLLVYEYI----CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
L C R + + L ++L + + + + RGL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
+VHRD++P NIL+T + + DFGLAR T V+ T
Sbjct: 135 HR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLW 180
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 4e-25
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 17/165 (10%)
Query: 408 FSQANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVM 466
++ + G FG V++ L D G+ VA+K+ Q E++++ H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 467 LIGFCIEDRRR------LLVYEYICNGSLDSHL-YGCHQEPLEWSARQKIAVGAARGLRY 519
L F + LV +Y+ Y ++ L + R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 520 LHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPDGDM 563
+H I HRD++P N+LL D L + DFG A+ G+
Sbjct: 138 IHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (254), Expect = 1e-24
Identities = 32/171 (18%), Positives = 63/171 (36%), Gaps = 17/171 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ G FG ++ G + G+ VA+K + + + E ++ Q + I +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
+ ++ + SL+ L+ +A + Y+H + +HR
Sbjct: 73 AEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIHSK----NFIHR 127
Query: 533 DMRPNNILLT---HDFEPLVGDFGLARWQPDGDMGVE------TRVIGTFG 574
D++P+N L+ + DFGLA+ D + GT
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 38/171 (22%), Positives = 63/171 (36%), Gaps = 18/171 (10%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHE------FCSEVEVLS--CAQHRNV 464
L GGFGSV+ G+ + D VA+K + E EV +L + V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
+ L+ + +L+ E D + + L+ + +R+ H
Sbjct: 72 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129
Query: 525 RVGCIVHRDMRPNNILLTHD-FEPLVGDFGLARWQPDGDMGVETRVIGTFG 574
++HRD++ NIL+ + E + DFG D T GT
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRV 174
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 42/175 (24%), Positives = 69/175 (39%), Gaps = 20/175 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGF 470
+ +G FG V + GQ VA+K+ + + + E+++L +H NVV LI
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 471 CIEDRRR--------LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHE 522
C LV+++ + S +++ GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 523 ECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW---QPDGDMGVETRVIGTFG 574
I+HRDM+ N+L+T D + DFGLAR + T + T
Sbjct: 136 NK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 8e-24
Identities = 33/159 (20%), Positives = 58/159 (36%), Gaps = 18/159 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLS-CAQHRNVVMLIGFC 471
L G G V + + A+K + + EVE+ +Q ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 472 ----IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVG 527
+ L+V E + G L S + + +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---- 130
Query: 528 CIVHRDMRPNNILLTHDFEPLV---GDFGLARWQPDGDM 563
I HRD++P N+L T + DFG A+ +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (249), Expect = 1e-23
Identities = 34/156 (21%), Positives = 55/156 (35%), Gaps = 10/156 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L G FG V G A+K K+ + +E +L +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
++ +V EY+ G + SHL + A YLH +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLD----L 162
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGV 565
++RD++P N+L+ V DFG A+ +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 99.1 bits (246), Expect = 1e-23
Identities = 26/157 (16%), Positives = 52/157 (33%), Gaps = 13/157 (8%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
+ EG FG + G L + Q VA+K + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 473 EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHR 532
++ ++ + G L A ++ +HE+ +V+R
Sbjct: 71 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVYR 125
Query: 533 DMRPNNILLTHDFEPLVG-----DFGLARWQPDGDMG 564
D++P+N L+ DFG+ ++ D
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99.1 bits (246), Expect = 2e-23
Identities = 37/192 (19%), Positives = 76/192 (39%), Gaps = 26/192 (13%)
Query: 391 KPPRWFSYAELELATGGFSQANF-----LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ 444
+P ++ Y + G +Q ++ L G + V + + + + V VK K +
Sbjct: 17 RPREYWDYESHVVEWG--NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK 74
Query: 445 GDHEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRL--LVYEYICNGSLDSHLYGCHQEPL 501
+ E+++L N++ L + R LV+E++ N + L
Sbjct: 75 ---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTL 126
Query: 502 EWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL-VGDFGLARWQPD 560
+ + L Y H I+HRD++P+N+++ H+ L + D+GLA +
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 561 GDMGVETRVIGT 572
G + +
Sbjct: 183 GQE--YNVRVAS 192
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 45/187 (24%), Positives = 63/187 (33%), Gaps = 28/187 (14%)
Query: 408 FSQANF---------LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH------EFCS 451
F Q N L G F V + G A K K ++ +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 452 EVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAV 511
EV +L QH NV+ L +L+ E + G L +E L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLK 120
Query: 512 GAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPL----VGDFGLARWQPDGDMGVET 567
G+ YLH I H D++P NI+L P + DFGLA G+
Sbjct: 121 QILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FK 174
Query: 568 RVIGTFG 574
+ GT
Sbjct: 175 NIFGTPE 181
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 9e-23
Identities = 34/152 (22%), Positives = 65/152 (42%), Gaps = 9/152 (5%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ EG +G+V + + VA+K+ +L E+ +L +H+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIV 530
D++ LV+E+ + L+ + +GL + H ++
Sbjct: 70 LHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN----VL 123
Query: 531 HRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562
HRD++P N+L+ + E + +FGLAR
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 6e-22
Identities = 37/163 (22%), Positives = 54/163 (33%), Gaps = 11/163 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ---HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIG 469
L +G FG V G+ A+K + + +E VL +H + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCI 529
R V EY G L HL E A + L +
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYLHSRD-V 126
Query: 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
V+RD++ N++L D + DFGL + D GT
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGT 168
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 1e-21
Identities = 38/149 (25%), Positives = 59/149 (39%), Gaps = 9/149 (6%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G +G+V V G VA+K+ S E+ +L +H NV+ L+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 471 CIEDRRRLLVYEYICNGSLDSHLYG--CHQEPLEWSARQKIAVGAARGLRYLHEECRVGC 528
D ++ G E L Q + +GLRY+H
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI--- 142
Query: 529 IVHRDMRPNNILLTHDFEPLVGDFGLARW 557
+HRD++P N+ + D E + DFGLAR
Sbjct: 143 -IHRDLKPGNLAVNEDCELKILDFGLARQ 170
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 1e-21
Identities = 35/167 (20%), Positives = 64/167 (38%), Gaps = 15/167 (8%)
Query: 414 LAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQHR-NV 464
L G +G V G+ A+K K A+ ++ +E +VL + +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 465 VMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
V L + + L+ +YI G L +HL + + L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVLALEHLH 146
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIG 571
++G I++RD++ NILL + ++ DFGL++ + G
Sbjct: 147 KLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 3e-21
Identities = 24/153 (15%), Positives = 45/153 (29%), Gaps = 20/153 (13%)
Query: 414 LAEGGFGSVHRGVLPDGQAVAVKQHKLASS----------QGDHEFCSEVEVLSCAQHRN 463
+ EG +V VK HK+ + GD F + + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 464 VVMLIGFCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEE 523
+ L G + Y + N L + + ++ + +
Sbjct: 68 LQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 524 CRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556
IVH D+ N+L+ + + DF +
Sbjct: 123 ----GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (216), Expect = 2e-19
Identities = 34/168 (20%), Positives = 61/168 (36%), Gaps = 20/168 (11%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQ--HKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGF 470
+ G G V + VA+K+ + E+ ++ C H+N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 471 CI------EDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC 524
E + LV E + + + G+++LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAG 139
Query: 525 RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMGVETRVIGT 572
+ HRD++P+NI++ D + DFGLAR M T + T
Sbjct: 140 II----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 181
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 1e-17
Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 15/152 (9%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDH--EFCSEVEVLSCAQHRNVVMLIGF 470
+ G +GSV G VAVK+ H E+ +L +H NV+ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 471 C-----IEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECR 525
+E+ + + ++ L++ + L Q + RGL+Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557
+HRD++P+N+ + D E + DFGLAR
Sbjct: 143 ----IHRDLKPSNLAVNEDCELKILDFGLARH 170
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.7 bits (169), Expect = 2e-13
Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 20/160 (12%)
Query: 414 LAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCI 472
L G F +V + + VA+K + E+++L +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 473 EDRRRLLVYEYICNGSL--------------DSHLYGCHQEPLEWSARQKIAVGAARGLR 518
+LL + + + + + ++I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 519 YLHEECRVGCIVHRDMRPNNILLT-HDFEPLVGDFGLARW 557
Y+H C I+H D++P N+L+ D + +A
Sbjct: 140 YMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADL 176
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 574 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.98 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.96 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.95 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.95 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.86 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.21 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 98.1 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 97.5 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 97.43 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 97.3 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.98 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-34 Score=287.27 Aligned_cols=171 Identities=25% Similarity=0.386 Sum_probs=149.6
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeC-CCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP-DGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
+..|++..++|++.+.||+|+||.||+|... +|+.||||+++... ...++|.+|+.+|+.++|||||+++++|.+.+.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3456677789999999999999999999964 58999999987543 445679999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.||||||+++|+|..++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999999766677899999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCCCccceeeccC
Q 008201 557 WQPDGDMGVETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~ 573 (574)
..........+...||+
T Consensus 164 ~~~~~~~~~~~~~~g~~ 180 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPI 180 (287)
T ss_dssp TCCSSSSEEETTEEECG
T ss_pred ecCCCCceeeccccccc
Confidence 77654443334445553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-33 Score=280.85 Aligned_cols=163 Identities=26% Similarity=0.349 Sum_probs=141.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4799999999999999999995 5799999999876533 2345689999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC-
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD- 562 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~- 562 (574)
+++|+|.+++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999986 456899999999999999999999998 99999999999999999999999999999875433
Q ss_pred CCccceeeccCC
Q 008201 563 MGVETRVIGTFG 574 (574)
Q Consensus 563 ~~~~t~v~GT~G 574 (574)
....+..+||++
T Consensus 159 ~~~~~~~~GT~~ 170 (271)
T d1nvra_ 159 ERLLNKMCGTLP 170 (271)
T ss_dssp ECCBCCCCSCGG
T ss_pred cccccceeeCcC
Confidence 233456788863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-33 Score=280.66 Aligned_cols=168 Identities=27% Similarity=0.377 Sum_probs=146.5
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
+|++..++|++.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.+|++++|||||++++++.. +..||
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4566778899999999999999999999888899999987543 445679999999999999999999998754 56799
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++|+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+.
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEcc
Confidence 99999999999988654445799999999999999999999998 99999999999999999999999999999887
Q ss_pred CCCCCccceeeccC
Q 008201 560 DGDMGVETRVIGTF 573 (574)
Q Consensus 560 ~~~~~~~t~v~GT~ 573 (574)
.......+...||+
T Consensus 161 ~~~~~~~~~~~gt~ 174 (272)
T d1qpca_ 161 DNEYTAREGAKFPI 174 (272)
T ss_dssp SSCEECCTTCCCCT
T ss_pred CCccccccccCCcc
Confidence 65544444556665
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-33 Score=281.78 Aligned_cols=160 Identities=22% Similarity=0.360 Sum_probs=143.7
Q ss_pred CCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.+|.+.+.||+|+||.||+|. ..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 469999999999999999999 4579999999998766556678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
++|+|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998853 4699999999999999999999998 999999999999999999999999999998754433
Q ss_pred ccceeeccC
Q 008201 565 VETRVIGTF 573 (574)
Q Consensus 565 ~~t~v~GT~ 573 (574)
.....+||+
T Consensus 172 ~~~~~~gt~ 180 (293)
T d1yhwa1 172 KRSTMVGTP 180 (293)
T ss_dssp CBCCCCSCG
T ss_pred cccccccCC
Confidence 335567886
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.2e-32 Score=275.14 Aligned_cols=163 Identities=26% Similarity=0.442 Sum_probs=133.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.++|++.+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|+.+|+.++|||||+++|+|..++..|+||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3579999999999999999999888889999998754 344568999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
++|+|.+++.. ....+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 83 ~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999864 456789999999999999999999998 9999999999999999999999999999987655444
Q ss_pred ccceeeccC
Q 008201 565 VETRVIGTF 573 (574)
Q Consensus 565 ~~t~v~GT~ 573 (574)
......||+
T Consensus 158 ~~~~~~gt~ 166 (263)
T d1sm2a_ 158 SSTGTKFPV 166 (263)
T ss_dssp -------CT
T ss_pred eecceecCc
Confidence 444456665
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.2e-32 Score=279.60 Aligned_cols=162 Identities=25% Similarity=0.370 Sum_probs=143.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
+.|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|+.++|||||++++++.+++..|||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4699999999999999999995 579999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
++|+|.+++.. ...++++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999998764 346799999999999999999999999 99999999999999999999999999998664321 1
Q ss_pred ccceeeccC
Q 008201 565 VETRVIGTF 573 (574)
Q Consensus 565 ~~t~v~GT~ 573 (574)
..+..+||+
T Consensus 166 ~~~~~~Gt~ 174 (288)
T d2jfla1 166 RRDSFIGTP 174 (288)
T ss_dssp HHTCCCSCC
T ss_pred ccccccccc
Confidence 223466775
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.6e-33 Score=288.07 Aligned_cols=165 Identities=27% Similarity=0.347 Sum_probs=142.3
Q ss_pred HhhcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 402 ELATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 402 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
++..++|++.+.||+|+||.||+|+. .+|+.||+|+++..... ....+.+|+.+|+.++|||||+++++|.+++..||
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45567899999999999999999994 57999999998765333 24578999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ +|+||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 VmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999999973 457999999999999999999999732 89999999999999999999999999999764
Q ss_pred CCCCCccceeeccCC
Q 008201 560 DGDMGVETRVIGTFG 574 (574)
Q Consensus 560 ~~~~~~~t~v~GT~G 574 (574)
+.. .+.++||++
T Consensus 157 ~~~---~~~~~GT~~ 168 (322)
T d1s9ja_ 157 DSM---ANSFVGTRS 168 (322)
T ss_dssp HHT---C---CCSSC
T ss_pred CCc---cccccCCcc
Confidence 322 245788864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-32 Score=272.67 Aligned_cols=159 Identities=27% Similarity=0.393 Sum_probs=140.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|.+.+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|+.+|+.++|||||++++++.+++..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4699999999999999999995 46999999998643 2234467899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
|||++|+|.+++.. ...+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999973 45799999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
. ....+||+
T Consensus 160 ~---~~~~~Gt~ 168 (263)
T d2j4za1 160 R---RTTLCGTL 168 (263)
T ss_dssp C---CEETTEEG
T ss_pred c---ccccCCCC
Confidence 3 24567776
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7e-32 Score=274.05 Aligned_cols=163 Identities=24% Similarity=0.308 Sum_probs=139.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||++++++|.+.+..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999995 579999999987432 234467899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+++|+|.+++. ..+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999886 356799999999999999999999999 9999999999999999999999999999987543
Q ss_pred C-CCccceeeccCC
Q 008201 562 D-MGVETRVIGTFG 574 (574)
Q Consensus 562 ~-~~~~t~v~GT~G 574 (574)
. ....+..+||++
T Consensus 162 ~~~~~~~~~~GT~~ 175 (288)
T d1uu3a_ 162 SKQARANSFVGTAQ 175 (288)
T ss_dssp --------CCCCGG
T ss_pred CcccccccccCCcc
Confidence 3 233455788863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-32 Score=275.31 Aligned_cols=166 Identities=30% Similarity=0.462 Sum_probs=136.7
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCC--CcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLAS--SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
+|++..++|.+.+.||+|+||.||+|++. ..||||+++... ....+.|.+|+.+|++++|||||++++++.. +..
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 35667788999999999999999999864 359999987543 2334679999999999999999999998754 568
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
+|||||+++|+|.+++.. ....+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceee
Confidence 999999999999999964 446799999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCC-CccceeeccC
Q 008201 558 QPDGDM-GVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~-~~~t~v~GT~ 573 (574)
...... ...+++.||+
T Consensus 154 ~~~~~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSI 170 (276)
T ss_dssp ------------CCCCG
T ss_pred ccccCCcccccccccCc
Confidence 754322 2334567775
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=2.9e-31 Score=276.84 Aligned_cols=161 Identities=22% Similarity=0.305 Sum_probs=142.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
++|++.+.||+|+||.||+|+. .+|+.||||++..........+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999994 579999999988665445567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc--CCCcEEEeeecceeecCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT--HDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd--~~~~vKLsDFGLAr~~~~~~ 562 (574)
+||+|.+++.. ...++++..++.|+.||+.||.|||++ ||+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999988753 455799999999999999999999998 999999999999998 57899999999999886543
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
. .....||+
T Consensus 184 ~--~~~~~gt~ 192 (352)
T d1koba_ 184 I--VKVTTATA 192 (352)
T ss_dssp C--EEEECSSG
T ss_pred c--eeeccCcc
Confidence 2 34566775
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=3.5e-31 Score=275.99 Aligned_cols=162 Identities=23% Similarity=0.339 Sum_probs=143.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
++|.+.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+..|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999995 579999999987665555567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC--CCcEEEeeecceeecCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH--DFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~--~~~vKLsDFGLAr~~~~~~ 562 (574)
+||+|.+++.. ..+.+++..+..|+.||+.||.|||++ |||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999864 345799999999999999999999999 9999999999999964 5789999999999875443
Q ss_pred CCccceeeccCC
Q 008201 563 MGVETRVIGTFG 574 (574)
Q Consensus 563 ~~~~t~v~GT~G 574 (574)
. ....+||++
T Consensus 181 ~--~~~~~gT~~ 190 (350)
T d1koaa2 181 S--VKVTTGTAE 190 (350)
T ss_dssp C--EEEECSCTT
T ss_pred c--cceecCccc
Confidence 2 345778863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.6e-32 Score=273.84 Aligned_cols=167 Identities=28% Similarity=0.375 Sum_probs=137.3
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
|++..++|++.+.||+|+||.||+|+..+++.||||+++.. ....+.|.+|+.+|++++|||||+++++|. ++..|+|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEE
Confidence 44556689999999999999999999888888999998754 344568999999999999999999999985 4568999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++|+|..++.......++|..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999999988654556799999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
......+...||+
T Consensus 166 ~~~~~~~~~~gt~ 178 (285)
T d1fmka3 166 NEYTARQGAKFPI 178 (285)
T ss_dssp ----------CCG
T ss_pred CCceeeccccccc
Confidence 5544445566665
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=276.67 Aligned_cols=163 Identities=23% Similarity=0.258 Sum_probs=143.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
.++|.+++.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 45799999999999999999994 57999999998743 223456789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||++||+|..++. ....+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999987 356799999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCCccceeeccCC
Q 008201 561 GDMGVETRVIGTFG 574 (574)
Q Consensus 561 ~~~~~~t~v~GT~G 574 (574)
... ....++||++
T Consensus 158 ~~~-~~~~~~GT~~ 170 (337)
T d1o6la_ 158 DGA-TMKTFCGTPE 170 (337)
T ss_dssp TTC-CBCCCEECGG
T ss_pred CCc-ccccceeCHH
Confidence 332 3456889873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.7e-32 Score=270.13 Aligned_cols=168 Identities=23% Similarity=0.324 Sum_probs=129.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIE--DRRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--~~~~~LV 480 (574)
++|++.+.||+|+||.||+|+. .+|+.||||.+...... ..+.+.+|+++|+.++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4799999999999999999984 57999999998765432 23468899999999999999999999965 4568999
Q ss_pred EEecCCCChHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhhCc-CCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGC--HQEPLEWSARQKIAVGAARGLRYLHEECR-VGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~--~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~-~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||++|+|.+++... ....+++..++.++.||+.||.|||+... .++|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 35679999999999999999999999720 01399999999999999999999999999998
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
+..... ..+..+||++
T Consensus 164 ~~~~~~-~~~~~~gt~~ 179 (269)
T d2java1 164 LNHDTS-FAKAFVGTPY 179 (269)
T ss_dssp C------------CCCS
T ss_pred cccCCC-ccccCCCCcc
Confidence 754332 3356788874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.3e-31 Score=272.71 Aligned_cols=156 Identities=29% Similarity=0.428 Sum_probs=137.8
Q ss_pred CeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
.|+.++.||+|+||.||+|+ ..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999998 4579999999987654332 2468899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
||.+|+|..++. ...++++..+..|+.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999987665 356799999999999999999999999 9999999999999999999999999999976432
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
...+||+
T Consensus 169 ----~~~~GT~ 175 (309)
T d1u5ra_ 169 ----NSFVGTP 175 (309)
T ss_dssp ----CCCCSCG
T ss_pred ----CccccCc
Confidence 3456776
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.6e-31 Score=264.37 Aligned_cols=163 Identities=25% Similarity=0.374 Sum_probs=144.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEec
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYI 484 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~ 484 (574)
.++|+..+.||+|+||.||+|++++++.||||.++... ...++|.+|+.+++.++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 35788999999999999999999888899999998643 34568999999999999999999999999999999999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG 564 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~ 564 (574)
++|+|..++.. ....+++..+.+++.|+++||.|||+. ||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999998764 455789999999999999999999998 9999999999999999999999999999977655444
Q ss_pred ccceeeccC
Q 008201 565 VETRVIGTF 573 (574)
Q Consensus 565 ~~t~v~GT~ 573 (574)
..+...||+
T Consensus 157 ~~~~~~~t~ 165 (258)
T d1k2pa_ 157 SSVGSKFPV 165 (258)
T ss_dssp CCCCSCCCG
T ss_pred eecccCCCC
Confidence 444455654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.2e-31 Score=272.49 Aligned_cols=163 Identities=23% Similarity=0.350 Sum_probs=126.1
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
..+.|.+.+.||+|+||.||+|+. .+|+.||||++...... ....+.+|+.+|+.++|||||++++++.+++..||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 346799999999999999999995 46999999998754332 2346889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEc---CCCcEEEeeecceeec
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLT---HDFEPLVGDFGLARWQ 558 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd---~~~~vKLsDFGLAr~~ 558 (574)
|||+||+|.+++. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||+. .++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997 466899999999999999999999999 999999999999995 5789999999999977
Q ss_pred CCCCCCccceeeccCC
Q 008201 559 PDGDMGVETRVIGTFG 574 (574)
Q Consensus 559 ~~~~~~~~t~v~GT~G 574 (574)
..+.. ....+||++
T Consensus 161 ~~~~~--~~~~~GT~~ 174 (307)
T d1a06a_ 161 DPGSV--LSTACGTPG 174 (307)
T ss_dssp --------------CT
T ss_pred cCCCe--eeeeeeCcc
Confidence 54432 345778874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=6.1e-31 Score=270.28 Aligned_cols=159 Identities=27% Similarity=0.363 Sum_probs=141.6
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|++.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4699999999999999999995 56999999998743 2234567899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+.||+|..++. ....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887 456788999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCccceeeccCC
Q 008201 562 DMGVETRVIGTFG 574 (574)
Q Consensus 562 ~~~~~t~v~GT~G 574 (574)
. +.++||++
T Consensus 158 ~----~~~~Gt~~ 166 (316)
T d1fota_ 158 T----YTLCGTPD 166 (316)
T ss_dssp B----CCCCSCTT
T ss_pred c----ccccCccc
Confidence 2 45788874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.1e-31 Score=265.14 Aligned_cols=158 Identities=25% Similarity=0.333 Sum_probs=134.2
Q ss_pred eeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE----DRRRLLV 480 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~----~~~~~LV 480 (574)
|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.|.+|+++|+.++|||||+++++|.. .+.+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36777899999999999995 4689999999875432 233568999999999999999999999875 3468999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC--eEeeCCCCCCeEEc-CCCcEEEeeecceee
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGC--IVHRDMRPNNILLT-HDFEPLVGDFGLARW 557 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g--IIHRDLKP~NILLd-~~~~vKLsDFGLAr~ 557 (574)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+||||+ .++.+||+|||+|+.
T Consensus 91 mE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~----~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC----CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999973 46799999999999999999999998 6 99999999999996 578999999999986
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
.... ....++||+.
T Consensus 165 ~~~~---~~~~~~GT~~ 178 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPE 178 (270)
T ss_dssp CCTT---SBEESCSSCC
T ss_pred ccCC---ccCCcccCcc
Confidence 5332 2346788874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=1.5e-30 Score=262.58 Aligned_cols=160 Identities=26% Similarity=0.338 Sum_probs=141.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---------hhHHHHHHHHHHhcC-CCCeeEEEEEEEeC
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---------DHEFCSEVEVLSCAQ-HRNVVMLIGFCIED 474 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---------~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~ 474 (574)
++|++.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999995 579999999987653321 135889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
+..||||||+++|+|.+++.. .+++++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999973 56799999999999999999999998 999999999999999999999999999
Q ss_pred eeecCCCCCCccceeeccC
Q 008201 555 ARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 555 Ar~~~~~~~~~~t~v~GT~ 573 (574)
|+.+..+.. .+..+||+
T Consensus 157 a~~~~~~~~--~~~~~gt~ 173 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTP 173 (277)
T ss_dssp CEECCTTCC--BCCCCSCG
T ss_pred eeEccCCCc--eeeeeccC
Confidence 998865432 24466775
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-30 Score=262.58 Aligned_cols=161 Identities=26% Similarity=0.313 Sum_probs=140.0
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC------cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS------QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~------~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999995 5799999999875422 1245799999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC----cEEEeeec
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----EPLVGDFG 553 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~----~vKLsDFG 553 (574)
|||||||++|+|.+++.. .+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999974 45799999999999999999999999 999999999999998776 59999999
Q ss_pred ceeecCCCCCCccceeeccC
Q 008201 554 LARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~ 573 (574)
+|+....+.. .....||+
T Consensus 163 ~a~~~~~~~~--~~~~~~t~ 180 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTP 180 (293)
T ss_dssp TCEECTTSCB--CSCCCCCG
T ss_pred hhhhcCCCcc--ccccCCCC
Confidence 9998765443 23445664
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=4e-31 Score=269.31 Aligned_cols=153 Identities=30% Similarity=0.471 Sum_probs=126.8
Q ss_pred hcCCeeEEeeeeccCcEEEEEEEeC-CCC---EEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 008201 404 ATGGFSQANFLAEGGFGSVHRGVLP-DGQ---AVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRL 478 (574)
Q Consensus 404 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~---~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~ 478 (574)
..++|.+.+.||+|+||.||+|+.. +|+ .||||.+..... ...+.|.+|+.+|+.++|||||+++++|...+..|
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 3467999999999999999999854 333 588898765433 23457999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
+|||||++|+|.+++.. ....+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+
T Consensus 104 iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999998864 456799999999999999999999998 9999999999999999999999999999977
Q ss_pred CCC
Q 008201 559 PDG 561 (574)
Q Consensus 559 ~~~ 561 (574)
...
T Consensus 179 ~~~ 181 (299)
T d1jpaa_ 179 EDD 181 (299)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=267.63 Aligned_cols=169 Identities=28% Similarity=0.374 Sum_probs=139.3
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCC-C-----CEEEEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPD-G-----QAVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCI 472 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g-----~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~ 472 (574)
|++..++|.+.+.||+|+||.||+|+... + ..||+|.+.... ......+.+|+.+|..+ +|||||+++++|.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 45666789999999999999999998432 2 368999886543 33445789999999998 8999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEe
Q 008201 473 EDRRRLLVYEYICNGSLDSHLYGCH---------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVH 531 (574)
Q Consensus 473 ~~~~~~LVmEy~~ggsL~~~L~~~~---------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIH 531 (574)
+.+..|||||||++|+|.++|.... ...+++..++.|+.||+.||.|||++ +|||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiH 187 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVH 187 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEE
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----Ceee
Confidence 9999999999999999999996432 23589999999999999999999998 9999
Q ss_pred eCCCCCCeEEcCCCcEEEeeecceeecCCCCC-CccceeeccC
Q 008201 532 RDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 532 RDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
|||||+|||++.++.+||+|||+|+....... ...+...||+
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 230 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence 99999999999999999999999997654432 2334566775
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=263.55 Aligned_cols=154 Identities=30% Similarity=0.478 Sum_probs=133.4
Q ss_pred hhcCCeeEEee-eeccCcEEEEEEEeC---CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 403 LATGGFSQANF-LAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 403 ~~~~~y~~~~~-LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
+..++|.+.+. ||+|+||.||+|.+. ++..||||.++..... ..+.|.+|+.+|+.++|||||+++++|.. +..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 34557888885 999999999999753 3557999998755432 34579999999999999999999999865 468
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||||+++|+|.+++.. ....+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999998854 456799999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCC
Q 008201 558 QPDGD 562 (574)
Q Consensus 558 ~~~~~ 562 (574)
+....
T Consensus 159 ~~~~~ 163 (285)
T d1u59a_ 159 LGADD 163 (285)
T ss_dssp CTTCS
T ss_pred ccccc
Confidence 76543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=262.44 Aligned_cols=154 Identities=27% Similarity=0.450 Sum_probs=130.3
Q ss_pred hhcCCeeEEeeeeccCcEEEEEEEeCC-C----CEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 008201 403 LATGGFSQANFLAEGGFGSVHRGVLPD-G----QAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRR 476 (574)
Q Consensus 403 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g----~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~ 476 (574)
+..+.|+..++||+|+||.||+|.+.. + ..||||.+...... ....|.+|+.+|+.++|||||+++|++...+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 344679999999999999999998543 2 36999998754332 23468999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.++||||+.++++.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999988764 456799999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCC
Q 008201 557 WQPDG 561 (574)
Q Consensus 557 ~~~~~ 561 (574)
.+...
T Consensus 159 ~~~~~ 163 (283)
T d1mqba_ 159 VLEDD 163 (283)
T ss_dssp -----
T ss_pred cccCC
Confidence 87543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.8e-30 Score=263.34 Aligned_cols=161 Identities=23% Similarity=0.268 Sum_probs=139.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+++|+.++|||||+++++|.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 45799999999999999999995 468999999997543 2334688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCC--CcEEEeeecceeecCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHD--FEPLVGDFGLARWQPDG 561 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~--~~vKLsDFGLAr~~~~~ 561 (574)
|+||+|.+++.. ....+++..+..|+.||+.||.|||+. ||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999964 345799999999999999999999998 99999999999999854 58999999999987544
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
.. ....+||+
T Consensus 158 ~~--~~~~~~t~ 167 (321)
T d1tkia_ 158 DN--FRLLFTAP 167 (321)
T ss_dssp CE--EEEEESCG
T ss_pred Cc--cccccccc
Confidence 32 23456664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-30 Score=261.27 Aligned_cols=167 Identities=26% Similarity=0.382 Sum_probs=128.7
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCC----CCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEEEEeCC
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGFCIEDR 475 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~ 475 (574)
|++..++|++.+.||+|+||.||+|.... +..||||.++...... .+.|.+|+.+|+.++||||++++++|. .+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45666789999999999999999998532 3568888876543332 356999999999999999999999995 56
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred eEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhh
Confidence 78999999999999998764 456799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+.+........+...||+
T Consensus 156 ~~~~~~~~~~~~~~~gt~ 173 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPI 173 (273)
T ss_dssp ---------------CCG
T ss_pred eeccCCcceeccceecCc
Confidence 987655544555666765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-30 Score=260.69 Aligned_cols=162 Identities=23% Similarity=0.351 Sum_probs=136.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|++++.||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|+.++|||||+++++|.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999994 6799999999875432 234678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|+. +.+..++.......+++..+..++.||+.||+|||+. |||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 985 5555555544667899999999999999999999998 99999999999999999999999999998775433
Q ss_pred CCccceeeccC
Q 008201 563 MGVETRVIGTF 573 (574)
Q Consensus 563 ~~~~t~v~GT~ 573 (574)
. ......||+
T Consensus 157 ~-~~~~~~gt~ 166 (298)
T d1gz8a_ 157 R-TYTHEVVTL 166 (298)
T ss_dssp B-CTTCCBCCC
T ss_pred c-cceeecccc
Confidence 2 233456665
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=3.9e-30 Score=267.89 Aligned_cols=158 Identities=23% Similarity=0.258 Sum_probs=140.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecC---CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLA---SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVm 481 (574)
++|++++.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+.+|+.++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 3699999999999999999995 57999999998643 2233457899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDG 561 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~ 561 (574)
||+.+|+|..++.. .+.+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999863 45799999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCccceeeccC
Q 008201 562 DMGVETRVIGTF 573 (574)
Q Consensus 562 ~~~~~t~v~GT~ 573 (574)
. ...+||+
T Consensus 195 ~----~~~~Gt~ 202 (350)
T d1rdqe_ 195 T----WTLCGTP 202 (350)
T ss_dssp B----CCCEECG
T ss_pred c----ccccCcc
Confidence 2 3567886
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=3.8e-30 Score=269.33 Aligned_cols=161 Identities=24% Similarity=0.299 Sum_probs=136.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHH---HHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSE---VEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~E---i~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ......+.+| +.+++.++|||||+++++|...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 35899999999999999999995 579999999986432 1222334444 5666777899999999999999999
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
||||||++||+|.++|.. ...+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999973 46789999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCccceeeccCC
Q 008201 558 QPDGDMGVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~G 574 (574)
+..... ...+||++
T Consensus 157 ~~~~~~---~~~~GT~~ 170 (364)
T d1omwa3 157 FSKKKP---HASVGTHG 170 (364)
T ss_dssp CSSSCC---CSCCSCGG
T ss_pred cCCCcc---cccccccc
Confidence 765432 45678863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.7e-30 Score=257.46 Aligned_cols=155 Identities=26% Similarity=0.365 Sum_probs=127.6
Q ss_pred eeeeccCcEEEEEEEeC---CCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEecCC
Q 008201 412 NFLAEGGFGSVHRGVLP---DGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEYICN 486 (574)
Q Consensus 412 ~~LG~G~fG~Vy~a~~~---~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy~~g 486 (574)
+.||+|+||.||+|.+. .++.||||+++..... ..+.|.+|+.+|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999853 3568999998754322 23579999999999999999999999965 467899999999
Q ss_pred CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCCC--
Q 008201 487 GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDMG-- 564 (574)
Q Consensus 487 gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~~-- 564 (574)
|+|.+++. ....+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+......
T Consensus 92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999987 356799999999999999999999998 9999999999999999999999999999987544322
Q ss_pred ccceeeccC
Q 008201 565 VETRVIGTF 573 (574)
Q Consensus 565 ~~t~v~GT~ 573 (574)
......||+
T Consensus 166 ~~~~~~gt~ 174 (277)
T d1xbba_ 166 AQTHGKWPV 174 (277)
T ss_dssp C----CCCG
T ss_pred cccccCCCc
Confidence 223355664
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7e-30 Score=258.58 Aligned_cols=157 Identities=27% Similarity=0.334 Sum_probs=131.1
Q ss_pred EEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc-----hhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 410 QANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG-----DHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 410 ~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~-----~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
.+++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.+|+.++|||||++++++...+..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999994 579999999987543221 24688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM 563 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~ 563 (574)
+.++++..++. ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98877666554 466789999999999999999999999 999999999999999999999999999997755433
Q ss_pred CccceeeccC
Q 008201 564 GVETRVIGTF 573 (574)
Q Consensus 564 ~~~t~v~GT~ 573 (574)
.....+||+
T Consensus 156 -~~~~~~gt~ 164 (299)
T d1ua2a_ 156 -AYTHQVVTR 164 (299)
T ss_dssp -CCCCSCCCC
T ss_pred -cccceecCh
Confidence 223456775
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-29 Score=259.88 Aligned_cols=161 Identities=27% Similarity=0.333 Sum_probs=139.2
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCC---CcchhHHHHHHHHHH-hcCCCCeeEEEEEEEeCCeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLAS---SQGDHEFCSEVEVLS-CAQHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~iL~-~L~HpNIV~L~g~~~~~~~~~LV 480 (574)
++|.+.+.||+|+||.||+|+. .+|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4799999999999999999995 579999999987532 233456777777765 68999999999999999999999
Q ss_pred EEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 481 YEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
|||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997 356789999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCCccceeeccC
Q 008201 561 GDMGVETRVIGTF 573 (574)
Q Consensus 561 ~~~~~~t~v~GT~ 573 (574)
.. ...+..+||+
T Consensus 156 ~~-~~~~~~~gt~ 167 (320)
T d1xjda_ 156 GD-AKTNTFCGTP 167 (320)
T ss_dssp TT-CCBCCCCSCG
T ss_pred cc-ccccccCCCC
Confidence 33 2345577886
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=6.7e-30 Score=259.66 Aligned_cols=172 Identities=28% Similarity=0.415 Sum_probs=143.7
Q ss_pred hhHHHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCcc-hhHHHHHHHHHHhcCCCCeeEEEEE
Q 008201 398 YAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQG-DHEFCSEVEVLSCAQHRNVVMLIGF 470 (574)
Q Consensus 398 ~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~~-~~~f~~Ei~iL~~L~HpNIV~L~g~ 470 (574)
+.++++..++|++.+.||+|+||.||+|+.. +++.||||+++...... .+.|.+|+.+|+.++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4567778889999999999999999999853 35789999987654332 4579999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCC
Q 008201 471 CIEDRRRLLVYEYICNGSLDSHLYGCH----------------------QEPLEWSARQKIAVGAARGLRYLHEECRVGC 528 (574)
Q Consensus 471 ~~~~~~~~LVmEy~~ggsL~~~L~~~~----------------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~g 528 (574)
|...+..+++|||+++|+|.+++.... ...+++..++.|+.||+.||.|||+. +
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ 160 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----K 160 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----C
Confidence 999999999999999999999986321 23588999999999999999999998 9
Q ss_pred eEeeCCCCCCeEEcCCCcEEEeeecceeecCCCCC-CccceeeccC
Q 008201 529 IVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 529 IIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
||||||||+||||+.++.+||+|||+|+....... ...+...||+
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~ 206 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI 206 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCG
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCc
Confidence 99999999999999999999999999987654332 2233455554
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.96 E-value=2.5e-29 Score=251.99 Aligned_cols=164 Identities=24% Similarity=0.329 Sum_probs=133.4
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcc---hhHHHHHHHHHHhcCCCCeeEEEEEEEeCC----e
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQG---DHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----R 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~ 476 (574)
.++|.+.+.||+|+||.||+|+. .+|+.||||+++...... ...+.+|+.+|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999994 579999999997654332 346899999999999999999999998654 4
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.||||||++|++|..++.. .+++++..++.|+.||+.||.|||++ ||+||||||+|||++.++..+|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhhh
Confidence 7999999999999998863 46799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCC--CCccceeeccCC
Q 008201 557 WQPDGD--MGVETRVIGTFG 574 (574)
Q Consensus 557 ~~~~~~--~~~~t~v~GT~G 574 (574)
...... .......+||++
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~ 179 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQ 179 (277)
T ss_dssp ECC----------------T
T ss_pred hhccccccccccccccCccc
Confidence 764332 223455678864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.6e-29 Score=258.16 Aligned_cols=158 Identities=22% Similarity=0.223 Sum_probs=134.4
Q ss_pred CCeeEEe-eeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHh-cCCCCeeEEEEEEEe----CCeEE
Q 008201 406 GGFSQAN-FLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSC-AQHRNVVMLIGFCIE----DRRRL 478 (574)
Q Consensus 406 ~~y~~~~-~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~-L~HpNIV~L~g~~~~----~~~~~ 478 (574)
++|.+.. .||+|+||.||+|+. .+|+.||||+++. ...+.+|+.++.+ ++|||||+++++|.+ .+.+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788764 699999999999994 6799999999863 3467889998765 489999999999975 45789
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecce
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLA 555 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGLA 555 (574)
||||||+||+|.++|.......+++..+..|+.||+.||.|||+. ||+||||||+|||++. .+.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc----CCcccccccccccccccccccccccccccee
Confidence 999999999999999764456899999999999999999999999 9999999999999985 567999999999
Q ss_pred eecCCCCCCccceeeccCC
Q 008201 556 RWQPDGDMGVETRVIGTFG 574 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~G 574 (574)
+....... ....+||++
T Consensus 162 ~~~~~~~~--~~~~~gt~~ 178 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPY 178 (335)
T ss_dssp EECCCCCC--CCCCSCCCS
T ss_pred eeccCCCc--cccccCCcc
Confidence 98765443 245678763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-29 Score=255.20 Aligned_cols=173 Identities=24% Similarity=0.304 Sum_probs=133.9
Q ss_pred chhHHHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCC-cchhHHHHHHHHHHhc-CCCCeeEEE
Q 008201 397 SYAELELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASS-QGDHEFCSEVEVLSCA-QHRNVVMLI 468 (574)
Q Consensus 397 s~~~le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L-~HpNIV~L~ 468 (574)
....|++..++|++.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 45667777889999999999999999999842 356899999875433 2335678888888776 689999999
Q ss_pred EEEEeC-CeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeC
Q 008201 469 GFCIED-RRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRD 533 (574)
Q Consensus 469 g~~~~~-~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRD 533 (574)
+++... +..++|||||++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+|||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrD 159 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRD 159 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCc
Confidence 998765 46899999999999999996421 34589999999999999999999998 999999
Q ss_pred CCCCCeEEcCCCcEEEeeecceeecCCCC-CCccceeeccC
Q 008201 534 MRPNNILLTHDFEPLVGDFGLARWQPDGD-MGVETRVIGTF 573 (574)
Q Consensus 534 LKP~NILLd~~~~vKLsDFGLAr~~~~~~-~~~~t~v~GT~ 573 (574)
|||+||||+.++.+||+|||+|+...... ....+..+||+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 99999999999999999999999765433 23344567875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-29 Score=252.38 Aligned_cols=160 Identities=23% Similarity=0.260 Sum_probs=136.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc------chhHHHHHHHHHHhcC--CCCeeEEEEEEEeCC
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ------GDHEFCSEVEVLSCAQ--HRNVVMLIGFCIEDR 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~iL~~L~--HpNIV~L~g~~~~~~ 475 (574)
.++|++.+.||+|+||.||+|+. .+|+.||||++...... ....+.+|+.+|+.++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999994 57999999998754221 1234678999999997 899999999999999
Q ss_pred eEEEEEEecCC-CChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-CCcEEEeeec
Q 008201 476 RRLLVYEYICN-GSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-DFEPLVGDFG 553 (574)
Q Consensus 476 ~~~LVmEy~~g-gsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-~~~vKLsDFG 553 (574)
..|+||||+.+ +++.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccc
Confidence 99999999975 57777775 346799999999999999999999998 9999999999999985 5799999999
Q ss_pred ceeecCCCCCCccceeeccC
Q 008201 554 LARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 554 LAr~~~~~~~~~~t~v~GT~ 573 (574)
+|+...... .+..+||+
T Consensus 157 ~a~~~~~~~---~~~~~GT~ 173 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTR 173 (273)
T ss_dssp TCEECCSSC---BCCCCSCG
T ss_pred cceeccccc---ccccccCC
Confidence 999765432 34567886
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=3e-29 Score=252.12 Aligned_cols=149 Identities=24% Similarity=0.350 Sum_probs=134.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmEy 483 (574)
++|.+.+.||+|+||.||+|+..+|+.||||+++.... ...+.+.+|+.+|+.++||||++++++|...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999988999999999876532 2246799999999999999999999999999999999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~ 560 (574)
+.++.+..+.. ..+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|.....
T Consensus 82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 97766666554 467899999999999999999999998 999999999999999999999999999987654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.9e-29 Score=254.60 Aligned_cols=162 Identities=25% Similarity=0.434 Sum_probs=131.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCC----EEEEEEeecC-CCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQ----AVAVKQHKLA-SSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~----~VAVK~l~~~-~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~L 479 (574)
.+|++++.||+|+||.||+|.. .+|+ .||+|.++.. .....+.|.+|+.+|++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4699999999999999999985 3454 5888887643 334456899999999999999999999999865 5778
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
++||+++++|.+++.. ....+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988865 566899999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCC-ccceeeccC
Q 008201 560 DGDMG-VETRVIGTF 573 (574)
Q Consensus 560 ~~~~~-~~t~v~GT~ 573 (574)
..... ..+...||+
T Consensus 163 ~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPI 177 (317)
T ss_dssp TTCC--------CCT
T ss_pred cccccccccccccCc
Confidence 54432 233456665
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=9.4e-29 Score=252.46 Aligned_cols=170 Identities=29% Similarity=0.397 Sum_probs=144.4
Q ss_pred HHHhhcCCeeEEeeeeccCcEEEEEEEe------CCCCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEEEEEE
Q 008201 400 ELELATGGFSQANFLAEGGFGSVHRGVL------PDGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGFC 471 (574)
Q Consensus 400 ~le~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~~ 471 (574)
.|++..++|++.+.||+|+||.||+|++ .+++.||||+++..... ....|.+|+.+++.+ +|||||+++++|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4566778999999999999999999984 24678999999865433 334689999999999 699999999999
Q ss_pred EeCCeEEEEEEecCCCChHHHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCC
Q 008201 472 IEDRRRLLVYEYICNGSLDSHLYGCH----------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMR 535 (574)
Q Consensus 472 ~~~~~~~LVmEy~~ggsL~~~L~~~~----------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLK 535 (574)
...+..+||||||++|+|.+++.... ...+++..++.|+.||+.||.|||++ +|+|||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLK 172 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLA 172 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCS
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----Ceeecccc
Confidence 99999999999999999999986422 23689999999999999999999999 99999999
Q ss_pred CCCeEEcCCCcEEEeeecceeecCCCCC-CccceeeccC
Q 008201 536 PNNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 536 P~NILLd~~~~vKLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
|+|||++.++.+||+|||+++....... ...+..+||+
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~ 211 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccCh
Confidence 9999999999999999999998765433 3334466665
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.3e-29 Score=250.70 Aligned_cols=153 Identities=29% Similarity=0.419 Sum_probs=129.7
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLL 479 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~L 479 (574)
|++..++|++.+.||+|+||.||+|.. .|..||||+++.. ...+.|.+|+++|++++||||++++|+|.+ .+.+||
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 345566899999999999999999998 5788999998643 345679999999999999999999999965 456899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecC
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQP 559 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~ 559 (574)
||||+++|+|.++|.......+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecC
Confidence 99999999999999754445689999999999999999999998 99999999999999999999999999999754
Q ss_pred C
Q 008201 560 D 560 (574)
Q Consensus 560 ~ 560 (574)
.
T Consensus 155 ~ 155 (262)
T d1byga_ 155 S 155 (262)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5e-28 Score=242.34 Aligned_cols=151 Identities=23% Similarity=0.326 Sum_probs=136.3
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~~LVmE 482 (574)
++|++++.||+|+||+||+|+. .+|+.||||+++..... ....+.+|+.+|+.++||||++++++|...+..++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999994 57999999998765432 23578999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
|+.+++|..++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998888776 567889999999999999999999998 99999999999999999999999999999875433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.9e-29 Score=253.32 Aligned_cols=169 Identities=28% Similarity=0.388 Sum_probs=141.5
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeC------CCCEEEEEEeecCCCc-chhHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLP------DGQAVAVKQHKLASSQ-GDHEFCSEVEVLSCAQHRNVVMLIGFCIE 473 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~ 473 (574)
|++..++|.+.+.||+|+||.||+|.+. +++.||||+++..... ....|.+|+.+|++++||||++++++|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 5666678999999999999999999852 3678999998754332 23468999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC
Q 008201 474 DRRRLLVYEYICNGSLDSHLYGC--------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF 545 (574)
Q Consensus 474 ~~~~~LVmEy~~ggsL~~~L~~~--------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~ 545 (574)
.+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||||+.++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCc
Confidence 99999999999999999988532 224578999999999999999999998 899999999999999999
Q ss_pred cEEEeeecceeecCCCCC-CccceeeccC
Q 008201 546 EPLVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 546 ~vKLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
++||+|||+|+.+..... ...+...||+
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~ 199 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPV 199 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECG
T ss_pred eEEEeecccceeccCCcceeeccceeccc
Confidence 999999999997654332 2233445664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-28 Score=249.44 Aligned_cols=150 Identities=30% Similarity=0.501 Sum_probs=130.1
Q ss_pred CCeeEEeeeeccCcEEEEEEEeC-CCC--EEEEEEeecCC-CcchhHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLP-DGQ--AVAVKQHKLAS-SQGDHEFCSEVEVLSCA-QHRNVVMLIGFCIEDRRRLLV 480 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L-~HpNIV~L~g~~~~~~~~~LV 480 (574)
++|++.+.||+|+||.||+|++. +|. .||||.+.... ....+.|.+|+++|+++ +|||||+++++|...+..|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57889999999999999999954 454 46788776432 33456799999999998 799999999999999999999
Q ss_pred EEecCCCChHHHHhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCc
Q 008201 481 YEYICNGSLDSHLYGC--------------HQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFE 546 (574)
Q Consensus 481 mEy~~ggsL~~~L~~~--------------~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~ 546 (574)
|||+++|+|.++|... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCc
Confidence 9999999999998642 246799999999999999999999999 9999999999999999999
Q ss_pred EEEeeecceeecC
Q 008201 547 PLVGDFGLARWQP 559 (574)
Q Consensus 547 vKLsDFGLAr~~~ 559 (574)
+||+|||+|+...
T Consensus 166 ~kl~DfG~a~~~~ 178 (309)
T d1fvra_ 166 AKIADFGLSRGQE 178 (309)
T ss_dssp EEECCTTCEESSC
T ss_pred eEEcccccccccc
Confidence 9999999998654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-28 Score=250.39 Aligned_cols=162 Identities=28% Similarity=0.344 Sum_probs=130.4
Q ss_pred CCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHH--HHHhcCCCCeeEEEEEEEeCC----eEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVE--VLSCAQHRNVVMLIGFCIEDR----RRLL 479 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~--iL~~L~HpNIV~L~g~~~~~~----~~~L 479 (574)
..|.+.+.||+|+||.||+|++ +|+.||||+++.. ..+.+.+|.+ .+..++||||++++++|...+ .+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4688999999999999999997 6889999998643 2334444444 556789999999999998654 5899
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC----cCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----RVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~----~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
||||+++|+|.++|.. ..++|..+..++.|++.||.|||... ...+|+||||||+||||+.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999964 46999999999999999999999731 1128999999999999999999999999999
Q ss_pred eecCCCCCC---ccceeeccCC
Q 008201 556 RWQPDGDMG---VETRVIGTFG 574 (574)
Q Consensus 556 r~~~~~~~~---~~t~v~GT~G 574 (574)
+........ .....+||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~ 177 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKR 177 (303)
T ss_dssp EEEETTTTEECC----CCSCGG
T ss_pred ccccCCCcceeccccceecccC
Confidence 987554321 2234677753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.4e-28 Score=247.31 Aligned_cols=151 Identities=32% Similarity=0.445 Sum_probs=123.5
Q ss_pred cCCeeEEeeeeccCcEEEEEEEeC--CC--CEEEEEEeecCCC---cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVLP--DG--QAVAVKQHKLASS---QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDRRR 477 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~~--~g--~~VAVK~l~~~~~---~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~~~ 477 (574)
.++|++.+.||+|+||.||+|++. ++ ..||||+++.... ...+.|.+|+.+|+.++||||++++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 357999999999999999999842 23 3689998875432 223579999999999999999999999965 467
Q ss_pred EEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 478 LLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 478 ~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988764 345799999999999999999999998 999999999999999999999999999998
Q ss_pred cCCC
Q 008201 558 QPDG 561 (574)
Q Consensus 558 ~~~~ 561 (574)
+...
T Consensus 161 ~~~~ 164 (273)
T d1u46a_ 161 LPQN 164 (273)
T ss_dssp CCC-
T ss_pred cccC
Confidence 7543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6.7e-28 Score=246.75 Aligned_cols=147 Identities=28% Similarity=0.446 Sum_probs=127.4
Q ss_pred EeeeeccCcEEEEEEEeCC----CCEEEEEEeecCC-CcchhHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEEec
Q 008201 411 ANFLAEGGFGSVHRGVLPD----GQAVAVKQHKLAS-SQGDHEFCSEVEVLSCAQHRNVVMLIGFCIE-DRRRLLVYEYI 484 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~-~~~~~LVmEy~ 484 (574)
.++||+|+||+||+|++.. ...||||.++... ....++|.+|+++|++++||||++++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999999543 2358999987433 2334679999999999999999999999876 46899999999
Q ss_pred CCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeecCCCC
Q 008201 485 CNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPDGD 562 (574)
Q Consensus 485 ~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~~~~~ 562 (574)
++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998875 455678889999999999999999998 99999999999999999999999999999775443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.1e-28 Score=248.51 Aligned_cols=169 Identities=30% Similarity=0.381 Sum_probs=136.1
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCC--------CCEEEEEEeecCCCc-chhHHHHHHHHHHhc-CCCCeeEEEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQ-GDHEFCSEVEVLSCA-QHRNVVMLIGF 470 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~--------g~~VAVK~l~~~~~~-~~~~f~~Ei~iL~~L-~HpNIV~L~g~ 470 (574)
|++..++|.+.+.||+|+||.||+|+... +..||||+++..... ...++.+|+..+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 34556789999999999999999998422 347999998765432 335788999999888 79999999999
Q ss_pred EEeCCeEEEEEEecCCCChHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCC
Q 008201 471 CIEDRRRLLVYEYICNGSLDSHLYGCH--------------QEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRP 536 (574)
Q Consensus 471 ~~~~~~~~LVmEy~~ggsL~~~L~~~~--------------~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP 536 (574)
|.+++..++||||+++|+|.++|.... ...+++..++.++.||+.||+|||+. +||||||||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp 163 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAA 163 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecc
Confidence 999999999999999999999996432 24689999999999999999999999 999999999
Q ss_pred CCeEEcCCCcEEEeeecceeecCCCCC-CccceeeccC
Q 008201 537 NNILLTHDFEPLVGDFGLARWQPDGDM-GVETRVIGTF 573 (574)
Q Consensus 537 ~NILLd~~~~vKLsDFGLAr~~~~~~~-~~~t~v~GT~ 573 (574)
+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 201 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 201 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGG
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCCh
Confidence 999999999999999999997754332 2233455554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=1.1e-27 Score=245.00 Aligned_cols=145 Identities=22% Similarity=0.372 Sum_probs=127.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeC--CeEEEEE
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIED--RRRLLVY 481 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~--~~~~LVm 481 (574)
++|++++.||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|+++|+.++ ||||++++++|... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4799999999999999999994 57999999998643 3467899999999995 99999999999853 5689999
Q ss_pred EecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceeecCC
Q 008201 482 EYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARWQPD 560 (574)
Q Consensus 482 Ey~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~~~~ 560 (574)
||+.+++|..+. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 4699999999999999999999999 999999999999998655 699999999998765
Q ss_pred CC
Q 008201 561 GD 562 (574)
Q Consensus 561 ~~ 562 (574)
..
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-27 Score=247.73 Aligned_cols=157 Identities=24% Similarity=0.303 Sum_probs=127.8
Q ss_pred CeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEEE
Q 008201 407 GFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVVMLIGFCIED------RRRLL 479 (574)
Q Consensus 407 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~------~~~~L 479 (574)
.|...++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|+.++||||++++++|... .++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 589999999999999999995 5699999999875432 234799999999999999999998643 35799
Q ss_pred EEEecCCCChHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-cEEEeeecceee
Q 008201 480 VYEYICNGSLDSHLY-GCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF-EPLVGDFGLARW 557 (574)
Q Consensus 480 VmEy~~ggsL~~~L~-~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~-~vKLsDFGLAr~ 557 (574)
||||++++.+..+.. ......+++..++.|+.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999996654333332 12566899999999999999999999998 999999999999999775 899999999998
Q ss_pred cCCCCCCccceeeccC
Q 008201 558 QPDGDMGVETRVIGTF 573 (574)
Q Consensus 558 ~~~~~~~~~t~v~GT~ 573 (574)
+...... ...+||+
T Consensus 173 ~~~~~~~--~~~~gt~ 186 (350)
T d1q5ka_ 173 LVRGEPN--VSYICSR 186 (350)
T ss_dssp CCTTSCC--CSCCSCT
T ss_pred ccCCccc--ccccccc
Confidence 7554332 2345554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.2e-28 Score=250.84 Aligned_cols=162 Identities=22% Similarity=0.316 Sum_probs=130.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCC-cchhHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASS-QGDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR----RRL 478 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~----~~~ 478 (574)
..+|.+++.||+|+||+||+|+ ..+|+.||||++..... ...+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3579999999999999999998 46899999999875432 22357889999999999999999999997643 234
Q ss_pred EEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 479 LVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 479 LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
++++|+.+++|.+++.. ..+++..++.++.||+.||+|||++ |||||||||+||||+.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 45566779999999963 4699999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCC--CccceeeccC
Q 008201 559 PDGDM--GVETRVIGTF 573 (574)
Q Consensus 559 ~~~~~--~~~t~v~GT~ 573 (574)
..... ......+||+
T Consensus 160 ~~~~~~~~~~~~~~gt~ 176 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATR 176 (345)
T ss_dssp CGGGCBCCTTCCCCSCG
T ss_pred cCCCccceeeccccccc
Confidence 54322 1223455654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.8e-28 Score=247.49 Aligned_cols=148 Identities=27% Similarity=0.401 Sum_probs=124.6
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeCC------
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIEDR------ 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~~------ 475 (574)
.++|++++.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 56899999999999999999994 57999999998754322 2346889999999999999999999998654
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..||||||+ +.+|..++. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccce
Confidence 569999998 777887774 45799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCC
Q 008201 556 RWQPD 560 (574)
Q Consensus 556 r~~~~ 560 (574)
+....
T Consensus 169 ~~~~~ 173 (346)
T d1cm8a_ 169 RQADS 173 (346)
T ss_dssp EECCS
T ss_pred eccCC
Confidence 97754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.5e-28 Score=247.97 Aligned_cols=162 Identities=25% Similarity=0.276 Sum_probs=138.9
Q ss_pred CCeeEEeeeeccCcEEEEEEEe----CCCCEEEEEEeecCC----CcchhHHHHHHHHHHhcCC-CCeeEEEEEEEeCCe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL----PDGQAVAVKQHKLAS----SQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRR 476 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~ 476 (574)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999983 258999999886432 2234568899999999976 899999999999999
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.+++|||+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999873 45678899999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCCCccceeeccC
Q 008201 557 WQPDGDMGVETRVIGTF 573 (574)
Q Consensus 557 ~~~~~~~~~~t~v~GT~ 573 (574)
.+............||+
T Consensus 178 ~~~~~~~~~~~~~~g~~ 194 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTI 194 (322)
T ss_dssp ECCGGGGGGGCGGGSCC
T ss_pred hhccccccccccccccc
Confidence 87654443344455554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.4e-27 Score=240.17 Aligned_cols=149 Identities=27% Similarity=0.367 Sum_probs=126.8
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCC--cchhHHHHHHHHHHhcCCCCeeEEEEEEEe--------C
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASS--QGDHEFCSEVEVLSCAQHRNVVMLIGFCIE--------D 474 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~--------~ 474 (574)
++|++++.||+|+||+||+|+. .+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5799999999999999999995 5799999999865432 334578999999999999999999999865 3
Q ss_pred CeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecc
Q 008201 475 RRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGL 554 (574)
Q Consensus 475 ~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGL 554 (574)
+..|+||||+.++.+..+.. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeecce
Confidence 46899999997766654443 566789999999999999999999998 999999999999999999999999999
Q ss_pred eeecCC
Q 008201 555 ARWQPD 560 (574)
Q Consensus 555 Ar~~~~ 560 (574)
|+.+..
T Consensus 164 ~~~~~~ 169 (318)
T d3blha1 164 ARAFSL 169 (318)
T ss_dssp CEECCC
T ss_pred eeeccc
Confidence 987754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=9.1e-27 Score=235.69 Aligned_cols=162 Identities=21% Similarity=0.257 Sum_probs=137.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEE
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH-RNVVMLIGFCIEDRRRLLVYE 482 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H-pNIV~L~g~~~~~~~~~LVmE 482 (574)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+|+++++.++| +|++.+++++......|+|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46899999999999999999994 579999999876442 33457889999999976 899999999999999999999
Q ss_pred ecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC-----CCcEEEeeecceee
Q 008201 483 YICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH-----DFEPLVGDFGLARW 557 (574)
Q Consensus 483 y~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~-----~~~vKLsDFGLAr~ 557 (574)
|+ +++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 8999998864 456799999999999999999999999 9999999999999974 57899999999998
Q ss_pred cCCCCC------CccceeeccCC
Q 008201 558 QPDGDM------GVETRVIGTFG 574 (574)
Q Consensus 558 ~~~~~~------~~~t~v~GT~G 574 (574)
+..... .....++||+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~ 178 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTAR 178 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTT
T ss_pred cccCccccceeecccCceEEchh
Confidence 754321 12345778873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4e-27 Score=238.06 Aligned_cols=162 Identities=27% Similarity=0.364 Sum_probs=131.9
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CC-CCEEEEEEeecCCC--cchhHHHHHHHHHHhc---CCCCeeEEEEEEEe----
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PD-GQAVAVKQHKLASS--QGDHEFCSEVEVLSCA---QHRNVVMLIGFCIE---- 473 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~iL~~L---~HpNIV~L~g~~~~---- 473 (574)
.++|++++.||+|+||.||+|+. .+ ++.||||+++.... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999985 44 67799999875432 2234577888887766 79999999999863
Q ss_pred -CCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeee
Q 008201 474 -DRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDF 552 (574)
Q Consensus 474 -~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDF 552 (574)
....+++|||+.++.+..... .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecch
Confidence 346899999997776654443 3567799999999999999999999999 9999999999999999999999999
Q ss_pred cceeecCCCCCCccceeeccC
Q 008201 553 GLARWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 553 GLAr~~~~~~~~~~t~v~GT~ 573 (574)
|+++...... .....+||+
T Consensus 161 g~~~~~~~~~--~~~~~~gT~ 179 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTL 179 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCC
T ss_pred hhhhhhcccc--cCCCcccCh
Confidence 9998654332 334567776
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=4.5e-26 Score=230.08 Aligned_cols=160 Identities=20% Similarity=0.287 Sum_probs=131.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRN-VVMLIGFCIEDRRRLLVYEY 483 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpN-IV~L~g~~~~~~~~~LVmEy 483 (574)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+..|+++++.++|+| |+.+.+++...+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4699999999999999999984 569999999887543 2346889999999998765 55566666788899999999
Q ss_pred cCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcC---CCcEEEeeecceeecCC
Q 008201 484 ICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTH---DFEPLVGDFGLARWQPD 560 (574)
Q Consensus 484 ~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~---~~~vKLsDFGLAr~~~~ 560 (574)
+ +++|...+.. ....+++..+..++.|++.||+|||++ ||+||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 8 6677666643 466899999999999999999999999 9999999999999864 45799999999998765
Q ss_pred CCCC------ccceeeccC
Q 008201 561 GDMG------VETRVIGTF 573 (574)
Q Consensus 561 ~~~~------~~t~v~GT~ 573 (574)
.... ....++||+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~ 177 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTA 177 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCS
T ss_pred cccccceeccccCCcCCCc
Confidence 4321 234567876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.6e-27 Score=239.80 Aligned_cols=148 Identities=25% Similarity=0.373 Sum_probs=125.7
Q ss_pred cCCeeEEeeeeccCcEEEEEEE-eCCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEeC-----Ce
Q 008201 405 TGGFSQANFLAEGGFGSVHRGV-LPDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIED-----RR 476 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~~-----~~ 476 (574)
.++|++.+.||+|+||+||+|+ ..+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999 467999999998754322 234688999999999999999999999643 33
Q ss_pred EEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 477 RLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 477 ~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
.+++|+|+.+|+|.+++. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhc
Confidence 466677888999999984 45799999999999999999999999 99999999999999999999999999998
Q ss_pred ecC
Q 008201 557 WQP 559 (574)
Q Consensus 557 ~~~ 559 (574)
...
T Consensus 170 ~~~ 172 (348)
T d2gfsa1 170 HTD 172 (348)
T ss_dssp CCT
T ss_pred ccC
Confidence 654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.1e-26 Score=234.84 Aligned_cols=158 Identities=22% Similarity=0.286 Sum_probs=122.1
Q ss_pred cCCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCc--chhHHHHHHHHHHhcCCCCeeEEEEEEEe------CC
Q 008201 405 TGGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQ--GDHEFCSEVEVLSCAQHRNVVMLIGFCIE------DR 475 (574)
Q Consensus 405 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~iL~~L~HpNIV~L~g~~~~------~~ 475 (574)
.++|++++.||+|+||+||+|+. .+|+.||||++...... ....+.+|+.+|+.++||||++++++|.. .+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999994 57999999999754322 23468899999999999999999999964 36
Q ss_pred eEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeecce
Q 008201 476 RRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLA 555 (574)
Q Consensus 476 ~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLA 555 (574)
..|+||||+.+ ++...+. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++++|||++
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhh
Confidence 88999999965 4545443 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccceeeccC
Q 008201 556 RWQPDGDMGVETRVIGTF 573 (574)
Q Consensus 556 r~~~~~~~~~~t~v~GT~ 573 (574)
+...... ..+..+||+
T Consensus 167 ~~~~~~~--~~~~~~~t~ 182 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTR 182 (355)
T ss_dssp ----------------CC
T ss_pred hcccccc--ccccccccc
Confidence 8765433 223445654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=5.2e-22 Score=187.66 Aligned_cols=135 Identities=16% Similarity=0.115 Sum_probs=107.2
Q ss_pred eeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCc-----c-------------hhHHHHHHHHHHhcCCCCeeEEEE
Q 008201 408 FSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQ-----G-------------DHEFCSEVEVLSCAQHRNVVMLIG 469 (574)
Q Consensus 408 y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~-----~-------------~~~f~~Ei~iL~~L~HpNIV~L~g 469 (574)
+.+.+.||+|+||.||+|...+|+.||||+++..... . ...+..|+..|..+.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4678999999999999999888999999987642110 0 023456888999999999999886
Q ss_pred EEEeCCeEEEEEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEE
Q 008201 470 FCIEDRRRLLVYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLV 549 (574)
Q Consensus 470 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKL 549 (574)
+. ..+++|||+++..+.. ++...+..++.|++.+|.|||++ ||+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CEEE
Confidence 63 2379999997765543 23344567899999999999998 99999999999999865 4899
Q ss_pred eeecceeecCC
Q 008201 550 GDFGLARWQPD 560 (574)
Q Consensus 550 sDFGLAr~~~~ 560 (574)
+|||+|+....
T Consensus 144 iDFG~a~~~~~ 154 (191)
T d1zara2 144 IDFPQSVEVGE 154 (191)
T ss_dssp CCCTTCEETTS
T ss_pred EECCCcccCCC
Confidence 99999987653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.86 E-value=8.7e-22 Score=202.40 Aligned_cols=151 Identities=19% Similarity=0.267 Sum_probs=121.0
Q ss_pred CCeeEEeeeeccCcEEEEEEEe-CCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-----------CCCeeEEEEEEEe
Q 008201 406 GGFSQANFLAEGGFGSVHRGVL-PDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-----------HRNVVMLIGFCIE 473 (574)
Q Consensus 406 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-----------HpNIV~L~g~~~~ 473 (574)
++|++++.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+|+.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999994 579999999987532 22356788999888775 5789999988864
Q ss_pred --CCeEEEEEEecCCCC-hHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCC-----
Q 008201 474 --DRRRLLVYEYICNGS-LDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDF----- 545 (574)
Q Consensus 474 --~~~~~LVmEy~~ggs-L~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~----- 545 (574)
....+++|+++..+. ............+++..+..++.||+.||.|||+.. ||+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 456677777765443 333344446678899999999999999999999832 899999999999998654
Q ss_pred -cEEEeeecceeecCC
Q 008201 546 -EPLVGDFGLARWQPD 560 (574)
Q Consensus 546 -~vKLsDFGLAr~~~~ 560 (574)
.++++|||.|+....
T Consensus 169 ~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE 184 (362)
T ss_dssp EEEEECCCTTCEETTB
T ss_pred ceeeEeeccccccccc
Confidence 489999999997654
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.21 E-value=5.4e-12 Score=116.03 Aligned_cols=144 Identities=17% Similarity=0.260 Sum_probs=103.2
Q ss_pred eEEEEEEeCCCC--------CCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhh
Q 008201 21 EKVVVAVKASKE--------IPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQ 92 (574)
Q Consensus 21 ~~Vvv~~dasr~--------i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (574)
-+|+||||.|-. -|+.||+|||+|+++.||+...|.+++-..... .++..+..... ..+...+.
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~--~~~~~~~~~~~------~~~~~~~~ 73 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDE--DGFDDVDSIYA------SPEDFRDM 73 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC------------CCCC------SHHHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccc--ccccccccccc------CHHHHHHH
Confidence 479999998752 478899999999999999755444443211100 11111111000 11123455
Q ss_pred hhhhHHHHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchh---------hhhhhhcccee
Q 008201 93 RGDITDSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHE---------EKCCMEELQCN 163 (574)
Q Consensus 93 ~~~~~~~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e---------~k~~~~~l~cn 163 (574)
.++..+...+++.++.+.|+..++.+++.|..|.|..+|..+|++.++.+||+-+|=+.. -.+|+++..|.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~cp 153 (171)
T d2gm3a1 74 RQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAECP 153 (171)
T ss_dssp TTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCSSC
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCceEEEEEeCChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCCCC
Confidence 566667778899999999999999999999999999999888999999999999884433 34899999999
Q ss_pred EEEEecCcc
Q 008201 164 IVVMKRSQA 172 (574)
Q Consensus 164 iv~~~~~~~ 172 (574)
|+++++..+
T Consensus 154 VlvV~~~~~ 162 (171)
T d2gm3a1 154 VMTIKRNAD 162 (171)
T ss_dssp EEEEECCGG
T ss_pred EEEEeCCCC
Confidence 999997764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=3.4e-07 Score=87.61 Aligned_cols=150 Identities=13% Similarity=0.020 Sum_probs=101.7
Q ss_pred HHhhcCCeeEEeeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEE
Q 008201 401 LELATGGFSQANFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 401 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~L 479 (574)
+.-....|+..+..+.++.+.||+... +++.+.+|............+.+|...|..+. +--+.+++.++..++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344445677776655555578998864 56677888776554444556788999988774 3346788888888899999
Q ss_pred EEEecCCCChHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhhC-----------------------------------
Q 008201 480 VYEYICNGSLDSHLYGCHQEPLEWSARQKIAVGAARGLRYLHEEC----------------------------------- 524 (574)
Q Consensus 480 VmEy~~ggsL~~~L~~~~~~~Ls~~~~~~Ia~qIa~gL~yLHs~~----------------------------------- 524 (574)
||++++|.++...... ... ...++.++++.|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 88 LMSEADGVLCSEEYED----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHTTT----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEecccccccccccc----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999998887654321 011 1223444555555555310
Q ss_pred --------------------cCCCeEeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 525 --------------------RVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 525 --------------------~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
....++|+|+.|.|||+++++.+-|+||+.+.+-
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 0113799999999999998766779999988753
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.10 E-value=2.2e-06 Score=74.87 Aligned_cols=133 Identities=13% Similarity=0.105 Sum_probs=86.8
Q ss_pred ceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHH
Q 008201 20 AEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDS 99 (574)
Q Consensus 20 ~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (574)
.++|+|++|.|. .+..||.||+.-.-+.|+.++++++.+.......... .. ..+...+..+.
T Consensus 5 yk~ILv~vD~s~-~s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~---------~~--------~~~~~~~~~~~ 66 (147)
T d1tq8a_ 5 YKTVVVGTDGSD-SSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADI---------LK--------DESYKVTGTAP 66 (147)
T ss_dssp CCEEEEECCSSH-HHHHHHHHHHHHHTTTSEEEEEEECCC-------------------------------------CCT
T ss_pred CCEEEEEECCCH-HHHHHHHHHHHHHhcCCCEEEEEEEeccccccccccc---------ch--------hhhHHHHHHHH
Confidence 478999999876 7889999999865444455555565554321111000 00 01112222233
Q ss_pred HHHHHHHHHhhcCCCCce-EEEEEEecCCCchhhHHhhhcCccEEEeccccchhh---------hhhhhccceeEEEEec
Q 008201 100 CSQMILQLHDVYDPNKIN-FKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEE---------KCCMEELQCNIVVMKR 169 (574)
Q Consensus 100 ~~~~~~~l~~~~~~~~i~-~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e~---------k~~~~~l~cniv~~~~ 169 (574)
..+.+.++.+.+...++. +++.+..|.+...+..+|++.++..||+=+|-+.-. .+++++.+|.|.++|.
T Consensus 67 ~~~~l~~~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~~pVlvV~~ 146 (147)
T d1tq8a_ 67 IYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDVLIVHT 146 (147)
T ss_dssp HHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEEEEECC
T ss_pred HHHHHHHHHHHHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCCCCEEEEec
Confidence 355667777777666665 899999999988888889999999999987754322 3689999999999986
Q ss_pred C
Q 008201 170 S 170 (574)
Q Consensus 170 ~ 170 (574)
+
T Consensus 147 ~ 147 (147)
T d1tq8a_ 147 T 147 (147)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=98.08 E-value=4.7e-06 Score=73.96 Aligned_cols=146 Identities=14% Similarity=0.150 Sum_probs=97.5
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|+||+|.|.. +..||.||+...-+.|..|+||=|.+...... +.......+...... .......+....+.+..
T Consensus 4 ~~ILvavD~s~~-s~~al~~a~~la~~~~a~l~llhV~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 79 (160)
T d1mjha_ 4 KKILYPTDFSET-AEIALKHVKAFKTLKAEEVILLHVIDEREIKK--RDIFSLLLGVAGLNK-SVEEFENELKNKLTEEA 79 (160)
T ss_dssp CEEEEECCSCHH-HHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC--------------------CHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCHH-HHHHHHHHHHHHHhcCCEEEEEEecccccccc--cccccccccccccch-hHHHHHHHHHHHHHHHH
Confidence 589999997655 89999999999888999999997776543211 110000111111111 01111222233334444
Q ss_pred HHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEecccc---------chhhhhhhhccceeEEEEecC
Q 008201 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQL---------KHEEKCCMEELQCNIVVMKRS 170 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~l---------k~e~k~~~~~l~cniv~~~~~ 170 (574)
.+.+.++.+.++..+|.++..+..|.|...|...|++.+|.=||+=+|= -.-..+++.+.+|.|.++++.
T Consensus 80 ~~~l~~~~~~~~~~gv~~~~~~~~G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~~pVlvV~~~ 158 (160)
T d1mjha_ 80 KNKMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEEECCC
T ss_pred HHHHHHHHHHHHhcCCeEEEEEEeccHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCCCCEEEEcCC
Confidence 5567777777888899999999999988888877999999999996541 234567899999999999864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=4e-05 Score=72.33 Aligned_cols=142 Identities=18% Similarity=0.086 Sum_probs=87.0
Q ss_pred eeeccCc-EEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEEEEecCCCCh
Q 008201 413 FLAEGGF-GSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQH--RNVVMLIGFCIEDRRRLLVYEYICNGSL 489 (574)
Q Consensus 413 ~LG~G~f-G~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~H--pNIV~L~g~~~~~~~~~LVmEy~~ggsL 489 (574)
.+..|.. +.||+....++..+.+|...... ...+..|...|+.+.. -.+.+++.+..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455543 67899988778888889755332 3357788888877643 3467788888888899999999988665
Q ss_pred HHH--------------HhccC-----CCCC--CHHHHHHHH--------------------HHHHHHHHHHHhhCc---
Q 008201 490 DSH--------------LYGCH-----QEPL--EWSARQKIA--------------------VGAARGLRYLHEECR--- 525 (574)
Q Consensus 490 ~~~--------------L~~~~-----~~~L--s~~~~~~Ia--------------------~qIa~gL~yLHs~~~--- 525 (574)
... +...+ ..++ .+.....-. ......+..+....+
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 321 10000 0000 000000000 001122333333221
Q ss_pred CCCeEeeCCCCCCeEEcCCCcEEEeeecceee
Q 008201 526 VGCIVHRDMRPNNILLTHDFEPLVGDFGLARW 557 (574)
Q Consensus 526 ~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr~ 557 (574)
...++|+|+.|.|||++.+..+-|+||+.+.+
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11489999999999999877678999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=6.9e-05 Score=76.73 Aligned_cols=77 Identities=14% Similarity=0.056 Sum_probs=49.9
Q ss_pred EeeeeccCcEEEEEEEeCC-CCEEEEEEeecC----C---CcchhHHHHHHHHHHhcC-C--CCeeEEEEEEEeCCeEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPD-GQAVAVKQHKLA----S---SQGDHEFCSEVEVLSCAQ-H--RNVVMLIGFCIEDRRRLL 479 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~-g~~VAVK~l~~~----~---~~~~~~f~~Ei~iL~~L~-H--pNIV~L~g~~~~~~~~~L 479 (574)
.+.||.|....||+....+ ++.++||.-... . .....+...|.+.|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998544 778999964321 1 112345667888887663 2 346666655 4455689
Q ss_pred EEEecCCCCh
Q 008201 480 VYEYICNGSL 489 (574)
Q Consensus 480 VmEy~~ggsL 489 (574)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=97.50 E-value=0.00015 Score=62.17 Aligned_cols=131 Identities=15% Similarity=0.138 Sum_probs=86.6
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|||++|.+. -+..||.||....-+.|+.|++|=|++..+. ..+. ..+. ...+..+++.+..
T Consensus 3 k~ILv~vD~s~-~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~--~~~~----~~~~----------~~~~~~~~~~~~~ 65 (140)
T d1jmva_ 3 KHILVAVDLSE-ESPILLKKAVGIAKRHDAKLSIIHVDVNFSD--LYTG----LIDV----------NMSSMQDRISTET 65 (140)
T ss_dssp SEEEEEECCST-THHHHHHHHHHHHHHHTCEEEEEEEEECCGG--GCCC----CEEH----------HHHHHTTCCCCHH
T ss_pred CeEEEEECCCH-HHHHHHHHHHHHHHHcCCeEEEEEEeeeccc--cccc----cccc----------chHHHHHHHHHHH
Confidence 68999999986 4899999999988888999999988775431 1110 0000 1112222222222
Q ss_pred HHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccch------hhhhhhhccceeEEEEecC
Q 008201 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH------EEKCCMEELQCNIVVMKRS 170 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~------e~k~~~~~l~cniv~~~~~ 170 (574)
.+.+.++..-++.. ..+.-+..|.+...|..+|++.+|..||+=+|=+. -..+++.+.+|.|.+++..
T Consensus 66 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lgs~~~~li~~~~~pVliVp~~ 139 (140)
T d1jmva_ 66 QKALLDLAESVDYP--ISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLMSSTRQVMNTIKIDMLVVPLR 139 (140)
T ss_dssp HHHHHHHHHHSSSC--CCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHHHHHHHHHTTCCSEEEEEECC
T ss_pred HHHHHHHHHhcCCc--eEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcccHHHHHHhccCCCEEEEecC
Confidence 33344444333322 23456778998888888899999999999866222 2357899999999999853
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=97.43 E-value=0.00012 Score=62.57 Aligned_cols=125 Identities=14% Similarity=0.183 Sum_probs=86.3
Q ss_pred eEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhHHHH
Q 008201 21 EKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDITDSC 100 (574)
Q Consensus 21 ~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (574)
++|+|++|.|. .+..|+.||+...-+.|..|+||-|++..... . +. ....+...+..+..
T Consensus 2 k~Ilv~~D~s~-~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~---------~-----~~-----~~~~~~~~~~~~~~ 61 (135)
T d2z3va1 2 KTILLAYDGSE-HARRAAEVAKAEAEAHGARLIVVHAYEPVPDY---------L-----GE-----PFFEEALRRRLERA 61 (135)
T ss_dssp CEEEEECCSSH-HHHHHHHHHHHHHHHHTCEEEEEEEECCCCTT---------C-----CT-----THHHHHHHHHHHHH
T ss_pred CEEEEEECCCH-HHHHHHHHHHHHHHHcCCEEEEEEEecCCccc---------c-----cc-----chhHHHHHHHHHHH
Confidence 57999999766 58899999999988899999999888753211 0 00 11223333333444
Q ss_pred HHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccch---------hhhhhhhccceeEEEE
Q 008201 101 SQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKH---------EEKCCMEELQCNIVVM 167 (574)
Q Consensus 101 ~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~---------e~k~~~~~l~cniv~~ 167 (574)
.+.+.++.+.++-.. .+..+..|.|..++...|++.++.=||+=.|-+. -..+++.+.+|.|.++
T Consensus 62 ~~~l~~~~~~~~~~~--~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~~pVlvV 135 (135)
T d2z3va1 62 EGVLEEARALTGVPK--EDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLV 135 (135)
T ss_dssp HHHHHHHHHHHCCCG--GGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHhcCCCe--EEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCCCCEEeC
Confidence 445555555443333 3455678998878877799999999999877443 2347889999999875
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=97.30 E-value=0.00027 Score=60.13 Aligned_cols=136 Identities=11% Similarity=0.030 Sum_probs=94.0
Q ss_pred CcceEEEEEEeCCCCCCHHHHHHHhhcccCCCCeEEEEEEecCCCCCcccccccccccccccCCcccccccchhhhhhhH
Q 008201 18 DVAEKVVVAVKASKEIPRTALVWALTHVVQPGDCITLLVVVPSHSSGRRFWVFPRFAGDCASGHRKSFSGTISEQRGDIT 97 (574)
Q Consensus 18 ~~~~~Vvv~~dasr~i~~~a~~wal~~vv~~gd~i~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (574)
+...+|+|++|.|. .+..||.||...--+-|..|+||-|+........ .... .+ .....+..+++.
T Consensus 2 ~~mk~ILv~~D~S~-~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~------~~~~--~~-----~~~~~~~~e~~~ 67 (138)
T d1q77a_ 2 NAMKVLLVLTDAYS-DCEKAITYAVNFSEKLGAELDILAVLEDVYNLER------ANVT--FG-----LPFPPEIKEESK 67 (138)
T ss_dssp CCCEEEEEEESTTC-CCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHH------HHHH--HC-----CCCCTHHHHHHH
T ss_pred CCCCEEEEEEeCCH-HHHHHHHHHHHhhhhccceEEEEEEccCcccccc------cccc--cc-----cchhhhhhhhhh
Confidence 44578999999985 5799999999998889999999999864221000 0000 00 012233444444
Q ss_pred HHHHHHHHHHHhhcCCCCceEEEEEEecCCCchhhHHhhhcCccEEEeccccchhhhhhhhccceeEEEE
Q 008201 98 DSCSQMILQLHDVYDPNKINFKIKIVSGSPCGAVAAEAKKAQAGWVVLDKQLKHEEKCCMEELQCNIVVM 167 (574)
Q Consensus 98 ~~~~~~~~~l~~~~~~~~i~~~ikv~~g~~~~~va~eak~~~a~wvvlDr~lk~e~k~~~~~l~cniv~~ 167 (574)
+.=.+.+.++.+-++..+++++..|..|.|...|...|++.++-=||+=.|=+.--.+.+...+|-..++
T Consensus 68 ~~~~~~l~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~~~~~liv 137 (138)
T d1q77a_ 68 KRIERRLREVWEKLTGSTEIPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIV 137 (138)
T ss_dssp HHHHHHHHHHHHHHHSCCCCCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEEC
T ss_pred hhccccchhhcccccccceeEEEeeecchhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCCCCCEEEe
Confidence 4445556666666677889999999999999998877999999999998886665555555555544443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.83 E-value=0.0019 Score=63.64 Aligned_cols=136 Identities=13% Similarity=0.073 Sum_probs=78.7
Q ss_pred EEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCee--EEE-----EEEEeCCeEEEEEEecCCCChH--
Q 008201 420 GSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNVV--MLI-----GFCIEDRRRLLVYEYICNGSLD-- 490 (574)
Q Consensus 420 G~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNIV--~L~-----g~~~~~~~~~LVmEy~~ggsL~-- 490 (574)
..||++...+|..+++|+.+... ....++..|...|..|...+|. ..+ ..+...+..+.+++++.|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 58999999899999999987542 3456788898888776422221 111 1223466788999998764331
Q ss_pred ---HH------H---hc----c---CCCCCCHHH-------------------HHHHHHHHHHHHHHHHhhC---cCCCe
Q 008201 491 ---SH------L---YG----C---HQEPLEWSA-------------------RQKIAVGAARGLRYLHEEC---RVGCI 529 (574)
Q Consensus 491 ---~~------L---~~----~---~~~~Ls~~~-------------------~~~Ia~qIa~gL~yLHs~~---~~~gI 529 (574)
.+ + +. . ....+++.. ...+...+...+..+.... .+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 1 00 0 011122111 1111112222333333321 12379
Q ss_pred EeeCCCCCCeEEcCCCcEEEeeecceeec
Q 008201 530 VHRDMRPNNILLTHDFEPLVGDFGLARWQ 558 (574)
Q Consensus 530 IHRDLKP~NILLd~~~~vKLsDFGLAr~~ 558 (574)
||+|+.+.|||++++ ..++||+-+..-
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred ecCCCCcccEEEeCC--ceEEechhcccC
Confidence 999999999999743 458999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.07 E-value=0.0095 Score=59.98 Aligned_cols=73 Identities=14% Similarity=0.087 Sum_probs=49.5
Q ss_pred EeeeeccCcEEEEEEEeCC--------CCEEEEEEeecCCCcchhHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 008201 411 ANFLAEGGFGSVHRGVLPD--------GQAVAVKQHKLASSQGDHEFCSEVEVLSCAQ-HRNVVMLIGFCIEDRRRLLVY 481 (574)
Q Consensus 411 ~~~LG~G~fG~Vy~a~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~-HpNIV~L~g~~~~~~~~~LVm 481 (574)
++.|+.|---.+|++...+ .+.|.+++.- . ........+|..+++.+. +.-..++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4578888889999998543 3567777654 2 223345678998888775 4334577887642 6889
Q ss_pred EecCCCCh
Q 008201 482 EYICNGSL 489 (574)
Q Consensus 482 Ey~~ggsL 489 (574)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.98 E-value=0.0095 Score=57.56 Aligned_cols=156 Identities=11% Similarity=-0.022 Sum_probs=78.0
Q ss_pred hhHHHhhcCCeeEE-----eeeeccCcEEEEEEEeCCCCEEEEEEeecCCCcchhHHHHHHHHHHhcCCCCe-----eEE
Q 008201 398 YAELELATGGFSQA-----NFLAEGGFGSVHRGVLPDGQAVAVKQHKLASSQGDHEFCSEVEVLSCAQHRNV-----VML 467 (574)
Q Consensus 398 ~~~le~~~~~y~~~-----~~LG~G~fG~Vy~a~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~iL~~L~HpNI-----V~L 467 (574)
..+++....+|.+. +.|..|--.+.|+....+|+ +++|++.... ...++..|+++|..|...++ +..
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~ 81 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 81 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccccee
Confidence 34455555556543 33556666788998876665 8899876432 23456667777776642222 111
Q ss_pred E---EEEEeCCeEEEEEEecCCCChHH-----------H---Hhc---c----CCCCCCHHH------------------
Q 008201 468 I---GFCIEDRRRLLVYEYICNGSLDS-----------H---LYG---C----HQEPLEWSA------------------ 505 (574)
Q Consensus 468 ~---g~~~~~~~~~LVmEy~~ggsL~~-----------~---L~~---~----~~~~Ls~~~------------------ 505 (574)
. .+.........++.++.+..... . ++. . .........
T Consensus 82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (316)
T d2ppqa1 82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 161 (316)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence 0 01122345566677665543311 0 000 0 000011110
Q ss_pred HHHHHHHHHHHHHHHHhhCcCCCeEeeCCCCCCeEEcCCCcEEEeeeccee
Q 008201 506 RQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLAR 556 (574)
Q Consensus 506 ~~~Ia~qIa~gL~yLHs~~~~~gIIHRDLKP~NILLd~~~~vKLsDFGLAr 556 (574)
....+..+...+.-.+...-+.|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111122222222211112379999999999999988777899999886
|